Citrus Sinensis ID: 022447
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 297 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.808 | 0.526 | 0.791 | 1e-114 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.993 | 0.697 | 0.604 | 1e-109 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.814 | 0.584 | 0.735 | 1e-106 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.784 | 0.546 | 0.6 | 9e-79 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.784 | 0.546 | 0.587 | 3e-77 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.791 | 0.570 | 0.567 | 3e-76 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.791 | 0.604 | 0.555 | 1e-75 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.777 | 0.468 | 0.580 | 1e-75 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.791 | 0.573 | 0.589 | 9e-75 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.777 | 0.471 | 0.580 | 2e-74 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 412 bits (1058), Expect = e-114, Method: Compositional matrix adjust.
Identities = 190/240 (79%), Positives = 210/240 (87%)
Query: 56 QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 115
QI A T FRELAAAT NF ++ LGEGGFGRVYKG L+S Q VA+KQLDRNG+QGNRE
Sbjct: 68 QIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNRE 127
Query: 116 FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 175
FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE+MPLGS+EDHLHDL P K+ LDWN R
Sbjct: 128 FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMR 187
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235
MKIAAGAA+GLE+LHDKA PPVIYRD K SNILLD G+HPKLSDFGLAKLGP GD +HVS
Sbjct: 188 MKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVS 247
Query: 236 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEP 295
TRVMGTYGYCAPEYA TGQLT+KSDVYSFGVV LE+++GRKA+D+ EQ+LVAW+ P
Sbjct: 248 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARP 307
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 395 bits (1014), Expect = e-109, Method: Compositional matrix adjust.
Identities = 196/324 (60%), Positives = 231/324 (71%), Gaps = 29/324 (8%)
Query: 1 MGWFPCSGDSFRKAKNKKKMKMQQKTL-------------DRINSIPDKLKMNSSLRVKE 47
MG F CS S ++++ K + +K + D+ D K++ V
Sbjct: 1 MGCFGCSKKSSKRSETNKDTVINRKIVGGTTSVAKSDKRDDQTQPSSDSTKVSPYRDVNN 60
Query: 48 ASEDGASDQIT----------------AQTLTFRELAAATKNFRSESLLGEGGFGRVYKG 91
G DQ++ AQT TF+ELA AT NFRS+ LGEGGFG+V+KG
Sbjct: 61 EGGVGKEDQLSLDVKGLNLNDQVTGKKAQTFTFQELAEATGNFRSDCFLGEGGFGKVFKG 120
Query: 92 YLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151
+E ++Q VAIKQLDRNGVQG REF+VEVL LSL HPNLV LIG+CA+GDQRLLVYEYM
Sbjct: 121 TIEKLDQVVAIKQLDRNGVQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVYEYM 180
Query: 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 211
P GS+EDHLH L GKKPLDWNTRMKIAAGAARGLEYLHD+ PPVIYRDLKCSNILL
Sbjct: 181 PQGSLEDHLHVLPSGKKPLDWNTRMKIAAGAARGLEYLHDRMTPPVIYRDLKCSNILLGE 240
Query: 212 GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 271
Y PKLSDFGLAK+GP GD THVSTRVMGTYGYCAP+YA TGQLT KSD+YSFGVVLLE+
Sbjct: 241 DYQPKLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLEL 300
Query: 272 LSGRKAVDTSKAAAEQSLVAWSEP 295
++GRKA+D +K +Q+LV W+ P
Sbjct: 301 ITGRKAIDNTKTRKDQNLVGWARP 324
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 384 bits (986), Expect = e-106, Method: Compositional matrix adjust.
Identities = 178/242 (73%), Positives = 208/242 (85%)
Query: 54 SDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN 113
++ I AQT +FRELA ATKNFR E L+GEGGFGRVYKG LE VA+KQLDRNG+QGN
Sbjct: 59 TNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGN 118
Query: 114 REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 173
+EF+VEVLMLSLLHH +LVNLIGYCADGDQRLLVYEYM GS+EDHL DL+P + PLDW+
Sbjct: 119 KEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWD 178
Query: 174 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233
TR++IA GAA GLEYLHDKA PPVIYRDLK +NILLD ++ KLSDFGLAKLGPVGD H
Sbjct: 179 TRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQH 238
Query: 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWS 293
VS+RVMGTYGYCAPEY +TGQLT KSDVYSFGVVLLE+++GR+ +DT++ EQ+LV W+
Sbjct: 239 VSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWA 298
Query: 294 EP 295
+P
Sbjct: 299 QP 300
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 293 bits (751), Expect = 9e-79, Method: Compositional matrix adjust.
Identities = 147/245 (60%), Positives = 178/245 (72%), Gaps = 12/245 (4%)
Query: 60 QTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD---------VAIKQLDRNGV 110
+ TF EL AT+NFR +SLLGEGGFG V+KG+++ VA+K+L G
Sbjct: 69 KAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEGY 128
Query: 111 QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 170
QG++E+L EV L L HPNLV L+GYC +G+ RLLVYE+MP GS+E+HL G +PL
Sbjct: 129 QGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHL--FRRGAQPL 186
Query: 171 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230
W RMK+A GAA+GL +LHD AK VIYRD K +NILLD ++ KLSDFGLAK GP GD
Sbjct: 187 TWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGD 245
Query: 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290
THVST+VMGT+GY APEY TG+LT KSDVYSFGVVLLE+LSGR+AVD SK EQSLV
Sbjct: 246 KTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLV 305
Query: 291 AWSEP 295
W+ P
Sbjct: 306 DWATP 310
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 288 bits (737), Expect = 3e-77, Method: Compositional matrix adjust.
Identities = 144/245 (58%), Positives = 179/245 (73%), Gaps = 12/245 (4%)
Query: 60 QTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD---------VAIKQLDRNGV 110
+ TF EL ATKNFR ++LLGEGGFG V+KG+++ + VA+KQL G
Sbjct: 72 KAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGF 131
Query: 111 QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 170
QG++E+L EV L L HPNLV L+GYCA+G+ RLLVYE+MP GS+E+HL G +PL
Sbjct: 132 QGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHL--FRRGAQPL 189
Query: 171 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230
W RMK+A GAA+GL +LH+ AK VIYRD K +NILLD ++ KLSDFGLAK GP GD
Sbjct: 190 TWAIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGD 248
Query: 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290
NTHVST+V+GT+GY APEY TG+LT KSDVYSFGVVLLE++SGR+A+D S E SLV
Sbjct: 249 NTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLV 308
Query: 291 AWSEP 295
W+ P
Sbjct: 309 DWATP 313
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 285 bits (728), Expect = 3e-76, Method: Compositional matrix adjust.
Identities = 139/245 (56%), Positives = 178/245 (72%), Gaps = 10/245 (4%)
Query: 60 QTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD---------VAIKQLDRNGV 110
++ TF EL AAT+NFR +S+LGEGGFG V+KG+++ +A+K+L+++G
Sbjct: 55 KSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGW 114
Query: 111 QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 170
QG++E+L EV L HPNLV LIGYC + + RLLVYE+MP GS+E+HL +PL
Sbjct: 115 QGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPL 174
Query: 171 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230
W R+K+A GAA+GL +LH+ A+ VIYRD K SNILLD Y+ KLSDFGLAK GP GD
Sbjct: 175 SWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGD 233
Query: 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290
+HVSTR+MGTYGY APEY TG LT KSDVYS+GVVLLE+LSGR+AVD ++ EQ LV
Sbjct: 234 KSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLV 293
Query: 291 AWSEP 295
W+ P
Sbjct: 294 EWARP 298
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 283 bits (724), Expect = 1e-75, Method: Compositional matrix adjust.
Identities = 136/245 (55%), Positives = 181/245 (73%), Gaps = 10/245 (4%)
Query: 60 QTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD---------VAIKQLDRNGV 110
+ + EL +AT+NFR +S++GEGGFG V+KG+++ + +A+K+L++ G
Sbjct: 54 KNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGF 113
Query: 111 QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 170
QG+RE+L E+ L L HPNLV LIGYC + + RLLVYE+M GS+E+HL +PL
Sbjct: 114 QGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPL 173
Query: 171 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230
WNTR+++A GAARGL +LH+ A+P VIYRD K SNILLD Y+ KLSDFGLA+ GP+GD
Sbjct: 174 SWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGD 232
Query: 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290
N+HVSTRVMGT GY APEY TG L++KSDVYSFGVVLLE+LSGR+A+D ++ E +LV
Sbjct: 233 NSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLV 292
Query: 291 AWSEP 295
W+ P
Sbjct: 293 DWARP 297
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 283 bits (723), Expect = 1e-75, Method: Compositional matrix adjust.
Identities = 141/243 (58%), Positives = 175/243 (72%), Gaps = 12/243 (4%)
Query: 62 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLES---------INQDVAIKQLDRNGVQG 112
TF +L +T+NFR ESLLGEGGFG V+KG++E VA+K L+ +G+QG
Sbjct: 130 FTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQG 189
Query: 113 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 172
++E+L E+ L L HPNLV L+GYC + DQRLLVYE+MP GS+E+HL S PL W
Sbjct: 190 HKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPW 246
Query: 173 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232
+ RMKIA GAA+GL +LH++A PVIYRD K SNILLD Y+ KLSDFGLAK P T
Sbjct: 247 SIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKT 306
Query: 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 292
HVSTRVMGTYGY APEY TG LT KSDVYSFGVVLLE+L+GR+++D ++ E +LV W
Sbjct: 307 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 366
Query: 293 SEP 295
+ P
Sbjct: 367 ARP 369
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 280 bits (716), Expect = 9e-75, Method: Compositional matrix adjust.
Identities = 145/246 (58%), Positives = 177/246 (71%), Gaps = 11/246 (4%)
Query: 59 AQTLTFR--ELAAATKNFRSESLLGEGGFGRVYKGYLES------INQDVAIKQLDRNGV 110
AQ + F EL TK+FR + +LGEGGFG VYKGY++ + VA+K L++ G+
Sbjct: 52 AQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGL 111
Query: 111 QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 170
QG+RE+L EV L L HPNLV LIGYC + D RLLVYE+M GS+E+HL PL
Sbjct: 112 QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHL--FRKTTAPL 169
Query: 171 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230
W+ RM IA GAA+GL +LH+ A+ PVIYRD K SNILLD Y KLSDFGLAK GP GD
Sbjct: 170 SWSRRMMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD 228
Query: 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290
THVSTRVMGTYGY APEY TG LT +SDVYSFGVVLLE+L+GRK+VD ++ + EQ+LV
Sbjct: 229 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLV 288
Query: 291 AWSEPE 296
W+ P+
Sbjct: 289 DWARPK 294
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 279 bits (713), Expect = 2e-74, Method: Compositional matrix adjust.
Identities = 141/243 (58%), Positives = 175/243 (72%), Gaps = 12/243 (4%)
Query: 62 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLES---------INQDVAIKQLDRNGVQG 112
+F +L AT+NFR ESLLGEGGFG V+KG++E VA+K L+ +G+QG
Sbjct: 124 FSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGLQG 183
Query: 113 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 172
++E+L E+ L L HPNLV L+GYC + DQRLLVYE+MP GS+E+HL S PL W
Sbjct: 184 HKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPW 240
Query: 173 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232
+ RMKIA GAA+GL +LH++A PVIYRD K SNILLD Y+ KLSDFGLAK P T
Sbjct: 241 SIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKT 300
Query: 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 292
HVSTRVMGTYGY APEY TG LT KSDVYSFGVVLLE+L+GR+++D ++ E +LV W
Sbjct: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
Query: 293 SEP 295
+ P
Sbjct: 361 ARP 363
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 297 | ||||||
| 357510543 | 377 | Serine/threonine protein kinase PBS1 [Me | 0.989 | 0.779 | 0.793 | 1e-137 | |
| 356505176 | 379 | PREDICTED: serine/threonine-protein kina | 0.986 | 0.773 | 0.787 | 1e-135 | |
| 351721314 | 383 | protein kinase-like protein [Glycine max | 0.993 | 0.770 | 0.785 | 1e-135 | |
| 356572387 | 380 | PREDICTED: serine/threonine-protein kina | 0.986 | 0.771 | 0.787 | 1e-135 | |
| 255568155 | 375 | receptor serine-threonine protein kinase | 0.979 | 0.776 | 0.793 | 1e-134 | |
| 356548196 | 383 | PREDICTED: serine/threonine-protein kina | 0.993 | 0.770 | 0.781 | 1e-134 | |
| 225439781 | 396 | PREDICTED: serine/threonine-protein kina | 0.983 | 0.737 | 0.786 | 1e-133 | |
| 224069304 | 393 | predicted protein [Populus trichocarpa] | 0.993 | 0.750 | 0.775 | 1e-132 | |
| 255568454 | 389 | receptor serine-threonine protein kinase | 0.993 | 0.758 | 0.765 | 1e-131 | |
| 37625033 | 376 | protein kinase-like protein [Vitis aesti | 0.979 | 0.773 | 0.787 | 1e-129 |
| >gi|357510543|ref|XP_003625560.1| Serine/threonine protein kinase PBS1 [Medicago truncatula] gi|355500575|gb|AES81778.1| Serine/threonine protein kinase PBS1 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 493 bits (1270), Expect = e-137, Method: Compositional matrix adjust.
Identities = 234/295 (79%), Positives = 260/295 (88%), Gaps = 1/295 (0%)
Query: 1 MGWFPCSGDSFRKAKNKKKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQ 60
MGW PCSG+S K K KM++Q +I + P KLK NSS K+ S++G+++ I AQ
Sbjct: 1 MGWIPCSGNSGTK-KKIVKMEVQDSVAPQIKATPGKLKRNSSTNSKDTSKNGSTEHIAAQ 59
Query: 61 TLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV 120
T +FRELA AT+NFR+E LLGEGGFGRVYKG+LESINQ VAIKQLDRNG+QGNREFLVEV
Sbjct: 60 TFSFRELATATRNFRAECLLGEGGFGRVYKGHLESINQVVAIKQLDRNGLQGNREFLVEV 119
Query: 121 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA 180
LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG +EDHLHD+SP KK LDWNTRMKIAA
Sbjct: 120 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGCLEDHLHDISPAKKRLDWNTRMKIAA 179
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG 240
GAA+GLEYLHDKA PPVIYRDLKCSNILL GYHPKLSDFGLAKLGPVG+NTHVSTRVMG
Sbjct: 180 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGENTHVSTRVMG 239
Query: 241 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEP 295
TYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D SK+AAEQ+LVAW+ P
Sbjct: 240 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDYSKSAAEQNLVAWARP 294
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505176|ref|XP_003521368.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 488 bits (1255), Expect = e-135, Method: Compositional matrix adjust.
Identities = 233/296 (78%), Positives = 258/296 (87%), Gaps = 3/296 (1%)
Query: 1 MGWFPCSGDSFRKAKNK-KKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITA 59
MGW PCSG + KNK +KM++Q + +I + P KLK NSS + K+ S++G D I A
Sbjct: 1 MGWIPCSG--YSGTKNKVEKMEVQDSLVGQIKATPGKLKRNSSTKSKDTSKNGNPDHIAA 58
Query: 60 QTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVE 119
QT FRELA AT+NFR++ LLGEGGFGRVYKG LESINQ VAIKQLDRNG+QGNREFLVE
Sbjct: 59 QTFAFRELATATRNFRNDCLLGEGGFGRVYKGRLESINQVVAIKQLDRNGLQGNREFLVE 118
Query: 120 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 179
VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG +EDHLHD+ PGKK LDWNTRMKIA
Sbjct: 119 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGCLEDHLHDIPPGKKRLDWNTRMKIA 178
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 239
AGAA+GLEYLHDKA PPVIYRDLKCSNILL GYHPKLSDFGLAKLGPVG+NTHVSTRVM
Sbjct: 179 AGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGENTHVSTRVM 238
Query: 240 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEP 295
GTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D SK+A EQ+LVAW+ P
Sbjct: 239 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKSAGEQNLVAWARP 294
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351721314|ref|NP_001237717.1| protein kinase-like protein [Glycine max] gi|223452496|gb|ACM89575.1| protein kinase-like protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 487 bits (1254), Expect = e-135, Method: Compositional matrix adjust.
Identities = 234/298 (78%), Positives = 259/298 (86%), Gaps = 3/298 (1%)
Query: 1 MGWFPCSGDS---FRKAKNKKKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQI 57
MGW PCSG S + K +KM+ Q +D I + P KLK NSS+ KE+S++G + I
Sbjct: 1 MGWIPCSGSSNSKKKLKKKLEKMEAQNSLVDPIKATPGKLKRNSSMNSKESSKNGNPEHI 60
Query: 58 TAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFL 117
AQT +FRELA AT+NF++E LLGEGGFGRVYKG LE+INQ VAIKQLDRNG+QGNREFL
Sbjct: 61 AAQTFSFRELATATRNFKAECLLGEGGFGRVYKGRLENINQIVAIKQLDRNGLQGNREFL 120
Query: 118 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 177
VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE+M LGS+EDHLHD+SPGKK LDWNTRMK
Sbjct: 121 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSLGSLEDHLHDISPGKKELDWNTRMK 180
Query: 178 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 237
IAAGAARGLEYLHDKA PPVIYRDLKCSNILL GYHPKLSDFGLAKLGPVG+NTHVSTR
Sbjct: 181 IAAGAARGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGENTHVSTR 240
Query: 238 VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEP 295
VMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D SKAA EQ+LVAW+ P
Sbjct: 241 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKAAGEQNLVAWARP 298
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356572387|ref|XP_003554350.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 486 bits (1252), Expect = e-135, Method: Compositional matrix adjust.
Identities = 233/296 (78%), Positives = 257/296 (86%), Gaps = 3/296 (1%)
Query: 1 MGWFPCSGDSFRKAKNK-KKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITA 59
MGW PCSG + KNK +KM+ Q + +I + KLK NSS + K+ S++G D I A
Sbjct: 1 MGWIPCSG--YSGTKNKVEKMEAQDSLVGQIKATTGKLKRNSSTKSKDTSKNGNPDHIAA 58
Query: 60 QTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVE 119
QT +FRELA AT+NFR+E LLGEGGFGRVYKG LESINQ VAIKQLDRNG+QGNREFLVE
Sbjct: 59 QTFSFRELATATRNFRAECLLGEGGFGRVYKGRLESINQVVAIKQLDRNGLQGNREFLVE 118
Query: 120 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 179
VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG +EDHLHD+ PGKK LDWNTRMKIA
Sbjct: 119 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGCLEDHLHDIPPGKKQLDWNTRMKIA 178
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 239
AGAA+GLEYLHDKA PPVIYRDLKCSNILL GYHPKLSDFGLAKLGPVG+NTHVSTRVM
Sbjct: 179 AGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGENTHVSTRVM 238
Query: 240 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEP 295
GTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D SK+A EQ+LVAW+ P
Sbjct: 239 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKSAGEQNLVAWARP 294
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568155|ref|XP_002525053.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223535634|gb|EEF37300.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 485 bits (1248), Expect = e-134, Method: Compositional matrix adjust.
Identities = 234/295 (79%), Positives = 256/295 (86%), Gaps = 4/295 (1%)
Query: 1 MGWFPCSGDSFRKAKNKKKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQ 60
MGWFPC+G K+ N K K++++ D+I S DK K + +L VKE S+DG SD I A
Sbjct: 1 MGWFPCAG----KSSNDAKKKLKKRPDDQIPSSSDKTKPSLALDVKETSKDGGSDHIAAH 56
Query: 61 TLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV 120
T TFRELAAATKNFR++ LLGEGGFGRVYKG LES +Q VAIKQLDRNG+QGNREFLVEV
Sbjct: 57 TFTFRELAAATKNFRADCLLGEGGFGRVYKGRLESTSQVVAIKQLDRNGLQGNREFLVEV 116
Query: 121 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA 180
LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+EDHLHDL P KK LDWNTRMKIAA
Sbjct: 117 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWNTRMKIAA 176
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG 240
GAA+GLEYLHDKA PPVIYRDLKCSNILL GYHPKLSDFGLAKLGPVGD THVSTRVMG
Sbjct: 177 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG 236
Query: 241 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEP 295
TYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D S+AA E +LVAW+ P
Sbjct: 237 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSRAAGEHNLVAWARP 291
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356548196|ref|XP_003542489.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 483 bits (1242), Expect = e-134, Method: Compositional matrix adjust.
Identities = 233/298 (78%), Positives = 257/298 (86%), Gaps = 3/298 (1%)
Query: 1 MGWFPCSGDS---FRKAKNKKKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQI 57
MGW PCSG S + K +KM+ Q +D I + P KLK N S+ K +S++G + I
Sbjct: 1 MGWIPCSGSSNTKKKLKKKLEKMEGQSSLVDPIKATPGKLKRNPSMNSKNSSKNGNPEHI 60
Query: 58 TAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFL 117
AQT +FRELA AT+NFR+E LLGEGGFGRVYKG LE+INQ VAIKQLDRNG+QGNREFL
Sbjct: 61 AAQTFSFRELATATRNFRAECLLGEGGFGRVYKGRLENINQIVAIKQLDRNGLQGNREFL 120
Query: 118 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 177
VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE+M LGS+EDHLHD+SPGKK LDWNTRMK
Sbjct: 121 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSLGSLEDHLHDISPGKKRLDWNTRMK 180
Query: 178 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 237
IAAGAARGLEYLHDKA PPVIYRDLKCSNILL GYHPKLSDFGLAKLGPVG+NTHVSTR
Sbjct: 181 IAAGAARGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGENTHVSTR 240
Query: 238 VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEP 295
VMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D SKAA EQ+LVAW+ P
Sbjct: 241 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKAAGEQNLVAWARP 298
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439781|ref|XP_002276042.1| PREDICTED: serine/threonine-protein kinase PBS1 [Vitis vinifera] gi|297741502|emb|CBI32634.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 482 bits (1240), Expect = e-133, Method: Compositional matrix adjust.
Identities = 232/295 (78%), Positives = 253/295 (85%), Gaps = 3/295 (1%)
Query: 1 MGWFPCSGDSFRKAKNKKKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQ 60
MGWF CSG S + K K+K + Q ++ + +KLK N S VKEAS++G D I AQ
Sbjct: 1 MGWFLCSGKSNQATKKKRKKPVDQI---QVQTTSEKLKANPSFNVKEASKNGGPDHIAAQ 57
Query: 61 TLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV 120
T TFRELAAATKNFR E LLGEGGFGRVYKG + + NQ VAIKQLDRNG+QGNREFLVEV
Sbjct: 58 TFTFRELAAATKNFRGECLLGEGGFGRVYKGRIANTNQAVAIKQLDRNGLQGNREFLVEV 117
Query: 121 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA 180
LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+EDHLHD+S GKK LDWNTRMKIAA
Sbjct: 118 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDVSLGKKRLDWNTRMKIAA 177
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG 240
GAA+GLEYLHDKA PPVIYRDLKCSNILL +HPKLSDFGLAKLGPVGDNTHVSTRVMG
Sbjct: 178 GAAKGLEYLHDKASPPVIYRDLKCSNILLGEDFHPKLSDFGLAKLGPVGDNTHVSTRVMG 237
Query: 241 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEP 295
TYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D SKAA E +LVAW+ P
Sbjct: 238 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKAAGEHNLVAWARP 292
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224069304|ref|XP_002326325.1| predicted protein [Populus trichocarpa] gi|222833518|gb|EEE71995.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 478 bits (1231), Expect = e-132, Method: Compositional matrix adjust.
Identities = 235/303 (77%), Positives = 259/303 (85%), Gaps = 8/303 (2%)
Query: 1 MGWFPCSGDSFRKAKNKK--------KMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDG 52
M W PCSG S R KNKK ++ + QK LD+ + P++L+ + LRVK S++G
Sbjct: 1 MEWIPCSGISKRATKNKKNNDNNNKNRVIVNQKPLDQTKTSPERLRNDYPLRVKGESKNG 60
Query: 53 ASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG 112
SD TAQT TFRELA ATKNFR+E LLGEGGFGRVYKGYLES NQ VAIKQL+RNG+QG
Sbjct: 61 GSDSTTAQTFTFRELAFATKNFRAECLLGEGGFGRVYKGYLESTNQVVAIKQLNRNGLQG 120
Query: 113 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 172
NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+EDHLH++ PGK LDW
Sbjct: 121 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHEVPPGKNWLDW 180
Query: 173 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232
NTRMKIAAGAA+GLE+LHDKA PPVIYRDLKCSNILLD YHPKLSDFGLAKLGPVGDNT
Sbjct: 181 NTRMKIAAGAAKGLEHLHDKASPPVIYRDLKCSNILLDESYHPKLSDFGLAKLGPVGDNT 240
Query: 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 292
HVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D SKA EQ+LVAW
Sbjct: 241 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKATGEQNLVAW 300
Query: 293 SEP 295
+ P
Sbjct: 301 ARP 303
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568454|ref|XP_002525201.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223535498|gb|EEF37167.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 475 bits (1222), Expect = e-131, Method: Compositional matrix adjust.
Identities = 228/298 (76%), Positives = 253/298 (84%), Gaps = 3/298 (1%)
Query: 1 MGWFPCSGDSFRKA--KNKKK-MKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQI 57
MGW PCSG S + KNKKK + + ++D+ +KL+ +S VK A + G SD I
Sbjct: 1 MGWIPCSGISRANSTTKNKKKVIIINHNSVDQTKPTSEKLRSHSRTSVKAAPKHGGSDNI 60
Query: 58 TAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFL 117
TAQT TF EL A KNFR+E LGEGGFGRVYKGYLES NQ VAIKQL+RNG+QGNREFL
Sbjct: 61 TAQTFTFSELVTAAKNFRAECFLGEGGFGRVYKGYLESTNQVVAIKQLNRNGLQGNREFL 120
Query: 118 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 177
VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+EDHL+++SPG K LDWNTRMK
Sbjct: 121 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLYEISPGVKTLDWNTRMK 180
Query: 178 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 237
IAAGAA+GLEYLHDKA PPVIYRDLKCSNILL +GYHPKLSDFGLAKLGPVGDNTHVSTR
Sbjct: 181 IAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGQGYHPKLSDFGLAKLGPVGDNTHVSTR 240
Query: 238 VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEP 295
VMGTYGYCAPEYA TGQLTLKSDVYS GVVLLEI++GR+A+D SKA EQ+LVAW+ P
Sbjct: 241 VMGTYGYCAPEYAMTGQLTLKSDVYSLGVVLLEIITGRRAIDNSKATGEQNLVAWARP 298
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|37625033|gb|AAQ96340.1| protein kinase-like protein [Vitis aestivalis] | Back alignment and taxonomy information |
|---|
Score = 468 bits (1203), Expect = e-129, Method: Compositional matrix adjust.
Identities = 233/296 (78%), Positives = 256/296 (86%), Gaps = 5/296 (1%)
Query: 1 MGWFPCSGDSFRKAKNKKKMKMQQKTLDRINSIPDKLKMNSSLR-VKEASEDGASDQITA 59
MG FPC+G S +K K + ++ + D+I S ++LK+NSS+ K+AS+DG SD I A
Sbjct: 1 MGCFPCAGKSNKKGKKNQ----EKNSKDQIPSTSERLKVNSSVDGRKDASKDGGSDHIAA 56
Query: 60 QTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVE 119
T TFRELAAATKNFR+E LLGEGGFGRVYKG LES N+ VAIKQLDRNG+QGNREFLVE
Sbjct: 57 HTFTFRELAAATKNFRAECLLGEGGFGRVYKGRLESTNKIVAIKQLDRNGLQGNREFLVE 116
Query: 120 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 179
VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM LGS+EDHLHDL P KK LDWNTRMKIA
Sbjct: 117 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMALGSLEDHLHDLPPDKKRLDWNTRMKIA 176
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 239
AGAA+GLEYLHDKA PPVIYRDLKCSNILL GYHPKLSDFGLAKLGPVGD THVSTRVM
Sbjct: 177 AGAAKGLEYLHDKASPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM 236
Query: 240 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEP 295
GTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D SKAA E +LVAW+ P
Sbjct: 237 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKAAGEHNLVAWARP 292
|
Source: Vitis aestivalis Species: Vitis aestivalis Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 297 | ||||||
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.983 | 0.772 | 0.737 | 7.3e-114 | |
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.989 | 0.573 | 0.708 | 4.3e-109 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.898 | 0.585 | 0.729 | 2.9e-103 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.878 | 0.719 | 0.725 | 6.4e-99 | |
| TAIR|locus:2056613 | 424 | AT2G28590 [Arabidopsis thalian | 0.838 | 0.587 | 0.718 | 1.1e-96 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.841 | 0.603 | 0.721 | 2.9e-96 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.865 | 0.665 | 0.698 | 1.1e-94 | |
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.794 | 0.619 | 0.742 | 3e-94 | |
| TAIR|locus:2119350 | 389 | AT4G13190 [Arabidopsis thalian | 0.804 | 0.614 | 0.698 | 7.3e-91 | |
| TAIR|locus:2014604 | 381 | AT1G76370 [Arabidopsis thalian | 0.794 | 0.619 | 0.708 | 9.6e-89 |
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1123 (400.4 bits), Expect = 7.3e-114, P = 7.3e-114
Identities = 219/297 (73%), Positives = 240/297 (80%)
Query: 1 MGWFPCSGDSF--RXXXXXXXXXXXXXTLDRINSIPDKLKMNSSLRVKEASEDGASDQIT 58
MGW PCSG S + D S +K + SSL E+ G SD I
Sbjct: 1 MGWIPCSGKSSGRNKTRRNGDHKLDRKSSDCSVSTSEKSRAKSSL--SESKSKG-SDHIV 57
Query: 59 AQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV 118
AQT TF ELA AT+NFR E L+GEGGFGRVYKGYL S +Q AIKQLD NG+QGNREFLV
Sbjct: 58 AQTFTFSELATATRNFRKECLIGEGGFGRVYKGYLASTSQTAAIKQLDHNGLQGNREFLV 117
Query: 119 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 178
EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+EDHLHD+SPGK+PLDWNTRMKI
Sbjct: 118 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKQPLDWNTRMKI 177
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 238
AAGAA+GLEYLHDK PPVIYRDLKCSNILLD Y PKLSDFGLAKLGPVGD +HVSTRV
Sbjct: 178 AAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPVGDKSHVSTRV 237
Query: 239 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEP 295
MGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA+D+S++ EQ+LVAW+ P
Sbjct: 238 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQNLVAWARP 294
|
|
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1078 (384.5 bits), Expect = 4.3e-109, P = 4.3e-109
Identities = 214/302 (70%), Positives = 236/302 (78%)
Query: 2 GWFPCSGDSFRXXXXXXXXXXXXXTLD----RINSIP-DKLKMNSSLRVKE---ASEDGA 53
G PC G S + D + + I DK K K+ A ++G
Sbjct: 3 GCLPCFGSSAKDAASKDSVKKELSAKDGSVTQSHHISLDKSKSRRGPEQKKELTAPKEGP 62
Query: 54 SDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN 113
+ I AQT TFRELAAATKNFR E LLGEGGFGRVYKG LE+ Q VA+KQLDRNG+QGN
Sbjct: 63 TAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLETTGQIVAVKQLDRNGLQGN 122
Query: 114 REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 173
REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+EDHLHDL P K+PLDW+
Sbjct: 123 REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKEPLDWS 182
Query: 174 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233
TRM IAAGAA+GLEYLHDKA PPVIYRDLK SNILL GYHPKLSDFGLAKLGPVGD TH
Sbjct: 183 TRMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKLSDFGLAKLGPVGDKTH 242
Query: 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWS 293
VSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVV LE+++GRKA+D ++A E +LVAW+
Sbjct: 243 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNARAPGEHNLVAWA 302
Query: 294 EP 295
P
Sbjct: 303 RP 304
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1023 (365.2 bits), Expect = 2.9e-103, P = 2.9e-103
Identities = 200/274 (72%), Positives = 224/274 (81%)
Query: 28 DRINSIP---DKL--KMNS-SLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLG 81
+ I+ +P +KL K N S R DG QI A T FRELAAAT NF ++ LG
Sbjct: 35 NNISGLPSGGEKLSSKTNGGSKRELLLPRDGLG-QIAAHTFAFRELAAATMNFHPDTFLG 93
Query: 82 EGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG 141
EGGFGRVYKG L+S Q VA+KQLDRNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADG
Sbjct: 94 EGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG 153
Query: 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRD 201
DQRLLVYE+MPLGS+EDHLHDL P K+ LDWN RMKIAAGAA+GLE+LHDKA PPVIYRD
Sbjct: 154 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRD 213
Query: 202 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDV 261
K SNILLD G+HPKLSDFGLAKLGP GD +HVSTRVMGTYGYCAPEYA TGQLT+KSDV
Sbjct: 214 FKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDV 273
Query: 262 YSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEP 295
YSFGVV LE+++GRKA+D+ EQ+LVAW+ P
Sbjct: 274 YSFGVVFLELITGRKAIDSEMPHGEQNLVAWARP 307
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 982 (350.7 bits), Expect = 6.4e-99, P = 6.4e-99
Identities = 190/262 (72%), Positives = 217/262 (82%)
Query: 34 PDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYL 93
P+ K + V + +G S+ + A+ TFRELA ATKNFR E L+GEGGFGRVYKG L
Sbjct: 8 PNSPKRTTG-EVVAKNANGPSNNMGARIFTFRELATATKNFRQECLIGEGGFGRVYKGKL 66
Query: 94 ESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153
E+ Q VA+KQLDRNG+QG REFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEYMPL
Sbjct: 67 ENPAQVVAVKQLDRNGLQGQREFLVEVLMLSLLHHRNLVNLIGYCADGDQRLLVYEYMPL 126
Query: 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 213
GS+EDHL DL PG+KPLDWNTR+KIA GAA+G+EYLHD+A PPVIYRDLK SNILLD Y
Sbjct: 127 GSLEDHLLDLEPGQKPLDWNTRIKIALGAAKGIEYLHDEADPPVIYRDLKSSNILLDPEY 186
Query: 214 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
KLSDFGLAKLGPVGD HVS+RVMGTYGYCAPEY +TG LT KSDVYSFGVVLLE++S
Sbjct: 187 VAKLSDFGLAKLGPVGDTLHVSSRVMGTYGYCAPEYQRTGYLTNKSDVYSFGVVLLELIS 246
Query: 274 GRKAVDTSKAAAEQSLVAWSEP 295
GR+ +DT + + EQ+LV W+ P
Sbjct: 247 GRRVIDTMRPSHEQNLVTWALP 268
|
|
| TAIR|locus:2056613 AT2G28590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 961 (343.3 bits), Expect = 1.1e-96, P = 1.1e-96
Identities = 181/252 (71%), Positives = 207/252 (82%)
Query: 47 EASEDGASDQIT---AQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIK 103
+A + D++ AQT TF EL+ +T NF+S+ LGEGGFG+VYKG++E INQ VAIK
Sbjct: 68 DAKDTNVEDEVIVKKAQTFTFEELSVSTGNFKSDCFLGEGGFGKVYKGFIEKINQVVAIK 127
Query: 104 QLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL 163
QLDRNG QG REF+VEVL LSL HPNLV LIG+CA+G QRLLVYEYMPLGS+++HLHDL
Sbjct: 128 QLDRNGAQGIREFVVEVLTLSLADHPNLVKLIGFCAEGVQRLLVYEYMPLGSLDNHLHDL 187
Query: 164 SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223
GK PL WNTRMKIAAGAARGLEYLHD KPPVIYRDLKCSNIL+D GYH KLSDFGLA
Sbjct: 188 PSGKNPLAWNTRMKIAAGAARGLEYLHDTMKPPVIYRDLKCSNILIDEGYHAKLSDFGLA 247
Query: 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283
K+GP G THVSTRVMGTYGYCAP+YA TGQLT KSDVYSFGVVLLE+++GRKA D ++
Sbjct: 248 KVGPRGSETHVSTRVMGTYGYCAPDYALTGQLTFKSDVYSFGVVLLELITGRKAYDNTRT 307
Query: 284 AAEQSLVAWSEP 295
QSLV W+ P
Sbjct: 308 RNHQSLVEWANP 319
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 957 (341.9 bits), Expect = 2.9e-96, P = 2.9e-96
Identities = 181/251 (72%), Positives = 211/251 (84%)
Query: 46 KEASEDG-ASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQ 104
K ED ++ I AQT +FRELA ATKNFR E L+GEGGFGRVYKG LE VA+KQ
Sbjct: 50 KNNDEDKEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQ 109
Query: 105 LDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS 164
LDRNG+QGN+EF+VEVLMLSLLHH +LVNLIGYCADGDQRLLVYEYM GS+EDHL DL+
Sbjct: 110 LDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLT 169
Query: 165 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224
P + PLDW+TR++IA GAA GLEYLHDKA PPVIYRDLK +NILLD ++ KLSDFGLAK
Sbjct: 170 PDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAK 229
Query: 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284
LGPVGD HVS+RVMGTYGYCAPEY +TGQLT KSDVYSFGVVLLE+++GR+ +DT++
Sbjct: 230 LGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPK 289
Query: 285 AEQSLVAWSEP 295
EQ+LV W++P
Sbjct: 290 DEQNLVTWAQP 300
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 942 (336.7 bits), Expect = 1.1e-94, P = 1.1e-94
Identities = 183/262 (69%), Positives = 213/262 (81%)
Query: 38 KMNSSLRVKEASEDGAS---DQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLE 94
K +SS R + SE+ A I+A TFREL ATKNF ++ LGEGGFGRVYKG +E
Sbjct: 44 KTDSSRR-RYISEEIAKLGKGNISAHIFTFRELCVATKNFNPDNQLGEGGFGRVYKGQIE 102
Query: 95 SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 154
+ Q VA+KQLDRNG QGNREFLVEV+MLSLLHH NLVNL+GYCADGDQR+LVYEYM G
Sbjct: 103 TPEQVVAVKQLDRNGYQGNREFLVEVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNG 162
Query: 155 SVEDHLHDLSPGKK-PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 213
S+EDHL +L+ KK PLDW+TRMK+AAGAARGLEYLH+ A PPVIYRD K SNILLD +
Sbjct: 163 SLEDHLLELARNKKKPLDWDTRMKVAAGAARGLEYLHETADPPVIYRDFKASNILLDEEF 222
Query: 214 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+PKLSDFGLAK+GP G THVSTRVMGTYGYCAPEYA TGQLT+KSDVYSFGVV LE+++
Sbjct: 223 NPKLSDFGLAKVGPTGGETHVSTRVMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMIT 282
Query: 274 GRKAVDTSKAAAEQSLVAWSEP 295
GR+ +DT+K EQ+LV W+ P
Sbjct: 283 GRRVIDTTKPTEEQNLVTWASP 304
|
|
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 938 (335.3 bits), Expect = 3.0e-94, P = 3.0e-94
Identities = 176/237 (74%), Positives = 204/237 (86%)
Query: 59 AQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV 118
A++ TF+ELAAAT+NFR +LLGEGGFGRVYKG L+S Q VAIKQL+ +G+QGNREF+V
Sbjct: 63 ARSFTFKELAAATRNFREVNLLGEGGFGRVYKGRLDS-GQVVAIKQLNPDGLQGNREFIV 121
Query: 119 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 178
EVLMLSLLHHPNLV LIGYC GDQRLLVYEYMP+GS+EDHL DL ++PL WNTRMKI
Sbjct: 122 EVLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKI 181
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 238
A GAARG+EYLH A PPVIYRDLK +NILLD+ + PKLSDFGLAKLGPVGD THVSTRV
Sbjct: 182 AVGAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRV 241
Query: 239 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEP 295
MGTYGYCAPEYA +G+LT+KSD+Y FGVVLLE+++GRKA+D + EQ+LV WS P
Sbjct: 242 MGTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTWSRP 298
|
|
| TAIR|locus:2119350 AT4G13190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 906 (324.0 bits), Expect = 7.3e-91, P = 7.3e-91
Identities = 167/239 (69%), Positives = 203/239 (84%)
Query: 57 ITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF 116
I A++ FRELA AT +FR E L+GEGGFGRVYKG +E Q VA+KQLDRNG+QGNREF
Sbjct: 54 IKAKSFKFRELATATNSFRQEFLIGEGGFGRVYKGKMEKTGQVVAVKQLDRNGLQGNREF 113
Query: 117 LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 176
LVE+ LSLLHHPNL NLIGYC DGDQRLLV+E+MPLGS+EDHL D+ G++PLDWN+R+
Sbjct: 114 LVEIFRLSLLHHPNLANLIGYCLDGDQRLLVHEFMPLGSLEDHLLDVVVGQQPLDWNSRI 173
Query: 177 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236
+IA GAA+GLEYLH+KA PPVIYRD K SNILL+ + KLSDFGLAKLG VGD +VS+
Sbjct: 174 RIALGAAKGLEYLHEKANPPVIYRDFKSSNILLNVDFDAKLSDFGLAKLGSVGDTQNVSS 233
Query: 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEP 295
RV+GTYGYCAPEY KTGQLT+KSDVYSFGVVLLE+++G++ +DT++ EQ+LV W++P
Sbjct: 234 RVVGTYGYCAPEYHKTGQLTVKSDVYSFGVVLLELITGKRVIDTTRPCHEQNLVTWAQP 292
|
|
| TAIR|locus:2014604 AT1G76370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 886 (316.9 bits), Expect = 9.6e-89, P = 9.6e-89
Identities = 168/237 (70%), Positives = 198/237 (83%)
Query: 59 AQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV 118
A++ TF+ELAAATKNFR +++G+GGFG VYKG L+S Q VAIKQL+ +G QGN+EF+V
Sbjct: 60 ARSFTFKELAAATKNFREGNIIGKGGFGSVYKGRLDS-GQVVAIKQLNPDGHQGNQEFIV 118
Query: 119 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 178
EV MLS+ HHPNLV LIGYC G QRLLVYEYMP+GS+EDHL DL P + PL W TRMKI
Sbjct: 119 EVCMLSVFHHPNLVTLIGYCTSGAQRLLVYEYMPMGSLEDHLFDLEPDQTPLSWYTRMKI 178
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 238
A GAARG+EYLH K P VIYRDLK +NILLD+ + KLSDFGLAK+GPVG+ THVSTRV
Sbjct: 179 AVGAARGIEYLHCKISPSVIYRDLKSANILLDKEFSVKLSDFGLAKVGPVGNRTHVSTRV 238
Query: 239 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEP 295
MGTYGYCAPEYA +G+LT+KSD+YSFGVVLLE++SGRKA+D SK EQ LVAW+ P
Sbjct: 239 MGTYGYCAPEYAMSGRLTIKSDIYSFGVVLLELISGRKAIDLSKPNGEQYLVAWARP 295
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 297 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-58 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-56 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-56 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-56 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-53 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-53 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-53 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-35 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-30 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-26 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-25 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-25 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-24 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-23 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-22 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-22 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-21 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-21 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-21 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-18 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-18 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-18 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-18 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-18 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-17 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-17 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-16 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-14 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-14 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-13 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 4e-58
Identities = 74/195 (37%), Positives = 104/195 (53%), Gaps = 11/195 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNLIGYC 138
LGEGGFG VY + + VAIK + + E L E+ +L L+HPN+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
D + LV EY GS++D L + + L + ++I GLEYLH +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 199 YRDLKCSNILLDRG-YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-TGQLT 256
+RDLK NILLD KL+DFGL+KL + + + ++GT Y APE G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 257 LKSDVYSFGVVLLEI 271
KSD++S GV+L E+
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 181 bits (463), Expect = 2e-56
Identities = 75/200 (37%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 80 LGEGGFGRVYKGYL----ESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNL 134
LGEG FG VYKG L E VA+K L + R EFL E ++ L HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
+G C G+ +V EYMP G + D L + L +++A A+G+EYL K
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
++RDL N L+ K+SDFGL++ D + APE K G+
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 255 LTLKSDVYSFGVVLLEILSG 274
T KSDV+SFGV+L EI +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 181 bits (463), Expect = 2e-56
Identities = 78/202 (38%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 77 ESLLGEGGFGRVYKGYLESIN----QDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNL 131
LGEG FG VYKG L+ +VA+K L + Q EFL E ++ L HPN+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L+G C + + ++V EYMP G + D+L P K L + + A ARG+EYL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLES 121
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
K I+RDL N L+ K+SDFGL++ D V + APE K
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPESLK 177
Query: 252 TGQLTLKSDVYSFGVVLLEILS 273
G+ T KSDV+SFGV+L EI +
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 6e-56
Identities = 72/202 (35%), Positives = 100/202 (49%), Gaps = 12/202 (5%)
Query: 77 ESLLGEGGFGRVYKGYLESIN----QDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNL 131
LGEG FG VYKG L+ +VA+K L + + EFL E ++ L HPN+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L+G C + + +V EYM G + +L + L + + A ARG+EYL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGMEYLES 120
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
K I+RDL N L+ K+SDFGL++ D + APE K
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPESLK 176
Query: 252 TGQLTLKSDVYSFGVVLLEILS 273
G+ T KSDV+SFGV+L EI +
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 1e-53
Identities = 78/205 (38%), Positives = 103/205 (50%), Gaps = 12/205 (5%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNL 131
+ LG G FG VYK + + VA+K L + ++ E+ +L L HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V LI D D LV EY G L D PL + KIA RGLEYLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGD----LFDYLSRGGPLSEDEAKKIALQILRGLEYLHS 116
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
+I+RDLK NILLD K++DFGLAK + ++ ++T V GT Y APE
Sbjct: 117 NG---IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLL 171
Query: 252 TGQL-TLKSDVYSFGVVLLEILSGR 275
G K DV+S GV+L E+L+G+
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 5e-53
Identities = 76/203 (37%), Positives = 104/203 (51%), Gaps = 12/203 (5%)
Query: 80 LGEGGFGRVYKGYLESIN---QDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLI 135
LGEG FG VYKG L+ + +VA+K L + + R +FL E ++ L HPN+V L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHL-----HDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
G C + + LV EYM G + D+L SP K L + A A+G+EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
K ++RDL N L+ K+SDFGL++ D T + APE
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 251 KTGQLTLKSDVYSFGVVLLEILS 273
K G T KSDV+SFGV+L EI +
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 8e-53
Identities = 72/203 (35%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLV 132
+ LGEG FG+VY + + VAIK + + ++ +RE L E+ +L L HPN+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
L D D+ LV EY G + D L + L + LEYLH K
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALEYLHSK 116
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 252
+++RDLK NILLD H KL+DFGLA+ + ++T V GT Y APE
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVLLG 170
Query: 253 GQLTLKSDVYSFGVVLLEILSGR 275
D++S GV+L E+L+G+
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 1e-37
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVL-----MLSLLHHPNLVN 133
LLG G FG VY + + +A+K ++ + G+ E +E L +LS L HPN+V
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVE---LSGDSEEELEALEREIRILSSLQHPNIVR 63
Query: 134 LIGYC--ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN-----TRMKIAAGAARGL 186
G + + + EY+ GS+ L L TR + GL
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQIL-----EGL 114
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 246
YLH +++RD+K +NIL+D KL+DFG AK + + V GT + A
Sbjct: 115 AYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 247 PEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
PE + + +D++S G ++E+ +G+
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 7e-35
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 9/202 (4%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN 133
F +G+GGFG VYK + ++VAIK + + + + E+ +L HPN+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
G D+ +V E+ GS++D L + L + + +GLEYLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
+I+RD+K +NILL KL DFGL+ +T ++GT + APE
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGK 172
Query: 254 QLTLKSDVYSFGVVLLEILSGR 275
K+D++S G+ +E+ G+
Sbjct: 173 PYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 69/227 (30%), Positives = 114/227 (50%), Gaps = 21/227 (9%)
Query: 74 FRSESLLGEGGFGRVYKGY----LESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHH 128
+LG G FG VYKG E + VAIK L + + N+E L E +++ + H
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD----LSPGKKPLDWNTRMKIAAGAAR 184
P++V L+G C Q L+ + MPLG + D++ + + + L+W ++ A+
Sbjct: 69 PHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGS-QYLLNWCVQI------AK 120
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244
G+ YL +K +++RDL N+L+ H K++DFGLAKL V + + + +
Sbjct: 121 GMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 290
A E T KSDV+S+GV + E+++ G K + A L+
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 6e-34
Identities = 75/212 (35%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 80 LGEGGFGRVYKGYLESIN-----QDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVN 133
LGEG FG+VYKG L N VAIK L N + +EF E ++S L HPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAG 181
L+G C +++EY+ G + + L SP K LD + + IA
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
A G+EYL + ++RDL N L+ G K+SDFGL++ D V ++ +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ PE G+ T +SD++SFGVVL EI S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 9e-34
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVN 133
LGEG FG+V + D VA+K L+ +G Q +F E+ +L L H N+V
Sbjct: 12 LGEGHFGKVELCRYD-PLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 134 LIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
G C R L+ EY+P GS+ D+L ++ + ++ +G++YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGS 127
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST--RVMGTYGYCAPEY 249
+ I+RDL NIL++ K+SDFGLAK+ P + + + Y APE
Sbjct: 128 QR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 250 AKTGQLTLKSDVYSFGVVLLEILS 273
+T + + SDV+SFGV L E+ +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-33
Identities = 70/199 (35%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGY 137
+ +G+G FG V G Q VA+K L + + FL E +++ L HPNLV L+G
Sbjct: 12 ATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197
G+ +V EYM GS+ D+L S G+ + ++ A G+EYL +K
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYLEEKN---F 123
Query: 198 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 257
++RDL N+L+ K+SDFGLAK G S ++ + APE + + +
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQG---QDSGKL--PVKWTAPEALREKKFST 178
Query: 258 KSDVYSFGVVLLEILS-GR 275
KSDV+SFG++L EI S GR
Sbjct: 179 KSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 9e-33
Identities = 68/202 (33%), Positives = 108/202 (53%), Gaps = 8/202 (3%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
+ F E LG G FG V++G L VAIK L + + ++F EV L L H +L
Sbjct: 6 EEFTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
++L C+ G+ ++ E M GS+ L SP + L + + +A A G+ YL +
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFLR--SPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
+ I+RDL NIL+ K++DFGLA+L + ++ ++S+ Y + APE A
Sbjct: 123 QN---SIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAAS 177
Query: 252 TGQLTLKSDVYSFGVVLLEILS 273
G + KSDV+SFG++L E+ +
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 6e-32
Identities = 82/215 (38%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLML-SLLHH 128
++R LGEG FG VY + VA+K L + ++E FL E+ +L SL H
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
PN+V L + D LV EY+ GS+ED L K PL + + I A LEY
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKK-IGRKGPLSESEALFILAQILSALEY 116
Query: 189 LHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKL----GPVGDNTHVSTRVMGTYG 243
LH K +I+RD+K NILLDR G KL DFGLAKL G + + +GT G
Sbjct: 117 LHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 244 YCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGR 275
Y APE + SD++S G+ L E+L+G
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-30
Identities = 71/200 (35%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V+ G VA+K L + G FL E ++ L H LV L C+
Sbjct: 14 LGAGQFGEVWMGTWNG-TTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ + +V EYM GS+ D L K L + +AA A G+ YL + I+
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIH 126
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 256
RDL NIL+ K++DFGLA+L + D+ + + G + APE A G+ T
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARL--IEDDEYTAR--EGAKFPIKWTAPEAANYGRFT 182
Query: 257 LKSDVYSFGVVLLEILS-GR 275
+KSDV+SFG++L EI++ GR
Sbjct: 183 IKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-30
Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVN 133
LGEG FG+V+ G + + VA+K L R+ F E +L+ H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP----------GKKPLDWNTRMKIAAGAA 183
G C +GD ++V+EYM G + L P L + ++IA A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
G+ YL A ++RDL N L+ K+ DFG+++ D V M
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ PE + T +SDV+SFGVVL EI +
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-29
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 79 LLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGN-REFLVEVLMLSLLHHPNLVNL 134
LG+G FG V +G + VA+K L + + +FL E ++ L H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD--WNTRMKIAAGAARGLEYLHDK 192
G ++V E PLGS+ D L + G + + ++IA G + YL K
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANG----MRYLESK 116
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST---RVMGTYGYCAPEY 249
I+RDL NILL K+ DFGL + P ++ +V +V + +CAPE
Sbjct: 117 R---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPES 171
Query: 250 AKTGQLTLKSDVYSFGVVLLEILS 273
+T + SDV+ FGV L E+ +
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 71/201 (35%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIG 136
LG+G FG+V + + A+K L + + +E L E +LS ++HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 137 YCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
+ A + LV EY P G + HL G+ + R AA LEYLH
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEER-ARF-YAAEIVLALEYLHSLG- 113
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
+IYRDLK NILLD H KL+DFGLAK + + +T GT Y APE
Sbjct: 114 --IIYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFC-GTPEYLAPEVLLGKG 169
Query: 255 LTLKSDVYSFGVVLLEILSGR 275
D +S GV+L E+L+G+
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-28
Identities = 66/197 (33%), Positives = 95/197 (48%), Gaps = 8/197 (4%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNLIGY 137
+G+G FG VYKG L+ N +VA+K + FL E +L HPN+V LIG
Sbjct: 2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197
C +V E +P GS+ L K L ++++ AA G+EYL K
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 198 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 257
I+RDL N L+ K+SDFG+++ G T + APE G+ T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 258 KSDVYSFGVVLLEILSG 274
+SDV+S+G++L E S
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLV-EVLMLSLLHHPN 130
+ +G+G FG+VY +S + +K++D N + RE + EV +L L+HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
++ + + +V EY G + + KP + L+YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-- 248
+ +++RD+K NI L KL DFG++K+ + ++ V+GT Y +PE
Sbjct: 121 SRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPELC 175
Query: 249 ----YAKTGQLTLKSDVYSFGVVLLEILSGRKA 277
Y KSD++S G VL E+ + +
Sbjct: 176 QNKPYNY------KSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-28
Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIG 136
L+G G FG VYKG VAIKQ+ ++ + + E+ +L L HPN+V IG
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
D ++ EY GS+ + P + L ++ +GL YLH++
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL----QGLAYLHEQG--- 119
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 256
VI+RD+K +NIL + KL+DFG+A + D + V+GT + APE + +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 257 LKSDVYSFGVVLLEILSGR 275
SD++S G ++E+L+G
Sbjct: 178 TASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 34/212 (16%)
Query: 79 LLGEGGFGRVYKGYLESINQD----VAIKQ--LDRNGVQGN---REFLVEVLMLSLLHHP 129
LLG G FG VY+G +N D A+K+ L +G G ++ E+ +LS L HP
Sbjct: 7 LLGSGSFGSVYEG----LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N+V +G + D + E +P GS+ L +P+ +I G LEYL
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYL 118
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-----GTYGY 244
HD+ ++RD+K +NIL+D KL+DFG+AK V G+ +
Sbjct: 119 HDRN---TVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYW 167
Query: 245 CAPEY-AKTGQLTLKSDVYSFGVVLLEILSGR 275
APE A+ G L +D++S G +LE+ +G+
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 3e-27
Identities = 65/228 (28%), Positives = 98/228 (42%), Gaps = 33/228 (14%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-----FLVEVLMLSLL 126
+F+ ++GEG F V + N++ AIK LD+ Q +E +E +L+ L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDK--RQLIKEKKVKYVKIEKEVLTRL 58
Query: 127 -HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
HP ++ L D + V EY P G + ++ LD AA
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLA 114
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVM----- 239
LEYLH K +I+RDLK NILLD+ H K++DFG AK L P
Sbjct: 115 LEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 240 ------------GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
GT Y +PE SD+++ G ++ ++L+G+
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 8e-27
Identities = 70/214 (32%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHP 129
+ +++ +GEG G VYK + ++VAIK++ + N+E ++ E+L++ HP
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLR--KQNKELIINEILIMKDCKHP 75
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN-TRMK---IAAGAA-- 183
N+V+ GD+ +V EYM GS L D+ + N RM IA
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGS----LTDI------ITQNFVRMNEPQIAYVCREV 125
Query: 184 -RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR--VMG 240
+GLEYLH + VI+RD+K NILL + KL+DFG A S R V+G
Sbjct: 126 LQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL----TKEKSKRNSVVG 178
Query: 241 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
T + APE K K D++S G++ +E+ G
Sbjct: 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-26
Identities = 71/198 (35%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V+ GY + VAIK L + G FL E ++ L HP LV L
Sbjct: 14 LGAGQFGEVWMGYYNG-HTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ ++ EYM GS+ D L +P L N + +AA A G+ ++ K I+
Sbjct: 72 Q-EPIYIITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIH 125
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAKTGQLTLK 258
RDL+ +NIL+ K++DFGLA+L + DN + + + APE G T+K
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 259 SDVYSFGVVLLEILS-GR 275
SDV+SFG++L EI++ GR
Sbjct: 184 SDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-26
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 133
LG+G FG VY+G + + + VAIK ++ N R EFL E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLH------DLSPGKKPLDWNTRMKIAAGAARGLE 187
L+G + G L+V E M G ++ +L + +PG P +++AA A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
YL K ++RDL N ++ K+ DFG+ + D + + + AP
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILS 273
E K G T KSDV+SFGVVL E+ +
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-26
Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 15/200 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V++G L + VA+K L + G ++FL E ++ L HP L+ L C
Sbjct: 14 LGAGQFGEVWEG-LWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ +V E M GS+ ++L + L + +AA A G+ YL + I+
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 256
RDL N+L+ K++DFGLA++ + ++ + + G + APE A + +
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARV--IKEDIYEARE--GAKFPIKWTAPEAALYNRFS 182
Query: 257 LKSDVYSFGVVLLEILS-GR 275
+KSDV+SFG++L EI++ GR
Sbjct: 183 IKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 7e-26
Identities = 70/202 (34%), Positives = 99/202 (49%), Gaps = 16/202 (7%)
Query: 80 LGEGGFGRVYKGYLESINQD----VAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNL 134
LGEG FG+V + N VA+K L R Q N + E+ +L L+H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 135 IGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
G C++ + L+ EY+PLGS+ D+L K L+ + A G+ YLH +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH-VSTRVMGTYGYCAPEYAK 251
I+RDL N+LLD K+ DFGLAK P G + V + A E K
Sbjct: 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 252 TGQLTLKSDVYSFGVVLLEILS 273
+ + SDV+SFGV L E+L+
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 67/203 (33%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 138
+G G VY N+ VAIK++D Q + + L EV +S +HPN+V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA---GAARGLEYLHDKAKP 195
GD+ LV Y+ GS L D+ P IA +GLEYLH +
Sbjct: 69 VVGDELWLVMPYLSGGS----LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ- 123
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTH-VSTRVMGTYGYCAPEYAKTG 253
I+RD+K NILL K++DFG+ A L GD T V +GT + APE +
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 254 Q-LTLKSDVYSFGVVLLEILSGR 275
K+D++SFG+ +E+ +G
Sbjct: 182 HGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 69/205 (33%), Positives = 105/205 (51%), Gaps = 17/205 (8%)
Query: 78 SLLGEGGFGRV----YKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN 133
LG+G FG V Y ++ + VA+K+L + + R+F E+ +L L H N+V
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 134 LIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
G C +R LV EY+P GS+ D+L ++ LD + A+ +G+EYL
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG---TYGYCAPE 248
K ++RDL NIL++ K+ DFGL K+ P D + R G + Y APE
Sbjct: 127 KR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWY-APE 181
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILS 273
+ ++ SDV+SFGVVL E+ +
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-25
Identities = 60/192 (31%), Positives = 101/192 (52%), Gaps = 7/192 (3%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G +G VY+G + + VA+K L + ++ EFL E ++ + HPNLV L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
++ E+M G++ D+L + ++ ++ + +A + +EYL K I+
Sbjct: 73 REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS 259
RDL N L+ + K++DFGL++L GD + APE + ++KS
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 260 DVYSFGVVLLEI 271
DV++FGV+L EI
Sbjct: 187 DVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-25
Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 80 LGEGGFGRVYKGYLESINQ---DVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLI 135
LG G FG V KG + +VA+K L + G +EFL E +++ L HP +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
G C G+ +LV E PLG + +L P + ++ A G+ YL K
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLESKH 115
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTY--GYCAPEYA 250
++RDL N+LL + K+SDFG+++ LG + + G + + APE
Sbjct: 116 ---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA--GSDYYRATTAGRWPLKWYAPECI 170
Query: 251 KTGQLTLKSDVYSFGVVLLEILS 273
G+ + KSDV+S+GV L E S
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-25
Identities = 77/226 (34%), Positives = 110/226 (48%), Gaps = 23/226 (10%)
Query: 66 ELAAATKNFRSESLLGEGGFGRVYKG--YLESIN--QDVAIKQL-DRNGVQGNREFLVEV 120
EL + F E LGE FG++YKG YL ++ Q VAIK L D N Q EF E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 121 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG-------------K 167
+++ LHHPN+V L+G +++EY+ G + + L SP K
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 168 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227
LD + IA A G+EYL + +++DL NIL+ H K+SD GL++
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
D V + + + PE G+ + SD++SFGVVL EI S
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-25
Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNL 131
+ +LG+G G VYK + + A+K++ +G + R+ L+ E+ L P +
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV 61
Query: 132 VNLIG-YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM--KIAAGAARGLEY 188
V G + +G+ + V EYM GS+ D L KK + IA +GL+Y
Sbjct: 62 VKCYGAFYKEGEISI-VLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLDY 114
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAP 247
LH K +I+RD+K SN+L++ K++DFG++K L D + T V GT Y +P
Sbjct: 115 LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSP 169
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSGR 275
E + + +D++S G+ LLE G+
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 7e-25
Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 25/208 (12%)
Query: 79 LLGEGGFGRVYKGYL---ESINQDVAIKQLDR-NGVQGNREFLVEVLMLSLLHHPNLVNL 134
++G+G FG VY G L + A+K L+R ++ +FL E +++ HPN+++L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 135 IGYCADGD-QRLLVYEYMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGLEYLHD 191
+G C + L+V YM G + + + + P K L + A+G+EYL
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEYL-- 114
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK------LGPVGDNTHVSTRVMGTYGYC 245
A ++RDL N +LD + K++DFGLA+ V ++T V +
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WM 169
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILS 273
A E +T + T KSDV+SFGV+L E+++
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-24
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 9/215 (4%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPN 130
+F + +G+G FG V+K ++ + A+KQ+D + + E + E +L+ L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
++ D + +V EY G + L +PL + + GL +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLK--MQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
K +++RD+K N+ LD + K+ D G+AKL + DNT+ + ++GT Y +PE
Sbjct: 119 SKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELC 173
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285
+ KSDV++ GVVL E +G+ D + A
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 3e-24
Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 9/205 (4%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLV-EVLMLSLLHHPN 130
+F+ LG+G +G VYK S NQ A+K++D + Q RE V E+ +L+ ++HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+++ DG++ +V EY P G + + +K + +I RGL+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
++ +++RDLK +NILL K+ D G++K V T +GT Y APE
Sbjct: 121 EQK---ILHRDLKSANILLVANDLVKIGDLGISK---VLKKNMAKT-QIGTPHYMAPEVW 173
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGR 275
K + KSD++S G +L E+ +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 5e-24
Identities = 70/212 (33%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHH 128
+F LG G FGRV + + A+K L + + ++ L E +L + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
P LVNL G D LV EY+P G + HL G+ P R AA LEY
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR--KSGRFPEPV-ARF-YAAQVVLALEY 116
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
LH ++YRDLK N+LLD + K++DFG AK V T+ + GT Y APE
Sbjct: 117 LHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYT---LCGTPEYLAPE 168
Query: 249 ------YAKTGQLTLKSDVYSFGVVLLEILSG 274
Y K D ++ G+++ E+L+G
Sbjct: 169 IILSKGYGKA------VDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 6e-24
Identities = 69/212 (32%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYL----ESINQDVAIKQL-DRNGVQGNREFLVEVLMLSL 125
R LLG G FG V+KG +SI VAIK + DR+G Q +E +L +
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 126 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH----DLSPGKKPLDWNTRMKIAAG 181
L H +V L+G C G LV + PLGS+ DH+ L P ++ L+W ++
Sbjct: 66 LDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDP-QRLLNWCVQI----- 118
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
A+G+ YL + +++R+L NILL +++DFG+A L D + +
Sbjct: 119 -AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTP 174
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ A E G+ T +SDV+S+GV + E++S
Sbjct: 175 IKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 6e-24
Identities = 67/205 (32%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN 133
F LGEG +G VYK + Q VAIK + +E + E+ +L P +V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA---GAARGLEYLH 190
G +V EY GSV D + + K L T +IAA +GLEYLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITN---KTL---TEEEIAAILYQTLKGLEYLH 116
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
K I+RD+K NILL+ KL+DFG++ G + D V+GT + APE
Sbjct: 117 SNKK---IHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVI 171
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGR 275
+ K+D++S G+ +E+ G+
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 8e-24
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 45/217 (20%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV----EVLMLSLLHHPNLVNLI 135
+GEG +G+VYK + + VA+K++ F + E+ +L L HPN+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 136 GYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------G 185
+ +V+EYM HDL+ G L + +K + G
Sbjct: 65 EIVTSKGKGSIYMVFEYMD--------HDLT-G---LLDSPEVKFTESQIKCYMKQLLEG 112
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
L+YLH +++RD+K SNIL++ KL+DFGLA+ N+ T + T Y
Sbjct: 113 LQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLWYR 168
Query: 246 APE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
PE Y + D++S G +L E+ G+
Sbjct: 169 PPELLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 2e-23
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYC 138
LG G G V K + +A+K + ++ L E+ +L + P +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
+ + EYM GS++ L + + KIA +GL YLH+K K +I
Sbjct: 69 YNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHEKHK--II 123
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM--------GTYGYCAPEYA 250
+RD+K SNIL++ KL DFG VS +++ GT Y APE
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSYMAPERI 171
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGR 275
+ ++KSD++S G+ L+E+ +GR
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-23
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LGEG FG+V+ ++ + VA+K L ++F E +L++L H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK-----------PLDWNTRMKIAAGAA 183
G C +G L+V+EYM G + L P K L + IA+ A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
G+ YL A ++RDL N L+ +G K+ DFG+++ D V R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ PE + T +SD++SFGVVL EI +
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 3e-23
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 77 ESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNL 131
E ++G G FG V +G L+ + DVAIK L + G +FL E ++ HPN+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHL--HDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
+ L G +++ EYM GS++ L +D GK + + G A G++YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLREND---GK--FTVGQLVGMLRGIASGMKYL 122
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----Y 244
+ ++RDL NIL++ K+SDFG L +++ + G G +
Sbjct: 123 SEMN---YVHRDLAARNILVNSNLVCKVSDFG---LSRRLEDSEATYTTKG--GKIPIRW 174
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
APE + T SDV+SFG+V+ E++S
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-23
Identities = 69/200 (34%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V+ G DVAIK + R G +F+ E ++ L HPNLV L G C
Sbjct: 12 LGSGQFGVVHLGKWRG-KIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+V EYM G + ++L + GK +W M + +EYL I+
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLDM--CSDVCEAMEYLESNG---FIH 123
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 256
RDL N L+ K+SDFGLA+ V D+ + S+ GT + PE + +
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSS--QGTKFPVKWAPPEVFDYSRFS 179
Query: 257 LKSDVYSFGVVLLEILSGRK 276
KSDV+SFGV++ E+ S K
Sbjct: 180 SKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 5e-23
Identities = 66/202 (32%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 83 GGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIGYCA 139
G +GRV+ +S AIK + + + + L E +LS P +V L Y
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 140 DGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
G + L LV EY+P G + L ++ LD + A LEYLH +I
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENVGS----LDEDVARIYIAEIVLALEYLH---SNGII 115
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS------TRVMGTYGYCAPEYAKT 252
+RDLK NIL+D H KL+DFGL+K+G V +++ R++GT Y APE
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 253 GQLTLKSDVYSFGVVLLEILSG 274
+ D +S G +L E L G
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 5e-23
Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLV 132
F +G+G FG VYK + NQ VAIK +D + E + E+ LS P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
G G + ++ EY GS L L PG LD I GLEYLH++
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC---LDLLKPG--KLDETYIAFILREVLLGLEYLHEE 117
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 252
K I+RD+K +NILL KL+DFG++ G + +GT + APE K
Sbjct: 118 GK---IHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTFVGTPFWMAPEVIKQ 172
Query: 253 GQLTLKSDVYSFGVVLLEILSG 274
K+D++S G+ +E+ G
Sbjct: 173 SGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 6e-23
Identities = 68/198 (34%), Positives = 108/198 (54%), Gaps = 18/198 (9%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
+GEG FG V +G E Q VA+K + + + FL E +++ LHH NLV L+G
Sbjct: 14 IGEGEFGAVLQG--EYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ +V E M G++ + L + G+ + ++ + A G+EYL K +++
Sbjct: 70 H-NGLYIVMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVH 123
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVG-DNTHVSTRVMGTYGYCAPEYAKTGQLTLK 258
RDL NIL+ K+SDFGLA++G +G DN+ + + + APE K + + K
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSK 177
Query: 259 SDVYSFGVVLLEILS-GR 275
SDV+S+GV+L E+ S GR
Sbjct: 178 SDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 7e-23
Identities = 67/231 (29%), Positives = 101/231 (43%), Gaps = 39/231 (16%)
Query: 73 NFRSESLLGEGGFGRVYK----GYLESINQD-VAIKQL-DRNGVQGNREFLVEVLMLSLL 126
N +G+G FGRV++ G L VA+K L + +F E +++
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 65
Query: 127 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------------GKK 168
HPN+V L+G CA G L++EYM G + + L SP
Sbjct: 66 DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125
Query: 169 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228
PL ++ IA A G+ YL ++ ++RDL N L+ K++DFGL++
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182
Query: 229 GD------NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
D N + R M PE + T +SDV+++GVVL EI S
Sbjct: 183 ADYYKASENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-22
Identities = 70/218 (32%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 80 LGEGGFGRVY------------KGYLESINQD----VAIKQLDRNGVQGNR-EFLVEVLM 122
LGEG FG V+ K + E+ N D VA+K L + R +FL EV +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 123 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH-------DLSPGKKPLDWNTR 175
LS L PN+ L+G C ++ EYM G + L L+ K L ++T
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235
+ +A A G+ YL ++RDL N L+ + Y K++DFG+++ D V
Sbjct: 133 LYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 236 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
R + A E G+ T KSDV++FGV L EIL+
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 1e-22
Identities = 68/203 (33%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIG 136
LG GGFGRV ++S N+ A+K + + + + E +L +HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 137 YCADGDQRLLVY---EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
Y D++ +Y EY G + L D G ++ R A EYLH++
Sbjct: 59 YRTFKDKKY-IYMLMEYCLGGELWTILRDR--GLFD-EYTARF-YIACVVLAFEYLHNRG 113
Query: 194 KPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 252
+IYRDLK N+LLD GY KL DFG AK G T GT Y APE
Sbjct: 114 ---IIYRDLKPENLLLDSNGY-VKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILN 166
Query: 253 GQLTLKSDVYSFGVVLLEILSGR 275
D +S G++L E+L+GR
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-22
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGY 137
+GEG +G VYK + + VAIK++ + L E+ +L L+HPN++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197
LV+E+M D + ++ L + +GL + H +
Sbjct: 67 FRHKGDLYLVFEFMD----TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGI 119
Query: 198 IYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAPEYAKT-G 253
++RDLK N+L++ KL+DFGLA+ PV TH V TR Y APE
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDK 174
Query: 254 QLTLKSDVYSFGVVLLEILSGR 275
+ D++S G + E+LS R
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 1e-22
Identities = 66/210 (31%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 79 LLGEGGFGRVYKGYLESINQD------VAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNL 131
LG G FG VY+G I VA+K L + Q +EFL E ++S +HPN+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP---LDWNTRMKIAAGAARGLEY 188
V L+G C + + ++ E M G + +L D + L + I A+G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 189 LHDKAKPPVIYRDLKCSNILL-----DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
L I+RDL N L+ D K+ DFGLA+ D +
Sbjct: 122 LEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ APE G+ T +SDV+SFGV++ EIL+
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 2e-22
Identities = 58/220 (26%), Positives = 106/220 (48%), Gaps = 19/220 (8%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPN 130
+ ++G G FG V+ ++ + V IKQ+ + + E +L LL HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD----LSPGKKPLDWNTRMKIAAGAARGL 186
++ + ++V EY P G++ +++ L L + ++ +A L
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------L 114
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
++H K +++RDLK NILLD+ K+ DFG++K+ + + T V+GT Y
Sbjct: 115 HHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYI 168
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285
+PE + KSD+++ G VL E+ S ++A + + A
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 2e-22
Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 22/212 (10%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQ--LDRNGVQG---NREFLV----EVLMLSLLHH 128
+L+G G FG VY G S + +A+KQ L R L E+ +L L H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
N+V +G D D + EY+P GSV L++ ++ L N +I +GL Y
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNY 121
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-----LGPVGDNTHVSTRVMGTYG 243
LH++ +I+RD+K +NIL+D K+SDFG++K N + + G+
Sbjct: 122 LHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQGSVF 177
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ APE K T K+D++S G +++E+L+G+
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-22
Identities = 65/208 (31%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQ-LDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
S LGEG G V K L++ A+K ++ L E+ + P +V G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 137 YCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRM------KIAAGAARGLEY 188
D + EY GS++ S KK R+ KIA +GL Y
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLD------SIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCAP 247
LH + +I+RD+K SNILL R KL DFG++ +L T GT Y AP
Sbjct: 121 LHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYMAP 172
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSGR 275
E + ++ SDV+S G+ LLE+ R
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-22
Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 15/197 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
+G G FG V+ GY + VAIK + R G +F+ E ++ L HP LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLE-KRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ LV+E+M G + D+L + T + + G+ YL VI+
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLR---AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 256
RDL N L+ K+SDFG+ + V D+ + S+ GT + +PE + +
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRF--VLDDQYTSST--GTKFPVKWSSPEVFSFSKYS 179
Query: 257 LKSDVYSFGVVLLEILS 273
KSDV+SFGV++ E+ S
Sbjct: 180 SKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (233), Expect = 3e-22
Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 44/221 (19%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHP 129
+ LGEG +G VYK + + VA+K++ + G+ L E+ +L L HP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA--LREISLLKELKHP 58
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA------ 183
N+V L+ + LV+EY DL KK LD ++
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCD--------MDL---KKYLD-KRPGPLSPNLIKSIMYQ 106
Query: 184 --RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
RGL Y H +++RDLK NIL++R KL+DFGLA+ + T+ + V+ T
Sbjct: 107 LLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-T 161
Query: 242 YGYCAPEYAKTGQLTLKS-------DVYSFGVVLLEILSGR 275
Y APE + L S D++S G + E+++G+
Sbjct: 162 LWYRAPE------ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-22
Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLL-HHPNLVNL 134
+LG+G FG+V L+ + A+K L ++ V + + +VE +L+L +P L +L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
+ V E++ G + H+ D K D AA GL++LH K
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
+IYRDLK N++LDR H K++DFG+ K GDN ++ GT Y APE + +
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLK 172
Query: 255 LTLKSDVYSFGVVLLEILSGR 275
T D +SFGV+L E+L G+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 5e-22
Identities = 71/213 (33%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM--------LSL 125
FR ++LG G FG+V + + AIK L + + E VE LM +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDE--VESLMCEKRIFETANS 58
Query: 126 LHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAA 183
HP LVNL C + + V EY G + H+H + R AA
Sbjct: 59 ERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP------RAVFYAACVV 111
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK--LGPVGDNTHVSTRVMGT 241
GL+YLH+ ++YRDLK N+LLD K++DFGL K +G GD T ST GT
Sbjct: 112 LGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GDRT--ST-FCGT 164
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
+ APE T D + GV++ E+L G
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-22
Identities = 68/203 (33%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSL-LHHPNLVNL 134
+LG+G FG+V L+ N+ AIK L ++ V + + +VE +L+L HP L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 135 IGYCA--DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
+C + V EY+ G + H+ D AA GL++LH K
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK 115
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 252
+IYRDLK N+LLD+ H K++DFG+ K G+ ++ GT Y APE K
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKG 170
Query: 253 GQLTLKSDVYSFGVVLLEILSGR 275
+ D +SFGV+L E+L G+
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 6e-22
Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIG 136
LG+GGFG V +++ + A K+LD+ + +G + L E +L + +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
D LV M G ++ H++++ G+ + AA GLE+LH +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR--- 115
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 256
++YRDLK N+LLD + ++SD GLA G GT GY APE +
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVYD 172
Query: 257 LKSDVYSFGVVLLEILSGR 275
D ++ G L E+++GR
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-21
Identities = 68/208 (32%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNRE---FLVEVLMLSLLH 127
N+R LLG+G FGRVY Y +++A+KQ+ D + + +E E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 128 HPNLVNLIGYCADGDQRLLVY-EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
H +V G C D+ L ++ EYMP GSV+D L L K G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGV 117
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYC 245
EYLH +++RD+K +NIL D + KL DFG +K L + + V GT +
Sbjct: 118 EYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILS 273
+PE K+DV+S G ++E+L+
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-21
Identities = 68/220 (30%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 72 KNFRSESLLGEGGFGRVYKGYL--ESINQDVAIKQLDRNGVQGN-REFLVEVLMLSLL-H 127
++ + E ++GEG FG+V + + + + + AIK L + + R+F E+ +L L H
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH-----DLSPG-------KKPLDWNTR 175
HPN++NL+G C + + EY P G++ D L + P L
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235
++ A+ A G++YL +K I+RDL N+L+ K++DFGL++ G+ +V
Sbjct: 122 LQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK 174
Query: 236 TRVMGTYG--YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ MG + A E T KSDV+SFGV+L EI+S
Sbjct: 175 -KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-21
Identities = 66/206 (32%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVN 133
LG G FG VY+G + D VA+K L + Q +FL+E L++S +H N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK---PLDWNTRMKIAAGAARGLEYLH 190
LIG + R ++ E M G ++ L + P + L + A A+G +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 191 DKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
+ I+RD+ N LL G K++DFG+A+ R M + P
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILS 273
E G T K+DV+SFGV+L EI S
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-21
Identities = 71/213 (33%), Positives = 106/213 (49%), Gaps = 26/213 (12%)
Query: 79 LLGEGGFGRVYKGYL--ESINQDVAIKQLDRNGVQGN-REFLVEVLMLSLL-HHPNLVNL 134
++GEG FG+V K + + + D AIK++ + + R+F E+ +L L HHPN++NL
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLH-----DLSPG-------KKPLDWNTRMKIAAGA 182
+G C L EY P G++ D L + P L + AA
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
ARG++YL K I+RDL NIL+ Y K++DFGL++ G +V + MG
Sbjct: 122 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRL 173
Query: 243 G--YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ A E T SDV+S+GV+L EI+S
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 33/226 (14%)
Query: 75 RSESLLGEGGFGRVYKGYLESINQDV--AIKQL-DRNGVQGNREFLVEVLMLSLLHHPNL 131
+ E+++ G G YKG +SI + +K++ D N + + E+ + L HPN+
Sbjct: 693 KEENVISRGKKGASYKG--KSIKNGMQFVVKEINDVNSIPSS-----EIADMGKLQHPNI 745
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V LIG C L++EY+ ++ + L +LS W R KIA G A+ L +LH
Sbjct: 746 VKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLS-------WERRRKIAIGIAKALRFLHC 798
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG----DNTHVSTRVMGTYGYCAP 247
+ P V+ +L I++D P L +L G D + Y AP
Sbjct: 799 RCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISS-----AYVAP 847
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWS 293
E +T +T KSD+Y FG++L+E+L+G+ D S+V W+
Sbjct: 848 ETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWA 892
|
Length = 968 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-21
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 80 LGEGGFGRVY--KGYLESINQD---VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LGEG FG+V+ + Y S +D VA+K L + ++F E +L+ L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGA 182
G C DGD ++V+EYM G + L P K L + + IA+
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
A G+ YL A ++RDL N L+ K+ DFG+++ D V M
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ PE + T +SDV+SFGV+L EI +
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-21
Identities = 69/201 (34%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLL-HHPNLVNL 134
+LG+G FG+V+ L+ NQ AIK L ++ V + + +VE +LSL HP L +L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
+ V EY+ G + H+ D AA GL++LH K
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSKG- 116
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
++YRDLK NILLD H K++DFG+ K +GD + GT Y APE +
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLGQK 172
Query: 255 LTLKSDVYSFGVVLLEILSGR 275
D +SFGV+L E+L G+
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-21
Identities = 77/204 (37%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIG 136
+G G FG VY N+ VAIK++ +G Q N ++ + EV L L HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
LV EY LGS D L KKPL I GA +GL YLH +
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHER-- 136
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKL-GPVGDNTHVSTRVMGTYGYCAPEY---AKT 252
I+RD+K NILL KL+DFG A L P N+ V GT + APE
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASLVSPA--NSFV-----GTPYWMAPEVILAMDE 188
Query: 253 GQLTLKSDVYSFGVVLLEILSGRK 276
GQ K DV+S G+ +E L+ RK
Sbjct: 189 GQYDGKVDVWSLGITCIE-LAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-21
Identities = 71/198 (35%), Positives = 107/198 (54%), Gaps = 12/198 (6%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V+ G N VA+K L + G FL E ++ L H LV L +
Sbjct: 14 LGNGQFGEVWMGTWNG-NTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ + +V EYM GS+ D L D G+ L + +AA A G+ Y+ + I+
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKD-GEGRA-LKLPNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAKTGQLTLK 258
RDL+ +NIL+ G K++DFGLA+L + DN + + + + APE A G+ T+K
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 259 SDVYSFGVVLLEILS-GR 275
SDV+SFG++L E+++ GR
Sbjct: 184 SDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 6e-21
Identities = 68/196 (34%), Positives = 97/196 (49%), Gaps = 9/196 (4%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGY 137
LLG+G FG V+KG L+ VA+K + Q + +FL E +L HPN+V LIG
Sbjct: 2 LLGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197
C QR +Y M L D L L K L +K A AA G+ YL K
Sbjct: 61 CT---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---C 114
Query: 198 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 257
I+RDL N L+ K+SDFG+++ G + + + + APE G+ +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSS 173
Query: 258 KSDVYSFGVVLLEILS 273
+SDV+S+G++L E S
Sbjct: 174 ESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 6e-21
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQ--LDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGY 137
+G G FG+VY + +A+K+ + N + +E E+ +L LL HPNLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197
++ + EY G++E+ L + LD + GL YLH +
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSHG---I 120
Query: 198 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM----GTYGYCAPEYAKTG 253
++RD+K +NI LD KL DFG A + +NT + GT Y APE G
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVK--LKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 254 QLTLK---SDVYSFGVVLLEILSGRK 276
+ +D++S G V+LE+ +G++
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-21
Identities = 67/226 (29%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 66 ELAAATKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQL-DRNGVQGNREFLVE 119
E+ +T F E LGE FG+VYKG+L Q VAIK L D+ EF E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 120 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG------------K 167
+M S L HPN+V L+G +++ Y + + L SP K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 168 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227
L+ + I A G+E+L + V+++DL N+L+ + K+SD GL +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
D + + + +PE G+ ++ SD++S+GVVL E+ S
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 8e-21
Identities = 68/210 (32%), Positives = 113/210 (53%), Gaps = 19/210 (9%)
Query: 79 LLGEGGFGRVYKGYL----ESINQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVN 133
+LG G FG VYKG E++ VAIK L+ G + N EF+ E L+++ + HP+LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLH---DLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
L+G C + LV + MP G + D++H D + L+W ++ A+G+ YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
++ +++RDL N+L+ H K++DFGLA+L + + + + A E
Sbjct: 127 ERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 251 KTGQLTLKSDVYSFGVVLLEILS-GRKAVD 279
+ T +SDV+S+GV + E+++ G K D
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 9e-21
Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLI-GYC 138
LG+G FG+VYK + A K + + +F+VE+ +LS HPN+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
+ +L+ E+ G+++ + +L ++ L + L +LH VI
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK---VI 125
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA-----KTG 253
+RDLK NILL KL+DFG++ + +GT + APE K
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDN 183
Query: 254 QLTLKSDVYSFGVVLLEILSGR 275
K+D++S G+ L+E+
Sbjct: 184 PYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-20
Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 29/227 (12%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESIN-----QDVAIKQLDRNGVQGN-REFLVEVLMLSLL 126
N LGEG FG+V K + VA+K L N R+ L E +L +
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 127 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHL--------------------HDLSPG 166
+HP+++ L G C+ LL+ EY GS+ L + +P
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 167 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226
++ L + A +RG++YL A+ +++RDL N+L+ G K+SDFGL++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
D+ ++ + A E T +SDV+SFGV+L EI++
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-20
Identities = 65/195 (33%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V+ GY + + VA+K L + G + FL E ++ L H LV L
Sbjct: 14 LGAGQFGEVWMGYYNN-STKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ ++ EYM GS+ D L GK L + +A A G+ Y+ K I+
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERKN---YIH 126
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAKTGQLTLK 258
RDL+ +N+L+ K++DFGLA++ + DN + + + APE G T+K
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 259 SDVYSFGVVLLEILS 273
SDV+SFG++L EI++
Sbjct: 185 SDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-20
Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLV-EVLMLSLL-HHPNLV 132
LG G FG+V + +++ VA+K L RE L+ E+ ++S L +H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
NL+G C G L++ EY G + + L + L + + A+G+ +L K
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSYQVAKGMAFLASK 160
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV---STRVMGTYGYCAPEY 249
I+RDL N+LL G K+ DFGLA+ + D+ +V + R+ + APE
Sbjct: 161 N---CIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVVKGNARL--PVKWMAPES 214
Query: 250 AKTGQLTLKSDVYSFGVVLLEILS 273
T +SDV+S+G++L EI S
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 21/205 (10%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM-----LSLL-HHPNLV 132
+LG+G FG+V L+ ++ A+K L ++ + + + VE M L+L HP L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD--VECTMTEKRVLALAGKHPFLT 59
Query: 133 NLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLH 190
L C RL V EY+ G + H+ +P R + AA GL++LH
Sbjct: 60 QLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-----RARFYAAEIVLGLQFLH 113
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
++ +IYRDLK N+LLD H K++DFG+ K G +G T ++ GT Y APE
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEIL 168
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGR 275
D ++ GV+L E+L+G+
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-20
Identities = 71/219 (32%), Positives = 109/219 (49%), Gaps = 26/219 (11%)
Query: 73 NFRSESLLGEGGFGRVYKGYL--ESINQDVAIKQLDRNGVQGN-REFLVEVLMLSLL-HH 128
+ + + ++GEG FG+V K + + + D AIK++ + + R+F E+ +L L HH
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH-----DLSPG-------KKPLDWNTRM 176
PN++NL+G C L EY P G++ D L + P L +
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 177 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236
AA ARG++YL K I+RDL NIL+ Y K++DFGL++ G +V
Sbjct: 128 HFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 179
Query: 237 RVMGTYG--YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ MG + A E T SDV+S+GV+L EI+S
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-20
Identities = 66/197 (33%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC 138
+G G FG V+ G L + N VA+K + +FL E +L HPN+V LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
Q+ +Y M L D L L L +++ AA G+EYL K I
Sbjct: 63 T---QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT--YGYCAPEYAKTGQLT 256
+RDL N L+ K+SDFG+++ D + ST M + APE G+ +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 257 LKSDVYSFGVVLLEILS 273
+SDV+SFG++L E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-20
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 32/214 (14%)
Query: 79 LLGEGGFGRVYKGYLESINQDV------AIKQLD--RNGVQGNREFLVEVL-----MLSL 125
LG G F Y+ +DV A+KQ+ RN +E +VE L +++
Sbjct: 7 QLGTGAFSSCYQA------RDVKTGTLMAVKQVTYVRNT-SSEQEEVVEALRKEIRLMAR 59
Query: 126 LHHPNLVNLIG-YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR 184
L+HP+++ ++G C D L V E+M GSV L K+ + N ++ R
Sbjct: 60 LNHPHIIRMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----R 114
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLA-KLGPVGDNT-HVSTRVMGT 241
GL YLH+ +I+RD+K +N+L+D G +++DFG A +L G +++GT
Sbjct: 115 GLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ APE + Q DV+S G V++E+ + +
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-20
Identities = 65/231 (28%), Positives = 106/231 (45%), Gaps = 26/231 (11%)
Query: 80 LGEGGFGRVY----KGYLESINQD----------VAIKQLDRNGVQGNR-EFLVEVLMLS 124
LGEG FG V+ +G E + + VA+K L + + R +FL E+ ++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 125 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD--------LSPGKKPLDWNTRM 176
L +PN++ L+G C D ++ EYM G + L + + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 177 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236
+A A G++YL A ++RDL N L+ Y K++DFG+++ GD +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287
R + + A E G+ T SDV++FGV L E+ + K S + EQ
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 8e-20
Identities = 70/206 (33%), Positives = 108/206 (52%), Gaps = 12/206 (5%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
++ R E LG+G FG V+ G + VAIK L + G FL E ++ L H L
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 63
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L ++ + +V EYM GS+ D L K L + +AA A G+ Y+
Sbjct: 64 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVE- 119
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYA 250
+ ++RDL+ +NIL+ K++DFGLA+L + DN + + + + APE A
Sbjct: 120 --RMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 251 KTGQLTLKSDVYSFGVVLLEILS-GR 275
G+ T+KSDV+SFG++L E+ + GR
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-19
Identities = 69/228 (30%), Positives = 111/228 (48%), Gaps = 26/228 (11%)
Query: 55 DQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR 114
++I + T + K + +G+G G VY + Q+VAIKQ++ Q +
Sbjct: 2 EEILEKLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKK 60
Query: 115 EFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 173
E ++ E+L++ HPN+VN + GD+ +V EY+ GS+ D + +
Sbjct: 61 ELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----------- 109
Query: 174 TRMKIAAGAA------RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLG 226
T M AA + LE+LH VI+RD+K NILL KL+DFG A++
Sbjct: 110 TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166
Query: 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
P + + ST V GT + APE K D++S G++ +E++ G
Sbjct: 167 P--EQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 1e-19
Identities = 61/208 (29%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHP 129
+F ++G+G FG+V + A+K +++ R L E +L L+HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEY 188
LVNL D + LV + + G + HL + ++K LEY
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE-----EQVKFWICEIVLALEY 115
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
LH K +I+RD+K NILLD H ++DF +A T T GT GY APE
Sbjct: 116 LHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPE 169
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGRK 276
++ D +S GV E L G++
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-19
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 79 LLGEGGFGRVYKGYLESIN-----QDVAIKQLDRNGVQGN-REFLVEVLMLSLL-HHPNL 131
LGEG FG+V K ++ VA+K L + + + + + E+ M+ ++ H N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP----GKKPLDWNTRMKI--------A 179
+NL+G C +V EY G++ D L P + A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 239
ARG+E+L K I+RDL N+L+ + K++DFGLA+ + +
Sbjct: 139 YQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKTTN 193
Query: 240 G--TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
G + APE T +SDV+SFGV+L EI +
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-19
Identities = 63/215 (29%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 74 FRSESLLGEGGFGRVYKGYL----ESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHH 128
F+ +LG G FG VYKG E + VAIK+L + + N+E L E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH---DLSPGKKPLDWNTRMKIAAGAARG 185
P++ L+G C +L + + MP G + D++ D + L+W ++ A+G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
+ YL ++ +++RDL N+L+ H K++DFGLAKL + + + +
Sbjct: 122 MNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVD 279
A E T +SDV+S+GV + E+++ G K D
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-19
Identities = 72/203 (35%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIG 136
+G G FG VY N+ VA+K++ +G Q N ++ + EV L L HPN + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
LV EY LGS D L KKPL I GA +GL YLH
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHNM-- 142
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY---AKTG 253
I+RD+K NILL KL+DFG A ++ +GT + APE G
Sbjct: 143 -IHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAMDEG 195
Query: 254 QLTLKSDVYSFGVVLLEILSGRK 276
Q K DV+S G+ +E L+ RK
Sbjct: 196 QYDGKVDVWSLGITCIE-LAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 8/202 (3%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLV-EVLMLSLLHHPNLVNLIGY 137
+G+G FG V K +S + + K++D N + ++ LV EV +L L HPN+V
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 138 CADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH--DKA 193
D + L V EY G + + +K ++ +I L H
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
V++RDLK +NI LD + KL DFGLAK+ +G ++ + +GT Y +PE
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKI--LGHDSSFAKTYVGTPYYMSPEQLNHM 185
Query: 254 QLTLKSDVYSFGVVLLEILSGR 275
KSD++S G ++ E+ +
Sbjct: 186 SYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-19
Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 80 LGEGGFGRVY--KGYLESINQD---VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LGEG FG+V+ + Y QD VA+K L ++F E +L+ L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-------GKKP--LDWNTRMKIAAGAARG 185
G C +GD ++V+EYM G + L P G +P L + + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
+ YL A ++RDL N L+ K+ DFG+++ D V M +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILS 273
PE + T +SDV+S GVVL EI +
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-19
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 133
LG+G FG VY+G + + +D VAIK ++ R EFL E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDL------SPGKKPLDWNTRMKIAAGAARGLE 187
L+G + G L++ E M G ++ +L L +P + P +++A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
YL+ ++RDL N ++ + K+ DFG+ + D + + + +P
Sbjct: 134 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEI 271
E K G T SDV+SFGVVL EI
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-19
Identities = 69/241 (28%), Positives = 109/241 (45%), Gaps = 37/241 (15%)
Query: 80 LGEGGFGRVYKGYLESINQD-----------------VAIKQLDRNGVQGNR-EFLVEVL 121
LGEG FG V+ + + QD VA+K L + + R +FL EV
Sbjct: 13 LGEGQFGEVHLCEVVN-PQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 122 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHL--HDLSPGKKP---------- 169
+LS L PN++ L+G C D D ++ EYM G + L H L ++
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 170 ---LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226
+ +++ + +A A G++YL + ++RDL N L+ K++DFG+++
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286
GD + R + + A E G+ T SDV++FGV L EIL K + E
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248
Query: 287 Q 287
Q
Sbjct: 249 Q 249
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-19
Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 79 LLGEGGFGRVYKGYL---ESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVN 133
+LGEG FG V +G L + VA+K + + + EFL E + HPN++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 134 LIGYCADGDQR------LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM--KIAAGAARG 185
LIG C + +++ +M G + L G P + K A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD---NTHVSTRVMGTY 242
+EYL ++ I+RDL N +L ++DFGL+K GD ++ +
Sbjct: 126 MEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 180
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ A E T KSDV++FGV + EI +
Sbjct: 181 -WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-19
Identities = 62/197 (31%), Positives = 95/197 (48%), Gaps = 15/197 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V G DVAIK + + G EF+ E ++ L H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+V EYM G + ++L + +P +++ G+ YL K I+
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYLESKQ---FIH 123
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 256
RDL N L+D K+SDFGL++ V D+ + S+ +G+ + PE + +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLLYSKFS 179
Query: 257 LKSDVYSFGVVLLEILS 273
KSDV++FGV++ E+ S
Sbjct: 180 SKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-19
Identities = 64/196 (32%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 138
+G+G FG VYKG + VAIK +D + E + E+ +LS P + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
G + ++ EY+ GS D L PG PL+ I +GL+YLH + K I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL---KPG--PLEETYIATILREILKGLDYLHSERK---I 123
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK 258
+RD+K +N+LL KL+DFG+A G + D +GT + APE K K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 259 SDVYSFGVVLLEILSG 274
+D++S G+ +E+ G
Sbjct: 182 ADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-19
Identities = 66/232 (28%), Positives = 112/232 (48%), Gaps = 27/232 (11%)
Query: 80 LGEGGFGRVY----KGYLESINQD------------VAIKQLDRNGVQGNR-EFLVEVLM 122
LGEG FG V+ +G + +++D VA+K L + + R +FL E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 123 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD-------WNTR 175
+S L PN++ L+ C D ++ EYM G + L P + ++T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235
+ +A A G++YL + ++RDL N L+ + Y K++DFG+++ GD +
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 236 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287
R + + + E G+ T SDV++FGV L EIL+ K S+ + EQ
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 5e-19
Identities = 70/217 (32%), Positives = 98/217 (45%), Gaps = 36/217 (16%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLML-SLLHHPNLVNLIG- 136
++GEG +G+VYK + Q VAIK +D + E E +L +HPN+ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 137 -----YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK------IAAGAARG 185
+ DQ LV E GSV D + K R+K I RG
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIAYILRETLRG 125
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTR--VMGTY 242
L YLH+ VI+RD+K NILL + KL DFG+ A+L D+T + R +GT
Sbjct: 126 LAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQL----DST-LGRRNTFIGTP 177
Query: 243 GYCAPE-----YAKTGQLTLKSDVYSFGVVLLEILSG 274
+ APE +SDV+S G+ +E+ G
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 6e-19
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH 127
A K + +G+G FG V G + VA+K + + + FL E +++ L
Sbjct: 2 ALNMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLR 57
Query: 128 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
H NLV L+G + L +V EYM GS+ D+L S G+ L + +K + +
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAM 115
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYC 245
EYL ++RDL N+L+ K+SDFGL K D + + +
Sbjct: 116 EYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WT 166
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILS-GR 275
APE + + + KSDV+SFG++L EI S GR
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 7e-19
Identities = 69/206 (33%), Positives = 110/206 (53%), Gaps = 12/206 (5%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
++ R + LG+G FG V+ G + VAIK L + G FL E ++ L H L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTK-VAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L ++ + +V E+M GS+ D L + K L + +AA A G+ Y+
Sbjct: 64 VPLYAVVSE-EPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIE- 119
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYA 250
+ I+RDL+ +NIL+ K++DFGLA+L + DN + + + + APE A
Sbjct: 120 --RMNYIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 251 KTGQLTLKSDVYSFGVVLLEILS-GR 275
G+ T+KSDV+SFG++L E+++ GR
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 9e-19
Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 39/217 (17%)
Query: 77 ESLLGEGGFGRVYKGYLESINQDVAIKQL-------DRNGVQGNREFLVEVLMLSLLHHP 129
LGEG + VYK + + VAIK++ ++G+ N L E+ +L L HP
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGI--NFTALREIKLLQELKHP 62
Query: 130 NLVNLIG-YCADGDQRL-LVYEYMPLGSVEDHLHD----LSPG-KKPLDWNTRMKIAAGA 182
N++ L+ + + LV+E+M +E + D L+P K T
Sbjct: 63 NIIGLLDVFGH--KSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT-------- 111
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD-NTHVSTRVMGT 241
RGLEYLH +++RDLK +N+L+ KL+DFGLA+ G N ++ +V+ T
Sbjct: 112 LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS--FGSPNRKMTHQVV-T 165
Query: 242 YGYCAPEY---AKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE A+ + D++S G + E+L
Sbjct: 166 RWYRAPELLFGAR--HYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 19/193 (9%)
Query: 98 QDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLL-VYEYMPL 153
+VAIK L + + + F E + + L+HPN+V L+ L V+EY+P
Sbjct: 4 HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63
Query: 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---D 210
++ + L L ++ L H++ +++RDLK NI++
Sbjct: 64 RTLREVLA----ADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116
Query: 211 RGYHPKLSDFGLAKLGP-VGDNTHV----STRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 265
H K+ DFG+ L P V D +T V+GT YCAPE + +T SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 266 VVLLEILSGRKAV 278
++ LE L+G++ V
Sbjct: 177 LIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-18
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQ--LDRNGVQGN----REFLVEVLMLSLLHHPNLV 132
+LG+G +G VY G L + Q +A+KQ LD + V + EV +L L H N+V
Sbjct: 7 VLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
+G C D + + E++P GS+ L+ P +P+ +I G A YLH+
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNN 121
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK----LGPVGDNTHVSTRVMGTYGYCAPE 248
V++RD+K +N++L KL DFG A+ +G G ++++ + GT + APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGR 275
KSD++S G + E+ +G+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-18
Identities = 66/201 (32%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLH-HPNLVNL 134
+LG+G FG+V L+ + A+K L ++ + + + + E +LSL HP L L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 135 IGYCADGDQRLL-VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
C RL V E++ G + H+ + D AA L +LHDK
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG 116
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
+IYRDLK N+LLD H KL+DFG+ K G + + ST GT Y APE +
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG-IFNGKTTST-FCGTPDYIAPEILQEM 171
Query: 254 QLTLKSDVYSFGVVLLEILSG 274
D ++ GV+L E+L G
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-18
Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 35/206 (16%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL------DRNGVQGNREFLVEVLMLSLLHHPNLVN 133
+G G +G VYK + + VAIK + D +Q E+ ML HPN+V
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ------EISMLKECRHPNIVA 64
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA---AGAARGLEYLH 190
G D+ +V EY GS++D + PL + ++IA +GL YLH
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVT---RGPL---SELQIAYVCRETLKGLAYLH 118
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGYCAP 247
+ K I+RD+K +NILL KL+DFG+ A+L T ++ R +GT + AP
Sbjct: 119 ETGK---IHRDIKGANILLTEDGDVKLADFGVSAQL----TAT-IAKRKSFIGTPYWMAP 170
Query: 248 EYA---KTGQLTLKSDVYSFGVVLLE 270
E A + G K D+++ G+ +E
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 57/209 (27%), Positives = 88/209 (42%), Gaps = 27/209 (12%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVN 133
++GEG +G V K ++ + VAIK+ D V+ + L EV +L L H N+VN
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK--KTALREVKVLRQLRHENIVN 64
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
L + LV+EY+ L L L + + + Y H
Sbjct: 65 LKEAFRRKGRLYLVFEYVE----RTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
+I+RD+K NIL+ KL DFG A+ + ++ V T Y APE
Sbjct: 121 ---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPE----- 171
Query: 254 QLTLKS-------DVYSFGVVLLEILSGR 275
L + DV++ G ++ E+L G
Sbjct: 172 -LLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-18
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE----------FLVEVLMLSLLHH 128
L+G+G +GRVY + + +A+KQ++ R E+ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
N+V +G+ + + EY+P GS+ L ++ L ++ GL Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL----EGLAY 123
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM---GTYGYC 245
LH K +++RDLK N+L+D K+SDFG++K D+ + + + M G+ +
Sbjct: 124 LHSKG---ILHRDLKADNLLVDADGICKISDFGISKK---SDDIYDNDQNMSMQGSVFWM 177
Query: 246 APEYAKTGQ--LTLKSDVYSFGVVLLEILSGRK 276
APE + + K D++S G V+LE+ +GR+
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-18
Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 14/222 (6%)
Query: 55 DQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR 114
++I + T + K + +G+G G V+ + Q+VAIKQ++ Q +
Sbjct: 2 EEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKK 60
Query: 115 EFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 173
E ++ E+L++ L +PN+VN + GD+ +V EY+ GS+ D + + +D
Sbjct: 61 ELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC-----MDEA 115
Query: 174 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNT 232
+ + LE+LH VI+RD+K N+LL KL+DFG A++ P + +
Sbjct: 116 QIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQS 170
Query: 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
ST V GT + APE K D++S G++ +E++ G
Sbjct: 171 KRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-18
Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 11/205 (5%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPN 130
FR +LG+GGFG V + + + A K+L++ ++ G L E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+VNL D LV M G ++ H++++ G + + AA GLE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLH 119
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
+ +YRDLK NILLD H ++SD GLA P G++ + RV GT GY APE
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVL 173
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGR 275
+ TL D + G ++ E++ G+
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-18
Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 15/212 (7%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 129
+F +LG+G FG+V + ++ AIK L ++ + + + +VE +L+L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 130 NLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
+ + C RL V EY+ G + H+ + K+P + AA A GL +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP----HAVFYAAEIAIGLFF 116
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 247
LH K +IYRDLK N++LD H K++DFG+ K G T TR GT Y AP
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAP 170
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 279
E D ++FGV+L E+L+G+ D
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 68/208 (32%), Positives = 99/208 (47%), Gaps = 32/208 (15%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV------EVLMLSLLHHPNLVN 133
+GEG +G V+K Q VAIK+ V+ + ++ E+ ML L HPNLVN
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF----VESEDDPVIKKIALREIRMLKQLKHPNLVN 64
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDH--LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
LI + LV+EY DH L++L + + + KI + + + H
Sbjct: 65 LIEVFRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH- 117
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNT-HVSTRVMGTYGYCAPE 248
K I+RD+K NIL+ + KL DFG A++ GP D T +V+TR Y APE
Sbjct: 118 --KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPE 170
Query: 249 YAKTGQLTLKS--DVYSFGVVLLEILSG 274
G DV++ G V E+L+G
Sbjct: 171 LL-VGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-18
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 15/212 (7%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 129
+F +LG+G FG+V + ++ AIK L ++ V + + +VE +L+L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 130 NLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
+ + C RL V EY+ G + H+ + K+P + AA + GL +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP----QAVFYAAEISVGLFF 116
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 247
LH + +IYRDLK N++LD H K++DFG+ K V V+TR GT Y AP
Sbjct: 117 LHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV---DGVTTRTFCGTPDYIAP 170
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 279
E D +++GV+L E+L+G+ D
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 65/199 (32%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIG 136
LG G FGRV + + AIK L + + ++ E +L L HP +VN++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKP 195
D ++ + E++ G + HL G+ P N K A EYLH K
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLR--KAGRFP---NDVAKFYHAELVLAFEYLHSKD-- 138
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 255
+IYRDLK N+LLD H K++DFG AK V D T + GT Y APE ++
Sbjct: 139 -IIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT---LCGTPEYLAPEVIQSKGH 192
Query: 256 TLKSDVYSFGVVLLEILSG 274
D ++ GV+L E ++G
Sbjct: 193 GKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-18
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPN 130
FR +LG+GGFG V + + + A K+L++ ++ G L E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V+L D LV M G ++ H++++ D + AA GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCGLEDLH 119
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
+ ++YRDLK NILLD H ++SD GLA P G+ + RV GT GY APE
Sbjct: 120 RER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVV 173
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGR 275
K + T D + G ++ E++ G+
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-18
Identities = 69/207 (33%), Positives = 99/207 (47%), Gaps = 28/207 (13%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
L+GEG +G V K + Q VAIK+ D V + + E+ ML L H NLVNL
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMV--KKIAMREIRMLKQLRHENLVNL 65
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDH--LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
I + LV+E++ DH L DL LD + K RG+E+ H
Sbjct: 66 IEVFRRKKRLYLVFEFV------DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEY-- 249
+I+RD+K NIL+ + KL DFG A+ L G+ V T + T Y APE
Sbjct: 120 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPELLV 173
Query: 250 --AKTGQLTLKSDVYSFGVVLLEILSG 274
K G+ D+++ G ++ E+L+G
Sbjct: 174 GDTKYGRAV---DIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-18
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 15/206 (7%)
Query: 79 LLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLV 132
LG G FG V+ E V +K L + + EF E+ M L H N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHL-----HDLSPGKKPLDWNTRMKIAAGAARGLE 187
L+G C + + ++ EY LG ++ L D PL ++ + A G++
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
+L + ++RDL N L+ K+S L+K + + + AP
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNALIPLRWLAP 187
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILS 273
E + + KSDV+SFGV++ E+ +
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-18
Identities = 72/203 (35%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIG 136
+G G FG VY N+ VAIK++ +G Q N ++ + EV L + HPN + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
LV EY LGS D L KKPL I GA +GL YLH
Sbjct: 93 CYLREHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHN--- 145
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY---AKTG 253
+I+RD+K NILL KL+DFG A + ++ +GT + APE G
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVILAMDEG 199
Query: 254 QLTLKSDVYSFGVVLLEILSGRK 276
Q K DV+S G+ +E L+ RK
Sbjct: 200 QYDGKVDVWSLGITCIE-LAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-18
Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 77 ESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNL 131
E ++G G FG V +G L+ + VAIK L ++G + R+FL E ++ HPN+
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
++L G +++ E+M G+++ L + G+ + M G A G++YL +
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLR-QNDGQFTVIQLVGM--LRGIAAGMKYLSE 124
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCA 246
++RDL NIL++ K+SDFGL++ + D+T T G + A
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRF--LEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 247 PEYAKTGQLTLKSDVYSFGVVLLEILS 273
PE + T SDV+S+G+V+ E++S
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-18
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 79 LLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNL 134
+GEG FG VY+G S + VA+K RE FL E ++ HP++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
IG + + +V E PLG + +L K LD + + + + L YL K
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKR- 127
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAKTG 253
++RD+ N+L+ KL DFGL++ + D ++ +++ + APE
Sbjct: 128 --FVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKWMAPESINFR 183
Query: 254 QLTLKSDVYSFGVVLLEILS 273
+ T SDV+ FGV + EIL
Sbjct: 184 RFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 5e-18
Identities = 63/196 (32%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 138
+G+G FG V+KG + VAIK +D + E + E+ +LS P + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
+ ++ EY+ GS D L PG PLD I +GL+YLH + K I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLE---PG--PLDETQIATILREILKGLDYLHSEKK---I 123
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK 258
+RD+K +N+LL KL+DFG+A G + D +GT + APE K K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 259 SDVYSFGVVLLEILSG 274
+D++S G+ +E+ G
Sbjct: 182 ADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-18
Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 77 ESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLV 132
+ ++G G FG V++G L+ + VAIK L + R +FL E ++ H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
L G +++ EYM G+++ +L D ++ G A G++YL D
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSDM 126
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAK 251
++RDL NIL++ K+SDFGL++ L + T+ ++ + APE
Sbjct: 127 N---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 252 TGQLTLKSDVYSFGVVLLEILS 273
+ T SDV+SFG+V+ E++S
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-18
Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 80 LGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 133
LG+G FG VY+G I VA+K ++ + R EFL E ++ ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDL------SPGKKPLDWNTRMKIAAGAARGLE 187
L+G + G L+V E M G ++ +L L +PG+ P +++AA A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
YL+ K ++RDL N ++ + K+ DFG+ + D + + + AP
Sbjct: 134 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILS 273
E K G T SD++SFGVVL EI S
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-18
Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 19/219 (8%)
Query: 74 FRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHH 128
+ +LG G FG VYKG E++ VAIK L N + N+E L E +++ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH---DLSPGKKPLDWNTRMKIAAGAARG 185
P + L+G C +L V + MP G + D++ D + L+W ++ A+G
Sbjct: 69 PYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKG 121
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
+ YL + +++RDL N+L+ H K++DFGLA+L + + + + +
Sbjct: 122 MSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKA 283
A E + T +SDV+S+GV + E+++ G K D A
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-18
Identities = 60/198 (30%), Positives = 84/198 (42%), Gaps = 21/198 (10%)
Query: 83 GGFGRVYKGYLESINQDVAIKQLDR------NGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
G FG VY S AIK L + N V + +M+ P + L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVK--AERAIMMIQGESPYVAKLYY 64
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
D LV EY+ G + L G P DW + A G+E LH +
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAK--QYIAEVVLGVEDLHQRG--- 117
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 256
+I+RD+K N+L+D+ H KL+DFGL++ G + + +GT Y APE
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDD 171
Query: 257 LKSDVYSFGVVLLEILSG 274
SD +S G V+ E L G
Sbjct: 172 KMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 5e-18
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGY 137
+GEG G V+K + VA+K++ ++G + L E+ L HP +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197
G +LV EYMP + + L D +PL +G+ Y+H +
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG---I 120
Query: 198 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE--YAKTGQL 255
++RDLK +N+L+ K++DFGLA+L + S +V T Y APE Y +
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGAR-KY 178
Query: 256 TLKSDVYSFGVVLLEILSGR 275
D+++ G + E+L+G
Sbjct: 179 DPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-18
Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNRE---FLVEVLMLSLLH 127
N+R LLG+G FGRVY Y +++A+KQ+ D + ++E E+ +L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 128 HPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
H +V G D +R L E+MP GS++D L L N K G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEG 118
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGY 244
+ YLH +++RD+K +NIL D + KL DFG +K L + + V GT +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
+PE K+D++S G ++E+L+ +
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 9e-18
Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
++ + E LG G FG V+ + VA+K + + G FL E ++ L H L
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKL 63
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L + ++ E+M GS+ D L K+PL + +A A G+ ++
Sbjct: 64 VKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ 120
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYA 250
+ I+RDL+ +NIL+ K++DFGLA++ + DN + + + APE
Sbjct: 121 RN---YIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAI 175
Query: 251 KTGQLTLKSDVYSFGVVLLEILS-GR 275
G T+KSDV+SFG++L+EI++ GR
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 9e-18
Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 16/233 (6%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNRE---FLVEVLMLSLLH 127
N+R LLG+G FGRVY Y +++A KQ+ D + ++E E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 128 HPNLVNLIGYCADGDQRLLV--YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
H +V G D ++ L EYMP GSV+D L L + K G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEG 118
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGY 244
+ YLH +++RD+K +NIL D + KL DFG +K L + + V GT +
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEPEN 297
+PE K+DV+S G ++E+L+ + +A A +A ++P N
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA-TQPTN 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-18
Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPN 130
FR +LG+GGFG V + + + A K+L++ ++ G L E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V+L D LV M G ++ H++ + G+ + + AA GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
+ ++YRDLK NILLD H ++SD GLA P G + RV GT GY APE
Sbjct: 120 ---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVV 173
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282
K + T D ++ G +L E+++G+ K
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-17
Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 74 FRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLH 127
LL EG FGR++ G L ++V +K + + +Q L E +L L
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL-LLQESCLLYGLS 66
Query: 128 HPNLVNLIGYCA-DGDQRLLVYEYMPLGSVEDHLHD--LSPGKKPLDWNTR--MKIAAGA 182
H N++ ++ C DG+ ++Y YM G+++ L L P +T+ + +A
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGP-----VGDNTHVST 236
A G+ YLH + VI++D+ N ++D K++D L++ L P +GDN +
Sbjct: 127 ACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ M A E + + SDV+SFGV+L E+++
Sbjct: 184 KWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-17
Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 17/201 (8%)
Query: 80 LGEGGFGRVYKGY--LESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIG 136
LG G FG V KG + DVAIK L + R E + E ++ L +P +V +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK-PLDWNTRMKIAAGAARGLEYLHDKAKP 195
C + + +LV E G L+ GKK + + +++ + G++YL K
Sbjct: 63 VC-EAEALMLVMEMASGGP----LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN-- 115
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTY--GYCAPEYAKT 252
++RDL N+LL ++ K+SDFGL+K LG D+++ R G + + APE
Sbjct: 116 -FVHRDLAARNVLLVNQHYAKISDFGLSKALG--ADDSYYKARSAGKWPLKWYAPECINF 172
Query: 253 GQLTLKSDVYSFGVVLLEILS 273
+ + +SDV+S+G+ + E S
Sbjct: 173 RKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-17
Identities = 68/198 (34%), Positives = 91/198 (45%), Gaps = 19/198 (9%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIG 136
+G G FG VY ++ VAIK++ +G Q N ++ + EV L L HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
LV EY LGS D L KKPL + GA +GL YLH
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY---AKTG 253
+I+RD+K NILL KL DFG A + + +GT + APE G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVILAMDEG 189
Query: 254 QLTLKSDVYSFGVVLLEI 271
Q K DV+S G+ +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-17
Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIG 136
LG+GGFG V +++ + A K+LD+ ++ G + L+E +L ++ P +VNL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 137 YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
Y + L LV M G ++ H++++ G++ L+ + +A G+ +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD-- 115
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 255
++YRD+K N+LLD + +LSD GLA G T+ GT GY APE K
Sbjct: 116 -IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPY 171
Query: 256 TLKSDVYSFGVVLLEILSGR 275
+ D ++ G + E+++GR
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-17
Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLD--RNGVQGNREFLVEVLMLSLLHHPNLVNLIGY 137
LG+G FG + V K+++ R + R+ L E+++LSLL HPN++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197
D + L+ EY G++ D + + + + + + Y+H K +
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGI 122
Query: 198 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 257
++RD+K NI L + KL DFG++K+ +G ++ V+GT Y +PE + +
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQGVKYNF 180
Query: 258 KSDVYSFGVVLLEILSGRKAVDTS 281
KSD+++ G VL E+L+ ++ D +
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-17
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLV--EVLMLSLLHHP 129
+ +G G FGRV+ A+K + ++ +E V E +L + HP
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 130 NLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
++ L + + DQR L + EY+P G + +L + G+ +T + A+ LE
Sbjct: 62 FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLR--NSGR--FSNSTGLFYASEIVCALE 115
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
YLH K ++YRDLK NILLD+ H KL+DFG AK + D T + GT Y AP
Sbjct: 116 YLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWT---LCGTPEYLAP 167
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSG 274
E ++ D ++ G+++ E+L G
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 5e-17
Identities = 64/218 (29%), Positives = 95/218 (43%), Gaps = 50/218 (22%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF--------LVEVLML-SLLHHPN 130
LG+G FG VY + + VAIK++ ++F L EV L L HPN
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTRMKIAAGAARGLEY 188
+V L + D+ V+EYM E +L+ L KP + I +GL +
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN----THVSTRVMGTYGY 244
+H K +RDLK N+L+ K++DFGLA+ + +VSTR Y
Sbjct: 115 IH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR-----WY 164
Query: 245 CAPEYAKTGQLTLKSDVYS-------FGVVLLEILSGR 275
APE + L+S YS G ++ E+ + R
Sbjct: 165 RAPE------ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-17
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPN 130
FR +LG+GGFG V + + + A K+L++ ++ G L E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V+L D LV M G ++ H++++ G D + AA GLE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
+ ++YRDLK NILLD H ++SD GLA P G+ V RV GT GY APE
Sbjct: 120 ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVI 173
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGR 275
+ T D + G ++ E++ G+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-17
Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 11/196 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 138
+G+G FG V+KG Q VAIK +D + E + E+ +LS P + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
G + ++ EY+ GS D L P D + +GL+YLH + K I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSEKK---I 123
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK 258
+RD+K +N+LL KL+DFG+A G + D +GT + APE + K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 259 SDVYSFGVVLLEILSG 274
+D++S G+ +E+ G
Sbjct: 182 ADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-17
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 24/202 (11%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 138
+GEG G V +S + VA+K++D Q RE L EV+++ HPN+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM---KIAA---GAARGLEYLHDK 192
GD+ +V E++ G++ D + +TRM +IA + L +LH +
Sbjct: 86 LVGDELWVVMEFLEGGALTDIVT-----------HTRMNEEQIATVCLAVLKALSFLHAQ 134
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 252
VI+RD+K +ILL KLSDFG V ++GT + APE
Sbjct: 135 G---VIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISR 189
Query: 253 GQLTLKSDVYSFGVVLLEILSG 274
+ D++S G++++E++ G
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-17
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 15/209 (7%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNRE---FLVEVLMLSLLH 127
N+R LLG G FG VY Y +++A+KQ+ D + + ++E E+ +L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 128 HPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
H +V G D +++ L EYMP GS++D L L N + +G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA----LTENVTRRYTRQILQG 118
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGY 244
+ YLH +++RD+K +NIL D + KL DFG +K + + + V GT +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+PE K+DV+S ++E+L+
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 7e-17
Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V+ G + + VAIK + G +F+ E ++ L HP LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIK-VAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+V E+M G + L+ L + L + + + G+EYL + I+
Sbjct: 70 QQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIH 123
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAKTGQLTLK 258
RDL N L+ K+SDFG+ + V D+ + S+ + PE + + K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 259 SDVYSFGVVLLEILS 273
SDV+SFGV++ E+ +
Sbjct: 182 SDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 8e-17
Identities = 66/210 (31%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLD-----RNGVQGNREFLVEVLMLSLLHHP 129
LGEG FG V +G L NQD VA+K + R+ ++ +FL E + + HP
Sbjct: 7 LGEGEFGSVMEGQL---NQDDSILKVAVKTMKIAICTRSEME---DFLSEAVCMKEFDHP 60
Query: 130 NLVNLIGYCADGDQR------LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM--KIAAG 181
N++ LIG C + +++ +M G + L G P T+M K
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
A G+EYL K+ I+RDL N +L+ + ++DFGL+K GD
Sbjct: 121 IASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 271
+ A E T KSDV+SFGV + EI
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-17
Identities = 64/201 (31%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSL-LHHPNLVNL 134
+LG+G FG+V L+ ++ AIK L ++ + + + + E +L+L HP L L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
D+ V EY+ G D + + +K D AA L +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGG---DLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRHG- 116
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
VIYRDLK NILLD H KL+DFG+ K G + T +T GT Y APE + +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQELE 172
Query: 255 LTLKSDVYSFGVVLLEILSGR 275
D ++ GV++ E+++G+
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 9e-17
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD--RNGVQGNREFLVEVLMLSLLHHPN 130
+ +GEG FG++Y +S ++ IK++D + V+ EV++L+ + HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD----LSPGKKPLDWNTRMKIAAGAARGL 186
+V + + +V EY G + ++ L + L W ++ + GL
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GL 114
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
+++HD+ +++RD+K NI L + G KL DFG+A+ + D+ ++ +GT Y
Sbjct: 115 KHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYL 169
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEI 271
+PE + K+D++S G VL E+
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-16
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGNR-EFLVEVLMLSLLHH 128
+ E ++G G FG V G L+ + VAIK L + R +FL E ++ H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHL--HDLSPGKKPLDWNTRMKIAAGAARGL 186
PN+++L G ++V EYM GS++ L HD L + + G A G+
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASGM 119
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG---TYG 243
+YL D ++RDL NIL++ K+SDFGL+++ + D+ + G
Sbjct: 120 KYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIR 174
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ APE + T SDV+S+G+V+ E++S
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 14/197 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 138
+G+G G VY + Q+VAIKQ++ Q +E ++ E+L++ +PN+VN +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
GD+ +V EY+ GS+ D + + +D + + L++LH VI
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALDFLHSNQ---VI 137
Query: 199 YRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 257
+RD+K NILL KL+DFG A++ P + + ST V GT + APE
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 258 KSDVYSFGVVLLEILSG 274
K D++S G++ +E++ G
Sbjct: 195 KVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 14/197 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 138
+G+G G VY + Q+VAI+Q++ Q +E ++ E+L++ +PN+VN +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
GD+ +V EY+ GS+ D + + +D + + LE+LH VI
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSNQ---VI 138
Query: 199 YRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 257
+RD+K NILL KL+DFG A++ P + ++GT + APE
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 258 KSDVYSFGVVLLEILSG 274
K D++S G++ +E++ G
Sbjct: 196 KVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLH 127
F + +GEG +G VY+ + + VA+K++ +R+G+ + L E+ +L L
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--LREITLLLNLR 64
Query: 128 HPNLVNLIGYCADGDQR---LLVYEY--MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGA 182
HPN+V L G LV EY L S+ D++ P + +
Sbjct: 65 HPNIVELKEVVV-GKHLDSIFLVMEYCEQDLASLLDNM------PTPFSESQVKCLMLQL 117
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
RGL+YLH+ +I+RDLK SN+LL K++DFGLA+ G T + T
Sbjct: 118 LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTL 172
Query: 243 GYCAPE--YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE T T D+++ G +L E+L+ +
Sbjct: 173 WYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 80 LGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGNREFLV-EVLMLSLL-HHPN 130
LGEG FG+V I++D VA+K L + + + LV E+ M+ ++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKI 178
++NL+G C ++ EY G++ ++L P + + + +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 238
ARG+EYL A I+RDL N+L+ K++DFGLA+ D +T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 239 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ APE T +SDV+SFGV++ EI +
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-16
Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 33/227 (14%)
Query: 80 LGEGGFGRVYKGYLESINQD----------VAIKQLDRNGVQGNREFLVEVLMLSLLHHP 129
LG+G F +YKG L + V +K L + + F ++S L H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHK 61
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
+LV L G C D+ ++V EY+ G ++ LH L W ++ +A A L YL
Sbjct: 62 HLVKLYGVCV-RDENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYL 117
Query: 190 HDKAKPPVIYRDLKCSNILLDR-----GYHP--KLSDFGLAKLGPVGDNTHVSTRVMGTY 242
DK +++ ++ NIL+ R GY P KLSD G+ V R+
Sbjct: 118 EDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI---- 168
Query: 243 GYCAPEYAKTGQ--LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287
+ APE + GQ LT+ +D +SFG LLEI S + ++ +++E+
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM-LSLLHH---PNLVNLI 135
LG G G V K +A K + + ++L L ++H P +V+
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVH---IGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 136 G-YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
G + + + + E+M GS++ P + KIA GL YL++ +
Sbjct: 70 GAFLNENNI-CMCMEFMDCGSLDRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNVHR 124
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD--NTHVSTRVMGTYGYCAPEYAKT 252
+++RD+K SNIL++ KL DFG++ G+ N+ T V GT Y +PE +
Sbjct: 125 --IMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFV-GTSTYMSPERIQG 176
Query: 253 GQLTLKSDVYSFGVVLLEILSGR 275
G+ T+KSDV+S G+ ++E+ G+
Sbjct: 177 GKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-16
Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 45/223 (20%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLV----EVLMLSLLHHPNLV 132
+GEG +G+VYK + + VA+K++ + +E F + E+ +L L+H N+V
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQLNHRNIV 69
Query: 133 NLIGYCADGDQRL----------LVYEYMP---LGSVEDHL------HDLSPGKKPLDWN 173
NL D L LV+EYM +G +E L H S K+ L+
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE-- 127
Query: 174 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233
GL Y H K ++RD+KCSNILL+ KL+DFGLA+L ++
Sbjct: 128 -----------GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 234 VSTRVMGTYGYCAPEYAKTGQLTLKS-DVYSFGVVLLEILSGR 275
+ +V+ T Y PE + + DV+S G +L E+ + +
Sbjct: 174 YTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-16
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 80 LGEGGFGRVYKGYLE--SINQDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
LG G FG V KG + + VA+K L D N E L E ++ L +P +V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
G C + + +LV E LG L+ K + ++ + G++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGP----LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY--GYCAPEYAKTG 253
++RDL N+LL ++ K+SDFGL+K D + + G + + APE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 254 QLTLKSDVYSFGVVLLEILS 273
+ + KSDV+SFGV++ E S
Sbjct: 174 KFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 6e-16
Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 45/217 (20%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQ----LDRNGVQGN--REFLVEVL-MLSLLHHPN 130
+ +GEG +G VYK + + VA+K+ L G+ + RE + +L L HPN
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE--IALLKQLESFEHPN 62
Query: 131 LVNLIGYCA--DGDQRL---LVYEYMPLGSVEDHLHDL-----SPGKKPLDWNTRMKIAA 180
+V L+ C D+ L LV+E+ V+ L PG L T +
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEH-----VDQDLATYLSKCPKPG---LPPETIKDLMR 114
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG 240
RG+++LH +++RDLK NIL+ K++DFGLA+ + T V+
Sbjct: 115 QLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVV 168
Query: 241 TYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEI 271
T Y APE YA D++S G + E+
Sbjct: 169 TLWYRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 7e-16
Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 80 LGEGGFGRV----YKGYLESINQDVAIKQLD-RNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LGEG FG+V Y ++ + VA+K L +G + E+ +L L+H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 135 IGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
G C + L+ E++P GS++++L K ++ ++K A +G++YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST----RVMGTYGYCAPE 248
++RDL N+L++ + K+ DFGL K + + T + Y APE
Sbjct: 129 Q---YVHRDLAARNVLVESEHQVKIGDFGLTK--AIETDKEYYTVKDDLDSPVFWY-APE 182
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILS 273
+ + SDV+SFGV L E+L+
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-16
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 80 LGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGNREFLV-EVLMLSLL-HHPN 130
LGEG FG+V + I++ VA+K L N + L+ E+ ++ L+ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLH-------DLSPG-----KKPLDWNTRMKI 178
++NL+G C ++ EY G++ + L D + ++ L + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 238
A ARG+EYL + I+RDL N+L+ K++DFGLA+ D ++
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 239 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ APE T +SDV+SFG+++ EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 80 LGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGNREFLV-EVLMLSLL-HHPN 130
LGEG FG+V I++D VA+K L + + LV E+ M+ ++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKI 178
++NL+G C ++ EY G++ ++L P ++ L + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 238
A ARG+EYL A I+RDL N+L+ K++DFGLA+ D +T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 239 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ APE T +SDV+SFGV+L EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-15
Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM---LSLLHH 128
+ + +G G G+VYK + +A+KQ+ R G N+E +LM + L H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSH 71
Query: 129 --PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
P +V GY + E M + D L L + P+ + K+ + L
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELM--STCLDKL--LKRIQGPIPEDILGKMTVAIVKAL 127
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 246
YL K K VI+RD+K SNILLD + KL DFG++ G + D + TR G Y A
Sbjct: 128 HYL--KEKHGVIHRDVKPSNILLDASGNVKLCDFGIS--GRLVD-SKAKTRSAGCAAYMA 182
Query: 247 PEY----AKTGQLTLKSDVYSFGVVLLEILSGR 275
PE + +++DV+S G+ L+E+ +G+
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 19/214 (8%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 129
+F +LG+G FG+V + ++ AIK L ++ V + + +VE +L+L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 130 NLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
+ + C RL V EY+ G + + + K+P + AA A GL +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP----HAVFYAAEIAIGLFF 116
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--HVSTRVM-GTYGYC 245
LH K +IYRDLK N++LD H K++DFG+ K +N V+T+ GT Y
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENMWDGVTTKTFCGTPDYI 168
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 279
APE D ++FGV+L E+L+G+ +
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-15
Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 8/204 (3%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL---DRNGVQGNREFLVEVLMLSLLH 127
NF+ E +G+G F VYK + VA+K++ + + ++ L E+ +L L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
HPN++ + + ++ +V E G + + K+ + T K LE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
++H K +++RD+K +N+ + KL D GL + T + ++GT Y +P
Sbjct: 121 HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSP 175
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEI 271
E KSD++S G +L E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN----REFLVEVLMLSLLHHPNLVNL 134
L+G+GG G VY Y ++ VA+K++ R + N + FL E + + L HP +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 135 IGYCADGDQRLLVYEYMP------LGSVEDHLHDLSPGKKPLDWNTRMK----IAAGAAR 184
C+DGD VY MP L S+ + K L T + I
Sbjct: 68 YSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL----------------GPV 228
+EY+H K V++RDLK NILL + D+G A
Sbjct: 125 TIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ + +++GT Y APE + +D+Y+ GV+L ++L+
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-15
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG+G FG+VYK + A K +D + +++VE+ +L+ HPN+V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ ++ E+ G+V+ + +L ++PL + L YLH+ +I+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENK---IIH 126
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAPEY-----AK 251
RDLK NIL KL+DFG++ NT R +GT + APE +K
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 252 TGQLTLKSDVYSFGVVLLEI 271
K+DV+S G+ L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 34/220 (15%)
Query: 80 LGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGN-REFLVEVLMLSLL-HHPN 130
LGEG FG+V ++++ VA+K L + + + + + E+ M+ ++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHL---------HDLSPGKKP---LDWNTRMKI 178
++NL+G C ++ EY G++ ++L + +P + P L + +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 238
A ARG+EYL K I+RDL N+L+ K++DFGLA+ D H+
Sbjct: 146 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 197
Query: 239 MGTYG-----YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
T G + APE T +SDV+SFGV+L EI +
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-15
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLD------RNGVQGNREFLVEVLMLSLLHHPNLVN 133
LG+GGFG V + + + A K+L+ R G +G +VE +L+ +H +V+
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGA---MVEKRILAKVHSRFIVS 57
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
L LV M G + H++++ A GLE+LH +
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
+IYRDLK N+LLD + ++SD GLA + D + GT G+ APE +
Sbjct: 118 ---IIYRDLKPENVLLDNDGNVRISDLGLAV--ELKDGQSKTKGYAGTPGFMAPELLQGE 172
Query: 254 QLTLKSDVYSFGVVLLEILSGR 275
+ D ++ GV L E+++ R
Sbjct: 173 EYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-15
Identities = 69/208 (33%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHH---PNLV 132
++G GGFG VY + A+K LD+ + QG L E +MLSL+ P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHD 191
+ D+ + + M G + HL + + M+ AA GLE++H+
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEAEMRFYAAEIILGLEHMHN 115
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA----KLGPVGDNTHVSTRVMGTYGYCAP 247
+ V+YRDLK +NILLD H ++SD GLA K P H S +GT+GY AP
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HAS---VGTHGYMAP 164
Query: 248 EYAKTGQLTLKS-DVYSFGVVLLEILSG 274
E + G S D +S G +L ++L G
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-15
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC 138
+LG+G +G VY S +AIK++ + + E+ + S L H N+V +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGK-KPLDWNTRMKIAAGAA--RGLEYLHDKAKP 195
++ + E +P GS L L K PL N + I GL+YLHD
Sbjct: 75 SENGFFKIFMEQVPGGS----LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ-- 128
Query: 196 PVIYRDLKCSNILLDRGYHP--KLSDFG----LAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
+++RD+K N+L++ Y K+SDFG LA + P + GT Y APE
Sbjct: 129 -IVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINPCTET------FTGTLQYMAPEV 180
Query: 250 AKTGQ--LTLKSDVYSFGVVLLEILSGR 275
G +D++S G ++E+ +G+
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-15
Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 11/206 (5%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNL 131
NF+ LGEG + VYKG + + VA+K++ + +G + E+ ++ L H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L ++ +LV+EYM ++ ++ D + LD NT +G+ + H+
Sbjct: 61 VRLHDVIHTENKLMLVFEYMD-KDLKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
V++RDLK N+L+++ KL+DFGLA+ + NT + V T Y AP+
Sbjct: 119 NR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPD-VL 172
Query: 252 TGQLTLKS--DVYSFGVVLLEILSGR 275
G T + D++S G ++ E+++GR
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-15
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-----EVLMLSLLHH 128
++ L+G G +G VY+G + VA+K ++ + + V EV +LS L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLRQ 58
Query: 129 ---PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
PN+ G G + ++ EY GSV + +K + R + A
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA----- 113
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
L+Y+H K VI+RD+K +NIL+ + KL DFG+A L + N+ + +GT +
Sbjct: 114 LKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGTPYWM 168
Query: 246 APEYAKTGQL-TLKSDVYSFGVVLLEILSG 274
APE G+ K+D++S G+ + E+ +G
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-15
Identities = 69/209 (33%), Positives = 103/209 (49%), Gaps = 30/209 (14%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHH---PNLV 132
++G GGFG VY + A+K LD+ + QG L E +MLSL+ P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHL--HDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+ D+ + + M G + HL H + K+ + T + + GLE++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMH 114
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA----KLGPVGDNTHVSTRVMGTYGYCA 246
++ V+YRDLK +NILLD H ++SD GLA K P H S +GT+GY A
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HAS---VGTHGYMA 163
Query: 247 PEYAKTGQLTLKS-DVYSFGVVLLEILSG 274
PE + G S D +S G +L ++L G
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-15
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 21/201 (10%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG-YC 138
LG+G FG+VYK + A K ++ + +++VE+ +L+ +HP +V L+G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
DG +++ E+ P G+V+ + +L G I L+YLH +I
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV---ICRQMLEALQYLHSMK---II 132
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAPEYA----- 250
+RDLK N+LL KL+DFG++ N R +GT + APE
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVS-----AKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 251 KTGQLTLKSDVYSFGVVLLEI 271
K K+D++S G+ L+E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-15
Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 16/208 (7%)
Query: 79 LLGEGGFGRVYKGYLESIN---QDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVN 133
+LG+G FG V + L+S + Q VA+K L D EFL E + HPN++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 134 LIGYC--ADGDQRL----LVYEYMPLGSVEDHLHDLSPGKKP--LDWNTRMKIAAGAARG 185
LIG + RL ++ +M G + L G++P L T ++ A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
+EYL K I+RDL N +L+ ++DFGL+K GD +
Sbjct: 126 MEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILS 273
A E T SDV++FGV + EI++
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-15
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 44/212 (20%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVN- 133
++GEG FGR + +Q A+K++ + V+ +R+ E ++L+ + HPN+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAF 63
Query: 134 ------------LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 181
++ YC GD + ++ L P L W +M +
Sbjct: 64 KESFEADGHLYIVMEYCDGGDL---------MQKIKLQRGKLFPEDTILQWFVQMCL--- 111
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVM 239
G++++H+K V++RD+K NI L + KL DFG A+L P + T V
Sbjct: 112 ---GVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---AYACTYV- 161
Query: 240 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 271
GT Y PE + KSD++S G +L E+
Sbjct: 162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 42/213 (19%)
Query: 82 EGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNREF----LVEVLMLSLLHHPNLVNL- 134
EG +G VY+ + + VA+K+L ++ +G F L E+ +L L HPN+V +
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLKMEKEK-EG---FPITSLREINILLKLQHPNIVTVK 70
Query: 135 -IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA---------- 183
+ ++ D+ +V EY+ HDL K ++ MK +
Sbjct: 71 EVVVGSNLDKIYMVMEYVE--------HDL---KSLME---TMKQPFLQSEVKCLMLQLL 116
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
G+ +LHD +++RDLK SN+LL+ K+ DFGLA+ G T+++ T
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLW 171
Query: 244 YCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE + + D++S G + E+L+ +
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 2e-14
Identities = 73/230 (31%), Positives = 105/230 (45%), Gaps = 68/230 (29%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL-D--RNGVQGNREFLVEVLMLS-LLHHPNLVNLI 135
LG+G +G V+K + VA+K++ D RN R F E++ L L HPN+V L+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL 73
Query: 136 G-YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGA----------- 182
A+ D+ + LV+EYM E LH + I A
Sbjct: 74 NVIKAENDKDIYLVFEYM-----ETDLHAV--------------IRANILEDVHKRYIMY 114
Query: 183 --ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNT------- 232
+ L+Y+H VI+RDLK SNILL+ KL+DFGLA+ L + +N
Sbjct: 115 QLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171
Query: 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGV-------VLLEILSGR 275
+V+TR Y APE + L S Y+ GV +L E+L G+
Sbjct: 172 YVATR-----WYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 2e-14
Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQL---DRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
+G G +G V + + VAIK++ + + R L E+ +L L H N++ L
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR-ILREIKLLRHLRHENIIGL 64
Query: 135 IGYCADGDQR-----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK-IAAGAARGLEY 188
+ +V E M E LH + +PL + ++ RGL+Y
Sbjct: 65 LDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLT-DDHIQYFLYQILRGLKY 118
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY----GY 244
LH A VI+RDLK SNIL++ K+ DFGLA+ D + Y Y
Sbjct: 119 LH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLAR---GVDPDEDEKGFLTEYVVTRWY 172
Query: 245 CAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
APE Y T D++S G + E+L+ +
Sbjct: 173 RAPELLLSSSRY------TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-14
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 80 LGEGGFGRVYKG-------YLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
LG+G F +++KG Y E +V +K LD++ + F M+S L H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
G C GD+ ++V EY+ GS++ +L + + W ++++A A L +L DK
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKK-NKNLINISW--KLEVAKQLAWALHFLEDK 119
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT--YGYCAPEYA 250
+ + ++ N+LL R K + KL G + V + + + PE
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 251 KTGQ-LTLKSDVYSFGVVLLEILSG 274
+ Q L+L +D +SFG L EI SG
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 5e-14
Identities = 54/203 (26%), Positives = 83/203 (40%), Gaps = 14/203 (6%)
Query: 80 LGEGGFGRVYKGYLESINQD--VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
+G G FG+V G V +K+L FL EV L+HPN++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL-DWNTRMKIAAGAARGLEYLHDKAKP 195
C + LLV E+ PLG ++++L + + ++A A GL +LH +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA----- 250
I+ DL N L K+ D+GLA D + APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 251 --KTGQLTLKSDVYSFGVVLLEI 271
T KS+++S GV + E+
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-14
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFL---VEVLMLSLLHHPNLVN 133
+G G FG V K + +A+K++ + ++ L ++V+M S P +V
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-DCPYIVK 67
Query: 134 LIGYC-ADGDQRLLVYEYMPLGSVED-----HLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
G +GD + E M + S++ + K + KIA + L
Sbjct: 68 FYGALFREGDC-WICMELMDI-SLDKFYKYVYEV----LKSVIPEEILGKIAVATVKALN 121
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCA 246
YL ++ K +I+RD+K SNILLDR + KL DFG++ +L ++ TR G Y A
Sbjct: 122 YLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL----VDSIAKTRDAGCRPYMA 175
Query: 247 PEYAKTGQLT---LKSDVYSFGVVLLEILSGR 275
PE ++SDV+S G+ L E+ +G+
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-14
Identities = 68/209 (32%), Positives = 99/209 (47%), Gaps = 30/209 (14%)
Query: 79 LLGEGGFGRVY---KGYLESINQDVAIKQL--------DRNGVQGNREFLVEVLMLSLLH 127
+LG+G FG+V+ K Q A+K L DR + R+ L EV +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------N 56
Query: 128 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARG 185
HP +V L Y + +L L+ +++ G + L K+ + +K A A
Sbjct: 57 HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAELALA 110
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
L++LH +IYRDLK NILLD H KL+DFGL+K + S GT Y
Sbjct: 111 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 165
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSG 274
APE T +D +SFGV++ E+L+G
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-14
Identities = 43/115 (37%), Positives = 62/115 (53%), Gaps = 9/115 (7%)
Query: 177 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236
KIA + LEYLH K VI+RD+K SN+L++R KL DFG++ G + D+ T
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSV-AKT 161
Query: 237 RVMGTYGYCAPEY----AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287
G Y APE +KSDV+S G+ ++E+ +GR D+ K +Q
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ 216
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-14
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
+GEG G V + + VA+K++D Q EV+++ HH N+V++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK------IAAGAARGLEYLHDKA 193
GD+ +V E++ G++ D + +TRM + R L YLH++
Sbjct: 90 VGDELWVVMEFLEGGALTD-----------IVTHTRMNEEQIATVCLSVLRALSYLHNQG 138
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
VI+RD+K +ILL KLSDFG V ++GT + APE
Sbjct: 139 ---VIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRL 193
Query: 254 QLTLKSDVYSFGVVLLEILSG 274
+ D++S G++++E++ G
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 9e-14
Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 15/155 (9%)
Query: 128 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
HP LV L C + RL V E++ G + H+ +K + + R +A + L
Sbjct: 55 HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQR---QRKLPEEHARF-YSAEISLAL 109
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGY 244
+LH++ +IYRDLK N+LLD H KL+D+G+ K + P GD T + GT Y
Sbjct: 110 NFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTT---STFCGTPNY 162
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 279
APE + D ++ GV++ E+++GR D
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 9e-14
Identities = 72/238 (30%), Positives = 94/238 (39%), Gaps = 43/238 (18%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVL----MLSLLH 127
K+F+ LLG+G GRV+ L+ + A+K LD+ + R + VL +L+ L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLD 59
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL---SPGKKPLDWNTRMKIAAGAAR 184
HP L L LV +Y P G L L PGK + R AA
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGE----LFRLLQRQPGKCLSEEVARF-YAAEVLL 114
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV---------- 234
LEYLH ++YRDLK NILL H LSDF L+K V
Sbjct: 115 ALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 235 --------------STRVM---GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
S R GT Y APE D ++ G++L E+L G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 62/201 (30%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLI 135
LLG+G FG+V ++ + A+K L + + E + E +L HP L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAK 194
D+ V EY G + HL ++ + R + A LEYLH +
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHSRD- 115
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
V+YRD+K N++LD+ H K++DFGL K G + D + T GT Y APE +
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLEDND 171
Query: 255 LTLKSDVYSFGVVLLEILSGR 275
D + GVV+ E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-13
Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
+GEG +G VYKG + Q VA+K++ + GV + E+ +L L HPN+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA--IREISLLKELQHPNIVCLQ 65
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
+ L++E++ + ++ +L D P + +D +G+ + H +
Sbjct: 66 DVLMQESRLYLIFEFLSM-DLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFCHSRR-- 121
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 255
V++RDLK N+L+D KL+DFGLA+ G V T + T Y APE
Sbjct: 122 -VLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 256 -TLKSDVYSFGVVLLEILSGR 275
+ D++S G + E+ + +
Sbjct: 179 YSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 64/200 (32%), Positives = 91/200 (45%), Gaps = 15/200 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVE-VLMLSLLHHPNLVNLI 135
+G+G FG+V ++ + A+K L + + +E + E ++L + HP LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAK 194
D+ V +Y+ G + HL +P R + AA A L YLH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLHSLN- 116
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
+IYRDLK NILLD H L+DFGL K G T ++ GT Y APE +
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQP 172
Query: 255 LTLKSDVYSFGVVLLEILSG 274
D + G VL E+L G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 63/201 (31%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLI 135
LLG+G FG+V ++ + A+K L + + E L E +L HP L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAK 194
D+ V EY G + HL ++ + R + A L+YLH ++
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDYLH--SE 114
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
V+YRDLK N++LD+ H K++DFGL K G + D + T GT Y APE +
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPEVLEDND 172
Query: 255 LTLKSDVYSFGVVLLEILSGR 275
D + GVV+ E++ GR
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 54/155 (34%), Positives = 78/155 (50%), Gaps = 15/155 (9%)
Query: 128 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
+P LV L C RL LV EY+ G + H+ ++ L AA L
Sbjct: 55 NPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIAL 109
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGY 244
+LH++ +IYRDLK N+LLD H KL+D+G+ K LGP GD T + GT Y
Sbjct: 110 NFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT---STFCGTPNY 162
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 279
APE + + D ++ GV++ E+++GR D
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-13
Identities = 68/217 (31%), Positives = 105/217 (48%), Gaps = 37/217 (17%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVA-------IKQLDRNGVQGNREFLVEVLMLSL 125
+F LG G G V K +A IK RN Q RE L +
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN--QIIRE-------LKV 52
Query: 126 LHHPNLVNLIGY----CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 181
LH N ++G+ +DG+ + + E+M GS++ L G+ P + ++ IA
Sbjct: 53 LHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLK--KAGRIPENILGKISIAV- 108
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD---NTHVSTRV 238
RGL YL +K K +++RD+K SNIL++ KL DFG++ G + D N+ V TR
Sbjct: 109 -LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFVGTR- 162
Query: 239 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y +PE + T++SD++S G+ L+E+ GR
Sbjct: 163 ----SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 64/200 (32%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLI 135
LLG+G FG+V ++ + A+K L + + E L E +L HP L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
D+ V EY+ G + HL S + + TR A L+YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHL---SRERVFSEDRTRF-YGAEIVSALDYLHSGK-- 115
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 255
++YRDLK N++LD+ H K++DFGL K G + D + T GT Y APE +
Sbjct: 116 -IVYRDLKLENLMLDKDGHIKITDFGLCKEG-ITDAATMKT-FCGTPEYLAPEVLEDNDY 172
Query: 256 TLKSDVYSFGVVLLEILSGR 275
D + GVV+ E++ GR
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF----LVEVLMLSLLHHPNLVNL 134
++G G + +V L+ + A+K + + V + + + + +HP LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 135 IGYCADGDQRLL-VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
C + RL V EY+ G + H+ ++ L +A + L YLH++
Sbjct: 62 HS-CFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG 116
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG-PVGDNTHVSTRVMGTYGYCAPEYAKT 252
+IYRDLK N+LLD H KL+D+G+ K G GD T + GT Y APE +
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG 170
Query: 253 GQLTLKSDVYSFGVVLLEILSGRKAVD 279
D ++ GV++ E+++GR D
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 66/237 (27%), Positives = 102/237 (43%), Gaps = 49/237 (20%)
Query: 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREF----LVEVL 121
+++ LGEG FG VYK + VA+K++ +++G F L E+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG------FPITALREIK 59
Query: 122 MLSLLHHPNLVNLIGYCAD-----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 176
+L L HPN+V LI + +R VY P HDLS L N +
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-----HDLSG----LLENPSV 110
Query: 177 KIAAGAAR--------GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--- 225
K+ + G+ YLH+ +++RD+K +NIL+D K++DFGLA+
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 226 ------GPVGDNTHVSTRVMGTYGYCAPEY-AKTGQLTLKSDVYSFGVVLLEILSGR 275
G G T T ++ T Y PE + T D++ G V E+ + R
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 67/222 (30%), Positives = 104/222 (46%), Gaps = 28/222 (12%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-----EVLMLSLLH---HPNL 131
+G G +G VYK VA+K + VQ N + L EV +L L HPN+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVR---VQTNEDGLPLSTVREVALLKRLEAFDHPNI 64
Query: 132 VNLIGYCADG--DQRL---LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
V L+ CA D+ LV+E++ + +L + P P + T + RGL
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAE--TIKDLMRQFLRGL 121
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS-TRVMGTYGYC 245
++LH +++RDLK NIL+ G KL+DFGLA++ + ++ T V+ T Y
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWYR 174
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287
APE D++S G + E+ RK + + A+Q
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-13
Identities = 48/202 (23%), Positives = 93/202 (46%), Gaps = 8/202 (3%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL---DRNGVQGNREFLVEVLMLSLLHHP 129
NF+ E +G G F VY+ + VA+K++ + + ++ + E+ +L L+HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N++ + + ++ +V E G + + K+ + T K +E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
H + V++RD+K +N+ + KL D GL + T + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 177
Query: 250 AKTGQLTLKSDVYSFGVVLLEI 271
KSD++S G +L E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 31/215 (14%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPN 130
+++ S +G G +G+V + + VAIK+L R + + R + E+ +L + H N
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHEN 75
Query: 131 LVNLIG-YCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
++ L+ + VY L + L+++ +K D + + + RGL+
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLMGAD--LNNIVKCQKLSDDHIQF-LVYQILRGLK 132
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
Y+H +I+RDLK SNI ++ K+ DFGLA+ +V+TR Y AP
Sbjct: 133 YIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 184
Query: 248 E-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
E Y +T D++S G ++ E+L+G+
Sbjct: 185 EIMLNWMHYNQT------VDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-13
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 18/198 (9%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV---EVLMLSLLHHPNLVNLIG 136
+G G +G VYK + + AIK + ++ +F V E++M+ H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
D+ + E+ GS++D H P L + ++ +GL YLH K K
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGP----LSESQIAYVSRETLQGLYYLHSKGK-- 127
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA---KTG 253
++RD+K +NILL H KL+DFG++ + +GT + APE A + G
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 254 QLTLKSDVYSFGVVLLEI 271
D+++ G+ +E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-13
Identities = 64/213 (30%), Positives = 90/213 (42%), Gaps = 20/213 (9%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLV 132
F L+G G +G+VYKG Q AIK +D G + E E+ ML HH N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 66
Query: 133 NLIGYCAD------GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
G DQ LV E+ GSV D + + +W I RGL
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 124
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 246
+LH VI+RD+K N+LL KL DFG++ + +GT + A
Sbjct: 125 SHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMA 179
Query: 247 PEYAKTGQ-----LTLKSDVYSFGVVLLEILSG 274
PE + KSD++S G+ +E+ G
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-13
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
+G G FG V + Q+VAIK++ + V R + E+ +L L H N+++L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSD 76
Query: 137 -YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
+ + + V E + LH L + PL+ RGL+Y+H
Sbjct: 77 IFISPLEDIYFVTELL-----GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAG-- 128
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ- 254
V++RDLK SNIL++ K+ DFGLA++ +VSTR Y APE T Q
Sbjct: 129 -VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQK 182
Query: 255 LTLKSDVYSFGVVLLEILSGR 275
++ D++S G + E+L G+
Sbjct: 183 YDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-13
Identities = 64/201 (31%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEV-LMLSLLHHPNLVNL 134
++G+G FG+V +S A+K L + + +E + E ++L L HP LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKA 193
++ V +Y+ G + HL +P R + AA A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----RARFYAAEVASAIGYLHSLN 116
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
+IYRDLK NILLD H L+DFGL K G + T ++ GT Y APE +
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171
Query: 254 QLTLKSDVYSFGVVLLEILSG 274
D + G VL E+L G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-13
Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 8/202 (3%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL---DRNGVQGNREFLVEVLMLSLLHHP 129
NFR E +G G F VY+ VA+K++ D + + + E+ +L L+HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N++ + ++ +V E G + + K+ + T K LE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
H + V++RD+K +N+ + KL D GL + T + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 177
Query: 250 AKTGQLTLKSDVYSFGVVLLEI 271
KSD++S G +L E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 8e-13
Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 35/221 (15%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD---------RNGVQGNREFLVEVLM 122
+++ S +GEG +G V + VAIK++ R L E+ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT--------LREIKI 56
Query: 123 LSLLHHPNLVNL------IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 176
L H N++ + + + D +V E M E L+ L + + + +
Sbjct: 57 LRRFKHENIIGILDIIRPPSFESFNDV-YIVQELM-----ETDLYKLIKTQHLSNDHIQY 110
Query: 177 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG-PVGDNTHVS 235
+ RGL+Y+H V++RDLK SN+LL+ K+ DFGLA++ P D+T
Sbjct: 111 FLYQ-ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL 166
Query: 236 TRVMGTYGYCAPEYAKTGQLTLKS-DVYSFGVVLLEILSGR 275
T + T Y APE + K+ D++S G +L E+LS R
Sbjct: 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-13
Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 80 LGEGGFGRVYKGYLES--INQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIG 136
+G G FG+V G + S V +K+L + VQ +FL E L H NL+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLH------DLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
C + LLV E+ PLG ++ +L ++P D T ++A A GL +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-----DPTTLQRMACEIALGLLHLH 117
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
K I+ DL N LL K+ D+GL+ D ++ + APE
Sbjct: 118 ---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174
Query: 251 KT--GQL-----TLKSDVYSFGVVLLEIL 272
G L T +S+V+S GV + E+
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-13
Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGY 137
+GEG FG+ + + IK+++ + + E EV +LS + HPN+V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHD----LSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
+ +V +Y G + ++ L P + LDW ++ +A L+++HD+
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHDRK 121
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
+++RD+K NI L + KL DFG+A++ + ++ +GT Y +PE +
Sbjct: 122 ---ILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEICENR 176
Query: 254 QLTLKSDVYSFGVVLLEILSGRKA 277
KSD+++ G VL E+ + + A
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 8e-13
Identities = 63/200 (31%), Positives = 88/200 (44%), Gaps = 12/200 (6%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLI 135
LLG+G FG+V ++ + A+K L + + E L E +L HP L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
D+ V EY G + HL + R A L YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARF-YGAEIVSALGYLHSCD-- 115
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 255
V+YRDLK N++LD+ H K++DFGL K G + D + T GT Y APE +
Sbjct: 116 -VVYRDLKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLEDNDY 172
Query: 256 TLKSDVYSFGVVLLEILSGR 275
D + GVV+ E++ GR
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-13
Identities = 63/201 (31%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEV-LMLSLLHHPNLVNL 134
++G+G FG+V + + A+K L + V +E + E ++L + HP LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKA 193
++ V +++ G + HL +P R + AA A L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLHSIN 116
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
++YRDLK NILLD H L+DFGL K G +T +T GT Y APE +
Sbjct: 117 ---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQ 171
Query: 254 QLTLKSDVYSFGVVLLEILSG 274
D + G VL E+L G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 68/229 (29%), Positives = 108/229 (47%), Gaps = 45/229 (19%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD------RNGVQGNREFLVEVLMLSLL 126
+F + L+ G +G VY + Q A+K+++ RN +Q + VE +L+
Sbjct: 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQ---QVFVERDILTFA 58
Query: 127 HHPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR 184
+P +V++ +C+ +R L V EY+ G L ++ P+D RM A
Sbjct: 59 ENPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGA--LPVDM-ARMYFAE-TVL 112
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV-------STR 237
LEYLH+ +++RDLK N+L+ H KL+DFGL+K+G + T++ TR
Sbjct: 113 ALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 238 ------VMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSG 274
V GT Y APE Y K D ++ G++L E L G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKP------VDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-12
Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 79 LLGEGGFGRVYKGYLESINQD-VAIKQLD-RNGVQGN---------REFLVEVLML-SLL 126
LG G FG VYK ++ Q+ +A+K+++ N G + + EV ++ L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 127 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD----WNTRMKIAAGA 182
HPN+V + D+ +V + + + +H + L K+ WN +++
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
L YLH + + +++RDL +NI+L ++DFGLAK + + T V+GT
Sbjct: 126 ---LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKL-TSVVGTI 177
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGVVLLEI 271
Y PE K K+DV++FG +L ++
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 67/204 (32%), Positives = 98/204 (48%), Gaps = 46/204 (22%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNL- 134
+GEG +G VYK + + VA+K++ + GV + E+ +L L+HPN+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA--IREISLLKELNHPNIVRLL 64
Query: 135 -IGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKK-----PLDWNTRMKIAA---GAAR 184
+ + + +L LV+E++ L DL KK PL I + +
Sbjct: 65 DVVHS---ENKLYLVFEFLDL--------DL---KKYMDSSPLTGLDPPLIKSYLYQLLQ 110
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LG-PVGDNTHVSTRVMGTY 242
G+ Y H V++RDLK N+L+DR KL+DFGLA+ G PV TH V+ T
Sbjct: 111 GIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TL 163
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGV 266
Y APE + L S YS V
Sbjct: 164 WYRAPE------ILLGSRQYSTPV 181
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 22/201 (10%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
+GEG G V ++S + VA+K++D Q EV+++ H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK------IAAGAARGLEYLHDKA 193
GD+ +V E++ G++ D + +TRM + + L LH +
Sbjct: 88 VGDELWVVMEFLEGGALTD-----------IVTHTRMNEEQIAAVCLAVLKALSVLHAQG 136
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
VI+RD+K +ILL KLSDFG V ++GT + APE
Sbjct: 137 ---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRL 191
Query: 254 QLTLKSDVYSFGVVLLEILSG 274
+ D++S G++++E++ G
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-12
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGN--REFLVEVLMLSLL 126
K+ + E +LG G FG + +G L+ ++ VAI L R G R FL E L L
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQF 63
Query: 127 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHL--HD--LSPGKKPLDWNTRMKIAAGA 182
H N+V L G G+ ++V EYM G+++ L H+ L G+ M + G
Sbjct: 64 DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQ-------LMGMLPGL 116
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
A G++YL + +++ L +L++ K+S F + + T + G
Sbjct: 117 ASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKS 170
Query: 243 G--YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ APE + + SDV+SFG+V+ E++S
Sbjct: 171 PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 59/235 (25%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLD----RNGVQGNREF----------LVEVLMLSL 125
LGEG +G+V K Y + VAIK++ N V +R+ L E+ +++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 126 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK------IA 179
+ H N++ L+ +GD LV + M DL KK +D R+ I
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA--------SDL---KKVVDRKIRLTESQVKCIL 125
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-------LGPVGDNT 232
GL LH K ++RDL +NI ++ K++DFGLA+ + +
Sbjct: 126 LQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 233 HVSTRVMGTYG-----YCAPEYAKTGQLTLKS-------DVYSFGVVLLEILSGR 275
+ R T Y APE L + + D++S G + E+L+G+
Sbjct: 183 TMQRREEMTSKVVTLWYRAPE------LLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-12
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQ----LDRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
LG+G +G VYK +A+K+ LD + + ++E+ +L P +V+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF---NQIIMELDILHKAVSPYIVDFY 65
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
G + EYM GS+ D L+ + + + +I +GL++L ++
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN- 123
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN--THVSTRVMGTYGYCAPEYAKTG 253
+I+RD+K +N+L++ KL DFG V N ++ +G Y APE K+G
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFG------VSGNLVASLAKTNIGCQSYMAPERIKSG 176
Query: 254 QL------TLKSDVYSFGVVLLEILSGR 275
T++SDV+S G+ +LE+ GR
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 68/236 (28%), Positives = 94/236 (39%), Gaps = 43/236 (18%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE----FLVEVLMLSLLH 127
+F ++G G FG V+ + Q A+K L R R E +L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDILADAD 59
Query: 128 HPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
P +V L Y + D+ L V EYMP G + + L P + R IA
Sbjct: 60 SPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEET-ARFYIAELVL-A 113
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK----------------LGPVG 229
L+ +H I+RD+K NIL+D H KL+DFGL K
Sbjct: 114 LDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 230 DNTHVSTR-----------VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
DN V R +GT Y APE + L+ D +S GV+L E+L G
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-12
Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 36/221 (16%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHH 128
NF+ +GEG +G VYK + + VA+K++ + GV + E+ +L L+H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNH 58
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR---- 184
PN+V L+ ++ LV+E++ DL KK +D + I +
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLH--------QDL---KKFMDASPLSGIPLPLIKSYLF 107
Query: 185 ----GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LG-PVGDNTHVSTRV 238
GL + H V++RDLK N+L++ KL+DFGLA+ G PV TH V
Sbjct: 108 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EV 161
Query: 239 MGTYGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGRKAV 278
+ T Y APE + D++S G + E+++ R+A+
Sbjct: 162 V-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-12
Identities = 36/108 (33%), Positives = 53/108 (49%), Gaps = 6/108 (5%)
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
L++LH + +IYRD+K NILLD H L+DFGL+K + + + GT Y
Sbjct: 118 LDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGTIEYM 173
Query: 246 APEYAKTGQLTLKS--DVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA 291
APE + G D +S GV+ E+L+G QS ++
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS 221
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-12
Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 30/212 (14%)
Query: 80 LGEGGFGRVYKGY-LESINQDVAIKQLDRNGVQGNREFL-------VEVL-MLSLLHHPN 130
+GEG +G+V+K L++ + VA+K R VQ E + V VL L HPN
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALK---RVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 131 LVNLIGYCA----DGDQRL-LVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
+V L C D + +L LV+E++ L + D + + PG T +
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPT---ETIKDMMFQLL 120
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
RGL++LH V++RDLK NIL+ KL+DFGLA++ T V+ T
Sbjct: 121 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLW 174
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE D++S G + E+ +
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 64/205 (31%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---------GNREFLVEVLMLSLLHHPN 130
+G+G FG+VY+ + + A+K L + + G R LV L+ P
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDE---SPF 57
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V L LV +YM G + HL G+ D + IA LE+LH
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ--KEGRFSED-RAKFYIAE-LVLALEHLH 113
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-Y 249
K ++YRDLK NILLD H L DFGL+K + T + GT Y APE
Sbjct: 114 ---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVL 168
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSG 274
T D +S GV++ E+ G
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-12
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 34/211 (16%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNL- 134
+GEG +G VYK N+ +A+K++ + GV + E+ +L + H N+V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHGNIVRLQ 67
Query: 135 -IGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG----AARGLEY 188
+ + ++RL LV+EY+ L ++ H+ D SP D+ ++ RG+ Y
Sbjct: 68 DVVHS---EKRLYLVFEYLDL-DLKKHM-DSSP-----DFAKNPRLIKTYLYQILRGIAY 117
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAK-LG-PVGDNTHVSTRVMGTYGYC 245
H V++RDLK N+L+DR + KL+DFGLA+ G PV TH T Y
Sbjct: 118 CHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYR 170
Query: 246 APE-YAKTGQLTLKSDVYSFGVVLLEILSGR 275
APE + + D++S G + E+++ +
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-12
Identities = 74/236 (31%), Positives = 106/236 (44%), Gaps = 29/236 (12%)
Query: 56 QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 115
+ L L T + +G+G +G+VYK + A+K LD + E
Sbjct: 6 PYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEE 64
Query: 116 FLVEVLML-SLLHHPNLVNLIG--YCAD---GDQRLLVYEYMPLGSVEDHLHDLSPGKKP 169
E +L SL +HPN+V G Y AD G Q LV E GSV + + L +
Sbjct: 65 IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124
Query: 170 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPV 228
LD I GA GL++LH+ +I+RD+K +NILL KL DFG+ A+L
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQL--- 178
Query: 229 GDNTHVSTRV-----MGTYGYCAPEYAKTGQ-----LTLKSDVYSFGVVLLEILSG 274
STR+ +GT + APE Q + DV+S G+ +E+ G
Sbjct: 179 -----TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 7e-12
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDR--NGVQGNREFLVEVLMLSLLHHPNLVN---- 133
+G G +G V + VAIK++ + + L E+ +L H N++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
L AD +V + M E LH + +PL RGL+Y+H
Sbjct: 73 LRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN 127
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL---GPVGDNTHVSTRVMGTYGYCAPEYA 250
VI+RDLK SN+L++ ++ DFG+A+ P ++ + T + T Y APE
Sbjct: 128 ---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT-EHKYFMTEYVATRWYRAPELL 183
Query: 251 KT-GQLTLKSDVYSFGVVLLEILSGRKAV 278
+ + T D++S G + E+L GR+ +
Sbjct: 184 LSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-12
Identities = 68/216 (31%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLV 132
F ++G G +G+VYKG Q AIK +D + E +E+ ML HH N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIA 76
Query: 133 NLIGY------CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
G DQ LV E+ GSV D + + DW I RGL
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYG 243
+LH VI+RD+K N+LL KL DFG+ A+L D T V R +GT
Sbjct: 135 AHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRT-VGRRNTFIGTPY 186
Query: 244 YCAPEYAKTGQ-----LTLKSDVYSFGVVLLEILSG 274
+ APE + +SD++S G+ +E+ G
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 34/208 (16%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEV-LMLSLLHHPNLVNLI 135
+GEG F V K + AIK + ++ Q N L E+ + L HPN++ LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64
Query: 136 GYCADGDQ-RL-LVYEYMPLGSVEDHLHDLSPGKK-PLDWNTRMKIAAGAARGLEYLHDK 192
D RL LV+E M + +L++L G+K PL + L+++H
Sbjct: 65 EVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH------VSTRVMGTYGYCA 246
+ +RD+K NIL+ KL+DFG + G + +STR Y A
Sbjct: 120 G---IFHRDIKPENILIK-DDILKLADFGSCR----GIYSKPPYTEYISTR-----WYRA 166
Query: 247 PEYAKT-GQLTLKSDVYSFGVVLLEILS 273
PE T G K D+++ G V EILS
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 64/201 (31%), Positives = 91/201 (45%), Gaps = 15/201 (7%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEV-LMLSLLHHPNLVNL 134
++G+G FG+V ++ + A+K L + + +E + E ++L + HP LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKA 193
D+ V +Y+ G + HL +P R + AA A L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIASALGYLHSLN 116
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
++YRDLK NILLD H L+DFGL K + N ST GT Y APE
Sbjct: 117 ---IVYRDLKPENILLDSQGHIVLTDFGLCKEN-IEHNGTTST-FCGTPEYLAPEVLHKQ 171
Query: 254 QLTLKSDVYSFGVVLLEILSG 274
D + G VL E+L G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 55/214 (25%), Positives = 103/214 (48%), Gaps = 36/214 (16%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFL-VEVLMLSLLHHPNLVN---- 133
+G+G +G V + + IK+L+ RN + R+ E +LS L HPN+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 134 ----------LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
++G+C GD +Y +++ L P + ++W ++ +A
Sbjct: 68 WEGEDGLLYIVMGFCEGGD----LYH-----KLKEQKGKLLPENQVVEWFVQIAMA---- 114
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
L+YLH+K +++RDLK N+ L R K+ D G+A++ + + +++ ++GT
Sbjct: 115 --LQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPY 167
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 277
Y +PE KSDV++ G + E+ + + A
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 78 SLLGEGGFGRVY---KGYLESINQDVAIKQLDRNGVQGNRE----FLVEVLMLSLLHHPN 130
+LG+GG+G+V+ K + A+K L + + N++ E +L + HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V+LI G + L+ EY+ G + HL + +T + + LE+LH
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLH 117
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEY 249
+ +IYRDLK NILLD H KL+DFGL K TH GT Y APE
Sbjct: 118 QQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPEI 171
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSG 274
D +S G ++ ++L+G
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDV-AIKQLDRNGVQGNRE---FLVEVLMLSLLH 127
K+F +SL+G G FG V + E D+ A+K + ++ + F E +LS+ +
Sbjct: 1 KDFDVKSLVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
P + L D D LV EY P G D L L+ + D + A +
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGG---DLLSLLNRYEDQFDEDMAQFYLAELVLAIH 116
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG-LAKLGPVGDNTHVSTRVMGTYGYCA 246
+H ++RD+K N+L+DR H KL+DFG A+L + S +GT Y A
Sbjct: 117 SVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLT--ANKMVNSKLPVGTPDYIA 171
Query: 247 PEYAKT------GQLTLKSDVYSFGVVLLEILSGR 275
PE T G ++ D +S GV+ E++ GR
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIK--QLDRNGVQGNREFLVEVLMLSLLHHP 129
++ + + +LG G G VYK Y + +A+K LD V+ ++ + E+ +L P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSP 59
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
++ G ++ + E+M GS++ + K P R IA +GL YL
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLDVY------RKIPEHVLGR--IAVAVVKGLTYL 111
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
+++RD+K SN+L++ KL DFG++ N+ T V GT Y APE
Sbjct: 112 WSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYV-GTNAYMAPER 164
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSGR 275
Q + SDV+S G+ +E+ GR
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 66/220 (30%), Positives = 99/220 (45%), Gaps = 22/220 (10%)
Query: 65 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVL 121
+L ++F ++G G FG V +S Q A+K L + + + F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 122 MLSLLHHPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 179
+++ + +V L + A D + L V EYMP G D ++ +S P W R A
Sbjct: 96 IMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGG---DLVNLMSNYDIPEKW-ARFYTA 149
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-KLGPVGDNTHVSTRV 238
L+ +H I+RD+K N+LLD+ H KL+DFG K+ G T V
Sbjct: 150 E-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAV 204
Query: 239 MGTYGYCAPEYAKT----GQLTLKSDVYSFGVVLLEILSG 274
GT Y +PE K+ G + D +S GV L E+L G
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-11
Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 80 LGEGGFGRVY--------KGYLESINQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPN 130
LG+G FG VY + +++ + +L+ N VQ N E +LS L HP
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQAN----QEAQLLSKLDHPA 63
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V + D ++ EY ++ L +L K L N + G+ Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
+ +++RDLK NI L + K+ DFG+++L + + ++T GT Y +PE
Sbjct: 124 QRR---ILHRDLKAKNIFL-KNNLLKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEAL 177
Query: 251 KTGQLTLKSDVYSFGVVLLEI 271
K KSD++S G +L E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 61/193 (31%), Positives = 88/193 (45%), Gaps = 43/193 (22%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQ-LDRNGVQGNREF----LVEVLMLSLLHHPNLVNL 134
+G+G FG V+K + Q VA+K+ L N +G F L E+ +L LL H N+VNL
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVVNL 76
Query: 135 IGYC---ADGDQR-----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR-- 184
I C A R LV+E+ HDL+ L N +K +
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCE--------HDLAG----LLSNKNVKFTLSEIKKV 124
Query: 185 ------GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK---LGPVGDNTHVS 235
GL Y+H +++RD+K +NIL+ + KL+DFGLA+ L +
Sbjct: 125 MKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 236 TRVMGTYGYCAPE 248
RV+ T Y PE
Sbjct: 182 NRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 64/237 (27%)
Query: 74 FRSESLLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQGN-------REFLVEVLMLS 124
+ E +G G +GRVYK + ++ AIK+ + Q RE + +L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLR 57
Query: 125 LLHHPNLVNLIGYC-ADGDQRL-LVYEYMPLGSVEDHLHDL--------SPGKKPLDWNT 174
L H N+V+L+ D+ + L+++Y HDL + + +
Sbjct: 58 ELKHENVVSLVEVFLEHADKSVYLLFDYAE--------HDLWQIIKFHRQAKRVSIPPSM 109
Query: 175 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL-----DRGYHPKLSDFGLAKL---- 225
+ G+ YLH V++RDLK +NIL+ +RG K+ D GLA+L
Sbjct: 110 VKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERG-VVKIGDLGLARLFNAP 165
Query: 226 --GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS-------DVYSFGVVLLEILS 273
+ V+ T Y APE L L + D+++ G + E+L+
Sbjct: 166 LKPLADLD-----PVVVTIWYRAPE------LLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 5e-11
Identities = 68/224 (30%), Positives = 99/224 (44%), Gaps = 39/224 (17%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN-----REFLVEVLMLSLLHHPNLVNL 134
LGEG + VYKG + Q VA+K++ +G RE +L L H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIRE----ASLLKDLKHANIVTL 68
Query: 135 IGYCADGDQRLLVYEYM--PLGS-VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
LV+EY+ L ++D LS N R+ + RGL Y H
Sbjct: 69 HDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMH------NVRLFLFQ-LLRGLAYCHQ 121
Query: 192 KAKPPVIYRDLKCSNILL-DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP--- 247
+ V++RDLK N+L+ +RG KL+DFGLA+ V T+ + V T Y P
Sbjct: 122 RR---VLHRDLKPQNLLISERG-ELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVL 175
Query: 248 ----EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287
EY + L D++ G + E+ +GR S +Q
Sbjct: 176 LGSTEY--STSL----DMWGVGCIFYEMATGRPLFPGSTDVEDQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-11
Identities = 47/157 (29%), Positives = 87/157 (55%), Gaps = 15/157 (9%)
Query: 123 LSLLHHPNLVNLIGYC----ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 178
L +LH N ++G+ +DG+ + + E+M GS++ L + K + K+
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKE----AKRIPEEILGKV 108
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 238
+ RGL YL +K + +++RD+K SNIL++ KL DFG++ G + D+ ++
Sbjct: 109 SIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 162
Query: 239 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
+GT Y +PE + +++SD++S G+ L+E+ GR
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-11
Identities = 64/220 (29%), Positives = 96/220 (43%), Gaps = 19/220 (8%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYC 138
LGEG + VYKG Q VA+K + +G + E +L L H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 139 ADGDQRLLVYEYMPLGSVE---DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
+ V+EYM + H L P +N R+ + RGL Y+H +
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPGGLHP------YNVRLFMFQ-LLRGLAYIHGQH-- 123
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 255
+++RDLK N+L+ KL+DFGLA+ + T+ S V T Y P+ G
Sbjct: 124 -ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD-VLLGAT 179
Query: 256 TLKS--DVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWS 293
S D++ G + +E+L G+ A EQ W+
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWT 219
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-11
Identities = 65/250 (26%), Positives = 114/250 (45%), Gaps = 35/250 (14%)
Query: 48 ASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR 107
A ED +++ + + K+++ +++G G FG VY+ ++ VAIK++ +
Sbjct: 46 AGEDEDEEKMIDNDIN----RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ 101
Query: 108 NGVQGNREFLVEVLMLSLLHHPNLVNLIGY----CADGDQRLL----VYEYMPLGSVEDH 159
+ NRE L+ + L+H N++ L Y C +++ + V E++P +V +
Sbjct: 102 DPQYKNRELLI----MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKY 156
Query: 160 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLS 218
+ + L + R L Y+H K + +RDLK N+L+D H KL
Sbjct: 157 MKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLC 213
Query: 219 DFGLAK--LGPVGDNTHVSTRVMGTYGYCAPEYA-KTGQLTLKSDVYSFGVVLLE----- 270
DFG AK L +++ +R Y APE T D++S G ++ E
Sbjct: 214 DFGSAKNLLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILGY 268
Query: 271 -ILSGRKAVD 279
I SG+ +VD
Sbjct: 269 PIFSGQSSVD 278
|
Length = 440 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-11
Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 138
+GEG G V + + VA+K +D Q RE L EV+++ H N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
G++ ++ E++ G++ D + L+ + + L YLH + VI
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTR-----LNEEQIATVCESVLQALCYLHSQG---VI 139
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK 258
+RD+K +ILL KLSDFG + + ++GT + APE +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 259 SDVYSFGVVLLEILSG 274
D++S G++++E++ G
Sbjct: 198 VDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 9e-11
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHH 128
K+F+ + +G+GG+G+V+ + + VA+K++ ++ + R L E +L+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN------TRMKIAAGA 182
LV L+ D + L EY+P G L++L L + M A A
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV----LSEDHARFYMAEMFEAVDA 116
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
L Y+H RDLK N L+D H KL+DFGL+K N+ V+G+
Sbjct: 117 LHELGYIH---------RDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSP 162
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
Y APE + D +S G +L E L G
Sbjct: 163 DYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 62/211 (29%), Positives = 108/211 (51%), Gaps = 25/211 (11%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVA-------IKQLDRNGVQGNREFLVEVLMLSL 125
+F S LG G G V+K + +A IK RN + + E+ +L
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN------QIIRELQVLHE 59
Query: 126 LHHPNLVNLIG-YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR 184
+ P +V G + +DG+ + + E+M GS++ L G+ P ++ IA +
Sbjct: 60 CNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLK--KAGRIPEQILGKVSIAV--IK 114
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244
GL YL +K K +++RD+K SNIL++ KL DFG++ G + D+ ++ +GT Y
Sbjct: 115 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSY 168
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
+PE + +++SD++S G+ L+E+ GR
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 65 RELAAATKNFRSESLLGEGGFGRVYKGYLESIN-QDVAIKQLDRNGVQGNREF---LVEV 120
R+ ++F LG G FGRV ++ + VAIK+ +++ + ++ E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 121 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA 180
+L+ ++HP VNL G D LV E++ G L K + AA
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAA 138
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR--- 237
EYL ++YRDLK N+LLD+ K++DFG AK+ V TR
Sbjct: 139 QIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYT 187
Query: 238 VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
+ GT Y APE +D ++ G+ + EIL G
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 66/235 (28%), Positives = 101/235 (42%), Gaps = 29/235 (12%)
Query: 57 ITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR-NGVQGNRE 115
++ +T+ F + + +G+G +G+V+K + A+K LD + + E
Sbjct: 3 LSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE 62
Query: 116 FLVEVLMLSLLHHPNLVNLIG--YCAD---GDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 170
+L +L HPN+V G Y D GDQ LV E GSV D + K L
Sbjct: 63 AEYNILK-ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV------KGFL 115
Query: 171 DWNTRMK------IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224
RM+ I A GL++LH I+RD+K +NILL KL DFG++
Sbjct: 116 KRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVS- 171
Query: 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ-----LTLKSDVYSFGVVLLEILSG 274
+ +GT + APE Q + DV+S G+ +E+ G
Sbjct: 172 -AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 66/256 (25%), Positives = 109/256 (42%), Gaps = 39/256 (15%)
Query: 32 SIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKG 91
++P L SS +S + +A + EL + +G G G VYK
Sbjct: 42 AVPLPLPPPSSSSSSSSSSSASGSAPSAA-KSLSELERVNR-------IGSGAGGTVYKV 93
Query: 92 YLESINQDVAIKQLDRNGVQGNREFLV------EVLMLSLLHHPNLVNLIGYCADGDQRL 145
+ A+K + GN E V E+ +L ++HPN+V +
Sbjct: 94 IHRPTGRLYALKVI-----YGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148
Query: 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 205
++ E+M GS+E G D +A G+ YLH + +++RD+K S
Sbjct: 149 VLLEFMDGGSLE--------GTHIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPS 197
Query: 206 NILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAKT----GQLT-LKS 259
N+L++ + K++DFG+++ L D + S +GT Y +PE T G
Sbjct: 198 NLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERINTDLNHGAYDGYAG 254
Query: 260 DVYSFGVVLLEILSGR 275
D++S GV +LE GR
Sbjct: 255 DIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 18/212 (8%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR--NGVQGNREFLVEVLMLSLLHHPNL 131
++ + ++G+G +G V + VAIK+++ V L E+ +L LL HP++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 132 VNLIGYCADGDQR-----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
V + +R +V+E M E LH + L R L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS-TRVMGTYGYC 245
+Y+H V +RDLK NIL + K+ DFGLA++ T + T + T Y
Sbjct: 117 KYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 246 APEYAKT--GQLTLKSDVYSFGVVLLEILSGR 275
APE + + T D++S G + E+L+G+
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIG 136
+G+G FG+V + + A+K + + + E L E +L+ ++ P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKP 195
++ LV ++ G + HL G+ L +R + A LE LH K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQ--REGRFDL---SRARFYTAELLCALENLH---KF 112
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 255
VIYRDLK NILLD H L DFGL KL D+ + GT Y APE
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLGHGY 170
Query: 256 TLKSDVYSFGVVLLEILSG 274
T D ++ GV+L E+L+G
Sbjct: 171 TKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 11/213 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYC 138
LGEG + V+KG + VA+K++ +G + EV +L L H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
LV+EY+ ++ ++ D G N ++ + RGL Y H + V+
Sbjct: 74 HTDKSLTLVFEYLD-KDLKQYMDDC--GNIMSMHNVKIFLYQ-ILRGLAYCH---RRKVL 126
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLTL 257
+RDLK N+L++ KL+DFGLA+ V T+ + V T Y P+ + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYST 184
Query: 258 KSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290
+ D++ G + E+ SGR S E L+
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 49/196 (25%), Positives = 86/196 (43%), Gaps = 18/196 (9%)
Query: 87 RVYKGYLESINQDVAIKQL--DRNGVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143
+YKG N++V I+ G + E+ L + N++ + G+ D
Sbjct: 35 SIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 144 RL----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
L L+ EY G + + L +K L + T++ +A +GL L+ P Y
Sbjct: 93 DLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--Y 146
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS 259
++L + L+ Y K+ GL K+ +V+ V +Y +++ T+K
Sbjct: 147 KNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSE---YTIKD 203
Query: 260 DVYSFGVVLLEILSGR 275
D+YS GVVL EI +G+
Sbjct: 204 DIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-10
Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 22/200 (11%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPNLVNLIGY 137
+G G +G VYK + A+K + G+ L+ E+ M+ H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA---AGAARGLEYLHDKAK 194
++ + EY GS++D H P + ++IA +GL YLH K K
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTGP-------LSELQIAYVCRETLQGLAYLHSKGK 127
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA---K 251
++RD+K +NILL KL+DFG+A + +GT + APE A K
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 252 TGQLTLKSDVYSFGVVLLEI 271
G D+++ G+ +E+
Sbjct: 183 NGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 22/220 (10%)
Query: 65 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVL 121
R+L +++ ++G G FG V +S + A+K L + + + F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 122 MLSLLHHPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 179
+++ + P +V L +CA D + L V EYMP G D ++ +S P W
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGG---DLVNLMSNYDVPEKWAKFY--T 148
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-KLGPVGDNTHVSTRV 238
A L+ +H +I+RD+K N+LLD+ H KL+DFG K+ G T V
Sbjct: 149 AEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAV 204
Query: 239 MGTYGYCAPEYAKT----GQLTLKSDVYSFGVVLLEILSG 274
GT Y +PE K+ G + D +S GV L E+L G
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-10
Identities = 47/157 (29%), Positives = 72/157 (45%), Gaps = 29/157 (18%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
+GEG +G V+K ++ VA+K++ D GV + L E+ +L L H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHKNIVRLY 65
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA--------RGLE 187
+ LV+EY DL KK D + I +GL
Sbjct: 66 DVLHSDKKLTLVFEYCD--------QDL---KKYFD-SCNGDIDPEIVKSFMFQLLKGLA 113
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224
+ H V++RDLK N+L+++ KL+DFGLA+
Sbjct: 114 FCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-10
Identities = 68/265 (25%), Positives = 102/265 (38%), Gaps = 70/265 (26%)
Query: 75 RSESLLGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGN--REFLVEV-LMLSLL 126
+ LG G FG+V + I + VA+K L + G + + + E+ +++ +
Sbjct: 10 KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKML-KEGATASEYKALMTELKILIHIG 68
Query: 127 HHPNLVNLIGYCADGDQRLLV-YEYMPLGSVEDHL----HDLSPGKKPLDWNTRMKIAAG 181
HH N+VNL+G C L+V EY G++ ++L SP + MK G
Sbjct: 69 HHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEG 128
Query: 182 AARGL--------------------------EYLHDKAKPPV------------------ 197
+ L E + K P+
Sbjct: 129 KKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEF 188
Query: 198 ------IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV---STRVMGTYGYCAPE 248
I+RDL NILL K+ DFGLA+ D +V R+ + APE
Sbjct: 189 LASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL--PLKWMAPE 245
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILS 273
T +SDV+SFGV+L EI S
Sbjct: 246 SIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-10
Identities = 44/158 (27%), Positives = 69/158 (43%), Gaps = 18/158 (11%)
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGL 186
PN+V L Y D LV ++ G + H+ P + W M +A L
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------L 98
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG-LAKLGPVGDNTHVSTRVMGTYGYC 245
+ LH + ++ RDL +NILLD H +L+ F +++ D V YC
Sbjct: 99 DALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YC 149
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283
APE + T D +S G +L E+L+G+ V+ +
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPS 187
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 26/222 (11%)
Query: 65 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVL 121
R+L +++ ++G G FG V +S + A+K L + + + F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 122 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS-PGKKPLDWNTRMKIAA 180
+++ + P +V L D +V EYMP G + + + + P K + + +A
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG----LAKLGPVGDNTHVST 236
A + ++H RD+K N+LLD+ H KL+DFG + K G V +T V
Sbjct: 156 DAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-- 204
Query: 237 RVMGTYGYCAPEYAKT----GQLTLKSDVYSFGVVLLEILSG 274
GT Y +PE K+ G + D +S GV L E+L G
Sbjct: 205 ---GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 16/206 (7%)
Query: 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH 127
A+ + L G GRV+ V +K G +G L+E ++L ++
Sbjct: 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI----GQKGTT--LIEAMLLQNVN 115
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
HP+++ + G +V + D L+ +PL + + I GL
Sbjct: 116 HPSVIRMKDTLVSGAITCMVLPHYS----SDLYTYLTKRSRPLPIDQALIIEKQILEGLR 171
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
YLH + +I+RD+K NI ++ + D G A+ PV + + GT AP
Sbjct: 172 YLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG--LAGTVETNAP 225
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILS 273
E + K+D++S G+VL E+L+
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-10
Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 28/217 (12%)
Query: 73 NFRSESLLGEGGFGRVY-----------KGYLESINQDVAIKQLDRNGVQGNREFLVEVL 121
NF +LG G +G+V+ K Y + + I Q + E V
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV--- 57
Query: 122 MLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA 180
+ + P LV L Y D +L L+ +Y+ G + HL K+ ++I +
Sbjct: 58 LEHIRQSPFLVTL-HYAFQTDTKLHLILDYINGGELFTHLSQRERFKE-----QEVQIYS 111
Query: 181 GA-ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 239
G LE+LH K +IYRD+K NILLD H L+DFGL+K D +
Sbjct: 112 GEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFC 167
Query: 240 GTYGYCAPEYAKTGQLTLKS--DVYSFGVVLLEILSG 274
GT Y AP+ + G D +S GV++ E+L+G
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYC 138
LGEG + VYKG + + VA+K++ +G + EV +L L H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
LV+EY+ ++ +L D G N ++ + RGL Y H + V+
Sbjct: 74 HTEKSLTLVFEYLD-KDLKQYLDDC--GNSINMHNVKLFLFQ-LLRGLNYCHRRK---VL 126
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLTL 257
+RDLK N+L++ KL+DFGLA+ + T+ + V T Y P+ + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYST 184
Query: 258 KSDVYSFGVVLLEILSGR 275
+ D++ G + E+ +GR
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 46/149 (30%), Positives = 72/149 (48%), Gaps = 16/149 (10%)
Query: 83 GGFGRVYKGYLESINQDVAIK------QLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
G FG+VY G ++ ++ A+K +++N V + E L+L P +V+L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVH---QVQAERDALALSKSPFIVHLYY 71
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
+ LV EY+ G V+ LH D +K + A L+YLH
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGY----FDEEMAVKYISEVALALDYLHRHG--- 124
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKL 225
+I+RDLK N+L+ H KL+DFGL+K+
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 11/210 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYC 138
LGEG + VYKG + + VA+K + +G + E +L L H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
+ LV+EY+ + D PG + N ++ + RGL Y+H + ++
Sbjct: 73 HTKETLTLVFEYVHTDLCQ--YMDKHPGGLHPE-NVKLFLFQ-LLRGLSYIHQRY---IL 125
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLTL 257
+RDLK N+L+ KL+DFGLA+ V +T+ + V T Y P+ + + +
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGSTEYST 183
Query: 258 KSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287
D++ G + +E++ G A K +Q
Sbjct: 184 CLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 15/215 (6%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYC 138
LGEG + V+KG + VA+K++ +G + EV +L L H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 139 ADGDQRLLVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
LV+EY+ L D+ +L + + RGL Y H +
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNCGNL------MSMHNVKIFMFQLLRGLSYCHKRK--- 123
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQL 255
+++RDLK N+L++ KL+DFGLA+ V T+ + V T Y P+ + +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEY 181
Query: 256 TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290
+ D++ G +L E+ +GR S E L+
Sbjct: 182 STPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 41/127 (32%), Positives = 62/127 (48%), Gaps = 7/127 (5%)
Query: 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 207
Y+ V++ L D G + L + ARG+E+L K ++RDL N+
Sbjct: 214 YKGSNDSEVKNLLSD--DGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV 268
Query: 208 LLDRGYHPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPEYAKTGQLTLKSDVYSFGV 266
LL +G K+ DFGLA+ + D+ +VS + APE T SDV+S+G+
Sbjct: 269 LLAQGKIVKICDFGLAR-DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 267 VLLEILS 273
+L EI S
Sbjct: 328 LLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 7e-09
Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 41/223 (18%)
Query: 73 NFRSESLLGEGGFGRVY-----------KGYLESINQDVAIKQLDRNGVQGNREFLVEVL 121
NF +LG G +G+V+ K Y + Q A+ Q + E
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTE------ 54
Query: 122 MLSLLHH----PNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 176
++L H P LV L Y + +L L+ +Y+ G + HL+ + +
Sbjct: 55 -RNVLEHVRQSPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-----DEV 107
Query: 177 KIAAGAA-RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK--LGPVGDNTH 233
+ +G LE+LH K ++YRD+K NILLD H L+DFGL+K L + T+
Sbjct: 108 RFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY 164
Query: 234 VSTRVMGTYGYCAPEY--AKTGQLTLKSDVYSFGVVLLEILSG 274
GT Y APE K G D +S G+++ E+L+G
Sbjct: 165 ---SFCGTIEYMAPEIIRGKGGHGKA-VDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 1e-08
Identities = 68/270 (25%), Positives = 103/270 (38%), Gaps = 61/270 (22%)
Query: 41 SSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVY----KGYLE-- 94
S L EA D A AQ + FR L G FG+++ + E
Sbjct: 118 SHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAH-FRVIDDLPAGAFGKIFICALRASTEEA 176
Query: 95 -------SINQDVA-----IKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD 142
S NQ I + + G + + E+L L L+H N++ +
Sbjct: 177 EARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI-------- 228
Query: 143 QRLLVYE---YMPLGSVEDHLH------DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
+ +L E YM + L+ +PL TR I +EY+HDK
Sbjct: 229 EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDKK 287
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLA----------KLGPVGDNTHVSTRVMGTYG 243
+I+RD+K NI L+ L DFG A G VG S ++ G
Sbjct: 288 ---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG 344
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
YC ++T D++S G++LL++LS
Sbjct: 345 YC--------EIT---DIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 14/206 (6%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF----LVEVLMLSLLHHP 129
F ++GEG +G V K + + VAIK+ + + N E L E+ ML L
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQE 60
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N+V L + LV+EY+ +E L + P P + K+ + + ++ +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPE-----KVRSYIYQLIKAI 113
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
H K +++RD+K N+L+ KL DFG A+ G N + T + T Y +PE
Sbjct: 114 HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPEL 172
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSGR 275
D++S G +L E+ G+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 33/212 (15%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
+G G +G V N+ VAIK++ N + R L E+ +L L H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLDHENVIAIKD 71
Query: 137 YCADGDQR-----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
+ +VYE M + LH + + L + RGL+Y+H
Sbjct: 72 IMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS 126
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
V++RDLK SN+LL+ K+ DFGLA+ + T + T Y APE
Sbjct: 127 AN---VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPE--- 178
Query: 252 TGQLTLKS-------DVYSFGVVLLEILSGRK 276
L L DV+S G + E+L GRK
Sbjct: 179 ---LLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 29/208 (13%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDR--NGVQGNREFLVEVLMLSLLHHPNLVNLIGY 137
+G G +G V Y + Q VA+K+L R + R E+ +L + H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 138 ---CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
+ VY L + L+++ +K D + + I RGL+Y+H
Sbjct: 83 FTPATSIENFNEVYLVTNLMGAD--LNNIVKCQKLSDEHVQFLIYQ-LLRGLKYIHSAG- 138
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE------ 248
+I+RDLK SN+ ++ ++ DFGLA+ +V+TR Y APE
Sbjct: 139 --IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIMLNWM 191
Query: 249 -YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y +T D++S G ++ E+L G+
Sbjct: 192 HYNQT------VDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 13/203 (6%)
Query: 80 LGEGGFGRVYKG--YLESINQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIG 136
+G G FG+V Y ++ V +K+L N + EFL + +L HPN++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
C + LLV+EY LG ++ +L ++ ++A A G+ ++H K
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHN 119
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK----- 251
++ DL N L K+ D+G+ D + APE
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179
Query: 252 --TGQLTLKSDVYSFGVVLLEIL 272
T + T S+V++ GV L E+
Sbjct: 180 LITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
RGL+YLH +++RD+K N+L++ K+ DFGLA++ ++ H++ V+ Y
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 244 YCAPEYAKTG--QLTLKSDVYSFGVVLLEILSGR 275
Y APE G T D++S G + E+L R
Sbjct: 170 YRAPEIL-MGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 61/250 (24%), Positives = 93/250 (37%), Gaps = 32/250 (12%)
Query: 35 DKLKMNSSLRVKEASEDGASDQITAQT----LTFRELAAATKNFRSE--SLLGEGGFGRV 88
D + + +A E+ S Q T A+ + S L G G V
Sbjct: 52 DDVTHATD---YDADEESLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEV 108
Query: 89 Y--KGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146
+ + + + V +K V G + E+ +L + H ++NLI +
Sbjct: 109 FVCTKHGDEQRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163
Query: 147 VYEYMPLGSVEDHLHDLSP---GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 203
V MP + DL PL + I L YLH + +I+RD+K
Sbjct: 164 V---MP-----KYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVK 212
Query: 204 CSNILLDRGYHPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVY 262
NI LD + L DFG A KL +T GT +PE K+D++
Sbjct: 213 TENIFLDEPENAVLGDFGAACKLD-AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIW 271
Query: 263 SFGVVLLEIL 272
S G+VL E+
Sbjct: 272 SAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 69/262 (26%), Positives = 101/262 (38%), Gaps = 71/262 (27%)
Query: 79 LLGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLVEVLMLSLLH---HPN 130
+LG G FG+V + I++ VA+K L + L+ L + L+H H N
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKI-LIHIGNHLN 72
Query: 131 LVNLIGYCADGDQRLLV-YEYMPLGSVEDHLH----------DLSPGKKPLDWNT----- 174
+VNL+G C + L+V E+ G++ + L + SP ++
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 175 -RMKIAAGAARGLEYLHDKAK-----PP-------------------------------- 196
+I AG A L + PP
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192
Query: 197 --VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV---STRVMGTYGYCAPEYAK 251
I+RDL NILL K+ DFGLA+ D +V S R+ + APE
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGSARL--PLKWMAPESIF 249
Query: 252 TGQLTLKSDVYSFGVVLLEILS 273
T +SDV+SFGV+L EI S
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHH 128
K +++ +G G G V Y Q+VAIK+L R N R + VLM L++H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLM-KLVNH 74
Query: 129 PNLVNLIGYCADGDQRLL-----VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
N++ L+ Q+ L VY M L ++ +L + + LD +
Sbjct: 75 KNIIGLLN--VFTPQKSLEEFQDVYLVMEL--MDANLCQVI--QMDLDHERMSYLLYQML 128
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
G+++LH +I+RDLK SNI++ K+ DFGLA+ G + ++ V+ Y
Sbjct: 129 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY- 182
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE D++S G ++ E++ G
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 30/83 (36%), Positives = 47/83 (56%)
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 256
+I+RD+K +NILL KL DFG +K+ + V GT Y APE + +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 257 LKSDVYSFGVVLLEILSGRKAVD 279
K+D++S GV+L E+L+ ++ D
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 34/91 (37%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
A+G+ +L K I+RDL NILL G K+ DFGLA+ N V
Sbjct: 224 AKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ APE T +SDV+S+G++L EI S
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 80 LGEGGFGRVYKG-YLESINQD-VAIKQLDR--NGVQGNREFLVEV-LMLSLLHHPNLVNL 134
LG+G +G V E+ ++ VAIK++ + + L E+ L+ H N+ L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 135 IGY-CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
+Y Y L +E LH + +PL GL+Y+H
Sbjct: 68 YDMDIVFPGNFNELYLYEEL--MEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN 125
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK---LGPVGDNTHVSTRVMGTYGYCAPEYA 250
V++RDLK N+L++ K+ DFGLA+ P G+N T + T Y APE
Sbjct: 126 ---VLHRDLKPGNLLVNADCELKICDFGLARGFSENP-GENAGFMTEYVATRWYRAPEIM 181
Query: 251 KTGQLTLKS-DVYSFGVVLLEILSGRKAV 278
+ Q K+ DV+S G +L E+L GRK V
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 3/109 (2%)
Query: 165 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224
PLD + ++ ++ A+G+++L K I+RD+ N+LL G K+ DFGLA+
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
N V + APE T++SDV+S+G++L EI S
Sbjct: 261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIK----QLDRNGVQGNREFLVEV-LMLSLLHHPNLVNL 134
+GEG +G+VYK ++ + VA+K ++D G+ L E+ L+ L +V L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSESIYIVRL 66
Query: 135 IGY----CADGDQRL-LVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
+ +G L LV+EY+ L D + PG +PL T +G+
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMD-SNGRGPG-RPLPAKTIKSFMYQLLKGVA 124
Query: 188 YLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLG--PVGDNTHVSTRVMGTYGY 244
+ H K V++RDLK N+L+D+ K++D GL + PV TH + T Y
Sbjct: 125 HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVTLWY 177
Query: 245 CAPEYAKTG-QLTLKSDVYSFGVVLLEILSG 274
APE + D++S G + E+
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 45/221 (20%)
Query: 80 LGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG- 136
+G G +G VYK + ++D A+KQ++ G+ + E+ +L L HPN+++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 66
Query: 137 YCADGDQRL-LVYEYMPLGSVEDHLHDL----------SPGKKPLDWNTRM--KIAAGAA 183
+ + D+++ L+++Y HDL KKP+ M +
Sbjct: 67 FLSHADRKVWLLFDYAE--------HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILL-----DRGYHPKLSDFGLAK-----LGPVGDNTH 233
G+ YLH V++RDLK +NIL+ +RG K++D G A+ L P+ D
Sbjct: 119 DGIHYLHANW---VLHRDLKPANILVMGEGPERG-RVKIADMGFARLFNSPLKPLAD--- 171
Query: 234 VSTRVMGTYGYCAPEYAKTGQLTLKS-DVYSFGVVLLEILS 273
V+ T+ Y APE + K+ D+++ G + E+L+
Sbjct: 172 -LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 41/224 (18%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---------NGVQGNREFLV--EV 120
++F ++G G FG V L++ ++ A+K L++ + R+ LV +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 121 LMLSLLHHP-----NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 175
++ LH+ NL ++ Y GD L+ ++ ED L P +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKF------EDRL----PEDMARFYLAE 110
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235
M IA + L Y+H RD+K NIL+D H +L+DFG + L + D T S
Sbjct: 111 MVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQS 160
Query: 236 TRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSG 274
+ +GT Y +PE + G+ + D +S GV + E+L G
Sbjct: 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-07
Identities = 37/154 (24%), Positives = 55/154 (35%), Gaps = 17/154 (11%)
Query: 76 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLV-N 133
S LL G RVY L + ++D +K +RE EV +L LL V
Sbjct: 2 SIKLLKGGLTNRVYL--LGTKDEDYVLKINPSREKGADRER--EVAILQLLARKGLPVPK 57
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
++ L+ E++ G D + + A L LH
Sbjct: 58 VLASGESDGWSYLLMEWIE-GETLDEVSEEEKEDIAEQ----------LAELLAKLHQLP 106
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227
+ + DL NIL+D G + D+ A GP
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 4e-07
Identities = 60/230 (26%), Positives = 107/230 (46%), Gaps = 27/230 (11%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHH 128
K +++ +G G G V Y ++++VAIK+L R N R + E++++ ++H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75
Query: 129 PNLVNLIGYCADGDQRLL-----VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
N+++L+ Q+ L VY M L ++ +L + + LD +
Sbjct: 76 KNIISLLNVFTP--QKSLEEFQDVYLVMEL--MDANLCQVI--QMELDHERMSYLLYQML 129
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
G+++LH +I+RDLK SNI++ K+ DFGLA+ G + ++ V+ Y
Sbjct: 130 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY- 183
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS------GRKAVDTSKAAAEQ 287
Y APE D++S G ++ E++ GR +D EQ
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 4e-07
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 40/221 (18%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHH 128
+ + S +G G +G V + + VAIK+L R + + R + E+ +L + H
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQH 73
Query: 129 PNLVNLI-----GYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGK-KPLDWNTRMKIAAG 181
N++ L+ D Q LV YM + H LS K + L +
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM------- 126
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
GL+Y+H +I+RDLK N+ ++ K+ DFGLA+ +V TR
Sbjct: 127 -LCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR---- 178
Query: 242 YGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE Y +T D++S G ++ E+L+G+
Sbjct: 179 -WYRAPEVILNWMHYNQT------VDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 39/219 (17%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPN 130
+++ S +G G +G V + VA+K+L R + + R + E+ +L + H N
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHEN 77
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVED-------------HLHDLSPGKKPLDWNTRMK 177
++ L+ + P S+E+ L+++ +K D + +
Sbjct: 78 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125
Query: 178 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 237
I RGL+Y+H +I+RDLK SN+ ++ K+ DFGLA+ +V+TR
Sbjct: 126 IYQ-ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 181
Query: 238 VMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGR 275
Y APE D++S G ++ E+L+GR
Sbjct: 182 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 9e-07
Identities = 64/252 (25%), Positives = 96/252 (38%), Gaps = 66/252 (26%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---------VQGNREFLVEVLM 122
+F S ++G G FG V + A+K+L ++ V+ R+ L E
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-- 58
Query: 123 LSLLHHPNLVNLIGYCA--DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN-TRMKIA 179
+P +V L Y + D + L+ EY+P G + L K TR IA
Sbjct: 59 ----DNPWVVKL--YYSFQDENYLYLIMEYLPGGD----MMTLLMKKDTFTEEETRFYIA 108
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK--------------- 224
++ +H K I+RD+K N+LLD H KLSDFGL
Sbjct: 109 E-TILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164
Query: 225 --LGPVGDNTHVSTR-------------------VMGTYGYCAPE-YAKTGQLTLKSDVY 262
L + +GT Y APE + +TG + D +
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWW 223
Query: 263 SFGVVLLEILSG 274
S GV++ E+L G
Sbjct: 224 SLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 45/221 (20%)
Query: 80 LGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG- 136
+G G +G VYK + ++ A+KQ++ G+ + E+ +L L HPN++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKV 66
Query: 137 YCADGDQRL-LVYEYMPLGSVEDHLHDL----------SPGKKPLDWNTRM--KIAAGAA 183
+ + D+++ L+++Y HDL KKP+ M +
Sbjct: 67 FLSHSDRKVWLLFDYAE--------HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQIL 118
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILL-----DRGYHPKLSDFGLAK-----LGPVGDNTH 233
G+ YLH V++RDLK +NIL+ +RG K++D G A+ L P+ D
Sbjct: 119 DGIHYLHANW---VLHRDLKPANILVMGEGPERG-RVKIADMGFARLFNSPLKPLAD--- 171
Query: 234 VSTRVMGTYGYCAPEYAKTGQLTLKS-DVYSFGVVLLEILS 273
V+ T+ Y APE + K+ D+++ G + E+L+
Sbjct: 172 -LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 40/110 (36%), Positives = 55/110 (50%), Gaps = 9/110 (8%)
Query: 167 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226
KK L + + A+G+E+L A I+RDL NILL K+ DFGLA+
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-D 228
Query: 227 PVGDNTHV---STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
D +V R+ + APE T++SDV+SFGV+L EI S
Sbjct: 229 IYKDPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 35/219 (15%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHH 128
K +++ +G G G V Y + ++VAIK+L R N R + E++++ ++H
Sbjct: 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN-----------TRMK 177
N++ L+ + P S+E+ D+ + +D N RM
Sbjct: 83 KNIIGLLNV------------FTPQKSLEE-FQDVYIVMELMDANLCQVIQMELDHERMS 129
Query: 178 -IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236
+ G+++LH +I+RDLK SNI++ K+ DFGLA+ G + ++
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 184
Query: 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
V+ Y Y APE D++S G ++ E++ G
Sbjct: 185 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 20/158 (12%)
Query: 122 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 181
++S + H +L + G C G + ++V E++ G ++ L G+ P+ W ++ +A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAW--KITVAQQ 125
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDR-----GYHP--KLSDFGLAKLGPVGDNTHV 234
A L YL DK +++ ++ NILL R G P KLSD G++ + V
Sbjct: 126 LASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERV 181
Query: 235 STRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEI 271
R+ + APE G L+ +D +SFG LLEI
Sbjct: 182 E-RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 28/77 (36%), Positives = 45/77 (58%)
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 256
+++RDLK +NI L KL DFG +K + V++ GT Y APE + + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 257 LKSDVYSFGVVLLEILS 273
K+D++S GV+L E+L+
Sbjct: 250 KKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 47/184 (25%), Positives = 76/184 (41%), Gaps = 21/184 (11%)
Query: 98 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 157
+ V IK R G E +L ++HP+++ L G L+ L +
Sbjct: 118 EHVVIKAGQRGGT------ATEAHILRAINHPSIIQLKGTFTYNKFTCLI-----LPRYK 166
Query: 158 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK- 216
L+ K+ + + I R ++YLH+ +I+RD+K NI ++ HP
Sbjct: 167 TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFIN---HPGD 220
Query: 217 --LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
L DFG A PV N + GT APE D++S G+VL E+ +
Sbjct: 221 VCLGDFGAACF-PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
Query: 275 RKAV 278
++
Sbjct: 280 HDSL 283
|
Length = 391 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 15/106 (14%)
Query: 174 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233
M +A + L Y+H RD+K N+LLD+ H +L+DFG + L + D T
Sbjct: 109 AEMVLAIDSVHQLGYVH---------RDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTV 158
Query: 234 VSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSG 274
S +GT Y +PE + G+ + D +S GV + E+L G
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 35/218 (16%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHH 128
K ++ +G G G V + + +VA+K+L R N R + E+++L ++H
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNH 79
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN-----------TRMK 177
N+++L+ + P S+E+ D+ + +D N RM
Sbjct: 80 KNIISLLNV------------FTPQKSLEE-FQDVYLVMELMDANLCQVIHMELDHERMS 126
Query: 178 -IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236
+ G+++LH +I+RDLK SNI++ K+ DFGLA+ N ++
Sbjct: 127 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT--NFMMTP 181
Query: 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
V+ Y Y APE D++S G ++ E++ G
Sbjct: 182 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-RVMGT 241
A G+E+L K ++RDL N+L+ G K+ DFGLA+ + D+ ++S
Sbjct: 249 ANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLAR-DIMRDSNYISKGSTFLP 304
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ APE T SDV+SFG++L EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 29/82 (35%), Positives = 45/82 (54%), Gaps = 6/82 (7%)
Query: 198 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT----- 252
++RD+K N+LLD H +L+DFG + L D T S+ +GT Y +PE +
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 253 GQLTLKSDVYSFGVVLLEILSG 274
G+ + D +S GV + E+L G
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 49/217 (22%), Positives = 85/217 (39%), Gaps = 30/217 (13%)
Query: 76 SESLLGEGGFGR--VYKGYLESINQDVAIKQLDRNGVQGNREFLV---EVLMLSLLHHPN 130
+L+G+ V+ + N VA+K+++ + + + E++ L HPN
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLD-SCSKEDLKLLQQEIITSRQLQHPN 60
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA---AGAARGLE 187
++ + + +V M GS ED L P P + IA L+
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKDVLNALD 115
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA--------KLGPVGDNTHVSTRVM 239
Y+H K I+R +K S+ILL LS + + V D S + +
Sbjct: 116 YIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 240 GTYGYCAPEYAKTGQL--TLKSDVYSFGVVLLEILSG 274
+ +PE + KSD+YS G+ E+ +G
Sbjct: 173 P---WLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 71/271 (26%), Positives = 101/271 (37%), Gaps = 66/271 (24%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLD------RNG---VQGNREFLVEVLMLS 124
F +G G FG V N A+K L RN V+ R+ L E
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA---- 58
Query: 125 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR 184
+ +V L D D V +Y+P G + L L ++ L R IA
Sbjct: 59 --DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARFYIAE-LTC 112
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL---------------------- 222
+E +H K I+RD+K NIL+DR H KL+DFGL
Sbjct: 113 AIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169
Query: 223 -------------AKLGPVGD-NTHVSTRVM-----GTYGYCAPE-YAKTGQLTLKSDVY 262
+L P+ R + GT Y APE +TG L D +
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWW 228
Query: 263 SFGVVLLEILSGRKA-VDTSKAAAEQSLVAW 292
S GV+L E+L G+ + + A + ++ W
Sbjct: 229 SVGVILYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 56/244 (22%), Positives = 99/244 (40%), Gaps = 48/244 (19%)
Query: 66 ELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSL 125
++ +T+ F+ SLLGEG FG+V + + + A+K + RN + R+ +E+ +
Sbjct: 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVK-IVRNVPKYTRDAKIEIQFMEK 181
Query: 126 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS-------PGKKP--LDW---- 172
+ AD R PL ++ + + + P P LDW
Sbjct: 182 VRQ----------ADPADRF------PLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKH 225
Query: 173 ---NTR--MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-----------RGYHPK 216
+ R +I L+Y H + +++ DLK NIL++ R P
Sbjct: 226 GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPD 283
Query: 217 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 276
+ LG D H T ++ T Y +PE +D++S G ++ E+ +G+
Sbjct: 284 PCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343
Query: 277 AVDT 280
DT
Sbjct: 344 LYDT 347
|
Length = 467 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 34/166 (20%)
Query: 73 NFRSESLLGEGGFGRVY--------KGY-LESINQDVAIKQLDRNGVQGNREFLVEVLML 123
+F + ++G+G FG V K Y ++++ + K+ V+ R+ L E
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES--- 58
Query: 124 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN------TRMK 177
P +V+L D L+ E++P G + L + ++ TR
Sbjct: 59 ---DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML---------IKYDTFSEDVTRFY 106
Query: 178 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223
+A +E +H K I+RD+K NIL+DRG H KLSDFGL+
Sbjct: 107 MAE-CVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 30/215 (13%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G G V+ ++ VA+K++ Q + L E+ ++ L H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 140 DGDQRL--------------LVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
L +V EYM L +V + PL
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ--------GPLSEEHARLFMYQLL 124
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGT 241
RGL+Y+H V++RDLK +N+ ++ K+ DFGLA+ + P + + + T
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 242 YGYCAPEYA-KTGQLTLKSDVYSFGVVLLEILSGR 275
Y +P T D+++ G + E+L+G+
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 6e-05
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 7/82 (8%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLV-EVLMLSLL-HHPNLV 132
LG G FG+V + + ++ VA+K L + RE L+ E+ +LS L H N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 133 NLIGYCADGDQRLLVYEYMPLG 154
NL+G C G L++ EY G
Sbjct: 106 NLLGACTHGGPVLVITEYCCYG 127
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 29/89 (32%), Positives = 42/89 (47%), Gaps = 7/89 (7%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLVEVL--MLSLLHHPNLV 132
LG G FGRV + ++ VA+K L ++ L+ L M L H N+V
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLH 161
NL+G C G ++ EY G + D+LH
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 6e-05
Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPN 130
+R +G G +G V VAIK+L R + + R + E+ +L + H N
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHEN 75
Query: 131 LVNLIG-YCADG--DQRLLVYEYMP-----LGSVEDHLHDLSPGKKPLDWNTRMKIAAGA 182
++ L+ + D D+ Y MP LG + H + L + +
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--------EKLSEDRIQFLVYQM 127
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
+GL+Y+H +I+RDLK N+ ++ K+ DFGLA+ +V TR
Sbjct: 128 LKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR----- 179
Query: 243 GYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGR 275
Y APE T D++S G ++ E+L+G+
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 1e-04
Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 30/223 (13%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR--EFLVEVLMLSLLHHPNLVNLIG- 136
+G G FG V+ + + K + G++ + ++EV ++ L H N+V I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 137 YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
+ +Q+L ++ E+ G + ++ ++ + + I L Y H+
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 196 P----VIYRDLKCSNILLDRGYH-----------------PKLSDFGLAKLGPVGDNTHV 234
P V++RDLK NI L G K+ DFGL+K + H
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH- 199
Query: 235 STRVMGTYGYCAPEYA--KTGQLTLKSDVYSFGVVLLEILSGR 275
+GT Y +PE +T KSD+++ G ++ E+ SG+
Sbjct: 200 --SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 46/167 (27%), Positives = 71/167 (42%), Gaps = 18/167 (10%)
Query: 119 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 178
EV++ HPN++ G ++ +M GS L P + + I
Sbjct: 49 EVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFP--EGMSEALIGNI 106
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD----FGLAKLGP----VGD 230
GA RGL YLH I+R++K S+IL+ LS + L + G V D
Sbjct: 107 LFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163
Query: 231 NTHVSTRVMGTYGYCAPEYAKTG--QLTLKSDVYSFGVVLLEILSGR 275
ST V+ + +PE + +KSD+YS G+ E+ +GR
Sbjct: 164 FPQFSTSVLP---WLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 31/96 (32%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 72 KNFRSESLLGEGGFGRV-----YKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSL 125
LG G FG+V Y + VA+K L + RE L+ E+ +LS
Sbjct: 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 94
Query: 126 L-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHL 160
L +H N+VNL+G C G L++ EY G + + L
Sbjct: 95 LGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 4e-04
Identities = 47/164 (28%), Positives = 67/164 (40%), Gaps = 23/164 (14%)
Query: 115 EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 174
E +V LM +PN + L +L+ +Y+ G L DL + L
Sbjct: 58 EPMVHQLMK---DNPNFIKLYYSVTTLKGHVLIMDYIKDGD----LFDLLKKEGKLSEAE 110
Query: 175 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKLGPVGDNTH 233
KI L LH K +I+ D+K N+L DR L D+GL K
Sbjct: 111 VKKIIRQLVEALNDLH-KHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCK--------I 159
Query: 234 VSTRVM--GTYGYCAPEYAKTGQLTLKS-DVYSFGVVLLEILSG 274
+ T GT Y +PE K G S D ++ GV+ E+L+G
Sbjct: 160 IGTPSCYDGTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 9e-04
Identities = 66/268 (24%), Positives = 97/268 (36%), Gaps = 68/268 (25%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGV---------QGNREFLVEVLMLSLLHHPN 130
LG G FG V A+K L + V + R+ L E +
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA------DNEW 62
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V L D D V +Y+P G + L + G P D R IA +E +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLL--IRMGIFPEDL-ARFYIAELTC-AVESVH 118
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL---------AKLGPVGDNTH-------- 233
K I+RD+K NIL+DR H KL+DFGL +K GD+
Sbjct: 119 ---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 234 ----------------------------VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 265
++ ++GT Y APE T D +S G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235
Query: 266 VVLLEILSGRKA-VDTSKAAAEQSLVAW 292
V+L E+L G+ + + + ++ W
Sbjct: 236 VILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 27/90 (30%), Positives = 44/90 (48%), Gaps = 7/90 (7%)
Query: 79 LLGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLVEVL--MLSLLHHPNL 131
+LG G FG+V +G +++ VA+K L ++ L+ L M L H N+
Sbjct: 44 ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNI 103
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLH 161
VNL+G C ++ EY G + ++LH
Sbjct: 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 30/111 (27%), Positives = 50/111 (45%), Gaps = 9/111 (8%)
Query: 163 LSPGKKPLDWNTRMKIAAGAAR---GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 219
L +PL ++ A A + ++Y+H + +I+RD+K N+L++ L D
Sbjct: 250 LGARLRPLG---LAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGD 303
Query: 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLE 270
FG A +T + GT APE T D++S G+V+ E
Sbjct: 304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 60/246 (24%), Positives = 93/246 (37%), Gaps = 57/246 (23%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---------NGVQGNREFLVEVLM 122
++F S ++G G FG V + A+K L + ++ R+ LVE
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 123 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGA 182
L + V + D L+ E++P G D + L + T+ IA
Sbjct: 61 LWV------VKMFYSFQDKLNLYLIMEFLPGG---DMMTLLMKKDTLTEEETQFYIAE-T 110
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT---------- 232
++ +H I+RD+K N+LLD H KLSDFGL T
Sbjct: 111 VLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167
Query: 233 -----------------------HVSTRVMGTYGYCAPE-YAKTGQLTLKSDVYSFGVVL 268
++ +GT Y APE + +TG L D +S GV++
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIM 226
Query: 269 LEILSG 274
E+L G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 297 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.75 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.65 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.62 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.56 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.55 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.55 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.54 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.48 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.46 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.41 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.38 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.37 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.22 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.22 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.17 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.09 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.07 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.01 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.91 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.9 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.88 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.79 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.65 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.65 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.63 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.61 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.59 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.56 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.52 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.43 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.41 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.39 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.35 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.28 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.27 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.26 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.16 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.15 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.1 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.02 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.02 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.91 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.89 | |
| PLN02236 | 344 | choline kinase | 97.88 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.82 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.8 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.73 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.64 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.63 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.54 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.52 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.51 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.47 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.42 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.34 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.3 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.19 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.14 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.86 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.72 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.66 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.63 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 96.54 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.41 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.07 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.73 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-52 Score=350.14 Aligned_cols=208 Identities=30% Similarity=0.443 Sum_probs=188.7
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
..+|.+.+.||+|+|++||+|+++.++..||||.+.+.. ....+.+..|+.+|+.++|||||.+++++..++..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 468999999999999999999999999999999998764 333455788999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC------CceEEecccC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG------YHPKLSDFGL 222 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~------~~~kl~Dfg~ 222 (297)
|||+||+|.++++. .+.+++..++.++.||+.|+++||+++ ||||||||.|||+... -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999998 678999999999999999999999999 9999999999999764 4589999999
Q ss_pred ccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 223 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
++.+.. .....+.||++-|||||++....|+.++|+||+|+|+|+|++|+.||+..+..+...
T Consensus 162 AR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 162 ARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred hhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 997543 334567899999999999999999999999999999999999999999887766544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-52 Score=344.72 Aligned_cols=211 Identities=29% Similarity=0.416 Sum_probs=192.3
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
...++|++++.||+|+||+||.++.+.+++.||+|++++..... .+....|..+|..++||+||+++..|++...+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 34578999999999999999999999999999999998865443 345788999999999999999999999999999
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+|+||+.||.|..++.. .+.+++..++.++.+|+.||.|||++| ||||||||+|||++.+|+++|+|||+|+.
T Consensus 102 lVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred EEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchh
Confidence 99999999999999997 788999999999999999999999999 99999999999999999999999999985
Q ss_pred cCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
. ........++|||+.|||||++.+..|+.++|.||||+++|||++|.+||.+.+......
T Consensus 175 ~--~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~ 235 (357)
T KOG0598|consen 175 D--LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD 235 (357)
T ss_pred c--ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHH
Confidence 2 223345566899999999999999999999999999999999999999999998655543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-52 Score=331.95 Aligned_cols=215 Identities=25% Similarity=0.353 Sum_probs=188.4
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceee-EeecCCe-eEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIG-YCADGDQ-RLL 146 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~-~~l 146 (297)
..+|+++++||+|+||.||++.+..+|+.+|.|.++..... ..+.+..|+.+|++|+|||||++++ .|.++.. .++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 34688999999999999999999999999999999855433 3356889999999999999999998 4555555 789
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA-KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
|||+|++|+|..+++.....+..+++..+|.++.|++.||..+|+.- .+.|+||||||.|||++.+|.+||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999999988878889999999999999999999999821 12399999999999999999999999999997
Q ss_pred cCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
+ ........+.+|||.||+||.+.+.+|+.++|||||||++|||+.-++||.+.+--..+
T Consensus 178 l--~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~ 237 (375)
T KOG0591|consen 178 L--SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLC 237 (375)
T ss_pred h--cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHH
Confidence 4 33444556789999999999999999999999999999999999999999998544433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=347.92 Aligned_cols=209 Identities=28% Similarity=0.467 Sum_probs=192.1
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
.+|...+.||+|+|+.+|.+++..+|+.||+|++++. .....+.+.+|+++.+.|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999999999999999999874 3344577899999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
|+|..++|..+++. ..+++|.+++.++.||+.||.|||+++ |+|||||..|+|++++.+|||+|||+|....
T Consensus 98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le- 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLE- 169 (592)
T ss_pred EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeec-
Confidence 99999999999986 688999999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
.......+.||||.|.|||++.....+..+||||+||+||.||.|++||+..+..+...-
T Consensus 170 -~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~ 229 (592)
T KOG0575|consen 170 -YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNK 229 (592)
T ss_pred -CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHH
Confidence 233456788999999999999999999999999999999999999999999987776543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-50 Score=336.83 Aligned_cols=206 Identities=30% Similarity=0.445 Sum_probs=182.8
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc-------hHHHHHHHHHHhccCCCCccceeeEeecCC
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-------NREFLVEVLMLSLLHHPNLVNLIGYCADGD 142 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 142 (297)
..+.|.+.+.||+|+||.|-+|..+.||+.||||++.+..... .....+|+++|++++|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4466888999999999999999999999999999997653322 123568999999999999999999999999
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC---CceEEec
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG---YHPKLSD 219 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~---~~~kl~D 219 (297)
..|+||||++||+|.+.+.. +..+.+...+.+++||+.|+.|||++| |+||||||+|||+..+ -.+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999987 778899999999999999999999999 9999999999999866 6799999
Q ss_pred ccCccccCCCCCcceeecccccccccCccccccCCC---CcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL---TLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 220 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
||+++... ....+.+.||||.|.|||++.+..+ ..++|||||||+||-+|+|.+||++...+.
T Consensus 323 FGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~ 388 (475)
T KOG0615|consen 323 FGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP 388 (475)
T ss_pred cchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence 99999633 4456778999999999999987654 347899999999999999999999876654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=342.65 Aligned_cols=225 Identities=25% Similarity=0.334 Sum_probs=195.3
Q ss_pred cCHHHHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccch---HHHHHHHHHHhccCCCCccceeeEe
Q 022447 62 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIGYC 138 (297)
Q Consensus 62 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~ 138 (297)
++........++|++++.||+|+||.||+|+-+.||+.+|+|++++...... ..+..|-.+|...++|+||++|..|
T Consensus 131 lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF 210 (550)
T KOG0605|consen 131 LRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF 210 (550)
T ss_pred HHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence 4444445577899999999999999999999999999999999988654433 4567799999999999999999999
Q ss_pred ecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEe
Q 022447 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 218 (297)
Q Consensus 139 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~ 218 (297)
++.+++||||||++||++..+|.. ...+++..++.++.+++.||+.||..| +|||||||+|+|||..|++||+
T Consensus 211 QD~~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLS 283 (550)
T KOG0605|consen 211 QDKEYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLS 283 (550)
T ss_pred cCCCeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeec
Confidence 999999999999999999999987 789999999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCC--------------------CCCcce-----e--------------------ecccccccccCccccccC
Q 022447 219 DFGLAKLGPV--------------------GDNTHV-----S--------------------TRVMGTYGYCAPEYAKTG 253 (297)
Q Consensus 219 Dfg~~~~~~~--------------------~~~~~~-----~--------------------~~~~g~~~y~aPE~~~~~ 253 (297)
|||+|..+.. ...... . ...+|||.|+|||++.+.
T Consensus 284 DFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k 363 (550)
T KOG0605|consen 284 DFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK 363 (550)
T ss_pred cccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC
Confidence 9999853110 000000 0 115799999999999999
Q ss_pred CCCcccchhhHHHHHHHHHhCCCCCCcchhHh-hhhHHhhc
Q 022447 254 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA-EQSLVAWS 293 (297)
Q Consensus 254 ~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~l~~~~ 293 (297)
.|+..+|.||||||+||||.|.+||.++++.+ ...+++|-
T Consensus 364 gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr 404 (550)
T KOG0605|consen 364 GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR 404 (550)
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999999999999999999999998855 46677774
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-49 Score=326.40 Aligned_cols=199 Identities=29% Similarity=0.417 Sum_probs=181.4
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhccCCCCccceeeEeecCC-eeEEEEe
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVYE 149 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 149 (297)
.+.+.++.||+|+.|+||+++|+.|++.+|+|++.... ....+++.+|+++++.++||+||.+|++|..+. ...++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 45667889999999999999999999999999995542 334577999999999999999999999999988 5999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+||+|.+.+.. .+.++|.....++.++++||.|||. ++ ||||||||+|+|++..|+|||+|||.+..+..
T Consensus 159 YMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 159 YMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999987 4779999999999999999999996 77 99999999999999999999999999975322
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
. ...+++||..|||||.+.+..|+.++||||||++++|+++|++||...
T Consensus 232 S----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 232 S----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred h----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 2 456789999999999999999999999999999999999999999985
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=315.67 Aligned_cols=202 Identities=32% Similarity=0.414 Sum_probs=186.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccch---HHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
.++|++++.||.|+||.|.+++.+.+|..+|+|++++...-.. +...+|..+|+.+.||+++++++.+.+.+..|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 3578899999999999999999999999999999987644333 4467799999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||.+||.|.++++. .+.+++..++.++.||+.||+|||+.+ |++||+||+|||+|.+|.+||+|||.++...
T Consensus 123 meyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999997 688999999999999999999999999 9999999999999999999999999998632
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
...-+.||||.|+|||++...++..++|.||||+++|||+.|.+||.++.+-
T Consensus 196 -----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~ 247 (355)
T KOG0616|consen 196 -----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI 247 (355)
T ss_pred -----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH
Confidence 2356789999999999999999999999999999999999999999998773
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=337.60 Aligned_cols=209 Identities=29% Similarity=0.444 Sum_probs=187.7
Q ss_pred HHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccch---HHHHHHHHHHhcc-CCCCccceeeEeecCCe
Q 022447 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 143 (297)
.....+|.+.+.||.|+|++|++|+.+.+++.||||++.+...... +.+..|-.+|.+| .||+|++++..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 4566899999999999999999999999999999999987644332 3466788888888 79999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
+|+|+||+++|+|.++|+. .+.|++..++.++.||+.||+|||++| ||||||||+|||++.+++++|+|||.+
T Consensus 149 LYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccc
Confidence 9999999999999999998 688999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCc---------ce--eecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 224 KLGPVGDNT---------HV--STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 224 ~~~~~~~~~---------~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
+.++..... .. ..+++||..|.+||++.....++++|||+||||||+|+.|.+||.+.+.
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne 292 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE 292 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence 875432211 11 2568999999999999999999999999999999999999999998765
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=308.56 Aligned_cols=212 Identities=27% Similarity=0.324 Sum_probs=186.5
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
+.|+.+..+|+|+||+||+++++.||+.||||.+..+... ..+-.++|+.+|++++|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4688899999999999999999999999999998754332 22457899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
||+ .++.+.+... ...+++..+..+++|++.|+.|+|+++ ++||||||+||||..+|.+||||||+|+.+..
T Consensus 82 ~~d-hTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCD-HTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecc-hHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 999 4555555543 356889999999999999999999999 99999999999999999999999999997543
Q ss_pred CCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHHhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 292 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~~~ 292 (297)
.....+.++.|.+|.|||++.+ ..|+..+||||+||++.||++|.+.|.+.++-++..++--
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~k 216 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRK 216 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHH
Confidence 3334567889999999999877 6899999999999999999999999999999888877643
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=326.30 Aligned_cols=211 Identities=30% Similarity=0.433 Sum_probs=187.7
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccC----Cc-cchHHHHHHHHHHhccC-CCCccceeeEeecCC
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN----GV-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGD 142 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 142 (297)
....+|.+.+.||+|+||.|++|.+..++..||+|++++. .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999999999999999988764 22 23345678999999999 999999999999999
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC-CceEEeccc
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFG 221 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~-~~~kl~Dfg 221 (297)
.+|+||||+.||+|.+++.+ ..++.+.+++.++.|+++|++|||++| |+||||||+|||++.+ +.+||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999998 688999999999999999999999999 9999999999999999 999999999
Q ss_pred CccccCCCCCcceeecccccccccCccccccCC-CC-cccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ-LT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
++.... .......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||++.+......
T Consensus 167 ~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ 233 (370)
T KOG0583|consen 167 LSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR 233 (370)
T ss_pred cccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH
Confidence 998643 2334566789999999999999877 76 78999999999999999999999976554433
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=327.45 Aligned_cols=207 Identities=33% Similarity=0.468 Sum_probs=190.7
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+.... +.+.+.+|+.+++.++||||+.++++|+...+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5789999999999999999999999999999999876443 34678999999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+.| +|..++.. ...++++.+..++.+++.||.|||+.+ |.|||+||.|||++.+|.+|++|||+++. ..
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~--m~ 151 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARA--MS 151 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhh--cc
Confidence 9995 99999998 788999999999999999999999999 99999999999999999999999999987 45
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
..+.......|||.|||||+..+.+|+..+|+||||||+|||++|++||...+.-....
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~ 210 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVK 210 (808)
T ss_pred cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHH
Confidence 56667778889999999999999999999999999999999999999999876554433
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=328.70 Aligned_cols=217 Identities=30% Similarity=0.469 Sum_probs=190.8
Q ss_pred HHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccch---HHHHHHHHHHhccC-CCCccceeeEeecCCe
Q 022447 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 143 (297)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 143 (297)
....++|.++++||+|+||+|+++..+.+++.+|||++++...-.. +....|..++.... ||.++.++..|+..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 3456789999999999999999999999999999999998755433 45677888887775 9999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
.|+||||+.||++..+.+ ...+++..++.++..|+.||+|||++| |||||||.+|||+|.+|.+||+|||+|
T Consensus 444 l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccc
Confidence 999999999999655554 377999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHHhhcC
Q 022447 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSE 294 (297)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~~~~~ 294 (297)
+..-. ....+.++||||.|+|||++.+..|+.++|.|||||+|||||.|..||.+++.++.-+-+-..+
T Consensus 516 Ke~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~ 584 (694)
T KOG0694|consen 516 KEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE 584 (694)
T ss_pred cccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC
Confidence 86322 3335678999999999999999999999999999999999999999999888777655443333
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=317.26 Aligned_cols=210 Identities=26% Similarity=0.358 Sum_probs=184.3
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecC--CeeEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLV 147 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 147 (297)
+.|+.+++||+|.||.||+|++..+|+.||+|.+...... -..-..+||.+|++|+||||+++.+.+.+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4688899999999999999999999999999998765433 235577899999999999999999998876 689999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
+|||+ .+|.-++.. ..-.|++.++..++.||+.||+|||++| |+|||||.+|||||++|.+||+|||+|++..
T Consensus 197 FeYMd-hDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMD-HDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eeccc-chhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 99998 688777765 3567999999999999999999999999 9999999999999999999999999999654
Q ss_pred CCCCcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
.... ...+..+-|..|.|||++.|. .|+.++|+||+||||.||++|++.|.+.+.-++...
T Consensus 270 ~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~k 331 (560)
T KOG0600|consen 270 PSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHK 331 (560)
T ss_pred CCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHH
Confidence 4432 235556789999999988775 799999999999999999999999999988777654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=316.48 Aligned_cols=233 Identities=62% Similarity=1.041 Sum_probs=203.2
Q ss_pred cccccCHHHHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeE
Q 022447 58 TAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGY 137 (297)
Q Consensus 58 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 137 (297)
....+++.++..++++|.-...||+|+||.||+|.... +..||||.+.........+|..|+.++.+++|||+++++++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 56779999999999999999999999999999999876 48999998876544314569999999999999999999999
Q ss_pred eecCC-eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceE
Q 022447 138 CADGD-QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (297)
Q Consensus 138 ~~~~~-~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~k 216 (297)
|.+.+ ..+||+||++.|+|.+++...... +++|.....|+.+++.||+|||....++|+||||||+|||+|.+...|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99988 599999999999999999873322 899999999999999999999998888899999999999999999999
Q ss_pred EecccCccccCCCCCcceeecc-cccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHHhhcCC
Q 022447 217 LSDFGLAKLGPVGDNTHVSTRV-MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEP 295 (297)
Q Consensus 217 l~Dfg~~~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~~~~~p 295 (297)
|+|||+++..+.. ... .... .||.+|+|||+...+..+.++||||||++|.||++|+.|.+.......+.++.|..|
T Consensus 218 lsDFGLa~~~~~~-~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 218 LSDFGLAKLGPEG-DTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred ccCccCcccCCcc-ccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 9999999764431 111 1122 799999999999989999999999999999999999999998776666778887543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=288.99 Aligned_cols=210 Identities=29% Similarity=0.399 Sum_probs=186.3
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.+|...+.||+|.||.||+|++..+|+.||||+++.....+ .....+|++.|+.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888899999999999999999999999999998764443 3457899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|++ .+|...+++ ....++..++..++.+++++|+|||++. |+||||||.|+||+.+|.+||+|||+++.....
T Consensus 82 fm~-tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 998 899999987 3577999999999999999999999999 999999999999999999999999999975433
Q ss_pred CCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHH
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~ 290 (297)
.. .....+-|..|.|||++.| +.|+..+||||.|||+.||+.|.+-|.+.++-++...+
T Consensus 155 ~~--~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~I 214 (318)
T KOG0659|consen 155 NR--IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKI 214 (318)
T ss_pred Cc--ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHH
Confidence 32 2333478999999998765 67999999999999999999999999999887776643
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=321.47 Aligned_cols=207 Identities=28% Similarity=0.396 Sum_probs=186.8
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC-cc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
.-|++.+-||.|+.|.|.+|++..||+.+|||++.+.. .. ....+.+|+.+|+.+.|||++++|++|.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45788999999999999999999999999999998762 22 2356889999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||++||.|++++.. ++++++.++..++.||+.|+.|+|..+ |+|||+||+|+|++..+.|||+|||.|.+-.
T Consensus 92 Eyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~- 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV- 163 (786)
T ss_pred EecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc-
Confidence 99999999999998 899999999999999999999999999 9999999999999999899999999998533
Q ss_pred CCCcceeecccccccccCccccccCCCC-cccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
......+.||+|.|.|||++.|.+|+ .++||||.|||||.||+|+.||++++.+....
T Consensus 164 --~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLl 222 (786)
T KOG0588|consen 164 --PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLL 222 (786)
T ss_pred --CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHH
Confidence 23345678999999999999999885 68999999999999999999999877655443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=307.77 Aligned_cols=209 Identities=40% Similarity=0.623 Sum_probs=179.8
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeE-EEEEEeccCCccc--hHHHHHHHHHHhccCCCCccceeeEeecCC-eeEEEE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQD-VAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVY 148 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 148 (297)
...+.+.||+|+||+||+|.++ |.. ||+|.+....... .+.+.+|+.++.+++|||||++++++.++. ...+||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 3445566999999999999998 555 9999997654332 458999999999999999999999999988 789999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC-ceEEecccCccccC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGP 227 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~-~~kl~Dfg~~~~~~ 227 (297)
||+++|+|.++++.. .+..++...+..++.+|+.|+.|||+.+. ||||||||+|+|++.++ ++||+|||+++...
T Consensus 120 Ey~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999999999874 35789999999999999999999999875 89999999999999997 99999999997632
Q ss_pred CCCCcceeecccccccccCccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAK--TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
... .......||+.|||||++. ...|+.++||||||+++|||+||+.||...+.......
T Consensus 196 ~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~ 257 (362)
T KOG0192|consen 196 ISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA 257 (362)
T ss_pred ccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 211 2333367999999999999 56999999999999999999999999999987444333
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=304.60 Aligned_cols=209 Identities=24% Similarity=0.416 Sum_probs=190.6
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchH---HHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
...+|++.+.||+|.||.|-+|.....|..||||.|++....+.+ .+.+|+++++.|+||||+.+|++|+..+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 346899999999999999999999999999999999887666554 47889999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||||..+|.|++|+.+ .+.+++.+++.++.||.+|+.|+|.++ ++|||||.+|||+|+++++||+|||++.++
T Consensus 131 vMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhh
Confidence 9999999999999998 788999999999999999999999999 999999999999999999999999998764
Q ss_pred CCCCCcceeecccccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
.... ...++||+|-|.+||++.+.+| ++.+|-||||++||.|+.|..||++.+......
T Consensus 204 ~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvr 263 (668)
T KOG0611|consen 204 ADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVR 263 (668)
T ss_pred cccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHH
Confidence 3332 3567899999999999999887 589999999999999999999999988765544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=311.88 Aligned_cols=212 Identities=26% Similarity=0.336 Sum_probs=188.8
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccC-CCCccceeeEeecCC-eeE
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADGD-QRL 145 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~ 145 (297)
...++|.+.+.||.|.||.||+|+.+.+|+.||||.+++.... +..--++|+..|++++ ||||+++.+++.+++ .+|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3557899999999999999999999999999999999765333 3334578999999999 999999999999988 899
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+|||||+ .+|+++++.+ ...|++..++.|+.||+++|+|+|.+| +.|||+||+|||+.....+||+|||+|+.
T Consensus 87 fVfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 9999998 8999999984 688999999999999999999999999 99999999999999888999999999984
Q ss_pred cCCCCCcceeecccccccccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHH
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~ 290 (297)
-....+.+.++.|..|.|||++. ...|+.++||||+|||++|+++-++.|.+.+.-++..-+
T Consensus 160 ---v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KI 222 (538)
T KOG0661|consen 160 ---VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKI 222 (538)
T ss_pred ---cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHH
Confidence 33445667789999999999764 567899999999999999999999999999887765433
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=312.81 Aligned_cols=212 Identities=29% Similarity=0.435 Sum_probs=193.9
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
..|...+.||+|+.|.||.|....+++.||||.+........+-+++|+.+++..+|+|||.+++.|...+..|+||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 46888999999999999999999999999999998877666677899999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
+||+|.+.+.. ..++|.++..|+.++++||+|||.+| |+|||||.+|||++.+|.+||+|||+|..+...
T Consensus 353 ~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~-- 422 (550)
T KOG0578|consen 353 EGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE-- 422 (550)
T ss_pred CCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccc--
Confidence 99999999985 55999999999999999999999999 999999999999999999999999999764333
Q ss_pred cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHHhhc
Q 022447 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWS 293 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~~~~ 293 (297)
.....+.+|||+|||||+.....|++++||||||++++||+-|.+||-..++--...|++.-
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n 484 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN 484 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc
Confidence 33567789999999999999999999999999999999999999999987776666666654
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=312.56 Aligned_cols=208 Identities=25% Similarity=0.313 Sum_probs=180.9
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+..|+.++..++|++|+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 478999999999999999999999999999999975422 22245778999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||++|++|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999986 567999999999999999999999999 99999999999999999999999999864321
Q ss_pred CCCc---------------------------------ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCC
Q 022447 229 GDNT---------------------------------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275 (297)
Q Consensus 229 ~~~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 275 (297)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1000 0012357999999999999999999999999999999999999
Q ss_pred CCCCcchhHhh
Q 022447 276 KAVDTSKAAAE 286 (297)
Q Consensus 276 ~Pf~~~~~~~~ 286 (297)
.||...+..+.
T Consensus 234 ~Pf~~~~~~~~ 244 (363)
T cd05628 234 PPFCSETPQET 244 (363)
T ss_pred CCCCCCCHHHH
Confidence 99987765443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=296.86 Aligned_cols=214 Identities=31% Similarity=0.398 Sum_probs=188.0
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccch---HHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
..+.|++++.||.|.-|+||++..+.++..+|+|++.+...... .+...|-+||+.++||.++.+|..|+.+...++
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 34568889999999999999999999999999999988755543 456779999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
+||||+||+|..+++.+. ...+++..++.++.+++-||+|||..| ||+|||||+||||.++|+|-|+||.++...
T Consensus 155 ~meyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 999999999999998744 678999999999999999999999999 999999999999999999999999885421
Q ss_pred CC---------------------------------C-C--------------------CcceeecccccccccCcccccc
Q 022447 227 PV---------------------------------G-D--------------------NTHVSTRVMGTYGYCAPEYAKT 252 (297)
Q Consensus 227 ~~---------------------------------~-~--------------------~~~~~~~~~g~~~y~aPE~~~~ 252 (297)
.. . . ....+..++||.+|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 00 0 0 0112234689999999999999
Q ss_pred CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 253 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 253 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
..-+.++|.|+||+++||||.|..||.+.+.++...
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~ 345 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR 345 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH
Confidence 999999999999999999999999999998877654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=299.26 Aligned_cols=212 Identities=27% Similarity=0.392 Sum_probs=187.7
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccch-HHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
...++|++.+.||.|..++||+|+...+++.||||++..+..... +.+.+|+..++.++||||++++..|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 456799999999999999999999999999999999988766554 7899999999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|.||.+|++.+.+..... ..+.|..+..|++++++||.|||.+| .||||||+.||||+.+|.|+|+|||.+-.+.
T Consensus 103 mpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred ehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999988653 45999999999999999999999999 9999999999999999999999999865432
Q ss_pred -CCCCccee-ecccccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 228 -VGDNTHVS-TRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 228 -~~~~~~~~-~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.+...... .+++||++|||||++.. ..|+.++||||||+++.||.+|..||....+-.
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk 239 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK 239 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH
Confidence 22222222 56789999999998643 579999999999999999999999999986543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=291.02 Aligned_cols=209 Identities=26% Similarity=0.349 Sum_probs=182.9
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhccCCCCccceeeEeec--CCeeEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLV 147 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 147 (297)
++|+.+..|++|+||.||+|+++.|++.||+|.++.....+ .-..++|+.+|.+++|||||.+-.++.. -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 56888999999999999999999999999999997653221 1346789999999999999999998764 4679999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
||||+ .+|.+++... ..+|...++..++.|++.|++|||... |+||||||+|+|++..|.+||+|||+|+...
T Consensus 156 Me~~E-hDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHH-hhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 99998 7999999874 468999999999999999999999999 9999999999999999999999999998733
Q ss_pred CCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
....+.+..+-|..|.|||++.+ ..|+.++|+||+|||+.||+++++.|.+.+.-++...
T Consensus 229 --sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~ 289 (419)
T KOG0663|consen 229 --SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK 289 (419)
T ss_pred --CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH
Confidence 33344566788999999998876 5799999999999999999999999999988776554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=298.79 Aligned_cols=204 Identities=31% Similarity=0.487 Sum_probs=175.4
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCC--eeEEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLVY 148 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 148 (297)
..++...+.||+|+||.||++.+..+|..+|||.+........+.+.+|+.+|++++|||||++++...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 456778899999999999999999999999999987664343567889999999999999999999754444 688999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC-CCceEEecccCccccC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGP 227 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~-~~~~kl~Dfg~~~~~~ 227 (297)
||+++|+|.+++.... ..+++..++.++.|++++|.|||++| |+||||||+|||++. ++.+||+|||++....
T Consensus 96 Ey~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999732 27999999999999999999999999 999999999999999 7999999999987543
Q ss_pred C-CCCcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCc
Q 022447 228 V-GDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDT 280 (297)
Q Consensus 228 ~-~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~ 280 (297)
. ...........||+.|||||++... ....++|||||||++.||+||+.||..
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 2 1122223457799999999999853 344699999999999999999999998
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=311.05 Aligned_cols=207 Identities=27% Similarity=0.300 Sum_probs=179.5
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.|++++.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68899999999999999999999999999999975432 223467889999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|++|++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999976 567899999999999999999999999 999999999999999999999999987532100
Q ss_pred CC---------------------------------------------cceeecccccccccCccccccCCCCcccchhhH
Q 022447 230 DN---------------------------------------------THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSF 264 (297)
Q Consensus 230 ~~---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 264 (297)
.. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 001123579999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCcchhHhh
Q 022447 265 GVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 265 G~il~ell~g~~Pf~~~~~~~~ 286 (297)
||++|||++|+.||...+..+.
T Consensus 235 G~il~elltG~~Pf~~~~~~~~ 256 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTET 256 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHH
Confidence 9999999999999988766443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=300.59 Aligned_cols=202 Identities=28% Similarity=0.366 Sum_probs=180.3
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 478999999999999999999999999999999865422 23356788999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+++++|.+++.. ...+++..++.++.|++.||+|||+++ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999986 567899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~ 205 (291)
T cd05612 154 -----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205 (291)
T ss_pred -----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1223568999999999999999999999999999999999999998876544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=302.97 Aligned_cols=202 Identities=29% Similarity=0.382 Sum_probs=176.5
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 154 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~ 154 (297)
+.||+|+||.||+|.++.+|+.||+|++..... .....+..|+.+++.++||||+++++++...+..++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975422 22345778999999999999999999999999999999999999
Q ss_pred ChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcce
Q 022447 155 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 234 (297)
Q Consensus 155 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 234 (297)
+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||+++.... ....
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~ 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGAT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCc
Confidence 99999976 567899999999999999999999999 99999999999999999999999999864211 1222
Q ss_pred eecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 235 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 235 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+......
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~ 205 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 205 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHH
Confidence 334679999999999999999999999999999999999999998776554433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=310.55 Aligned_cols=207 Identities=26% Similarity=0.328 Sum_probs=178.8
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 478999999999999999999999999999999865322 22345778999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||++|++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999976 567899999999999999999999999 99999999999999999999999999852111
Q ss_pred CCC------------c---------------------------------ceeecccccccccCccccccCCCCcccchhh
Q 022447 229 GDN------------T---------------------------------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYS 263 (297)
Q Consensus 229 ~~~------------~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Diws 263 (297)
... . ......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 000 0 0001246999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCcchhHh
Q 022447 264 FGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 264 lG~il~ell~g~~Pf~~~~~~~ 285 (297)
|||++|||++|..||...+..+
T Consensus 234 lGvil~elltG~~Pf~~~~~~~ 255 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHE 255 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHH
Confidence 9999999999999998776544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=309.34 Aligned_cols=207 Identities=27% Similarity=0.343 Sum_probs=180.1
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 478999999999999999999999999999999975421 22345778999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+.|++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999976 567999999999999999999999999 99999999999999999999999999864321
Q ss_pred CCCc------------------------------------ceeecccccccccCccccccCCCCcccchhhHHHHHHHHH
Q 022447 229 GDNT------------------------------------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 272 (297)
Q Consensus 229 ~~~~------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell 272 (297)
.... ......+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 0011246999999999999999999999999999999999
Q ss_pred hCCCCCCcchhHh
Q 022447 273 SGRKAVDTSKAAA 285 (297)
Q Consensus 273 ~g~~Pf~~~~~~~ 285 (297)
+|..||...+..+
T Consensus 234 ~G~~Pf~~~~~~~ 246 (364)
T cd05599 234 VGYPPFCSDNPQE 246 (364)
T ss_pred cCCCCCCCCCHHH
Confidence 9999998876543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=310.60 Aligned_cols=207 Identities=27% Similarity=0.296 Sum_probs=178.9
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
+|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 68899999999999999999999999999999875432 223467789999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|++|++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999976 456899999999999999999999999 999999999999999999999999997432100
Q ss_pred C---------------------------------------------CcceeecccccccccCccccccCCCCcccchhhH
Q 022447 230 D---------------------------------------------NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSF 264 (297)
Q Consensus 230 ~---------------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 264 (297)
. ........+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0001123569999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCcchhHhh
Q 022447 265 GVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 265 G~il~ell~g~~Pf~~~~~~~~ 286 (297)
||++|||++|+.||...+..+.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~ 256 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLET 256 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999988765443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=303.87 Aligned_cols=203 Identities=30% Similarity=0.412 Sum_probs=181.1
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
.++|++.+.||+|+||.||+|.++.+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 3678999999999999999999999999999999875422 2335678899999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||+.|++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++....
T Consensus 97 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 97 LEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999999986 567899999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 170 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 222 (329)
T PTZ00263 170 DR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR 222 (329)
T ss_pred CC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH
Confidence 21 223579999999999999999999999999999999999999998766543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=304.42 Aligned_cols=203 Identities=29% Similarity=0.396 Sum_probs=181.7
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+..|+.++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 478999999999999999999999999999999975422 23356788999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||++|++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999976 567899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
......|++.|+|||++.+..++.++|||||||++|||++|..||...+..+.
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~ 206 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET 206 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH
Confidence 23345799999999999999999999999999999999999999988766543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=280.95 Aligned_cols=208 Identities=29% Similarity=0.423 Sum_probs=187.8
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
..++|++.+.||+|-||.||+|+.+.++-.||+|++.++.. .....+.+|+++-+.|+||||+++|++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 34689999999999999999999999999999999876532 233578899999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
++||...|+|+..+.+.. ...+++...+.++.|++.|+.|+|..+ ++||||||+|+|++..+.+||+|||.+...
T Consensus 100 ilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 999999999999998633 567999999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
+ .....+.|||..|.+||+..+...+..+|+|++|++.||++.|.+||...+..+.
T Consensus 175 p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et 230 (281)
T KOG0580|consen 175 P----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET 230 (281)
T ss_pred C----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH
Confidence 2 3456778999999999999999999999999999999999999999998875443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=289.11 Aligned_cols=212 Identities=25% Similarity=0.340 Sum_probs=182.8
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCC-ccceeeEeecCC------
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPN-LVNLIGYCADGD------ 142 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~------ 142 (297)
..|..+++||+|+||+||+|+++.+|+.||+|++...... ......+|+.+++.++|+| |+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4566778899999999999999999999999999765432 2345688999999999999 999999998877
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
..++|+||++ -+|..++.........++...++.++.||+.||+|||+++ |+||||||.||+|++.|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 7889999998 8999999875433246777899999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 223 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
++...... ......++|..|.|||++.+. .|+..+||||+|||++||++++..|.+++..++...
T Consensus 167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~ 232 (323)
T KOG0594|consen 167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFR 232 (323)
T ss_pred HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence 98543222 224456789999999998876 799999999999999999999999999988665543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=295.39 Aligned_cols=207 Identities=27% Similarity=0.406 Sum_probs=177.6
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCC-----eeEEE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRLLV 147 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv 147 (297)
.|+-.+++|+|+||.||.|....+++.||||..-.+.. ---+|+.+|+.++|||||++..+|.... +..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 45667899999999999999999999999998754322 2235999999999999999999886432 23489
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC-CceEEecccCcccc
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKLG 226 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~-~~~kl~Dfg~~~~~ 226 (297)
|||++ .+|.+.++.....+..++...++-+.+||++||.|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99998 8999999876555788999999999999999999999999 9999999999999965 99999999999975
Q ss_pred CCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHH
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~ 290 (297)
..+.. ..+...|..|.|||++.+ ..|+.+.||||.||++.||+-|++.|.+.+..++..++
T Consensus 177 ~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eI 238 (364)
T KOG0658|consen 177 VKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEI 238 (364)
T ss_pred ccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHH
Confidence 44432 355678999999998866 57999999999999999999999999999988887654
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=310.55 Aligned_cols=208 Identities=27% Similarity=0.306 Sum_probs=179.9
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++|+||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999999865322 22345778999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||++|++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999976 567899999999999999999999999 99999999999999999999999998742110
Q ss_pred CC-----------------------------------------CcceeecccccccccCccccccCCCCcccchhhHHHH
Q 022447 229 GD-----------------------------------------NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVV 267 (297)
Q Consensus 229 ~~-----------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~i 267 (297)
.. ........+||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 0001123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCcchhHhh
Q 022447 268 LLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 268 l~ell~g~~Pf~~~~~~~~ 286 (297)
+|+|++|+.||...+..+.
T Consensus 234 lyell~G~~Pf~~~~~~~~ 252 (376)
T cd05598 234 LYEMLVGQPPFLADTPAET 252 (376)
T ss_pred eeehhhCCCCCCCCCHHHH
Confidence 9999999999998776544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=297.01 Aligned_cols=210 Identities=31% Similarity=0.411 Sum_probs=176.3
Q ss_pred HHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--------------chHHHHHHHHHHhccCCCCccc
Q 022447 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--------------GNREFLVEVLMLSLLHHPNLVN 133 (297)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~ 133 (297)
....++|++.+.||+|.||.|.+|++..+++.||||++.+.... ..++..+|+.++++|+|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34568899999999999999999999999999999999753221 1246889999999999999999
Q ss_pred eeeEeecC--CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC
Q 022447 134 LIGYCADG--DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 211 (297)
Q Consensus 134 ~~~~~~~~--~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~ 211 (297)
++++..++ +.+|||+|||..|.+...-.. +..+++.+++.++..++.+|+|||.+| |+||||||+|+|++.
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d----~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPD----KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCC----cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence 99999875 578999999998887644332 333999999999999999999999999 999999999999999
Q ss_pred CCceEEecccCccccCCC---CCcceeecccccccccCccccccCC----CCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 212 GYHPKLSDFGLAKLGPVG---DNTHVSTRVMGTYGYCAPEYAKTGQ----LTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 212 ~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
+|++||+|||.+...+.+ .........+|||.|+|||.+.++. .+.+.|||||||+||.|+.|+.||-++..-
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 999999999998754222 1122233468999999999887632 357899999999999999999999887543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=291.06 Aligned_cols=217 Identities=26% Similarity=0.340 Sum_probs=191.0
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEec--cCCccchHHHHHHHHHHhccCCCCccceeeEeec-----CC
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD--RNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-----GD 142 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 142 (297)
....|...+.||.|+||.|..|.++.+|+.||||++. .......++..+|+.+++.++|+||+.+++++.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4456777899999999999999999999999999997 4555667889999999999999999999999865 34
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
..|+|+|+|+ .+|...++. ...+++..+..+++|++.||.|+|+.+ ++|||+||.|+|++.+..+||+|||+
T Consensus 100 DvYiV~elMe-tDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHHh-hHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 6899999996 899999987 566999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHHhhcC
Q 022447 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSE 294 (297)
Q Consensus 223 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~~~~~ 294 (297)
|+...........+..+.|..|.|||++. ...|+.+.||||+|||+.||++|++.|.+.+.-.+..++.-..
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l 244 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL 244 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence 99754433344456788999999999764 5689999999999999999999999999999988877765443
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=299.24 Aligned_cols=202 Identities=29% Similarity=0.384 Sum_probs=175.8
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 154 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~ 154 (297)
+.||+|+||.||++.+..+|..||+|++..... .....+..|+.+++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999999999999999999875422 22345678999999999999999999999999999999999999
Q ss_pred ChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcce
Q 022447 155 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 234 (297)
Q Consensus 155 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 234 (297)
+|..++.. ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~ 151 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GAT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCc
Confidence 99998876 567899999999999999999999999 999999999999999999999999998642111 112
Q ss_pred eecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 235 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 235 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+......
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~ 205 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 205 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 234569999999999999999999999999999999999999998876655443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=299.00 Aligned_cols=203 Identities=29% Similarity=0.403 Sum_probs=176.7
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 154 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~ 154 (297)
+.||+|+||.||++.+..++..||+|++..... .....+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975422 23356778999999999999999999999999999999999999
Q ss_pred ChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcce
Q 022447 155 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 234 (297)
Q Consensus 155 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 234 (297)
+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++..... ....
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~ 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAAT 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCC--cccc
Confidence 99998876 567899999999999999999999999 99999999999999999999999999864221 1122
Q ss_pred eecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 235 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 235 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~ 206 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH
Confidence 3345799999999999988999999999999999999999999987766544433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=304.77 Aligned_cols=207 Identities=28% Similarity=0.395 Sum_probs=188.1
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccch--HHHHHHHHHHhccCCCCccceeeEeecCCe-eEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQ-RLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~ 148 (297)
++|..++.+|+|+||.+++++++.+++.|++|.+......+. +...+|+.+++++.|||||.+++.|.+++. .+|+|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 579999999999999999999999999999999987654433 457889999999999999999999999888 89999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
+||+||+|.+.+.... +.-++++.++.|+.|++.|+.|||+.+ |+|||||+.|||+..++.|+|.|||+++....
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998754 577999999999999999999999998 99999999999999999999999999997433
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
. .....+.+||+.|++||++.+.+|..++|||||||++|||++-+++|.+.+...
T Consensus 159 ~--~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~ 213 (426)
T KOG0589|consen 159 E--DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE 213 (426)
T ss_pred c--hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH
Confidence 3 234567889999999999999999999999999999999999999999986644
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=301.84 Aligned_cols=203 Identities=29% Similarity=0.404 Sum_probs=179.0
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCC-eEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESIN-QDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~-~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
.++|.+.+.||+|+||.||+|.+..++ ..||+|.+..... .....+..|+.+++.++||||+++++++.+.+..|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 357999999999999999999976654 7899999865322 233567889999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||||+.|++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++...
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999986 567899999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.. ......||+.|+|||++.+..++.++|+|||||++|+|++|..||...+...
T Consensus 182 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 235 (340)
T PTZ00426 182 DT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL 235 (340)
T ss_pred CC-----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH
Confidence 21 1234579999999999998889999999999999999999999999876543
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=304.81 Aligned_cols=208 Identities=25% Similarity=0.329 Sum_probs=179.4
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
...++|++.+.||+|+||.||+|.+..+++.||+|++.+... .....+..|+.+++.++||||+++++++.++...|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 345789999999999999999999999999999999865321 22345778999999999999999999999999999
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+||||++|++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999999975 45889999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCCCcceeecccccccccCccccccCC----CCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQ----LTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
..... ........||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||...+...
T Consensus 192 ~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~ 254 (370)
T cd05621 192 MDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG 254 (370)
T ss_pred cccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH
Confidence 32211 11223567999999999987543 7889999999999999999999998876543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=305.62 Aligned_cols=208 Identities=25% Similarity=0.311 Sum_probs=180.5
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++.+.||+|+||.||+|.++.+++.||+|++.... ......+..|+.++..++||+|+++++.+.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999999999999999987532 222356778999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||++|++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999976 567899999999999999999999999 99999999999999999999999999864321
Q ss_pred CCC---------------------------------cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCC
Q 022447 229 GDN---------------------------------THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275 (297)
Q Consensus 229 ~~~---------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 275 (297)
... .......+||+.|+|||++.+..++.++|+|||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 100 00012357999999999999999999999999999999999999
Q ss_pred CCCCcchhHhh
Q 022447 276 KAVDTSKAAAE 286 (297)
Q Consensus 276 ~Pf~~~~~~~~ 286 (297)
.||...+....
T Consensus 234 ~Pf~~~~~~~~ 244 (360)
T cd05627 234 PPFCSETPQET 244 (360)
T ss_pred CCCCCCCHHHH
Confidence 99988766543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=295.81 Aligned_cols=197 Identities=29% Similarity=0.375 Sum_probs=173.8
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCCh
Q 022447 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (297)
Q Consensus 80 lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L 156 (297)
||+|+||.||+|.+..+++.||+|++.... ......+..|+.++..++||||+++++++...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999999999999999987532 22335677899999999999999999999999999999999999999
Q ss_pred HhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcceee
Q 022447 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236 (297)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 236 (297)
.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..... ......
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccc
Confidence 999976 567899999999999999999999999 99999999999999999999999999875221 112233
Q ss_pred cccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 237 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~ 200 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE 200 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH
Confidence 4679999999999999999999999999999999999999998765544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=291.81 Aligned_cols=203 Identities=31% Similarity=0.458 Sum_probs=177.2
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++|++|+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999999999999999998754322 22457789999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999998886422 346899999999999999999999999 999999999999999999999999998753222
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
. ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 156 E---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred C---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 1 22345689999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=295.29 Aligned_cols=204 Identities=31% Similarity=0.441 Sum_probs=176.9
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCC-CCccceeeEeecCCeeEEEE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 148 (297)
+|++.+.||+|+||.||+|.+..+++.||+|++..... .....+..|..++..+.| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58899999999999999999999999999999875422 233557788899988876 56888999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||++|++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999999976 567899999999999999999999999 99999999999999999999999999864221
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
. .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+
T Consensus 154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~ 208 (324)
T cd05587 154 G--GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208 (324)
T ss_pred C--CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 1 122334679999999999999999999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=296.03 Aligned_cols=204 Identities=30% Similarity=0.437 Sum_probs=175.0
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHH---hccCCCCccceeeEeecCCeeEEE
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLML---SLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
|++.+.||+|+||.||+|.+..+++.||||++.... ......+..|+.++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999999999999999997542 12234566666554 566799999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||++|++|..++.. ..+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988864 56899999999999999999999999 9999999999999999999999999986421
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
. .........|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+..
T Consensus 153 ~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~ 210 (324)
T cd05589 153 G--FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210 (324)
T ss_pred C--CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 1 122234567999999999999999999999999999999999999999987655443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=297.65 Aligned_cols=203 Identities=30% Similarity=0.393 Sum_probs=175.8
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 154 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~ 154 (297)
+.||+|+||.||+|.+..++..||+|++..... .....+..|+.++..++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975422 22345678999999999999999999999999999999999999
Q ss_pred ChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 155 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 155 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
+|..++.. ...+++..++.++.||+.||.|||+ .+ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~ 151 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GA 151 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cc
Confidence 99998876 5678999999999999999999997 78 999999999999999999999999998642211 11
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~ 207 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 207 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH
Confidence 22345699999999999999999999999999999999999999988766554443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=300.38 Aligned_cols=207 Identities=29% Similarity=0.407 Sum_probs=187.4
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc-hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
..|..++.||+|+||.||+|.+..+++.||+|++......+ ..++.+|+.++.+++++||.++|+.+.....++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777789999999999999999999999999998875554 46788899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
|.||++.+.++. +..+.+..+..++.+++.|+.|||..+ .+|||||+.|||+..+|.+||+|||++-....
T Consensus 93 ~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~-- 163 (467)
T KOG0201|consen 93 CGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTN-- 163 (467)
T ss_pred hcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeec--
Confidence 999999999987 566699999999999999999999999 99999999999999999999999999876333
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
......+++|||.|||||++....|+.++||||||++++||++|.+|+.+.++....
T Consensus 164 ~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl 220 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL 220 (467)
T ss_pred hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE
Confidence 333447889999999999999999999999999999999999999999998874433
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=302.26 Aligned_cols=211 Identities=25% Similarity=0.329 Sum_probs=180.9
Q ss_pred HHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCC
Q 022447 66 ELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD 142 (297)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 142 (297)
++....++|++.+.||+|+||.||+|.++.+++.||+|++..... .....+..|+.+++.++||||+++++.+.+..
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 334455799999999999999999999999999999999864322 22345678999999999999999999999999
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
..++||||++|++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999875 45889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccCccccccCC----CCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ----LTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 223 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
+....... ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+...
T Consensus 189 a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 254 (371)
T cd05622 189 CMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 254 (371)
T ss_pred eeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH
Confidence 87543221 11223567999999999987543 7889999999999999999999999876543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=295.04 Aligned_cols=205 Identities=30% Similarity=0.402 Sum_probs=177.0
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEEE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
+|.+.+.||+|+||.||+|.+..++..||+|++.+.... ....+..|..++..+ +|++|+++++.+...+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588899999999999999999999999999998754221 223456677777766 5899999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999999876 467899999999999999999999999 99999999999999999999999999874221
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~ 209 (323)
T cd05616 154 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209 (323)
T ss_pred C--CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH
Confidence 1 1123346799999999999999999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=301.87 Aligned_cols=207 Identities=29% Similarity=0.362 Sum_probs=182.1
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 478999999999999999999999999999999975422 23356788999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||++|++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999986 467899999999999999999999999 99999999999999999999999999875332
Q ss_pred CC---------------------------CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 229 GD---------------------------NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 229 ~~---------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
.. .........||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 001223456999999999999999999999999999999999999999887
Q ss_pred hhHh
Q 022447 282 KAAA 285 (297)
Q Consensus 282 ~~~~ 285 (297)
+...
T Consensus 234 ~~~~ 237 (350)
T cd05573 234 TLQE 237 (350)
T ss_pred CHHH
Confidence 6544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=293.37 Aligned_cols=200 Identities=34% Similarity=0.494 Sum_probs=171.8
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhc-cCCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.||+|+||.||+|.+..+++.||+|++..... .....+..|..++.. .+||||+++++++...+..++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999999875421 223345566666654 4799999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 999999976 567999999999999999999999999 9999999999999999999999999987532222 2
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~ 204 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL 204 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 23446799999999999998999999999999999999999999988765443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=296.15 Aligned_cols=209 Identities=30% Similarity=0.362 Sum_probs=188.1
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhccC-CCCccceeeEeecCCee
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLH-HPNLVNLIGYCADGDQR 144 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 144 (297)
.....|.+.+.||+|.||.||+++.+.+|+.+|+|.+.+..... ...+.+|+.+|+.+. ||||+.++++|++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34567999999999999999999999999999999998765543 357889999999998 99999999999999999
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC----CceEEecc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG----YHPKLSDF 220 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~----~~~kl~Df 220 (297)
++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.| ++||||||+|+|+... +.++++||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 9999999999999999874 3999999999999999999999999 9999999999999643 47999999
Q ss_pred cCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
|++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.+.+......
T Consensus 184 Gla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~ 248 (382)
T KOG0032|consen 184 GLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL 248 (382)
T ss_pred CCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH
Confidence 99987443 445677899999999999999999999999999999999999999999988655433
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=304.61 Aligned_cols=206 Identities=25% Similarity=0.348 Sum_probs=181.2
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC-C-----CCccceeeEeecCCeeEE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-H-----PNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~~~l 146 (297)
+|++++.||+|+||.|.+|.+..|++.||||+++... .-..+...|+.+|..++ | -|+|+++++|.-.++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 6899999999999999999999999999999997543 23345567999999887 4 489999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC--CceEEecccCcc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG--YHPKLSDFGLAK 224 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~--~~~kl~Dfg~~~ 224 (297)
|+|++. .+|+++++... ..+++...++.++.||+.||.+||..+ |||+||||+|||+.+. ..|||+|||++.
T Consensus 266 VfELL~-~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eehhhh-hhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 999997 89999999854 466999999999999999999999999 9999999999999754 469999999998
Q ss_pred ccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHH
Q 022447 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~ 290 (297)
..... ..+++.+..|.|||++.+.+|+.+.||||||||++||++|.+.|.+++..++...+
T Consensus 340 ~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I 400 (586)
T KOG0667|consen 340 FESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARI 400 (586)
T ss_pred ccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHH
Confidence 62221 22667889999999999999999999999999999999999999999888876654
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=289.61 Aligned_cols=208 Identities=25% Similarity=0.371 Sum_probs=178.1
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.++|.+.+.||.|+||.||+|.+..++..||+|++...... ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 35799999999999999999999999999999998754322 23467789999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|++ ++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 84 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 84 YLD-SDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCC-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 998 5899888652 345789999999999999999999999 999999999999999999999999998753222
Q ss_pred CCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
. .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+..
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~ 213 (288)
T cd07871 157 T--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL 213 (288)
T ss_pred C--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 1 12233468999999998865 56899999999999999999999999887765543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=308.54 Aligned_cols=212 Identities=22% Similarity=0.247 Sum_probs=184.4
Q ss_pred cCCCCcceecccCcEEEEEEEECCC-CeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESI-NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
..|.+.+.||+|++|.||+|.+..+ +..|++|.+..........+..|+.+++.++||||+++++++...+..|+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 3489999999999999999999887 788999987655444445677899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
++|++|.+++........++++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999988754434567999999999999999999999999 9999999999999999999999999997643332
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~ 279 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI 279 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 22234456799999999999999999999999999999999999999988765443
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=292.12 Aligned_cols=202 Identities=32% Similarity=0.492 Sum_probs=173.6
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhc-cCCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.||+|+||.||+|.++.++..||+|+++.... ........|..++.. .+||+|+++++++.+.+..|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999975421 223456667777765 4899999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DN 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CC
Confidence 999999876 567899999999999999999999999 999999999999999999999999998642211 12
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~ 206 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE 206 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 2345679999999999999999999999999999999999999998876654433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=292.15 Aligned_cols=200 Identities=31% Similarity=0.452 Sum_probs=173.5
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.||+|+||.||+|.++.++..||+|++.+.. ......+..|..++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999987532 12234567788888766 699999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~ 151 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GK 151 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CC
Confidence 999999876 567999999999999999999999999 999999999999999999999999998642211 22
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~ 204 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL 204 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH
Confidence 23345799999999999989999999999999999999999999988766543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=300.60 Aligned_cols=207 Identities=26% Similarity=0.313 Sum_probs=178.4
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
..++|++.+.||+|+||.||+|.+..++..||+|++..... .....+..|+.+++.++||||+++++++.+....|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 34689999999999999999999999999999999865321 223446789999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||||++|++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999999875 45889999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCcceeecccccccccCccccccC----CCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTG----QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...+...
T Consensus 193 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 254 (370)
T cd05596 193 DANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 254 (370)
T ss_pred cCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH
Confidence 2211 1122345799999999988653 47889999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=292.70 Aligned_cols=200 Identities=31% Similarity=0.448 Sum_probs=173.2
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.||+|+||.||+|.+..++..||+|++..... .....+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999999999999999999875422 2234567788888765 799999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~ 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GV 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC--Cc
Confidence 999999876 567899999999999999999999999 999999999999999999999999998743221 12
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~ 204 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH
Confidence 23345699999999999999999999999999999999999999988765443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=290.34 Aligned_cols=202 Identities=34% Similarity=0.498 Sum_probs=173.4
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhc-cCCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.||+|+||.||+|.+..+++.||+|++..... ........|..++.. ++||||+++++++.+.+..++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999876421 223445667777765 5899999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--A 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--C
Confidence 999999976 467899999999999999999999999 9999999999999999999999999986422211 1
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~ 206 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ 206 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 2334579999999999999999999999999999999999999998876655443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=289.24 Aligned_cols=204 Identities=25% Similarity=0.354 Sum_probs=175.1
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 46899999999999999999999999999999998754332 23457789999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+. ++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 997 6888877652 356889999999999999999999999 999999999999999999999999998643221
Q ss_pred CCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
........+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+...
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 209 (303)
T cd07869 157 --SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209 (303)
T ss_pred --CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 112234568999999998765 4578899999999999999999999987543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=282.83 Aligned_cols=213 Identities=28% Similarity=0.375 Sum_probs=191.8
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchH---HHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
-.++|+.+++||+|.||.|-+++-+.+++.||+|++++.-.-..+ .-+.|-.+|+..+||.+..+...|+..+++++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 346899999999999999999999999999999999876554433 34668899999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||||..||.|.-++.. ...+++...+.+-.+|+.||.|||+++ ||+||+|.+|+|+|.+|++||+|||+|+-
T Consensus 246 VMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE- 317 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKE- 317 (516)
T ss_pred EEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchh-
Confidence 9999999999988876 678999999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHHh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA 291 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~~ 291 (297)
.-.......++||||.|+|||++....|+.++|.|.+|+++|||++|+.||...+..-.-.|+-
T Consensus 318 -~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl 381 (516)
T KOG0690|consen 318 -EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL 381 (516)
T ss_pred -cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH
Confidence 2233456678999999999999999999999999999999999999999999988776655554
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=292.07 Aligned_cols=199 Identities=31% Similarity=0.435 Sum_probs=171.0
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHH-HHhccCCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.||+|+||.||+|.+..+|+.||+|++..... .....+..|.. +++.++||||+++++.+.+.+..++||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999999999999999875422 22234555554 45778999999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SK 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CC
Confidence 999999876 567899999999999999999999999 999999999999999999999999998642211 12
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~ 203 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE 203 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH
Confidence 2334579999999999999999999999999999999999999998876544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=290.99 Aligned_cols=203 Identities=30% Similarity=0.428 Sum_probs=175.6
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccC-CCCccceeeEeecCCeeEEEE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 148 (297)
+|++.+.||+|+||.||+|.++.+++.||+|++..... .....+..|..++..+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47788999999999999999999999999999875421 22345677888888775 577888999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||++|++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999976 567999999999999999999999999 99999999999999999999999999864221
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
. ........||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..
T Consensus 154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~ 207 (323)
T cd05615 154 D--GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED 207 (323)
T ss_pred C--CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 1 11233456999999999999889999999999999999999999999887654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=291.02 Aligned_cols=200 Identities=30% Similarity=0.421 Sum_probs=172.7
Q ss_pred cceecccCcEEEEEEEEC---CCCeEEEEEEeccCCc----cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 77 ESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV----QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
++.||+|+||.||++.+. .+++.||+|++..... .....+..|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999874 4688999999875321 223456789999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+.|++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 81 YLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 9999999999976 567889999999999999999999999 999999999999999999999999998642111
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
........|++.|+|||++.+..++.++|||||||++|||++|+.||...+...
T Consensus 154 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~ 207 (323)
T cd05584 154 --GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK 207 (323)
T ss_pred --CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH
Confidence 122334579999999999998889999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=285.86 Aligned_cols=206 Identities=23% Similarity=0.295 Sum_probs=177.3
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
++|++.+.||+|+||.||+|.++.++..||+|++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 479999999999999999999999999999999875432 223567889999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|++++.+..+... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9998766655433 456899999999999999999999999 999999999999999999999999998764322
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
. ........|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+
T Consensus 154 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~ 208 (287)
T cd07848 154 S-NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID 208 (287)
T ss_pred c-cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 1 112234568999999999988889999999999999999999999998765433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=292.51 Aligned_cols=194 Identities=27% Similarity=0.440 Sum_probs=170.6
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.||+|+||.||+|.+..+++.||+|+++..... ....+..|..++..+ +||||+++++++.+....|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999764322 234577899999888 699999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++..... ...
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~ 151 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc--CCC
Confidence 999998876 567999999999999999999999999 99999999999999999999999999864211 112
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDT 280 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 280 (297)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|+.||+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 23346799999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=291.13 Aligned_cols=199 Identities=30% Similarity=0.410 Sum_probs=170.6
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHH-HHhccCCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.||+|+||.||+|.+..++..||+|++.+... .....+..|.. +++.++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999875422 12234555554 57889999999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 151 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EE 151 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CC
Confidence 999988875 567899999999999999999999999 999999999999999999999999998642111 12
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 203 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ 203 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH
Confidence 2334578999999999998899999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=292.91 Aligned_cols=207 Identities=24% Similarity=0.281 Sum_probs=177.6
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++.+.||+|+||.||++.+..+++.||+|++..... .....+..|..++..++|++|+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 478999999999999999999999999999999865321 12244677899999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||++|++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999752 356899999999999999999999999 99999999999999999999999999865322
Q ss_pred CCCcceeecccccccccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.. ........|++.|+|||++.+ ..++.++|+||||+++|+|++|+.||...+..+
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~ 215 (331)
T cd05624 155 DG-TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215 (331)
T ss_pred CC-ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH
Confidence 21 112233569999999998865 467889999999999999999999998766543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=290.55 Aligned_cols=206 Identities=26% Similarity=0.348 Sum_probs=181.9
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.++|++.+.||+|+||.||++.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4689999999999999999999999999999999876432 233568899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999999976 45689999999999999999999985 5 99999999999999999999999999865322
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
. ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+..
T Consensus 157 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~ 211 (331)
T cd06649 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE 211 (331)
T ss_pred c----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 1 223456899999999999889999999999999999999999999877665443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=292.39 Aligned_cols=199 Identities=30% Similarity=0.411 Sum_probs=171.2
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHH-HHhccCCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.||+|+||.||+|.+..+|+.||+|++..... .....+..|.. +++.++||||+++++++...+..|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999875422 22234555554 46778999999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|..++.. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~ 151 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SD 151 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CC
Confidence 999998876 567999999999999999999999999 999999999999999999999999998642211 12
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~ 203 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE 203 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH
Confidence 2334679999999999999999999999999999999999999998876544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=295.44 Aligned_cols=207 Identities=29% Similarity=0.362 Sum_probs=179.2
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+..|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 478999999999999999999999999999999975432 22345778999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999762 257999999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCcceeecccccccccCccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAK------TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||...+...
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~ 216 (330)
T cd05601 155 NKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK 216 (330)
T ss_pred CCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH
Confidence 221 1223456899999999986 4567899999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=291.01 Aligned_cols=199 Identities=30% Similarity=0.418 Sum_probs=170.3
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHH-HHHhccCCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.||+|+||.||+|.+..++..||+|++..... .....+..|. .+++.++||||+++++++...+..|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999875322 1223344444 456778999999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++..... ...
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~ 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNG 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc--CCC
Confidence 999999976 567889999999999999999999999 99999999999999999999999999864211 122
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 203 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH
Confidence 2345679999999999999999999999999999999999999998766544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=291.40 Aligned_cols=207 Identities=24% Similarity=0.293 Sum_probs=176.9
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++.+.||+|+||.||++.+..+++.||+|++.+.. ......+..|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999999999999999987532 122345778999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||++|++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999999752 356899999999999999999999999 99999999999999999999999999865322
Q ss_pred CCCcceeecccccccccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~ 215 (331)
T cd05597 155 DGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215 (331)
T ss_pred CCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH
Confidence 211 11223468999999999863 457889999999999999999999998765433
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=293.41 Aligned_cols=210 Identities=24% Similarity=0.352 Sum_probs=187.7
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccch--HHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.=|.+.+-||+|.|++|-+|++.-+|+.||||++.+....+. ..+.+|+..++.++|||||++|++...+..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 447788899999999999999999999999999998766544 468899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE-cCCCceEEecccCccccCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL-DRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili-~~~~~~kl~Dfg~~~~~~~ 228 (297)
+-++|+|++||-.. ...+.+..+.+++.||+.||.|+|..+ +|||||||+|+.+ ..-|-+||+|||++..+..
T Consensus 98 LGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999763 467999999999999999999999999 9999999999876 5679999999999875444
Q ss_pred CCCcceeecccccccccCccccccCCCC-cccchhhHHHHHHHHHhCCCCCCcchhHhhhhHH
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~ 290 (297)
+. ...+.||+..|.|||++.+..|+ +++||||||+|||.|++|++||...++.+.+-++
T Consensus 172 G~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI 231 (864)
T KOG4717|consen 172 GK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI 231 (864)
T ss_pred cc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh
Confidence 33 45678999999999999998886 7899999999999999999999998887766543
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=291.11 Aligned_cols=193 Identities=28% Similarity=0.452 Sum_probs=169.2
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.||+|+||.||+|.+..+++.||+|++.+... .....+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999976422 2234567788888766 799999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|..++.. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~ 151 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CC
Confidence 999988876 567999999999999999999999999 999999999999999999999999998642111 11
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 279 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 279 (297)
......||+.|+|||++.+..++.++|+|||||++|+|++|+.||.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 2334679999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=291.75 Aligned_cols=205 Identities=25% Similarity=0.401 Sum_probs=173.8
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhccCCCCccceeeEeecC-----CeeE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQRL 145 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 145 (297)
+|++.+.||+|+||.||+|.+..++..||||.+.... .....++.+|+.+++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999999999999999986432 22335688999999999999999999987543 2479
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999996 789998876 567999999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCCC-cceeecccccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 226 GPVGDN-THVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 226 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
...... ........|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+...
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~ 215 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 215 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH
Confidence 322111 112234579999999999866 678999999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=292.20 Aligned_cols=210 Identities=34% Similarity=0.504 Sum_probs=182.3
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCC
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 152 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 152 (297)
.+.+.+.||+|.||.||+|.++. ...||+|.++... .....+.+|++++++|+|++||++++++..+..+||||||++
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 34567789999999999999984 4589999987542 334678899999999999999999999999889999999999
Q ss_pred CCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCc
Q 022447 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232 (297)
Q Consensus 153 g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 232 (297)
.|+|.+++.. ..+..+...+.+.++.||++|++||++++ +|||||..+||||++++.+||+|||+++.. ..+..
T Consensus 285 ~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~~Y 358 (468)
T KOG0197|consen 285 KGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLI-GDDEY 358 (468)
T ss_pred cCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccccccc-CCCce
Confidence 9999999987 34677889999999999999999999999 999999999999999999999999999942 22333
Q ss_pred ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHH
Q 022447 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~ 290 (297)
.......-...|.|||.+....++.+|||||||++||||+| |+.||...+..+...++
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l 417 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL 417 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH
Confidence 33333445678999999999999999999999999999999 99999999887766554
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=282.92 Aligned_cols=198 Identities=28% Similarity=0.395 Sum_probs=172.4
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCCh
Q 022447 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (297)
Q Consensus 80 lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L 156 (297)
||+|+||.||++.+..+++.||+|.+....... ...+..|+.+++.++|+||+++++++......++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999999999999999987543222 24567899999999999999999999999999999999999999
Q ss_pred HhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcceee
Q 022447 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236 (297)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 236 (297)
.+++.........+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 9888654334567999999999999999999999999 9999999999999999999999999987533222 1233
Q ss_pred cccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 237 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
...|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 4568999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=292.36 Aligned_cols=210 Identities=30% Similarity=0.442 Sum_probs=172.8
Q ss_pred hcCCCCcceecccCcEEEEEEEE-----CCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcc-CCCCccceeeEeecCC-
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD- 142 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~- 142 (297)
.++|++.+.||+|+||.||+|.+ ..++..||+|++..... .....+.+|+.++..+ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46899999999999999999985 23457899999875432 2335688999999999 8999999999887644
Q ss_pred eeEEEEecCCCCChHhhhcccCC---------------------------------------------------------
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSP--------------------------------------------------------- 165 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~--------------------------------------------------------- 165 (297)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999999875221
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcceeecccccccc
Q 022447 166 -GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244 (297)
Q Consensus 166 -~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y 244 (297)
...++++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 0235788899999999999999999999 999999999999999999999999998754322222222233466789
Q ss_pred cCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchh
Q 022447 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKA 283 (297)
Q Consensus 245 ~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~ 283 (297)
+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~ 282 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI 282 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc
Confidence 99999998999999999999999999997 9999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=317.16 Aligned_cols=217 Identities=27% Similarity=0.326 Sum_probs=189.6
Q ss_pred HHHHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeec
Q 022447 64 FRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCAD 140 (297)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 140 (297)
..++.....+|+++++||+|+||.|.+++++.+++.||+|++.+... .+..-|..|-.++...+.+-|+.++.+|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 34445566899999999999999999999999999999999987422 233457788899988899999999999999
Q ss_pred CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecc
Q 022447 141 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (297)
Q Consensus 141 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Df 220 (297)
+.++|+||||++||+|..++.. ...+++..++.++..|+.||..||+.| +|||||||+|||+|..|+++|+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 9999999999999999999987 447999999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCCcceeecccccccccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
|.|-... .+....+...+|||.|.+||++.. +.|++.+|.|||||++|||+.|..||..++..+...
T Consensus 220 GsClkm~-~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~ 291 (1317)
T KOG0612|consen 220 GSCLKMD-ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYG 291 (1317)
T ss_pred hhHHhcC-CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHH
Confidence 9986532 234445667789999999998853 568899999999999999999999999987765543
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=289.40 Aligned_cols=207 Identities=24% Similarity=0.293 Sum_probs=176.9
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++.+.||+|+||.||++.++.+++.||+|++.+... .....+..|+.++..++|++|+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478999999999999999999999999999999864321 12234677899999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+++++|.+++... ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999752 356899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCCcceeecccccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
. .........||+.|+|||++. ...++.++|||||||++|||++|+.||...+...
T Consensus 155 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~ 215 (332)
T cd05623 155 D-GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215 (332)
T ss_pred C-CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH
Confidence 1 112223456999999999886 3467899999999999999999999998776544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=290.03 Aligned_cols=201 Identities=26% Similarity=0.363 Sum_probs=172.5
Q ss_pred CCCCcceecccCcEEEEEEEEC---CCCeEEEEEEeccCCc----cchHHHHHHHHHHhccC-CCCccceeeEeecCCee
Q 022447 73 NFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV----QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQR 144 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 144 (297)
+|++.+.||+|+||.||+|.+. .++..||+|++.+... .....+..|+.+++.++ |++|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5889999999999999998874 4689999999875322 22345778999999994 89999999999999999
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999976 567899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
....... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 154 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 154 EFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred cccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 5322211 122345799999999998765 4788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=286.48 Aligned_cols=200 Identities=31% Similarity=0.468 Sum_probs=173.3
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.||+|+||.||+|.+..++..||+|++.+.. ......+..|..++..+ +||||+++++++...+..++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997542 22334567788888877 699999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~ 151 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GV 151 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC--CC
Confidence 999999876 567999999999999999999999999 999999999999999999999999998642111 11
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
.....+|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+....
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~ 204 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL 204 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH
Confidence 22345689999999999999999999999999999999999999987765443
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=295.24 Aligned_cols=195 Identities=23% Similarity=0.282 Sum_probs=171.8
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
..+|.+.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||+++++++......++++|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 3679999999999999999999999999999997542 3467899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+. ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 165 ~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~- 235 (391)
T PHA03212 165 YK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI- 235 (391)
T ss_pred CC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc-
Confidence 96 788888876 567899999999999999999999999 999999999999999999999999998642211
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDT 280 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 280 (297)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 11123346799999999999999999999999999999999999988754
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=275.71 Aligned_cols=211 Identities=23% Similarity=0.335 Sum_probs=185.2
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
+.+.|++.+.||+|.|+.|+++.+..+|+.+++|+++... ....+++.+|+.+-+.++||||+++++.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4467888899999999999999999999999999987543 33557889999999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC---CCceEEecccCcc
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAK 224 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~---~~~~kl~Dfg~~~ 224 (297)
+|++.|++|..-+.. ..-+++..+-.++.||++||.|+|.++ |||||+||.|+++-. ..-+||+|||++.
T Consensus 89 Fe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence 999999999988876 466889999999999999999999999 999999999999953 4569999999998
Q ss_pred ccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh-HhhhhHH
Q 022447 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA-AAEQSLV 290 (297)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~l~ 290 (297)
... ........+|||.|||||+++..+|+..+|||+.|++||-||.|.+||.+.+. +-.+.++
T Consensus 162 ~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~ 225 (355)
T KOG0033|consen 162 EVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK 225 (355)
T ss_pred EeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 654 33445567899999999999999999999999999999999999999999444 4444444
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=289.26 Aligned_cols=194 Identities=28% Similarity=0.438 Sum_probs=170.3
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.||+|+||.||+|.+..++..||+|++...... ....+..|+.++..+ +||+|+.+++.+.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999764322 234577888888887 699999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|..++.. ...+++..++.++.||+.||+|||+++ ++||||||+|||++.++.++|+|||++..... ...
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~ 151 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGD 151 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccC--CCC
Confidence 999998875 467999999999999999999999999 99999999999999999999999999864211 112
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDT 280 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 280 (297)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 23456799999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=302.00 Aligned_cols=213 Identities=25% Similarity=0.318 Sum_probs=182.4
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCC-----
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD----- 142 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 142 (297)
..++|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.++..++|+||++++..+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 446999999999999999999999999999999998765332 2356778999999999999999988765332
Q ss_pred ---eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEec
Q 022447 143 ---QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 219 (297)
Q Consensus 143 ---~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~D 219 (297)
..++||||+++|+|.+++.........+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEe
Confidence 367999999999999999765444567999999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 220 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~ 252 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE 252 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 999875433222223345679999999999999999999999999999999999999998776543
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=289.51 Aligned_cols=199 Identities=29% Similarity=0.386 Sum_probs=173.3
Q ss_pred ceecccCcEEEEEEEE---CCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCC
Q 022447 78 SLLGEGGFGRVYKGYL---ESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 152 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 152 (297)
+.||+|+||.||++.+ ..+|..||+|++...... ....+..|+.+++.++||||+++++++.++...|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999886 457899999999754322 23456789999999999999999999999999999999999
Q ss_pred CCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCc
Q 022447 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232 (297)
Q Consensus 153 g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 232 (297)
+++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++...... .
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~ 152 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--E 152 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC--C
Confidence 9999999976 567899999999999999999999999 999999999999999999999999998753221 1
Q ss_pred ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+...
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 205 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE 205 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH
Confidence 22334679999999999998889999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=279.82 Aligned_cols=203 Identities=32% Similarity=0.466 Sum_probs=177.1
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
+|++.+.||+|+||.||++.+..++..||+|++...... ....+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478899999999999999999999999999998754322 22346789999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+.+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999998886522 356899999999999999999999999 999999999999999999999999998753222
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
. ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||...+.
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 156 E---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred C---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence 1 12334689999999999888999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=269.96 Aligned_cols=213 Identities=27% Similarity=0.394 Sum_probs=186.9
Q ss_pred HHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc----ch----HHHHHHHHHHhcc-CCCCccceeeEe
Q 022447 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ----GN----REFLVEVLMLSLL-HHPNLVNLIGYC 138 (297)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~----~~----~~~~~e~~~l~~l-~h~~i~~~~~~~ 138 (297)
..+...|.-.+.||.|..++|.++.++.+|..+|+|++...... .. +.-.+|+.+|+++ .||+|+.+.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 44567788889999999999999999999999999998643211 11 3457799999987 499999999999
Q ss_pred ecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEe
Q 022447 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 218 (297)
Q Consensus 139 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~ 218 (297)
+.+...++|+|+|+-|.|.+++.+ ...+++...+.|+.|++++++|||..+ ||||||||+|||++++.+++|+
T Consensus 93 es~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEe
Confidence 999999999999999999999998 788999999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCCcceeecccccccccCcccccc------CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHH
Q 022447 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~ 290 (297)
|||++..++.+. .....||||+|+|||.+.. ..|+..+|+||+|+|+|.||.|-+||-....--.++++
T Consensus 166 DFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~I 240 (411)
T KOG0599|consen 166 DFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMI 240 (411)
T ss_pred ccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHH
Confidence 999998765544 3456899999999998753 46788999999999999999999999887766665554
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=285.35 Aligned_cols=206 Identities=25% Similarity=0.345 Sum_probs=180.6
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.++|++.+.||.|+||.||++.+..++..+++|.+..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4789999999999999999999999999999999876432 223568899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. + ++|+||||+|||++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999976 45688999999999999999999974 6 99999999999999999999999999864321
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
. ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.....
T Consensus 157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~ 211 (333)
T cd06650 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE 211 (333)
T ss_pred h----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH
Confidence 1 123356899999999999888999999999999999999999999877654443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=297.57 Aligned_cols=205 Identities=28% Similarity=0.406 Sum_probs=177.2
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhccCCCCccceeeEeec------CCeeEE
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCAD------GDQRLL 146 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~l 146 (297)
+...+.||+|+||.||+++++.+|+.||||.++... ....++..+|++++++++|+|||+++++=.+ .+...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 455678999999999999999999999999998643 3445678899999999999999999987554 345789
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC--CC--ceEEecccC
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR--GY--HPKLSDFGL 222 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~--~~--~~kl~Dfg~ 222 (297)
+||||.||+|...+.+-. +...+++.+++.++..+..|+.|||.++ |+||||||.||++.. +| ..||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999998633 4577999999999999999999999999 999999999999843 23 469999999
Q ss_pred ccccCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 223 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
|+-.+.+ ....+.+||+.|++||+... +.|+..+|.|||||++|++.||..||-..-.+.
T Consensus 171 Arel~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk 231 (732)
T KOG4250|consen 171 ARELDDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK 231 (732)
T ss_pred cccCCCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc
Confidence 9964333 36778899999999999984 889999999999999999999999998765553
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=277.00 Aligned_cols=206 Identities=27% Similarity=0.392 Sum_probs=171.1
Q ss_pred cCCCCcceecccCcEEEEEEEECC-CCeEEEEEEeccCCcc--chHHHHHHHHHHhcc---CCCCccceeeEee-----c
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLES-INQDVAIKQLDRNGVQ--GNREFLVEVLMLSLL---HHPNLVNLIGYCA-----D 140 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~ 140 (297)
++|++.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 4788999998654322 223456677776655 6999999999875 3
Q ss_pred CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecc
Q 022447 141 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (297)
Q Consensus 141 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Df 220 (297)
....++||||++ ++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 456889999997 68999987532 345899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
|++...... .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~ 217 (290)
T cd07862 155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 217 (290)
T ss_pred cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence 998753322 223345689999999999888999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=287.37 Aligned_cols=198 Identities=28% Similarity=0.359 Sum_probs=167.7
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcc---CCCCccceeeEeecCCeeEEEEecCCC
Q 022447 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLL---HHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 80 lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
||+|+||.||+|.+..++..||+|++...... .......|..++... .||+|+++++.+.+....|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999999999999999998653222 123345566666554 699999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~ 151 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD--NK 151 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CC
Confidence 999999876 567999999999999999999999999 999999999999999999999999998642221 12
Q ss_pred eeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 234 VSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~ 205 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM 205 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH
Confidence 23346799999999988654 589999999999999999999999988765543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=302.75 Aligned_cols=211 Identities=27% Similarity=0.340 Sum_probs=177.6
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC-CCCccceeeEe-ec------
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYC-AD------ 140 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~------ 140 (297)
....++++.+.|.+|||+.||+|.+...|..||+|.+-..+....+.+.+|+.++++|+ |+|||.+++.. ..
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 34567889999999999999999999988999999987666666678999999999997 99999999942 21
Q ss_pred CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecc
Q 022447 141 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (297)
Q Consensus 141 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Df 220 (297)
.-.++|+||||.||.|-+++..+.. ..|++.+++.|+.++++|+.+||.. ++||||||||-+||||..+|.+|||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 1346799999999999999997653 4499999999999999999999999 588999999999999999999999999
Q ss_pred cCccccCCCCCccee-------ecccccccccCcccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 221 GLAKLGPVGDNTHVS-------TRVMGTYGYCAPEYA---KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 221 g~~~~~~~~~~~~~~-------~~~~g~~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
|.+.-.......... -...-|+.|.|||++ .+.+.++++|||||||+||-|+...+||+...
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg 262 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG 262 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc
Confidence 998642222111000 012368999999976 57889999999999999999999999999873
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=294.18 Aligned_cols=204 Identities=26% Similarity=0.374 Sum_probs=170.1
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecC--------C
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--------D 142 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~ 142 (297)
..+|++.+.||+|+||.||+|.+..++..||||.+.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999999999999999885432 2344699999999999999999886432 2
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC-ceEEeccc
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFG 221 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~-~~kl~Dfg 221 (297)
.+++||||++ ++|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 4678999998 5787777654434577999999999999999999999999 99999999999998654 79999999
Q ss_pred CccccCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+
T Consensus 217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 278 (440)
T PTZ00036 217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278 (440)
T ss_pred cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 997543222 2234568999999998765 468999999999999999999999998876543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=278.77 Aligned_cols=211 Identities=29% Similarity=0.432 Sum_probs=174.7
Q ss_pred hcCCCCcceecccCcEEEEEEEECC----------------CCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccc
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLES----------------INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVN 133 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~----------------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~ 133 (297)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578999999999999999998642 3457999998764322 2356889999999999999999
Q ss_pred eeeEeecCCeeEEEEecCCCCChHhhhcccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 022447 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP---------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198 (297)
Q Consensus 134 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iv 198 (297)
+++++.+.+..+++|||+.+++|.+++..... ....+++..++.++.||+.||.|||+.+ ++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999999865321 1234678899999999999999999999 99
Q ss_pred ecCCCCCcEEEcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh--CCC
Q 022447 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS--GRK 276 (297)
Q Consensus 199 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~ 276 (297)
||||||+|||++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999875433322222333456788999999988889999999999999999987 668
Q ss_pred CCCcchhH
Q 022447 277 AVDTSKAA 284 (297)
Q Consensus 277 Pf~~~~~~ 284 (297)
||...+..
T Consensus 241 p~~~~~~~ 248 (304)
T cd05096 241 PYGELTDE 248 (304)
T ss_pred CCCcCCHH
Confidence 88876543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=291.18 Aligned_cols=203 Identities=31% Similarity=0.516 Sum_probs=176.6
Q ss_pred HHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
.....+..+...||+|.||+||+|.+-. .||||+++...... .+.|..|+..+++-+|.||+-+.+++..+.. .
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 3344566788999999999999999975 59999998765554 4679999999999999999999999998877 9
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+|+.+|+|.+|+.+++.. ...|.....+.|+.|+++|+.|||.++ |||||||..|||+.++++|||+|||++..
T Consensus 464 IiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred eeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence 999999999999999973 467899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCCcceeecccccccccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCc
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDT 280 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~ 280 (297)
..............|...|||||+++. .+|++++||||||+++|||++|.+||+.
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi 595 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI 595 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC
Confidence 433333333344568889999998864 4789999999999999999999999993
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=287.06 Aligned_cols=206 Identities=23% Similarity=0.358 Sum_probs=175.7
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhccCCCCccceeeEeecCC-----eeE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRL 145 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 145 (297)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... .....++.+|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999999999999999986532 223457889999999999999999999998776 789
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+||||+. ++|.+.+.. ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999997 688888765 567999999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCCCcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
...... .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+.....
T Consensus 153 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 214 (372)
T cd07853 153 EEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL 214 (372)
T ss_pred cccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 332221 122334678999999988764 5789999999999999999999999887765443
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=305.27 Aligned_cols=210 Identities=26% Similarity=0.399 Sum_probs=178.3
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+++.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999999999999999998754222 2356889999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 022447 149 EYMPLGSVEDHLHDLSP-------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg 221 (297)
||++|++|.+++..... ....++...++.++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 1234566788999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCC----------------cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 222 LAKLGPVGDN----------------THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 222 ~~~~~~~~~~----------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
++........ .......+||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9875411100 01112356999999999999999999999999999999999999999875543
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=286.30 Aligned_cols=199 Identities=26% Similarity=0.390 Sum_probs=168.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..+|+..+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 35677889999999999999999999999999998654322 23568899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+++++|.+. ....+..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 153 ~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 153 FMDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred cCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 9999998643 23457788899999999999999999 999999999999999999999999998753221
Q ss_pred CCcceeecccccccccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
........|+..|+|||++.. ...+.++|||||||++|||++|+.||....
T Consensus 222 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 277 (353)
T PLN00034 222 --MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277 (353)
T ss_pred --cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 112234579999999998743 234568999999999999999999998543
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=285.16 Aligned_cols=203 Identities=25% Similarity=0.344 Sum_probs=173.2
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhccCCCCccceeeEeecCC----
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD---- 142 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 142 (297)
...++|++.+.||+|+||.||+|.+..+|..||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34589999999999999999999999999999999986542 223456788999999999999999999986543
Q ss_pred --eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecc
Q 022447 143 --QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (297)
Q Consensus 143 --~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Df 220 (297)
..|+||||++ ++|.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 98 ~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 98 FQDVYLVMELMD-ANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred cceeEEEEeCCC-cCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecC
Confidence 4789999998 46666664 24788899999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
|++..... ........||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..
T Consensus 168 g~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~ 228 (359)
T cd07876 168 GLARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI 228 (359)
T ss_pred CCcccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99874221 11223456899999999999999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=279.25 Aligned_cols=206 Identities=26% Similarity=0.390 Sum_probs=176.3
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
++|.+.+.||+|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5799999999999999999999999999999998754332 234577899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
++ ++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LD-KDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 98 5888887652 345889999999999999999999999 9999999999999999999999999987532221
Q ss_pred CcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
.......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+.
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 213 (309)
T cd07872 159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213 (309)
T ss_pred --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 12223467899999998765 4688999999999999999999999988776544
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=262.36 Aligned_cols=213 Identities=28% Similarity=0.356 Sum_probs=184.1
Q ss_pred HHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCC-----
Q 022447 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----- 142 (297)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 142 (297)
....++|++.+.||+|+|+.||++.+..++..||+|.+......+.+..++|+...++++|||+++++++...+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 345689999999999999999999999999999999998877777888999999999999999999998865433
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
..|++++|+..|+|.+.+......+..+++.+++.|+.++++||++||... +|+.||||||.|||+.+.+.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 489999999999999999987777778999999999999999999999985 5799999999999999999999999999
Q ss_pred ccccCCCCCcc-------eeecccccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 223 AKLGPVGDNTH-------VSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 223 ~~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
+...+...... .......|..|.|||++. +...+.++|||||||+||+|+.|..||+..
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI 244 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence 87533221111 112234688999999885 345688999999999999999999999864
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=287.07 Aligned_cols=210 Identities=30% Similarity=0.474 Sum_probs=174.4
Q ss_pred hcCCCCcceecccCcEEEEEEEECCC-----CeEEEEEEeccCCcc-chHHHHHHHHHHhcc-CCCCccceeeEeecCCe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 143 (297)
.++|++.+.||+|+||.||+|++..+ +..||+|.+...... ....+.+|+.+++.+ +|+||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 45799999999999999999986543 357999999754322 335678899999999 89999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCC----------------------------------------------------------
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSP---------------------------------------------------------- 165 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~---------------------------------------------------------- 165 (297)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999998854210
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcceeec
Q 022447 166 --------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 237 (297)
Q Consensus 166 --------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 237 (297)
...++++..++.++.||+.||.|||+++ ++||||||+|||+++++.++|+|||++..............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1135788999999999999999999999 99999999999999999999999999875432222112222
Q ss_pred ccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchh
Q 022447 238 VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKA 283 (297)
Q Consensus 238 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~ 283 (297)
..++..|+|||++.+..++.++|||||||++|+|++ |+.||.....
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~ 320 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Confidence 335678999999988899999999999999999997 9999987654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=268.89 Aligned_cols=199 Identities=26% Similarity=0.387 Sum_probs=174.2
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC-CCCccceeeEeecCCeeEEEEecCCCCCh
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~g~~L 156 (297)
+.||+|+++.|-.+++..+|..||||++.+.......++.+|++++..++ |+||+.++++|+++..+|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 57999999999999999999999999999886667788999999999985 99999999999999999999999999999
Q ss_pred HhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC---ceEEecccCccccCCCC---
Q 022447 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLSDFGLAKLGPVGD--- 230 (297)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~---~~kl~Dfg~~~~~~~~~--- 230 (297)
.+.|.+ ...|++.++..++..|+.||.+||.+| |.|||+||+|||-...+ -+||+||.+..-.....
T Consensus 164 LshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 164 LSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 999998 678999999999999999999999999 99999999999986544 48999998865321111
Q ss_pred --CcceeecccccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 231 --NTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 231 --~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
.+....+.+|+..|||||+.. ...|+.++|.||||+|||.||+|.+||.+.=.
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 122334578999999999763 24688999999999999999999999988644
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=272.15 Aligned_cols=194 Identities=30% Similarity=0.460 Sum_probs=168.7
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCCh
Q 022447 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (297)
Q Consensus 80 lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L 156 (297)
||+|+||.||++.++.+|+.||+|.+...... ....+..|+.+++.++||||+++++.+......++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999998653222 223456799999999999999999999999999999999999999
Q ss_pred HhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcceee
Q 022447 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236 (297)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 236 (297)
.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...... ....
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~ 152 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTIT 152 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceee
Confidence 98886522 345889999999999999999999999 999999999999999999999999998753222 1223
Q ss_pred cccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 237 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
...|++.|+|||++.+..++.++|+|||||++|+|++|+.||...
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 456899999999998888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=271.41 Aligned_cols=200 Identities=37% Similarity=0.580 Sum_probs=178.5
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchH--HHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR--EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
|++.+.||+|+||.||++.+..+++.||+|++......... ....|+.+++.++||||+++++++.+....+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 66789999999999999999999999999999876544332 3456999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
++++|.+++.. ...+++..++.++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||.+... ...
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SEN 151 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TST
T ss_pred ccccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--ccc
Confidence 98899999984 577899999999999999999999999 999999999999999999999999998743 222
Q ss_pred cceeecccccccccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 232 THVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
........++..|+|||++. +..++.++|+||||+++|+|++|..||....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~ 203 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN 203 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 33445567899999999998 8889999999999999999999999999873
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=274.74 Aligned_cols=204 Identities=27% Similarity=0.420 Sum_probs=181.1
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
..+|++.+.||+|++|.||+|.+..++..|++|.+..........+.+|+.+++.++|+||+++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 36899999999999999999999999999999999876655567788999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999999864 45789999999999999999999999 9999999999999999999999999886532221
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
.......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..
T Consensus 171 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~ 222 (296)
T cd06654 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222 (296)
T ss_pred --cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 1123346889999999998888999999999999999999999999877653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=268.06 Aligned_cols=207 Identities=31% Similarity=0.440 Sum_probs=178.9
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-----chHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-----GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
++|.+.+.||+|++|.||+|.+..++..|++|.+...... ....+.+|+.+++.++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999999999999999998654322 22457889999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
++||+++++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999986 456889999999999999999999999 999999999999999999999999998653
Q ss_pred CCCCCcce-eecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 227 PVGDNTHV-STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 227 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
........ .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 214 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA 214 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH
Confidence 22111111 123457889999999999889999999999999999999999998765543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=272.13 Aligned_cols=203 Identities=26% Similarity=0.370 Sum_probs=177.8
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
++|.+.+.||+|+||.||+|.+..+++.|++|+++.........+.+|+.+++.++||||+++++.+...+..+++|||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 47888899999999999999999999999999987654444456788999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
++++|.+++.. ...+++..++.++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++..... .
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--~ 159 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITA--T 159 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccC--c
Confidence 99999999876 567899999999999999999999999 99999999999999999999999999865322 1
Q ss_pred cceeecccccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 232 THVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
........|+..|+|||.+. ...++.++|+|||||++|+|++|..||.....
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~ 214 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence 22233456899999999874 45688899999999999999999999976543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=269.68 Aligned_cols=204 Identities=25% Similarity=0.340 Sum_probs=177.3
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|++.+.||+|+||.||+|.+..++..|++|++..........+.+|+.+++.++||||+++++.+......++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45799999999999999999999999999999998765444455678899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++.. ..++++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITAT- 159 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccc-
Confidence 999999999875 467899999999999999999999999 999999999999999999999999998753221
Q ss_pred CcceeecccccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
........++..|+|||.+. ...++.++|+|||||++|+|++|+.||...+.
T Consensus 160 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~ 214 (267)
T cd06646 160 -IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred -ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 11123346889999999874 34577899999999999999999999976544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=284.26 Aligned_cols=209 Identities=31% Similarity=0.453 Sum_probs=174.2
Q ss_pred hcCCCCcceecccCcEEEEEEEE-----CCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcc-CCCCccceeeEeecCCe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 143 (297)
.++|++.+.||+|+||.||+|.+ ..++..||||+++... ......+.+|+.++..+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999974 3457789999986543 23345688899999999 89999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCC----------------------------------------------------------
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSP---------------------------------------------------------- 165 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~---------------------------------------------------------- 165 (297)
.++||||++||+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999865221
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCc
Q 022447 166 -------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232 (297)
Q Consensus 166 -------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 232 (297)
....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 0125788899999999999999999999 999999999999999999999999998754322221
Q ss_pred ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcch
Q 022447 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSK 282 (297)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~ 282 (297)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 12222335668999999999999999999999999999998 889997754
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=271.63 Aligned_cols=203 Identities=31% Similarity=0.445 Sum_probs=176.4
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
|+..+.||.|+||.||+|.+..+++.||+|.+....... ...+.+|+.+++.++|++|+.+++.+...+..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 677889999999999999999999999999987543222 23467899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+.+++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999998886522 346999999999999999999999999 9999999999999999999999999986532221
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......
T Consensus 157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~ 207 (285)
T cd05632 157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK 207 (285)
T ss_pred ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 123346899999999998889999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=272.64 Aligned_cols=202 Identities=31% Similarity=0.463 Sum_probs=175.7
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.|++.+.||+|+||.||++.+..+++.||+|.+....... ...+..|+.+++.++|++|+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999999999999999987543322 2346789999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+.|++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999999886422 346899999999999999999999999 999999999999999999999999998653222
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 156 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred c---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1223468999999999998899999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=304.51 Aligned_cols=213 Identities=22% Similarity=0.360 Sum_probs=176.7
Q ss_pred HHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeec--CCe
Q 022447 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQ 143 (297)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 143 (297)
.....+|++++.||.|+||.||+|.+..++..+++|++...... ....+..|+.+++.++||||++++++|.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 34567899999999999999999999999999999998754332 33568889999999999999999998854 457
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeeecCCCCCcEEEcC--------
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK----PPVIYRDLKCSNILLDR-------- 211 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~----~~ivH~dikp~Nili~~-------- 211 (297)
+|+||||+++++|.+++.........+++..++.|+.||+.||.|||+.+. .+|+||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999997644334679999999999999999999998431 22999999999999964
Q ss_pred ---------CCceEEecccCccccCCCCCcceeecccccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCc
Q 022447 212 ---------GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDT 280 (297)
Q Consensus 212 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~ 280 (297)
.+.++|+|||++...... .......||+.|+|||++.+ ..++.++||||||||||+|++|+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 234899999998753222 12234579999999998854 4588999999999999999999999986
Q ss_pred chh
Q 022447 281 SKA 283 (297)
Q Consensus 281 ~~~ 283 (297)
.+.
T Consensus 246 ~~~ 248 (1021)
T PTZ00266 246 ANN 248 (1021)
T ss_pred CCc
Confidence 554
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=272.14 Aligned_cols=215 Identities=29% Similarity=0.452 Sum_probs=180.4
Q ss_pred hcCCCCcceecccCcEEEEEEEECC-----CCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 144 (297)
.++|.+.+.||+|+||.||+|.+.. ++..|++|.+...... ....+.+|+.+++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568889999999999999998743 4688999998765443 346788999999999999999999999999999
Q ss_pred EEEEecCCCCChHhhhcccC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCc
Q 022447 145 LLVYEYMPLGSVEDHLHDLS----------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 214 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~----------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~ 214 (297)
+++|||+++++|.+++.... .....+++..+..++.|++.|+.+||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999997532 12345788999999999999999999999 999999999999999999
Q ss_pred eEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 215 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 215 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999865322222122223346788999999999999999999999999999998 999998776655443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=275.82 Aligned_cols=202 Identities=29% Similarity=0.427 Sum_probs=184.2
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCC
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
|.++++||+|+||.||+|.++.+|..+|||.++.. .+.+++..|+.++++++.|++|++|+.|.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 66788999999999999999999999999998754 4567899999999999999999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
|++.+.++.+ ..++++.++..++..-+.+|+|||... -+|||||..|||++.+|..||+|||.+-. ..+.-.
T Consensus 113 GSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQ--LTDTMA 184 (502)
T KOG0574|consen 113 GSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQ--LTDTMA 184 (502)
T ss_pred CcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccch--hhhhHH
Confidence 9999999863 578999999999999999999999998 89999999999999999999999999864 333334
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
...+..|||-|||||++..-.|+..+||||||++..||.-|++||++-++-.
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR 236 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR 236 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc
Confidence 5567889999999999999999999999999999999999999999876543
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=272.03 Aligned_cols=201 Identities=31% Similarity=0.423 Sum_probs=179.5
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++.+.||+|++|.||++.+..+++.|++|++..... .....+.+|+.+++.++||||+++++.+.+...+++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 478899999999999999999999999999999875432 23356788999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+++++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999986 467899999999999999999999999 99999999999999999999999999875332
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
. .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 204 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI 204 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 2 23446889999999998888899999999999999999999999877643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=281.90 Aligned_cols=203 Identities=24% Similarity=0.340 Sum_probs=173.8
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhccCCCCccceeeEeecC------
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------ 141 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 141 (297)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999999999999999987542 22345678899999999999999999987543
Q ss_pred CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg 221 (297)
...|+||||++ ++|.+.+.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 35799999997 577777643 4788899999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
++..... ........+++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+
T Consensus 172 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 232 (364)
T cd07875 172 LARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID 232 (364)
T ss_pred CccccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 9975322 112234568999999999999999999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=265.45 Aligned_cols=206 Identities=28% Similarity=0.407 Sum_probs=180.3
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+|.+.+.||+|++|.||+|.+..++..|++|.+..... .....+.+|+.+++.++||||+++++.+.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 47788999999999999999999999999999875432 3346688899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
++|++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~- 154 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN- 154 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc-
Confidence 99999999998632 457899999999999999999999999 999999999999999999999999998754322
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
........|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+...
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 208 (256)
T cd08529 155 -TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA 208 (256)
T ss_pred -cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 122234568899999999998899999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=272.85 Aligned_cols=206 Identities=27% Similarity=0.423 Sum_probs=182.6
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
.+|++.+.||.|++|.||+|.+..+++.|++|.+..........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46999999999999999999999999999999997665555677889999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
++++|.+++.. ..+++.++..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~- 169 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ- 169 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc-
Confidence 99999998864 46899999999999999999999999 9999999999999999999999999987533221
Q ss_pred cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
.......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.....
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~ 224 (296)
T cd06655 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224 (296)
T ss_pred -ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 1223346889999999998888999999999999999999999999887665443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=271.27 Aligned_cols=214 Identities=36% Similarity=0.538 Sum_probs=179.5
Q ss_pred cCCCCcceecccCcEEEEEEEECCCC-----eEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESIN-----QDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~-----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
++|++.+.||+|+||.||+|.+...+ ..|++|.+...... ....+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 47889999999999999999986554 78999998754332 2356888999999999999999999999988999
Q ss_pred EEEecCCCCChHhhhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC
Q 022447 146 LVYEYMPLGSVEDHLHDLSPG------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 213 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~ 213 (297)
++|||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 999999999999999763211 145888999999999999999999999 99999999999999999
Q ss_pred ceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 214 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 214 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999875433222222334456889999999988889999999999999999998 999998766554433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=281.23 Aligned_cols=202 Identities=24% Similarity=0.336 Sum_probs=173.1
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecC-----
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG----- 141 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 141 (297)
...++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 355799999999999999999999999999999999875432 2335677899999999999999999988643
Q ss_pred -CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecc
Q 022447 142 -DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (297)
Q Consensus 142 -~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Df 220 (297)
...+++|||++ ++|.+.+.. .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeC
Confidence 35789999998 467766642 4788999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
|++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 164 g~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 223 (355)
T cd07874 164 GLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223 (355)
T ss_pred cccccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99975322 1222345689999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=271.22 Aligned_cols=198 Identities=24% Similarity=0.371 Sum_probs=169.8
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhccCCCCccceeeEeec----CCeeEEEEec
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLVYEY 150 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~ 150 (297)
..||+|+++.||+|.. +|+.||||.+....... .+.+.+|+.++++++||||+++++++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999998 48999999997654333 3567799999999999999999999876 4567899999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
++||+|.+++.. ...+++.....++.+++.|+.|||+. + ++||||||+||+++.++.+||+|||++......
T Consensus 104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 999999999986 46788999999999999999999984 7 889999999999999999999999998753221
Q ss_pred CCcceeecccccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....
T Consensus 177 -----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~ 233 (283)
T PHA02988 177 -----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL 233 (283)
T ss_pred -----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 123458899999999976 6889999999999999999999999998876554433
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=271.22 Aligned_cols=204 Identities=28% Similarity=0.405 Sum_probs=170.0
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcc---CCCCccceeeEeec-----CC
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLL---HHPNLVNLIGYCAD-----GD 142 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~ 142 (297)
+|++.+.||+|+||.||+|.++.+++.||+|.+...... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588899999999999999999999999999998754222 223455677766655 79999999998764 34
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
..+++||++. ++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 5789999998 58888887532 345899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 223 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
+...... .......++..|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 155 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~ 214 (288)
T cd07863 155 ARIYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 214 (288)
T ss_pred cccccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH
Confidence 8753221 12233468899999999988899999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=275.65 Aligned_cols=209 Identities=29% Similarity=0.483 Sum_probs=175.3
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCe----EEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQ----DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
..+|++.+.||+|+||.||+|.+..++. .||+|.+..... ....++..|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 3579999999999999999999866555 489999865432 3346788899999999999999999998764 567
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999999862 345888999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
..............++..|+|||.+.+..++.++||||||+++|||++ |..||.+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~ 220 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 220 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 443332222222334678999999999999999999999999999998 9999988765543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=266.70 Aligned_cols=205 Identities=27% Similarity=0.361 Sum_probs=181.1
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
++|++.+.||.|++|.||+|.+..++..+++|++........+.+.+|+.+++.++||||+++++.+.+...++++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57899999999999999999999999999999998765556678899999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
.+++|.+++... ..++++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~-- 154 (262)
T cd06613 83 GGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-- 154 (262)
T ss_pred CCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh--
Confidence 999999998762 267899999999999999999999999 999999999999999999999999998653221
Q ss_pred cceeecccccccccCccccccC---CCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 232 THVSTRVMGTYGYCAPEYAKTG---QLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
........++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~ 210 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM 210 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 1122345688899999998776 7889999999999999999999999876543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=273.41 Aligned_cols=205 Identities=26% Similarity=0.340 Sum_probs=179.1
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
++|++.+.||+|+||.||++.+..++..+++|.+...... ...++.+|+.+++.++||||+++++.+.+++..+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 4689999999999999999999999999999998754322 235678899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
++|++|.+++.. ...+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999999986 4678999999999999999999997 57 999999999999999999999999988643211
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.....
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 207 (308)
T cd06615 154 ----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE 207 (308)
T ss_pred ----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH
Confidence 123456889999999998888999999999999999999999999876644433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=284.71 Aligned_cols=205 Identities=26% Similarity=0.378 Sum_probs=185.8
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
-...|.+.+.||+|.|+.|.+|++..++..||||.+++..... ...+.+|+++++.++||||++++.+...+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3457899999999999999999999999999999998764433 24588999999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||+.+|.+.+++.. ...+.+..+..++.|+.+|++|||++. |||||||++|+|++.+..+||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 999999999999998 677788999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCcceeecccccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
......+++|++.|.|||++.+..| ++.+|+||||+++|.|+.|..||++.+-.
T Consensus 207 ---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk 261 (596)
T KOG0586|consen 207 ---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK 261 (596)
T ss_pred ---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc
Confidence 3445678899999999999998776 58999999999999999999999987643
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=291.75 Aligned_cols=206 Identities=22% Similarity=0.336 Sum_probs=169.8
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCC------CCccceeeEeecC-
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH------PNLVNLIGYCADG- 141 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~- 141 (297)
...++|++.+.||+|+||.||+|.+..+++.||||+++... ........|+.+++.++| .+++.+++++...
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 34578999999999999999999999999999999986432 122344557766666654 4588888888764
Q ss_pred CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEEcCCC-------
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGY------- 213 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~dikp~Nili~~~~------- 213 (297)
..+++|||++ |++|.+++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence 5788999988 6889998876 5679999999999999999999997 58 99999999999998765
Q ss_pred ---------ceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 214 ---------HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 214 ---------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
.+||+|||.+... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDE-----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccCCCCceEEECCCCccccC-----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 4999999987532 11233567999999999999999999999999999999999999999987765
Q ss_pred hhhh
Q 022447 285 AEQS 288 (297)
Q Consensus 285 ~~~~ 288 (297)
+...
T Consensus 352 ~~~~ 355 (467)
T PTZ00284 352 EHLH 355 (467)
T ss_pred HHHH
Confidence 5443
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=270.39 Aligned_cols=212 Identities=30% Similarity=0.461 Sum_probs=178.4
Q ss_pred hcCCCCcceecccCcEEEEEEEE-----CCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
.++|.+.+.||+|+||.||++.+ ..++..+++|.+..........+.+|+.+++.++||||+++++++...+.++
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 35788999999999999999985 3346779999987655445567889999999999999999999999999999
Q ss_pred EEEecCCCCChHhhhcccCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceE
Q 022447 146 LVYEYMPLGSVEDHLHDLSP---------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~---------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~k 216 (297)
++|||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 99999999999999975321 1235899999999999999999999999 99999999999999999999
Q ss_pred EecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 217 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 217 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
|+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |..||......+
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~ 230 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 230 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999875322222222223345778999999998899999999999999999998 999998766543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=286.19 Aligned_cols=189 Identities=31% Similarity=0.490 Sum_probs=170.9
Q ss_pred CcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCC
Q 022447 76 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 155 (297)
Q Consensus 76 ~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~ 155 (297)
-++-||+|+.|-||+|+.. ++.||||+++.- -..+|+-|++|+|+||+.+.++|....+++||||||..|-
T Consensus 128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 4578999999999999887 789999987531 1247888999999999999999999999999999999999
Q ss_pred hHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCccee
Q 022447 156 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235 (297)
Q Consensus 156 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 235 (297)
|++.++. ..++.......|..+|+.++.|||.+. |||||||.-||||..+..|||+|||.++.... ....
T Consensus 199 L~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~---~STk 268 (904)
T KOG4721|consen 199 LYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSD---KSTK 268 (904)
T ss_pred HHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhh---hhhh
Confidence 9999998 788999999999999999999999999 99999999999999999999999999875322 2345
Q ss_pred ecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 236 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 236 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
..++||..|||||++++++.+.++|||||||+|||||||..||.+-+.
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds 316 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS 316 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch
Confidence 678999999999999999999999999999999999999999988544
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=278.58 Aligned_cols=201 Identities=25% Similarity=0.385 Sum_probs=172.6
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecC-----
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADG----- 141 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 141 (297)
...++|++.+.||.|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4567899999999999999999999999999999998754322 234577899999999999999999987543
Q ss_pred -CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecc
Q 022447 142 -DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (297)
Q Consensus 142 -~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Df 220 (297)
...|++++++ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence 3468999988 6899888763 56999999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
|++..... ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus 163 g~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 221 (343)
T cd07878 163 GLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY 221 (343)
T ss_pred ccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 99875322 1234568999999999876 5688999999999999999999999987654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=273.13 Aligned_cols=203 Identities=27% Similarity=0.419 Sum_probs=180.7
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
..+|++.+.||+|++|.||+|.+..++..|++|.+..........+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36899999999999999999999999999999999766555556788899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++.. ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999999864 45889999999999999999999999 9999999999999999999999999986532221
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred --cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 122334688999999999988899999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=268.28 Aligned_cols=206 Identities=23% Similarity=0.372 Sum_probs=178.6
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++.+.||+|+||.||+|.+..++..|++|.+..... .....+..|+.+++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 579999999999999999999999999999998765322 22345788999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+++++|.+++.........+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988754433566899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
.. .......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 210 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence 21 12223468889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=270.73 Aligned_cols=206 Identities=26% Similarity=0.377 Sum_probs=179.0
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
++|++.+.||.|++|.||+|.+..++..+++|.+..........+..|+.+++.++||||+++++.+..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 56899999999999999999999899999999997665555567889999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
++++|.+++... ...+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 85 ~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 156 (280)
T cd06611 85 DGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-- 156 (280)
T ss_pred CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc--
Confidence 999999998752 356899999999999999999999999 999999999999999999999999987653221
Q ss_pred cceeecccccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 232 THVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
........+++.|+|||.+. ...++.++|+||||+++|+|++|+.||...+...
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~ 215 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR 215 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH
Confidence 11223456899999999874 3456789999999999999999999998775443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=268.03 Aligned_cols=209 Identities=27% Similarity=0.425 Sum_probs=175.2
Q ss_pred hcCCCCcceecccCcEEEEEEEEC---CCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
.++|++.+.||+|+||.||+|.++ ..+..||+|.++..... ....+.+|+.+++.++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 357889999999999999999875 34678999998765332 23568889999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999998752 346899999999999999999999999 999999999999999999999999987542
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
.... ........++..|+|||.+.+..++.++|||||||++||+++ |..||...+..+.
T Consensus 158 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~ 217 (266)
T cd05064 158 KSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV 217 (266)
T ss_pred cccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH
Confidence 1111 111112335678999999998999999999999999999875 9999987765543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=264.24 Aligned_cols=205 Identities=30% Similarity=0.433 Sum_probs=171.3
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCCh
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L 156 (297)
+.||+|+||.||+|.+..++..|++|.+...... ....+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999999999999999987654322 235688999999999999999999999999999999999999999
Q ss_pred HhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcceee
Q 022447 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236 (297)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 236 (297)
.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9998652 346889999999999999999999999 9999999999999999999999999986432211111111
Q ss_pred cccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 237 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+......
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~ 207 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE 207 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH
Confidence 1123457999999988889999999999999999998 999998766544433
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=283.69 Aligned_cols=200 Identities=23% Similarity=0.266 Sum_probs=174.0
Q ss_pred HhcCCCCcceecccCcEEEEEEEEC--CCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
...+|.+.+.||.|+||.||+|... .++..|++|.+... ....+|+.+++.++||||+++++++......+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3467999999999999999999764 35688999987643 2345799999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
||++. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 165 ~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99996 688888854 567999999999999999999999999 9999999999999999999999999987544
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
............||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 3333333345679999999999999999999999999999999999999997654
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=269.46 Aligned_cols=204 Identities=26% Similarity=0.405 Sum_probs=177.1
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
+.|++.+.||.|+||.||+|.+..++..|++|.+..........+.+|+.+++.++|+||+++++.+..+..+++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56899999999999999999999999999999998765555677888999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
++++|..++.+. ...+++..++.++.|++.++.+||+.+ ++||||+|+||+++.++.++|+|||.+..... .
T Consensus 92 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--~ 163 (292)
T cd06644 92 PGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--T 163 (292)
T ss_pred CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccc--c
Confidence 999998887642 356899999999999999999999999 99999999999999999999999998764211 1
Q ss_pred cceeecccccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 232 THVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
........+++.|+|||++. ...++.++|+|||||++|+|++|..||...+.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 220 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH
Confidence 12223456888999999874 34568899999999999999999999977553
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=271.66 Aligned_cols=206 Identities=26% Similarity=0.387 Sum_probs=175.9
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.++|.+.+.||.|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++++......++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 35799999999999999999999999999999998754322 23457789999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|++ ++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 85 YLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred ccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 998 6898888652 356889999999999999999999999 999999999999999999999999998653222
Q ss_pred CCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
. .......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+...
T Consensus 158 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~ 212 (301)
T cd07873 158 T--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212 (301)
T ss_pred C--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1 11223457889999998765 457889999999999999999999998876543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=265.45 Aligned_cols=206 Identities=24% Similarity=0.341 Sum_probs=179.5
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
+|++.+.||.|+||.||++.+..++..+++|.+.... ....+.+..|+.+++.++|+||+++++.+.+.+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788999999999999999999999999999986432 233456788999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
++++|.+++.... ...+++..++.++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 153 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-- 153 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc--
Confidence 9999999886522 356889999999999999999999999 999999999999999999999999998753221
Q ss_pred cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
........+++.|+|||++.+..++.++|+||||+++|+|++|..||...+...
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~ 207 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN 207 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH
Confidence 122234568899999999998889999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=264.93 Aligned_cols=207 Identities=30% Similarity=0.398 Sum_probs=175.5
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-----cchHHHHHHHHHHhccCCCCccceeeEeecC--Cee
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-----QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 144 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 144 (297)
.+|++.+.||+|+||.||+|.+..++..|++|.+..... .....+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 578999999999999999999999999999998854321 1234678899999999999999999988763 567
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
+++|||+++++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999876 456889999999999999999999999 9999999999999999999999999887
Q ss_pred ccCCCCC-cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 225 LGPVGDN-THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 225 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
....... ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 216 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA 216 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH
Confidence 4322111 111223458889999999988889999999999999999999999998764433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=264.90 Aligned_cols=206 Identities=25% Similarity=0.377 Sum_probs=179.8
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++.+.||+|++|.||+|.+..+|..|++|.++... ......+.+|+.+++.++|++++++++.+.+.+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999999999999999886432 223457889999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+++++|.+++.........+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998764444567899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
.. .......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 21 11233468889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=268.27 Aligned_cols=216 Identities=27% Similarity=0.444 Sum_probs=177.5
Q ss_pred HhcCCCCcceecccCcEEEEEEEECC-----CCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 143 (297)
..++|++.+.||+|++|.||+|.+.. ++..||+|.+..... ....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45679999999999999999998752 357899999864322 234568889999999999999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEE
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPG------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 217 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl 217 (297)
.++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999998753211 234677889999999999999999999 999999999999999999999
Q ss_pred ecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 218 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 218 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
+|||++................+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~ 232 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999865332222222222345778999999988889999999999999999999 789998776654443
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=264.93 Aligned_cols=202 Identities=24% Similarity=0.316 Sum_probs=175.0
Q ss_pred HhcCCCCc-ceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcc-CCCCccceeeEeec----CCe
Q 022447 70 ATKNFRSE-SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD----GDQ 143 (297)
Q Consensus 70 ~~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~ 143 (297)
.+++|.+. .+||-|-.|.|..+.++.|++.+|+|++. +....++|+++.-.. .|||||.++++|.+ ..+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45667665 58999999999999999999999999975 335567788876665 49999999999864 467
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC---CCceEEecc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDF 220 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~---~~~~kl~Df 220 (297)
+.+|||.++||.|.+.+.+.. ...+++.++..|+.||..|+.|||+.+ |.||||||+|+|... +..+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 889999999999999999843 567999999999999999999999999 999999999999964 567999999
Q ss_pred cCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
|+++.- .......+.+-||+|.|||++..+.|+..+|+||||+++|-||.|.+||...+..
T Consensus 209 GFAK~t---~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ 269 (400)
T KOG0604|consen 209 GFAKET---QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269 (400)
T ss_pred cccccc---CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc
Confidence 999842 2234456778999999999999999999999999999999999999999987663
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=266.71 Aligned_cols=203 Identities=30% Similarity=0.400 Sum_probs=179.4
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
++|++.+.||.|++|.||+|.+..++..|++|.+.... ......+.+|+.+++.++|+||+++++.+.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888999999999999999999999999999987653 23345678899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++.. .++++..++.++.|++.|+.+||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999975 37899999999999999999999999 9999999999999999999999999987643221
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~ 204 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM 204 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH
Confidence 2223456888999999998888999999999999999999999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=286.90 Aligned_cols=203 Identities=28% Similarity=0.477 Sum_probs=177.3
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccC----CccchHHHHHHHHHHhccCCCCccceeeEeecCCe--eEEE
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN----GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ--RLLV 147 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~lv 147 (297)
.+...+||+|+|.+||+|.|..+|..||.-.++.. .....+++..|+.+|+.|+||||+++|++|.+... ..+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 35667899999999999999999999998665432 33445789999999999999999999999987654 7799
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC-CCceEEecccCcccc
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLG 226 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~-~~~~kl~Dfg~~~~~ 226 (297)
+|++..|+|..|+++ .+.++...+..|+.||+.+|.|||++ .|||+|||||-+||||+. .|.|||+|+|+|...
T Consensus 122 TEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 122 TELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 999999999999998 67788999999999999999999998 588999999999999984 599999999999864
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
.... ....+|||.|||||+.. ..|+..+||||||.++.||+|+.+||+.-..+++
T Consensus 197 r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ 251 (632)
T KOG0584|consen 197 RKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ 251 (632)
T ss_pred hccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH
Confidence 3322 23368999999999987 8899999999999999999999999998776654
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=266.59 Aligned_cols=207 Identities=24% Similarity=0.368 Sum_probs=179.5
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
.+|++.+.||+|++|.||+|.+..++..++||.+...... ...++.+|+.+++.++|+||+++++.+...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999999999999999999988653322 2356788999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+++++|.+++.........+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998754434567899999999999999999999999 99999999999999999999999998875332
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 211 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 21 122345688999999999888899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=267.33 Aligned_cols=195 Identities=26% Similarity=0.396 Sum_probs=171.5
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
++|++.+.||+|++|.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++.+...+..+++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 468889999999999999999999999999999865432 2335688899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|..+ ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 999988653 23678899999999999999999999 999999999999999999999999998653221
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 223457899999999999889999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=266.36 Aligned_cols=211 Identities=29% Similarity=0.434 Sum_probs=174.4
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCe----EEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQ----DVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~----~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
++|++.+.||+|+||.||+|.+..++. .+++|.+...... ...++..|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 578889999999999999999977765 4777776543222 23456778888899999999999998764 45788
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
++||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999752 356899999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhH
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l 289 (297)
.............++..|+|||.+.+..++.++||||||+++|||++ |..||.+.+......+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~ 223 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL 223 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 33332222334457778999999988889999999999999999998 9999988766554333
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=279.91 Aligned_cols=210 Identities=29% Similarity=0.420 Sum_probs=174.8
Q ss_pred HhcCCCCcceecccCcEEEEEEEECC-----CCeEEEEEEeccCCcc-chHHHHHHHHHHhccC-CCCccceeeEeecCC
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADGD 142 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 142 (297)
..++|.+.+.||+|+||.||+|.+.. ++..||||++...... ....+.+|+.+++.+. ||||+++++++.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 45789999999999999999998743 2457999998754332 2356889999999996 999999999999999
Q ss_pred eeEEEEecCCCCChHhhhcccCC---------------------------------------------------------
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSP--------------------------------------------------------- 165 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~--------------------------------------------------------- 165 (297)
..|+||||+++|+|.+++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999998864210
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEc
Q 022447 166 -----------------------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 210 (297)
Q Consensus 166 -----------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~ 210 (297)
....+++..+..++.|++.||.|||+.+ ++|+||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 0134788889999999999999999999 99999999999999
Q ss_pred CCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcch
Q 022447 211 RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSK 282 (297)
Q Consensus 211 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~ 282 (297)
.++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 999999999999875432222222233456788999999988899999999999999999997 999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=265.89 Aligned_cols=203 Identities=27% Similarity=0.421 Sum_probs=176.0
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCC
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
|++.+.||+|+||.||+|.+..++..+++|.+..........+.+|+.+++.++||||+++++.+......++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 67888999999999999999999999999999765555556788899999999999999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|..++... ..++++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++..... ...
T Consensus 87 ~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~--~~~ 158 (282)
T cd06643 87 GAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQ 158 (282)
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccc--ccc
Confidence 9999887641 357899999999999999999999999 99999999999999999999999999865321 112
Q ss_pred eeecccccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 234 VSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
......+++.|+|||++. +..++.++|+|||||++|+|++|+.||...+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~ 214 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM 214 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH
Confidence 223456899999999873 455788999999999999999999999876543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=268.20 Aligned_cols=211 Identities=30% Similarity=0.480 Sum_probs=178.4
Q ss_pred cCCCCcceecccCcEEEEEEEEC-----CCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+........+.+.+|+.+++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46788899999999999999853 3456789999876555555678899999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCc
Q 022447 147 VYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 214 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~ 214 (297)
||||+++++|.+++..... ....+++..++.++.||+.|++|||+++ ++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999975321 1245889999999999999999999999 999999999999999999
Q ss_pred eEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 215 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 215 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 233 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999875333222222233456789999999998999999999999999999999 999997766544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=283.49 Aligned_cols=206 Identities=28% Similarity=0.348 Sum_probs=185.9
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccch---HHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
..++..+.-||-|+||.|=++..+.....+|+|.+++.+.-+. ..+..|-.++..++.|.||++|..|.++.+.|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 4567778889999999999999887666789999987655443 4477899999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
||-|-||.|+..+.. .+.|++..++.++..+++|++|||+++ ||+|||||+|.+++.+|.+||.|||+++...
T Consensus 499 mEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 499 MEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999998 788999999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
.+. .+-++||||.|.|||++.+..-+.++|.||||+++||||+|.+||++.++--.
T Consensus 572 ~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt 627 (732)
T KOG0614|consen 572 SGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT 627 (732)
T ss_pred cCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH
Confidence 433 44578999999999999999999999999999999999999999999987544
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=266.58 Aligned_cols=213 Identities=30% Similarity=0.481 Sum_probs=178.0
Q ss_pred hcCCCCcceecccCcEEEEEEEE-----CCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
..+|.+.+.||+|+||.||+|.. ..++..+++|.+..........+.+|+.+++.++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 35788899999999999999974 3357789999987665555567889999999999999999999999999999
Q ss_pred EEEecCCCCChHhhhcccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPG-----------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 214 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~-----------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~ 214 (297)
++|||+++++|.+++...... ...+++..++.++.|++.|++|||+.+ ++|+||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 999999999999999763210 135889999999999999999999999 999999999999999999
Q ss_pred eEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 215 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 215 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+.
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 233 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH
Confidence 99999999865322221112223345678999999998899999999999999999998 9999977655443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=266.30 Aligned_cols=218 Identities=29% Similarity=0.438 Sum_probs=181.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCC-----CeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 144 (297)
.++|++.+.||+|+||.||+|.+... +..|++|.+..... .....+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 46889999999999999999998643 48899999865432 2335678899999999999999999999999999
Q ss_pred EEEEecCCCCChHhhhcccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEe
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPG------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 218 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~ 218 (297)
+++|||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 9999999999999999753321 234788899999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHHh
Q 022447 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVA 291 (297)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~~ 291 (297)
|||+++...............++..|+|||.+.+..++.++|||||||++|++++ |..||...+.......+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 9999875433222222233456789999999988889999999999999999998 999998776655544443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=265.85 Aligned_cols=205 Identities=29% Similarity=0.358 Sum_probs=176.3
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
++|++.+.||+|++|.||+|.++.+++.|++|++..... ...+.+..|+.+++.++|+|++++++++......+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 478899999999999999999999999999999865432 223457789999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+++++|..++.. ...+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9998888877654 456899999999999999999999999 999999999999999999999999998764332
Q ss_pred CCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..+
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~ 208 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD 208 (286)
T ss_pred cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 21 2223457889999998865 457889999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=266.54 Aligned_cols=204 Identities=26% Similarity=0.379 Sum_probs=174.1
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+|++.+.||+|++|.||+|.+..++..|++|.+...... ....+.+|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 578899999999999999999999999999998654322 235678899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+. ++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 154 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP- 154 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC-
Confidence 98 688888865332 356899999999999999999999999 999999999999999999999999998653222
Q ss_pred CcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
........+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~ 207 (285)
T cd07861 155 -VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207 (285)
T ss_pred -cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 112223457889999998765 4578899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=267.01 Aligned_cols=210 Identities=34% Similarity=0.484 Sum_probs=175.2
Q ss_pred cCCCCcceecccCcEEEEEEEE----CCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~----~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
.+|++.+.||+|+||.||+|.+ ..++..|++|.+...... ....+.+|+.+++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5688899999999999999985 345688999998754332 23567889999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC
Q 022447 147 VYEYMPLGSVEDHLHDLSP-------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 213 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~-------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~ 213 (297)
+|||+++++|.+++..... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853211 1235788999999999999999999999 99999999999999999
Q ss_pred ceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhH
Q 022447 214 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAA 284 (297)
Q Consensus 214 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~ 284 (297)
.++|+|||++................++..|+|||.+.+..++.++|+||||+++|||++ |..||...+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~ 233 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ 233 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999875433222222333446778999999988889999999999999999998 99999776543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=264.98 Aligned_cols=208 Identities=32% Similarity=0.494 Sum_probs=181.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
..+|++.+.||.|++|.||+|.+.. +..+++|.+..........+..|+.+++.++|+||+++++++.+....+++|||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 4578899999999999999999988 899999999876665567788999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999998632 456899999999999999999999999 9999999999999999999999999987542221
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
.......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+.
T Consensus 159 --~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~ 213 (261)
T cd05148 159 --YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV 213 (261)
T ss_pred --ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 11223345678999999988889999999999999999998 8999988765443
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=262.71 Aligned_cols=210 Identities=29% Similarity=0.448 Sum_probs=177.6
Q ss_pred hcCCCCcceecccCcEEEEEEEECCC---CeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
.++|++.+.||+|+||.||+|.+..+ ...|++|.+...... ....+..|+.+++.++||||+++++++......++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 45789999999999999999998654 467999998754333 23568889999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
+|||+++++|.+++... ...+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 99999999999999752 346899999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
.............++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~ 217 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV 217 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH
Confidence 32222222222345678999999998899999999999999999998 9999977665443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=269.74 Aligned_cols=203 Identities=26% Similarity=0.382 Sum_probs=176.9
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCC
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 152 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 152 (297)
.|.....||+|+||.||++.+..++..|+||.+..........+.+|+.+++.++|+||+++++.+...+..+++|||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 44555779999999999999999999999999876554555678899999999999999999999999999999999999
Q ss_pred CCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCc
Q 022447 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232 (297)
Q Consensus 153 g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 232 (297)
+++|.+++.. ..+++..++.++.||+.|+.|||+.+ ++||||+|+||++++++.++|+|||++...... .
T Consensus 103 ~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~ 172 (292)
T cd06658 103 GGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--V 172 (292)
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccc--c
Confidence 9999998864 45889999999999999999999999 999999999999999999999999998643221 1
Q ss_pred ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.......++..|+|||.+.+..++.++|+||||+++|||++|+.||...+...
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~ 225 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ 225 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 22233568899999999988889999999999999999999999998765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=283.51 Aligned_cols=207 Identities=34% Similarity=0.440 Sum_probs=183.6
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.|.-++.||.|+||-||-|++..+.+.||||.+...+... ..+++.|+..|++++|||++.+-+.|......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4666788999999999999999999999999987665443 3678999999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
||- |+-.|++.-. +.++.+.++..|+.+.+.||.|||+.+ .||||||..|||+.+.|.|||+|||.+..
T Consensus 107 YCl-GSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi---- 175 (948)
T KOG0577|consen 107 YCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASI---- 175 (948)
T ss_pred HHh-ccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhh----
Confidence 998 6777777652 578999999999999999999999999 99999999999999999999999999875
Q ss_pred CCcceeecccccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHHhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 292 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~~~ 292 (297)
..+..+++|||+|||||++. .+.|+-++||||||++..||.-.++|+..++.-..+.+++-
T Consensus 176 --~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ 239 (948)
T KOG0577|consen 176 --MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 239 (948)
T ss_pred --cCchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh
Confidence 23455689999999999874 46799999999999999999999999988887776666653
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=267.87 Aligned_cols=207 Identities=27% Similarity=0.403 Sum_probs=178.0
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++.+.||+|+||.||++.+..+++.|++|.+..... .....+..|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 478899999999999999999999999999999876532 22346778999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||++|++|.+++.. ...+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999976 467899999999999999999999999 99999999999999999999999998763211
Q ss_pred CCCc-------------ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 229 GDNT-------------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 229 ~~~~-------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~ 223 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1000 01112457889999999988889999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=262.74 Aligned_cols=204 Identities=30% Similarity=0.487 Sum_probs=176.3
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc---------hHHHHHHHHHHhccCCCCccceeeEeecCCe
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 143 (297)
+|.+.+.||.|++|.||+|.+..++..+++|.+....... ...+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999999899999999886543321 1457789999999999999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
.+++|||+++++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999976 467889999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCC----cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 224 KLGPVGDN----THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 224 ~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
........ ........|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 217 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH
Confidence 75432111 1111234588899999999888899999999999999999999999987644
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=262.29 Aligned_cols=208 Identities=28% Similarity=0.467 Sum_probs=177.6
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
.+|.+.+.||+|++|.||+|.++.++..|++|.+.... .....+.+|+.+++.++|+||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 46788899999999999999999999999999987542 33456888999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
++++|.+++.... ...+++..++.++.|++.+|.|||+.+ ++||||||+||++++++.++|+|||.+........
T Consensus 85 ~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999997532 356889999999999999999999999 99999999999999999999999999875322211
Q ss_pred cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~ 214 (263)
T cd05052 160 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 214 (263)
T ss_pred -eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 11112234568999999988899999999999999999998 9999987665443
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=264.20 Aligned_cols=201 Identities=30% Similarity=0.402 Sum_probs=179.5
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
+|++.+.||.|+||.||+|.+..++..|++|++..... ...+.+.+|+.+++.++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58889999999999999999999999999999976433 234678889999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+.|++|.+++.. ..++++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999986 457899999999999999999999999 999999999999999999999999998754322
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 1 22345688899999999888899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=265.35 Aligned_cols=217 Identities=30% Similarity=0.452 Sum_probs=178.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECC-----CCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 144 (297)
.++|.+.+.||+|++|.||+|.+.. ++..|++|.+...... ....+..|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 3578899999999999999999987 7789999988654332 234688899999999999999999999998899
Q ss_pred EEEEecCCCCChHhhhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC---ceEEe
Q 022447 145 LLVYEYMPLGSVEDHLHDLSP---GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLS 218 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~---~~kl~ 218 (297)
+++|||++|++|.+++..... ....+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++ .++|+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999976421 1235889999999999999999999999 99999999999998654 58999
Q ss_pred cccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHH
Q 022447 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~ 290 (297)
|||++.................+..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999875422211111122234568999999988899999999999999999997 99999887665544433
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=260.99 Aligned_cols=206 Identities=24% Similarity=0.360 Sum_probs=177.2
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeec-CCeeEEEEe
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYE 149 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 149 (297)
+|++.+.||.|++|.||++.++.+++.|++|.+..... ...+.+.+|+.+++.++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 48899999999999999999999999999999865432 233567889999999999999999998764 446789999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+++++|.+++.... ...+++.+++.++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999997632 356899999999999999999999999 999999999999999999999999998754221
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
........+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+...
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~ 209 (257)
T cd08223 156 --CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS 209 (257)
T ss_pred --CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 122334568899999999999999999999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=286.02 Aligned_cols=197 Identities=27% Similarity=0.425 Sum_probs=178.3
Q ss_pred eecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCChHh
Q 022447 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 158 (297)
Q Consensus 79 ~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~ 158 (297)
+||+|.||+||-|++..+...+|||.++.......+.+..|+.+.+.++|.|||++++.+.+++.+-+.||-.+||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999999999999999988777777888999999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC-CCceEEecccCccccCCCCCccee
Q 022447 159 HLHDLSPGKKPL--DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVS 235 (297)
Q Consensus 159 ~l~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~ 235 (297)
++... -+++ .+..+..+..||+++|.|||... |||||||-+|+||+. .|.+||+|||.++. .......+
T Consensus 662 LLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKR--LAginP~T 733 (1226)
T KOG4279|consen 662 LLRSK---WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKR--LAGINPCT 733 (1226)
T ss_pred HHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchh--hccCCccc
Confidence 99862 4667 78899999999999999999999 999999999999984 78999999999976 33344556
Q ss_pred ecccccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 236 TRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 236 ~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
.++.||..|||||++.. ..|+.++|||||||++.||.||++||-....
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs 783 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS 783 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC
Confidence 77889999999999965 4689999999999999999999999976544
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=287.13 Aligned_cols=215 Identities=25% Similarity=0.368 Sum_probs=189.4
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCC
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 152 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 152 (297)
-|.|+..||.|+||.||+|.++.++...|.|+|......+..+++.|+.+|..+.||+|++++++|...+.+|++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 46778889999999999999999999999999988777777889999999999999999999999999999999999999
Q ss_pred CCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCc
Q 022447 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232 (297)
Q Consensus 153 g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 232 (297)
||-....+.+ .+..+.+.++..+++|++.||.|||+++ |+|||||..|||+..+|.++|+|||.+-. .....
T Consensus 113 GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAK--n~~t~ 184 (1187)
T KOG0579|consen 113 GGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAK--NKSTR 184 (1187)
T ss_pred CchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccccccc--chhHH
Confidence 9999988876 3678999999999999999999999999 99999999999999999999999998753 22333
Q ss_pred ceeecccccccccCcccc-----ccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHHhhcCC
Q 022447 233 HVSTRVMGTYGYCAPEYA-----KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEP 295 (297)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~~~~~p 295 (297)
....+++|||+|||||+. ...+|+.++||||||++|.||..+.+|-...++-.-.--++-.+|
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSeP 252 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP 252 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCC
Confidence 456678999999999976 456899999999999999999999999887766555444444444
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=268.63 Aligned_cols=209 Identities=33% Similarity=0.413 Sum_probs=179.8
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++.+.||+|++|.||+|.+..+++.|++|.+...... ....+..|+.+++.++|+||+++++.+.+....+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4688999999999999999999999999999999765433 3356788999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+.|++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999987532 357899999999999999999999999 99999999999999999999999998764322
Q ss_pred CCCc---------------------------ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 229 GDNT---------------------------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 229 ~~~~---------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
.... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1100 0112346888999999999888999999999999999999999999876
Q ss_pred hhHh
Q 022447 282 KAAA 285 (297)
Q Consensus 282 ~~~~ 285 (297)
+...
T Consensus 236 ~~~~ 239 (316)
T cd05574 236 NRDE 239 (316)
T ss_pred chHH
Confidence 6543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=267.22 Aligned_cols=216 Identities=27% Similarity=0.363 Sum_probs=180.6
Q ss_pred cCHHHHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcc-CCCCccceeeEee-
Q 022447 62 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCA- 139 (297)
Q Consensus 62 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~- 139 (297)
+.++.+....++|++.+.||+|+||.||+|.+..+++.+++|++.... .....+..|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445556667889999999999999999999999999999999876432 2235677899999998 6999999999874
Q ss_pred ----cCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCce
Q 022447 140 ----DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (297)
Q Consensus 140 ----~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~ 215 (297)
....++++|||++|++|.+++.........+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345789999999999999988654333567899999999999999999999999 9999999999999999999
Q ss_pred EEecccCccccCCCCCcceeecccccccccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
+|+|||++....... .......|++.|+|||.+.. ..++.++|+|||||++|+|++|+.||...+.
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 999999987543221 12233468999999998753 4578899999999999999999999987654
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=283.16 Aligned_cols=225 Identities=26% Similarity=0.325 Sum_probs=189.2
Q ss_pred CHHHHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchH---HHHHHHHHHhccCCCCccceeeEee
Q 022447 63 TFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHHPNLVNLIGYCA 139 (297)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~e~~~l~~l~h~~i~~~~~~~~ 139 (297)
++..-.-...-|..++.||-|+||.|.++....|...||+|.+.+....... ....|-.||...+++-||++|..|.
T Consensus 620 RLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 620 RLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ 699 (1034)
T ss_pred HHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence 3333333445577888999999999999999999999999999876544332 3566889999999999999999999
Q ss_pred cCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEec
Q 022447 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 219 (297)
Q Consensus 140 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~D 219 (297)
+.+.+|+||+|++||++-+++-. .+-|.|..++.++.++..||++.|.+| +|||||||+|||||.+|+|||+|
T Consensus 700 DkdnLYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTD 772 (1034)
T KOG0608|consen 700 DKDNLYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTD 772 (1034)
T ss_pred cCCceEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeee
Confidence 99999999999999999999987 678999999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCC---------CCCc-------------------------------ceeecccccccccCccccccCCCCccc
Q 022447 220 FGLAKLGPV---------GDNT-------------------------------HVSTRVMGTYGYCAPEYAKTGQLTLKS 259 (297)
Q Consensus 220 fg~~~~~~~---------~~~~-------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~ 259 (297)
||+|.-+.. ++.. ......+||+.|+|||++....|+..+
T Consensus 773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c 852 (1034)
T KOG0608|consen 773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC 852 (1034)
T ss_pred ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc
Confidence 999862110 0000 000125799999999999999999999
Q ss_pred chhhHHHHHHHHHhCCCCCCcchhH-hhhhHHhhcC
Q 022447 260 DVYSFGVVLLEILSGRKAVDTSKAA-AEQSLVAWSE 294 (297)
Q Consensus 260 DiwslG~il~ell~g~~Pf~~~~~~-~~~~l~~~~~ 294 (297)
|.||.|+|||||+.|+.||-++++- ++...++|..
T Consensus 853 dwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~ 888 (1034)
T KOG0608|consen 853 DWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRN 888 (1034)
T ss_pred hhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh
Confidence 9999999999999999999988774 4556777753
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=282.32 Aligned_cols=196 Identities=23% Similarity=0.271 Sum_probs=170.0
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
...|.+.+.||+|+||.||+|.+..++..|+||.... ..+.+|+.+++.++|+||+++++++......+++||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3469999999999999999999999999999996432 2356799999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+. ++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++......
T Consensus 242 ~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 96 7888888652 346999999999999999999999999 9999999999999999999999999987643322
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 279 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 279 (297)
.........||+.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 2222234579999999999999999999999999999999999886553
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=261.10 Aligned_cols=206 Identities=27% Similarity=0.428 Sum_probs=174.9
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
++|++.+.||+|+||.||++..+. +..+++|.+.... .....+..|+.+++.++||||+++++++......+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 568889999999999999998865 5679999886443 23457888999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999998752 245889999999999999999999999 99999999999999999999999998875322211
Q ss_pred cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
.......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~ 210 (256)
T cd05114 156 -TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV 210 (256)
T ss_pred -eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 11122235668999999988889999999999999999999 9999988765543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=259.53 Aligned_cols=207 Identities=25% Similarity=0.397 Sum_probs=181.4
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+|++.+.||.|+||.||.+.+..++..+++|.+.... .....++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5889999999999999999999999999999987543 23345688999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++.... ...+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997632 356899999999999999999999999 9999999999999999999999999987543322
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+.
T Consensus 156 --~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~ 209 (256)
T cd08221 156 --SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL 209 (256)
T ss_pred --ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 123345689999999999888889999999999999999999999988665443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=264.21 Aligned_cols=208 Identities=29% Similarity=0.467 Sum_probs=173.7
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCe----EEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQ----DVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~----~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
.++|++.+.||+|+||.||+|.+..++. .||+|++...... ....+..|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 4578899999999999999999876665 4899998654332 34567889999999999999999999875 4567
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+++||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999998752 346899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
..............+++.|+|||...+..++.++|||||||++|||++ |..||+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 219 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 433222222222335678999999988889999999999999999998 999998765543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=275.67 Aligned_cols=217 Identities=22% Similarity=0.266 Sum_probs=180.9
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEecc--CCccchHHHHHHHHHHhccC-CCCccceeeEeecCCeeEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR--NGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 146 (297)
....|++++.||+||.+.||++..... ..||+|.+.. .......-+..|+.+|.+|+ |.+|+++|++-..++.+|+
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 346799999999999999999988654 4555555432 23334467999999999996 8999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
|||+=+ .+|..++.... ..++.-.++.++.||+.|+.++|..| |||.||||.|||+.. |.+||+|||+|...
T Consensus 438 vmE~Gd-~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred Eeeccc-ccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 999865 79999998732 23333489999999999999999999 999999999999976 58999999999987
Q ss_pred CCCCCcceeecccccccccCccccccCC-----------CCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHHhhcCC
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQ-----------LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEP 295 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~-----------~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~~~~~p 295 (297)
............+||+.||+||.+.... .++++||||||||||+|+.|++||..- ..-.+.+.++++|
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-~n~~aKl~aI~~P 588 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-INQIAKLHAITDP 588 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-HHHHHHHHhhcCC
Confidence 7777777778899999999999875432 457899999999999999999999875 4466788888888
Q ss_pred C
Q 022447 296 E 296 (297)
Q Consensus 296 ~ 296 (297)
.
T Consensus 589 ~ 589 (677)
T KOG0596|consen 589 N 589 (677)
T ss_pred C
Confidence 3
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=268.27 Aligned_cols=202 Identities=24% Similarity=0.363 Sum_probs=176.2
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCC
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
|.....||+|+||.||+|.+..++..|++|.+..........+.+|+.+++.++||||+++++.+...+..++++||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 44455799999999999999999999999998765545556788999999999999999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|.+++.. ..+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~ 172 (297)
T cd06659 103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VP 172 (297)
T ss_pred CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccc--cc
Confidence 999987754 56889999999999999999999999 999999999999999999999999998643221 12
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+...
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 224 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ 224 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 2234568999999999988889999999999999999999999998765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=260.08 Aligned_cols=206 Identities=36% Similarity=0.540 Sum_probs=178.1
Q ss_pred ceecccCcEEEEEEEECCC---CeEEEEEEeccCCccc-hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~---~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.||+|+||.||+|.+... +..|++|.+....... ...+.+|+.+++.++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999866 8999999997654433 56788999999999999999999999999999999999999
Q ss_pred CChHhhhcccCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 154 GSVEDHLHDLSPG-----KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 154 ~~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
++|.+++...... ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999874221 377999999999999999999999999 99999999999999999999999999976543
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||...+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 216 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV 216 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 322222334557889999999988889999999999999999999 6999988765443
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=263.77 Aligned_cols=204 Identities=28% Similarity=0.413 Sum_probs=178.4
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
..|+..+.||.|+||.||+|.+..++..||+|.+..... .....+..|+.+++.+.|+||+++++.+.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 457788899999999999999999999999999875432 3345688899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
++|++|.+++.. .++++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999999864 46889999999999999999999999 9999999999999999999999999986533222
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+...
T Consensus 156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 208 (277)
T cd06640 156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR 208 (277)
T ss_pred --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh
Confidence 12233467889999999988889999999999999999999999998766544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=272.82 Aligned_cols=205 Identities=32% Similarity=0.443 Sum_probs=182.6
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
+.|+.-++||+|+||.|+-++.+.||+.||.|.+.+..... ..-.+.|-.+|.+++.+.||.+-.+|+..+.+++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 56888899999999999999999999999999886543322 234678999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
..|.||+|.-+|-+.. ...+++..++.++.+|+.+|++||+.+ ||+||+||+|||+|+.|++.|+|+|+|...+.
T Consensus 265 tlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999998887643 468999999999999999999999999 99999999999999999999999999986544
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
+. +....+||.+|||||++.++.|+...|.|||||++|||+.|+.||......
T Consensus 340 g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK 392 (591)
T KOG0986|consen 340 GK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK 392 (591)
T ss_pred CC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence 43 233348999999999999999999999999999999999999999987653
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=273.05 Aligned_cols=193 Identities=24% Similarity=0.373 Sum_probs=167.7
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
...+|++.+.||+|+||.||+|.+..++..||+|+.... ....|+.+++.++|+||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 346799999999999999999999999999999985432 23458999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
++. ++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 138 ~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 138 HYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred ccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 996 688888865 2467899999999999999999999999 999999999999999999999999998742211
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAV 278 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf 278 (297)
.......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456899999999999999999999999999999999866554
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=272.60 Aligned_cols=208 Identities=30% Similarity=0.445 Sum_probs=171.3
Q ss_pred hcCCCCcceecccCcEEEEEEEEC-----CCCeEEEEEEeccCCc-cchHHHHHHHHHHhcc-CCCCccceeeEeecC-C
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG-D 142 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~ 142 (297)
.++|++.+.||+|+||.||+|... .+++.||+|++..... .....+..|+.++..+ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357999999999999999999753 3457899999875432 2235677899999999 799999999988654 5
Q ss_pred eeEEEEecCCCCChHhhhcccCCC--------------------------------------------------------
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPG-------------------------------------------------------- 166 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~-------------------------------------------------------- 166 (297)
..+++|||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 678999999999999998642210
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcceeeccccccccc
Q 022447 167 -KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245 (297)
Q Consensus 167 -~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~ 245 (297)
..++++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++................++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 136889999999999999999999999 9999999999999999999999999997643322222223344667899
Q ss_pred CccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcc
Q 022447 246 APEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTS 281 (297)
Q Consensus 246 aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~ 281 (297)
|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~ 279 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=267.79 Aligned_cols=210 Identities=33% Similarity=0.487 Sum_probs=172.7
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeE--EEEEEeccCCc-cchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQD--VAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~--vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 146 (297)
.++|++.+.||+|+||.||+|.++.++.. +++|.+..... .....+.+|+.++..+ +|+||+++++++...+.+|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 46789999999999999999999877754 46776654322 2335678899999999 89999999999999999999
Q ss_pred EEecCCCCChHhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCc
Q 022447 147 VYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 214 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~ 214 (297)
+|||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 9999999999999975321 1235889999999999999999999999 999999999999999999
Q ss_pred eEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 215 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 215 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
++|+|||++..... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+.
T Consensus 163 ~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 232 (303)
T cd05088 163 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 232 (303)
T ss_pred EEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH
Confidence 99999999853111 111111224567999999988889999999999999999998 9999987655443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=260.24 Aligned_cols=207 Identities=31% Similarity=0.423 Sum_probs=175.6
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-----chHHHHHHHHHHhccCCCCccceeeEeec--CCee
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-----GNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQR 144 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 144 (297)
.+|++.+.||+|++|.||+|.+..++..|++|.+...... ....+.+|+.+++.++||||+++++.+.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4789999999999999999999999999999988643221 22457889999999999999999998875 3577
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
++++||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999976 456889999999999999999999999 9999999999999999999999999986
Q ss_pred ccCCCC-CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 225 LGPVGD-NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 225 ~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
...... .........++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~ 216 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA 216 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH
Confidence 432211 1111223458889999999988889999999999999999999999998765433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=268.60 Aligned_cols=200 Identities=25% Similarity=0.355 Sum_probs=162.7
Q ss_pred cceecccCcEEEEEEEEC--CCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeec--CCeeEEEEecCC
Q 022447 77 ESLLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMP 152 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~ 152 (297)
...||+|+||.||+|.++ .++..||+|.+..... ...+.+|+.+++.++||||+++++++.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 457999999999999975 4678999999875432 3456789999999999999999999854 456789999987
Q ss_pred CCChHhhhcccCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE----cCCCceEEecccCc
Q 022447 153 LGSVEDHLHDLSP-----GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL----DRGYHPKLSDFGLA 223 (297)
Q Consensus 153 g~~L~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili----~~~~~~kl~Dfg~~ 223 (297)
++|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 688888754221 1235899999999999999999999999 9999999999999 45678999999999
Q ss_pred cccCCCCC-cceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 224 KLGPVGDN-THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 224 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 75432211 112234578999999998876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=268.17 Aligned_cols=215 Identities=29% Similarity=0.416 Sum_probs=176.5
Q ss_pred cCCCCcceecccCcEEEEEEEECC-------CCeEEEEEEeccCCc-cchHHHHHHHHHHhcc-CCCCccceeeEeecCC
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLES-------INQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD 142 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 142 (297)
++|.+.+.||+|+||.||+|.+.. +...+|+|.+..... .....+..|+.+++.+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 579999999999999999998643 235799999875432 2335678899999999 7999999999999999
Q ss_pred eeEEEEecCCCCChHhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEc
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 210 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~ 210 (297)
..|+||||+.+++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999976432 1235888999999999999999999999 99999999999999
Q ss_pred CCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhH
Q 022447 211 RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (297)
Q Consensus 211 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l 289 (297)
.++.++|+|||.+................+++.|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 999999999999875332221111222234568999999988889999999999999999998 8899988766554433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=264.93 Aligned_cols=203 Identities=27% Similarity=0.384 Sum_probs=173.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.++|++.+.||+|++|.||+|.++.+++.|++|.+...... ....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 36799999999999999999999999999999998654322 22456789999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+. ++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 998 5899988752 346899999999999999999999999 999999999999999999999999998643221
Q ss_pred CCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
. .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+
T Consensus 157 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 157 S--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred C--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1 11122346889999998865 457899999999999999999999997765
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=264.84 Aligned_cols=207 Identities=26% Similarity=0.348 Sum_probs=174.3
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc-hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.++|.+.+.||+|+||.||+|.+..++..|++|.+....... ...+.+|+.+++.++|+||+++++++......++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 468999999999999999999999999999999987543322 2456789999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+. ++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 996 6777776542 345788899999999999999999999 999999999999999999999999998653221
Q ss_pred CCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+....
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~ 212 (291)
T cd07870 157 --SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE 212 (291)
T ss_pred --CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH
Confidence 111233457889999998865 3578899999999999999999999987765433
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=260.79 Aligned_cols=208 Identities=29% Similarity=0.467 Sum_probs=176.4
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|++.+.||+|++|.||+|.+.. +..|++|.+..... ..+.+..|+.+++.++|+||+++++.+.+....+++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 4678999999999999999999754 67799998765432 346788899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999997532 356888899999999999999999999 9999999999999999999999999997643221
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
. .......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+....
T Consensus 158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~ 213 (261)
T cd05072 158 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV 213 (261)
T ss_pred e-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH
Confidence 1 11222345678999999988889999999999999999998 9999987655443
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=263.15 Aligned_cols=208 Identities=31% Similarity=0.416 Sum_probs=175.4
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcc-CCCCccceeeEeecC------C
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG------D 142 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~ 142 (297)
....|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+.+++.+ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 3467888999999999999999999999999999987543 3345678899999988 699999999998652 4
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
..|++|||+.+++|.+++.... ...+++..+..++.|++.|+.|||+++ ++|+||+|+||++++++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 6889999999999999987622 356889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 223 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
+...... ........|++.|+|||++. +..++.++|+|||||++|+|++|+.||...+...
T Consensus 158 ~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~ 223 (272)
T cd06637 158 SAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 223 (272)
T ss_pred ceecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 8753221 12233456899999999885 3457889999999999999999999997665433
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=269.76 Aligned_cols=209 Identities=30% Similarity=0.425 Sum_probs=183.6
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHH---HHHHHHHHhcc-CCCCccceeeEeecCCeeEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 146 (297)
..+|.++.+||.|+||.|.+|..+.+.+.||||++++.-....++ -+.|-.+|... +-|.+++++..|+.-+++|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 457889999999999999999999999999999998764433222 34566676655 47899999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||||+.||+|--.+++ -+.+.+..+..++.+|+-+|-+||++| |++||||.+||+++.+|++||+|||+++-.
T Consensus 428 VMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999998987 677889999999999999999999999 999999999999999999999999999853
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
... ...+.+++|||.|+|||++.-++|+.++|.||+|++||||+.|++||++.+.++.-.
T Consensus 501 i~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~ 560 (683)
T KOG0696|consen 501 IFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ 560 (683)
T ss_pred ccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 332 334567999999999999999999999999999999999999999999998766543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=276.38 Aligned_cols=201 Identities=30% Similarity=0.435 Sum_probs=177.6
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 155 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~ 155 (297)
+.||+|.||+||-|+++.+|+.||||+|.+... .....++.|+.+|+.++||+||.+...|+..+..|+|||-+. |+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-ch
Confidence 789999999999999999999999999986533 334678999999999999999999999999999999999997 67
Q ss_pred hHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC---CceEEecccCccccCCCCCc
Q 022447 156 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG---YHPKLSDFGLAKLGPVGDNT 232 (297)
Q Consensus 156 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~ 232 (297)
..++|-. ..++.+++..-..++.||+.||.|||.++ |+|+||||+|||+... -++||+|||+++.... .
T Consensus 649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---k 720 (888)
T KOG4236|consen 649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---K 720 (888)
T ss_pred HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch---h
Confidence 7777754 24788999999999999999999999999 9999999999999754 4699999999997433 2
Q ss_pred ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
....+.+|||.|+|||+++++.|..+.|+||+|+|+|--|+|..||..+.+-..|
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ 775 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ 775 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH
Confidence 3456688999999999999999999999999999999999999999987654433
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=260.27 Aligned_cols=209 Identities=29% Similarity=0.412 Sum_probs=172.3
Q ss_pred CCCcceecccCcEEEEEEEECCC---CeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCe-----
Q 022447 74 FRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ----- 143 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~---~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 143 (297)
|.+.+.||+|+||.||+|....+ +..||+|.+...... ....+..|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 57889999999999999997653 478999998754322 23568889999999999999999998866544
Q ss_pred -eEEEEecCCCCChHhhhcccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecc
Q 022447 144 -RLLVYEYMPLGSVEDHLHDLSP--GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (297)
Q Consensus 144 -~~lv~e~~~g~~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Df 220 (297)
.++++||+++++|..++..... ....+++..++.++.|++.||.|||+.+ ++||||||+||++++++.++|+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 7899999999999999865321 2346899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
|+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~ 223 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE 223 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99875433322222222335678999999988899999999999999999999 889998766544
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=266.62 Aligned_cols=214 Identities=30% Similarity=0.438 Sum_probs=177.9
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCC-----CeEEEEEEeccCCc-cchHHHHHHHHHHhcc-CCCCccceeeEeecC
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 141 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 141 (297)
...++|++.+.||+|++|.||++.+... ...+++|.+..... ....++.+|+.+++.+ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 3456789999999999999999998643 37899999875422 2335678899999999 799999999999999
Q ss_pred CeeEEEEecCCCCChHhhhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLS------------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili 209 (297)
...+++|||+++++|.+++.... .....+++..++.++.|++.||.|||+.+ ++||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 99999999999999999996532 22456899999999999999999999999 9999999999999
Q ss_pred cCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 210 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 210 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
+.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 9999999999999875433222222222335578999999988899999999999999999998 999998776544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=259.40 Aligned_cols=208 Identities=29% Similarity=0.404 Sum_probs=176.4
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC-----ccchHHHHHHHHHHhccCCCCccceeeEeecC--Cee
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-----VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 144 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 144 (297)
.+|++.+.||+|++|.||+|.+..++..|++|.+.... ......+.+|+.+++.++|+||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57899999999999999999999999999999875321 12234678899999999999999999998764 467
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
++++||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999876 456889999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCC-cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 225 LGPVGDN-THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 225 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
....... ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 217 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA 217 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH
Confidence 5322111 1112235688999999999888899999999999999999999999987654443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=264.88 Aligned_cols=216 Identities=29% Similarity=0.343 Sum_probs=179.2
Q ss_pred CHHHHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcc-CCCCccceeeEeecC
Q 022447 63 TFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 141 (297)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 141 (297)
.+.++....++|++.+.||+|+||.||+|.+..+++.+++|++..... ....+..|+.+++.+ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 334444557889999999999999999999999999999999865322 235567889999888 799999999998653
Q ss_pred -----CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceE
Q 022447 142 -----DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (297)
Q Consensus 142 -----~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~k 216 (297)
...++||||++|++|.+++.........+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 3589999999999999998754434567899999999999999999999999 99999999999999999999
Q ss_pred EecccCccccCCCCCcceeecccccccccCccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 217 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-----QLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 217 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
|+|||++....... .......|+..|+|||.+... .++.++|+|||||++|+|++|+.||...+..
T Consensus 169 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~ 239 (291)
T cd06639 169 LVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239 (291)
T ss_pred Eeecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence 99999987532221 112334688999999987543 3688999999999999999999999877653
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=259.38 Aligned_cols=208 Identities=30% Similarity=0.466 Sum_probs=176.1
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|++.+.||+|++|.||+|.+.. +..|++|.+..... ..+.+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 4578999999999999999999764 57899999875432 346688899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+.+++|.+++.... ...+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999997632 346899999999999999999999999 9999999999999999999999999987643211
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
.........+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+....
T Consensus 158 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 213 (261)
T cd05068 158 -YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV 213 (261)
T ss_pred -ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 111111223457999999998899999999999999999999 9999988665443
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=258.77 Aligned_cols=204 Identities=30% Similarity=0.400 Sum_probs=180.0
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
++|++.+.||+|++|.||+|.+..++..+++|.+..... ...+.+|+.+++.++|+||+++++.+.+....|+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 679999999999999999999999899999999875432 567889999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
.+++|.+++... ...+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~- 153 (256)
T cd06612 81 GAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM- 153 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc-
Confidence 999999998652 467899999999999999999999999 9999999999999999999999999987533221
Q ss_pred cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+...
T Consensus 154 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~ 206 (256)
T cd06612 154 -AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR 206 (256)
T ss_pred -cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh
Confidence 12233457889999999988899999999999999999999999998765433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=266.10 Aligned_cols=200 Identities=23% Similarity=0.337 Sum_probs=169.8
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+|++.+.||+|++|.||+|.+..+|+.|++|.+...... ....+.+|+.+++.++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 588899999999999999999999999999998654222 224577899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+. ++|.+++... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 5788877642 356899999999999999999999999 9999999999999999999999999987532221
Q ss_pred CcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
.......+++.|+|||.+.+. .++.++|||||||++|+|++|..||...
T Consensus 154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~ 203 (284)
T cd07839 154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 203 (284)
T ss_pred --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 112234578899999988664 4789999999999999999999886443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=259.28 Aligned_cols=207 Identities=29% Similarity=0.438 Sum_probs=174.0
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
.+|++.+.||+|++|.||+|.++. +..+++|.+..... ....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 468899999999999999998864 67899999865433 3356788999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
+|++|.+++... ...+++..++.++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||.++.......
T Consensus 82 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999998752 246899999999999999999999999 99999999999999999999999999875322111
Q ss_pred cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhh
Q 022447 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQ 287 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~ 287 (297)
.......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+..
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~ 211 (256)
T cd05059 156 -TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211 (256)
T ss_pred -cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH
Confidence 11111223457999999988899999999999999999999 89999876655433
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=259.68 Aligned_cols=202 Identities=27% Similarity=0.396 Sum_probs=180.6
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
++|++.+.||.|++|.||+|.+..+++.|++|.+..... .....+..|+..+..++|+|++++++++......+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 468899999999999999999999999999999876544 3346788999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
+++++|.+++.. ..++++..++.++.|++.|+.+||+ .+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999986 4778999999999999999999999 99 999999999999999999999999998754322
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 154 ~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 154 LD--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred CC--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 21 1224568889999999998899999999999999999999999998875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=257.85 Aligned_cols=201 Identities=29% Similarity=0.436 Sum_probs=176.4
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-----cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-----QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
+|+..+.||+|++|.||+|.+..++..|++|.+..... ...+.+.+|+.+++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47788999999999999999998899999999865432 1335688899999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
+||+++++|.+++.. ..++++..++.++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999976 456889999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCcceeecccccccccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQ-LTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
... ......++..|++||.+.... ++.++|+||||+++|+|++|+.||...+.
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~ 207 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG 207 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH
Confidence 222 233456889999999987766 89999999999999999999999987663
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=261.08 Aligned_cols=203 Identities=25% Similarity=0.400 Sum_probs=175.3
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
+|+..+.||+|++|.||+|.+..+++.|++|++...... ....+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999999999999999998754321 23568889999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC-ceEEecccCccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKL 225 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~-~~kl~Dfg~~~~ 225 (297)
|+||+.|++|.+++.. ..++++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999976 567899999999999999999999999 99999999999998765 599999999865
Q ss_pred cCCCCC--cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 226 GPVGDN--THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 226 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
...... ........++..|+|||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 332211 111223468889999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=264.68 Aligned_cols=215 Identities=29% Similarity=0.413 Sum_probs=177.0
Q ss_pred cCCCCcceecccCcEEEEEEEECC-----CCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
.+|++.+.||.|+||.||+|.+.. .+..||+|++...... ....+..|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 357788899999999999998754 3578999998754322 2355788999999999999999999999999999
Q ss_pred EEEecCCCCChHhhhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC
Q 022447 146 LVYEYMPLGSVEDHLHDLS------------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 213 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~ 213 (297)
+++||+.+++|.+++.... .....+++..++.++.|++.||.|||+++ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985321 11245788899999999999999999999 99999999999999999
Q ss_pred ceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhH
Q 022447 214 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (297)
Q Consensus 214 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l 289 (297)
.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||...+..+....
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999875433222222233446789999999988889999999999999999998 8899988766544443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=263.65 Aligned_cols=212 Identities=30% Similarity=0.421 Sum_probs=175.3
Q ss_pred CCCCcceecccCcEEEEEEEECC-----CCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
+|++.+.||+|+||.||+|.+.. ....+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47888999999999999998753 235788888865433 233568889999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 022447 147 VYEYMPLGSVEDHLHDLSP--------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 206 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~N 206 (297)
++||+.+++|.+++..... ...++++..++.++.|++.||.|||+.+ ++||||+|+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999999864211 1245889999999999999999999999 9999999999
Q ss_pred EEEcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 207 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 207 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
|++++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999875332222112223345678999999988889999999999999999998 999998776554
Q ss_pred hh
Q 022447 286 EQ 287 (297)
Q Consensus 286 ~~ 287 (297)
..
T Consensus 238 ~~ 239 (290)
T cd05045 238 LF 239 (290)
T ss_pred HH
Confidence 33
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=264.63 Aligned_cols=203 Identities=28% Similarity=0.428 Sum_probs=179.2
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
++|.+.+.||+|+||.||++.+..++..|++|.+..........+..|+.+++.++||||+++++.+......|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 68999999999999999999999889999999987554445567888999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~- 169 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 169 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc-
Confidence 99999999875 45788999999999999999999999 9999999999999999999999999876532222
Q ss_pred cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
.......+++.|+|||.+.+..++.++|+||||+++|++++|+.||...+..
T Consensus 170 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~ 221 (293)
T cd06647 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221 (293)
T ss_pred -cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh
Confidence 1223346888999999998888999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=263.45 Aligned_cols=215 Identities=29% Similarity=0.457 Sum_probs=176.2
Q ss_pred HhcCCCCcceecccCcEEEEEEEECC-----CCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 143 (297)
..++|++.+.||+|+||.||+|.++. .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999997652 356899998865432 223457789999999999999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEE
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSP------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 217 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl 217 (297)
.+++|||+++++|.+++..... ....++...+..++.|++.||.|||+++ ++||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999975321 1234567789999999999999999999 999999999999999999999
Q ss_pred ecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhh
Q 022447 218 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQ 287 (297)
Q Consensus 218 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~ 287 (297)
+|||+++...............++..|+|||.+.+..++.++|+|||||++|||++ |..||...+..+..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~ 231 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 231 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999875332222222222345678999999988889999999999999999998 78999876655443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=263.68 Aligned_cols=204 Identities=25% Similarity=0.391 Sum_probs=173.7
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
++|++++.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 368899999999999999999999999999998865422 2235688899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
++|++|.+++.... ....+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999998887521 13478999999999999999999996 47 999999999999999999999999998643211
Q ss_pred CCcceeecccccccccCccccccC------CCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTG------QLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 212 (286)
T cd06622 157 ----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY 212 (286)
T ss_pred ----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch
Confidence 12334588899999988543 357899999999999999999999976544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=268.15 Aligned_cols=203 Identities=19% Similarity=0.243 Sum_probs=168.7
Q ss_pred Ccceeccc--CcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 76 SESLLGEG--GFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 76 ~~~~lg~G--~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
++++||+| +|++||++.++.+|+.||+|.+...... ....+..|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 7789999999999999999999765332 2245677999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999996532 345899999999999999999999999 99999999999999999999999986543211100
Q ss_pred -c----ceeecccccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 232 -T----HVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 232 -~----~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 215 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 215 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcch
Confidence 0 01112346778999999876 4688999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=262.12 Aligned_cols=203 Identities=26% Similarity=0.399 Sum_probs=175.9
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+|++.+.||.|++|.||+|.+..+|..|++|++..... .....+..|+.+++.++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 58889999999999999999999999999999876542 2235688899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+ +++|.+++... ..++++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 89999998752 356899999999999999999999999 9999999999999999999999999987543322
Q ss_pred CcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
. .......++..|+|||.+.+. .++.++||||||+++|+|++|.+||...+.
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 206 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND 206 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH
Confidence 1 122335689999999988654 468999999999999999999988877654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=262.28 Aligned_cols=203 Identities=27% Similarity=0.368 Sum_probs=170.4
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHH-HhccCCCCccceeeEeecCCeeEEEEe
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLM-LSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.... .....+..|+.. ++.++||||+++++++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 478899999999999999999999999999999876532 223455666665 566789999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
|++ ++|.+++.........+++..++.++.|++.||.|||++ + ++||||||+||+++.++.++|+|||.+.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 788888865444456799999999999999999999987 8 99999999999999999999999999875322
Q ss_pred CCCcceeecccccccccCcccccc----CCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKT----GQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
. .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 1 11223457889999998865 45688999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=264.20 Aligned_cols=208 Identities=32% Similarity=0.491 Sum_probs=171.9
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCe--EEEEEEeccC-CccchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQ--DVAIKQLDRN-GVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 147 (297)
++|++.+.||+|+||.||+|..+.++. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999999887765 4688877642 222345688899999998 799999999999999999999
Q ss_pred EecCCCCChHhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCce
Q 022447 148 YEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~ 215 (297)
+||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999975321 1235889999999999999999999999 9999999999999999999
Q ss_pred EEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
+|+|||++...... ........+..|+|||.+.+..++.++|||||||++|+|++ |..||...+...
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~ 226 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE 226 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999998532111 11111223457999999988889999999999999999997 999998776544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=265.24 Aligned_cols=209 Identities=30% Similarity=0.433 Sum_probs=175.8
Q ss_pred hcCCCCcceecccCcEEEEEEEE-----CCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcc-CCCCccceeeEeecCCe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 143 (297)
.++|.+.+.||+|+||.||+|.+ ..++..||+|.+..... .....+.+|+.+++++ +||||+++++.+...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 35799999999999999999985 33467899999875432 2335688999999999 79999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
.+++|||+.+++|.+++.... ...+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999999997522 234899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhH
Q 022447 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAA 284 (297)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~ 284 (297)
................++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~ 250 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD 250 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch
Confidence 75433222112223346778999999988889999999999999999998 99999876544
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=258.59 Aligned_cols=207 Identities=26% Similarity=0.361 Sum_probs=178.5
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeec--CCeeEEEE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVY 148 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 148 (297)
+|++.+.||.|++|.||+|.+..++..+++|.+...... ..+++..|+.+++.++|+||+++++.+.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588899999999999999999999999999998754332 23567889999999999999999997754 45678999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH-----DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-----~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
||+++++|.+++........++++..++.++.||+.||.+|| +.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999765444577999999999999999999999 777 999999999999999999999999998
Q ss_pred cccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
....... .......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 216 (265)
T cd08217 158 KILGHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL 216 (265)
T ss_pred ccccCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH
Confidence 7643322 1123456899999999998888999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=258.68 Aligned_cols=207 Identities=33% Similarity=0.470 Sum_probs=173.4
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
..+|++.+.||+|++|.||+|.+..+ ..|++|.+..... ....+.+|+.+++.++||||+++++.+.+ ...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 35799999999999999999998765 4599999875433 33568889999999999999999998754 567899999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++.... ...+++..+..++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999997532 345789999999999999999999999 9999999999999999999999999987543222
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
.. ......++..|+|||...+..++.++|+||||+++|+|++ |..||........
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~ 212 (262)
T cd05071 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 212 (262)
T ss_pred cc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH
Confidence 11 1123346678999999988889999999999999999999 8899987765443
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=260.07 Aligned_cols=204 Identities=27% Similarity=0.432 Sum_probs=174.0
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc----------chHHHHHHHHHHhccCCCCccceeeEeecCC
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ----------GNREFLVEVLMLSLLHHPNLVNLIGYCADGD 142 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 142 (297)
+|.+.+.||.|++|.||+|.+..+++.|++|.+...... ..+.+..|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 577889999999999999999999999999987532111 1135678999999999999999999999999
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
..++||||+++++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999986 467899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ--LTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 223 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
+................++..|+|||.+.... ++.++|+||||+++|+|++|..||...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 217 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA 217 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch
Confidence 87532221112223445889999999887654 78999999999999999999999976544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=264.02 Aligned_cols=216 Identities=27% Similarity=0.398 Sum_probs=178.1
Q ss_pred HhcCCCCcceecccCcEEEEEEEEC-------CCCeEEEEEEeccCC-ccchHHHHHHHHHHhcc-CCCCccceeeEeec
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLE-------SINQDVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD 140 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 140 (297)
...+|.+.+.||+|+||.||+|.+. .++..|++|.+.... .....++.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 4567889999999999999999752 235679999886542 23346788999999999 79999999999999
Q ss_pred CCeeEEEEecCCCCChHhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEE
Q 022447 141 GDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 208 (297)
Q Consensus 141 ~~~~~lv~e~~~g~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nil 208 (297)
....+++|||+++++|.+++..... ....+++..+..++.|++.||.|||+.+ ++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 9999999999999999999976321 1245788899999999999999999999 999999999999
Q ss_pred EcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhh
Q 022447 209 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQ 287 (297)
Q Consensus 209 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~ 287 (297)
++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 99999999999999875433222222223345678999999988889999999999999999998 88999877665543
Q ss_pred h
Q 022447 288 S 288 (297)
Q Consensus 288 ~ 288 (297)
.
T Consensus 250 ~ 250 (304)
T cd05101 250 K 250 (304)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=263.24 Aligned_cols=211 Identities=30% Similarity=0.453 Sum_probs=177.5
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCC----------------eEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccc
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESIN----------------QDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVN 133 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~----------------~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~ 133 (297)
.++|++.+.||+|+||.||+|.+...+ ..|++|.+...... ....+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 468999999999999999999876543 56899998765332 3456888999999999999999
Q ss_pred eeeEeecCCeeEEEEecCCCCChHhhhcccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 022447 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 206 (297)
Q Consensus 134 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~N 206 (297)
+++++......+++||++.+++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999976331 1236899999999999999999999999 9999999999
Q ss_pred EEEcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh--CCCCCCcchhH
Q 022447 207 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS--GRKAVDTSKAA 284 (297)
Q Consensus 207 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~Pf~~~~~~ 284 (297)
|+++.++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999875433322223334456788999999988889999999999999999998 77899876543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=263.88 Aligned_cols=203 Identities=29% Similarity=0.353 Sum_probs=173.7
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-----chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-----GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
+|++.+.||+|++|.||+|.+..++..|++|.+...... ....+..|+.+++.++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999999999999999999765433 234567899999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||+ +++|.+++... ...+++..++.++.||++||.|||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 89999999762 137999999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
... .......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+..
T Consensus 154 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~ 209 (298)
T cd07841 154 SPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI 209 (298)
T ss_pred CCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH
Confidence 221 12223346788999998754 46789999999999999999998888876643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=276.69 Aligned_cols=211 Identities=34% Similarity=0.498 Sum_probs=179.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCe---E-EEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecCCe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQ---D-VAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~---~-vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 143 (297)
+++..+.+.||+|+||.||+|..+..+. . ||+|...... .....++++|+.++++++||||+++||+......
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3556677999999999999999865422 3 8999887522 3344679999999999999999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
+++|||+|+||+|.+++... ...++..+...++.+.+.||+|||+++ ++||||..+|+|+..++.+||+|||++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred cEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccc
Confidence 99999999999999999972 236999999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCcceee-cccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHH
Q 022447 224 KLGPVGDNTHVST-RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 224 ~~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~ 290 (297)
+... ...... ...-..+|+|||.+....|++++||||+||++||+++ |..||.+....+...-+
T Consensus 310 ~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI 375 (474)
T KOG0194|consen 310 RAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI 375 (474)
T ss_pred cCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH
Confidence 7532 111111 1135679999999999999999999999999999999 88999999877665544
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=260.42 Aligned_cols=209 Identities=32% Similarity=0.488 Sum_probs=175.9
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCe----EEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQ----DVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~----~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
..+|++.+.||+|+||.||+|.++.+|. .+++|.+...... ....+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3578899999999999999999876654 5899988765432 33568889999999999999999999887 7889
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
++|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+..
T Consensus 85 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999999762 345899999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
..............++..|+|||.+....++.++|+||||+++||+++ |+.||...+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 220 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI 220 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 443222222222224568999999988889999999999999999998 9999988765543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=257.77 Aligned_cols=206 Identities=29% Similarity=0.435 Sum_probs=174.3
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|++.+.||+|++|.||+|.+.. +..+|+|.+..... ....+.+|+.+++.++||||+++++++......+++|||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 3568889999999999999998764 45699999875433 346788999999999999999999999998899999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+.+++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 81 MSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 9999999998752 236899999999999999999999999 9999999999999999999999999987532221
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
. .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......
T Consensus 155 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~ 209 (256)
T cd05113 155 Y-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE 209 (256)
T ss_pred e-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence 1 11112335678999999988889999999999999999998 999998766543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=263.37 Aligned_cols=201 Identities=29% Similarity=0.434 Sum_probs=175.1
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
.|+..+.||+|++|.||+|.+..++..||+|.+..... .....+..|+.+++.++||||+++++.+......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 46667789999999999999999999999999875432 23356888999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
++++|.+++.. ..+++..++.++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-- 154 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT-- 154 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCc--
Confidence 99999998864 56889999999999999999999999 999999999999999999999999998653222
Q ss_pred cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
........++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 206 (277)
T cd06642 155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP 206 (277)
T ss_pred chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch
Confidence 1122234578899999999988899999999999999999999999976543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=260.38 Aligned_cols=208 Identities=32% Similarity=0.410 Sum_probs=176.3
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcc-CCCCccceeeEeecCC------
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD------ 142 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------ 142 (297)
..++|++.+.||+|++|.||+|.++.++..+++|++..... ....+..|+.+++.+ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 45789999999999999999999998999999999876533 345688899999998 6999999999987544
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
.++++|||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999998764433567899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 223 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
+...... ........++..|+|||.+.. ..++.++||||||+++|+|++|+.||...+.
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 223 (275)
T cd06608 160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223 (275)
T ss_pred ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch
Confidence 8653221 222334568899999998753 3467889999999999999999999986543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=260.17 Aligned_cols=208 Identities=27% Similarity=0.450 Sum_probs=174.2
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCe---EEEEEEeccCC-ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
.+|++.+.||+|+||.||+|.+..++. .|++|.+.... ......+..|+.+++.++||||+++++++.+....+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 468889999999999999999887664 69999987542 22345788999999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999998752 356889999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCcceeeccc---ccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 228 VGDNTHVSTRVM---GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 228 ~~~~~~~~~~~~---g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
............ .+..|+|||.+.+..++.++||||||+++||+++ |..||...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~ 219 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 219 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH
Confidence 222111111111 2457999999998899999999999999999886 999998765543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=260.54 Aligned_cols=205 Identities=40% Similarity=0.603 Sum_probs=171.9
Q ss_pred CcceecccCcEEEEEEEEC----CCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 76 SESLLGEGGFGRVYKGYLE----SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 76 ~~~~lg~G~~g~v~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+.+.||.|+||.||+|... ..+..|+||.++..... ..+.+.+|+..+++++||||+++++++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999998 45688999999654332 357899999999999999999999999988889999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++... ....+++..++.|+.|++.||.|||+.+ ++|++|+++||+++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 9999999999983 1467899999999999999999999999 9999999999999999999999999987642222
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
.............|+|||.+.+..++.++||||||+++||+++ |+.||...+...
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~ 213 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE 213 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2233334457789999999998889999999999999999999 789998876554
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=261.25 Aligned_cols=215 Identities=29% Similarity=0.399 Sum_probs=177.9
Q ss_pred CHHHHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcc-CCCCccceeeEeec-
Q 022447 63 TFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD- 140 (297)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~- 140 (297)
++.++......|++.+.||.|+||.||+|.+..+++.+++|++.... .....+..|+.+++.+ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34444456678999999999999999999999999999999986543 2335677888888888 69999999999853
Q ss_pred -----CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCce
Q 022447 141 -----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (297)
Q Consensus 141 -----~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~ 215 (297)
...++++|||+.+++|.+++.... ...+++..++.++.|++.|+.|||+.+ ++|+||+|+||++++++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 457899999999999999997633 345888899999999999999999999 9999999999999999999
Q ss_pred EEecccCccccCCCCCcceeecccccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
+|+|||++...... ........|++.|+|||.+. +..++.++|+|||||++|+|++|..||.......
T Consensus 161 ~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~ 233 (282)
T cd06636 161 KLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233 (282)
T ss_pred EEeeCcchhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence 99999998643211 11223456899999999875 3467889999999999999999999997765433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=263.82 Aligned_cols=209 Identities=29% Similarity=0.460 Sum_probs=172.9
Q ss_pred cCCCCcceecccCcEEEEEEEECC----------------CCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccce
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLES----------------INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNL 134 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~----------------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~ 134 (297)
++|++.+.||+|+||.||++.+.. ++..+|+|.+...... ....+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 579999999999999999986432 3457899998754322 33578899999999999999999
Q ss_pred eeEeecCCeeEEEEecCCCCChHhhhcccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcE
Q 022447 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG-------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 207 (297)
Q Consensus 135 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Ni 207 (297)
++++...+..+++|||+++++|.+++...... ...+++..+..++.|++.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 99999999999999999999999998763211 134778899999999999999999999 99999999999
Q ss_pred EEcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh--CCCCCCcchh
Q 022447 208 LLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS--GRKAVDTSKA 283 (297)
Q Consensus 208 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~Pf~~~~~ 283 (297)
+++.++.++|+|||++................++..|++||...+..++.++|+|||||++|||++ |..||...+.
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999875322222122223345678999998888889999999999999999998 7799976654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=259.75 Aligned_cols=204 Identities=27% Similarity=0.419 Sum_probs=176.4
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccC---CCCccceeeEeecCCeeEEEE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~ 148 (297)
.|++.+.||.|+||.||+|.+..++..|++|.+..... .....+.+|+.+++.++ |||++++++++.+...++++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 57888999999999999999999999999999875432 33456788999999886 999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||++|++|.+++.. ..+++..++.++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999999864 37899999999999999999999999 99999999999999999999999999876433
Q ss_pred CCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
.. .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+....
T Consensus 154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~ 210 (277)
T cd06917 154 NS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA 210 (277)
T ss_pred Cc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh
Confidence 22 22334568899999998764 4578999999999999999999999987765443
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=259.70 Aligned_cols=203 Identities=25% Similarity=0.376 Sum_probs=177.1
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCC
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 152 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 152 (297)
+|...+.||.|++|.||++.+..++..+++|++........+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 45566799999999999999999999999999875544445668889999999999999999999999999999999999
Q ss_pred CCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCc
Q 022447 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232 (297)
Q Consensus 153 g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 232 (297)
|++|.+++.. .++++..+..++.|++.|+++||+.+ ++||||+|+||+++.++.++|+|||.+...... .
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~ 169 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--V 169 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccC--C
Confidence 9999999875 45889999999999999999999999 999999999999999999999999987643221 1
Q ss_pred ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+...
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~ 222 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ 222 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH
Confidence 12233568899999999988889999999999999999999999998765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=257.18 Aligned_cols=204 Identities=28% Similarity=0.438 Sum_probs=174.6
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
+|++.+.||.|+||.||+|.+. ++..+|+|.+...... ....+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5788999999999999999874 6889999988643221 12457789999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
++||++|++|.+++.. ..++++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||.+...
T Consensus 80 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 80 FMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999976 456889999999999999999999999 999999999999999999999999988653
Q ss_pred CCC----CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 227 PVG----DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 227 ~~~----~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
... ..........++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 214 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL 214 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH
Confidence 211 1111223356889999999999888999999999999999999999999876543
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=263.99 Aligned_cols=209 Identities=28% Similarity=0.444 Sum_probs=173.0
Q ss_pred cCCCCcceecccCcEEEEEEEECCC--------------CeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceee
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESI--------------NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIG 136 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~--------------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~ 136 (297)
++|++.+.||+|+||.||+|.+..+ ...||+|.+...... ....+.+|+.+++.++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5899999999999999999987543 235899998754322 2356888999999999999999999
Q ss_pred EeecCCeeEEEEecCCCCChHhhhcccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEE
Q 022447 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSP--------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 208 (297)
Q Consensus 137 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nil 208 (297)
++......++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999864211 1124688899999999999999999999 999999999999
Q ss_pred EcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh--CCCCCCcchh
Q 022447 209 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS--GRKAVDTSKA 283 (297)
Q Consensus 209 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~Pf~~~~~ 283 (297)
++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+.
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 99999999999999875433222222223345778999999988889999999999999999988 6789887554
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=257.27 Aligned_cols=208 Identities=29% Similarity=0.435 Sum_probs=179.7
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
++|++.+.||.|++|.||+|.+..++..+++|++..... .....+.+|+.+++.++|+||+++++.+......+++||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 478999999999999999999998999999999875432 2446788999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++..... ...+++..++.++.|++.|+.+||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976321 246899999999999999999999999 9999999999999999999999999986543322
Q ss_pred Ccc--eeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 231 NTH--VSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 231 ~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
... ......|+..|+|||.+... .++.++|+||||+++|+|++|+.||...+.
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~ 212 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh
Confidence 221 22344688999999988776 789999999999999999999999987654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=260.69 Aligned_cols=215 Identities=25% Similarity=0.388 Sum_probs=178.2
Q ss_pred HhcCCCCcceecccCcEEEEEEEECC----CCeEEEEEEeccCC-ccchHHHHHHHHHHhccCCCCccceeeEeec-CCe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLES----INQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQ 143 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 143 (297)
..++|.+.+.||+|+||.||+|.+.. ++..|++|.+.... ......+.+|+.+++.++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999999876 35889999886442 2234567889999999999999999998765 567
Q ss_pred eEEEEecCCCCChHhhhcccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEec
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPG----KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 219 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~D 219 (297)
.++++||+.+++|.+++...... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 88999999999999998764322 156899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhh
Q 022447 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQ 287 (297)
Q Consensus 220 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~ 287 (297)
||+++...............++..|+|||.+.+..++.++||||||+++|++++ |+.||...+..+..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 229 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH
Confidence 999875433222222223346678999999988889999999999999999999 99999877654443
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=258.31 Aligned_cols=209 Identities=29% Similarity=0.408 Sum_probs=169.5
Q ss_pred CCCcceecccCcEEEEEEEECCCCe--EEEEEEeccCC--ccchHHHHHHHHHHhccCCCCccceeeEeecC------Ce
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQ--DVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQ 143 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 143 (297)
|.+.+.||+|+||.||+|.+..++. .+|+|.++... ......+..|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999999999887665 68999886542 22345678899999999999999999976432 24
Q ss_pred eEEEEecCCCCChHhhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg 221 (297)
.+++|||+.+++|.+++.... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874321 12345889999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
++................+++.|++||...+..++.++||||||+++|+|++ |+.||...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 222 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9875432221111222346778999999998999999999999999999999 889998765543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=286.91 Aligned_cols=215 Identities=33% Similarity=0.503 Sum_probs=187.2
Q ss_pred cCCCCcceecccCcEEEEEEEEC-----CCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
.+....+.||+|+||+||+|.-. .....||||.++..... ...+|.+|++++..++|||||++++++.+.+..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 45567789999999999999853 33567999999876555 5678999999999999999999999999999999
Q ss_pred EEEecCCCCChHhhhcccCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCce
Q 022447 146 LVYEYMPLGSVEDHLHDLSPG----------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~----------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~ 215 (297)
+|+|||..|+|.+++...... ..+++..+.+.|+.||+.+++||-++. +|||||..+|.||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 999999999999999865321 234889999999999999999999999 9999999999999999999
Q ss_pred EEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhH
Q 022447 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (297)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l 289 (297)
||+|||+++.....+.........-..+|||||.+..+.++.++||||+||+|||+++ |+-||.+.+..+--..
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 9999999987655555555445556789999999999999999999999999999999 9999998877665443
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=263.10 Aligned_cols=203 Identities=29% Similarity=0.382 Sum_probs=174.7
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
++|++.+.||+|++|.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4688999999999999999999989999999998654322 23567789999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+++++|..+... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999888887764 455899999999999999999999999 999999999999999999999999998753222
Q ss_pred CCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
. .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.
T Consensus 154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~ 206 (286)
T cd07846 154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD 206 (286)
T ss_pred c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch
Confidence 2 22233567889999998865 4567899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=255.84 Aligned_cols=207 Identities=23% Similarity=0.351 Sum_probs=179.1
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+|++.+.||+|+||.+|++.+..++..|++|.+.... ......+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999999999999999986542 22335788899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+.+++|.+++.... ...+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~- 154 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST- 154 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcc-
Confidence 99999999987522 345789999999999999999999999 999999999999999999999999998753221
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
........|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+.
T Consensus 155 -~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~ 209 (256)
T cd08218 155 -VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL 209 (256)
T ss_pred -hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH
Confidence 1122234588899999999888899999999999999999999999987765443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=255.16 Aligned_cols=205 Identities=34% Similarity=0.547 Sum_probs=170.3
Q ss_pred ceecccCcEEEEEEEECCCC---eEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYLESIN---QDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~---~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.||+|+||.||+|.+..++ ..+++|.+...... ....+..|+.+++.+.|+||+++++++. .+..+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999876554 78999998765442 3456888999999999999999999876 4567999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|.+++.. ...+++..++.++.|++.|+.+||+.+ ++|+||||+||+++.++.++|+|||.+..........
T Consensus 80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999986 447899999999999999999999999 9999999999999999999999999987543322211
Q ss_pred e-eecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHH
Q 022447 234 V-STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 234 ~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~ 290 (297)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~ 211 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML 211 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 1 111223467999999988899999999999999999998 99999887765544433
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=257.62 Aligned_cols=201 Identities=25% Similarity=0.343 Sum_probs=170.6
Q ss_pred HHHHHHhcCCCCccee--cccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcc-CCCCccceeeEeecC
Q 022447 65 RELAAATKNFRSESLL--GEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 141 (297)
Q Consensus 65 ~~~~~~~~~y~~~~~l--g~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 141 (297)
.+.....++|++.+.+ |+|+||.||++.++.++..+++|.+........ |+.....+ +||||+++++.+...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 3445556788888877 999999999999999999999999875433221 22222222 699999999999999
Q ss_pred CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC-ceEEecc
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDF 220 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~-~~kl~Df 220 (297)
+..++||||+++++|.+++.. ..++++..++.++.|++.||.+||+.+ ++||||+|+||+++.++ .++|+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecC
Confidence 999999999999999999986 458999999999999999999999999 99999999999999988 9999999
Q ss_pred cCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
|++..... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....
T Consensus 155 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 211 (267)
T PHA03390 155 GLCKIIGT------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211 (267)
T ss_pred ccceecCC------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc
Confidence 99875321 1234588999999999988899999999999999999999999986543
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=264.78 Aligned_cols=208 Identities=24% Similarity=0.315 Sum_probs=174.0
Q ss_pred CCCCcceecccCcEEEEEEEECC--CCeEEEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecC--CeeE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLES--INQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRL 145 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 145 (297)
+|++.+.||+|++|.||+|.+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47889999999999999999988 89999999987633 23335678899999999999999999999988 8899
Q ss_pred EEEecCCCCChHhhhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC----CCceEEecc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPG-KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR----GYHPKLSDF 220 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~----~~~~kl~Df 220 (297)
+||||++ ++|.+++...... ...+++..++.++.|++.||.|||+.+ ++||||+|+||+++. ++.++|+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999997 5777777543322 247899999999999999999999999 999999999999999 899999999
Q ss_pred cCccccCCCCC-cceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 221 GLAKLGPVGDN-THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 221 g~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
|++........ ........++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence 99875432221 112234467889999998765 45789999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=257.56 Aligned_cols=204 Identities=26% Similarity=0.372 Sum_probs=163.2
Q ss_pred eecccCcEEEEEEEECC--CCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCC
Q 022447 79 LLGEGGFGRVYKGYLES--INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 155 (297)
Q Consensus 79 ~lg~G~~g~v~~~~~~~--~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~ 155 (297)
.||+|+||.||+|.... ....+++|.+...... ....+.+|+.+++.++|+||+++++.+......++||||+++++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999996532 3567888887644322 23457889999999999999999999999999999999999999
Q ss_pred hHhhhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcce
Q 022447 156 VEDHLHDLSPG-KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 234 (297)
Q Consensus 156 L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 234 (297)
|.+++...... ....++..+..++.||+.||+|||+++ ++||||||+|||++.++.++|+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999764321 233467788999999999999999999 99999999999999999999999999864322211111
Q ss_pred eecccccccccCcccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 235 STRVMGTYGYCAPEYAKT-------GQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 235 ~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
.....++..|+|||++.. ..++.++|||||||++|+|++ |..||......+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ 217 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH
Confidence 223345678999998643 356789999999999999999 789998765443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=260.97 Aligned_cols=206 Identities=26% Similarity=0.311 Sum_probs=177.2
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
++|++.+.||+|++|.||+|.+..+++.|++|.+..... .....+.+|+.+++.++|+||+++++.+...+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 368899999999999999999999999999999875432 233678899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|++++.+..+... ...+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9997666665544 456899999999999999999999999 999999999999999999999999998764332
Q ss_pred CCcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.. .......++..|+|||++.+. .++.++|+||||+++|+|++|+.||...+..+
T Consensus 154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~ 209 (288)
T cd07833 154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID 209 (288)
T ss_pred cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 21 122345678899999999887 88999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=263.00 Aligned_cols=214 Identities=28% Similarity=0.421 Sum_probs=175.1
Q ss_pred hcCCCCcceecccCcEEEEEEEEC-------CCCeEEEEEEeccCCc-cchHHHHHHHHHHhcc-CCCCccceeeEeecC
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLE-------SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 141 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 141 (297)
..+|.+.+.||+|+||.||+|.+. .....+++|.+..... .....+..|+.+++.+ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357889999999999999999863 2356799998875432 2335678899999998 699999999999998
Q ss_pred CeeEEEEecCCCCChHhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili 209 (297)
...+++|||+++++|.+++..... ....+++..+..++.|++.||.|||+.+ ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 999999999999999999976321 1245888999999999999999999999 9999999999999
Q ss_pred cCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhh
Q 022447 210 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQ 287 (297)
Q Consensus 210 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~ 287 (297)
+.++.++|+|||.++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999975332221111122234567999999988889999999999999999999 89999887654433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=257.82 Aligned_cols=208 Identities=29% Similarity=0.452 Sum_probs=174.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCC---eEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESIN---QDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~---~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
..+|++.+.||+|+||.||+|.+..++ ..+++|.+...... ....+..|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357889999999999999999986544 47999998654322 23568889999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
+|||+++++|.+++... ...+++.+++.++.|++.|+.+||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 99999999999999752 346899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCcce-eecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhH
Q 022447 227 PVGDNTHV-STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAA 284 (297)
Q Consensus 227 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~ 284 (297)
........ .....++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~ 216 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ 216 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH
Confidence 33221111 111223568999999998889999999999999999887 99999876554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=262.13 Aligned_cols=202 Identities=27% Similarity=0.382 Sum_probs=177.5
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.++|++.+.||+|++|.||++.+..++..|++|++..... .....+.+|+.+++.++||||+++++.+.....+++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 3578889999999999999999999999999998865432 234678899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
|+++++|.+++.. ..++++..+..++.+++.+|.|||+ .+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 9999999999876 4578999999999999999999997 57 99999999999999999999999998764211
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
. ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.....
T Consensus 157 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 157 S----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred h----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 1 12235689999999999888899999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=255.57 Aligned_cols=210 Identities=32% Similarity=0.490 Sum_probs=174.7
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|++.+.||+|++|.||+|.+.. +..+++|.+..... ....+.+|+.+++.++|++++++++++.. ...+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence 4578999999999999999998764 66799999875433 34568899999999999999999998754 567899999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999997522 345889999999999999999999999 9999999999999999999999999987533221
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhH
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l 289 (297)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~ 215 (260)
T cd05070 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ 215 (260)
T ss_pred cc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 11 1122235567999999988889999999999999999999 8999988766554443
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=260.98 Aligned_cols=205 Identities=24% Similarity=0.354 Sum_probs=176.7
Q ss_pred CcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCC
Q 022447 76 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 155 (297)
Q Consensus 76 ~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~ 155 (297)
....||+|++|.||++.+..++..|++|++..........+.+|+.+++.++|+||+++++.+...+..+++|||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 34679999999999999999999999999865544455678889999999999999999999999999999999999999
Q ss_pred hHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCccee
Q 022447 156 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235 (297)
Q Consensus 156 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 235 (297)
|.+++.. ..+++..++.++.|++.+++|||+.+ ++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus 104 L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--~~~~ 173 (292)
T cd06657 104 LTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRR 173 (292)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccc--cccc
Confidence 9998754 45889999999999999999999999 999999999999999999999999987653221 1122
Q ss_pred ecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHH
Q 022447 236 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 236 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~ 290 (297)
....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~ 228 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 3356889999999998888899999999999999999999999877655443333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=242.14 Aligned_cols=212 Identities=25% Similarity=0.304 Sum_probs=180.3
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccC-CccchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEEEe
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN-GVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
++..-...||+|++|.|-+.++..+|...|+|.+... ..++.+++++|+.+.... .+|++|.+|+.+.+....|+.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 3444566799999999999999999999999998754 334456788899887665 68999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
.|+ .+|..+..+....+..++|..+-+|+..++.|+.|||++-. ++|||+||+||||+.+|++|+||||.+-.+...
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 998 78888887766668889999999999999999999998654 999999999999999999999999998653222
Q ss_pred CCcceeecccccccccCcccccc----CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKT----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
...+...|...|||||.+.. ..|+.++||||||+++.||.++++||+.+..+.+|--
T Consensus 203 ---iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLk 263 (282)
T KOG0984|consen 203 ---IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLK 263 (282)
T ss_pred ---hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHH
Confidence 12233568899999998743 4789999999999999999999999999988877653
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=254.29 Aligned_cols=204 Identities=29% Similarity=0.445 Sum_probs=167.6
Q ss_pred eecccCcEEEEEEEEC--CCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCC
Q 022447 79 LLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 155 (297)
Q Consensus 79 ~lg~G~~g~v~~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~ 155 (297)
.||+|+||.||+|.+. ..+..||+|++...... ....+.+|+.+++.++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999875 44667999998755332 23568899999999999999999998754 57899999999999
Q ss_pred hHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcce-
Q 022447 156 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV- 234 (297)
Q Consensus 156 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~- 234 (297)
|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99998742 356899999999999999999999999 99999999999999999999999999875332222111
Q ss_pred eecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhH
Q 022447 235 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (297)
Q Consensus 235 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l 289 (297)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 210 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF 210 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence 111223578999999988889999999999999999996 9999988766554443
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=253.99 Aligned_cols=205 Identities=28% Similarity=0.418 Sum_probs=177.6
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+|++.+.||+|++|.||+|.+..++..+++|.+..... .....+.+|+.+++.++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 58889999999999999999999999999999876533 2345688899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC-CceEEecccCccccCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~ 229 (297)
+++++|.+++.... ...+++..++.++.|++.++.|||+++ ++|+||+|+||+++++ +.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997632 345899999999999999999999999 9999999999999855 46899999998754322
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+...
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~ 208 (256)
T cd08220 156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA 208 (256)
T ss_pred c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH
Confidence 1 2223568889999999988888999999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=257.65 Aligned_cols=209 Identities=27% Similarity=0.448 Sum_probs=174.7
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCe---EEEEEEeccCC-ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
.++|+..+.||+|++|.||+|.+..++. .+++|.+.... ......+..|+.+++.++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3578888999999999999999876554 79999886543 2234568889999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
+|||+++++|.+++... ...+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence 99999999999999752 356899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCccee-ecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 227 PVGDNTHVS-TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 227 ~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
......... .....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~ 218 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH
Confidence 322211111 11223457999999988889999999999999999998 999997765544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=257.30 Aligned_cols=203 Identities=29% Similarity=0.413 Sum_probs=176.5
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
-|++.+.||.|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 477888999999999999999999999999998654322 2356788999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
++++|.+++.. ..+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence 99999999864 46889999999999999999999999 9999999999999999999999999986533221
Q ss_pred cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||...+...
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 208 (277)
T cd06641 156 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK 208 (277)
T ss_pred -hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH
Confidence 12233467889999999988888999999999999999999999998765443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=260.32 Aligned_cols=215 Identities=30% Similarity=0.461 Sum_probs=177.7
Q ss_pred hcCCCCcceecccCcEEEEEEEEC-----CCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 144 (297)
.++|++.+.||+|+||.||+|.+. .++..|++|.+...... ....+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467999999999999999999874 36789999998754332 235688899999999999999999999999999
Q ss_pred EEEEecCCCCChHhhhcccCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSP------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 206 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~N 206 (297)
+++|||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++||||+|+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999975321 1235788899999999999999999999 9999999999
Q ss_pred EEEcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 207 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 207 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
|+++.++.++|+|||.+.................+..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+..+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999864322221111222335667999999988899999999999999999998 888997765554
Q ss_pred hhh
Q 022447 286 EQS 288 (297)
Q Consensus 286 ~~~ 288 (297)
...
T Consensus 241 ~~~ 243 (288)
T cd05050 241 VIY 243 (288)
T ss_pred HHH
Confidence 433
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=262.81 Aligned_cols=213 Identities=31% Similarity=0.494 Sum_probs=174.7
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCe----EEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQ----DVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~----~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
.++|+..+.||+|+||.||+|.+..++. .+++|.+...... ....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 3578889999999999999999877775 4688887654322 224678899999999999999999998764 467
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+++||+++|+|.+++... ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence 899999999999998752 346889999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHH
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~ 290 (297)
..............++..|+|||.+.+..++.++||||||+++|||++ |..||.+........++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~ 224 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 433222222223345678999999988899999999999999999998 99999876555444433
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=255.14 Aligned_cols=203 Identities=29% Similarity=0.435 Sum_probs=177.4
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+|.+.+.||+|++|.||+|.+..++..|++|.+...... ....+..|+.+++.++|+||+++++.+...+.+++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588899999999999999999989999999998766443 456788999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++.. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999986 456889999999999999999999999 9999999999999999999999999987543322
Q ss_pred Ccce--eecccccccccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 231 NTHV--STRVMGTYGYCAPEYAKTGQ---LTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 231 ~~~~--~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
.... .....++..|+|||.+.+.. ++.++||||||+++|++++|+.||...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 2111 12345788999999987766 8899999999999999999999997654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=256.70 Aligned_cols=206 Identities=27% Similarity=0.375 Sum_probs=166.6
Q ss_pred ceecccCcEEEEEEEEC--CCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCC
Q 022447 78 SLLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 154 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~ 154 (297)
+.||+|+||.||+|... .++..+++|.+...... ....+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 35899999999999864 34678999988755432 2346788999999999999999999999989999999999999
Q ss_pred ChHhhhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 155 SVEDHLHDLSP-GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 155 ~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
+|.+++..... .....++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975322 1234667788899999999999999999 9999999999999999999999999986432222111
Q ss_pred eeecccccccccCccccccC-------CCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 234 VSTRVMGTYGYCAPEYAKTG-------QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~-------~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
......++..|+|||++.+. .++.++|+||||+++|||++ |+.||...+..+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 218 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV 218 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH
Confidence 22234577889999988642 35789999999999999996 9999987655443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=258.73 Aligned_cols=194 Identities=30% Similarity=0.412 Sum_probs=162.3
Q ss_pred eecccCcEEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHh---ccCCCCccceeeEeecCCeeEEEEecCC
Q 022447 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLS---LLHHPNLVNLIGYCADGDQRLLVYEYMP 152 (297)
Q Consensus 79 ~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~---~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 152 (297)
.||+|+||.||++.+..++..+|+|.+....... ......|..+++ ..+||+|+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999986543221 122334443333 3479999999999999999999999999
Q ss_pred CCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCc
Q 022447 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232 (297)
Q Consensus 153 g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 232 (297)
+++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--- 150 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc---
Confidence 9999999876 567999999999999999999999999 999999999999999999999999998643221
Q ss_pred ceeecccccccccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 233 HVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
......|+..|+|||.+. +..++.++|+||+||++|+|++|..||.....
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 201 (279)
T cd05633 151 -KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (279)
T ss_pred -CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence 122346899999999886 45688999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=257.12 Aligned_cols=205 Identities=26% Similarity=0.382 Sum_probs=174.0
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..+++.....||+|+||.||+|.+..++..|++|.+..........+.+|+.+++.++|+||+++++++...+..++++|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 34455566789999999999999999999999999877665566778899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC-CCceEEecccCcccc
Q 022447 150 YMPLGSVEDHLHDLSPGKKPL--DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLG 226 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~-~~~~kl~Dfg~~~~~ 226 (297)
|+++++|.+++... ..++ ++..+..++.|++.||.|||+.+ ++||||+|+||+++. ++.++|+|||.+...
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 86 QVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred cCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 99999999999752 1334 78889999999999999999999 999999999999976 679999999998653
Q ss_pred CCCCCcceeecccccccccCccccccC--CCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTG--QLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
.... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||....
T Consensus 160 ~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 160 AGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred ccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 2211 122234588999999988654 37889999999999999999999997653
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=271.15 Aligned_cols=211 Identities=29% Similarity=0.429 Sum_probs=174.2
Q ss_pred hcCCCCcceecccCcEEEEEEEEC-----CCCeEEEEEEeccCCcc-chHHHHHHHHHHhccC-CCCccceeeEeecCCe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 143 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 143 (297)
.++|.+.+.||+|+||.||+|++. .++..||+|++...... ....+..|+.++..+. ||||+++++++...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 356888899999999999999964 34678999999754322 2346888999999997 9999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCC----------------------------------------------------------
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSP---------------------------------------------------------- 165 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~---------------------------------------------------------- 165 (297)
.++||||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999964311
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE
Q 022447 166 ------------------------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (297)
Q Consensus 166 ------------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili 209 (297)
....+++..++.++.||+.||.|||+.+ ++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 1134677888999999999999999999 9999999999999
Q ss_pred cCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhH
Q 022447 210 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAA 284 (297)
Q Consensus 210 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~ 284 (297)
+.++.++|+|||++................+++.|+|||.+.+..++.++|+||||+++|||++ |..||......
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 9999999999999875322221112223457788999999988889999999999999999998 89999765443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=253.24 Aligned_cols=206 Identities=36% Similarity=0.544 Sum_probs=175.6
Q ss_pred CCCcceecccCcEEEEEEEECCCC----eEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 74 FRSESLLGEGGFGRVYKGYLESIN----QDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
+++.+.||.|+||.||++.+..++ ..|++|.+...... ....+..|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 457789999999999999998766 89999999765443 4567889999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
|++++++|.+++.... ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999997622 112899999999999999999999999 99999999999999999999999999876433
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
...... ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+...
T Consensus 156 ~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~ 212 (258)
T smart00219 156 DDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE 212 (258)
T ss_pred cccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 321111 12236789999999988889999999999999999998 889998765544
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=259.53 Aligned_cols=203 Identities=33% Similarity=0.490 Sum_probs=169.4
Q ss_pred cCC-CCcceecccCcEEEEEEE----ECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecC--Ce
Q 022447 72 KNF-RSESLLGEGGFGRVYKGY----LESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQ 143 (297)
Q Consensus 72 ~~y-~~~~~lg~G~~g~v~~~~----~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 143 (297)
++| .+.+.||+|+||.||++. ...++..||+|.+..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 889999999999998865 345688999999876432 2345678899999999999999999987653 46
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
.+++|||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccc
Confidence 7899999999999999975 45899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCcce-eecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 224 KLGPVGDNTHV-STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 224 ~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
........... .....++..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 214 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPP 214 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCc
Confidence 75433221111 122335667999999988889999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=255.09 Aligned_cols=208 Identities=33% Similarity=0.510 Sum_probs=177.1
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..++|++.+.||+|++|.||+|.+.. +..+++|.+..... ...++..|+.+++.++|+||+++++++......+++||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 35689999999999999999999864 57799999875433 34678899999999999999999999999889999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+++++|.+++.... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 82 YMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred ccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999999997632 346899999999999999999999999 999999999999999999999999998753321
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
. ........++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+...
T Consensus 157 ~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 212 (261)
T cd05034 157 E-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE 212 (261)
T ss_pred h-hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 1 111122234568999999998889999999999999999998 999998766543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=263.59 Aligned_cols=199 Identities=24% Similarity=0.354 Sum_probs=161.5
Q ss_pred ceecccCcEEEEEEEECC--CCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeec--CCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYLES--INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~g 153 (297)
..||+|+||.||+|.+.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. +...+++|||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 579999999999999754 568899999875432 3457789999999999999999998853 567889999987
Q ss_pred CChHhhhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE----cCCCceEEecccCcc
Q 022447 154 GSVEDHLHDLS-----PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL----DRGYHPKLSDFGLAK 224 (297)
Q Consensus 154 ~~L~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili----~~~~~~kl~Dfg~~~ 224 (297)
++|.+++.... .....+++..++.++.||+.||.|||+.+ ++||||||+|||+ +.++.++|+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 57887775321 11235889999999999999999999999 9999999999999 456789999999997
Q ss_pred ccCCCCCc-ceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 225 LGPVGDNT-HVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 225 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
........ .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 54322111 12234568999999998876 457899999999999999999999997644
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=257.93 Aligned_cols=208 Identities=29% Similarity=0.418 Sum_probs=181.1
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..+.|++.+.||+|++|.||+|.+..++..+++|++..... ....+..|+.+++.++|+|++++++.+......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 34568888999999999999999998899999999976544 45678889999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|++|++|.+++.... ..+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999998721 37999999999999999999999999 999999999999999999999999987643222
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
........+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+....
T Consensus 170 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~ 224 (286)
T cd06614 170 --KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA 224 (286)
T ss_pred --hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 1122334578899999999888899999999999999999999999987665433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=254.22 Aligned_cols=210 Identities=32% Similarity=0.501 Sum_probs=175.8
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..++|++.+.||+|+||.||+|.... +..|++|.+..... ....+.+|+.+++.++|+||+++++++. .+..+++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 34679999999999999999998654 78899999875443 3457888999999999999999999874 457899999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+.+++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999986532 356889999999999999999999999 999999999999999999999999998754322
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
.. .......++..|+|||.+....++.++||||||+++|+|++ |+.||...+..+...
T Consensus 156 ~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 214 (260)
T cd05067 156 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ 214 (260)
T ss_pred Cc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH
Confidence 11 11122345678999999988889999999999999999999 999998776654433
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=257.68 Aligned_cols=200 Identities=28% Similarity=0.393 Sum_probs=176.7
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
++|++.+.||.|++|.||+|.++.+++.+++|.+..... ....++.+|+.+++.++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 368888999999999999999999999999999876543 3345688899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
+.+++|.+++... ...+++..+..++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999999863 2678999999999999999999999 88 999999999999999999999999988643211
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
. .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 155 ~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 155 L----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred H----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 1 11256888999999998889999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=266.73 Aligned_cols=201 Identities=26% Similarity=0.360 Sum_probs=173.2
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhccCCCCccceeeEeecC------
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------ 141 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 141 (297)
..++|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999999999999999986532 22335677899999999999999999988643
Q ss_pred CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg 221 (297)
...|+||||+. ++|.+.+.. .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 35789999997 588888764 2888999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
++...... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.
T Consensus 164 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~ 222 (353)
T cd07850 164 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH 222 (353)
T ss_pred cceeCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 99753221 112334578899999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=253.11 Aligned_cols=200 Identities=31% Similarity=0.467 Sum_probs=166.5
Q ss_pred eecccCcEEEEEEEE--CCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCC
Q 022447 79 LLGEGGFGRVYKGYL--ESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 154 (297)
Q Consensus 79 ~lg~G~~g~v~~~~~--~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~ 154 (297)
.||+|+||.||+|.+ ..++..+++|++...... ..+.+..|+.+++.+.||||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999965 456889999998654322 23568889999999999999999998754 5678999999999
Q ss_pred ChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcce
Q 022447 155 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 234 (297)
Q Consensus 155 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 234 (297)
+|.+++.. ...+++..+..++.|++.||++||+++ ++||||||.||+++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999975 457899999999999999999999999 99999999999999999999999999875432221111
Q ss_pred -eecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 235 -STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 235 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
.....++..|+|||.+.+..++.++|+||||+++|||++ |..||...+..+.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 207 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV 207 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 112234578999999988889999999999999999998 9999987655443
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=234.31 Aligned_cols=211 Identities=24% Similarity=0.335 Sum_probs=181.1
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+|.-.++||+|.||+||+|++..+++.||+|.+......+ .....+|+.+++.++|.||++++++...++..-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4666788999999999999999999999999987653332 35678999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
|+ .+|..+... ..+.++.+.++.++.|++.++.++|+++ +.|||+||.|.+|+.+|++||.|||+++-....
T Consensus 83 cd-qdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip- 154 (292)
T KOG0662|consen 83 CD-QDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP- 154 (292)
T ss_pred hh-HHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc-
Confidence 98 688888776 3577999999999999999999999999 999999999999999999999999999863322
Q ss_pred CcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHHhh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAW 292 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~~~ 292 (297)
.......+-|..|.+|.++.+. -|+.+.|+||.|||+.|+.. |++.|.+.+..++..-+-|
T Consensus 155 -vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~ 217 (292)
T KOG0662|consen 155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_pred -eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHH
Confidence 2233345678999999988664 68999999999999999987 7788998888877654443
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=252.93 Aligned_cols=204 Identities=33% Similarity=0.494 Sum_probs=172.2
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCCh
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L 156 (297)
+.||.|++|.||+|.+.. ++.|++|.+...... ....+..|+.+++.++|+||+++++++.+....+++|||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 468999999999999988 999999998765444 345788999999999999999999999999999999999999999
Q ss_pred HhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcceee
Q 022447 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236 (297)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 236 (297)
.+++... ...+++..+..++.+++.+|.|||+.+ ++||||+|+||+++.++.++|+|||.+.............
T Consensus 80 ~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 9998652 346789999999999999999999999 9999999999999999999999999987532211111111
Q ss_pred cccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 237 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+......
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~ 206 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE 206 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH
Confidence 2234567999999988889999999999999999999 889998776544433
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=264.12 Aligned_cols=216 Identities=29% Similarity=0.419 Sum_probs=176.6
Q ss_pred hcCCCCcceecccCcEEEEEEEECCC-------CeEEEEEEeccCCc-cchHHHHHHHHHHhcc-CCCCccceeeEeecC
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESI-------NQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 141 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 141 (297)
..+|.+.+.||+|+||.||+|.+... +..|++|.+..... .....+.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 35789999999999999999986432 34689998875422 2345788899999999 799999999999999
Q ss_pred CeeEEEEecCCCCChHhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili 209 (297)
...++++||+++++|.+++..... ....++...+..++.|++.||.|||+.+ ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 999999999999999999975321 1235788899999999999999999999 9999999999999
Q ss_pred cCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 210 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 210 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
+.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999999875432221111222234567999999999999999999999999999998 889998877655544
Q ss_pred H
Q 022447 289 L 289 (297)
Q Consensus 289 l 289 (297)
.
T Consensus 248 ~ 248 (334)
T cd05100 248 L 248 (334)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=255.91 Aligned_cols=210 Identities=29% Similarity=0.408 Sum_probs=174.0
Q ss_pred hcCCCCcceecccCcEEEEEEEECCC---CeEEEEEEeccCC-ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
.++|.+.+.||+|++|.||+|.+... ...|++|...... ....+.+.+|+.+++.++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 35688899999999999999987543 4578999887554 2334578889999999999999999998876 45789
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
+|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999999752 345899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
..... .......++..|+|||.+....++.++||||||+++|+|++ |..||...+..+...
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~ 219 (270)
T cd05056 158 EDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG 219 (270)
T ss_pred ccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 32211 11122234568999999988889999999999999999986 999998877655443
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=257.63 Aligned_cols=208 Identities=32% Similarity=0.486 Sum_probs=172.0
Q ss_pred ceecccCcEEEEEEEECCCC------eEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 78 SLLGEGGFGRVYKGYLESIN------QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~------~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+.||+|+||.||+|.+.... ..+++|.+..... .....+.+|+.+++.++||||+++++++......+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999986443 7899998765432 3345788899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC-----ceEEecccC
Q 022447 151 MPLGSVEDHLHDLSP---GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-----HPKLSDFGL 222 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~-----~~kl~Dfg~ 222 (297)
+++++|.+++..... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975322 1244788999999999999999999999 99999999999999877 899999999
Q ss_pred ccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 223 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
+................++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~ 224 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ 224 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHH
Confidence 875433222222223346788999999998899999999999999999998 999998766554443
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=254.93 Aligned_cols=193 Identities=33% Similarity=0.449 Sum_probs=171.8
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCCh
Q 022447 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (297)
Q Consensus 80 lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L 156 (297)
||.|++|.||+|.+..++..|++|++...... ..+.+.+|+.+++.++||||+++++.+.+....++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999999999999999998764332 335688899999999999999999999999999999999999999
Q ss_pred HhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcceee
Q 022447 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236 (297)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 236 (297)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 999976 456899999999999999999999999 9999999999999999999999999987543221 223
Q ss_pred cccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 237 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
...+++.|++||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 3468899999999988889999999999999999999999998776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=253.89 Aligned_cols=202 Identities=31% Similarity=0.477 Sum_probs=171.7
Q ss_pred ceecccCcEEEEEEEECC-CC--eEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYLES-IN--QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.||+|++|.||+|.+.. .+ ..|++|.+..... ...+.+..|+.++++++||||+++++.+.+ ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999865 23 3699999987665 445678899999999999999999999988 889999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999986321 56899999999999999999999999 9999999999999999999999999987643322211
Q ss_pred -eeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 234 -VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 234 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 208 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ 208 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 1123456788999999988899999999999999999999 999997665544
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=256.17 Aligned_cols=202 Identities=27% Similarity=0.431 Sum_probs=180.2
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 145 (297)
..++|.++.+||+|+|++|.++..+.|.+.||+|+++++-. .+.+....|-.+..+. +||.+|-++..|....+++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 34789999999999999999999999999999999987533 3344556677777665 6999999999999999999
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+|.||.+||+|--.+.. ...++++.++.+..+|+.||.|||++| |++||+|.+|+|++..|++||+|+|.++-
T Consensus 328 fvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999877776 678999999999999999999999999 99999999999999999999999999985
Q ss_pred cCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDT 280 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 280 (297)
. ......+.+++|||.|.|||++++..|..++|.|+||++++||+.|+.||+-
T Consensus 401 ~--l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 401 G--LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred C--CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 2 2223446679999999999999999999999999999999999999999973
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=258.33 Aligned_cols=203 Identities=26% Similarity=0.366 Sum_probs=173.1
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+|++.+.||.|++|.||+|.+..++..|+||.+...... ....+..|+.+++.++||||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488899999999999999999999999999998754322 235688899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+. ++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 68988886532 456899999999999999999999999 9999999999999999999999999987532221
Q ss_pred CcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
.......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~ 206 (284)
T cd07860 155 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 206 (284)
T ss_pred --cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 112233568899999987654 468899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=257.39 Aligned_cols=206 Identities=26% Similarity=0.417 Sum_probs=175.2
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
+|++.+.||.|++|.||+|.+..+|..|++|++...... ....+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 588899999999999999999999999999998765332 2356778999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
+ ++|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 81 D-KDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred C-ccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 8 588888865321 356899999999999999999999999 9999999999999999999999999986532211
Q ss_pred cceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 232 THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.......++..|++||.+.+ ..++.++|+||||+++|+|++|+.||...+..+
T Consensus 155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~ 208 (284)
T cd07836 155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208 (284)
T ss_pred -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 11223457889999998765 457889999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=258.10 Aligned_cols=204 Identities=31% Similarity=0.475 Sum_probs=170.7
Q ss_pred cCCCCcceecccCcEEEEEEE----ECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeec--CCeeE
Q 022447 72 KNFRSESLLGEGGFGRVYKGY----LESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRL 145 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 145 (297)
++|++.+.||+|+||.||+|. +..++..|++|.+..........+.+|+.+++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 578899999999999999997 445788999999876655555678899999999999999999998654 34688
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999999752 345889999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCCcce-eecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 226 GPVGDNTHV-STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 226 ~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
......... .....++..|+|||.+.+..++.++|+||||+++|||++|..|+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 214 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSP 214 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCc
Confidence 433222111 11122345699999998888999999999999999999988776544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=255.48 Aligned_cols=193 Identities=31% Similarity=0.420 Sum_probs=162.5
Q ss_pred eecccCcEEEEEEEECCCCeEEEEEEeccCCccch---HHHHHHHH---HHhccCCCCccceeeEeecCCeeEEEEecCC
Q 022447 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVL---MLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 152 (297)
Q Consensus 79 ~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~e~~---~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 152 (297)
.||+|+||.||+|.+..+++.||+|.+........ .....|.. +++...||+|+.+++.+...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999876433211 12333433 3444579999999999999999999999999
Q ss_pred CCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCc
Q 022447 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232 (297)
Q Consensus 153 g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 232 (297)
|++|.+++.. ...+++..++.++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--- 150 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc---
Confidence 9999998875 567999999999999999999999999 999999999999999999999999998643221
Q ss_pred ceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 233 HVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
......|+..|+|||.+.+. .++.++|+||+|+++|+|++|+.||....
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 12234689999999998744 68999999999999999999999998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=258.60 Aligned_cols=203 Identities=29% Similarity=0.367 Sum_probs=175.5
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeec--CCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 148 (297)
++|+..+.||.|++|.||+|.+..++..+++|.+..... ....++.+|+.+++.++||||+++++++.+ ...+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 367888999999999999999999999999999875433 234568899999999999999999998865 34789999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||++|++|.+++.........+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987654434567899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 158 ~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 S----LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred c----ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 1 112345788999999999889999999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=265.28 Aligned_cols=209 Identities=30% Similarity=0.437 Sum_probs=170.2
Q ss_pred hcCCCCcceecccCcEEEEEEEE-----CCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcc-CCCCccceeeEeecC-C
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADG-D 142 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~ 142 (297)
.++|++.+.||+|+||.||+|.+ ..+++.||||.++..... ....+.+|+.++..+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35899999999999999999985 346789999999754322 335678899999999 689999999988654 4
Q ss_pred eeEEEEecCCCCChHhhhcccCC---------------------------------------------------------
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSP--------------------------------------------------------- 165 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~--------------------------------------------------------- 165 (297)
..+++|||+++++|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999999864211
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcceeeccc
Q 022447 166 ------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 239 (297)
Q Consensus 166 ------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 239 (297)
....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0124678888999999999999999999 9999999999999999999999999987532222111222234
Q ss_pred ccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcch
Q 022447 240 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSK 282 (297)
Q Consensus 240 g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~ 282 (297)
++..|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 5678999999988899999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=260.48 Aligned_cols=208 Identities=28% Similarity=0.399 Sum_probs=174.4
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhccCCCCccceeeEeecC--CeeEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLL 146 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 146 (297)
.++|++.+.||.|++|.||+|.+..+|+.||+|.+....... ...+.+|+.+++.++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 468999999999999999999999999999999987543222 23456799999999999999999998765 56899
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||||+. ++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+...
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999997 5888888752 356899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
.... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..+..
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~ 218 (309)
T cd07845 159 GLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL 218 (309)
T ss_pred CCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 3221 11222345788999998865 56789999999999999999999999887765543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=252.81 Aligned_cols=203 Identities=33% Similarity=0.540 Sum_probs=176.4
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|++.+.||.|++|.||+|... |..|++|.+..... ..+++..|+.+++.++|+||+++++++.+....++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 467899999999999999999876 78999999976543 456788999999999999999999999998999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++.... ...+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999997622 236899999999999999999999999 9999999999999999999999999987542211
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+.
T Consensus 157 -----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 208 (256)
T cd05039 157 -----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 208 (256)
T ss_pred -----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 12234567999999988889999999999999999997 9999987765543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=249.61 Aligned_cols=202 Identities=29% Similarity=0.467 Sum_probs=180.1
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCC
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 152 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 152 (297)
+|++.+.||+|++|.||++.+..++..+++|++..........+.+|+.+++.++|++++++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 47888999999999999999998999999999977655455778899999999999999999999999999999999999
Q ss_pred CCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCc
Q 022447 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232 (297)
Q Consensus 153 g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 232 (297)
+++|.+++... ...+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999998762 257899999999999999999999999 99999999999999999999999999875433221
Q ss_pred ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 202 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP 202 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch
Confidence 3345688999999999888899999999999999999999999988743
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=258.33 Aligned_cols=208 Identities=23% Similarity=0.317 Sum_probs=172.2
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccC-CCCccceeeEeecCCe-----
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ----- 143 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~----- 143 (297)
++|++.+.||+|+||.||+|.+..+++.|++|.+...... ....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688999999999999999999999999999998654322 2356788999999995 6999999999877655
Q ss_pred eEEEEecCCCCChHhhhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC-CCceEEeccc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPG-KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFG 221 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~-~~~~kl~Dfg 221 (297)
.|++|||+++ +|.+++...... ...+++..++.++.||+.||.|||+.+ ++||||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 898888654322 356899999999999999999999999 999999999999998 8899999999
Q ss_pred CccccCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.+........ ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+...
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~ 219 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 9875322111 1122356888999998754 457899999999999999999999998765433
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=254.60 Aligned_cols=202 Identities=35% Similarity=0.515 Sum_probs=166.4
Q ss_pred ceecccCcEEEEEEEECCCCe--EEEEEEeccCCc-cchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQ--DVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.||+|+||.||+|.+..++. .+++|.+..... .....+..|+.++..+ +||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999988775 468888764322 2335688899999999 799999999999999999999999999
Q ss_pred CChHhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 022447 154 GSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (297)
Q Consensus 154 ~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg 221 (297)
++|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999975321 1235789999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
++..... .........+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~ 219 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 219 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH
Confidence 8753111 111111223567999999988889999999999999999997 999998765543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=256.92 Aligned_cols=196 Identities=30% Similarity=0.406 Sum_probs=169.7
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCCh
Q 022447 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (297)
Q Consensus 80 lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L 156 (297)
||+|+||.||+|.+..+|+.|++|.+...... ....+..|+.+++.++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999999999999998754322 234567899999999999999999999999999999999999999
Q ss_pred HhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcceee
Q 022447 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236 (297)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 236 (297)
.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+..... .....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~ 152 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIK 152 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccc
Confidence 99997632 246899999999999999999999999 99999999999999999999999998865322 11223
Q ss_pred cccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 237 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 34578899999999888899999999999999999999999977644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=255.42 Aligned_cols=211 Identities=25% Similarity=0.390 Sum_probs=176.2
Q ss_pred cCCCCcceecccCcEEEEEEEECC-----CCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
++|++...||.|+||.||+|..+. +...+++|.+...... ....+.+|+.++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 578899999999999999999754 3467999988654433 3467889999999999999999999999989999
Q ss_pred EEEecCCCCChHhhhcccCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGK-----KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Df 220 (297)
+||||+++++|.+++....... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997633111 26899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
|++...... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~ 227 (275)
T cd05046 162 SLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227 (275)
T ss_pred ccccccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH
Confidence 988643211 1112233456778999999988888999999999999999999 8899976555443
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=258.66 Aligned_cols=206 Identities=35% Similarity=0.454 Sum_probs=175.0
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
+.|.+.+.||+|++|.||+|.+..+++.|++|++...... ....+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 5688999999999999999999999999999998654322 2346788999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+. ++|.+.+... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9998 6777776542 346899999999999999999999999 99999999999999999999999998865321
Q ss_pred CCCcceeecccccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHH
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~ 290 (297)
.....+++.|+|||.+. ...++.++||||||+++|+|++|+.||...+.......+
T Consensus 168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~ 226 (307)
T cd06607 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226 (307)
T ss_pred ------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH
Confidence 12346788999999874 356888999999999999999999999877655544333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=252.23 Aligned_cols=206 Identities=33% Similarity=0.468 Sum_probs=172.0
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
.+|.+.+.||+|++|.||+|.+..+ ..+++|.+.... .....+.+|+.+++.++|+|++++++++.. +..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 4688999999999999999998764 468999876543 234568889999999999999999988754 5688999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
.+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 9999999997532 345889999999999999999999999 99999999999999999999999999875432221
Q ss_pred cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
. ......++..|+|||...+..++.++|+||||+++|+|++ |..||......+.
T Consensus 158 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 212 (260)
T cd05069 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV 212 (260)
T ss_pred c-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 1 1122345678999999988889999999999999999999 9999988765543
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=250.64 Aligned_cols=207 Identities=26% Similarity=0.414 Sum_probs=182.4
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+|++.+.||.|++|.||++.+..++..+++|++..... .....+..|+.+++.++|+|++++++.+......++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 58889999999999999999999999999999876543 3446688899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++.........+++..+..++.+++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999875433477999999999999999999999999 9999999999999999999999999987533221
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
.......|++.|+|||...+..++.++|+||+|+++|+|++|..||...+..
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 209 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL 209 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH
Confidence 2233456889999999998888999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=251.36 Aligned_cols=201 Identities=30% Similarity=0.469 Sum_probs=170.7
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEee-cCCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA-DGDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e 149 (297)
.++|++.+.||+|++|.||++... +..+++|.+.... ..+.+.+|+.+++.++|+|++++++++. .....+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 357899999999999999999775 7889999986432 3457889999999999999999999754 5567899999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 81 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999999997632 345889999999999999999999999 999999999999999999999999998743221
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
.....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+...
T Consensus 156 -----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~ 207 (256)
T cd05082 156 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 207 (256)
T ss_pred -----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 122335668999999988889999999999999999998 999998765543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=253.40 Aligned_cols=200 Identities=32% Similarity=0.439 Sum_probs=173.8
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCCh
Q 022447 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (297)
Q Consensus 80 lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L 156 (297)
||.|++|.||++.+..+++.+++|.+..... .....+.+|+.+++.++||||+++++.+......|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999999999999999876543 2345688899999999999999999999999999999999999999
Q ss_pred HhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC-----
Q 022447 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN----- 231 (297)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~----- 231 (297)
.+++.. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999986 357899999999999999999999999 99999999999999999999999999875322211
Q ss_pred -cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 232 -THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 232 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
........++..|+|||...+..++.++|+||||+++|+|++|..||...+....
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~ 209 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI 209 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 1122345678899999999888899999999999999999999999987765543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=263.46 Aligned_cols=204 Identities=26% Similarity=0.372 Sum_probs=171.1
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecC-----Cee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 144 (297)
.++|++.+.||+|++|.||+|.+..+|..||+|.+..... ....++.+|+.+++.++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4689999999999999999999999999999999864322 2335678899999999999999999987654 357
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
++++||+. ++|.+++.. ..+++..++.++.|++.||.+||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 89999997 588877764 56899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCc-ceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 225 LGPVGDNT-HVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 225 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
........ .......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~ 215 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY 215 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 53222111 11233568899999998654 5688999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=253.37 Aligned_cols=207 Identities=29% Similarity=0.437 Sum_probs=181.6
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+|++.+.||.|++|.||++.+..+++.+++|.+..... ....++.+|+.+++.++|+||+++++.+.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 58889999999999999999999999999999876432 2335677899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++.........+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998764444567899999999999999999999999 999999999999999999999999998764332
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+.
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~ 209 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL 209 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 22234588899999999988899999999999999999999999988776543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=257.71 Aligned_cols=205 Identities=25% Similarity=0.354 Sum_probs=174.0
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhccCCCCccceeeEeecC--CeeEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLV 147 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 147 (297)
++|++.+.||.|++|.||+|.+..++..+++|.++...... ...+.+|+.+++.++||||+++++++... ...|++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57899999999999999999999999999999987543322 23567899999999999999999998877 889999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||++ ++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99998 5898888752 236899999999999999999999999 9999999999999999999999999987533
Q ss_pred CCCCcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+
T Consensus 158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~ 214 (293)
T cd07843 158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214 (293)
T ss_pred CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 221 122334578899999988654 46889999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=257.11 Aligned_cols=205 Identities=25% Similarity=0.365 Sum_probs=171.6
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
++|++.+.||.|++|.||+|.++.+++.|++|.+...... ....+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5789999999999999999999999999999998654322 23567889999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC-CCceEEecccCccccCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~-~~~~kl~Dfg~~~~~~~ 228 (297)
|++ ++|.+++.... ...+++..++.++.||+.||+|||+++ ++|+||+|+||+++. ++.++|+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 997 57888775422 344688899999999999999999999 999999999999985 56799999999865322
Q ss_pred CCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
. ........+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..
T Consensus 156 ~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~ 210 (294)
T PLN00009 156 P--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI 210 (294)
T ss_pred C--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 1 111223457889999998765 45789999999999999999999999876543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=248.76 Aligned_cols=207 Identities=30% Similarity=0.446 Sum_probs=174.3
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhccC-CCCccceeeEeecCCeeEE
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 146 (297)
...++.+++..||.|+.|.|+++..+.+|...|||.+.+.. ..+.++++..+.++.+.+ +|+||+.+++|..+...++
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 34566778889999999999999999999999999998764 345578888888877665 8999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
.||.|. ..+..++.. -+.+++|..+-.+...+++||.||-.+++ |+|||+||+|||+|+.|.+||+|||++-.+
T Consensus 169 cMelMs-~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 169 CMELMS-TCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred HHHHHH-HHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeeccccccee
Confidence 999985 455555544 25789999999999999999999987554 999999999999999999999999998543
Q ss_pred CCCCCcceeecccccccccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
... ...+...|.+.|||||.+.- ..|+.++||||||++++||.||++||...+.+
T Consensus 243 vdS---kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td 300 (391)
T KOG0983|consen 243 VDS---KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD 300 (391)
T ss_pred ecc---cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc
Confidence 222 23445679999999998853 46899999999999999999999999995443
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=251.50 Aligned_cols=196 Identities=28% Similarity=0.354 Sum_probs=167.6
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHH-hccCCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLML-SLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.||.|++|.||+|.+..+++.||+|.+....... ...+..|..++ ...+|+|++++++++...+.+|+++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999999999999999987543222 12344454443 455899999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|.+++.. ..++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999976 467899999999999999999999999 99999999999999999999999998864222
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+....
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 201 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV 201 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 2334588899999999888889999999999999999999999987765543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=251.87 Aligned_cols=203 Identities=24% Similarity=0.365 Sum_probs=162.7
Q ss_pred eecccCcEEEEEEEECCC--CeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCC
Q 022447 79 LLGEGGFGRVYKGYLESI--NQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 155 (297)
Q Consensus 79 ~lg~G~~g~v~~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~ 155 (297)
.||+|+||.||++....+ ...+++|.+..... .....+.+|+.+++.++||||+++++.+......++||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975432 34567777665432 334678899999999999999999999999999999999999999
Q ss_pred hHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCccee
Q 022447 156 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235 (297)
Q Consensus 156 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 235 (297)
|.+++.........+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999764333345677888999999999999999999 999999999999999999999999987532111111122
Q ss_pred ecccccccccCcccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCcchhH
Q 022447 236 TRVMGTYGYCAPEYAKT-------GQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAA 284 (297)
Q Consensus 236 ~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~ 284 (297)
....++..|+|||++.. ..++.++||||||+++|||++ |..||...+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~ 215 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR 215 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 34567889999998743 245789999999999999997 56788766554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=251.39 Aligned_cols=209 Identities=28% Similarity=0.446 Sum_probs=174.6
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
..+|++.+.||+|+||.||+|.+.. +..+++|.+.... .....+.+|+.+++.++|+||+++++.+.. ...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 4688999999999999999998654 5679999886532 234568889999999999999999999887 778999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999997632 355788899999999999999999999 9999999999999999999999999987543221
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
.. ......++..|+|||.+....++.++|+||||+++|++++ |+.||...+..+...
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~ 214 (260)
T cd05073 157 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 214 (260)
T ss_pred cc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 11 1122335677999999988889999999999999999999 999998876654443
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=256.43 Aligned_cols=202 Identities=28% Similarity=0.452 Sum_probs=169.7
Q ss_pred cCCCCcceecccCcEEEEEEEE----CCCCeEEEEEEeccCC-ccchHHHHHHHHHHhccCCCCccceeeEeecC--Cee
Q 022447 72 KNFRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 144 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 144 (297)
+.|++++.||+|+||.||+|.. ..++..|++|.+.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3578899999999999999984 4568899999987543 22335688999999999999999999998775 568
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
+++|||++|++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 8999999999999998652 245899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCc-ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 022447 225 LGPVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 279 (297)
Q Consensus 225 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 279 (297)
........ .......++..|+|||.+.+..++.++||||||+++|+|++++.|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 54332211 11223456778999999988889999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=249.30 Aligned_cols=202 Identities=31% Similarity=0.467 Sum_probs=179.2
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+|++.+.||+|++|.||++.+..+++.|++|.+..... .....+.+|+.+++.++|+|++++++++.+....+++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 57889999999999999999999999999999977654 3346788999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++.. ...+++..++.++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999976 467899999999999999999999999 9999999999999999999999999987643322
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
. ......++..|+|||...+..++.++|+||||+++|+|++|+.||...+.
T Consensus 154 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~ 204 (254)
T cd06627 154 K--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP 204 (254)
T ss_pred c--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH
Confidence 2 12345688999999999888889999999999999999999999976553
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=252.40 Aligned_cols=196 Identities=27% Similarity=0.396 Sum_probs=163.0
Q ss_pred ceecccCcEEEEEEEECC------------CCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 78 SLLGEGGFGRVYKGYLES------------INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
+.||+|+||.||+|.... ....+++|++..........+..|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 23468899877654444456788899999999999999999999989999
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCc-------eEEe
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH-------PKLS 218 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~-------~kl~ 218 (297)
++|||+++++|..++... ...+++..++.++.||+.|++|||+.+ ++||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999888642 356899999999999999999999999 999999999999986654 8999
Q ss_pred cccCccccCCCCCcceeecccccccccCccccc-cCCCCcccchhhHHHHHHHHH-hCCCCCCcchhHh
Q 022447 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEIL-SGRKAVDTSKAAA 285 (297)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell-~g~~Pf~~~~~~~ 285 (297)
|||++..... .....++..|+|||.+. +..++.++|||||||++|+|+ .|..||......+
T Consensus 155 d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (262)
T cd05077 155 DPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217 (262)
T ss_pred CCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence 9998864211 12345788899999886 467899999999999999997 5889998765443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=262.39 Aligned_cols=207 Identities=24% Similarity=0.336 Sum_probs=174.5
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeec----CCee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 144 (297)
..+|++.+.||.|++|.||+|.+..++..|++|.+..... .....+..|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3689999999999999999999999999999999875422 334567789999999999999999998753 3568
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
++||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999996 689888875 456999999999999999999999999 9999999999999999999999999986
Q ss_pred ccCCCCC--cceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 225 LGPVGDN--THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 225 ~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
....... ........++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~ 219 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH 219 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH
Confidence 5322211 111234568899999998765 468899999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=249.99 Aligned_cols=203 Identities=29% Similarity=0.400 Sum_probs=179.6
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecC--CeeEEEE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVY 148 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 148 (297)
+|+..+.||+|++|.||+|.+..++..|++|++..... ...+.+.+|+.+++.++|+||+++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47788999999999999999999999999999876543 3346788999999999999999999999988 8899999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
|++++++|.+++.. ...+++..++.++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999986 348999999999999999999999999 99999999999999999999999999876443
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
...........++..|+|||.+.+...+.++|+||||+++|+|++|..||...+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 322112334568899999999988889999999999999999999999998876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=254.35 Aligned_cols=202 Identities=27% Similarity=0.376 Sum_probs=172.3
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
|++.+.||.|++|.||+|.+..+|..|++|++...... ....+.+|+.+++.++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67889999999999999999999999999998754322 2356788999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
+ ++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~- 153 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV- 153 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-
Confidence 6 68999987632 246899999999999999999999999 9999999999999999999999999986532221
Q ss_pred cceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 232 THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
.......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.
T Consensus 154 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 205 (283)
T cd07835 154 -RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE 205 (283)
T ss_pred -cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 112223568899999987654 578899999999999999999999987655
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=253.04 Aligned_cols=207 Identities=26% Similarity=0.407 Sum_probs=175.5
Q ss_pred CCCCcceecccCcEEEEEEEECC-CCeEEEEEEeccCCc----------cchHHHHHHHHHHhc-cCCCCccceeeEeec
Q 022447 73 NFRSESLLGEGGFGRVYKGYLES-INQDVAIKQLDRNGV----------QGNREFLVEVLMLSL-LHHPNLVNLIGYCAD 140 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 140 (297)
+|++.+.||+|+||.||+|.+.. ++..+++|.+..... ....++..|+.++.. ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999987 688999998754321 122456778887764 789999999999999
Q ss_pred CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEEcCCCceEEec
Q 022447 141 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSD 219 (297)
Q Consensus 141 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~dikp~Nili~~~~~~kl~D 219 (297)
.+..+++|||++|++|.+++.........+++..++.++.|++.++.+||+ .+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999886543345679999999999999999999996 67 99999999999999999999999
Q ss_pred ccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 220 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~ 220 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS 220 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH
Confidence 99987533222 2334568899999999988889999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=254.90 Aligned_cols=198 Identities=29% Similarity=0.466 Sum_probs=165.3
Q ss_pred ceecccCcEEEEEEEECCCCe-------EEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 78 SLLGEGGFGRVYKGYLESINQ-------DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+.||+|+||.||+|.+..++. .+++|.+........+.+..|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999999865544 4888887665444456788899999999999999999999998999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCc--------eEEecccC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH--------PKLSDFGL 222 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~--------~kl~Dfg~ 222 (297)
+++++|.+++... ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++. ++++|||.
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999752 346889999999999999999999999 999999999999987664 68999998
Q ss_pred ccccCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhC-CCCCCcchhHhhh
Q 022447 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAAEQ 287 (297)
Q Consensus 223 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g-~~Pf~~~~~~~~~ 287 (297)
+.... ......++..|+|||.+.+ ..++.++|+||||+++|+|++| ..||...+.....
T Consensus 155 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~ 215 (258)
T cd05078 155 SITVL------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL 215 (258)
T ss_pred ccccC------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH
Confidence 75421 1223457889999999876 4578999999999999999998 4777766655443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=248.44 Aligned_cols=200 Identities=34% Similarity=0.482 Sum_probs=167.8
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCccc-hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCCh
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L 156 (297)
+.||+|+||.||+|... ++..+++|.+....... ...+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36899999999999865 58899999987654332 34678899999999999999999999999999999999999999
Q ss_pred HhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcceee
Q 022447 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236 (297)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 236 (297)
.+++... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 80 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~ 152 (250)
T cd05085 80 LSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSG 152 (250)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCC
Confidence 9998652 345789999999999999999999999 99999999999999999999999999864322111 1111
Q ss_pred cccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 237 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
...++..|+|||++.+..++.++|+||||+++|++++ |..||.......
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~ 202 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ 202 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence 2234567999999988889999999999999999998 999998765443
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=251.13 Aligned_cols=194 Identities=31% Similarity=0.494 Sum_probs=164.7
Q ss_pred ceecccCcEEEEEEEECCCC----------eEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 78 SLLGEGGFGRVYKGYLESIN----------QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999998766 45788877654333 5678889999999999999999999888 778999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC-------ceEEecc
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-------HPKLSDF 220 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~-------~~kl~Df 220 (297)
|||+++++|.+++... ...+++..+..++.||+.||.|||+++ ++||||||+||+++.++ .++|+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999999862 226899999999999999999999999 99999999999999877 7999999
Q ss_pred cCccccCCCCCcceeecccccccccCccccccC--CCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG--QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
|++..... .....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+...
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~ 214 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh
Confidence 99875322 2234467789999998776 78999999999999999999 688888775443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=256.95 Aligned_cols=210 Identities=25% Similarity=0.374 Sum_probs=172.5
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCC-----
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD----- 142 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 142 (297)
..++|++.+.||+|++|.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 446799999999999999999999999999999988643222 2235567999999999999999999886543
Q ss_pred ---eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEec
Q 022447 143 ---QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 219 (297)
Q Consensus 143 ---~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~D 219 (297)
..++||||+. ++|.+++... ...+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECc
Confidence 4599999997 5888877642 346899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCCc--ceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 220 FGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 220 fg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
||++......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~ 232 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ 232 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9998754322211 111234578889999987654 478899999999999999999999988765443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=254.79 Aligned_cols=198 Identities=26% Similarity=0.382 Sum_probs=162.7
Q ss_pred eecccCcEEEEEEEECCC------------------------CeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccce
Q 022447 79 LLGEGGFGRVYKGYLESI------------------------NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNL 134 (297)
Q Consensus 79 ~lg~G~~g~v~~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 134 (297)
.||+|+||.||+|....+ ...|++|.+..........+..|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999985321 24588998876544444678889999999999999999
Q ss_pred eeEeecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC-
Q 022447 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY- 213 (297)
Q Consensus 135 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~- 213 (297)
++++......++||||+++++|..++.. ....+++..+..++.|++.||+|||+++ ++||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999998864 2456889999999999999999999999 99999999999997543
Q ss_pred ------ceEEecccCccccCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHH-hCCCCCCcchhHh
Q 022447 214 ------HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEIL-SGRKAVDTSKAAA 285 (297)
Q Consensus 214 ------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell-~g~~Pf~~~~~~~ 285 (297)
.++++|||.+..... .....++..|+|||.+.+ ..++.++|+||||+++|||+ +|..||...+..+
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 389999998753211 122347788999998865 56899999999999999985 6999998776554
Q ss_pred hhh
Q 022447 286 EQS 288 (297)
Q Consensus 286 ~~~ 288 (297)
...
T Consensus 230 ~~~ 232 (274)
T cd05076 230 KER 232 (274)
T ss_pred HHH
Confidence 433
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=285.25 Aligned_cols=215 Identities=36% Similarity=0.527 Sum_probs=183.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCC-----eEEEEEEeccCC-ccchHHHHHHHHHHhccCCCCccceeeEeecCCee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESIN-----QDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 144 (297)
....++.+.||+|+||.||.|....-. ..||+|.+.+.. ..+..+|++|..+++.++||||+++++++.+...+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 345667889999999999999975432 348999887653 34457899999999999999999999999999999
Q ss_pred EEEEecCCCCChHhhhcccCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPG---KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg 221 (297)
++++|||.||+|..++++.+.. ...++..+.+.++.+|++++.||++++ +|||||..+|+|++....+||.|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999975322 456889999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
+|+.....+.........-...|||||.+....++.++|||||||++||++| |..||.+.+..+...
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~ 915 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL 915 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH
Confidence 9995544444444333334579999999999999999999999999999999 889999887655443
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=261.44 Aligned_cols=203 Identities=26% Similarity=0.370 Sum_probs=172.9
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhccCCCCccceeeEeecC-----Ce
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQ 143 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 143 (297)
.++|.+.+.||.|+||.||+|.+..++..|+||.+.... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999999999999999987532 22335677899999999999999999987654 34
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
.|+++||+. ++|.+++.. ..++++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 789888876 567999999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
....... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 214 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY 214 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh
Confidence 7543221 22234467889999998764 4688999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=250.65 Aligned_cols=204 Identities=24% Similarity=0.422 Sum_probs=176.0
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+|++.+.||.|++|.||+|.++.+|..+++|.+..... ...+.+.+|+.+++.++|+||+++++.+......++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 57889999999999999999999999999999875422 2345678899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC-ceEEecccCccccCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGPVG 229 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~ 229 (297)
+++++|.+++.... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++ .++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999997532 345789999999999999999999999 99999999999999875 4699999998754322
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 156 --~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 207 (257)
T cd08225 156 --MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL 207 (257)
T ss_pred --cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 1122234588899999999888899999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=260.77 Aligned_cols=207 Identities=29% Similarity=0.405 Sum_probs=173.5
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhcc-CCCCccceeeEeecC--Cee
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG--DQR 144 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~ 144 (297)
..++|++.+.||+|+||.||+|.+..++..+++|.+... .......+.+|+.+++.+ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 457899999999999999999999989999999988543 223335577899999999 999999999988653 367
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
++||||++ ++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999998 599988875 26888899999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCc---ceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 225 LGPVGDNT---HVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 225 ~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
........ .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~ 220 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN 220 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 54332211 22234568899999998754 567889999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=261.52 Aligned_cols=208 Identities=23% Similarity=0.346 Sum_probs=173.1
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecC---------
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--------- 141 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------- 141 (297)
..+|.+.+.||.|+||.||+|.+..++..|++|.+........+.+.+|+.+++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46899999999999999999999999999999998776655566788899999999999999999876543
Q ss_pred -----CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEc-CCCce
Q 022447 142 -----DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHP 215 (297)
Q Consensus 142 -----~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~-~~~~~ 215 (297)
...+++|||+. ++|.+++.. ..+++..++.++.||+.||.|||+.+ ++||||||+||+++ .++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35789999997 588888764 46889999999999999999999999 99999999999997 45678
Q ss_pred EEecccCccccCCCCC-cceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 216 KLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 216 kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
+|+|||.+........ ........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+..
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~ 228 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999875322111 111122357889999997654 56788999999999999999999999877654443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=255.30 Aligned_cols=205 Identities=19% Similarity=0.214 Sum_probs=159.7
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCC---CeEEEEEEeccCCccchH-----------HHHHHHHHHhccCCCCcccee
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQGNR-----------EFLVEVLMLSLLHHPNLVNLI 135 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~vavK~~~~~~~~~~~-----------~~~~e~~~l~~l~h~~i~~~~ 135 (297)
..++|.+.+.||+|+||.||+|.+..+ +..+++|+.......... ....+...+..+.|+++++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346899999999999999999999877 667777765432221110 122233445667899999999
Q ss_pred eEeecCC----eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC
Q 022447 136 GYCADGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 211 (297)
Q Consensus 136 ~~~~~~~----~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~ 211 (297)
+...... ..++++|++. .++.+.+.. ....++..++.++.|++.||.|||+.+ ++||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 8765443 3467888775 567776654 334678889999999999999999999 999999999999999
Q ss_pred CCceEEecccCccccCCCCCc-----ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 212 GYHPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 212 ~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
++.++|+|||+++........ .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 999999999998754322111 11223469999999999999999999999999999999999999998774
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=275.47 Aligned_cols=209 Identities=22% Similarity=0.271 Sum_probs=162.5
Q ss_pred HHHhcCCCCcceecccCcEEEEEEEECCCC-eEEEEEEe--------------cc---CCccchHHHHHHHHHHhccCCC
Q 022447 68 AAATKNFRSESLLGEGGFGRVYKGYLESIN-QDVAIKQL--------------DR---NGVQGNREFLVEVLMLSLLHHP 129 (297)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~-~~vavK~~--------------~~---~~~~~~~~~~~e~~~l~~l~h~ 129 (297)
.....+|++.+.||+|+||.||+|..+... ...+.|.+ .+ ........+.+|+.+++.++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 345678999999999999999998765322 22222211 10 1111234578899999999999
Q ss_pred CccceeeEeecCCeeEEEEecCCCCChHhhhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEE
Q 022447 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 208 (297)
Q Consensus 130 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nil 208 (297)
||+++++++...+..|++++++. ++|.+++..... .........++.++.||+.||.|||+++ |+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 99999999999999999999986 677777653211 1223446778899999999999999999 999999999999
Q ss_pred EcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCC-CCCcc
Q 022447 209 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK-AVDTS 281 (297)
Q Consensus 209 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~-Pf~~~ 281 (297)
++.++.++|+|||++....... ........||+.|+|||++.+..++.++|||||||++|||++|.. ||...
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~ 372 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDG 372 (501)
T ss_pred ECCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCC
Confidence 9999999999999997543221 112234679999999999999999999999999999999999885 55443
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=254.30 Aligned_cols=205 Identities=30% Similarity=0.467 Sum_probs=178.8
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccC-CCCccceeeEeecCCeeEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 147 (297)
++|.+.+.||+|++|.||+|.+..++..|++|++..... .....+..|..+++.+. |+||+++++++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 478999999999999999999999999999999876432 22356778999999998 99999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
||++.+++|.+++.. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999987 457999999999999999999999999 9999999999999999999999999987533
Q ss_pred CCCC------------------cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 228 VGDN------------------THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 228 ~~~~------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
.... ........++..|+|||...+..++.++|+||||++++++++|+.||...+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 2221 0222334578899999999888899999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=248.62 Aligned_cols=206 Identities=29% Similarity=0.493 Sum_probs=174.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
..+|++.+.||.|++|.||+|.+.. +..+++|.+..... ....+.+|+.+++.++||+++++++++......+++|||
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 3578889999999999999998864 67899998865433 345788899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+.+++|.+++... ...+++..++.++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 81 MEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred CCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 9999999998752 346889999999999999999999999 9999999999999999999999999986532211
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
. .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+...
T Consensus 155 ~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 209 (256)
T cd05112 155 Y-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE 209 (256)
T ss_pred c-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 1 11122335678999999988889999999999999999998 999998766543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=249.87 Aligned_cols=211 Identities=25% Similarity=0.319 Sum_probs=176.4
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCC----eEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeec-CC
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESIN----QDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GD 142 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~----~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 142 (297)
....|+..+.||+|.||.||+|..+.++ +.+|||.++.+.. .......+|+.+++.++|||++.+..+|.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 4567999999999999999999765543 3789999876522 233567899999999999999999999877 78
Q ss_pred eeEEEEecCCCCChHhhhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC----CceEE
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPG-KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG----YHPKL 217 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~----~~~kl 217 (297)
..++++||.+ -+|++.|+-.+.. ...++...+..|++||+.++.|||+.- |+||||||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 8999999998 7999998754432 356889999999999999999999998 9999999999999876 99999
Q ss_pred ecccCccccCCCCCc-ceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 218 SDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 218 ~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
+|||+++.....-.. ......+-|..|.|||++.+ ..|+.+.||||+|||+.||++-.+.|......
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k 246 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEK 246 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhh
Confidence 999999875332221 23345678999999998876 47999999999999999999999999886543
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=252.18 Aligned_cols=205 Identities=26% Similarity=0.373 Sum_probs=174.5
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhccCCCCccceeeEeecC--CeeEEEEe
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYE 149 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 149 (297)
|++.+.||.|++|.||+|.+..+++.+++|.+.... ......+.+|+.+++.++|+|++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999999999999999998653 22335678899999999999999999999888 88999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|++ ++|.+++... ...+++..++.++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 998 5888888752 257899999999999999999999999 999999999999999999999999998754332
Q ss_pred CCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
.. .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+....
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~ 210 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ 210 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 21 11223356788999997764 4578999999999999999999999988775443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=252.91 Aligned_cols=201 Identities=27% Similarity=0.395 Sum_probs=170.9
Q ss_pred CCCCcceecccCcEEEEEEEEC---CCCeEEEEEEeccCCc----cchHHHHHHHHHHhcc-CCCCccceeeEeecCCee
Q 022447 73 NFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV----QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 144 (297)
+|++.+.||.|+||.||+|.+. .+|..||+|++..... .....+..|+.+++.+ +|++|+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788999999999999999875 4789999999875322 2235677899999999 589999999999999999
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
++||||+++++|.+++.. ..++++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999976 567889999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCcceeecccccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
...... ........|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...
T Consensus 154 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 154 EFHEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred eccccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 532221 112224568899999998865 34678999999999999999999999743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=253.16 Aligned_cols=205 Identities=31% Similarity=0.511 Sum_probs=173.3
Q ss_pred cCCCCcceecccCcEEEEEEEEC----CCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeec--CCee
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLE----SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQR 144 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 144 (297)
.+|++.+.||+|+||.||+|... .++..+|+|.+...... ....+.+|+.+++.+.|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999864 34889999999765443 35678899999999999999999999877 5678
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
+++|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999762 235899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCcc-eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 225 LGPVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 225 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
......... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 643222111 1112335567999999988889999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=251.34 Aligned_cols=201 Identities=27% Similarity=0.318 Sum_probs=168.1
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccC-CCCccceeeEeecC--CeeEEEEe
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADG--DQRLLVYE 149 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e 149 (297)
|++.+.||+|++|.||+|.+..++..||+|.+...... .......|+.++..+. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 67888999999999999999999999999998754222 2234457888888885 99999999999987 88999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+. ++|.+.+... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||.+......
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 998 5888877652 356899999999999999999999999 999999999999999 99999999998753221
Q ss_pred CCcceeecccccccccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
. ......++..|+|||.+. +..++.++|+|||||++|+|++|..||...+..+
T Consensus 153 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~ 206 (282)
T cd07831 153 P---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD 206 (282)
T ss_pred C---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH
Confidence 1 122345788999999764 4567889999999999999999999998766533
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=259.39 Aligned_cols=205 Identities=26% Similarity=0.370 Sum_probs=177.1
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhccCCCCccceeeEeecCC-----eeE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRL 145 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 145 (297)
+|++.+.||.|++|.||+|.+..+++.|++|.+.... ....+.+.+|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999999999999999987643 334467889999999999999999999988775 789
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
++|||+. ++|.+++.. ..++++..++.++.||+.||.+||+.+ ++|+||||+||+++.++.++|+|||.+..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999998 588888875 458999999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCCc-ceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 226 GPVGDNT-HVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 226 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~ 214 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID 214 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH
Confidence 4332210 112334578899999999887 88999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=247.96 Aligned_cols=201 Identities=32% Similarity=0.513 Sum_probs=170.5
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
++|++.+.||+|+||.||++.. +++.|++|.+.... ....+.+|+.+++.++|||++++++++... ..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 5689999999999999999864 57889999986532 335688899999999999999999998764 578999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
.+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 81 SKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 9999999997632 346889999999999999999999999 999999999999999999999999998753221
Q ss_pred cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhh
Q 022447 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQ 287 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~ 287 (297)
......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+..
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 207 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK 207 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH
Confidence 112234568999999988889999999999999999998 99999887665433
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=249.92 Aligned_cols=211 Identities=28% Similarity=0.387 Sum_probs=170.8
Q ss_pred CCCcceecccCcEEEEEEEEC---CCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCC------
Q 022447 74 FRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 142 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 142 (297)
|.+.+.||+|+||.||+|... .++..||||++..... ...+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677889999999999999864 3578999999875432 23456888999999999999999999876432
Q ss_pred eeEEEEecCCCCChHhhhcccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecc
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSP--GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Df 220 (297)
..++++||+.+++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 24688999999999988753221 1235788999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhh
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQ 287 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~ 287 (297)
|++................+++.|++||.+.+..++.++||||||+++|+|++ |+.||...+..+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~ 225 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY 225 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHH
Confidence 99875433222222223345678999999988889999999999999999999 89999877655443
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=258.56 Aligned_cols=206 Identities=24% Similarity=0.359 Sum_probs=173.7
Q ss_pred HHHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecC-
Q 022447 65 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG- 141 (297)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 141 (297)
.++....++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 4455677899999999999999999999999999999999875422 2235677899999999999999999987543
Q ss_pred -----CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceE
Q 022447 142 -----DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (297)
Q Consensus 142 -----~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~k 216 (297)
...+++++++ |++|.+++.. ..+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.++
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3467888876 6899888764 45899999999999999999999999 99999999999999999999
Q ss_pred EecccCccccCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 217 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 217 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
|+|||++..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+..
T Consensus 161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 224 (345)
T cd07877 161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 224 (345)
T ss_pred Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999875321 2233567889999998766 56888999999999999999999999766543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=257.89 Aligned_cols=207 Identities=25% Similarity=0.341 Sum_probs=172.8
Q ss_pred hcCCC-CcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc--------------hHHHHHHHHHHhccCCCCcccee
Q 022447 71 TKNFR-SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--------------NREFLVEVLMLSLLHHPNLVNLI 135 (297)
Q Consensus 71 ~~~y~-~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~~~ 135 (297)
.++|. +.+.||.|+||.||+|.+..+++.||||++....... ...+.+|+.+++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 35665 4577999999999999999999999999986543222 12467899999999999999999
Q ss_pred eEeecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCce
Q 022447 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (297)
Q Consensus 136 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~ 215 (297)
+++...+..+++|||+. ++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCE
Confidence 99999999999999997 689998875 566899999999999999999999999 9999999999999999999
Q ss_pred EEecccCccccCCC------------CCcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 216 KLSDFGLAKLGPVG------------DNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 216 kl~Dfg~~~~~~~~------------~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
+|+|||.+...... ..........+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999998753310 001111223467889999988664 46889999999999999999999998876
Q ss_pred hHh
Q 022447 283 AAA 285 (297)
Q Consensus 283 ~~~ 285 (297)
..+
T Consensus 239 ~~~ 241 (335)
T PTZ00024 239 EID 241 (335)
T ss_pred HHH
Confidence 544
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=247.25 Aligned_cols=202 Identities=30% Similarity=0.472 Sum_probs=161.9
Q ss_pred ceecccCcEEEEEEEECC---CCeEEEEEEeccCC-ccchHHHHHHHHHHhccCCCCccceeeEee-cCCeeEEEEecCC
Q 022447 78 SLLGEGGFGRVYKGYLES---INQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCA-DGDQRLLVYEYMP 152 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~ 152 (297)
+.||+|+||.||+|.+.. .+..||+|.+.... ......+.+|+.+++.++||||+++++++. .+...+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998643 35679999875432 233457788999999999999999999765 4556889999999
Q ss_pred CCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCc
Q 022447 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232 (297)
Q Consensus 153 g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 232 (297)
+++|.+++... ....++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999752 234677788999999999999999999 999999999999999999999999998643221110
Q ss_pred --ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhC-CCCCCcchhHh
Q 022447 233 --HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAA 285 (297)
Q Consensus 233 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~Pf~~~~~~~ 285 (297)
.......++..|+|||.+.+..++.++||||||+++|||++| .+||...+..+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~ 210 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD 210 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 111123456789999999888899999999999999999995 66777655433
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=253.10 Aligned_cols=209 Identities=28% Similarity=0.378 Sum_probs=172.4
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhc-cCCCCccceeeEeecCCeeEEEEec
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+.+-+..||.|+||+|++-.++.+|+..|||.|..... .+.++++.|.....+ -+.||||++|++...++..|+.||+
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 34456789999999999999999999999999987655 345678888776554 4689999999999999999999999
Q ss_pred CCCCChHhhhccc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 151 MPLGSVEDHLHDL-SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 151 ~~g~~L~~~l~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+ .+|..+.... .-.+..++|+.+-.|....+.||.||-..-+ |+|||+||+|||++..|.+||+|||++-.+..
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~- 220 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVD- 220 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHH-
Confidence 97 6665544321 1125678999999999999999999986544 99999999999999999999999999864322
Q ss_pred CCcceeecccccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
....+...|...|||||.+.. ..|+.++|+||||++|||+.||+.|+..++.-.+|
T Consensus 221 --SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq 278 (361)
T KOG1006|consen 221 --SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ 278 (361)
T ss_pred --HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH
Confidence 223445679999999998853 46899999999999999999999999999886554
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=252.91 Aligned_cols=209 Identities=29% Similarity=0.381 Sum_probs=173.4
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCC----
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD---- 142 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 142 (297)
...++|++.+.||.|++|.||+|.++.+++.|++|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 355789999999999999999999999999999999875432 22345678999999999999999999987654
Q ss_pred ------eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceE
Q 022447 143 ------QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (297)
Q Consensus 143 ------~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~k 216 (297)
.+++++||+++ ++...+... ...+++..++.++.|++.||.|||+.+ |+|+||+|+||++++++.++
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999985 777776642 356899999999999999999999999 99999999999999999999
Q ss_pred EecccCccccCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 217 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 217 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
|+|||.+........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+
T Consensus 157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~ 225 (302)
T cd07864 157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA 225 (302)
T ss_pred eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 999999875432221 11122346778999998764 457889999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=255.38 Aligned_cols=209 Identities=26% Similarity=0.372 Sum_probs=171.8
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhccCCCCccceeeEeecC-------
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADG------- 141 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------- 141 (297)
.++|++.+.||.|++|.||+|.+..++..+++|.+....... ...+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999999999999999986543322 24567899999999999999999987543
Q ss_pred -CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecc
Q 022447 142 -DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (297)
Q Consensus 142 -~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Df 220 (297)
...+++|||+. ++|...+.. ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 34689999997 567776654 2457999999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCCc---------ceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 221 GLAKLGPVGDNT---------HVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 221 g~~~~~~~~~~~---------~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
|++......... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+....
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~ 235 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ 235 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 998753222111 11123456888999998765 4578999999999999999999999987766543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=253.04 Aligned_cols=200 Identities=35% Similarity=0.474 Sum_probs=171.2
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.|...+.||+|+||.||+|.+..++..+++|.+...... ....+..|+.+++.++|||++++++++.+....++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 477888999999999999999999999999998754322 23467889999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+. ++|.+.+... ..++++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 106 YCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred CCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 998 5777777542 456899999999999999999999999 99999999999999999999999998864221
Q ss_pred CCcceeecccccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.....++..|+|||.+. +..++.++|+||||+++|+|++|+.||...+...
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~ 231 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 231 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 22345888999999873 4568899999999999999999999997765433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=250.41 Aligned_cols=204 Identities=26% Similarity=0.350 Sum_probs=175.5
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
|++.+.||+|++|.||+|.+..+++.+++|.+...... ....+.+|+.+++.++|+||+++++++......++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67788999999999999999999999999998765333 3456788999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
+ ++|.+.+... ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 D-TDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred C-CCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 8 4888887652 357899999999999999999999999 9999999999999999999999999987643322
Q ss_pred cceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 232 THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+.
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~ 207 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ 207 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 122234578899999998776 789999999999999999999999988765443
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=257.26 Aligned_cols=200 Identities=25% Similarity=0.346 Sum_probs=171.4
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCC-----
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD----- 142 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 142 (297)
..++|++.+.||+|++|.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 567899999999999999999999999999999998653222 2345778999999999999999999987543
Q ss_pred -eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 022447 143 -QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (297)
Q Consensus 143 -~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg 221 (297)
.+++||||+ |++|.+++.. ..+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999998 6899888864 56899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
++..... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.
T Consensus 164 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 221 (343)
T cd07880 164 LARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221 (343)
T ss_pred ccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9875321 1223457889999998865 4578899999999999999999999987654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=251.23 Aligned_cols=199 Identities=35% Similarity=0.479 Sum_probs=170.4
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
|...+.||+|++|.||+|.+..++..|++|.+...... ....+..|+.+++.++|||++++++++.+....|++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999999999999999998754322 224678899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+. ++|.+++... ..++++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~--- 172 (313)
T cd06633 103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS--- 172 (313)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC---
Confidence 97 5777777542 456899999999999999999999999 9999999999999999999999999875421
Q ss_pred CcceeecccccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
......|+..|+|||++. +..++.++|+||||+++|+|++|..||...+...
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~ 227 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 227 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 122456889999999874 4568889999999999999999999998765433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=252.94 Aligned_cols=204 Identities=26% Similarity=0.356 Sum_probs=168.2
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccC-CCCccceeeEeecCCeeEEEEe
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.+|+..+.||+|+||.||++.+..++..||+|.+..... .....+..|+.++.++. |+||+++++++......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 356667889999999999999999999999999875433 23456788999999886 9999999999999999999999
Q ss_pred cCCCCChHhhhccc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 150 YMPLGSVEDHLHDL-SPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 150 ~~~g~~L~~~l~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|+. +++.++.... ......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+|||++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 986 4655543221 11136789999999999999999999974 7 9999999999999999999999999986432
Q ss_pred CCCCcceeecccccccccCccccccC---CCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTG---QLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
... ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||....
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 211 11233588899999998765 68899999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=290.83 Aligned_cols=206 Identities=27% Similarity=0.355 Sum_probs=177.4
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
-++.-...||.|.||.||.|.+..+|+..|+|.+..... .....+-+|..++..++|||+|++|++-...+..+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 456777899999999999999999999999998764322 223457789999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
||+||+|.+.+.. +.-.++.....+..|++.|+.|||++| ||||||||+|||++.+|.+|++|||.|......
T Consensus 1315 yC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999986 566788888999999999999999999 999999999999999999999999999764333
Q ss_pred C--CcceeecccccccccCccccccC---CCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 230 D--NTHVSTRVMGTYGYCAPEYAKTG---QLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 230 ~--~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
. .........||+-|||||++.+. .-..++|||||||++.||+||+.||...+.+
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence 1 11122356799999999999764 3457899999999999999999999987654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=243.63 Aligned_cols=196 Identities=34% Similarity=0.427 Sum_probs=172.5
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCCh
Q 022447 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (297)
Q Consensus 80 lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L 156 (297)
||.|++|.||++.+..+++.+++|.+...... ....+..|+.+++.++|+||+++++.+......+++||++.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999989999999998765433 234678899999999999999999999999999999999999999
Q ss_pred HhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcceee
Q 022447 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236 (297)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 236 (297)
.+++.. ...+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 999986 457899999999999999999999999 9999999999999999999999999987532221 1233
Q ss_pred cccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 237 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
...++..|+|||...+...+.++|+||||+++|+|++|..||...+..
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~ 199 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK 199 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 456888999999998888899999999999999999999999877653
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=254.51 Aligned_cols=201 Identities=27% Similarity=0.376 Sum_probs=172.2
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeec-CCeeE
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRL 145 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 145 (297)
...++|++.+.||.|+||.||+|.+..++..|++|.+..... .....+..|+.+++.++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 456789999999999999999999999999999998865322 234567889999999999999999999865 55788
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+++||+. ++|.+++.. .++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+..
T Consensus 87 lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 87 FVTELLG-TDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEeehhc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999984 688888764 46788899999999999999999999 99999999999999999999999999864
Q ss_pred cCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.
T Consensus 158 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~ 211 (328)
T cd07856 158 QDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211 (328)
T ss_pred cCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 221 1223457889999998765 5789999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=262.94 Aligned_cols=200 Identities=25% Similarity=0.353 Sum_probs=176.0
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccch--------HHHHHHHHHHhccC---CCCccceeeEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--------REFLVEVLMLSLLH---HPNLVNLIGYC 138 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~e~~~l~~l~---h~~i~~~~~~~ 138 (297)
...+|..+..+|.|+||.|++|+++.+...|+||.|.++..-.. -.+-.|+++|..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 34569999999999999999999999999999999876543221 12456999999987 99999999999
Q ss_pred ecCCeeEEEEecC-CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEE
Q 022447 139 ADGDQRLLVYEYM-PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 217 (297)
Q Consensus 139 ~~~~~~~lv~e~~-~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl 217 (297)
++++.+|++||-- +|-+|.++|.. +..++|.++..|+.|++.|+++||++| |||||||-+|++++.+|-+||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEE
Confidence 9999999999975 57799999987 788999999999999999999999999 999999999999999999999
Q ss_pred ecccCccccCCCCCcceeecccccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCc
Q 022447 218 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDT 280 (297)
Q Consensus 218 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~ 280 (297)
+|||.+... ...+...++||..|.|||++.+..| +..-|||+||++||.++...-||..
T Consensus 712 idfgsaa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 712 IDFGSAAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eeccchhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999998652 2334567889999999999998877 5668999999999999999988853
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=254.56 Aligned_cols=199 Identities=25% Similarity=0.377 Sum_probs=168.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCC------
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 142 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 142 (297)
.++|.+.+.||+|++|.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999999999999999998754222 2345788999999999999999999986542
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
.+++++||+. .+|..++. ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4689999986 46666542 35889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 223 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
+..... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..
T Consensus 164 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~ 221 (342)
T cd07879 164 ARHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL 221 (342)
T ss_pred CcCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 875321 1223457889999998866 46889999999999999999999999987643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=253.38 Aligned_cols=202 Identities=22% Similarity=0.303 Sum_probs=165.4
Q ss_pred ceeccc--CcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEG--GFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G--~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
..||.| +|++||+|.+..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++...+..++++||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 9999999999999999999998754322 235678899999999999999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999988633 245889999999999999999999999 9999999999999999999999997643211110000
Q ss_pred -----eeecccccccccCccccccC--CCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 234 -----VSTRVMGTYGYCAPEYAKTG--QLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 234 -----~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~ 216 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT 216 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH
Confidence 00112345679999998763 4789999999999999999999999876543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=253.15 Aligned_cols=210 Identities=24% Similarity=0.338 Sum_probs=178.7
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCC--C----CccceeeEeecCC
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH--P----NLVNLIGYCADGD 142 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~----~i~~~~~~~~~~~ 142 (297)
...++|.+++.+|+|.||.|-.+.+..++..||||+++.-.. -.+..+-|+.++.++.+ | -++.+.++|.-.+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 347899999999999999999999999999999999864321 22445668999998842 3 3778888999999
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC-----------
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR----------- 211 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~----------- 211 (297)
+.++|+|.+ |.++++++.+. +..+++...++.+.+|+++++++||+.+ ++|.||||+|||+.+
T Consensus 165 hiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred ceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCC
Confidence 999999998 47999999873 3678999999999999999999999999 999999999999832
Q ss_pred ---------CCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 212 ---------GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 212 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
+..|+++|||.+..... .....+.|..|.|||++.+.+|+..+||||+||||+||++|...|...+
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred ccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 23489999999986322 2356778999999999999999999999999999999999999999998
Q ss_pred hHhhhhHH
Q 022447 283 AAAEQSLV 290 (297)
Q Consensus 283 ~~~~~~l~ 290 (297)
..+.++++
T Consensus 314 n~EHLaMM 321 (415)
T KOG0671|consen 314 NLEHLAMM 321 (415)
T ss_pred cHHHHHHH
Confidence 87766554
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=246.48 Aligned_cols=203 Identities=28% Similarity=0.401 Sum_probs=170.2
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhcc---CCCCccceeeEeecCCe-----
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLL---HHPNLVNLIGYCADGDQ----- 143 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~----- 143 (297)
|++.+.||+|++|.||+|.++.++..|++|.+....... ...+.+|+.+++.+ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677889999999999999999899999999997543222 23456677776655 59999999999988776
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
.+++||++. ++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999998 58988887532 235899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
....... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||...+..+
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~ 213 (287)
T cd07838 155 RIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD 213 (287)
T ss_pred eeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH
Confidence 7543221 1223357889999999998889999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=247.58 Aligned_cols=202 Identities=30% Similarity=0.408 Sum_probs=174.3
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
|++.+.||+|++|.||+|.+..+++.|++|.+.... ......+..|+.+++.++|+|++++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567789999999999999999999999999997653 222356788999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
. ++|.+++... ...+++..++.++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~- 152 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL- 152 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc-
Confidence 8 5899999862 157999999999999999999999999 9999999999999999999999999987533221
Q ss_pred cceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 232 THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..
T Consensus 153 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 205 (282)
T cd07829 153 -RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI 205 (282)
T ss_pred -cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH
Confidence 122234467789999988766 7899999999999999999999999887643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=252.58 Aligned_cols=203 Identities=25% Similarity=0.303 Sum_probs=168.5
Q ss_pred CCCCcceecccCcEEEEEEEECCC--CeEEEEEEeccCCc--cchHHHHHHHHHHhcc-CCCCccceeeEeec----CCe
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESI--NQDVAIKQLDRNGV--QGNREFLVEVLMLSLL-HHPNLVNLIGYCAD----GDQ 143 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~ 143 (297)
+|++.+.||+|+||.||++.+..+ +..||+|.+..... .....+.+|+.+++.+ .||||+++++.... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 478889999999999999999988 89999999865322 2235678899999998 59999999987532 245
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
.++++|++. ++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788999986 689988875 567999999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCC--cceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 224 KLGPVGDN--THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 224 ~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
........ ........|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~ 215 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY 215 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH
Confidence 75332211 111233568999999998765 5688999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=256.49 Aligned_cols=206 Identities=31% Similarity=0.432 Sum_probs=173.6
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-ch------HHHHHHHHHHhccCCCCccceeeEee-cCCe
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GN------REFLVEVLMLSLLHHPNLVNLIGYCA-DGDQ 143 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~------~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 143 (297)
++|-++.+||+|+|+.||+|.+......||+|+-..+..+ +. +...+|..+.+.|.||.||++|++|. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 5688999999999999999999999999999986543222 21 23678999999999999999999986 5567
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC---CCceEEecc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDF 220 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~---~~~~kl~Df 220 (297)
++-|+|||+|.+|.=|++. ...+++.+++.|+.||+.||.||... ++||+|-||||.|||+.+ .|.+||+||
T Consensus 543 FCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 7899999999999999987 67899999999999999999999998 588999999999999964 488999999
Q ss_pred cCccccCCCCCc-----ceeecccccccccCcccccc----CCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 221 GLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAKT----GQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 221 g~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
|+++........ .......||.+|++||.+.- ...+.++||||+|||+|.++.|+.||..+-
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 999874332222 22344679999999997642 245789999999999999999999998753
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=249.70 Aligned_cols=195 Identities=22% Similarity=0.249 Sum_probs=162.6
Q ss_pred CcEEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCChHhhhc
Q 022447 84 GFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH 161 (297)
Q Consensus 84 ~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~ 161 (297)
+++.||.+.+..+++.||+|++.... ......+..|+.+++.++|+||+++++++.+....+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 45667777777789999999987642 2334678899999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC-----cceee
Q 022447 162 DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN-----THVST 236 (297)
Q Consensus 162 ~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~ 236 (297)
... ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||.+........ .....
T Consensus 92 ~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 92 THF--PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred Hhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 632 345889999999999999999999999 99999999999999999999999998764321111 11112
Q ss_pred cccccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 237 RVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 237 ~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
...++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~ 215 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA 215 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 3457778999999865 3588999999999999999999999987654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=258.62 Aligned_cols=209 Identities=30% Similarity=0.459 Sum_probs=184.3
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc-hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+...+.+.||+|-||.|.++.... +..||+|.++...... ..+|..|+++|.+|+||||+.++++|..++.+++|+||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 456788999999999999998765 7899999998765444 37899999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
++.|+|.+++.+... ..+.-.....|+.||+.|++||.+.+ +|||||.++|+|++.++++||+|||.++-+..++
T Consensus 617 mEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999987422 22345566779999999999999999 9999999999999999999999999999776777
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh--CCCCCCcchhHhh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS--GRKAVDTSKAAAE 286 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~Pf~~~~~~~~ 286 (297)
........+-..+|||+|.+..+.++.++|+|++|+++||+++ ...||+..+++..
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v 749 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV 749 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH
Confidence 7776667778899999999999999999999999999999865 7799999877653
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=246.10 Aligned_cols=203 Identities=28% Similarity=0.377 Sum_probs=171.9
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccC-CCCccceeeEeecCCeeEEEEecC
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
|++.+.||+|++|.||+|....+++.|+||.+...... ......+|+..++.++ |+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 67888999999999999999989999999998654322 2234567899999999 999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
+++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~-- 152 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSR-- 152 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCC--
Confidence 689999887622 247899999999999999999999999 999999999999999999999999998753221
Q ss_pred cceeecccccccccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 232 THVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.......++..|+|||.+. +..++.++|+||||+++++|++|+.||...+..+
T Consensus 153 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~ 206 (283)
T cd07830 153 -PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID 206 (283)
T ss_pred -CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH
Confidence 1123356788999999874 4567899999999999999999999997765433
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=243.88 Aligned_cols=205 Identities=26% Similarity=0.351 Sum_probs=172.2
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC-----ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-----VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
+|.+.+.||+|++|.||++.+..++..+++|+++... ......+..|+.+++.++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888999999999999999998877777777665322 12233566789999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
+||+++++|.+++.........+++..++.++.|++.|+.|||+.+ ++|+||+|+||++++ +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999998764444567999999999999999999999999 999999999999975 569999999986532
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
.. ........+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 157 ~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~ 210 (260)
T cd08222 157 GS--CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF 210 (260)
T ss_pred CC--cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 21 1222345578899999999888889999999999999999999999976544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=249.28 Aligned_cols=201 Identities=34% Similarity=0.454 Sum_probs=170.4
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
..|...+.||.|++|.||+|.+..++..+++|.+..... ....++.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 347777889999999999999999999999999864322 22346778999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+. ++|.+.+... ..++++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9997 6787777542 356899999999999999999999999 99999999999999999999999998865321
Q ss_pred CCCcceeecccccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.....+++.|+|||.+. ...++.++|||||||++|+|++|..||...+...
T Consensus 168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 221 (308)
T cd06634 168 ------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (308)
T ss_pred ------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH
Confidence 22345888999999874 3467889999999999999999999997765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=261.45 Aligned_cols=198 Identities=29% Similarity=0.380 Sum_probs=171.9
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
+...|.+...+|.|+|+.|..+.+..+++..++|++.+.... ..+|+.++... +||||+++++.+.+....|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 467899999999999999999999999999999999876222 22366555544 6999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE-cCCCceEEecccCccccC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL-DRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili-~~~~~~kl~Dfg~~~~~~ 227 (297)
|.+.|+.+.+.+.. ...+. .++..|+.+|+.|+.|||++| +||||+||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~----~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS----KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHh----cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999999998886 33333 788899999999999999999 9999999999999 688999999999997533
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
.. ..+.+-|..|.|||++...+|++++|+||||++||+||+|+.||......
T Consensus 468 ~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 468 RS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred hh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 22 33456788999999999999999999999999999999999999987665
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=255.07 Aligned_cols=203 Identities=26% Similarity=0.374 Sum_probs=173.4
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhccCCCCccceeeEeecCCe---
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ--- 143 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 143 (297)
...++|++.+.||+|++|.||+|.+..++..|++|++.... ......+.+|+.+++.++|+|++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999999999999999986532 2233567789999999999999999998876554
Q ss_pred ---eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecc
Q 022447 144 ---RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (297)
Q Consensus 144 ---~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Df 220 (297)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccc
Confidence 89999998 5799998874 56899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
|++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+...
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~ 223 (343)
T cd07851 163 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID 223 (343)
T ss_pred ccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 998753221 233457889999998765 467899999999999999999999998766543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=246.68 Aligned_cols=201 Identities=28% Similarity=0.382 Sum_probs=169.9
Q ss_pred CCCCcceecccCcEEEEEEEEC---CCCeEEEEEEeccCCc----cchHHHHHHHHHHhcc-CCCCccceeeEeecCCee
Q 022447 73 NFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV----QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 144 (297)
+|++.+.||+|++|.||++.+. .++..|+||.+..... .....+..|+.++..+ +||+|+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999999864 4678999999875322 2234577899999999 599999999999999999
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
++||||+.+++|.+++.. ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999875 456899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCcceeecccccccccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ--LTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
....... .......|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||...
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 154 EFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred ccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 5332211 1122345889999999987654 788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=271.13 Aligned_cols=147 Identities=31% Similarity=0.418 Sum_probs=133.8
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
.++|.+.+.||.|+||.||+|.+..++..||||++....... ...+..|+.++..++||||+++++.+......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468999999999999999999999999999999997543322 25677899999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
|||+.|++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999976 456889999999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=245.67 Aligned_cols=203 Identities=28% Similarity=0.467 Sum_probs=168.2
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccC-CCCccceeeEeecCCeeEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 147 (297)
..++|++.+.||+|++|.||+|.+..++..||||.+...... ....+..|+.++.... |+||+++++++.+....+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 346789999999999999999999999999999999764332 2345666777666664 99999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
|||+. ++|.+++... ...+++..+..++.|++.|+.|||+ .+ ++||||+|+||+++.++.++|+|||++...
T Consensus 93 ~e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 93 MELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eeccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99986 5777776542 3478999999999999999999997 57 999999999999999999999999998653
Q ss_pred CCCCCcceeecccccccccCccccccCC----CCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQ----LTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
.... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||....
T Consensus 166 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 222 (296)
T cd06618 166 VDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK 222 (296)
T ss_pred cCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch
Confidence 2211 112335788999999987553 7889999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=275.63 Aligned_cols=199 Identities=32% Similarity=0.423 Sum_probs=163.4
Q ss_pred HHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecC-----
Q 022447 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG----- 141 (297)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 141 (297)
..-..+|+.++.||+|+||.||+++++-+|..||||+|+.... .....+.+|+..+.+|+|||||+++.+|.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 3456788999999999999999999999999999999987642 2235688999999999999999998764210
Q ss_pred --------------------------------------------------------------------------------
Q 022447 142 -------------------------------------------------------------------------------- 141 (297)
Q Consensus 142 -------------------------------------------------------------------------------- 141 (297)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeeEEEEecCCCCChHhhhcccCCCCCCC-CHHHHHHHHHHHHHHH
Q 022447 142 ----------------------------------DQRLLVYEYMPLGSVEDHLHDLSPGKKPL-DWNTRMKIAAGAARGL 186 (297)
Q Consensus 142 ----------------------------------~~~~lv~e~~~g~~L~~~l~~~~~~~~~l-~~~~~~~i~~qi~~al 186 (297)
...||.||||+..++.+++... ... ....+|.++.+|+.||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N----~~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN----HFNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc----ccchhhHHHHHHHHHHHHHH
Confidence 0127889999876777777652 222 4778999999999999
Q ss_pred HHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC----------------CCCCcceeecccccccccCcccc
Q 022447 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP----------------VGDNTHVSTRVMGTYGYCAPEYA 250 (297)
Q Consensus 187 ~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~----------------~~~~~~~~~~~~g~~~y~aPE~~ 250 (297)
.|+|++| +|||||||.|||++..+.|||+|||++.... .+......+..+||.-|+|||++
T Consensus 711 aYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 9999999 9999999999999999999999999987511 11122234567899999999999
Q ss_pred ccCC---CCcccchhhHHHHHHHHHh
Q 022447 251 KTGQ---LTLKSDVYSFGVVLLEILS 273 (297)
Q Consensus 251 ~~~~---~~~~~DiwslG~il~ell~ 273 (297)
.+.. |+.++||||||+|++||+.
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc
Confidence 7654 9999999999999999985
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=239.56 Aligned_cols=182 Identities=26% Similarity=0.312 Sum_probs=156.7
Q ss_pred cCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCChHhhhcc
Q 022447 83 GGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD 162 (297)
Q Consensus 83 G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~ 162 (297)
|.+|.||+|.+..+++.||+|.+.... ....|...+....||||+++++++.+.+..+++|||++|++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999999999999999997643 222344455556799999999999999999999999999999999976
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcceeecccccc
Q 022447 163 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242 (297)
Q Consensus 163 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~ 242 (297)
...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++|||.+..... ......++.
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~ 146 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVEN 146 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCc
Confidence 456899999999999999999999999 99999999999999999999999998754221 122334677
Q ss_pred cccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 243 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 243 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
.|+|||.+.+..++.++|+||+|+++|+|++|+.||...
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 899999998888999999999999999999999887654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=249.73 Aligned_cols=198 Identities=36% Similarity=0.547 Sum_probs=168.2
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhc--cCCCCccceeeEeecCC----eeE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSL--LHHPNLVNLIGYCADGD----QRL 145 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~ 145 (297)
....+.++||+|.||.||+|... ++.||||+++.. +.+.+..|-.+.+. +.|+||++++++-...+ .++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 44566788999999999999876 699999999753 34566777777765 57999999999876554 789
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh------CCCCCeeecCCCCCcEEEcCCCceEEec
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD------KAKPPVIYRDLKCSNILLDRGYHPKLSD 219 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~------~~~~~ivH~dikp~Nili~~~~~~kl~D 219 (297)
||++|.+.|+|.+|+.. ..+++.....++..|+++|+|||+ +.+++|+|||||..||||.++++..|+|
T Consensus 285 LVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 99999999999999996 679999999999999999999995 4478899999999999999999999999
Q ss_pred ccCccccCCCCCcceeecccccccccCccccccCC-CC-----cccchhhHHHHHHHHHhCCCCCC
Q 022447 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ-LT-----LKSDVYSFGVVLLEILSGRKAVD 279 (297)
Q Consensus 220 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-----~~~DiwslG~il~ell~g~~Pf~ 279 (297)
||++..+..+.........+||.+|||||++.+.. +. .+.||||+|.+||||+++-.-+.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~ 425 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD 425 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 99998777666666666689999999999997642 22 36999999999999999765554
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=242.03 Aligned_cols=210 Identities=23% Similarity=0.349 Sum_probs=179.4
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhccCCCCccceeeEeecCC-----eeE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRL 145 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 145 (297)
+.+-.+.||-|+||.||.+.+..+|+.|++|++..- +....+++.+|+.++..++|.|++..++...-.. ..|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 444567899999999999999999999999998643 3334578999999999999999999998876543 356
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+++|++. .+|...+.+ ...++...+.-+++||+.+|.|||+.+ |.||||||.|.|++.+..+||+|||+++.
T Consensus 134 V~TELmQ-SDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHH-hhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 8889887 788887776 678999999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHHh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA 291 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~~ 291 (297)
....+. ..++..+-|.+|.|||++.+ ..|+.++||||+|||+.||+.++..|....+-.+..++.
T Consensus 206 ee~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lIt 271 (449)
T KOG0664|consen 206 WDQRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMII 271 (449)
T ss_pred cchhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHH
Confidence 544333 23444567889999999987 469999999999999999999999999998888877764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=261.56 Aligned_cols=218 Identities=29% Similarity=0.410 Sum_probs=186.7
Q ss_pred CHHHHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcc-CCCCccceeeEee--
Q 022447 63 TFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCA-- 139 (297)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-- 139 (297)
.++.+..-.+-|++.+.||.|.+|.||+++++.++...|+|+....... ..++..|..+++.. .|||++.+|++|.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3444444556789999999999999999999999999999998765433 35667788898877 5999999999985
Q ss_pred ---cCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceE
Q 022447 140 ---DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (297)
Q Consensus 140 ---~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~k 216 (297)
.++++|||||||.||+..|+++... +..+.|..+..|+..++.|+.+||... ++|||||-.|||++.++.||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 3678999999999999999999866 678999999999999999999999999 99999999999999999999
Q ss_pred EecccCccccCCCCCcceeecccccccccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 217 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 217 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
|+|||++..+ ........+.+|||.|||||++.. ..|+..+|+||||++..||.-|.+|+-++.+....-
T Consensus 164 LvDFGvSaQl--dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF 238 (953)
T KOG0587|consen 164 LVDFGVSAQL--DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF 238 (953)
T ss_pred Eeeeeeeeee--ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc
Confidence 9999998653 223334567889999999998854 346789999999999999999999999988765544
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=252.53 Aligned_cols=205 Identities=31% Similarity=0.478 Sum_probs=175.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECC----CCeEEEEEEeccC-CccchHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLES----INQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
.......++||.|-||.||.|+... ....||||.-+.+ .+...+.|+.|..+++.++||||+++++++.+. ..|
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence 3344566799999999999999743 2456889988764 344457799999999999999999999999874 679
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+|||+++.|.|.++++. ++..++......++.||+.|+.|||+.. +|||||..+|||+....-+||+|||+++.
T Consensus 467 ivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred EEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence 99999999999999987 3677999999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKA 283 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~ 283 (297)
........ .....-..-|||||.+.-..++.++|||.||+++||++. |..||.+-+.
T Consensus 541 ~ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN 598 (974)
T KOG4257|consen 541 LEDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN 598 (974)
T ss_pred ccccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc
Confidence 65544332 223445678999999999999999999999999999987 9999987654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=237.43 Aligned_cols=211 Identities=25% Similarity=0.391 Sum_probs=174.3
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeec--------C
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--------G 141 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~ 141 (297)
..|+-+.+||+|.||.||+|+.+.+|+.|++|++-.++. .-....++|+.+|..++|+|++.+++.+.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 456667789999999999999999999999987543221 112456789999999999999999987743 3
Q ss_pred CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg 221 (297)
..+|+|+.+|+ .+|.-++.+ ....++..++..++.+++.+|.|+|+.. |+|||+||+|+||+.+|.++|+|||
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence 45899999998 688888875 2467999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcc--eeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 222 LAKLGPVGDNTH--VSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 222 ~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
+++.+...+... ..+..+-|..|.+||.+.+ ..|++..|||+.|||+.||++|.+-|++.+..-+..+
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~ 240 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHL 240 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHH
Confidence 997654433322 1234456999999998765 5899999999999999999999999999876555444
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=227.06 Aligned_cols=199 Identities=34% Similarity=0.444 Sum_probs=175.0
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCC
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 152 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 152 (297)
|.+.+.||.|++|.||++.+..+++.+++|.+...... ..+.+.+|+..++.++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 56778999999999999999988999999999876554 56778899999999999999999999999899999999999
Q ss_pred CCChHhhhcccCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 153 LGSVEDHLHDLSPGKKP-LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 153 g~~L~~~l~~~~~~~~~-l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
+++|.+++... .. +++..++.++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 99999999862 33 889999999999999999999998 99999999999999999999999999876433220
Q ss_pred cceeecccccccccCcccc-ccCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 022447 232 THVSTRVMGTYGYCAPEYA-KTGQLTLKSDVYSFGVVLLEILSGRKAVDT 280 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 280 (297)
.......++..|++||.+ ....++.++|+||||+++++|++|+.||+.
T Consensus 154 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 -ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122345678889999998 667788899999999999999999999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=253.07 Aligned_cols=211 Identities=29% Similarity=0.460 Sum_probs=181.0
Q ss_pred CCCcceecccCcEEEEEEEECCC---CeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 74 FRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..+.++||+|+||+|++|.++.. -..||||.+...... ...+|++|+.++.+|+|+|++++|+++.+ ....+|||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 44567899999999999998753 246899998766554 55789999999999999999999999988 56779999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
+++.|+|.+.++. ..+..|.......++.||+.|+.||.+++ +|||||..+|+++-....|||+|||+.+-+..+
T Consensus 191 LaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 9999999999998 34677889999999999999999999999 999999999999999999999999999987666
Q ss_pred CCcceeec-ccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHH
Q 022447 230 DNTHVSTR-VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 230 ~~~~~~~~-~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~ 290 (297)
+..+.+.. ..-...|+|||.+....++.++|+|++||++|||++ |..||-+-.....+..+
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i 328 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI 328 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc
Confidence 55543332 224557999999999999999999999999999999 77999987765554443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=272.73 Aligned_cols=192 Identities=31% Similarity=0.553 Sum_probs=161.7
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
...|...+.||+|+||.||+|.+..++..||+|.+....... ..|+..+++++||||+++++++.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 356778889999999999999999899999999986433221 2468889999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++.. +++..+..++.|++.|++|||.....+++||||||+||+++.++..++. ||......
T Consensus 765 ~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~--- 833 (968)
T PLN00113 765 IEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC--- 833 (968)
T ss_pred CCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc---
Confidence 999999999963 7788999999999999999994422239999999999999988887765 55443211
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDT 280 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 280 (297)
......+++.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 834 ---~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 834 ---TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred ---cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 11223578999999999999999999999999999999999999964
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=237.61 Aligned_cols=196 Identities=30% Similarity=0.456 Sum_probs=162.8
Q ss_pred HHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhc--cCCCCccceeeEeecC----
Q 022447 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSL--LHHPNLVNLIGYCADG---- 141 (297)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~---- 141 (297)
....++..+.+.||+|.||.||+|.++ |+.||||++.. .+.....+|.++++. ++|+||+.++.+-..+
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc--CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 345577889999999999999999998 89999999964 344566778877764 6999999999875433
Q ss_pred CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeeecCCCCCcEEEcCCCceE
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH-----DKAKPPVIYRDLKCSNILLDRGYHPK 216 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-----~~~~~~ivH~dikp~Nili~~~~~~k 216 (297)
.++|||++|.+.|||+|++.. .+++.+....++..++.+|++|| .+|+|.|.|||||..||||..++...
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 367999999999999999986 77999999999999999999999 47889999999999999999999999
Q ss_pred EecccCccccCCC--CCcceeecccccccccCccccccCCC------CcccchhhHHHHHHHHHh
Q 022447 217 LSDFGLAKLGPVG--DNTHVSTRVMGTYGYCAPEYAKTGQL------TLKSDVYSFGVVLLEILS 273 (297)
Q Consensus 217 l~Dfg~~~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~------~~~~DiwslG~il~ell~ 273 (297)
|+|+|+|...... .........+||.+|||||++...-. -..+||||||.++||+..
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 9999998653322 11223345689999999999865321 135999999999999875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=224.12 Aligned_cols=202 Identities=20% Similarity=0.332 Sum_probs=171.8
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC-CCCccceeeEeecC--CeeEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADG--DQRLL 146 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~l 146 (297)
..++|++.+.+|+|-++.||.|.+..+.+.++||++++- ..+.+.+|+.+|+.++ ||||+++++++.++ ..+.+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 457899999999999999999999999999999999753 3467889999999997 99999999999875 45679
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC-CceEEecccCccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKL 225 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~-~~~kl~Dfg~~~~ 225 (297)
|+|+++..+...+.. .++..+++.++.+++.||.|+|++| |.|||+||.|++|+.. ..++|+|+|+|..
T Consensus 113 iFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhh
Confidence 999998877776554 4778899999999999999999999 9999999999999964 6799999999987
Q ss_pred cCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
...+..... .+.+..|-.||++-. ..|+.+.|+|||||++..|+..+.||....+...|
T Consensus 183 YHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ 242 (338)
T KOG0668|consen 183 YHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 242 (338)
T ss_pred cCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH
Confidence 544433322 346778899998765 57899999999999999999999998877665544
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=252.76 Aligned_cols=210 Identities=32% Similarity=0.488 Sum_probs=183.1
Q ss_pred CCcceecccCcEEEEEEEECCCC----eEEEEEEeccC-CccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 75 RSESLLGEGGFGRVYKGYLESIN----QDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 75 ~~~~~lg~G~~g~v~~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
...++||+|+||+||+|.+.-.| .+||+|++... ......+++.|+.++.+++|||++++++++.... +-||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 34678999999999999986544 46888887654 4445678999999999999999999999998765 778999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+++|+|.++++.. +.++-....+.|..||++|+.|||.+. +|||||..+||||..-..+|+.|||+++.+...
T Consensus 778 ~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999973 567888999999999999999999999 999999999999999999999999999987666
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHHh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVA 291 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~~ 291 (297)
..........-.+.|||-|.+....|+.++||||+||++||++| |..|+++...++.-+++.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle 914 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE 914 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh
Confidence 55555544445678999999999999999999999999999999 999999999988877654
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=244.59 Aligned_cols=214 Identities=28% Similarity=0.447 Sum_probs=183.2
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
...+..+..+||.|.||.||.|+++...-.||||.++.. .-...+|+.|..+++.++|||+|+++++|.....+|||+|
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 344566678999999999999999999999999998654 3445789999999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
||..|+|.+|+++- +...++....++++.||.+|++||..++ +|||||..+|.|+.++..+|+.|||++++....
T Consensus 344 fM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 344 FMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred cccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 99999999999873 3456777888999999999999999999 999999999999999999999999999875333
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHH
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~ 290 (297)
. ........-..-|.|||-+.-..++.++|||+||++|||+.| |-.||.+-+...-..|+
T Consensus 419 T-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL 479 (1157)
T KOG4278|consen 419 T-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL 479 (1157)
T ss_pred c-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH
Confidence 2 222233334668999999998999999999999999999988 88999987665544443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-33 Score=252.72 Aligned_cols=206 Identities=30% Similarity=0.478 Sum_probs=177.0
Q ss_pred cCCCCcceecccCcEEEEEEEECCCC---eEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESIN---QDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~---~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
....+.++||.|.||.|++|..+..| ..||||.++..... ...+|+.|+.|+-+++||||+++.+++.......+|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 45678899999999999999987766 57999999765443 345799999999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
+|||+.|+|..+++.. .+.|+..++..++..|+.++.||-+++ +|||||..+||||+.+-..|++|||+++.+.
T Consensus 709 TEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999873 567999999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCcceeecccc--cccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhH
Q 022447 228 VGDNTHVSTRVMG--TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAA 284 (297)
Q Consensus 228 ~~~~~~~~~~~~g--~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~ 284 (297)
..... ..++.-| ..+|.|||.+.-..++.++||||+|++|||.++ |..||=+++..
T Consensus 783 dd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ 841 (996)
T KOG0196|consen 783 DDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 841 (996)
T ss_pred cCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH
Confidence 44311 1122222 469999999999999999999999999999887 88886665543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=220.54 Aligned_cols=187 Identities=36% Similarity=0.505 Sum_probs=167.1
Q ss_pred CcEEEEEEEECCCCeEEEEEEeccCCccc-hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCChHhhhcc
Q 022447 84 GFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD 162 (297)
Q Consensus 84 ~~g~v~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~ 162 (297)
+||.||+|.+..+++.+++|++....... ...+.+|+..++.++|+|++++++.+......++++|++.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999899999999997765544 57889999999999999999999999998999999999998999999976
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcceeecccccc
Q 022447 163 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242 (297)
Q Consensus 163 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~ 242 (297)
...++...++.++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++.
T Consensus 81 ----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 ----RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred ----ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 334899999999999999999999999 9999999999999999999999999987643321 233456888
Q ss_pred cccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 022447 243 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDT 280 (297)
Q Consensus 243 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 280 (297)
.|++||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999888889999999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-33 Score=240.28 Aligned_cols=212 Identities=23% Similarity=0.261 Sum_probs=181.8
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCC------CCccceeeEeecCC
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH------PNLVNLIGYCADGD 142 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~ 142 (297)
....+|.+..-.|+|-|++|.+|.+..-|..||||+|..+..- .+.=+.|+++|++|+. -|+++++..|...+
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 3457899999999999999999999999999999999865432 2444679999999863 48999999999999
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC-CceEEeccc
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFG 221 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~-~~~kl~Dfg 221 (297)
++|||+|.+. .+|.+.++.+.. +..+....+..++.||+.||..|-..+ |+|.||||+||||++. +.+||||||
T Consensus 508 HLClVFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 508 HLCLVFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred eeEEEehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 9999999986 899999987653 466889999999999999999999999 9999999999999965 678999999
Q ss_pred CccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHH
Q 022447 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~ 290 (297)
.|....... .+.+.-+.-|.|||++.|.+|+...|+||+||+||||+||+..|.+.+...++.|.
T Consensus 583 SA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~ 647 (752)
T KOG0670|consen 583 SASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF 647 (752)
T ss_pred ccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence 987533222 12233456799999999999999999999999999999999999999988887764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=244.41 Aligned_cols=204 Identities=22% Similarity=0.268 Sum_probs=146.0
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCC----CeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeE------ee
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESI----NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGY------CA 139 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~ 139 (297)
..++|.+.+.||+|+||.||+|.+..+ +..||+|.+...... .....+ .+....+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 457899999999999999999999998 899999987643221 111111 1111122222222221 23
Q ss_pred cCCeeEEEEecCCCCChHhhhcccCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 022447 140 DGDQRLLVYEYMPLGSVEDHLHDLSPG----------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 203 (297)
Q Consensus 140 ~~~~~~lv~e~~~g~~L~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dik 203 (297)
.....++|+||+.+++|.+++...... ........+..++.||+.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 456789999999999999998752100 011123456789999999999999999 9999999
Q ss_pred CCcEEEcC-CCceEEecccCccccCCCCCcceeecccccccccCccccccC----------------------CCCcccc
Q 022447 204 CSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG----------------------QLTLKSD 260 (297)
Q Consensus 204 p~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~D 260 (297)
|+|||++. ++.+||+|||++....... ........+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 5799999999997543222 2223456789999999965332 2334569
Q ss_pred hhhHHHHHHHHHhCCCCCCcc
Q 022447 261 VYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 261 iwslG~il~ell~g~~Pf~~~ 281 (297)
||||||++|||+++..|++..
T Consensus 362 VwSlGviL~el~~~~~~~~~~ 382 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN 382 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH
Confidence 999999999999988776543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=236.09 Aligned_cols=206 Identities=23% Similarity=0.289 Sum_probs=152.0
Q ss_pred hcCCCCcceecccCcEEEEEEEEC----------------CCCeEEEEEEeccCCccchHH--------------HHHHH
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLE----------------SINQDVAIKQLDRNGVQGNRE--------------FLVEV 120 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e~ 120 (297)
.++|.+.++||+|+||.||+|... ..+..||||.+........++ ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 468999999999999999999752 235679999986543222222 33466
Q ss_pred HHHhccCCCC-----ccceeeEeec--------CCeeEEEEecCCCCChHhhhcccCC--------------------CC
Q 022447 121 LMLSLLHHPN-----LVNLIGYCAD--------GDQRLLVYEYMPLGSVEDHLHDLSP--------------------GK 167 (297)
Q Consensus 121 ~~l~~l~h~~-----i~~~~~~~~~--------~~~~~lv~e~~~g~~L~~~l~~~~~--------------------~~ 167 (297)
.++.+++|.+ ++++++++.. ....++|+||+.+++|.++++.... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 6677776554 3666666543 3567999999999999999874211 01
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcceeecccccccccCc
Q 022447 168 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247 (297)
Q Consensus 168 ~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aP 247 (297)
..+++..++.++.|++.+|.|||+.+ ++||||||+|||++.++.++|+|||++......... ......+++.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence 23466788999999999999999999 999999999999999999999999998653222111 11122357899999
Q ss_pred cccccCCC--------------------C--cccchhhHHHHHHHHHhCCC-CCCc
Q 022447 248 EYAKTGQL--------------------T--LKSDVYSFGVVLLEILSGRK-AVDT 280 (297)
Q Consensus 248 E~~~~~~~--------------------~--~~~DiwslG~il~ell~g~~-Pf~~ 280 (297)
|.+..... + ...|+||+||++|+|++|.. ||..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 98754321 1 24799999999999999985 7764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=217.16 Aligned_cols=199 Identities=23% Similarity=0.397 Sum_probs=163.5
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC-CCCccceeeE-eecCCeeEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGY-CADGDQRLLV 147 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~~~~~~lv 147 (297)
..+.|.+.+.||+|.||.+-++.++.+...+++|.++... ....+|.+|...--.|. |.||+..|++ |+..+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3467999999999999999999999999999999987653 34578889987766664 8999988875 6677788899
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEc--CCCceEEecccCccc
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD--RGYHPKLSDFGLAKL 225 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~--~~~~~kl~Dfg~~~~ 225 (297)
+||++.|+|.+-+.. ..+-|.....++.|+++||.|+|+.+ +||||||.+||||- +..++||+|||....
T Consensus 101 qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence 999999999988875 56889999999999999999999999 99999999999984 335899999998764
Q ss_pred cCCCCCcceeecccccccccCccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTG-----QLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
... .-....-+..|.+||.+... ...+.+|+|.||+++|.+++|..||....
T Consensus 173 ~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~ 229 (378)
T KOG1345|consen 173 VGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS 229 (378)
T ss_pred cCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh
Confidence 111 11112245568999976432 34688999999999999999999999543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=242.18 Aligned_cols=216 Identities=25% Similarity=0.328 Sum_probs=193.6
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|+++..+|+|.+|.||+|+++.+++..|+|+++.....+..-+.+|+-+++.++||||+.+++.+...+..|+.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 35799999999999999999999999999999999987767777788899999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
|.||+|.+..+- ..++++.++..++.+.+++++|||+++ -+|||||-.||++++.|.++|.|||.+-.+ ..
T Consensus 94 cgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqi--ta 164 (829)
T KOG0576|consen 94 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQI--TA 164 (829)
T ss_pred cCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhh--hh
Confidence 999999999887 789999999999999999999999999 899999999999999999999999987542 22
Q ss_pred CcceeecccccccccCcccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHHhhcCC
Q 022447 231 NTHVSTRVMGTYGYCAPEYA---KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEP 295 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~~~~~p 295 (297)
...+...+.||++|||||+. +...|...+|||++|++..|+---+.|..+..+-....|++-..|
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~ 232 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGF 232 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCC
Confidence 33455678899999999975 456789999999999999999999999888877777777766554
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=218.56 Aligned_cols=202 Identities=25% Similarity=0.324 Sum_probs=173.8
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhccCCCCccceeeEeecC------
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------ 141 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 141 (297)
...+|.-+..+|.|+- .|..|.+.-.+.+|++|..... .....++..+|..++..+.|+||++++.+|.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 3467888899999998 7888999999999999987543 334456788999999999999999999998643
Q ss_pred CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg 221 (297)
...|+|||+++ .+|.+.+.. .++-+.+..++.|++.|+++||+.+ |+||||||+||++..+..+||.|||
T Consensus 94 ~e~y~v~e~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 94 QEVYLVMELMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred HhHHHHHHhhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccch
Confidence 34689999998 789888873 3677899999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
+++... .....+.++.+..|.|||++.+..+.+.+||||+||++.||++|+..|.+.+.-+
T Consensus 164 ~ar~e~---~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~id 224 (369)
T KOG0665|consen 164 LARTED---TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHID 224 (369)
T ss_pred hhcccC---cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHH
Confidence 997522 2235566789999999999999999999999999999999999999999766543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=234.58 Aligned_cols=207 Identities=31% Similarity=0.472 Sum_probs=171.1
Q ss_pred hcCCCCcceecccCcEEEEEEEEC----C---CCeEEEEEEeccCCc-cchHHHHHHHHHHhcc-CCCCccceeeEeecC
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLE----S---INQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 141 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~----~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 141 (297)
.++..+.+.||+|+||.|++|.-. . ....||||.++.... .+.+.+..|+.+++.+ +|+||+.+++++...
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 344566779999999999998743 1 156799999875433 3456789999999988 599999999999998
Q ss_pred CeeEEEEecCCCCChHhhhcccC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLS---PG-------K--KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~---~~-------~--~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili 209 (297)
...++|+||+..|+|.+++...+ .- . ..++..+.+.++.||+.|++||++.. +|||||..+|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 89999999999999999998754 00 0 23889999999999999999999999 9999999999999
Q ss_pred cCCCceEEecccCccccCCCCCcceeeccc--ccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcc
Q 022447 210 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVM--GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTS 281 (297)
Q Consensus 210 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~ 281 (297)
..+..+||+|||+++.......... .... -...|||||.+....|+.++||||+|++|||+++ |..||.+-
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 9999999999999985433322221 1112 2446999999999999999999999999999999 88999874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=216.68 Aligned_cols=132 Identities=23% Similarity=0.328 Sum_probs=113.0
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC-----C---CCccceeeEeec---
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-----H---PNLVNLIGYCAD--- 140 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~i~~~~~~~~~--- 140 (297)
.+|.+.++||-|.|++||+|.+..+...||+|+.+... .-.+..+.||.+|++++ | .+||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 68999999999999999999999999999999986432 12245678999999874 2 479999999864
Q ss_pred -CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE
Q 022447 141 -GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (297)
Q Consensus 141 -~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili 209 (297)
..+.++|+|++ |.+|..+|.... ...++...+++|++||+.||.|||+.- +|+|.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56889999998 689999998633 577899999999999999999999843 39999999999999
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=236.45 Aligned_cols=203 Identities=27% Similarity=0.371 Sum_probs=165.8
Q ss_pred CCCcceecccCcE-EEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEEEecC
Q 022447 74 FRSESLLGEGGFG-RVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 74 y~~~~~lg~G~~g-~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
|.-.+.+|.|+.| .||+|... |+.||||.+-... .....+|+..++.- .||||+++|+.-.++...|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 3344678999987 58999987 7899999875432 23456799999887 4999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCC-CHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC---C--CceEEecccCccc
Q 022447 152 PLGSVEDHLHDLSPGKKPL-DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---G--YHPKLSDFGLAKL 225 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l-~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~---~--~~~kl~Dfg~~~~ 225 (297)
. .+|.+++.... ..... .....+.++.|+++||++||+.+ ||||||||.||||.. + ..++|+|||+++.
T Consensus 586 ~-~sL~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 586 A-CSLQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred h-hhHHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 8 89999998631 11111 11466889999999999999999 999999999999975 3 4689999999988
Q ss_pred cCCCCCcce-eecccccccccCccccccCCCCcccchhhHHHHHHHHHhC-CCCCCcchhHhh
Q 022447 226 GPVGDNTHV-STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAAE 286 (297)
Q Consensus 226 ~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~Pf~~~~~~~~ 286 (297)
+..+..... .....||.+|+|||++.+...+.++|||||||++|+.++| .+||.+.-.++.
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~ 723 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA 723 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh
Confidence 766554432 3456799999999999998888999999999999999996 899998876643
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=215.94 Aligned_cols=207 Identities=29% Similarity=0.373 Sum_probs=173.1
Q ss_pred HHHHhcCCCCcceecccCcEEEEEEEECC---CCeEEEEEEeccCCccchHHHHHHHHHHhccC-CCCccceeeEeecCC
Q 022447 67 LAAATKNFRSESLLGEGGFGRVYKGYLES---INQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGD 142 (297)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 142 (297)
+....+.|.+.++||.|+|++||++.+.. ....||+|.+..... -.++..|+++|..+. +.||+++.+.+..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 44556789999999999999999999887 789999999876433 356888999999885 899999999999999
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC-CCceEEeccc
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFG 221 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~-~~~~kl~Dfg 221 (297)
...+|+||++.....++... ++..++..+++.++.||.++|..| ||||||||.||+.+. .+.-.|+|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 99999999999888888875 668899999999999999999999 999999999999985 5778999999
Q ss_pred Ccccc-----------------CC--C-----------------------CCcceeecccccccccCcccccc-CCCCcc
Q 022447 222 LAKLG-----------------PV--G-----------------------DNTHVSTRVMGTYGYCAPEYAKT-GQLTLK 258 (297)
Q Consensus 222 ~~~~~-----------------~~--~-----------------------~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~ 258 (297)
++... .. + ..........||++|.|||++.. ...+.+
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 98610 00 0 00001112469999999998865 456889
Q ss_pred cchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 259 SDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 259 ~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
+||||.|+|+..++++++||....++.
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~ 285 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDA 285 (418)
T ss_pred cceeeccceeehhhccccccccCcccc
Confidence 999999999999999999998776543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=201.07 Aligned_cols=209 Identities=24% Similarity=0.300 Sum_probs=176.1
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCC-CCccceeeEeecCCeeEEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 148 (297)
....|.+++.||+|+||.+|+|.+..+|+.||||+-.... ....+..|..+.+.+++ ..|..+..+..+..+..+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 4578999999999999999999999999999999864321 22346678999998874 78888888888889999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC---CCceEEecccCccc
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKL 225 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~---~~~~kl~Dfg~~~~ 225 (297)
+++ |.+|.++..- ....++..+++.++.|++.-++|+|.++ ++||||||+|+|..- .+.+.|+|||+++.
T Consensus 91 dLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 998 6899888864 3577999999999999999999999999 999999999999963 46799999999976
Q ss_pred cCCCCC-----cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 226 GPVGDN-----THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 226 ~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
.-.... ........||.+|.+-..+.+...+.+.|+-|+|.+|.++..|..||.+......+
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~ 230 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK 230 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH
Confidence 422211 12233567999999999888888999999999999999999999999998876653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=205.33 Aligned_cols=207 Identities=25% Similarity=0.321 Sum_probs=176.9
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC-CCCccceeeEeecCCeeEEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 148 (297)
..-.|++.++||+|+||.++.|.+--+++.||||.-+.. .+.-.+..|....+.|. .++|..+|.+..+..+..||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 345799999999999999999999999999999986543 23345677888888875 799999999999988999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC-----CCceEEecccCc
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-----GYHPKLSDFGLA 223 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~-----~~~~kl~Dfg~~ 223 (297)
|++ |.+|.|+..- .+..|+..++..++.||+.-++++|++. +|+|||||+||||.. .+.|.++|||++
T Consensus 104 dLL-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhh-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 998 6899888764 3688999999999999999999999999 999999999999964 356899999999
Q ss_pred cccCCCCC-----cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 224 KLGPVGDN-----THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 224 ~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
+....... ........||.+||+-..+.+.+.+.+.|+-|||-++++.|.|..||.+...+.
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 86433322 223345679999999999999999999999999999999999999999887654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-28 Score=196.36 Aligned_cols=184 Identities=40% Similarity=0.582 Sum_probs=160.4
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCChHh
Q 022447 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 158 (297)
Q Consensus 80 lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~ 158 (297)
||+|++|.||++....+++.+++|++...... ....+.+|+..++.+.|++++++++++......++++|++.|++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999988999999999765433 34678899999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC-CCceEEecccCccccCCCCCcceeec
Q 022447 159 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTR 237 (297)
Q Consensus 159 ~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 237 (297)
++.... ..++...++.++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 998621 46899999999999999999999999 999999999999999 89999999999875432211 1233
Q ss_pred ccccccccCccccccC-CCCcccchhhHHHHHHHH
Q 022447 238 VMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEI 271 (297)
Q Consensus 238 ~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el 271 (297)
..+...|++||..... ..+.++|+|+||+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 4578899999998777 788999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=207.97 Aligned_cols=205 Identities=24% Similarity=0.268 Sum_probs=169.6
Q ss_pred CCCCcceecccCcEEEEEEEECCCC-eEEEEEEeccCCccchHHHHHHHHHHhccC----CCCccceeeEe-ecCCeeEE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESIN-QDVAIKQLDRNGVQGNREFLVEVLMLSLLH----HPNLVNLIGYC-ADGDQRLL 146 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~l 146 (297)
+|.+.+.||+|+||.||.|.+..++ ..+|+|+...........+..|..++..+. .+++..+++.. ......|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 8999999999999999999998775 678888876543332235667888888776 36899999999 57788999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC-----CceEEeccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-----YHPKLSDFG 221 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~-----~~~kl~Dfg 221 (297)
||+.+ |.+|.++..... ...++..++..++.|++.+|++||+.| ++||||||+|+++... ..+.|+|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99987 699999886643 577999999999999999999999999 9999999999999865 469999999
Q ss_pred Ccc--ccCCCCC-----cce-eecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 222 LAK--LGPVGDN-----THV-STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 222 ~~~--~~~~~~~-----~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
+++ ....... ... .....||.+|.++..+.+...+.+.|+||++.++.+++.|..||...+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 998 3211111 111 2235599999999999999999999999999999999999999977664
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=203.63 Aligned_cols=226 Identities=24% Similarity=0.364 Sum_probs=188.1
Q ss_pred CHHHHHHHhcCCCCcceecccCcEEEEEEEECCCC-----eEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceee
Q 022447 63 TFRELAAATKNFRSESLLGEGGFGRVYKGYLESIN-----QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIG 136 (297)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~ 136 (297)
+..++.....+++....+-+|.||.||.|+++... +.|.+|.++.... -....++.|..++..+.|||+.++.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 34556667788999999999999999999876432 4466676654322 23356888999999999999999999
Q ss_pred Eeec-CCeeEEEEecCCCCChHhhhc-----ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEc
Q 022447 137 YCAD-GDQRLLVYEYMPLGSVEDHLH-----DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 210 (297)
Q Consensus 137 ~~~~-~~~~~lv~e~~~g~~L~~~l~-----~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~ 210 (297)
+..+ ...+++++.++..|+|..++. +.. .-..++-.+...++.|++.|++|||+++ +||.||..+|.+|+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~-~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPS-YAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVID 430 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCc-cccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceeh
Confidence 8754 567889999999999999998 221 1345677788999999999999999999 99999999999999
Q ss_pred CCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhH
Q 022447 211 RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (297)
Q Consensus 211 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l 289 (297)
+.-++||+|=.+++.+-..+........-....||+||.+.+..|+.++|+||||++||||+| |+.|+..-++.+...+
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y 510 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY 510 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence 999999999999987766666666655667789999999999999999999999999999999 9999999999888776
Q ss_pred Hhh
Q 022447 290 VAW 292 (297)
Q Consensus 290 ~~~ 292 (297)
+..
T Consensus 511 lkd 513 (563)
T KOG1024|consen 511 LKD 513 (563)
T ss_pred Hhc
Confidence 653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=207.07 Aligned_cols=172 Identities=17% Similarity=0.112 Sum_probs=131.8
Q ss_pred HHHHHHHhcCCCCcceecccCcEEEEEEEECC-CCeEEEEEEeccCC-----ccchHHHHHHHHHHhccCCCCccceeeE
Q 022447 64 FRELAAATKNFRSESLLGEGGFGRVYKGYLES-INQDVAIKQLDRNG-----VQGNREFLVEVLMLSLLHHPNLVNLIGY 137 (297)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 137 (297)
.++......+|.+.+.||+|+||+||+|.+.. ++..||||++.... ......+.+|+.+++.++|+|+++.+..
T Consensus 10 ~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~ 89 (365)
T PRK09188 10 GDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA 89 (365)
T ss_pred ccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence 34455677899999999999999999999876 67888999875331 1123458899999999999999853322
Q ss_pred eecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC-CCCcEEEcCCCceE
Q 022447 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDL-KCSNILLDRGYHPK 216 (297)
Q Consensus 138 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~di-kp~Nili~~~~~~k 216 (297)
+ ...|+||||++|++|.. +.. .. ...++.|++++|.|||++| |+|||| ||+|||++.++.++
T Consensus 90 ~---~~~~LVmE~~~G~~L~~-~~~----~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 90 T---GKDGLVRGWTEGVPLHL-ARP----HG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred c---CCcEEEEEccCCCCHHH-hCc----cc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEE
Confidence 2 45799999999999963 211 11 1467889999999999999 999999 99999999999999
Q ss_pred EecccCccccCCCCCcce------eecccccccccCcccccc
Q 022447 217 LSDFGLAKLGPVGDNTHV------STRVMGTYGYCAPEYAKT 252 (297)
Q Consensus 217 l~Dfg~~~~~~~~~~~~~------~~~~~g~~~y~aPE~~~~ 252 (297)
|+|||+++.......... -....+++.|+|||.+..
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999999986433221111 134567888999998754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-24 Score=187.15 Aligned_cols=203 Identities=39% Similarity=0.559 Sum_probs=172.7
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhccCCC-CccceeeEeecCCeeEEEEe
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHP-NLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e 149 (297)
|.+...||.|+|+.||++.+. ..+++|.+....... ...+.+|+.++..+.|+ +++++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 677889999999999999988 788999987654433 56788899999999988 79999999987777899999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC-ceEEecccCccccCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGPV 228 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~-~~kl~Dfg~~~~~~~ 228 (297)
++.++++.+++...... ..+....+..++.|++.++.++|+.+ ++|||+||+||+++..+ .++++|||.+.....
T Consensus 79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 99999999777652111 37899999999999999999999999 99999999999999988 799999999875433
Q ss_pred CCCcc----eeecccccccccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 229 GDNTH----VSTRVMGTYGYCAPEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 229 ~~~~~----~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
..... ......|+..|++||.+.+ ..++...|+||+|++++++++|..||.....
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 32221 3456789999999999987 5788999999999999999999999888764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=181.70 Aligned_cols=170 Identities=12% Similarity=0.117 Sum_probs=132.7
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHH---------HHHHHHHHhccCCCCccceeeEeec
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---------FLVEVLMLSLLHHPNLVNLIGYCAD 140 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~~i~~~~~~~~~ 140 (297)
...+|++.+++|.|+||.||++.. ++..+|||++.......... +.+|+..+.++.|++|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 468999999999999999999755 36689999997654433322 5788999999999999999988664
Q ss_pred C--------CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC
Q 022447 141 G--------DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 212 (297)
Q Consensus 141 ~--------~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~ 212 (297)
. ...+++|||++|.+|.++.. +++ ....+++.++..+|+.| ++||||+|+||+++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence 3 35789999999999987632 222 24568999999999999 9999999999999998
Q ss_pred CceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHH
Q 022447 213 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 271 (297)
Q Consensus 213 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el 271 (297)
| ++|+|||.......... ...+.....+..++|+||||+++..+
T Consensus 172 g-i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred C-EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHH
Confidence 8 99999998764211100 01134455677899999999987654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-26 Score=218.47 Aligned_cols=149 Identities=18% Similarity=0.236 Sum_probs=113.1
Q ss_pred cCC-CCccceeeEe-------ecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 022447 126 LHH-PNLVNLIGYC-------ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197 (297)
Q Consensus 126 l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i 197 (297)
++| .||++++++| .....+++++|++. ++|.+++.. ....+++.+++.++.||+.||.|||+++ |
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 344 5777777776 23346678889875 799999975 2356999999999999999999999999 9
Q ss_pred eecCCCCCcEEEcCCCce-------------------EEecccCccccCCCC--------------Ccceeecccccccc
Q 022447 198 IYRDLKCSNILLDRGYHP-------------------KLSDFGLAKLGPVGD--------------NTHVSTRVMGTYGY 244 (297)
Q Consensus 198 vH~dikp~Nili~~~~~~-------------------kl~Dfg~~~~~~~~~--------------~~~~~~~~~g~~~y 244 (297)
+||||||+|||++..+.+ |++|||+++...... .........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999655444 455555543211000 00001124588899
Q ss_pred cCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 245 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
+|||++.+..++.++|||||||+||||++|..||...
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~ 218 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK 218 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH
Confidence 9999999999999999999999999999999998753
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-25 Score=175.35 Aligned_cols=138 Identities=15% Similarity=0.084 Sum_probs=108.9
Q ss_pred cceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--c-------h-----------------HHHHHHHHHHhccCCCC
Q 022447 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--G-------N-----------------REFLVEVLMLSLLHHPN 130 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~~ 130 (297)
...||+|++|.||+|.+. +|+.||||+++..... . . .....|+..+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 8999999998754221 1 0 11234899999998887
Q ss_pred ccceeeEeecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeecCCCCCcEEE
Q 022447 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL-HDKAKPPVIYRDLKCSNILL 209 (297)
Q Consensus 131 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~~ivH~dikp~Nili 209 (297)
+........ ...++||||++|+++...... ..++++..+..++.|++.+|.++ |+.| |+||||||+||++
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 754443322 223899999998777654332 35788999999999999999999 7999 9999999999999
Q ss_pred cCCCceEEecccCccc
Q 022447 210 DRGYHPKLSDFGLAKL 225 (297)
Q Consensus 210 ~~~~~~kl~Dfg~~~~ 225 (297)
+ ++.++|+|||++..
T Consensus 152 ~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 152 H-DGKLYIIDVSQSVE 166 (190)
T ss_pred E-CCcEEEEEcccccc
Confidence 8 47899999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=204.81 Aligned_cols=197 Identities=22% Similarity=0.238 Sum_probs=165.6
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC---CCCccceeeEeecCCeeEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 146 (297)
....|.|.+.||+|+||.||+|.+.. |+.||+|+-+.....+..-. .+++.+|+ -+.|+.+..++.-.+.-++
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~---~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC---LQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh---HHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 44678899999999999999999988 99999999887766643211 12223333 3567778888888888899
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC-------CCceEEec
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-------GYHPKLSD 219 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~-------~~~~kl~D 219 (297)
|+||.+.|+|.+++.. ...+++..+..+..||+..|+.||..+ |||+||||+|+|+.. ..-++|+|
T Consensus 772 v~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999984 678999999999999999999999999 999999999999942 34589999
Q ss_pred ccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 022447 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 277 (297)
Q Consensus 220 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 277 (297)
||.+...............++|-.+-.+|+..|..|+.++|.|.|+.+++-||.|++-
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9998765444455566777899999999999999999999999999999999999853
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=167.38 Aligned_cols=139 Identities=16% Similarity=0.099 Sum_probs=110.9
Q ss_pred CcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc--------------------------hHHHHHHHHHHhccCCC
Q 022447 76 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--------------------------NREFLVEVLMLSLLHHP 129 (297)
Q Consensus 76 ~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~ 129 (297)
+.+.||+|++|.||+|.+. +|+.||||++....... ...+..|...+..+.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 89999999987642210 11235688899999999
Q ss_pred CccceeeEeecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEE
Q 022447 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNIL 208 (297)
Q Consensus 130 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~dikp~Nil 208 (297)
++.....+... ..++||||++|+++...... ...++...+..++.|++.++.++|. .| |+||||||+||+
T Consensus 80 ~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIl 150 (190)
T cd05145 80 GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNIL 150 (190)
T ss_pred CCCCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEE
Confidence 87655544433 24899999998755443222 3467888999999999999999999 99 999999999999
Q ss_pred EcCCCceEEecccCccc
Q 022447 209 LDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 209 i~~~~~~kl~Dfg~~~~ 225 (297)
++ ++.++|+|||++..
T Consensus 151 l~-~~~~~liDFG~a~~ 166 (190)
T cd05145 151 YH-DGKPYIIDVSQAVE 166 (190)
T ss_pred EE-CCCEEEEEccccee
Confidence 99 78999999999875
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-25 Score=203.64 Aligned_cols=205 Identities=24% Similarity=0.312 Sum_probs=169.6
Q ss_pred CCcceecccCcEEEEEEEECCCCeEEEEEEeccC--Cccch----HHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 75 RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGN----REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 75 ~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
.....+|.|++|.|+.+......+....|.+... ..... ..+..|+.+-..++|+|++..+..+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 5667899999998888887766666666654311 11111 12455677778889999999888888777777779
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
|||++ +|+..+.. ...+...++..++.|++.++.|+|++| |.|||+||+|+++..+|.+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99998 99999987 457888999999999999999999999 99999999999999999999999999987655
Q ss_pred CCCc--ceeecccccccccCccccccCCCCc-ccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 229 GDNT--HVSTRVMGTYGYCAPEYAKTGQLTL-KSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 229 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
.... ......+|+..|+|||.+.+..|++ ..||||.|++++.|.+|+.||......+.+
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~ 534 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS 534 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccc
Confidence 5544 5566788999999999999999986 599999999999999999999988776554
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=161.06 Aligned_cols=188 Identities=19% Similarity=0.137 Sum_probs=139.0
Q ss_pred CCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccch----HHHHHHHHHHhccC-CCCccceeeEeecCCeeEEEEe
Q 022447 75 RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN----REFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 75 ~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.+...|++|+||+|+.+.. .+.+++.+.+........ ..+.+|+.+++++. ++++++++++ ...+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567899999999997765 478888777765433211 24778999999995 5889999886 44699999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC-CCCcEEEcCCCceEEecccCccccCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDL-KCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~di-kp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
|+.|.+|...+.. ....++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||++.....
T Consensus 79 yI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 79 YLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999998754321 11357789999999999999 999999 79999999999999999999975322
Q ss_pred CCCc----ce-------eecccccccccCccccccC-CCC-cccchhhHHHHHHHHHhCCCCCCcch
Q 022447 229 GDNT----HV-------STRVMGTYGYCAPEYAKTG-QLT-LKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 229 ~~~~----~~-------~~~~~g~~~y~aPE~~~~~-~~~-~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
.... .. ......++.|++|+...-. ..+ .+.+.++.|+-+|.++|++.|+-.+.
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 1110 00 0011257788888754322 233 56788899999999999998865543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-24 Score=197.69 Aligned_cols=198 Identities=25% Similarity=0.253 Sum_probs=157.6
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chH---HHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNR---EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~---~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
+|...+.||++.|=+|.+|++.+ |. |+||++-+..+. ... +.+.|++ ...+++||++++.-+...+...|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 78889999999999999999876 55 999998665433 223 3334455 55678999999999888888889999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc--c
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--G 226 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~--~ 226 (297)
+|.. .+|+|.+.. .+-+...+.++|+.|++.||..+|..| |+|||||.+||||..-+.+.|+||...+. +
T Consensus 101 qyvk-hnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHh-hhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence 9987 799999986 455778899999999999999999999 99999999999999999999999987653 1
Q ss_pred CC---CCCcceeecccccccccCccccccC----------C-CCcccchhhHHHHHHHHHh-CCCCCCcc
Q 022447 227 PV---GDNTHVSTRVMGTYGYCAPEYAKTG----------Q-LTLKSDVYSFGVVLLEILS-GRKAVDTS 281 (297)
Q Consensus 227 ~~---~~~~~~~~~~~g~~~y~aPE~~~~~----------~-~~~~~DiwslG~il~ell~-g~~Pf~~~ 281 (297)
+. .+......+...-..|.|||.+-.. . .+++.||||+||++.||++ |++||.-.
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS 242 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS 242 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH
Confidence 11 2222333344455689999977431 1 5789999999999999988 78888643
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.1e-23 Score=163.01 Aligned_cols=109 Identities=28% Similarity=0.289 Sum_probs=94.5
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
|+|.+++... +.++++..++.++.|++.||.|||+.+ ||+|||++.++.+++ ||++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 6888888752 456999999999999999999999875 999999999999999 9998753221
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
...|++.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 109 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE 109 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 12589999999999999999999999999999999999999976543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.3e-22 Score=159.79 Aligned_cols=137 Identities=20% Similarity=0.275 Sum_probs=108.6
Q ss_pred CCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcc-----CCCCccceeeEeecCC---eeE-
Q 022447 75 RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-----HHPNLVNLIGYCADGD---QRL- 145 (297)
Q Consensus 75 ~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~~~- 145 (297)
.-.+.||+|+++.||. +..++.. +||++........+.+.+|+.+++.+ .||||+++++++.++. ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3456899999999995 7766666 69998765444556789999999999 5799999999998864 334
Q ss_pred EEEec--CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeeecCCCCCcEEEcCC----CceEEe
Q 022447 146 LVYEY--MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL-EYLHDKAKPPVIYRDLKCSNILLDRG----YHPKLS 218 (297)
Q Consensus 146 lv~e~--~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al-~~LH~~~~~~ivH~dikp~Nili~~~----~~~kl~ 218 (297)
+|+|| +.+++|.+++.+ ..+++. ..++.|++.++ +|||+++ |+||||||+|||++.. ..++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 557999999975 235555 35577888777 9999999 9999999999999743 379999
Q ss_pred c-ccCcc
Q 022447 219 D-FGLAK 224 (297)
Q Consensus 219 D-fg~~~ 224 (297)
| ||...
T Consensus 152 Dg~G~~~ 158 (210)
T PRK10345 152 DNIGEST 158 (210)
T ss_pred ECCCCcc
Confidence 9 55443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=169.36 Aligned_cols=203 Identities=20% Similarity=0.288 Sum_probs=132.5
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCC----------CCccceeeEeec
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHH----------PNLVNLIGYCAD 140 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h----------~~i~~~~~~~~~ 140 (297)
+...+.||.|+++.||.+.+..|++.+++|++..... ...+.+.+|......+.+ -.++-.++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3456789999999999999999999999999754331 123456666555544322 233333333221
Q ss_pred ------------CCe-----eEEEEecCCCCChHhhhcc---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 022447 141 ------------GDQ-----RLLVYEYMPLGSVEDHLHD---LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYR 200 (297)
Q Consensus 141 ------------~~~-----~~lv~e~~~g~~L~~~l~~---~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~ 200 (297)
... .+++|+-+. ++|.+++.. .......+.......+..|+++.+++||+.| ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 112 267888776 788777653 1211122334455677799999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEecccCccccCCCCCcceeecccccccccCcccccc--------CCCCcccchhhHHHHHHHHH
Q 022447 201 DLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT--------GQLTLKSDVYSFGVVLLEIL 272 (297)
Q Consensus 201 dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell 272 (297)
||+|+|||++.+|.+.|+||+.... .+. .......+..|.+||.... -.++.+.|.|+||+++|.|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r--~g~---~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVR--AGT---RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEE--TTE---EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHee--cCc---eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999987754 111 1111335577999997643 24788999999999999999
Q ss_pred hCCCCCCcchhHh
Q 022447 273 SGRKAVDTSKAAA 285 (297)
Q Consensus 273 ~g~~Pf~~~~~~~ 285 (297)
+|+.||...+...
T Consensus 245 C~~lPf~~~~~~~ 257 (288)
T PF14531_consen 245 CGRLPFGLSSPEA 257 (288)
T ss_dssp HSS-STCCCGGGS
T ss_pred HccCCCCCCCccc
Confidence 9999999776543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-23 Score=186.20 Aligned_cols=186 Identities=29% Similarity=0.390 Sum_probs=159.4
Q ss_pred ecccCcEEEEEEEE---CCCCeEEEEEEeccCCccch--HHHHHHHHHHhccC-CCCccceeeEeecCCeeEEEEecCCC
Q 022447 80 LGEGGFGRVYKGYL---ESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 80 lg~G~~g~v~~~~~---~~~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+|+|++|.|+++.- ...+..+++|+..+...... .....|..++..++ ||.+++++..++.+...++++++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 78999999997653 44578899998876433221 23455777888776 99999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
+.|...+.. ...+.+.....+...++-+++++|..+ ++|||+|++||+++.+|++++.|||..+.......
T Consensus 82 g~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 82 GDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred chhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 999988876 677889999999999999999999999 99999999999999999999999999875322221
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDT 280 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 280 (297)
.|||..|||||++. ....++|.||+|+++++|++|..||..
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28999999999987 667899999999999999999999998
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=7e-21 Score=157.64 Aligned_cols=143 Identities=13% Similarity=0.107 Sum_probs=112.2
Q ss_pred cCCCCcceecccCcEEEEEEE-ECCCCeEEEEEEeccCCcc------------------------chHHHHHHHHHHhcc
Q 022447 72 KNFRSESLLGEGGFGRVYKGY-LESINQDVAIKQLDRNGVQ------------------------GNREFLVEVLMLSLL 126 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l 126 (297)
.-|.+.+.||+|++|.||+|. +..+|..||+|++...... ....+..|+..+..+
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358899999999999999999 6778999999998754211 002246799999998
Q ss_pred CCCC--ccceeeEeecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 022447 127 HHPN--LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKC 204 (297)
Q Consensus 127 ~h~~--i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp 204 (297)
.+.+ +.+++.. ...++||||++|.+|...... ...+....+..++.|++.++.+||+.+. ++||||||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp 177 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSE 177 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCCh
Confidence 7532 3333432 235899999998888766533 3456667788999999999999998864 99999999
Q ss_pred CcEEEcCCCceEEecccCccc
Q 022447 205 SNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 205 ~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+||+++ ++.++|+|||.+..
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhc
Confidence 999999 88999999998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-21 Score=180.55 Aligned_cols=177 Identities=28% Similarity=0.419 Sum_probs=133.7
Q ss_pred HHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
.....+|..++.|..|++|.||+++|+.+.+++|+ .+++...-... ++.....|.+|
T Consensus 79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lilRn-------ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLILRN-------ILTFAGNPFVV--------------- 135 (1205)
T ss_pred CCCccccceeEeeccCCCCceeeeeccccccchhh-cccccchhhhc-------cccccCCccee---------------
Confidence 34567899999999999999999999999999999 44433221111 23333344333
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|+-...++. -++++.. ++.|++|||+.+ |+|||+||+|.+|..-|++|++|||+.+.+.
T Consensus 136 ------gDc~tllk~----~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 ------GDCATLLKN----IGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred ------chhhhhccc----CCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhh
Confidence 333444443 2333332 378999999999 9999999999999999999999999987542
Q ss_pred CCCCc-------------ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 228 VGDNT-------------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 228 ~~~~~-------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
..... ......+|||.|.|||++..+.|...+|.|++|+|+||.+.|..||.++++++...
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg 268 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 268 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh
Confidence 22111 11123589999999999999999999999999999999999999999998776543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.6e-20 Score=150.33 Aligned_cols=134 Identities=22% Similarity=0.315 Sum_probs=113.3
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCccc--------hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
+.||+|++|.||+|.+ .|..+++|+........ ..++.+|+.++..+.|+++.....++......+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 47789999865432211 1346789999999999998887777777788899999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
|++|++|.+++.. .. . ....++.+++.++.++|+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~----~~---~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINS----NG---M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHh----cc---H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999865 11 1 78899999999999999999 99999999999999 78899999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=146.37 Aligned_cols=130 Identities=23% Similarity=0.332 Sum_probs=106.4
Q ss_pred eecccCcEEEEEEEECCCCeEEEEEEeccCCcc--------chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 79 ~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.||+|++|.||+|.. ++..+++|........ ...++.+|+.++..+.|+++.....++...+..+++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 4788999986543211 124567899999999988776666566666778999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
++|++|.+.+.. ... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEE----GND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhh----cHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988764 111 78999999999999999 99999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.3e-19 Score=143.68 Aligned_cols=142 Identities=16% Similarity=0.051 Sum_probs=109.8
Q ss_pred HHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc----------------------chHHHHHHHHHH
Q 022447 66 ELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ----------------------GNREFLVEVLML 123 (297)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l 123 (297)
++......|.+.+.||+|+||.||++.+. +|..||||++...... .......|+.++
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 34444445888999999999999999875 6999999987643210 011256688888
Q ss_pred hccCCCC--ccceeeEeecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecC
Q 022447 124 SLLHHPN--LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRD 201 (297)
Q Consensus 124 ~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~d 201 (297)
..+.+++ +...++ ....+++|||++|++|...... .....++.+++.++.++|..+ ++|+|
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~D 150 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGD 150 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence 8887764 444443 2455899999999988765431 245678899999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEecccCccc
Q 022447 202 LKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 202 ikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
|+|+||+++.++.++|+|||.+..
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred CCcccEEEcCCCcEEEEECCcccc
Confidence 999999999999999999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-20 Score=151.90 Aligned_cols=198 Identities=22% Similarity=0.399 Sum_probs=157.1
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
..+..+|.....|..|+|++. |..+++|++...... ...+|..|.-.++.+.||||+.+++++..+..+.++..|+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 345567889999999999998 556777777654333 3356888999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeec-CCCCCcEEEcCCCceEEe--cccCccccCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYR-DLKCSNILLDRGYHPKLS--DFGLAKLGPV 228 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~-dikp~Nili~~~~~~kl~--Dfg~~~~~~~ 228 (297)
+.|+|+..+++.. ..-.+..++..++..++.+++|||+... ++-| -+....++|+++.+.+|. |--++.
T Consensus 270 p~gslynvlhe~t--~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarismad~kfsf---- 341 (448)
T KOG0195|consen 270 PFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISMADTKFSF---- 341 (448)
T ss_pred cchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheecccceeee----
Confidence 9999999999732 4456778899999999999999999753 5544 688999999998766553 332221
Q ss_pred CCCcceeecccccccccCccccccCCCC---cccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLT---LKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~---~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
......-.|.|++||.+...+-+ .++|+|||++++|||.|...||.+.++-+.
T Consensus 342 -----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec 397 (448)
T KOG0195|consen 342 -----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC 397 (448)
T ss_pred -----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh
Confidence 11122357889999998776544 579999999999999999999999887654
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-18 Score=160.66 Aligned_cols=137 Identities=23% Similarity=0.304 Sum_probs=111.0
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccC--Ccc------chHHHHHHHHHHhccCCCCccceeeEeecCC
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGD 142 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 142 (297)
...|...+.||+|+||.||++.+.. ..+++|+.... ... ...++.+|+.+++.++|++++....+..+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 3455678999999999999998764 34444432211 111 1245788999999999999998877777777
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
..++||||++|++|.+++. ....++.+++.+|.+||+.+ ++||||||+||++ .++.++|+|||+
T Consensus 410 ~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcc
Confidence 8899999999999998875 34678999999999999999 9999999999999 677899999999
Q ss_pred ccc
Q 022447 223 AKL 225 (297)
Q Consensus 223 ~~~ 225 (297)
++.
T Consensus 474 a~~ 476 (535)
T PRK09605 474 GKY 476 (535)
T ss_pred ccc
Confidence 975
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.6e-20 Score=159.61 Aligned_cols=124 Identities=28% Similarity=0.392 Sum_probs=106.6
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
++|+.|++|.-.+|.+++.... .....+......++.|++.+++| ++ .+|+|+||.||++..+..++|.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 5789999999999999997433 24556778899999999999999 77 99999999999999999999999999
Q ss_pred ccccCCCC----CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh
Q 022447 223 AKLGPVGD----NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273 (297)
Q Consensus 223 ~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 273 (297)
........ .....+...||..||+||.+.+..|+.++||||||++|+||+.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 86532222 2334556789999999999999999999999999999999998
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=133.82 Aligned_cols=134 Identities=19% Similarity=0.159 Sum_probs=95.9
Q ss_pred cceecccCcEEEEEEEECCCCeEEEEEEeccCCccch--HH----------------------HHHHHHHHhccCCCC--
Q 022447 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--RE----------------------FLVEVLMLSLLHHPN-- 130 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~--~~----------------------~~~e~~~l~~l~h~~-- 130 (297)
.+.||+|+||.||+|.+. ++..||||++........ .. ...|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999987 799999999875422111 11 123455555554332
Q ss_pred ccceeeEeecCCeeEEEEecCCCCChHh-hhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEE
Q 022447 131 LVNLIGYCADGDQRLLVYEYMPLGSVED-HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNIL 208 (297)
Q Consensus 131 i~~~~~~~~~~~~~~lv~e~~~g~~L~~-~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~dikp~Nil 208 (297)
+.+.+.. ...+++|||++|+.+.. .+.. ... ...+..++.+++.++.++|. .+ ++|+||+|+||+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~-----~~~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nil 147 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKD-----VRL-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNIL 147 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhh-----hhh-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEE
Confidence 3333332 24589999999854332 1111 001 15788999999999999999 88 999999999999
Q ss_pred EcCCCceEEecccCccc
Q 022447 209 LDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 209 i~~~~~~kl~Dfg~~~~ 225 (297)
++ ++.++|+|||.+..
T Consensus 148 i~-~~~~~liDfg~a~~ 163 (187)
T cd05119 148 VD-DGKVYIIDVPQAVE 163 (187)
T ss_pred EE-CCcEEEEECccccc
Confidence 99 88999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-17 Score=128.07 Aligned_cols=135 Identities=23% Similarity=0.199 Sum_probs=112.2
Q ss_pred CcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCC--CCccceeeEeecCCeeEEEEecCCC
Q 022447 76 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH--PNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 76 ~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.+.||.|.++.||++.... ..+++|....... ...+..|+.+++.+++ .++++++.+....+..+++|||++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 45779999999999999864 7899999865433 4567889999999976 5888998888888889999999998
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
..+..+ +......++.+++.++..||.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777543 4456678899999999999986333399999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.8e-17 Score=134.99 Aligned_cols=134 Identities=21% Similarity=0.230 Sum_probs=103.0
Q ss_pred ceec-ccCcEEEEEEEECCCCeEEEEEEeccCCc-------------cchHHHHHHHHHHhccCCCCc--cceeeEeecC
Q 022447 78 SLLG-EGGFGRVYKGYLESINQDVAIKQLDRNGV-------------QGNREFLVEVLMLSLLHHPNL--VNLIGYCADG 141 (297)
Q Consensus 78 ~~lg-~G~~g~v~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~ 141 (297)
..|| .|+.|+||.+... +..++||.+..... ....++.+|+.++..+.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 7888888888765 77899998753211 122467889999999998875 5666654332
Q ss_pred C----eeEEEEecCCC-CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceE
Q 022447 142 D----QRLLVYEYMPL-GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (297)
Q Consensus 142 ~----~~~lv~e~~~g-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~k 216 (297)
. ..++|||+++| .+|.+++.. .++++. .+.+++.+|.+||+.| |+|+||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 689888764 345543 3568999999999999 99999999999999988999
Q ss_pred EecccCccc
Q 022447 217 LSDFGLAKL 225 (297)
Q Consensus 217 l~Dfg~~~~ 225 (297)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.1e-19 Score=164.43 Aligned_cols=208 Identities=25% Similarity=0.289 Sum_probs=169.2
Q ss_pred cCCCCcceecccCcEEEEEEEECCC-CeEEEEEEeccCC--ccchHHHHHHHHHHhccC-CCCccceeeEeecCCeeEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESI-NQDVAIKQLDRNG--VQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 147 (297)
..|.+.+.||+|+++.|-++....+ ...++.|.+.... ......+..|..+-..+. |+|++.+++........+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 4577778899999999988877443 4456666665433 112233445777777776 99999999999999999999
Q ss_pred EecCCCCChHhhh-cccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeecCCCCCcEEEcCCC-ceEEecccCcc
Q 022447 148 YEYMPLGSVEDHL-HDLSPGKKPLDWNTRMKIAAGAARGLEYLH-DKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAK 224 (297)
Q Consensus 148 ~e~~~g~~L~~~l-~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~~ivH~dikp~Nili~~~~-~~kl~Dfg~~~ 224 (297)
+++.+|+++.+-+ .. .....+...+-.++.|+..++.|+| ..+ +.|+||||+|.+++..+ .+++.|||++.
T Consensus 100 ~~~s~g~~~f~~i~~~---~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP---DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccC---CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999999988 43 1225677788999999999999999 888 99999999999999999 99999999998
Q ss_pred ccCC-CCCcceeecccc-cccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 225 LGPV-GDNTHVSTRVMG-TYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 225 ~~~~-~~~~~~~~~~~g-~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.... ..........+| ++.|+|||...+. ...+..|+||+|+++..+++|..|++......
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 7655 444555566778 9999999998874 55789999999999999999999998876654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.4e-17 Score=139.74 Aligned_cols=145 Identities=24% Similarity=0.268 Sum_probs=112.4
Q ss_pred CCCCccceeeEeec---------------------------CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHH
Q 022447 127 HHPNLVNLIGYCAD---------------------------GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 179 (297)
Q Consensus 127 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~ 179 (297)
+||||+++..+|.+ +...|+||..++ .+|.+++-. ...+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 59999999988753 235689999887 799999875 556778889999
Q ss_pred HHHHHHHHHHHhCCCCCeeecCCCCCcEEEc--CCC--ceEEecccCccccCC----CCCcceeecccccccccCccccc
Q 022447 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLD--RGY--HPKLSDFGLAKLGPV----GDNTHVSTRVMGTYGYCAPEYAK 251 (297)
Q Consensus 180 ~qi~~al~~LH~~~~~~ivH~dikp~Nili~--~~~--~~kl~Dfg~~~~~~~----~~~~~~~~~~~g~~~y~aPE~~~ 251 (297)
.|+++|+.|||.+| +.|||+|.+|||+. +++ .+.++|||+|---.. -......-...|....||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 99999999999984 443 478899999742111 01111122334777889999875
Q ss_pred cCCC------CcccchhhHHHHHHHHHhCCCCCCc
Q 022447 252 TGQL------TLKSDVYSFGVVLLEILSGRKAVDT 280 (297)
Q Consensus 252 ~~~~------~~~~DiwslG~il~ell~g~~Pf~~ 280 (297)
..+- -.++|.|+.|.+.||++...-||..
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 4321 2479999999999999999999988
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.1e-15 Score=135.99 Aligned_cols=180 Identities=15% Similarity=0.154 Sum_probs=135.9
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCChHhh
Q 022447 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 159 (297)
Q Consensus 80 lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~ 159 (297)
..-++.+....|..+.++.+|.|.+++...........+-+..++.++||||+++++.+...+..|+|+|.+ ..|..+
T Consensus 20 ~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~ 97 (690)
T KOG1243|consen 20 TAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETV 97 (690)
T ss_pred ccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHH
Confidence 333344422256777889999999988765533455677889999999999999999999999999999998 467778
Q ss_pred hcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcceeeccc
Q 022447 160 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 239 (297)
Q Consensus 160 l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 239 (297)
+.+ +....+..-+.||+.||.+||+.+. ++|++|..+.|+|+..|.+||.+|.++........ ......
T Consensus 98 lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~ 166 (690)
T KOG1243|consen 98 LKE-------LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLY 166 (690)
T ss_pred HHH-------hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccch
Confidence 876 3367888899999999999985443 99999999999999999999999988754222211 111112
Q ss_pred ccccccCccccccCCCCcccchhhHHHHHHHHHhC
Q 022447 240 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274 (297)
Q Consensus 240 g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 274 (297)
.--.|..|+.+.... -..|.|.|||++++++.|
T Consensus 167 ~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 167 LIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 223456666544332 357999999999999999
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.3e-15 Score=135.52 Aligned_cols=155 Identities=32% Similarity=0.503 Sum_probs=127.9
Q ss_pred HhccCCCCccceeeEeecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-eecC
Q 022447 123 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV-IYRD 201 (297)
Q Consensus 123 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i-vH~d 201 (297)
|+.+.|.|+.++++.+.++...++|.+||.-|+|.+.+.. ....++..-...++..++.++.|||... | .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 3568899999999999999999999999999999999986 3567888889999999999999999876 4 9999
Q ss_pred CCCCcEEEcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCC-------CCcccchhhHHHHHHHHHhC
Q 022447 202 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ-------LTLKSDVYSFGVVLLEILSG 274 (297)
Q Consensus 202 ikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~g 274 (297)
++..|.+++..-.+||+|||+.................-..-|.|||.+.+.. .+.+.|+||+|++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987643211111111222455789999987642 36679999999999999999
Q ss_pred CCCCCcchh
Q 022447 275 RKAVDTSKA 283 (297)
Q Consensus 275 ~~Pf~~~~~ 283 (297)
..||+....
T Consensus 155 ~~~~~~~~~ 163 (484)
T KOG1023|consen 155 SGPFDLRNL 163 (484)
T ss_pred cCccccccc
Confidence 999998443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.7e-14 Score=127.59 Aligned_cols=140 Identities=21% Similarity=0.143 Sum_probs=95.2
Q ss_pred cceecccCcEEEEEEEECCCCeEEEEEEeccCCccch----------------------------------------HHH
Q 022447 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN----------------------------------------REF 116 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~ 116 (297)
.+.||.|++|.||+|+.. +|+.||||+..+.-.... -++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 368999999999999976 589999999864311100 013
Q ss_pred HHHHHHHhcc----CCCCccceeeEe-ecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 022447 117 LVEVLMLSLL----HHPNLVNLIGYC-ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR-GLEYLH 190 (297)
Q Consensus 117 ~~e~~~l~~l----~h~~i~~~~~~~-~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~-al~~LH 190 (297)
.+|...+..+ .+.+-+.+-.++ ......++||||++|.+|.+...... ...+ ...++.+++. .+..+|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHHHHHH
Confidence 3344444333 222222332232 22445789999999999988765311 1122 2345555555 467889
Q ss_pred hCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 191 ~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
..| ++|+|++|.||+++.++.++++|||++...
T Consensus 275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999 999999999999999999999999998653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.7e-15 Score=131.74 Aligned_cols=203 Identities=26% Similarity=0.263 Sum_probs=165.1
Q ss_pred hcCCCCcceecc--cCcEEEEEEEE--CCCCeEEEEEEe--ccCCccchHHHHHHHHHHhccC-CCCccceeeEeecCCe
Q 022447 71 TKNFRSESLLGE--GGFGRVYKGYL--ESINQDVAIKQL--DRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 143 (297)
Q Consensus 71 ~~~y~~~~~lg~--G~~g~v~~~~~--~~~~~~vavK~~--~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 143 (297)
...+-+.+.+|. |.+|.||.+.. ..++..+|+|.- .........+-.+|+.....++ |++.++.+..|...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345777889999 99999999998 888999999984 3333344445556777777775 9999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeeecCCCCCcEEEcCC-CceEEe
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLS 218 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~----al~~LH~~~~~~ivH~dikp~Nili~~~-~~~kl~ 218 (297)
.|+-+|+|. .+|.++.+.. ..-++...++..+.+... |+.++|+.+ ++|-|++|.||+...+ ...+++
T Consensus 193 lfiqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred ceeeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecC
Confidence 999999996 8888888873 244788899999999999 999999999 9999999999999988 889999
Q ss_pred cccCccccCCCCCc---ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 219 DFGLAKLGPVGDNT---HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 219 Dfg~~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
|||....+..+... .......|...|++||... ..++...|+||||.+..+..++..+....
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCC
Confidence 99998765443322 2223346888999999764 56788999999999999999888776555
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=8.7e-15 Score=133.35 Aligned_cols=145 Identities=17% Similarity=0.125 Sum_probs=95.7
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc----------------------------------hH--
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG----------------------------------NR-- 114 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~----------------------------------~~-- 114 (297)
...|+. +.||+|++|.||+|+.+.+|+.||||++.+.-... .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 79999999999999999889999999997531000 01
Q ss_pred ----HHHHHHHHHhccC----CCCccceeeEeec-CCeeEEEEecCCCCChHhhh--cccCCCCCCCCHHHHHHHHHHHH
Q 022447 115 ----EFLVEVLMLSLLH----HPNLVNLIGYCAD-GDQRLLVYEYMPLGSVEDHL--HDLSPGKKPLDWNTRMKIAAGAA 183 (297)
Q Consensus 115 ----~~~~e~~~l~~l~----h~~i~~~~~~~~~-~~~~~lv~e~~~g~~L~~~l--~~~~~~~~~l~~~~~~~i~~qi~ 183 (297)
++.+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.+.. .........+.+..+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 1233443333332 3333443344332 45668999999999998743 22100011244444555555544
Q ss_pred HHHHHHHhCCCCCeeecCCCCCcEEEcCCC----ceEEecccCcccc
Q 022447 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSDFGLAKLG 226 (297)
Q Consensus 184 ~al~~LH~~~~~~ivH~dikp~Nili~~~~----~~kl~Dfg~~~~~ 226 (297)
..| ++|+|++|.||+++.++ .++++|||++...
T Consensus 278 -------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 -------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred -------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 477 99999999999999887 9999999998653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.1e-14 Score=110.93 Aligned_cols=131 Identities=18% Similarity=0.110 Sum_probs=95.9
Q ss_pred cceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCcc-ceeeEeecCCeeEEEEecCCCCC
Q 022447 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEYMPLGS 155 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~g~~ 155 (297)
.+.|+.|.++.||++... +..|++|....... ....+..|+.+++.+.+.+++ +++... ....++|||+++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 356889999999999875 78899999765432 122356788888888655554 444433 234589999999987
Q ss_pred hHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 156 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA--KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 156 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+.+. . . ....++.+++.++..||..+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 78 l~~~--~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTE--D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc--c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 7643 0 0 11345678999999999987 12249999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=5e-13 Score=106.49 Aligned_cols=136 Identities=15% Similarity=0.093 Sum_probs=98.7
Q ss_pred cceecccCcEEEEEEEECC------CCeEEEEEEeccCCc----------------------cchHH----HHHHHHHHh
Q 022447 77 ESLLGEGGFGRVYKGYLES------INQDVAIKQLDRNGV----------------------QGNRE----FLVEVLMLS 124 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~------~~~~vavK~~~~~~~----------------------~~~~~----~~~e~~~l~ 124 (297)
...||.|--+.||.|.... .+..+|||+.+.... ...+. ..+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998653 357999998743110 00111 237888888
Q ss_pred ccCC--CCccceeeEeecCCeeEEEEecCCCCChHh-hhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeec
Q 022447 125 LLHH--PNLVNLIGYCADGDQRLLVYEYMPLGSVED-HLHDLSPGKKPLDWNTRMKIAAGAARGLEYL-HDKAKPPVIYR 200 (297)
Q Consensus 125 ~l~h--~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~-~l~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~~ivH~ 200 (297)
++.. -.+..++++ ...++||||+.+..+.. .+.+ ..++...+..+..+++.++..| |..+ +||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 8864 455566654 45689999997654422 2222 3355567778889999999988 8999 9999
Q ss_pred CCCCCcEEEcCCCceEEecccCccc
Q 022447 201 DLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 201 dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
||++.||++.+ +.+.|+|||.+..
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~ 173 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVE 173 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCcee
Confidence 99999999974 6799999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=9.8e-13 Score=101.64 Aligned_cols=131 Identities=24% Similarity=0.305 Sum_probs=104.0
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEec-cC--Cccch-----HHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLD-RN--GVQGN-----REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~-~~--~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..+++|+-+.++.+... |..+++|.-. +. .+... .+..+|+.++..++.-.|...+-+..+++...++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 45789999999999664 5567777532 22 11111 346779999999987777777777778888899999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
|++|..|.+.+... ...++..+-..+.-||..| |+|+||.++||++..++ +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999999862 2466777888899999999 99999999999998775 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.1e-12 Score=99.48 Aligned_cols=143 Identities=22% Similarity=0.229 Sum_probs=110.6
Q ss_pred CcceecccCcEEEEEEEECCCCeEEEEEEeccC---Ccc-----chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 76 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQ-----GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 76 ~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
.+..+.+|+-+.|+++... |+.++||.-... .+. ...+..+|+.++.++.--.|.-..-++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5678999999999999876 888888863221 111 124678899999998877777666677777788899
Q ss_pred EecCCC-CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC-c--eEEecccCc
Q 022447 148 YEYMPL-GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-H--PKLSDFGLA 223 (297)
Q Consensus 148 ~e~~~g-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~-~--~kl~Dfg~~ 223 (297)
|||++| .++.+++.+... ..........++..+-+.|.-||..+ |+|+||..+||++..++ . +.++|||++
T Consensus 89 ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecch
Confidence 999986 488888876432 22333344788999999999999999 99999999999997654 3 489999998
Q ss_pred cc
Q 022447 224 KL 225 (297)
Q Consensus 224 ~~ 225 (297)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 64
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=7.7e-14 Score=131.25 Aligned_cols=210 Identities=20% Similarity=0.202 Sum_probs=157.0
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
...+.+.+.+.+-+|+++.++.+.-..+|...++++...... .+......+-.++-..++|-++.....+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 456778888899999999999998888786666665432211 11122223333333334565555444444556778
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
|+++|+.+++|...++. ..+.+.+-++..+..+..+.++||+.. +.|+|++|.|.++..++..++.|||....
T Consensus 881 L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence 99999999999999987 456777788888889999999999997 89999999999999999999999984321
Q ss_pred cCCC-----------------------------CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCC
Q 022447 226 GPVG-----------------------------DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 276 (297)
Q Consensus 226 ~~~~-----------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 276 (297)
.... +.........+|+.|.+||...+..-...+|.|++|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 1000 00011223568999999999999999999999999999999999999
Q ss_pred CCCcchhHh
Q 022447 277 AVDTSKAAA 285 (297)
Q Consensus 277 Pf~~~~~~~ 285 (297)
||.+.++..
T Consensus 1034 p~na~tpq~ 1042 (1205)
T KOG0606|consen 1034 PFNAETPQQ 1042 (1205)
T ss_pred CCCCcchhh
Confidence 999887643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.1e-11 Score=101.82 Aligned_cols=142 Identities=19% Similarity=0.243 Sum_probs=107.5
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCC--CccceeeEeecCC---eeEEEEecC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHP--NLVNLIGYCADGD---QRLLVYEYM 151 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~---~~~lv~e~~ 151 (297)
+.|+.|..+.+|++.... |..+++|....... .....+..|..+++.+.+. .+.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998754 68899999765432 1345678899999998764 4566777765542 668999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA-------------------------------------- 193 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------------------------------------- 193 (297)
+|.++.+.+.. ..+++.....++.+++.++..||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99888776531 34667777778888888888887421
Q ss_pred ---------------CCCeeecCCCCCcEEEcC--CCceEEecccCccc
Q 022447 194 ---------------KPPVIYRDLKCSNILLDR--GYHPKLSDFGLAKL 225 (297)
Q Consensus 194 ---------------~~~ivH~dikp~Nili~~--~~~~kl~Dfg~~~~ 225 (297)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=8.1e-13 Score=110.02 Aligned_cols=189 Identities=24% Similarity=0.315 Sum_probs=132.2
Q ss_pred EEEEEECCCCeEEEEEEeccC---Cc-cchHHHHHHHHHHhccCCCCccceeeEeecCC-----eeEEEEecCCCCChHh
Q 022447 88 VYKGYLESINQDVAIKQLDRN---GV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRLLVYEYMPLGSVED 158 (297)
Q Consensus 88 v~~~~~~~~~~~vavK~~~~~---~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~g~~L~~ 158 (297)
||++-++..|.+|+.-.++.. +. ........-..-+-.+-|.||++++.+|.+.+ ...+++||+..|++.+
T Consensus 82 v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~ 161 (458)
T KOG1266|consen 82 VYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQ 161 (458)
T ss_pred HHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHH
Confidence 455556666666654433211 11 11112222233445567999999999986543 4679999999999999
Q ss_pred hhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC--cceee
Q 022447 159 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN--THVST 236 (297)
Q Consensus 159 ~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~ 236 (297)
++++.......+......+|+.||+.||.|||+. .+||+|+++..+-|++..+|-+|+.--.-...-+.... .....
T Consensus 162 fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~ 240 (458)
T KOG1266|consen 162 FLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKS 240 (458)
T ss_pred HHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhh
Confidence 9998776778888999999999999999999998 58899999999999999998888743211110000000 11111
Q ss_pred cccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 022447 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 277 (297)
Q Consensus 237 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 277 (297)
...+-++|.+||.=.....+.++|||++|....+|..+..-
T Consensus 241 ~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 241 VNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred ccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheec
Confidence 23367889999976556677899999999999999887743
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.5e-12 Score=116.38 Aligned_cols=194 Identities=23% Similarity=0.228 Sum_probs=148.9
Q ss_pred HhcCCCCcceecccCcEEEEEEEEC-CCCeEEEEEEeccCCccchHH--HHHHHHHHhcc-CCCCccceeeEeecCCeeE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLE-SINQDVAIKQLDRNGVQGNRE--FLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 145 (297)
...+|..+..||.|.|+.|+.+..+ .++..|++|...........+ -..|+.+...+ .|.+++.++..|...+..|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3457889999999999999987765 678889999876544333322 34566666555 4888999888888888888
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC-CceEEecccCcc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAK 224 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~-~~~kl~Dfg~~~ 224 (297)
+-.|||.++++...+.- ...+++...+.+..|++.++.++|+.. ++|+|++|+||++..+ +..++.|||++.
T Consensus 343 ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 99999999988877743 566788899999999999999999999 9999999999999876 778899999875
Q ss_pred ccCCCCCcceeeccccccccc--CccccccCCCCcccchhhHHHHHHHHHhCC
Q 022447 225 LGPVGDNTHVSTRVMGTYGYC--APEYAKTGQLTLKSDVYSFGVVLLEILSGR 275 (297)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~DiwslG~il~ell~g~ 275 (297)
.+.. .........+++ ++.......+..+.|++|||..+.+..++.
T Consensus 416 ~~~~-----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~ 463 (524)
T KOG0601|consen 416 RLAF-----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGS 463 (524)
T ss_pred ccce-----ecccccccccccccchhhccccccccccccccccccccccccCc
Confidence 3111 111122334444 455555667788999999999999888776
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.2e-10 Score=94.66 Aligned_cols=139 Identities=17% Similarity=0.099 Sum_probs=98.8
Q ss_pred eecccCcEEEEEEEECCCCeEEEEEEeccCCccc-h----------HHHHHHHHHHhccCCCCcc--ceeeEeec-----
Q 022447 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-N----------REFLVEVLMLSLLHHPNLV--NLIGYCAD----- 140 (297)
Q Consensus 79 ~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~e~~~l~~l~h~~i~--~~~~~~~~----- 140 (297)
.+-......|+++.. .|+.|.||......... . ..+.+|...+..+..-+|. .++.+...
T Consensus 29 ~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 29 VFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 344444445666654 37889999774332111 1 1367888888887544443 33444432
Q ss_pred CCeeEEEEecCCCC-ChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC-------C
Q 022447 141 GDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-------G 212 (297)
Q Consensus 141 ~~~~~lv~e~~~g~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~-------~ 212 (297)
....++|||++++. +|.+++.... ..+.+......++.+++..+..||..| |+|+|+++.|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCC
Confidence 23568999999876 8988886432 244567788899999999999999999 999999999999975 4
Q ss_pred CceEEecccCcc
Q 022447 213 YHPKLSDFGLAK 224 (297)
Q Consensus 213 ~~~kl~Dfg~~~ 224 (297)
..+.|+||+.+.
T Consensus 182 ~~~~LIDl~r~~ 193 (268)
T PRK15123 182 LKLSVIDLHRAQ 193 (268)
T ss_pred ceEEEEECCccc
Confidence 679999999875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.22 E-value=4e-10 Score=99.58 Aligned_cols=171 Identities=18% Similarity=0.192 Sum_probs=130.6
Q ss_pred cEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEee----cCCeeEEEEecCCC-CChHhh
Q 022447 85 FGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA----DGDQRLLVYEYMPL-GSVEDH 159 (297)
Q Consensus 85 ~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~g-~~L~~~ 159 (297)
-.+.|+++...+|..|++|.+.............-+++++++.|+|+|++.++|. .+...++|++|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3688999999999999999994433333333344678899999999999999886 34567899999874 577776
Q ss_pred hcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 160 LHDLSP-----------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 160 l~~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
...... .....+++.+|.++.|+..||.++|+.| +..+-+.|.+|+++.+.+++|...|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 643221 2345788999999999999999999999 99999999999999888999988777654322
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 277 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 277 (297)
.. . +-+. -..+-|.=.||.++..|.+|..-
T Consensus 446 d~--------------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DP--------------T--EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC--------------C--cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 21 0 1111 12357999999999999999654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.7e-10 Score=90.48 Aligned_cols=124 Identities=21% Similarity=0.194 Sum_probs=80.5
Q ss_pred EEEEEEECCCCeEEEEEEeccCCc----------------------cc----hHHHHHHHHHHhccCCC--CccceeeEe
Q 022447 87 RVYKGYLESINQDVAIKQLDRNGV----------------------QG----NREFLVEVLMLSLLHHP--NLVNLIGYC 138 (297)
Q Consensus 87 ~v~~~~~~~~~~~vavK~~~~~~~----------------------~~----~~~~~~e~~~l~~l~h~--~i~~~~~~~ 138 (297)
.||.|.... |..+|||+...... .. .....+|...|..+..- ++.+++++.
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 388888754 88999998743100 00 12467799999999865 456666442
Q ss_pred ecCCeeEEEEecCC--CCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeeecCCCCCcEEEcCCCce
Q 022447 139 ADGDQRLLVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY-LHDKAKPPVIYRDLKCSNILLDRGYHP 215 (297)
Q Consensus 139 ~~~~~~~lv~e~~~--g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~-LH~~~~~~ivH~dikp~Nili~~~~~~ 215 (297)
..++||||++ |..+..+... .++......++.+++..+.. +|..| |+|+|+++.||+++++ .+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ----CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 3479999998 6555543332 11134556777888885444 67998 9999999999999988 99
Q ss_pred EEecccCccc
Q 022447 216 KLSDFGLAKL 225 (297)
Q Consensus 216 kl~Dfg~~~~ 225 (297)
.++|||.+..
T Consensus 146 ~iIDf~qav~ 155 (188)
T PF01163_consen 146 YIIDFGQAVD 155 (188)
T ss_dssp EE--GTTEEE
T ss_pred EEEecCccee
Confidence 9999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=6.7e-10 Score=95.98 Aligned_cols=194 Identities=16% Similarity=0.174 Sum_probs=130.5
Q ss_pred CcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcc-CCCCccc----eeeEe--ec-CCeeEEE
Q 022447 76 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVN----LIGYC--AD-GDQRLLV 147 (297)
Q Consensus 76 ~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~----~~~~~--~~-~~~~~lv 147 (297)
....||+|+-+.+|-.-.- .-.+.|++.........+. +..|... .||-+.. ..... -+ ....-++
T Consensus 15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchh---hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4567999999999865221 2245677765444333222 2222222 3543322 11111 11 2225578
Q ss_pred EecCCCCChHhhhcc---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 148 YEYMPLGSVEDHLHD---LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~---~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
|+.+.|..--..+-+ ++.......+..+......++.+.+.||..| .+-+|+.++|+|+.+++.+.|+|-....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 888876532222211 1122345678899999999999999999999 8999999999999999999999865543
Q ss_pred ccCCCCCcceeecccccccccCccccc-----cCCCCcccchhhHHHHHHHHHhC-CCCCCcc
Q 022447 225 LGPVGDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSG-RKAVDTS 281 (297)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g-~~Pf~~~ 281 (297)
. ..+.......+|.+.|.+||... +..-+...|.|.||++++++|.| ++||++-
T Consensus 166 i---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 166 I---NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred e---ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 2 23344555678999999999764 34557789999999999999886 8999874
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.3e-09 Score=89.46 Aligned_cols=134 Identities=18% Similarity=0.100 Sum_probs=99.2
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccC------------------Ccc----chHHHHHHHHHHhccCCC--
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN------------------GVQ----GNREFLVEVLMLSLLHHP-- 129 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~------------------~~~----~~~~~~~e~~~l~~l~h~-- 129 (297)
+.+...||-|--+.||.|.+. .|.+++||.=..- ... ......+|.++|.++...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 567789999999999999987 4899999964210 000 012356789999988754
Q ss_pred CccceeeEeecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE
Q 022447 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (297)
Q Consensus 130 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili 209 (297)
.+.+.+++ +...+|||+++|-.|...- ++.+..-.++..|+.-+..+-..| +||+|+++=||++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence 66666655 6678999999986665332 233445566666666666666788 9999999999999
Q ss_pred cCCCceEEecccCcc
Q 022447 210 DRGYHPKLSDFGLAK 224 (297)
Q Consensus 210 ~~~~~~kl~Dfg~~~ 224 (297)
+++|.+.++||--+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999996553
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.4e-09 Score=85.47 Aligned_cols=105 Identities=25% Similarity=0.257 Sum_probs=82.5
Q ss_pred HHHHHHHHHHhccCCCC--ccceeeEeecC----CeeEEEEecCCCC-ChHhhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 022447 114 REFLVEVLMLSLLHHPN--LVNLIGYCADG----DQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186 (297)
Q Consensus 114 ~~~~~e~~~l~~l~h~~--i~~~~~~~~~~----~~~~lv~e~~~g~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al 186 (297)
.+..+|...+..+..-+ +.+++.+.... ...++|+|++++. +|.+++... ...+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHH
Confidence 45777888877775433 34555555442 2457999999874 799888762 2366677889999999999
Q ss_pred HHHHhCCCCCeeecCCCCCcEEEcCCC---ceEEecccCccc
Q 022447 187 EYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLSDFGLAKL 225 (297)
Q Consensus 187 ~~LH~~~~~~ivH~dikp~Nili~~~~---~~kl~Dfg~~~~ 225 (297)
.-||..| |+|+|++|.|||++.++ .+.|+||+.+..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 99999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=5.4e-08 Score=78.02 Aligned_cols=137 Identities=15% Similarity=0.153 Sum_probs=100.1
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEeccC------CccchHHHHHHHHHHhccCCCC--ccceeeEeec-----CCeeEE
Q 022447 80 LGEGGFGRVYKGYLESINQDVAIKQLDRN------GVQGNREFLVEVLMLSLLHHPN--LVNLIGYCAD-----GDQRLL 146 (297)
Q Consensus 80 lg~G~~g~v~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~-----~~~~~l 146 (297)
-|+|+-+.|++.... |..+-+|..... .+.....+.+|+..+..+..-+ +.++. ++.. ..+-+|
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 356888889987665 447888876421 1234467899999998886433 33444 3221 224579
Q ss_pred EEecCC-CCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCc--eEEecccCc
Q 022447 147 VYEYMP-LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH--PKLSDFGLA 223 (297)
Q Consensus 147 v~e~~~-g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~--~kl~Dfg~~ 223 (297)
|+|-+. ..+|.+++.+.. ..+.+......++.+++.++.-||+.| +.|+|+.+.||+++.++. +.++||..+
T Consensus 103 VTe~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 999765 358888876522 235677788899999999999999999 999999999999986667 999999876
Q ss_pred c
Q 022447 224 K 224 (297)
Q Consensus 224 ~ 224 (297)
+
T Consensus 178 r 178 (216)
T PRK09902 178 R 178 (216)
T ss_pred c
Confidence 5
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.90 E-value=5e-08 Score=80.35 Aligned_cols=140 Identities=14% Similarity=0.138 Sum_probs=85.3
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCC--ccceeeEeecCCeeEEEEecCCCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNLIGYCADGDQRLLVYEYMPLGS 155 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~g~~ 155 (297)
..||+|..+.||+. .+..+++|...... ....+.+|..+++.+..-+ +.+++.+....+...++||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 56899999999984 24567889876432 3345788999998886443 4677777777777889999999863
Q ss_pred -hHhhh---------------------cccCCCCCCCCHHHHHHHHHH----------HHH-HHHHHHh-CCCCCeeecC
Q 022447 156 -VEDHL---------------------HDLSPGKKPLDWNTRMKIAAG----------AAR-GLEYLHD-KAKPPVIYRD 201 (297)
Q Consensus 156 -L~~~l---------------------~~~~~~~~~l~~~~~~~i~~q----------i~~-al~~LH~-~~~~~ivH~d 201 (297)
+...+ +........+... ...+..+ +.. ...+|.. .....++|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 21111 1100011111100 0000000 001 1111111 1234479999
Q ss_pred CCCCcEEEcCCCceEEecccCccc
Q 022447 202 LKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 202 ikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+.|.||++++++ +.++||+.+..
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.88 E-value=4.4e-08 Score=78.87 Aligned_cols=137 Identities=12% Similarity=0.088 Sum_probs=90.1
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHH---------HHHHHHHHhccCCC---CccceeeE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---------FLVEVLMLSLLHHP---NLVNLIGY 137 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~---~i~~~~~~ 137 (297)
...+|.+.+.+.......|.+... +|..+++|..........+. ..+.+..+..+... .+..++-+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 446788888888877666666544 47899999886543322221 22333333333322 23332322
Q ss_pred ee-----cCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC
Q 022447 138 CA-----DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 212 (297)
Q Consensus 138 ~~-----~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~ 212 (297)
.. -....+++|||++|..|.+... +++ .+...+.+++.-||..| ++|+|+.|.||++.++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC
Confidence 22 2345568999999988876542 222 24456778899999999 9999999999999865
Q ss_pred CceEEecccCcc
Q 022447 213 YHPKLSDFGLAK 224 (297)
Q Consensus 213 ~~~kl~Dfg~~~ 224 (297)
.++++||+..+
T Consensus 172 -~i~iID~~~k~ 182 (229)
T PF06176_consen 172 -GIRIIDTQGKR 182 (229)
T ss_pred -cEEEEECcccc
Confidence 49999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.6e-08 Score=90.69 Aligned_cols=139 Identities=18% Similarity=0.178 Sum_probs=90.1
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCccc--------------------------h--------H------HHH
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--------------------------N--------R------EFL 117 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--------------------------~--------~------~~~ 117 (297)
+.|+.++-|.||+|+..+ |+.||||+..+.-... . + ++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 689999999999999987 9999999985411000 0 0 133
Q ss_pred HHHHHHhccC-----CCCccceeeEeecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022447 118 VEVLMLSLLH-----HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192 (297)
Q Consensus 118 ~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~ 192 (297)
+|..-+.+++ .+++.=..-+++-.....++|||++|-.+.+...-. ...++...+...+.++. +..+-..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~ia~~~~~~f--~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRKELAELLVRAF--LRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHHHHHHHHHHHH--HHHHHhc
Confidence 4444444332 233322222333456778999999999888875321 13344333333222221 2333345
Q ss_pred CCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 193 ~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
| ++|.|..|.||+++.+|++.+.|||+...
T Consensus 285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred C---ccccCCCccceEEecCCcEEEEcCcceec
Confidence 6 99999999999999999999999999764
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.7e-07 Score=76.20 Aligned_cols=145 Identities=21% Similarity=0.203 Sum_probs=82.6
Q ss_pred cceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCC--ccceeeEee---cCCeeEEEEecC
Q 022447 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNLIGYCA---DGDQRLLVYEYM 151 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~---~~~~~~lv~e~~ 151 (297)
++.|+.|..+.||++.... ..+++|..... .....+..|..+++.+.... +.+++.... .....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 3578999999999999875 48999997644 33456778888888775333 455665332 234578999999
Q ss_pred CCCChHh----------------hhc---ccCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 022447 152 PLGSVED----------------HLH---DLSPGKKPLDWNT---------RMKI------------AAGAAR-GLEYLH 190 (297)
Q Consensus 152 ~g~~L~~----------------~l~---~~~~~~~~l~~~~---------~~~i------------~~qi~~-al~~LH 190 (297)
+|..+.. .+. .......++.... .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9887777 111 1100011111100 0000 011111 233333
Q ss_pred h----CCCCCeeecCCCCCcEEEc-CCCceEEecccCccc
Q 022447 191 D----KAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKL 225 (297)
Q Consensus 191 ~----~~~~~ivH~dikp~Nili~-~~~~~kl~Dfg~~~~ 225 (297)
. .....++|+|+.|.||+++ .++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 1234499999999999999 666678999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.7e-07 Score=71.25 Aligned_cols=129 Identities=21% Similarity=0.193 Sum_probs=94.7
Q ss_pred CCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCcc-ceeeEeecCCeeEEEEecCCC
Q 022447 75 RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 75 ~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~g 153 (297)
...+.|++|.+|.||++.+. |..+|+|+-..+. ....+..|++++..+.-.++. ++|.+-.+ ++.|||++|
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G 96 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG 96 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence 34568999999999999987 6689999876543 335678899999988866654 44544333 456999998
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC-CCcEEEcCCCceEEecccCccc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK-CSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dik-p~Nili~~~~~~kl~Dfg~~~~ 225 (297)
..|.+.-.. . + .+-+..++++.--|...| |-|+.|+ |...++..++.+.|+||..|+.
T Consensus 97 ~~L~~~~~~-----~--~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIG-----G--D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhc-----c--c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 888776543 0 2 233445666666778888 9999987 6666666666999999998874
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=7.2e-09 Score=94.64 Aligned_cols=104 Identities=24% Similarity=0.355 Sum_probs=77.9
Q ss_pred HHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCc-------ceeecccccccccCccccccC
Q 022447 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-------HVSTRVMGTYGYCAPEYAKTG 253 (297)
Q Consensus 181 qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~ 253 (297)
+++.|+.++|+.-+ +||++|.|++|.++.++.+||+.|+.+......... ....-..-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 34489999998765 999999999999999999999999987543221110 000112245689999999998
Q ss_pred CCCcccchhhHHHHHHHHH-hCCCCCCcchhHhh
Q 022447 254 QLTLKSDVYSFGVVLLEIL-SGRKAVDTSKAAAE 286 (297)
Q Consensus 254 ~~~~~~DiwslG~il~ell-~g~~Pf~~~~~~~~ 286 (297)
..+.++|+||||+++|.+. .|+.-|........
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~ 218 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS 218 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcch
Confidence 8899999999999999999 45566665544333
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.61 E-value=6.5e-07 Score=73.03 Aligned_cols=150 Identities=19% Similarity=0.132 Sum_probs=96.5
Q ss_pred cCHHHHHHHhcCCCCcce---ecccCcEEEEEEEECCCCeEEEEEEeccCCccch-------------------H-----
Q 022447 62 LTFRELAAATKNFRSESL---LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN-------------------R----- 114 (297)
Q Consensus 62 ~~~~~~~~~~~~y~~~~~---lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~-------------------~----- 114 (297)
.+...+.....+..+... |++|--+.||+|.. .++..+|+|++......-. .
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 345555566666665554 55666678999876 3488999999864321110 0
Q ss_pred HHHHHHHHHhccC--CCCccceeeEeecCCeeEEEEecCCCC-ChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022447 115 EFLVEVLMLSLLH--HPNLVNLIGYCADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191 (297)
Q Consensus 115 ~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~g~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~ 191 (297)
....|+.-|+++. +-.+.+.+.+. ...|||||+... .-.-.+. ..++...++..+..++++.+.-|-.
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHH
Confidence 1233555555543 22333444442 236999998532 1111222 2334444788888889998888877
Q ss_pred -CCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 192 -KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 192 -~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
.+ +||+||+.=|||+. ++.+.+||||-+..
T Consensus 185 ~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 185 EAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred hcC---cccccchhhheEEE-CCeEEEEECccccc
Confidence 77 99999999999999 78999999997753
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.59 E-value=9.7e-07 Score=73.70 Aligned_cols=141 Identities=22% Similarity=0.216 Sum_probs=84.1
Q ss_pred ecccCc-EEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC-CCCccceeeEeecCCeeEEEEecCCCCChH
Q 022447 80 LGEGGF-GRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVE 157 (297)
Q Consensus 80 lg~G~~-g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~ 157 (297)
|..|.. ..||++... +..+++|...... ...+.+|+.+++.+. +--+.+++.+....+..++|||+++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 445555 788998654 4678888875443 334667888887774 333556777776666789999999987776
Q ss_pred hhh-------------------cccCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----C
Q 022447 158 DHL-------------------HDLSPGKKPLDWN--TRMKIAA--------------------GAARGLEYLHD----K 192 (297)
Q Consensus 158 ~~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------qi~~al~~LH~----~ 192 (297)
+.. +.......++... ....... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 1111001111100 0000000 01111122211 1
Q ss_pred CCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 193 ~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
..+.++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234599999999999999987788999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.1e-08 Score=92.79 Aligned_cols=189 Identities=17% Similarity=0.097 Sum_probs=137.6
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCC-ccceeeEeecCCeeEEEEec
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN-LVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~ 150 (297)
+-+......++++++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-+..++..++.+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 33555567889999999999877654444 5555432 33455899999999999 66777777777888999999
Q ss_pred CCCC-ChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 151 MPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 151 ~~g~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
+.++ +....+.. ....+...+...++..-+.++++||+.- -+|+| ||+..+ +..++.||+....+...
T Consensus 316 ~s~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 316 CSTGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hcCCccccccCCh---hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 9876 22222211 1233444556666777788899999875 58998 666544 68899999987653322
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDT 280 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 280 (297)
. ......+++.++|||......+....|.|++|.-..++.-|.+|-..
T Consensus 385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 2 34567799999999999999999999999999877788778877665
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.8e-06 Score=83.08 Aligned_cols=80 Identities=15% Similarity=0.215 Sum_probs=57.1
Q ss_pred cceecccCcEEEEEEEECCCC--eEEEEEEeccCCc-cchHHHHHHHHHHhccC-CCCc--cceeeEeecC---CeeEEE
Q 022447 77 ESLLGEGGFGRVYKGYLESIN--QDVAIKQLDRNGV-QGNREFLVEVLMLSLLH-HPNL--VNLIGYCADG---DQRLLV 147 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv 147 (297)
++.++.|.+..+|+......+ ..+++|+.+.... .....+.+|+.+++.+. |.++ .+++.++.+. ...|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 567889999999998765432 4678887654322 23356788999999885 6665 6777776654 467899
Q ss_pred EecCCCCCh
Q 022447 148 YEYMPLGSV 156 (297)
Q Consensus 148 ~e~~~g~~L 156 (297)
||+++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999997653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.43 E-value=8.7e-06 Score=65.34 Aligned_cols=128 Identities=22% Similarity=0.248 Sum_probs=90.6
Q ss_pred cceecccCcEEEEEEEECCCCeEEEEEEeccCC----------------ccchHHHHHHHHHHhccC------CCCccce
Q 022447 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG----------------VQGNREFLVEVLMLSLLH------HPNLVNL 134 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~i~~~ 134 (297)
...||+|+.-.||.-- .....+||+..... ....+...+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 4579999999988542 35567899987655 112345566666555554 7899999
Q ss_pred eeEeecCCeeEEEEecCC------CCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEE
Q 022447 135 IGYCADGDQRLLVYEYMP------LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 208 (297)
Q Consensus 135 ~~~~~~~~~~~lv~e~~~------g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nil 208 (297)
+++...+-..-+|+|.+. ..+|.+++.+ ..+++ ..... +-.-..+|-+.+ |+.+|++|.||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEE
Confidence 999999999999999863 3478888854 44555 33433 444556677777 999999999999
Q ss_pred EcCC--C--ceEEec
Q 022447 209 LDRG--Y--HPKLSD 219 (297)
Q Consensus 209 i~~~--~--~~kl~D 219 (297)
+... + .+.|+|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 9643 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.4e-06 Score=70.98 Aligned_cols=139 Identities=15% Similarity=0.049 Sum_probs=78.4
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCcc-ceeeEeecCCeeEEEEecCCCCChHh
Q 022447 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEYMPLGSVED 158 (297)
Q Consensus 80 lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~g~~L~~ 158 (297)
+..|-...+|+.. .++..+++|..............+|..+++.+...++. +++... . -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-~---~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-E---HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-C---CEEEEEeccCccccc
Confidence 4567778899886 34778889976543222112346688888888654443 333332 1 368999999866542
Q ss_pred h-----------------hcccCCCCCCCCHH-HHHHHHHHH---------HHHHHHHHhC-----CCCCeeecCCCCCc
Q 022447 159 H-----------------LHDLSPGKKPLDWN-TRMKIAAGA---------ARGLEYLHDK-----AKPPVIYRDLKCSN 206 (297)
Q Consensus 159 ~-----------------l~~~~~~~~~l~~~-~~~~i~~qi---------~~al~~LH~~-----~~~~ivH~dikp~N 206 (297)
. ++.......+++.. .+..+..++ ...+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111111222221 111211111 1112222111 12348999999999
Q ss_pred EEEcCCCceEEecccCccc
Q 022447 207 ILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 207 ili~~~~~~kl~Dfg~~~~ 225 (297)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.39 E-value=5e-06 Score=69.05 Aligned_cols=73 Identities=15% Similarity=0.191 Sum_probs=45.1
Q ss_pred ceecccCcE-EEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCC---CccceeeEeecC---CeeEEEEec
Q 022447 78 SLLGEGGFG-RVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHP---NLVNLIGYCADG---DQRLLVYEY 150 (297)
Q Consensus 78 ~~lg~G~~g-~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~lv~e~ 150 (297)
+.|+.|+.. .||+. +..+++|...... ....+..|..++..+... -+..++...... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 456766665 58876 2357788765422 234678899888877532 233444333222 245889999
Q ss_pred CCCCChH
Q 022447 151 MPLGSVE 157 (297)
Q Consensus 151 ~~g~~L~ 157 (297)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.9e-06 Score=75.92 Aligned_cols=139 Identities=19% Similarity=0.143 Sum_probs=87.6
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCccc----h---------------------------H------HHHHHH
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG----N---------------------------R------EFLVEV 120 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~----~---------------------------~------~~~~e~ 120 (297)
+.||..+.|.||+|+.+. |+.||||+-++.-... . + +|.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999999987 9999999875311000 0 0 133344
Q ss_pred HHHhc----cCCCCc---cceeeEee-cCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022447 121 LMLSL----LHHPNL---VNLIGYCA-DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192 (297)
Q Consensus 121 ~~l~~----l~h~~i---~~~~~~~~-~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~ 192 (297)
+-..+ +.|-+. +.+-.++. -.....|+|||++|..+.+.-.-. ...++...+..-+.+.. .+.+-..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~---~~gi~~~~i~~~l~~~~--~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID---KRGISPHDILNKLVEAY--LEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH---HcCCCHHHHHHHHHHHH--HHHHHhc
Confidence 33322 234441 12223332 234678999999998777653321 24466554444333322 2233345
Q ss_pred CCCCeeecCCCCCcEEEcC----CCceEEecccCccc
Q 022447 193 AKPPVIYRDLKCSNILLDR----GYHPKLSDFGLAKL 225 (297)
Q Consensus 193 ~~~~ivH~dikp~Nili~~----~~~~kl~Dfg~~~~ 225 (297)
| ++|+|-.|.||++.. ++.+.+.|||+...
T Consensus 321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred C---CccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 6 999999999999984 67899999999865
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.28 E-value=6.1e-06 Score=65.84 Aligned_cols=103 Identities=26% Similarity=0.275 Sum_probs=80.4
Q ss_pred HHHHHHhccCC-CCccceeeEeecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 022447 118 VEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196 (297)
Q Consensus 118 ~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ 196 (297)
.|..+++.+.+ +++.+++|++-. +++.|+...+++....... ..-...++..+..|+.++++.+.+|+......
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47888888875 699999999844 6789998866664321000 00234678999999999999999999865555
Q ss_pred eeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 197 ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+.-.|++|+||-++++++++++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.27 E-value=1e-05 Score=69.49 Aligned_cols=144 Identities=17% Similarity=0.109 Sum_probs=81.9
Q ss_pred cceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCC--ccceeeE------eecCCeeEEEE
Q 022447 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNLIGY------CADGDQRLLVY 148 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~lv~ 148 (297)
.+.+..|....+|++... +..+++|+... .....+..|+.++..+.+.+ +.+++.. ....+..++++
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 345777777889988653 45788998764 22345666777777764332 3444331 22345678999
Q ss_pred ecCCCCChHh-----------h---hcccCCC-CC------CCCHHHH----------HHHHHHHHHHHHHHHh----CC
Q 022447 149 EYMPLGSVED-----------H---LHDLSPG-KK------PLDWNTR----------MKIAAGAARGLEYLHD----KA 193 (297)
Q Consensus 149 e~~~g~~L~~-----------~---l~~~~~~-~~------~l~~~~~----------~~i~~qi~~al~~LH~----~~ 193 (297)
++++|..+.. . ++..... .. ...+... ......+..++.++.. ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999876532 0 0110000 00 0000000 0011112233444442 11
Q ss_pred CCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 194 ~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
...++|+|+.|.|+++++++.+.|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 23399999999999999987778999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.26 E-value=5e-05 Score=67.51 Aligned_cols=75 Identities=16% Similarity=0.122 Sum_probs=52.8
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccC------C-ccchHHHHHHHHHHhccC---CCCccceeeEeecCCeeEEE
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRN------G-VQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv 147 (297)
+.||.|.+..||++.....++.++||.-... . .....+...|...|..+. ...+.+++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5789999999999998754468999985421 1 223456777888887763 2355666666 44567899
Q ss_pred EecCCCC
Q 022447 148 YEYMPLG 154 (297)
Q Consensus 148 ~e~~~g~ 154 (297)
||++++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999754
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.16 E-value=8.6e-05 Score=63.86 Aligned_cols=77 Identities=14% Similarity=0.098 Sum_probs=54.5
Q ss_pred CcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCC---CCccceeeEeec---CCeeEEEEe
Q 022447 76 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH---PNLVNLIGYCAD---GDQRLLVYE 149 (297)
Q Consensus 76 ~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~lv~e 149 (297)
-.+.||.|..+.||+..... + .+++|..+. ......+..|...++.+.. -.+.++++++.. .+..++|||
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQ-G-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred eeeecCCccceeEEEEEcCC-C-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 34679999999999986543 3 567777533 1123467789998888753 357778877654 366899999
Q ss_pred cCCCCCh
Q 022447 150 YMPLGSV 156 (297)
Q Consensus 150 ~~~g~~L 156 (297)
+++|.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.9e-05 Score=63.56 Aligned_cols=74 Identities=16% Similarity=0.156 Sum_probs=46.8
Q ss_pred ceecccCcEEEEEEEECC-CCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCcc-ceeeEeecCCeeEEEEecCCCCC
Q 022447 78 SLLGEGGFGRVYKGYLES-INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEYMPLGS 155 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~g~~ 155 (297)
+.|..|-...+|++.... .+..|++|+....... .....+|..+++.+...+++ +++.... -.++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457777788999987543 3578889977543221 12234688888887644443 3433322 247999999876
Q ss_pred h
Q 022447 156 V 156 (297)
Q Consensus 156 L 156 (297)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.10 E-value=9e-05 Score=64.45 Aligned_cols=159 Identities=14% Similarity=0.099 Sum_probs=82.6
Q ss_pred cCHHHHHHHhcCCCC-----cceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCC--ccce
Q 022447 62 LTFRELAAATKNFRS-----ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNL 134 (297)
Q Consensus 62 ~~~~~~~~~~~~y~~-----~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~ 134 (297)
++..++......|.+ .+.++.|....+|++... +..+++|++. . .....+..|..++..+...+ +.++
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~ 81 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTT--QGEYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAP 81 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeC--CCcEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcc
Confidence 444555555555654 245666777789988754 3368899876 2 12233444555555543222 3333
Q ss_pred ee------EeecCCeeEEEEecCCCCChH-----------hhhc---ccCCC-------CCCCCH-HHHH----------
Q 022447 135 IG------YCADGDQRLLVYEYMPLGSVE-----------DHLH---DLSPG-------KKPLDW-NTRM---------- 176 (297)
Q Consensus 135 ~~------~~~~~~~~~lv~e~~~g~~L~-----------~~l~---~~~~~-------~~~l~~-~~~~---------- 176 (297)
+. +....+..++++||++|..+. ..+. ..... ...+.. ....
T Consensus 82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (319)
T PRK05231 82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE 161 (319)
T ss_pred eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence 32 122345678999999986432 1111 11100 000100 0100
Q ss_pred --HHHHH-HHHHHHHHHhC----CCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 177 --KIAAG-AARGLEYLHDK----AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 177 --~i~~q-i~~al~~LH~~----~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
..+.+ +...+..+... -..++||+|+.|.||+++.+...-++||+.+..
T Consensus 162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 01111 11122222211 122399999999999999766568999998864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.02 E-value=8.4e-05 Score=64.29 Aligned_cols=160 Identities=16% Similarity=0.120 Sum_probs=86.9
Q ss_pred cCHHHHHHHhcCCCC-----cceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCC--ccce
Q 022447 62 LTFRELAAATKNFRS-----ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNL 134 (297)
Q Consensus 62 ~~~~~~~~~~~~y~~-----~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~ 134 (297)
.+.+++......|.+ ...++.|....+|++... +..+++|+..... ....+..|..++..+...+ +.++
T Consensus 7 ~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~ 82 (307)
T TIGR00938 7 VSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKP 82 (307)
T ss_pred CCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeC--CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 344555555555654 345667777889988643 3467889875422 1234455666666664222 3343
Q ss_pred eeE------eecCCeeEEEEecCCCCChH-----------hh---hcccCCCC-CC----CCHH---HHH----------
Q 022447 135 IGY------CADGDQRLLVYEYMPLGSVE-----------DH---LHDLSPGK-KP----LDWN---TRM---------- 176 (297)
Q Consensus 135 ~~~------~~~~~~~~lv~e~~~g~~L~-----------~~---l~~~~~~~-~~----l~~~---~~~---------- 176 (297)
+.. ....+..+++++|++|..+. .. ++.....- .+ .... ...
T Consensus 83 i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l 162 (307)
T TIGR00938 83 VKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQL 162 (307)
T ss_pred ccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhccccc
Confidence 332 12245678999999985432 11 11111000 00 0000 000
Q ss_pred --HHHHHHHHHHHHHHh----CCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 177 --KIAAGAARGLEYLHD----KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 177 --~i~~qi~~al~~LH~----~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
.....+...++++.. .-...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 163 EAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 001112334444432 1123399999999999999887778999998754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.02 E-value=9.4e-05 Score=59.09 Aligned_cols=125 Identities=26% Similarity=0.324 Sum_probs=85.7
Q ss_pred cCCCCcceecccCc-EEEEEEEECCCCeEEEEEEecc---CCc-------c-----------chHHHHHHHHHHhcc---
Q 022447 72 KNFRSESLLGEGGF-GRVYKGYLESINQDVAIKQLDR---NGV-------Q-----------GNREFLVEVLMLSLL--- 126 (297)
Q Consensus 72 ~~y~~~~~lg~G~~-g~v~~~~~~~~~~~vavK~~~~---~~~-------~-----------~~~~~~~e~~~l~~l--- 126 (297)
.+++.++.||.|.- |.||++... |..||+|++.. ..+ . -...|..|-....+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68889999999999 999999887 78999999422 110 0 012356676665555
Q ss_pred CCCCc--cceeeEeecC------------------CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 022447 127 HHPNL--VNLIGYCADG------------------DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186 (297)
Q Consensus 127 ~h~~i--~~~~~~~~~~------------------~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al 186 (297)
.+.++ ++.+++..-. ....||-||.+... .++. .-+.+|.+-+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~~dl 177 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQMLRDL 177 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHHHHH
Confidence 45566 8888886321 11236666654322 2222 3345677788
Q ss_pred HHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 187 ~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
..+|..| |+-+|+++.|.. .=+|+|||.+
T Consensus 178 ~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 8999999 999999999997 3488999864
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00026 Score=60.88 Aligned_cols=140 Identities=20% Similarity=0.232 Sum_probs=88.6
Q ss_pred CCcceecccCcEEEEEEEECCCCeEEEEEEecc--CCccchHHHHHHHHHHhccCCC--CccceeeEeecCC--eeEEEE
Q 022447 75 RSESLLGEGGFGRVYKGYLESINQDVAIKQLDR--NGVQGNREFLVEVLMLSLLHHP--NLVNLIGYCADGD--QRLLVY 148 (297)
Q Consensus 75 ~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~--~~~lv~ 148 (297)
.+.+.+..|-.-.+|..... ++.++++ .+. ..........+|+.+++.+.-- -+...++.+.+.. ..|.||
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 34444544444455555544 7889999 332 2223334566788888776532 2334455555554 679999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHH-HHHHHHHHHHHhCC----------------------------------
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA-AGAARGLEYLHDKA---------------------------------- 193 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~-~qi~~al~~LH~~~---------------------------------- 193 (297)
+|++|..+.+..... ... ...+ ..+...|..||+-.
T Consensus 105 ~~veGe~~~~~~~~~-----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~ 175 (321)
T COG3173 105 EWVEGEVVWSALPPE-----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGG 175 (321)
T ss_pred EEecceeccCcCCcc-----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccC
Confidence 999986555444321 111 1122 36666666666521
Q ss_pred ---------------------CCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 194 ---------------------KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 194 ---------------------~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
.++++|+|+.+.|+++++++.+=++||+.+.+.
T Consensus 176 ~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 176 RIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 567999999999999999988999999998753
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00028 Score=61.62 Aligned_cols=72 Identities=17% Similarity=0.187 Sum_probs=48.2
Q ss_pred eecccCcEEEEEEEECCCCeEEEEEEecc-------CCccchHHHHHHHHHHhccC--CCC-ccceeeEeecCCeeEEEE
Q 022447 79 LLGEGGFGRVYKGYLESINQDVAIKQLDR-------NGVQGNREFLVEVLMLSLLH--HPN-LVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 79 ~lg~G~~g~v~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~e~~~l~~l~--h~~-i~~~~~~~~~~~~~~lv~ 148 (297)
.||.|....||++.+...++.|+||.-.. ..+-...+...|...|+... .|. +.++|.+ ++....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57999999999999865447899997431 12333456667888886654 343 4444433 555667999
Q ss_pred ecCC
Q 022447 149 EYMP 152 (297)
Q Consensus 149 e~~~ 152 (297)
|+++
T Consensus 80 EdL~ 83 (370)
T TIGR01767 80 EDLS 83 (370)
T ss_pred hhCc
Confidence 9985
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00025 Score=62.36 Aligned_cols=142 Identities=15% Similarity=0.165 Sum_probs=80.4
Q ss_pred eecccCcEEEEEEEECC----CCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCcc-ceeeEeecCCeeEEEEecCCC
Q 022447 79 LLGEGGFGRVYKGYLES----INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 79 ~lg~G~~g~v~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~g 153 (297)
.+..|-.-.+|++.... .++.|++|+.........+ ..+|..+++.+..-++. ++++.+... .|.+|++|
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 45456777899886432 2468999987654322222 36688888888655554 455554332 57899887
Q ss_pred CChHhh-----------------hcccCCCCC--CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-C
Q 022447 154 GSVEDH-----------------LHDLSPGKK--PLDWNTRMKIAAGA-----------------ARGLEYL----HD-K 192 (297)
Q Consensus 154 ~~L~~~-----------------l~~~~~~~~--~l~~~~~~~i~~qi-----------------~~al~~L----H~-~ 192 (297)
.+|... ++....... ......+..++.++ ...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 665421 111110011 11122333332221 1111122 11 1
Q ss_pred CCCCeeecCCCCCcEEEcC-CCceEEecccCccc
Q 022447 193 AKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKL 225 (297)
Q Consensus 193 ~~~~ivH~dikp~Nili~~-~~~~kl~Dfg~~~~ 225 (297)
....++|+|+++.||++++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1334899999999999986 47899999998864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00027 Score=61.00 Aligned_cols=143 Identities=22% Similarity=0.226 Sum_probs=81.7
Q ss_pred ceecccCcEEEEEEEECC------CCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCcc-ceeeEeecCCeeEEEEec
Q 022447 78 SLLGEGGFGRVYKGYLES------INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~ 150 (297)
+.+..|-...+|++.... .++.+++|+..... .......+|..++..+...++. +++..+.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 345566667889887543 25789999976543 2223456788888877644443 44444432 358999
Q ss_pred CCCCChHhh-----------------hcccCCCC--C---CCC--HHHHH--------------------------HHHH
Q 022447 151 MPLGSVEDH-----------------LHDLSPGK--K---PLD--WNTRM--------------------------KIAA 180 (297)
Q Consensus 151 ~~g~~L~~~-----------------l~~~~~~~--~---~l~--~~~~~--------------------------~i~~ 180 (297)
++|.++... ++...... . ..+ +..+. .+..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988766431 11111110 0 010 00110 1112
Q ss_pred HHHHHHHHHHh------CCCCCeeecCCCCCcEEEcCC----CceEEecccCccc
Q 022447 181 GAARGLEYLHD------KAKPPVIYRDLKCSNILLDRG----YHPKLSDFGLAKL 225 (297)
Q Consensus 181 qi~~al~~LH~------~~~~~ivH~dikp~Nili~~~----~~~kl~Dfg~~~~ 225 (297)
.+...+..|-. .....++|+|+.|.||+++++ +.+.++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 134559999999999999874 8899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00023 Score=60.67 Aligned_cols=74 Identities=19% Similarity=0.241 Sum_probs=47.0
Q ss_pred CcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC---CCCccceeeEeecCCeeEEEEecCC
Q 022447 76 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYMP 152 (297)
Q Consensus 76 ~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~ 152 (297)
-.+.++.|....+|+.. .++..+.||+-.. .....+..|..-|+.|. .-.+.+++.+....+..||+|||++
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 34578889999999887 5688999998762 22345677887777773 4457788888877777899999997
Q ss_pred CC
Q 022447 153 LG 154 (297)
Q Consensus 153 g~ 154 (297)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 55
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.73 E-value=3.4e-05 Score=65.56 Aligned_cols=133 Identities=14% Similarity=0.069 Sum_probs=94.3
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEecc-------------------CCcc-c--hHHHHHHHHHHhccCCC--
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR-------------------NGVQ-G--NREFLVEVLMLSLLHHP-- 129 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~-------------------~~~~-~--~~~~~~e~~~l~~l~h~-- 129 (297)
+.+...||-|--+-+|.+.+.. |.+.++|.-.. ...+ . .-...+|...++.+...
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 6788899999999999998865 78888875321 0000 0 01245677788777532
Q ss_pred CccceeeEeecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE
Q 022447 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (297)
Q Consensus 130 ~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili 209 (297)
-+.+.++ .++.++|||+++|-.|...-+- ..+..+...++..|.-|-.+| +||+|..-=||++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v----------~d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV----------EDPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMV 235 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeec----------CChHHHHHHHHHHHHHHHHcC---ceecccchheeEE
Confidence 2334443 3567899999998887655432 123445566677777888888 9999999999999
Q ss_pred cCCCceEEecccCcc
Q 022447 210 DRGYHPKLSDFGLAK 224 (297)
Q Consensus 210 ~~~~~~kl~Dfg~~~ 224 (297)
++++.++++||--+.
T Consensus 236 ~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMV 250 (465)
T ss_pred ecCCCEEEeechHhh
Confidence 999999999996543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.0014 Score=58.36 Aligned_cols=73 Identities=15% Similarity=0.115 Sum_probs=49.5
Q ss_pred cceecccCcEEEEEEEECCCCeEEEEEEecc-----CC--ccchHHHHHHHHHHhccC---CCCccceeeEeecCCeeEE
Q 022447 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDR-----NG--VQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~-----~~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 146 (297)
.+.||.|....||++.+. +..++||.-.. .. +....+...|...|+.+. ...+.+++.+.. +..++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 457899999999998874 45799998652 11 113345555677776553 246777777766 44678
Q ss_pred EEecCCC
Q 022447 147 VYEYMPL 153 (297)
Q Consensus 147 v~e~~~g 153 (297)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999976
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00083 Score=57.13 Aligned_cols=31 Identities=29% Similarity=0.380 Sum_probs=25.8
Q ss_pred CCeeecCCCCCcEEEcCCCc-eEEecccCccc
Q 022447 195 PPVIYRDLKCSNILLDRGYH-PKLSDFGLAKL 225 (297)
Q Consensus 195 ~~ivH~dikp~Nili~~~~~-~kl~Dfg~~~~ 225 (297)
..++|+|+.|.||++++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 44899999999999997555 46999998874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0007 Score=59.89 Aligned_cols=74 Identities=20% Similarity=0.244 Sum_probs=50.2
Q ss_pred cceecccCcEEEEEEEECCCCeEEEEEEecc------CCccchHHHHHHHHHHhccC--CCC-ccceeeEeecCCeeEEE
Q 022447 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDR------NGVQGNREFLVEVLMLSLLH--HPN-LVNLIGYCADGDQRLLV 147 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~------~~~~~~~~~~~e~~~l~~l~--h~~-i~~~~~~~~~~~~~~lv 147 (297)
.+.||.|....||++.+...+..|+||.-.. +.+-..++...|...|+... .|. +.++|.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4578999999999999854467899997431 12334467777888887664 354 4444443 44566788
Q ss_pred EecCC
Q 022447 148 YEYMP 152 (297)
Q Consensus 148 ~e~~~ 152 (297)
||+++
T Consensus 112 MEdL~ 116 (409)
T PRK12396 112 MEDLS 116 (409)
T ss_pred HHhCc
Confidence 99885
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.52 E-value=1.2e-05 Score=80.14 Aligned_cols=166 Identities=13% Similarity=-0.013 Sum_probs=120.1
Q ss_pred HHHHHHHhccCCCCccceeeEeec--CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--
Q 022447 117 LVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-- 192 (297)
Q Consensus 117 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-- 192 (297)
..|...++...|+++...+.-... ...-+..++++.+|.+.+.+-.......++...-+.....+.+.+..-+|+.
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 344445555678888776655433 3455789999999999999987554455555555555555446666665543
Q ss_pred CCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHH
Q 022447 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 272 (297)
Q Consensus 193 ~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell 272 (297)
++..-+|+++++.|.+|..+..+++.++|+.+.. ...........+++.|++|++...-.++.++|+|..|+-+|+..
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk--np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK--NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCCccccccccccccc--CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 2344689999999999999999999999998831 22222334456888999999888888888899999999999999
Q ss_pred hCCCCCCcchhH
Q 022447 273 SGRKAVDTSKAA 284 (297)
Q Consensus 273 ~g~~Pf~~~~~~ 284 (297)
.|..||-.-...
T Consensus 1435 ~~n~~fi~flq~ 1446 (2724)
T KOG1826|consen 1435 DGNAYFIFFLQP 1446 (2724)
T ss_pred cccHHHHHHHHH
Confidence 998887654433
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0018 Score=56.67 Aligned_cols=142 Identities=17% Similarity=0.203 Sum_probs=77.8
Q ss_pred eecccCcEEEEEEEECCC---CeEEEEEEeccCCccchHHHHHHHHHHhccCCCCcc-ceeeEeecCCeeEEEEecCCCC
Q 022447 79 LLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEYMPLG 154 (297)
Q Consensus 79 ~lg~G~~g~v~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~g~ 154 (297)
.|..|-.-.+|++..... +..|++|+....... .-.-.+|..+++.+..-++. ++++++. .. +|.+|++|.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence 344466677888865432 347899987543222 22235688888888765554 4454442 22 588888876
Q ss_pred ChHh--------------hhcccCCCC----C-CCCHHHHHHHHHHH----------------------HHHHHH---HH
Q 022447 155 SVED--------------HLHDLSPGK----K-PLDWNTRMKIAAGA----------------------ARGLEY---LH 190 (297)
Q Consensus 155 ~L~~--------------~l~~~~~~~----~-~l~~~~~~~i~~qi----------------------~~al~~---LH 190 (297)
+|.. .+....... . +-....+..++.++ ...+.. +.
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 5521 111111101 1 11122222222221 111211 11
Q ss_pred -h-CCCCCeeecCCCCCcEEEcC-CCceEEecccCccc
Q 022447 191 -D-KAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKL 225 (297)
Q Consensus 191 -~-~~~~~ivH~dikp~Nili~~-~~~~kl~Dfg~~~~ 225 (297)
. .....++|+|+.+.||++++ ++.++++||..+-.
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 11234899999999999974 57899999998764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00045 Score=67.69 Aligned_cols=152 Identities=22% Similarity=0.182 Sum_probs=110.3
Q ss_pred HHHHHHHHhccCCCCccceeeEeecCCee----EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022447 116 FLVEVLMLSLLHHPNLVNLIGYCADGDQR----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191 (297)
Q Consensus 116 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~----~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~ 191 (297)
...|...+.++.|+|++.++.+..+.... .+..++|.+-++...+.. ...++....+.+..++..++.++|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 44567778888999999999887654332 245678888888888876 6778999999999999999999999
Q ss_pred CCCCCeeecCCCCC---cEEEcCCCceEEe--cccCccccCCCCCcceeecccccccccCccccccCCCCcc--cchhhH
Q 022447 192 KAKPPVIYRDLKCS---NILLDRGYHPKLS--DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK--SDVYSF 264 (297)
Q Consensus 192 ~~~~~ivH~dikp~---Nili~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~--~Diwsl 264 (297)
.. ..|.-+... +.-++..+.+..+ ||+....++... .......+..+.++|......+..+ .|+|.+
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~---~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE---KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcc---cchhhcCccccccccccccccchhhhhhHHHHH
Confidence 87 777665555 4444555566655 888776533222 2222334556778887766665544 799999
Q ss_pred HHHHHHHHhCCCC
Q 022447 265 GVVLLEILSGRKA 277 (297)
Q Consensus 265 G~il~ell~g~~P 277 (297)
|..+..+..|..+
T Consensus 379 gll~~~~~~~~~i 391 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDI 391 (1351)
T ss_pred HHHHhhhhhcCcc
Confidence 9999999887654
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00051 Score=55.95 Aligned_cols=31 Identities=32% Similarity=0.341 Sum_probs=21.7
Q ss_pred CCeeecCCCCCcEEE-cCCCceEEecccCccc
Q 022447 195 PPVIYRDLKCSNILL-DRGYHPKLSDFGLAKL 225 (297)
Q Consensus 195 ~~ivH~dikp~Nili-~~~~~~kl~Dfg~~~~ 225 (297)
.+++|+|+.|.||++ +.++.++|+||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 348999999999999 7889999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.004 Score=53.84 Aligned_cols=29 Identities=24% Similarity=0.307 Sum_probs=25.3
Q ss_pred CeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 196 ~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 3999999999999987 6789999997653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0043 Score=53.74 Aligned_cols=30 Identities=20% Similarity=0.218 Sum_probs=27.5
Q ss_pred CeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 196 ~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
++||+|+.+.|++++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0049 Score=53.73 Aligned_cols=139 Identities=17% Similarity=0.142 Sum_probs=89.4
Q ss_pred CCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cch------------------------HHHHHHHHHHhccCC
Q 022447 75 RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGN------------------------REFLVEVLMLSLLHH 128 (297)
Q Consensus 75 ~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~------------------------~~~~~e~~~l~~l~h 128 (297)
.+..+|..|--+.||.|... +|..+|||+++.+-. .+. -....|+.-|.+++.
T Consensus 147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 45578889999999998765 488899998853200 000 013345666666655
Q ss_pred CCccceeeEeecCCeeEEEEecCCCCC-hHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcE
Q 022447 129 PNLVNLIGYCADGDQRLLVYEYMPLGS-VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 207 (297)
Q Consensus 129 ~~i~~~~~~~~~~~~~~lv~e~~~g~~-L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Ni 207 (297)
..|.-.--... ...+|||+|+.... -.-.++ ..+++...+..+-.|++.-+.-|....+ +||.||+-=|+
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~ 296 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNL 296 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhh
Confidence 54432211111 23468999985211 111122 3567777888888888888877765332 99999999999
Q ss_pred EEcCCCceEEecccCcc
Q 022447 208 LLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 208 li~~~~~~kl~Dfg~~~ 224 (297)
|+-+ |.+.++|.+-+.
T Consensus 297 Lyhd-G~lyiIDVSQSV 312 (520)
T KOG2270|consen 297 LYHD-GKLYIIDVSQSV 312 (520)
T ss_pred eEEC-CEEEEEEccccc
Confidence 9865 589999987653
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0029 Score=54.93 Aligned_cols=72 Identities=22% Similarity=0.207 Sum_probs=55.1
Q ss_pred CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg 221 (297)
.+.|++|++- |+++ ..+.. ...+++..++.+.+..+.-+... .++-|||+...||+|+ +|.|.|+||.
T Consensus 299 ~y~yl~~kdh-gt~i-s~ik~-------~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 299 LYLYLHFKDH-GTPI-SIIKA-------DRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred eEEEEEEecC-Ccee-eeeec-------ccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEee
Confidence 4456777763 3343 33332 35678888999988888888764 3489999999999999 9999999999
Q ss_pred Cccc
Q 022447 222 LAKL 225 (297)
Q Consensus 222 ~~~~ 225 (297)
+++.
T Consensus 367 lsRl 370 (488)
T COG5072 367 LSRL 370 (488)
T ss_pred eeec
Confidence 9984
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.014 Score=47.57 Aligned_cols=75 Identities=23% Similarity=0.290 Sum_probs=48.5
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC---CCCccceeeEeecCCeeEEEEecCCCC
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYMPLG 154 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~g~ 154 (297)
+.+..|.--..|...+- ..++.||+-... ....+..|+.-|+.+. .-.+.+++.+-.+.++.|+||||++.+
T Consensus 22 ~~v~gG~inea~~v~dg--~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 22 EEVSGGDINEAWRLRDG--TDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred cccCCccccceeEeecC--CcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 34444554555555443 457788874432 2344666776666654 355778888888999999999999865
Q ss_pred ChH
Q 022447 155 SVE 157 (297)
Q Consensus 155 ~L~ 157 (297)
.+.
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 444
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.035 Score=49.53 Aligned_cols=75 Identities=19% Similarity=0.189 Sum_probs=44.2
Q ss_pred ceecccCcEEEEEEEECCCC-e-----EEEEEEeccCCccchHHHHHHHHHHhccCCCCccc-eeeEeecCCeeEEEEec
Q 022447 78 SLLGEGGFGRVYKGYLESIN-Q-----DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN-LIGYCADGDQRLLVYEY 150 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~-~-----~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e~ 150 (297)
+.|..|-...+|++...... . .|.++.... .....-.-.+|+.+++.+...++.+ +++.+.. +++.||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 34555777889998754321 2 245554322 1111122356888998887665554 4555432 589999
Q ss_pred CCCCChH
Q 022447 151 MPLGSVE 157 (297)
Q Consensus 151 ~~g~~L~ 157 (297)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987654
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.034 Score=50.56 Aligned_cols=74 Identities=9% Similarity=0.093 Sum_probs=44.4
Q ss_pred ceecccCcEEEEEEEECC--------CCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCcc-ceeeEeecCCeeEEEE
Q 022447 78 SLLGEGGFGRVYKGYLES--------INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVY 148 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~ 148 (297)
+.|..|-.-.+|++.... .++.|++|+.-....... .-..|..+++.+...+|. ++++.+. -+.|.
T Consensus 111 ~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I~ 185 (442)
T PTZ00296 111 NQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGRIE 185 (442)
T ss_pred EEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCEEE
Confidence 455556667788887542 156789998754322222 234577777777655554 4454443 24578
Q ss_pred ecCCCCCh
Q 022447 149 EYMPLGSV 156 (297)
Q Consensus 149 e~~~g~~L 156 (297)
||++|.+|
T Consensus 186 efi~g~~l 193 (442)
T PTZ00296 186 EWLYGDPL 193 (442)
T ss_pred EeeCCccC
Confidence 99987644
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.038 Score=48.16 Aligned_cols=142 Identities=20% Similarity=0.268 Sum_probs=78.2
Q ss_pred eecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCC---ccc---eee----EeecCCeeEEEE
Q 022447 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN---LVN---LIG----YCADGDQRLLVY 148 (297)
Q Consensus 79 ~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~---i~~---~~~----~~~~~~~~~lv~ 148 (297)
.|.+ .-..+|+..... |. +++|+.... ....++..|...+..+.-.. .++ .-+ .+....+.+-++
T Consensus 33 ~l~s-~eN~~f~~~~~~-g~-~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 33 GLNS-EENSNFRVQTED-GR-YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred cccc-ccCceEEEEecC-CC-eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 3444 456788887664 33 489988765 33455666777776663211 112 111 122223778899
Q ss_pred ecCCCCChHh-hh--------------cc----cC----CCCCCCCHH-------------HHHHHHHHHHHHHHHHHhC
Q 022447 149 EYMPLGSVED-HL--------------HD----LS----PGKKPLDWN-------------TRMKIAAGAARGLEYLHDK 192 (297)
Q Consensus 149 e~~~g~~L~~-~l--------------~~----~~----~~~~~l~~~-------------~~~~i~~qi~~al~~LH~~ 192 (297)
+|++|..+.. .- +. .. .......+. .-.....++...+..+.+.
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999877762 11 10 00 000011111 0011223334444444431
Q ss_pred ----C-C--CCeeecCCCCCcEEEcCCCc-eEEecccCccc
Q 022447 193 ----A-K--PPVIYRDLKCSNILLDRGYH-PKLSDFGLAKL 225 (297)
Q Consensus 193 ----~-~--~~ivH~dikp~Nili~~~~~-~kl~Dfg~~~~ 225 (297)
- . ..+||+|+.|.||+++.+.. .-++||+-+..
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 1 1 12899999999999998875 88999998764
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.024 Score=48.63 Aligned_cols=32 Identities=28% Similarity=0.237 Sum_probs=26.2
Q ss_pred CCCeeecCCCCCcEEEcCC--C---ceEEecccCccc
Q 022447 194 KPPVIYRDLKCSNILLDRG--Y---HPKLSDFGLAKL 225 (297)
Q Consensus 194 ~~~ivH~dikp~Nili~~~--~---~~kl~Dfg~~~~ 225 (297)
...++|||+.+.|||+..+ | .++++||-+++.
T Consensus 214 ~~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 214 FNVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred ceEEEcCccCHHhEeEccccccccccceeeccccccC
Confidence 4459999999999999654 3 689999988764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.26 Score=42.96 Aligned_cols=94 Identities=19% Similarity=0.083 Sum_probs=50.4
Q ss_pred ccccCHHHHHHHhcCCCCc-----ceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCC--c
Q 022447 59 AQTLTFRELAAATKNFRSE-----SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--L 131 (297)
Q Consensus 59 ~~~~~~~~~~~~~~~y~~~-----~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i 131 (297)
...++.+.+..+...+-+. ..|+ +.-..||++... ++..+++|+..... .....+..|...+..+.... +
T Consensus 8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~-s~eN~vy~v~~~-~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv 84 (325)
T PRK11768 8 FQTLTPDLILDALESLGLRVDGRLLALN-SYENRVYQFGDE-DGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPV 84 (325)
T ss_pred CCCCChHHHHHHHHHcCCCCccceEeec-cccceEEEEecC-CCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCC
Confidence 3445555555544444332 1222 334568888653 36679999875432 23445666777766553211 2
Q ss_pred ccee---e--EeecCCeeEEEEecCCCCC
Q 022447 132 VNLI---G--YCADGDQRLLVYEYMPLGS 155 (297)
Q Consensus 132 ~~~~---~--~~~~~~~~~lv~e~~~g~~ 155 (297)
+... + ....++..+.++++++|..
T Consensus 85 ~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 85 VAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred CCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 2211 1 1223456788999998764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.13 Score=51.81 Aligned_cols=29 Identities=41% Similarity=0.382 Sum_probs=25.0
Q ss_pred eeecCCCCCcEEEcCCC--ceE-EecccCccc
Q 022447 197 VIYRDLKCSNILLDRGY--HPK-LSDFGLAKL 225 (297)
Q Consensus 197 ivH~dikp~Nili~~~~--~~k-l~Dfg~~~~ 225 (297)
+||+|+.+.||+++.++ .+. |+|||.+..
T Consensus 205 vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 205 VIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred eECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 99999999999999775 555 999998753
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.066 Score=43.59 Aligned_cols=102 Identities=16% Similarity=0.127 Sum_probs=63.4
Q ss_pred EEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCC-eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHH
Q 022447 99 DVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 176 (297)
Q Consensus 99 ~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~ 176 (297)
+..+|++...... ...-+..+..++.+++ +|+++. .+.. .+-++.|.|-.. .. ...-
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~---NDn~~~yGvIlE~Cy~~--------------~i--~~~N 145 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLK---NDNNYKYGVILERCYKI--------------KI--NFSN 145 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEee---cCCCceeEEEEeeccCc--------------cc--chhH
Confidence 4556666544444 2344567777777665 455555 2333 344888988421 11 1111
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 177 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 177 ~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
.+. .=+.+|.-.|+.. +..+|+|-.|+||+-|..|.+||.|-+..
T Consensus 146 ~i~-agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 146 FIT-AGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHH-HhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 221 1256788888432 23999999999999999999999997753
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 297 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-50 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-49 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-46 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-45 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-45 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-45 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-44 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-42 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-24 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-21 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-19 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-19 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-12 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 448 bits (1154), Expect = e-160
Identities = 103/256 (40%), Positives = 146/256 (57%), Gaps = 4/256 (1%)
Query: 40 NSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQD 99
++ + +A + + +L AT NF + L+G G FG+VYKG L
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAK 65
Query: 100 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 159
VA+K+ QG EF E+ LS HP+LV+LIG+C + ++ +L+Y+YM G+++ H
Sbjct: 66 VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH 125
Query: 160 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 219
L+ + W R++I GAARGL YLH +I+RD+K NILLD + PK++D
Sbjct: 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITD 182
Query: 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 279
FG++K G D TH+ST V GT GY PEY G+LT KSDVYSFGVVL E+L R A+
Sbjct: 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 280 TSKAAAEQSLVAWSEP 295
S +L W+
Sbjct: 243 QSLPREMVNLAEWAVE 258
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 446 bits (1150), Expect = e-160
Identities = 105/256 (41%), Positives = 146/256 (57%), Gaps = 19/256 (7%)
Query: 50 EDGASDQITAQTLTFRELAAATKNFRSE------SLLGEGGFGRVYKGYLESINQDVAIK 103
+ + +F EL T NF + +GEGGFG VYKGY+ N VA+K
Sbjct: 3 KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVK 60
Query: 104 QL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 159
+L D + ++F E+ +++ H NLV L+G+ +DGD LVY YMP GS+ D
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 160 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 219
L L G PL W+ R KIA GAA G+ +LH+ I+RD+K +NILLD + K+SD
Sbjct: 121 LSCL-DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISD 176
Query: 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 279
FGLA+ T +++R++GT Y APE G++T KSD+YSFGVVLLEI++G AVD
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 280 TSKAAAEQSLVAWSEP 295
+ Q L+ E
Sbjct: 236 EHR--EPQLLLDIKEE 249
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 432 bits (1112), Expect = e-154
Identities = 110/252 (43%), Positives = 154/252 (61%), Gaps = 5/252 (1%)
Query: 47 EASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD 106
A ED + + REL A+ NF ++++LG GGFG+VYKG L VA+K+L
Sbjct: 5 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLK 63
Query: 107 RNGVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 165
QG +F EV M+S+ H NL+ L G+C +RLLVY YM GSV L +
Sbjct: 64 EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 123
Query: 166 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225
+ PLDW R +IA G+ARGL YLHD P +I+RD+K +NILLD + + DFGLAKL
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285
D THV+T V GT G+ APEY TG+ + K+DV+ +GV+LLE+++G++A D ++ A
Sbjct: 184 MDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
Query: 286 EQS--LVAWSEP 295
+ L+ W +
Sbjct: 243 DDDVMLLDWVKG 254
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 7e-84
Identities = 68/247 (27%), Positives = 97/247 (39%), Gaps = 24/247 (9%)
Query: 62 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVL 121
L L + + + G FG V+K L N+ VA+K Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQS-WQNEYEVY 70
Query: 122 MLSLLHHPNLVNLIGYCADGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 177
L + H N++ IG G L+ + GS+ D L + WN
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCH 125
Query: 178 IAAGAARGLEYLH-------DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230
IA ARGL YLH D KP + +RD+K N+LL ++DFGLA G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 231 NTHVSTRVMGTYGYCAPEYAKTG-----QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285
+ + +GT Y APE + L+ D+Y+ G+VL E+ S A D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 286 EQSLVAW 292
Sbjct: 246 MLPFEEE 252
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 3e-70
Identities = 75/247 (30%), Positives = 116/247 (46%), Gaps = 20/247 (8%)
Query: 31 NSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYK 90
+ + D + + + DG I L +E +G G FG V++
Sbjct: 8 HPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEK------------IGAGSFGTVHR 55
Query: 91 GYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148
DVA+K L EFL EV ++ L HPN+V +G +V
Sbjct: 56 AEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113
Query: 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 208
EY+ GS+ LH ++ LD R+ +A A+G+ YLH++ PP+++R+LK N+L
Sbjct: 114 EYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLL 171
Query: 209 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVL 268
+D+ Y K+ DFGL++L S GT + APE + KSDVYSFGV+L
Sbjct: 172 VDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVIL 229
Query: 269 LEILSGR 275
E+ + +
Sbjct: 230 WELATLQ 236
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 3e-69
Identities = 69/214 (32%), Positives = 112/214 (52%), Gaps = 25/214 (11%)
Query: 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN-------REFLVEVLMLSLLHHP 129
E +G+GGFG V+KG L VAIK L +G +EF EV ++S L+HP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N+V L G + +V E++P G + L D P+ W+ ++++ A G+EY+
Sbjct: 84 NIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYM 138
Query: 190 HDKAKPPVIYRDLKCSNILLD-----RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244
++ PP+++RDL+ NI L K++DFGL++ + H + ++G + +
Sbjct: 139 QNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQW 192
Query: 245 CAPE--YAKTGQLTLKSDVYSFGVVLLEILSGRK 276
APE A+ T K+D YSF ++L IL+G
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-67
Identities = 64/251 (25%), Positives = 102/251 (40%), Gaps = 36/251 (14%)
Query: 62 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFL--VE 119
E + N + L+G G +G VYKG L+ + VA+K + F+
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSF---ANRQNFINEKN 57
Query: 120 VLMLSLLHHPNLVNLIGYCADGD-----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 174
+ + L+ H N+ I + LLV EY P GS+ +L DW +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVS 112
Query: 175 RMKIAAGAARGLEYLH------DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK---- 224
++A RGL YLH D KP + +RDL N+L+ +SDFGL+
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 225 --LGPVGDNTHVSTRVMGTYGYCAPEYAK-------TGQLTLKSDVYSFGVVLLEILSGR 275
L G+ + + +GT Y APE + + D+Y+ G++ EI
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 276 KAVDTSKAAAE 286
+ ++ E
Sbjct: 233 TDLFPGESVPE 243
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 8e-67
Identities = 67/208 (32%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
+G GGFG+VY+ + +VA+K D + Q E + ++L HPN++ L
Sbjct: 15 IGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
G C LV E+ G + L K + + + A ARG+ YLHD+A
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 196 PVIYRDLKCSNILLDRGYHP--------KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
P+I+RDLK SNIL+ + K++DFGLA+ T + G Y + AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAA-GAYAWMAP 183
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSGR 275
E + + SDV+S+GV+L E+L+G
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 8e-66
Identities = 67/198 (33%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
+G G FG V K +DVAIKQ++ + + F+VE+ LS ++HPN+V L G C
Sbjct: 16 VGRGAFGVVCKAKWR--AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ LV EY GS+ + LH P M ++G+ YLH +I+
Sbjct: 72 N--PVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 200 RDLKCSNILLD-RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK 258
RDLK N+LL G K+ DFG A D T G+ + APE + + K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 259 SDVYSFGVVLLEILSGRK 276
DV+S+G++L E+++ RK
Sbjct: 184 CDVFSWGIILWEVITRRK 201
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-65
Identities = 46/203 (22%), Positives = 85/203 (41%), Gaps = 19/203 (9%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGY 137
L E G ++KG + D+ +K L R+F E L + HPN++ ++G
Sbjct: 18 LNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 138 CADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
C + +MP GS+ + LH+ +D + +K A ARG+ +LH +P
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL-EP 132
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE---YAKT 252
+ L ++++D ++S + + S M + APE
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPE 185
Query: 253 GQLTLKSDVYSFGVVLLEILSGR 275
+D++SF V+L E+++
Sbjct: 186 DTNRRSADMWSFAVLLWELVTRE 208
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 3e-63
Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 18/213 (8%)
Query: 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
+LG+G FG+ K + + +K+L R + R FL EV ++ L HPN++ IG
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
+ + EY+ G++ + W+ R+ A A G+ YLH
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---N 128
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKL------------GPVGDNTHVSTRVMGTYGY 244
+I+RDL N L+ + ++DFGLA+L + V+G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 277
APE K DV+SFG+VL EI+ A
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 1e-62
Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGY 137
+G+G FG+VY G + +VAI+ +D + + F EV+ H N+V +G
Sbjct: 41 IGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197
C ++ ++ + D K LD N +IA +G+ YLH K +
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GI 151
Query: 198 IYRDLKCSNILLDRGYHPKLSDFGLAKL---GPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
+++DLK N+ D G ++DFGL + G G + APE +
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 255 L---------TLKSDVYSFGVVLLEILSGR 275
+ SDV++ G + E+ +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-62
Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGY 137
+G G FG VYKG + DVA+K L+ + F EV +L H N++ +GY
Sbjct: 32 IGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197
Q +V ++ S+ HLH + + + IA ARG++YLH K +
Sbjct: 89 STA-PQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 198 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE---YAKTGQ 254
I+RDLK +NI L K+ DFGLA +H ++ G+ + APE +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 255 LTLKSDVYSFGVVLLEILSGR 275
+ +SDVY+FG+VL E+++G+
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ 222
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 8e-61
Identities = 61/264 (23%), Positives = 106/264 (40%), Gaps = 36/264 (13%)
Query: 30 INSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVY 89
+ IP + + ++S G+ + Q +++ + +G+G +G V+
Sbjct: 2 MTYIPPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQI-------QMVKQIGKGRYGEVW 54
Query: 90 KGYLESINQDVAIKQLDRNGVQGNREFL--VEVLMLSLLHHPNLVNLIGYCADGD----Q 143
G + VA+K + E+ L+ H N++ I G Q
Sbjct: 55 MGKWR--GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109
Query: 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH-----DKAKPPVI 198
L+ +Y GS+ D+L LD + +K+A + GL +LH + KP +
Sbjct: 110 LYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIA 164
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPE------YA 250
+RDLK NIL+ + ++D GLA N +GT Y PE
Sbjct: 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR 224
Query: 251 KTGQLTLKSDVYSFGVVLLEILSG 274
Q + +D+YSFG++L E+
Sbjct: 225 NHFQSYIMADMYSFGLILWEVARR 248
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-60
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFL--VEVLMLSLLHHPNLVNL 134
+G+G +G V++G + ++VA+K + + + E+ +L H N++
Sbjct: 13 LECVGKGRYGEVWRGSWQ--GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGF 67
Query: 135 IGYCADGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
I Q L+ Y +GS+ D+L LD + ++I A GL +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLH 122
Query: 191 -----DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV--STRVMGTYG 243
+ KP + +RDLK NIL+ + ++D GLA + N + +GT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 244 YCAPE------YAKTGQLTLKSDVYSFGVVLLEILSG 274
Y APE + D+++FG+VL E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-58
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 29/217 (13%)
Query: 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFL--VEVLMLSLLHHPNLVNL 134
+ +G+G FG V++G ++VA+K + R + E+ +L H N++
Sbjct: 47 QESIGKGRFGEVWRGKWR--GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGF 101
Query: 135 IGYCADGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
I + Q LV +Y GS+ D+L+ + + +K+A A GL +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLH 156
Query: 191 -----DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH--VSTRVMGTYG 243
+ KP + +RDLK NIL+ + ++D GLA +T +GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 244 YCAPE------YAKTGQLTLKSDVYSFGVVLLEILSG 274
Y APE K + ++D+Y+ G+V EI
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 6e-47
Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC 138
+G G FG V+ G L + N VA+K + +FL E +L HPN+V LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
+V E + G L L T +++ AA G+EYL K I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY--CAPEYAKTGQLT 256
+RDL N L+ K+SDFG+++ D + ++ + APE G+ +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 257 LKSDVYSFGVVLLEILS 273
+SDV+SFG++L E S
Sbjct: 294 SESDVWSFGILLWETFS 310
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-46
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 13/203 (6%)
Query: 80 LGEGGFGRVYKGYL----ESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LG G FG VYKG E + VAIK+L + + N+E L E +++ + +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
+G C L+ + MP G + D++ + K + + A+G+ YL D+
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
+++RDL N+L+ H K++DFGLAKL + + + + A E
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 255 LTLKSDVYSFGVVLLEILS-GRK 276
T +SDV+S+GV + E+++ G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-45
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 77 ESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
S LG+G FG V ++ VA+KQL +G R+F E+ +L LH +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 133 NLIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
G ++ LV EY+P G + D L + LD + + ++ +G+EYL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLG 144
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YC 245
+ ++RDL NIL++ H K++DFGLAKL P+ + +V G +
Sbjct: 145 SRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----EPGQSPIFWY 197
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILS 273
APE + +SDV+SFGVVL E+ +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-44
Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 77 ESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
LG+G FG V ++ + VA+K+L + + R+F E+ +L L H N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 133 NLIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
G C +R L+ EY+P GS+ D+L K+ +D ++ + +G+EYL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLG 131
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YC 245
K I+RDL NIL++ K+ DFGL K+ P G +
Sbjct: 132 TKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWY 184
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILS 273
APE + ++ SDV+SFGVVL E+ +
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-44
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 77 ESLLGEGGFGRVYKGYLESINQD----VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
LG+G FG V + + + VA+K+L + + R+F E+ +L L H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 133 NLIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
G C +R L+ EY+P GS+ D+L K+ +D ++ + +G+EYL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLG 162
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YC 245
K I+RDL NIL++ K+ DFGL K+ P + G +
Sbjct: 163 TKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWY 215
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILS 273
APE + ++ SDV+SFGVVL E+ +
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 5e-44
Identities = 58/195 (29%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G +G VY+G + + VA+K L + EFL E ++ + HPNLV L+G C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
++ E+M G++ D+L ++ + + +A + +EYL K I+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 341
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG-TYGYCAPEYAKTGQLTLK 258
R+L N L+ + K++DFGL++L + +T+ + + APE + ++K
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 259 SDVYSFGVVLLEILS 273
SDV++FGV+L EI +
Sbjct: 400 SDVWAFGVLLWEIAT 414
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 7e-44
Identities = 70/234 (29%), Positives = 101/234 (43%), Gaps = 25/234 (10%)
Query: 77 ESLLGEGGFGRVYKGYLESINQD----VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNL 131
LGEG FG+V + N VA+K L G Q + E+ +L L+H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 132 VNLIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
+ G C D LV EY+PLGS+ D+L + + + A G+ YL
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYL 150
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----Y 244
H + I+RDL N+LLD K+ DFGLAK P G + + G +
Sbjct: 151 HAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFW 203
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWSEPEN 297
APE K + SDV+SFGV L E+L+ + E +A +
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-43
Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 80 LGEGGFGRVYKGYL----ESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LG G FG V+KG ESI V IK + D++G Q + +L + L H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
+G C G LV +Y+PLGS+ DH+ + L + A+G+ YL +
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG- 135
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
+++R+L N+LL +++DFG+A L P D + + + A E G+
Sbjct: 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 255 LTLKSDVYSFGVVLLEILS-GRK 276
T +SDV+S+GV + E+++ G +
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAE 216
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-43
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 13/203 (6%)
Query: 80 LGEGGFGRVYKGYL----ESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LG G FG VYKG E + VAIK+L + + N+E L E +++ + +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
+G C L+ + MP G + D++ + K + + A+G+ YL D+
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
+++RDL N+L+ H K++DFGLAKL + + + + A E
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 255 LTLKSDVYSFGVVLLEILS-GRK 276
T +SDV+S+GV + E+++ G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-43
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 77 ESLLGEGGFGRVYKGYLESINQD----VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNL 131
LGEG FG+V + + VA+K L +G + E+ +L L+H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 132 VNLIGYCADGDQR--LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
V G C + L+ E++P GS++++L K ++ ++K A +G++YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYL 142
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----Y 244
+ ++RDL N+L++ + K+ DFGL K + +
Sbjct: 143 GSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----DDRDSPVFW 195
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
APE + + SDV+SFGV L E+L+
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-43
Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G +G VY+G + + VA+K L + EFL E ++ + HPNLV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
++ E+M G++ D+L ++ + + +A + +EYL K I+
Sbjct: 80 REPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 134
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 256
RDL N L+ + K++DFGL++L + +T+ + G + APE + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHA--GAKFPIKWTAPESLAYNKFS 190
Query: 257 LKSDVYSFGVVLLEILS 273
+KSDV++FGV+L EI +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-42
Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 18/237 (7%)
Query: 46 KEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL 105
+E D +T ++ + + + +G G F VYKG +VA +L
Sbjct: 1 QEERNQQQDDIEELET-KAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL 59
Query: 106 DRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCAD---GDQRLLVY-EYMPLGSVEDH 159
+ + + F E ML L HPN+V G + +++ E M G+++ +
Sbjct: 60 QDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY 119
Query: 160 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLS 218
L K + +GL++LH + PP+I+RDLKC NI + K+
Sbjct: 120 LKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIG 174
Query: 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
D GLA L + V+GT + APE + DVY+FG+ +LE+ +
Sbjct: 175 DLGLATLK----RASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE 226
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-42
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 133
LG+G FG VY+G + + +D VAIK ++ R EFL E ++ + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------GKKPLDWNTRMKIAAGAARGLE 187
L+G + G L++ E M G ++ +L L P P + +++A A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV------MGT 241
YL+ ++RDL N ++ + K+ DFG+ + D + M
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+PE K G T SDV+SFGVVL EI +
Sbjct: 208 ----SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-42
Identities = 66/215 (30%), Positives = 95/215 (44%), Gaps = 19/215 (8%)
Query: 72 KNFRSESLLGEGGFGRVYKGYL---ESINQDVAIKQL---DRNGVQGNREFLVEVLMLSL 125
K+ R LG+G FG V +G VA+K L + + +F+ EV +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 126 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
L H NL+ L G +V E PLGS+ D L + T + A A G
Sbjct: 78 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEG 133
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---Y 242
+ YL K I+RDL N+LL K+ DFGL + P D+ +V +
Sbjct: 134 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPF 188
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRK 276
+CAPE KT + SD + FGV L E+ + G++
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-42
Identities = 64/209 (30%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
+G G FG V+ GY + VAIK + R G +F+ E ++ L HP L
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 65
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L G C + LV E+M G + D+L + T + + G+ YL +
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPE 248
VI+RDL N L+ K+SDFG+ + V D+ + T GT + +PE
Sbjct: 123 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQY--TSSTGTKFPVKWASPE 175
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILS-GRK 276
+ + KSDV+SFGV++ E+ S G+
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 8e-42
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 80 LGEGGFGRVYKGYLESINQ-------DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
LG+G F +++KG + +V +K LD+ + F M+S L H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
G C GD+ +LV E++ GS++ +L K ++ ++++A A + +L +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN 132
Query: 193 AKPPVIYRDLKCSNILLDRGYHP--------KLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244
+I+ ++ NILL R KLSD G++ V + R+
Sbjct: 133 T---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPKDILQERIPWV--- 184
Query: 245 CAPEYAKTGQL-TLKSDVYSFGVVLLEILS-GRK 276
PE + + L +D +SFG L EI S G K
Sbjct: 185 -PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-41
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 77 ESLLGEGGFGRVYKGYL--ESINQDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLV 132
+ LG G FG V KGY + + + VA+K L + N E L E ++ L +P +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
+IG C + + +LV E LG + +L + + +++ + G++YL +
Sbjct: 82 RMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCA 246
++RDL N+LL ++ K+SDFGL+K +N + + + A
Sbjct: 137 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYA 188
Query: 247 PEYAKTGQLTLKSDVYSFGVVLLEILS-GRK 276
PE + + KSDV+SFGV++ E S G+K
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-41
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V G + DVA+K + + G EF E + L HP LV G C+
Sbjct: 16 LGSGQFGVVKLGKWKG-QYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+V EY+ G + ++L K L+ + +++ G+ +L I+
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIH 127
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 256
RDL N L+DR K+SDFG+ + V D+ + +GT + APE + +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQY--VSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 257 LKSDVYSFGVVLLEILS-GRK 276
KSDV++FG+++ E+ S G+
Sbjct: 184 SKSDVWAFGILMWEVFSLGKM 204
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-41
Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V G DVAIK + + G EF+ E ++ L H LV L G C
Sbjct: 32 LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
++ EYM G + ++L + + +++ +EYL K ++
Sbjct: 90 KQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLH 143
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 256
RDL N L++ K+SDFGL++ V D+ + T +G+ + PE + +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEY--TSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 257 LKSDVYSFGVVLLEILS 273
KSD+++FGV++ EI S
Sbjct: 200 SKSDIWAFGVLMWEIYS 216
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-41
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LGEG FG+V+ +++ VA+K L + ++F E +L+ L H ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGA 182
G C DGD ++V+EYM G + L P K L + + IA+
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV---- 238
A G+ YL + ++RDL N L+ K+ DFG+++ D V
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 239 --MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
M PE + T +SDV+SFGV+L EI +
Sbjct: 200 RWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-41
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 77 ESLLGEGGFGRVYKGYLESINQ--DVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLV 132
+ LG G FG V +G + DVAIK L + G + E + E ++ L +P +V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
LIG C + +LV E G + L ++ + + ++ + G++YL +K
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCA 246
++RDL N+LL ++ K+SDFGL+K D+ + + + A
Sbjct: 130 N---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYA 181
Query: 247 PEYAKTGQLTLKSDVYSFGVVLLEILS-GRK 276
PE + + +SDV+S+GV + E LS G+K
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-41
Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LGEG FG+V+ ++ + VA+K L ++F E +L++L H ++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-----------GKKPLDWNTRMKIAAGAA 183
G C +G L+V+EYM G + L P PL + +A+ A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV----- 238
G+ YL ++RDL N L+ +G K+ DFG+++ D V R
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 239 -MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
M PE + T +SDV+SFGVVL EI +
Sbjct: 226 WM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-41
Identities = 55/221 (24%), Positives = 86/221 (38%), Gaps = 23/221 (10%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
K++ LGEGGF V A+K++ + Q E E M L +HPN+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 132 VNLIGYCADGDQR----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
+ L+ YC L+ + G++ + + L L + + + G RGLE
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-------G 240
+H +RDLK +NILL P L D G + +
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 241 TYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
T Y APE + + ++DV+S G VL ++ G
Sbjct: 206 TISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGE 243
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-41
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 77 ESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLV 132
E ++G G G V G L + VAIK L + R +FL E ++ HPN++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
L G G ++V EYM GS++ L + + G G+ YL D
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEY 249
++RDL N+L+D K+SDFGL+++ + D+ + G + APE
Sbjct: 171 G---YVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 250 AKTGQLTLKSDVYSFGVVLLEILS-GRK 276
+ SDV+SFGVV+ E+L+ G +
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-40
Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 23/199 (11%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
+G+G FG V G VA+K + + + FL E +++ L H NLV L+G
Sbjct: 201 IGKGEFGDVMLGDYR--GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 140 DGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
+ L +V EYM GS+ D+L S G+ L + +K + +EYL +
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 311
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV----MGTYGYCAPEYAKTGQ 254
+RDL N+L+ K+SDFGL K +T + ++ APE + +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKK 362
Query: 255 LTLKSDVYSFGVVLLEILS 273
+ KSDV+SFG++L EI S
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-40
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 24/203 (11%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
+G+G FG V G VA+K + +N + FL E +++ L H NLV L+G
Sbjct: 29 IGKGEFGDVMLGDYR--GNKVAVKCI-KNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 140 DGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
+ L +V EYM GS+ D+L S G+ L + +K + +EYL +
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 139
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV----MGTYGYCAPEYAKTGQ 254
+RDL N+L+ K+SDFGL K +T + ++ APE + +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKK 190
Query: 255 LTLKSDVYSFGVVLLEILS-GRK 276
+ KSDV+SFG++L EI S GR
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRV 213
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-40
Identities = 63/206 (30%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVN 133
LG G FG VY+G + + D VA+K L + Q +FL+E L++S +H N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG---KKPLDWNTRMKIAAGAARGLEYLH 190
IG R ++ E M G ++ L + P L + +A A G +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 191 DKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
+ I+RD+ N LL G K+ DFG+A+ M + P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILS 273
E G T K+D +SFGV+L EI S
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-40
Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 133
LGE FG+VYKG+L VAIK L R EF E ++ + L HPN+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG------------KKPLDWNTRMKIAAG 181
L+G +++ Y G + + L SP K L+ + + A
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST----- 236
A G+EYL V+++DL N+L+ + K+SD GL + D +
Sbjct: 137 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 237 -RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
R M APE G+ ++ SD++S+GVVL E+ S
Sbjct: 194 IRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-40
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 17/214 (7%)
Query: 72 KNFRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNGVQGNR-EFLVEVLMLSLL 126
+ ++G G FG VYKG L VAIK L + R +FL E ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 127 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
H N++ L G + +++ EYM G+++ L + + + G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGM 160
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YG 243
+YL + ++RDL NIL++ K+SDFGL+++ + D+ + G
Sbjct: 161 KYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIR 215
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRK 276
+ APE + T SDV+SFG+V+ E+++ G +
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-40
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 80 LGEGGFGRVYKGYLESINQ---DVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLI 135
LGEG FG VY+G + +VA+K ++ N+ +F+ E +++ L HP++V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
G + + ++ E P G + +L K L T + + + + YL
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN-- 133
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCAPEY 249
++RD+ NIL+ KL DFGL++ + D + + +PE
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS-----VTRLPIKWMSPES 185
Query: 250 AKTGQLTLKSDVYSFGVVLLEILS-GRK 276
+ T SDV+ F V + EILS G++
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-40
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 80 LGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLI 135
+G G FG VY G L + A+K L+R G +FL E +++ HPN+++L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 136 GYCADGD-QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
G C + L+V YM G + + + + + + A+G++YL K
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLASKK- 148
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG------TYGYCAPE 248
++RDL N +LD + K++DFGLA+ + V + A E
Sbjct: 149 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----ALE 202
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILS 273
+T + T KSDV+SFGV+L E+++
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-40
Identities = 68/197 (34%), Positives = 102/197 (51%), Gaps = 15/197 (7%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V+ GY + VA+K L + G FL E ++ L H LV L
Sbjct: 21 LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ ++ EYM GS+ D L +P L N + +AA A G+ ++ ++ I+
Sbjct: 78 TQEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLT 256
RDL+ +NIL+ K++DFGLA+L + DN + T G + APE G T
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARL--IEDNEY--TAREGAKFPIKWTAPEAINYGTFT 188
Query: 257 LKSDVYSFGVVLLEILS 273
+KSDV+SFG++L EI++
Sbjct: 189 IKSDVWSFGILLTEIVT 205
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-39
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLH 127
N + ++G G FG V G L+ VAIK L + R +FL E ++
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
HPN++ L G ++V EYM GS++ L + + G A G++
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMK 161
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGY 244
YL D ++RDL NIL++ K+SDFGL ++ + D+ + G +
Sbjct: 162 YLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRW 216
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRK 276
+PE + T SDV+S+G+VL E++S G +
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 65/281 (23%), Positives = 108/281 (38%), Gaps = 18/281 (6%)
Query: 3 WFPCSGDSFRKAKNKKKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTL 62
P + + + I K E SD +
Sbjct: 269 TLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDK 328
Query: 63 TFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQ--DVAIKQL-DRNGVQGNREFLVE 119
E LG G FG V +G + DVAIK L E + E
Sbjct: 329 KLFLKRDNLLIADIE--LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMRE 386
Query: 120 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 179
++ L +P +V LIG C + +LV E G + L ++ + + ++
Sbjct: 387 AQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELL 442
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 239
+ G++YL +K ++R+L N+LL ++ K+SDFGL+K D+ + +
Sbjct: 443 HQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-- 497
Query: 240 GT---YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRK 276
+ APE + + +SDV+S+GV + E LS G+K
Sbjct: 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 66/197 (33%), Positives = 95/197 (48%), Gaps = 9/197 (4%)
Query: 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
E LG+G FG V+ G VAIK L + G FL E ++ L H LV L
Sbjct: 189 EVKLGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
+ +V EYM GS+ D L K L + +AA A G+ Y+
Sbjct: 247 VV-SEEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN--- 300
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 256
++RDL+ +NIL+ K++DFGLA+L + T + APE A G+ T
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFT 359
Query: 257 LKSDVYSFGVVLLEILS 273
+KSDV+SFG++L E+ +
Sbjct: 360 IKSDVWSFGILLTELTT 376
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-39
Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 25/212 (11%)
Query: 75 RSESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPN 130
S+ ++G+G FG VY G Q+ AIK L R FL E L++ L+HPN
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 131 LVNLIGYCADGD-QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
++ LIG + ++ YM G + + ++ + ARG+EYL
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYL 140
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG--------T 241
++ ++RDL N +LD + K++DFGLA+ + D + S + T
Sbjct: 141 AEQK---FVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHARLPVKWT 195
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
A E +T + T KSDV+SFGV+L E+L+
Sbjct: 196 ----ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-39
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 80 LGEGGFGRVYKGYLESINQD---VAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LGEG FG V +G L+ + VA+K + D + + EFL E + HPN++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 135 IGYCADGDQR-----LLVYEYMPLGSVEDHL--HDLSPGKKPLDWNTRMKIAAGAARGLE 187
+G C + + +++ +M G + +L L G K + T +K A G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV------MGT 241
YL ++ ++RDL N +L ++DFGL+K GD +
Sbjct: 162 YLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI-- 216
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
A E T KSDV++FGV + EI +
Sbjct: 217 ----AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-39
Identities = 62/206 (30%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 133
LG G FG VY+G + + D VA+K L + + +FL+E L++S +H N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG---KKPLDWNTRMKIAAGAARGLEYLH 190
IG R ++ E M G ++ L + P L + +A A G +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 191 DKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
+ I+RD+ N LL G K+ DFG+A+ M + P
Sbjct: 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILS 273
E G T K+D +SFGV+L EI S
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-39
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 77 ESLLGEGGFGRVYKGYLESINQD---VAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLV 132
++G G FG VY G L + A+K L+R + +FL E +++ HPN++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 133 NLIGYCADGD-QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
+L+G C + L+V YM G + + + + + + A+G+++L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLAS 210
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG------TYGYC 245
K ++RDL N +LD + K++DFGLA+ + V +
Sbjct: 211 KK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM---- 263
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILS 273
A E +T + T KSDV+SFGV+L E+++
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-39
Identities = 65/194 (33%), Positives = 94/194 (48%), Gaps = 9/194 (4%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG+G FG V+ G VAIK L + G FL E ++ L H LV L
Sbjct: 275 LGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 331
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 199
+ +V EYM GS+ D L K L + +AA A G+ Y+ ++
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 386
Query: 200 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS 259
RDL+ +NIL+ K++DFGLA+L + T + APE A G+ T+KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 260 DVYSFGVVLLEILS 273
DV+SFG++L E+ +
Sbjct: 446 DVWSFGILLTELTT 459
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-39
Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
E LG G FG V+ + VA+K + + G FL E ++ L H LV L
Sbjct: 193 EKKLGAGQFGEVWMATYNK-HTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 196
+ ++ E+M GS+ D L S + +A A G+ ++ +
Sbjct: 251 VVT-KEPIYIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--- 304
Query: 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTG 253
I+RDL+ +NIL+ K++DFGLA++ + DN + T G + APE G
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARV--IEDNEY--TAREGAKFPIKWTAPEAINFG 360
Query: 254 QLTLKSDVYSFGVVLLEILS 273
T+KSDV+SFG++L+EI++
Sbjct: 361 SFTIKSDVWSFGILLMEIVT 380
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-39
Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 28/213 (13%)
Query: 80 LGEGGFGRVYKGYLESINQD---VAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVNL 134
LG+G FG V + L+ + VA+K L D EFL E + HP++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 135 IGYCADGDQR------LLVYEYMPLGSVEDHLHDLSPGKKP--LDWNTRMKIAAGAARGL 186
+G + +++ +M G + L G+ P L T ++ A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV------MG 240
EYL + I+RDL N +L ++DFGL++ GD +
Sbjct: 151 EYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL- 206
Query: 241 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
A E T+ SDV++FGV + EI++
Sbjct: 207 -----ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-38
Identities = 62/209 (29%), Positives = 91/209 (43%), Gaps = 27/209 (12%)
Query: 80 LGEGGFGRVYKGYLESINQ---DVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNL 134
+GEG FG V++G S VAIK +N +FL E L + HP++V L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
IG + ++ E LG + L K LD + + A + L YL K
Sbjct: 82 IGVI-TENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR- 136
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCAPE 248
++RD+ N+L+ KL DFGL++ + D+T+ + APE
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKAS-----KGKLPIKWMAPE 187
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILS-GRK 276
+ T SDV+ FGV + EIL G K
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 69/269 (25%), Positives = 108/269 (40%), Gaps = 27/269 (10%)
Query: 19 KMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSES 78
K ++ L I + + K SE +I + T+ + + E
Sbjct: 332 PQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRER 391
Query: 79 L-----LGEGGFGRVYKGYLESINQ---DVAIKQL-DRNGVQGNREFLVEVLMLSLLHHP 129
+ +GEG FG V++G S VAIK + +FL E L + HP
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
++V LIG + ++ E LG + L K LD + + A + L YL
Sbjct: 452 HIVKLIGVI-TENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYL 507
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----Y 244
K ++RD+ N+L+ KL DFGL++ + D+T+ G +
Sbjct: 508 ESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASK----GKLPIKW 558
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
APE + T SDV+ FGV + EIL
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-38
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV----EVLMLSLLHHP 129
++ LG GG VY +N VAIK + + E L EV S L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N+V++I + D LV EY+ ++ +++ PL +T + G+++
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHA 127
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPE 248
HD +++RD+K NIL+D K+ DFG+AK + + + T V+GT Y +PE
Sbjct: 128 HDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPE 182
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGR 275
AK +D+YS G+VL E+L G
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-38
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 80 LGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGNR-EFLVEV-LMLSLLHHPN 130
LGEG FG+V I++D VA+K L + + + + + E+ +M + H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHL------------HDLSPGKKPLDWNTRMKI 178
++NL+G C ++ EY G++ ++L ++ + + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-- 236
ARG+EYL + I+RDL N+L+ K++DFGLA+ D +T
Sbjct: 163 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 237 ----RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ M APE T +SDV+SFGV++ EI +
Sbjct: 220 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-38
Identities = 68/219 (31%), Positives = 102/219 (46%), Gaps = 34/219 (15%)
Query: 77 ESLLGEGGFGRVYKGYL--ESINQDVAIKQL-DRNGVQGNREFLVEV-LMLSLLHHPNLV 132
+ ++GEG FG+V K + + + D AIK++ + +R+F E+ ++ L HHPN++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAA 180
NL+G C L EY P G++ D L L + AA
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST---- 236
ARG++YL K I+RDL NIL+ Y K++DFGL++ + T
Sbjct: 150 DVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 203
Query: 237 --RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
R M A E T SDV+S+GV+L EI+S
Sbjct: 204 PVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-38
Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 80 LGEGGFGRVYKGYLESINQD-------VAIKQL-DRNGVQGNREFLVEV-LMLSLLHHPN 130
LGEG FG+V I++D VA+K L D + + + E+ +M + H N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKI 178
++NL+G C ++ EY G++ ++L P ++ + + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-- 236
ARG+EYL + I+RDL N+L+ K++DFGLA+ D +T
Sbjct: 209 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 237 ----RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ M APE T +SDV+SFGV++ EI +
Sbjct: 266 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 32/217 (14%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQL-DRNGVQGNREFLVEV-LMLSLLHHPNLV 132
LG G FG+V + + ++ VA+K L + E+ +M L H N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP----------GKKPLDWNTRMKIAAGA 182
NL+G C G L++ EY G + + L S + ++
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST------ 236
A+G+ +L K I+RD+ N+LL G+ K+ DFGLA+ N V
Sbjct: 174 AQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ M APE T++SDV+S+G++L EI S
Sbjct: 231 KWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 41/226 (18%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 133
+GEG FGRV++ + VA+K L + +F E +++ +PN+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP--------------------GKKPLDWN 173
L+G CA G L++EYM G + + L +SP G PL
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 174 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233
++ IA A G+ YL ++ ++RDL N L+ K++DFGL++ D
Sbjct: 175 EQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 234 VSTRV------MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
M PE + T +SDV+++GVVL EI S
Sbjct: 232 ADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-37
Identities = 62/221 (28%), Positives = 94/221 (42%), Gaps = 36/221 (16%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEV-LMLSLLHHPNLV 132
LG G FG+V + + + VA+K L + R + E+ ++ L +H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP--------------GKKPLDWNTRMKI 178
NL+G C G L++ EY G + + L + LD +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-- 236
+ A+G+ +L K I+RDL NILL G K+ DFGLA+ N V
Sbjct: 151 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 237 ----RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ M APE T +SDV+S+G+ L E+ S
Sbjct: 208 RLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-37
Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 41/226 (18%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVN 133
LGEG FG+V K + VA+K L N + L E +L ++HP+++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHL--------------------HDLSPGKKPLDWN 173
L G C+ LL+ EY GS+ L P ++ L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 174 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233
+ A ++G++YL + +++RDL NIL+ G K+SDFGL++ D+
Sbjct: 151 DLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 234 VST------RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ + M A E T +SDV+SFGV+L EI++
Sbjct: 208 KRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-37
Identities = 55/231 (23%), Positives = 97/231 (41%), Gaps = 35/231 (15%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 130
+F ++LG+G FG+V K ++ AIK++ + L EV++L+ L+H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 131 LVNLIGYCADGDQRL-------------LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 177
+V + + + EY G++ D +H + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWR 120
Query: 178 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL------------ 225
+ L Y+H + +I+RDLK NI +D + K+ DFGLAK
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 226 -GPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSG 274
G + ++++ + GT Y A E TG K D+YS G++ E++
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-36
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 28/221 (12%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
+F+ L+G GGFG+V+K + IK++ N N + EV L+ L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNI 66
Query: 132 VNLIGYCADGDQRL----------------LVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 175
V+ G D + E+ G++E + + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLA 124
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235
+++ +G++Y+H K +I RDLK SNI L K+ DFGL N
Sbjct: 125 LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKR 178
Query: 236 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 276
TR GT Y +PE + + D+Y+ G++L E+L
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 80 LGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGNR-EFLVEV-LMLSLLHHPN 130
LGEG FG+V +++D VA+K L + + + + + E+ +M + H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR------------MKI 178
++NL+G C ++ EY G++ ++L P +N +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-- 236
A ARG+EYL K I+RDL N+L+ K++DFGLA+ D +T
Sbjct: 197 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 237 ----RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ M APE T +SDV+SFGV+L EI +
Sbjct: 254 RLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-36
Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 8/212 (3%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLV-EVLMLSLLHHP 129
+++ +G G +GR K +S + + K+LD + + ++ LV EV +L L HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 130 NLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
N+V D L V EY G + + + ++ LD +++ L+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 188 YLHDKAKPP--VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
H ++ V++RDLK +N+ LD + KL DFGLA++ + +T + +GT Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPYYM 183
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 277
+PE KSD++S G +L E+ +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-36
Identities = 61/200 (30%), Positives = 87/200 (43%), Gaps = 14/200 (7%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHHPNLVNLI 135
LG+G FG VY + +A+K L + ++ + EV + S L HPN++ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
GY D + L+ EY PLG+V L D A L Y H K
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR-- 129
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 255
VI+RD+K N+LL K++DFG + P + GT Y PE +
Sbjct: 130 -VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDL--CGTLDYLPPEMIEGRMH 184
Query: 256 TLKSDVYSFGVVLLEILSGR 275
K D++S GV+ E L G+
Sbjct: 185 DEKVDLWSLGVLCYEFLVGK 204
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-36
Identities = 50/243 (20%), Positives = 89/243 (36%), Gaps = 25/243 (10%)
Query: 48 ASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR 107
+ + + L F+ ++ + + +G GG +V++ E Q AIK ++
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNL 62
Query: 108 NGVQGN--REFLVEVLMLSLLHHPNL--VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL 163
+ E+ L+ L + + L Y +V E + L
Sbjct: 63 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK- 120
Query: 164 SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223
KK +D R + +H +++ DLK +N L+ G KL DFG+A
Sbjct: 121 ---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIA 173
Query: 224 KLGPVGDNTHVSTRVMGTYGYCAPE-----------YAKTGQLTLKSDVYSFGVVLLEIL 272
+ V +GT Y PE +++ KSDV+S G +L +
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
Query: 273 SGR 275
G+
Sbjct: 234 YGK 236
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-36
Identities = 49/207 (23%), Positives = 77/207 (37%), Gaps = 15/207 (7%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV----EVLMLSLLHHP 129
+R L+G GG G VY+ + VA+K + + + F E L P
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
++V + + Q + + + L + PL + I L+
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAA 150
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPE 248
H +RD+K NIL+ L DFG+A D +GT Y APE
Sbjct: 151 HAAG---ATHRDVKPENILVSADDFAYLVDFGIASA--TTDEKLTQLGNTVGTLYYMAPE 205
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGR 275
T ++D+Y+ VL E L+G
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGS 232
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-36
Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEV-LMLSLLHHPNLV 132
LG G FG+V + I++ VA+K L + E+ +++ + HH N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 133 NLIGYCADGDQ-RLLVYEYMPLGSVEDHL------------HDLSPGKKPLDWNTRMKIA 179
NL+G C +++ E+ G++ +L K L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST--- 236
A+G+E+L + I+RDL NILL K+ DFGLA+ +
Sbjct: 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 237 ---RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
+ M APE T++SDV+SFGV+L EI S
Sbjct: 212 LPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-35
Identities = 45/226 (19%), Positives = 94/226 (41%), Gaps = 31/226 (13%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-------------- 118
++R L +G F ++ E N+ A+K+ +++ ++ R+F
Sbjct: 32 DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 119 ---EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 175
E+ +++ + + + G + D+ ++YEYM S+ K
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 176 MKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231
+++ + Y+H++ + +RD+K SNIL+D+ KLSDFG ++ +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV---D 204
Query: 232 THVSTRVMGTYGYCAPE--YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ GTY + PE ++ K D++S G+ L +
Sbjct: 205 KKIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 8/209 (3%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHH 128
NFR E +G G F VY+ VA+K++ + + + E+ +L L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
PN++ + ++ +V E G + + K+ + T K LE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
+H + V++RD+K +N+ + KL D GL + T + ++GT Y +PE
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPE 206
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGRKA 277
KSD++S G +L E+ + +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 51/208 (24%), Positives = 81/208 (38%), Gaps = 14/208 (6%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEV-LMLSLLHH 128
++F+ S LG G +G V+K + + A+K+ G + L EV + H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
P V L +G L E S++ H L L +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAW---GASLPEAQVWGYLRDTLLALAH 172
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
LH + +++ D+K +NI L KL DFGL +G + G Y APE
Sbjct: 173 LHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE-GDPRYMAPE 226
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGRK 276
+ G +DV+S G+ +LE+ +
Sbjct: 227 LLQ-GSYGTAADVFSLGLTILEVACNME 253
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 51/268 (19%), Positives = 95/268 (35%), Gaps = 25/268 (9%)
Query: 23 QQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGE 82
+ R + + + + ++ + G D A + ++ + + +G
Sbjct: 7 SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGS 66
Query: 83 GGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNL--VNLIGYC 138
GG +V++ E Q AIK ++ + E+ L+ L + + L Y
Sbjct: 67 GGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
+V E + L KK +D R + +H ++
Sbjct: 126 ITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IV 177
Query: 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE---------- 248
+ DLK +N L+ G KL DFG+A + V +G Y PE
Sbjct: 178 HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE 236
Query: 249 -YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+++ KSDV+S G +L + G+
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-35
Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 23/214 (10%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV----EVLMLSLLHHP 129
+ +LG GG V+ ++DVA+K L R + + F + E + L+HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHP 72
Query: 130 NLVNL--IGYCADGDQRLLVY---EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR 184
+V + G A+ L Y EY+ ++ D +H + P+ +++ A A +
Sbjct: 73 AIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQ 127
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR---VMGT 241
L + H +I+RD+K +NI++ K+ DFG+A+ + D+ + T+ V+GT
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAAVIGT 182
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y +PE A+ + +SDVYS G VL E+L+G
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-35
Identities = 56/261 (21%), Positives = 95/261 (36%), Gaps = 17/261 (6%)
Query: 19 KMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSES 78
+ L + +G + + + E +
Sbjct: 6 SSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQP 64
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC 138
+G G FG V++ + A+K++ + E++ + L P +V L G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAV 119
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
+G + E + GS L L L + + A GLEYLH + ++
Sbjct: 120 REGPWVNIFMELLEGGS----LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---IL 172
Query: 199 YRDLKCSNILLDR-GYHPKLSDFGLAK-LGPVGDNTHVSTR--VMGTYGYCAPEYAKTGQ 254
+ D+K N+LL G L DFG A L P G + T + GT + APE
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 255 LTLKSDVYSFGVVLLEILSGR 275
K D++S ++L +L+G
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGC 253
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-35
Identities = 42/291 (14%), Positives = 87/291 (29%), Gaps = 55/291 (18%)
Query: 31 NSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFR---ELAAATKNFRSESLLGEGGFGR 87
N IP +S ++ A++ S + FR EL + ++LG+
Sbjct: 29 NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYA 88
Query: 88 VYKGYLESINQDVAIKQLDRNG----------------------------VQGNREFLVE 119
+ + + + + + F+
Sbjct: 89 YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148
Query: 120 VLMLSLLHHPNLVNLIGYCADGD--QRLLVYEYM--PLGSVEDHLHDLSPGKKPLDWNTR 175
++ ++ + D R +Y M L + + L S K L + R
Sbjct: 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHAR 208
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235
+++ R L LH +++ L+ +I+LD+ L+ F G
Sbjct: 209 LQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGA----R 259
Query: 236 TRVMGTYGYCAPEY-----------AKTGQLTLKSDVYSFGVVLLEILSGR 275
+ G+ PE + +T D ++ G+V+ I
Sbjct: 260 VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 64/226 (28%), Positives = 96/226 (42%), Gaps = 41/226 (18%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEV-LMLSLLHHPNLV 132
LG G FG+V I++ VA+K L R + E+ +M L H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-------------------GKKPLDWN 173
NL+G C L++EY G + ++L L +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 174 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233
+ A A+G+E+L K+ ++RDL N+L+ G K+ DFGLA+ N
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 234 VST------RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
V + M APE G T+KSDV+S+G++L EI S
Sbjct: 230 VRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 1e-34
Identities = 34/288 (11%), Positives = 67/288 (23%), Gaps = 45/288 (15%)
Query: 24 QKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFR---ELAAATKNFRSESLL 80
+ L R + + +L+ A + + + Q L+ + + L
Sbjct: 12 RDLLKREEELIGYCR-EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPL 70
Query: 81 GEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGY 137
G V+ +D A+K E + L +
Sbjct: 71 RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130
Query: 138 C--------------------------ADGDQRLLVYEYMP--LGSVEDHLHDLSPGKKP 169
LL+ L + L + +
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGD 190
Query: 170 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229
+ A R L K +++ N+ + L D VG
Sbjct: 191 EGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--KVG 245
Query: 230 DNTHVSTRVMGTYGYCAPEY--AKTGQLTLKSDVYSFGVVLLEILSGR 275
S+ Y E+ A T T + + G+ + +
Sbjct: 246 TRGPASS---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 53/224 (23%), Positives = 94/224 (41%), Gaps = 27/224 (12%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPN 130
+F LG GGFG V++ + + + AIK++ + RE + EV L+ L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 131 LVNLIGYCADGD---------QRLLVY---EYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 178
+V + + ++ +Y + +++D ++ + + + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG-RCTIEERERSVCLHI 123
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL----------GPV 228
A +E+LH K +++RDLK SNI K+ DFGL
Sbjct: 124 FLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 272
T +GT Y +PE + K D++S G++L E+L
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 48/219 (21%), Positives = 81/219 (36%), Gaps = 25/219 (11%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHP 129
+ + +G GG +V++ E Q AIK ++ + E+ L+ L
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 130 NL--VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
+ + L Y +V E + L KK +D R +
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYWKNMLEAVH 122
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
+H +++ DLK +N L+ G KL DFG+A + V +GT Y P
Sbjct: 123 TIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 248 E-----------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
E +++ KSDV+S G +L + G+
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 42/293 (14%), Positives = 86/293 (29%), Gaps = 54/293 (18%)
Query: 28 DRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFR---ELAAATKNFRSESLLGEGG 84
+ N IP +S ++ A++ S + FR EL + ++LG+
Sbjct: 31 ELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQED 90
Query: 85 FGRVYKGYLESINQDVAIKQLDR----------------------------NGVQGNREF 116
+ + + + + + F
Sbjct: 91 PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150
Query: 117 LVEVLMLSLLHHPNLVNLIGYCADGD--QRLLVYEYM--PLGSVEDHLHDLSPGKKPLDW 172
+ ++ ++ + D R +Y M L + + L S K L
Sbjct: 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 210
Query: 173 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232
+ R+++ R L LH +++ L+ +I+LD+ L+ F G
Sbjct: 211 HARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGA-- 263
Query: 233 HVSTRVMGTYGYCAPEY----------AKTGQLTLKSDVYSFGVVLLEILSGR 275
S G+ PE +T D ++ G+ + I
Sbjct: 264 --SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-34
Identities = 46/208 (22%), Positives = 93/208 (44%), Gaps = 9/208 (4%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLV-EVLMLSLLHHP 129
+ + +GEG FG+ + IK+++ + + RE EV +L+ + HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N+V + +V +Y G + ++ + + L+++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHV 141
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
HD+ +++RD+K NI L + +L DFG+A++ + ++ +GT Y +PE
Sbjct: 142 HDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEI 196
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSGRKA 277
+ KSD+++ G VL E+ + + A
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-34
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 25/226 (11%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV-LMLSLLHHPN 130
R +L EGGF VY+ ++ A+K+L N + NR + EV M L HPN
Sbjct: 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN 87
Query: 131 LVNLIGYCADGDQR-------LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
+V + G + L+ + G + + L + + PL +T +KI
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTC 146
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA---KLGPVGDNTHVSTRVM- 239
R ++++H + KPP+I+RDLK N+LL KL DFG A P + ++
Sbjct: 147 RAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 240 ------GTYGYCAPE----YAKTGQLTLKSDVYSFGVVLLEILSGR 275
T Y PE Y+ + K D+++ G +L + +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQ 250
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 9/200 (4%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC 138
+LG+G +G VY G S +AIK++ + ++ E+ + L H N+V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198
++ + E +P GS+ L G + T GL+YLHD ++
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IV 144
Query: 199 YRDLKCSNILLDRGY-HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL-- 255
+RD+K N+L++ K+SDFG +K + + GT Y APE G
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 256 TLKSDVYSFGVVLLEILSGR 275
+D++S G ++E+ +G+
Sbjct: 203 GKAADIWSLGCTIIEMATGK 222
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-33
Identities = 52/200 (26%), Positives = 83/200 (41%), Gaps = 14/200 (7%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHHPNLVNLI 135
LG+G FG VY + +A+K L ++ ++ + E+ + S L HPN++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
Y D + L+ E+ P G + L D A L Y H++
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK-- 134
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 255
VI+RD+K N+L+ K++DFG + P GT Y PE +
Sbjct: 135 -VIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLDYLPPEMIEGKTH 189
Query: 256 TLKSDVYSFGVVLLEILSGR 275
K D++ GV+ E L G
Sbjct: 190 DEKVDLWCAGVLCYEFLVGM 209
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-33
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 11/205 (5%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHP 129
+ F +G+G FG V+KG + VAIK +D + E + E+ +LS P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
+ G + ++ EY+ GS D L PLD I +GL+YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYL 135
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
H + K I+RD+K +N+LL KL+DFG+A G + D +GT + APE
Sbjct: 136 HSEKK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEV 190
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSG 274
K K+D++S G+ +E+ G
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARG 215
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 130
K + +G+G G VY + Q+VAI+Q++ + E+L++ +PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+VN + GD+ +V EY+ GS+ D + + +D + + LE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH 133
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGD--NTHVSTRVMGTYGYCAP 247
I+RD+K NILL KL+DFG A++ P +T V GT + AP
Sbjct: 134 SNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAP 185
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSG 274
E K D++S G++ +E++ G
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-32
Identities = 46/209 (22%), Positives = 80/209 (38%), Gaps = 24/209 (11%)
Query: 74 FRSESLLGEGGFGRVYKGYLESIN-QDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNL 131
+ + + GG G +Y ++N + V +K L +G + + E L+ + HP++
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 132 VNLIGYCADGDQRL-----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
V + + D+ +V EY+ S++ L + L
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPAL 195
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 246
YLH ++Y DLK NI+L KL D G + + GT G+ A
Sbjct: 196 SYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINS----FGYLYGTPGFQA 245
Query: 247 PEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
PE T+ +D+Y+ G L +
Sbjct: 246 PEIV-RTGPTVATDIYTVGRTLAALTLDL 273
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 3e-32
Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 14/208 (6%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHH 128
+ + LG+GGF + ++ + A K + ++ + + +E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
++V G+ D D +V E S L +L +K L G +Y
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRS----LLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 247
LH VI+RDLK N+ L+ K+ DFGLA +V+ GT Y AP
Sbjct: 131 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAP 184
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSGR 275
E + + DV+S G ++ +L G+
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-32
Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 130
+ + LG+G FG+VYK + A K ++ + +++VE+ +L+ HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V L+G + ++ E+ P G+V+ + +L + L + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLH 134
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAP 247
K I+RDLK N+L+ +L+DFG++ N + +GT + AP
Sbjct: 135 SKRI---IHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYWMAP 186
Query: 248 E-----YAKTGQLTLKSDVYSFGVVLLEILSG 274
E K K+D++S G+ L+E+
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-32
Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 130
S +GEG G V + + VA+K +D Q EV+++ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V + G++ ++ E++ G++ D + + L+ + + L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLH 158
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGYCAP 247
+ I+RD+K +ILL KLSDFG A++ + V R ++GT + AP
Sbjct: 159 AQGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQI-----SKDVPKRKSLVGTPYWMAP 210
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSG 274
E + D++S G++++E++ G
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-32
Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 130
+ F LGEG +G VYK + Q VAIKQ+ +E + E+ ++ P+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V G +V EY GSV D + K L + I +GLEYLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLH 142
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGD--NTHVSTRVMGTYGYCAP 247
K I+RD+K NILL+ H KL+DFG+ +L NT + GT + AP
Sbjct: 143 FMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPFWMAP 194
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSG 274
E + +D++S G+ +E+ G
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-32
Identities = 48/219 (21%), Positives = 87/219 (39%), Gaps = 22/219 (10%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPN 130
+ +LG+G V++G + AIK + + + E +L L+H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 131 LVNLIGYCADGDQRL--LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
+V L + R L+ E+ P GS+ L + S L + + + G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNH 127
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244
L + +++R++K NI+ G KL+DFG A+ + D+ + GT Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEY 181
Query: 245 CAPEYAKTGQL--------TLKSDVYSFGVVLLEILSGR 275
P+ + L D++S GV +G
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-32
Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 20/212 (9%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM-----LSLLHH 128
LG G +G V K Q +A+K++ N + +LM + +
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---NSQEQKRLLMDLDISMRTVDC 65
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
P V G + E M S++ + + + + KIA + LE+
Sbjct: 66 PFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAP 247
LH K VI+RD+K SN+L++ K+ DFG+ L + G Y AP
Sbjct: 125 LHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAGCKPYMAP 178
Query: 248 E----YAKTGQLTLKSDVYSFGVVLLEILSGR 275
E ++KSD++S G+ ++E+ R
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-32
Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 14/208 (6%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHH 128
+ + LG+GGF + ++ + A K + ++ + + +E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
++V G+ D D +V E S L +L +K L G +Y
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRS----LLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 247
LH VI+RDLK N+ L+ K+ DFGLA +V+ GT Y AP
Sbjct: 157 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAP 210
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSGR 275
E + + DV+S G ++ +L G+
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-32
Identities = 39/228 (17%), Positives = 72/228 (31%), Gaps = 20/228 (8%)
Query: 65 RELAAATKNFRSESLLGEGGFGRVYKGYLESIN-----QDVAIKQLDRNGVQGNREFLVE 119
E +K LLGEG F +VY+ +N Q +K
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 120 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL-SPGKKPLDWNTRMKI 178
+ L + + +LV E G++ + ++ + +K + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-----------KLSDFGLAKLGP 227
A +E +HD +I+ D+K N +L G+ L D G +
Sbjct: 178 AMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ + T T G+ E + D + + +L G
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-32
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 11/207 (5%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHH 128
++F+ +LLG+G F VY+ +VAIK +D+ + EV + L H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
P+++ L Y D + LV E G + +L + K + R G+ Y
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEAR-HFMHQIITGMLY 127
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
LH +++RDL SN+LL R + K++DFGLA + H T + GT Y +PE
Sbjct: 128 LHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT-LCGTPNYISPE 182
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGR 275
A L+SDV+S G + +L GR
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 12/213 (5%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPN 130
++ + ++G G V Y + VAIK+++ Q + + L+ E+ +S HHPN
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN-TRMKIAA---GAARGL 186
+V+ D+ LV + + GSV D + + + IA GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYG 243
EYLH + I+RD+K NILL +++DFG+ A L GD T R +GT
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 244 YCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGR 275
+ APE + + K+D++SFG+ +E+ +G
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLV 132
F S LG G G V+K + +A K + R ++ E+ +L + P +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
G + + E+M GS++ L + K++ +GL YL +K
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
K +++RD+K SNIL++ KL DFG++ +L ++ ++ V GT Y +PE +
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV-GTRSYMSPERLQ 203
Query: 252 TGQLTLKSDVYSFGVVLLEILSGR 275
+++SD++S G+ L+E+ GR
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNL 131
+ + LG GGFG V + + + VAIKQ + NRE E+ ++ L+HPN+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 132 VNLI------GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK-PLDWNTRMKIAAGAAR 184
V+ A D LL EY G + +L+ L + + +
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ--FENCCGLKEGPIRTLLSDISS 132
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHP---KLSDFGLAKLGPVGDNTHVSTRVMGT 241
L YLH+ +I+RDLK NI+L G K+ D G AK + + V GT
Sbjct: 133 ALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEFV-GT 186
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE + + T+ D +SFG + E ++G
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 48/220 (21%), Positives = 87/220 (39%), Gaps = 24/220 (10%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPN 130
+ +LG+G V++G + AIK + + + E +L L+H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 131 LVNLIGYCADGDQRL--LVYEYMPLGSVEDHLHDLSPGKK-PLDWNTRMKIAAGAARGLE 187
+V L + R L+ E+ P GS+ L + P L + + + G+
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE--PSNAYGLPESEFLIVLRDVVGGMN 126
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
+L + +++R++K NI+ G KL+DFG A+ + D+ + GT
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEE 180
Query: 244 YCAPEYAKTGQL--------TLKSDVYSFGVVLLEILSGR 275
Y P+ + L D++S GV +G
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 19/213 (8%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM-----LSLLH 127
+ + +G G +G V K + Q +A+K++ + + ++LM +
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSD 79
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
P +V G + E M + + + S + KI + L
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCA 246
+L + K +I+RD+K SNILLDR + KL DFG+ +L ++ TR G Y A
Sbjct: 140 HLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDAGCRPYMA 193
Query: 247 PEYAKTGQL----TLKSDVYSFGVVLLEILSGR 275
PE ++SDV+S G+ L E+ +GR
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 65/222 (29%), Positives = 90/222 (40%), Gaps = 32/222 (14%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLS-LLHHP 129
F L+G G +G+VYKG Q AIK +D G E E+ ML HH
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR 81
Query: 130 NLVNLIG-----YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA--- 180
N+ G D +L LV E+ GSV D + + +W IA
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICR 136
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR--- 237
RGL +LH I+RD+K N+LL KL DFG++ R
Sbjct: 137 EILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNT 188
Query: 238 VMGTYGYCAPEYAKTGQLT-----LKSDVYSFGVVLLEILSG 274
+GT + APE + KSD++S G+ +E+ G
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 12/209 (5%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHH 128
F +LG GGFG V+ +++ + A K+L++ ++ + + +VE +L+ +H
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 129 PNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGL 186
+V+L Y + L LV M G + H++++ R A GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGL 302
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 246
E+LH + +IYRDLK N+LLD + ++SD GLA G GT G+ A
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFMA 357
Query: 247 PEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
PE + D ++ GV L E+++ R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 21/212 (9%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNL 131
+F + +LG G G + + N+DVA+K++ +RE V++L HPN+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECFSFADRE--VQLLR-ESDEHPNV 80
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
+ D + + E ++++++ L+ T ++ GL +LH
Sbjct: 81 IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQ---QTTSGLAHLHS 136
Query: 192 KAKPPVIYRDLKCSNILL-----DRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYC 245
+++RDLK NIL+ +SDFGL K L + + V GT G+
Sbjct: 137 LN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 246 APEY---AKTGQLTLKSDVYSFGVVLLEILSG 274
APE T D++S G V ++S
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-29
Identities = 42/219 (19%), Positives = 81/219 (36%), Gaps = 22/219 (10%)
Query: 71 TKNFRSESLLGEG--GFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLV-EVLMLSLL 126
+ +++G+G V + + V +++++ FL E+ + L
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 127 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA---GAA 183
+HPN+V ++ +V +M GS +D + IA G
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVL 138
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG-LAKLGPVGDNTHV----STRV 238
+ L+Y+H ++R +K S+IL+ LS + G V
Sbjct: 139 KALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 239 MGTYGYCAPEYAKTGQL--TLKSDVYSFGVVLLEILSGR 275
+ + +PE + KSD+YS G+ E+ +G
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 15/209 (7%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHH 128
FR +LG+GGFG V + + + A K+L++ ++ + L E +L ++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 129 PNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGL 186
+V+L Y + L LV M G ++ H++ + P R AA GL
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFYAAEICCGL 299
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 246
E LH + ++YRDLK NILLD H ++SD GLA P G RV GT GY A
Sbjct: 300 EDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYMA 353
Query: 247 PEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
PE K + T D ++ G +L E+++G+
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 56/236 (23%), Positives = 97/236 (41%), Gaps = 20/236 (8%)
Query: 49 SEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN 108
S + Q T+ + A + + +G G G+V+K +A+KQ+ R+
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS 61
Query: 109 GVQGNREFLV---EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 165
G + + ++ +V++ P +V G + E M +
Sbjct: 62 GNKEENKRILMDLDVVL-KSHDCPYIVQCFGTFITNTDVFIAMELMGTCA----EKLKKR 116
Query: 166 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AK 224
+ P+ K+ + L YL +K VI+RD+K SNILLD KL DFG+ +
Sbjct: 117 MQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGR 174
Query: 225 LGPVGDNTHVSTRVMGTYGYCAPE-----YAKTGQLTLKSDVYSFGVVLLEILSGR 275
L + R G Y APE +++DV+S G+ L+E+ +G+
Sbjct: 175 L----VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-29
Identities = 73/214 (34%), Positives = 97/214 (45%), Gaps = 27/214 (12%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLH 127
K F +G G FG VY ++ VAIK++ +G Q N ++ + EV L L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA---GAAR 184
HPN + G LV EY GS D L KKPL ++IAA GA +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASD---LLEVHKKPLQ---EVEIAAVTHGALQ 165
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTRVMGTYG 243
GL YLH I+RD+K NILL KL DFG + + P N+ +GT
Sbjct: 166 GLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANS-----FVGTPY 215
Query: 244 YCAPE---YAKTGQLTLKSDVYSFGVVLLEILSG 274
+ APE GQ K DV+S G+ +E+
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-29
Identities = 47/228 (20%), Positives = 78/228 (34%), Gaps = 32/228 (14%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEV-LMLSLLH 127
T F +G G FG V+K AIK+ + G + L EV L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
H ++V A+ D L+ EY GS+ D + + + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHP-------------------KLSDFGLAKLGPV 228
Y+H + +++ D+K SNI + R P K+ D G
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---R 183
Query: 229 GDNTHVSTRVMGTYGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ V G + A E + K+D+++ + ++
Sbjct: 184 ISSPQVEE---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-27
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 24/214 (11%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHH 128
++F+ +LGEG F V + +++ AIK L++ + + E ++S L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLE 187
P V L D ++ Y G + ++ + G + A LE
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDET---CTRFYTAEIVSALE 144
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
YLH K +I+RDLK NILL+ H +++DFG AK+ + +GT Y +P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 248 E------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
E K+ SD+++ G ++ ++++G
Sbjct: 202 ELLTEKSACKS------SDLWALGCIIYQLVAGL 229
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 66/242 (27%), Positives = 100/242 (41%), Gaps = 31/242 (12%)
Query: 51 DGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV 110
G+ + A F+ E + G+G FG V G +S VAIK++ ++
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61
Query: 111 QGNREFLVEVLMLSLLHHPNLVNLI------GYCADGDQRL-LVYEYMPLGSVEDHLHDL 163
NRE L + L++LHHPN+V L G D L +V EY+P ++ +
Sbjct: 62 FRNRE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNY 119
Query: 164 SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGL 222
+ R + LH + V +RD+K N+L++ KL DFG
Sbjct: 120 YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGS 178
Query: 223 AK-LGPVGDNTH-VSTRVMGTYGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILS 273
AK L P N + +R Y Y APE Y T D++S G + E++
Sbjct: 179 AKKLSPSEPNVAYICSR----Y-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMML 227
Query: 274 GR 275
G
Sbjct: 228 GE 229
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 57/234 (24%), Positives = 86/234 (36%), Gaps = 44/234 (18%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPN 130
SE +LG G G V + VA+K++ + E +++L S HPN
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALME--IKLLTESD-DHPN 70
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR------ 184
++ + E + L DL K D N +++
Sbjct: 71 VIRYYCSETTDRFLYIALELCN-LN----LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 185 -GLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-------------KLSDFGLAKL---GP 227
G+ +LH +I+RDLK NIL+ +SDFGL K G
Sbjct: 126 SGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 228 VGDNTHVSTRVMGTYGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSG 274
T+++ GT G+ APE +LT D++S G V ILS
Sbjct: 183 SSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-27
Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 30/213 (14%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV----EVLMLSLLHHPNLVNL 134
LLGEG +G+V + A+K L + ++ E+ +L L H N++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 135 --IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR-------- 184
+ Y + + +V EY G E + D P K R + A
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK-------RFPVCQ--AHGYFCQLID 120
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244
GLEYLH + ++++D+K N+LL G K+S G+A+ G+ +
Sbjct: 121 GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 245 CAPEYAKTGQL--TLKSDVYSFGVVLLEILSGR 275
PE A K D++S GV L I +G
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 68/213 (31%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLH- 127
+F ++G GGFG VY + A+K LD+ ++ + L E +MLSL+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 128 --HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAA 183
P +V + Y +L + + M G + HL G M+ AA
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEA---DMRFYAAEII 302
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
GLE++H++ V+YRDLK +NILLD H ++SD GLA H V GT+G
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--ASV-GTHG 355
Query: 244 YCAPEYAKTGQLTLKS-DVYSFGVVLLEILSGR 275
Y APE + G S D +S G +L ++L G
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 60/227 (26%), Positives = 92/227 (40%), Gaps = 23/227 (10%)
Query: 60 QTLTFRELAAATKNFRS----ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 115
+ RE + LG G FG V+ S + IK ++++ Q E
Sbjct: 6 HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME 65
Query: 116 -FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 174
E+ +L L HPN++ + D +V E G + + + K L
Sbjct: 66 QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALS--- 122
Query: 175 RMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGP 227
A + L Y H + V+++DLK NIL K+ DFGLA+L
Sbjct: 123 -EGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL-- 176
Query: 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
+ H + GT Y APE K +T K D++S GVV+ +L+G
Sbjct: 177 FKSDEHSTNAA-GTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 16/225 (7%)
Query: 56 QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 115
Q T + ++ ++ LG G +G V + + + AIK + + V +
Sbjct: 21 QATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN 80
Query: 116 FLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 173
+ EV +L LL HPN++ L + D LV E G + D + + +
Sbjct: 81 SKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEV 136
Query: 174 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGD 230
I G+ YLH +++RDLK N+LL ++ K+ DFGL+ V +
Sbjct: 137 DAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA---VFE 190
Query: 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
N +GT Y APE + + K DV+S GV+L +L+G
Sbjct: 191 NQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGY 234
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 17/226 (7%)
Query: 56 QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 115
T A + ++ + +LG+G FG V + Q+ A+K + + V+ +
Sbjct: 10 HATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD 69
Query: 116 ---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 172
L EV +L L HPN++ L + D LV E G + D + +K
Sbjct: 70 KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSE 125
Query: 173 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVG 229
+I G+ Y+H +++RDLK N+LL + + ++ DFGL+
Sbjct: 126 VDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST---HF 179
Query: 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ + +GT Y APE G K DV+S GV+L +LSG
Sbjct: 180 EASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGC 224
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-25
Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 129
F LG G FGRV + A+K LD+ V ++ L E +L ++ P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEY 188
LV L D +V EY+ G + HL + G+ + AA EY
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFS---EPHARFYAAQIVLTFEY 156
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
LH +IYRDLK N+L+D+ + +++DFG AK V T + GT APE
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWT---LCGTPEALAPE 208
Query: 249 ------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y K D ++ GV++ E+ +G
Sbjct: 209 IILSKGYNKA------VDWWALGVLIYEMAAGY 235
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-25
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 25/207 (12%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGY 137
LGEG +G V + VA+K +D E + E+ + +L+H N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------GLEYL 189
+G+ + L EY G + D + + M A+ G+ YL
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPD--AQRFFHQLMAGVVYL 121
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE- 248
H + +RD+K N+LLD + K+SDFGLA + + + ++ GT Y APE
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ DV+S G+VL +L+G
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 35/221 (15%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 130
++ ++G G FG VY+ L + VAIK++ +Q R E+ ++ L H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCN 108
Query: 131 LVNLIGY-CADGDQRL-----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR 184
+V L + + G+++ LV +Y+P +V S K+ L R
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAK-LGPVGDNTH-VSTRVMGT 241
L Y+H + +RD+K N+LLD KL DFG AK L N + +R
Sbjct: 168 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---- 220
Query: 242 YGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y Y APE Y T DV+S G VL E+L G+
Sbjct: 221 Y-YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-25
Identities = 75/261 (28%), Positives = 111/261 (42%), Gaps = 20/261 (7%)
Query: 24 QKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATK----NFRSESL 79
++ I ++ D LK ++ + S SD A+ + + F L
Sbjct: 97 EEWTTAIQTVADGLKKQAAAEMDFRSGSP-SDNSGAEEMEVSLAKPKHRVTMNEFEYLKL 155
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIG 136
LG+G FG+V ++ + A+K L + + E L E +L HP L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 137 YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAK 194
Y RL V EY G + HL D R + A L+YLH +
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLS--RERVFSED---RARFYGAEIVSALDYLHSEKN 269
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
V+YRDLK N++LD+ H K++DFGL K G + D + T GT Y APE +
Sbjct: 270 --VVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPEVLEDND 325
Query: 255 LTLKSDVYSFGVVLLEILSGR 275
D + GVV+ E++ GR
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGR 346
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-24
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 25/207 (12%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGY 137
LGEG +G V + VA+K +D E + E+ + +L+H N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------GLEYL 189
+G+ + L EY G + D + + M A+ G+ YL
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPD--AQRFFHQLMAGVVYL 121
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE- 248
H + +RD+K N+LLD + K+SDFGLA + + + ++ GT Y APE
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ DV+S G+VL +L+G
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-24
Identities = 57/260 (21%), Positives = 100/260 (38%), Gaps = 33/260 (12%)
Query: 31 NSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRS------ESLLGEGG 84
L ++ K S R + A S +LG G
Sbjct: 42 VWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGR 101
Query: 85 FGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144
FG+V+K + +A K + G++ E E+ +++ L H NL+ L +
Sbjct: 102 FGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161
Query: 145 LLVYEYMPLGSVEDHL----HDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPP 196
+LV EY+ G + D + ++L+ + G+ ++H
Sbjct: 162 VLVMEYVDGGELFDRIIDESYNLTE-----------LDTILFMKQICEGIRHMHQMY--- 207
Query: 197 VIYRDLKCSNILL-DRGYHP-KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 254
+++ DLK NIL +R K+ DFGLA+ + GT + APE
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREKLKVNF-GTPEFLAPEVVNYDF 264
Query: 255 LTLKSDVYSFGVVLLEILSG 274
++ +D++S GV+ +LSG
Sbjct: 265 VSFPTDMWSVGVIAYMLLSG 284
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 61/278 (21%), Positives = 106/278 (38%), Gaps = 26/278 (9%)
Query: 5 PCSGDSFRKAKNKKKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTF 64
PC + ++ + + +D I SS + +
Sbjct: 93 PCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKH 152
Query: 65 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLS 124
+ ++ LG G FG V++ + + A K + E+ +S
Sbjct: 153 DHV---LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 209
Query: 125 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM--KIAAGA 182
+L HP LVNL D ++ +++YE+M G + + + D + +M A
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV---------ADEHNKMSEDEAVEY 260
Query: 183 AR----GLEYLHDKAKPPVIYRDLKCSNILL--DRGYHPKLSDFGLAKLGPVGDNTHVST 236
R GL ++H+ ++ DLK NI+ R KL DFGL + V
Sbjct: 261 MRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKV 315
Query: 237 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
GT + APE A+ + +D++S GV+ +LSG
Sbjct: 316 TT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 60/242 (24%), Positives = 95/242 (39%), Gaps = 47/242 (19%)
Query: 60 QTLTFRELAAATKNFRSE----SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 115
LT + + K R E LG G G V + + VAI+ + +
Sbjct: 119 FDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA 178
Query: 116 FLV--------EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 167
E+ +L L+HP ++ + + D + +V E M G +L
Sbjct: 179 READPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG-------EL---- 226
Query: 168 KPLDW---NTRM--KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHP 215
D N R+ ++YLH+ +I+RDLK N+LL +
Sbjct: 227 --FDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLI 281
Query: 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE---YAKTGQLTLKSDVYSFGVVLLEIL 272
K++DFG +K+ +G+ + + T GT Y APE T D +S GV+L L
Sbjct: 282 KITDFGHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338
Query: 273 SG 274
SG
Sbjct: 339 SG 340
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 65/229 (28%), Positives = 98/229 (42%), Gaps = 28/229 (12%)
Query: 60 QTLTFRELAAATKNFRS----ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 115
+ RE F +LG+G FG V K Q+ A+K +++ +
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 116 FLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 173
+ EV +L L HPN++ L D +V E G + D + +K
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFS-- 119
Query: 174 TRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLG 226
AA + G+ Y+H +++RDLK NILL ++ K+ DFGL+
Sbjct: 120 --EHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC- 173
Query: 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
NT + R+ GT Y APE + G K DV+S GV+L +LSG
Sbjct: 174 -FQQNTKMKDRI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT 219
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 6e-24
Identities = 63/210 (30%), Positives = 90/210 (42%), Gaps = 34/210 (16%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
+GEG +G V+K Q VAIK+ D + + L E+ ML L HPNLVNL+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI--KKIALREIRMLKQLKHPNLVNLL 68
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
+ LV+EY LH+L ++ + + I + + + H
Sbjct: 69 EVFRRKRRLHLVFEYCDH----TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN-- 122
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAPEYAKT 252
I+RD+K NIL+ + KL DFG A+L GP V+TR Y +PE
Sbjct: 123 -CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPE---- 172
Query: 253 GQLTLKSDVYSFGV-------VLLEILSGR 275
L + Y V V E+LSG
Sbjct: 173 --LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 7e-24
Identities = 61/260 (23%), Positives = 103/260 (39%), Gaps = 23/260 (8%)
Query: 27 LDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFG 86
LD + + D+ + R K E + T +++ ++F ++G G FG
Sbjct: 31 LDILICLYDECNNSPLRREKNILEY--LEWAKPFTSKVKQMRLHREDFEILKVIGRGAFG 88
Query: 87 RVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCA--DG 141
V L++ ++ A+K L++ + E F E +L + L + A D
Sbjct: 89 EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL--HYAFQDD 146
Query: 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYR 200
+ LV +Y G D L LS + L + A ++ +H ++R
Sbjct: 147 NNLYLVMDYYVGG---DLLTLLSKFEDRLP-EEMARFYLAEMVIAIDSVHQLH---YVHR 199
Query: 201 DLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS- 259
D+K NIL+D H +L+DFG S V GT Y +PE + +
Sbjct: 200 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRY 258
Query: 260 ----DVYSFGVVLLEILSGR 275
D +S GV + E+L G
Sbjct: 259 GPECDWWSLGVCMYEMLYGE 278
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 8e-24
Identities = 58/257 (22%), Positives = 105/257 (40%), Gaps = 22/257 (8%)
Query: 30 INSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVY 89
+ S +S L + + +D + +E ++ LLG GGFG VY
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVY 60
Query: 90 KGYLESINQDVAIKQLDRNGVQGNREFLV------EVLMLSLLHH--PNLVNLIGYCADG 141
G S N VAIK ++++ + E EV++L + ++ L+ +
Sbjct: 61 SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120
Query: 142 DQRLLVYEY-MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYR 200
D +L+ E P+ + D + + + L + + H+ V++R
Sbjct: 121 DSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHR 173
Query: 201 DLKCSNILLD-RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT-LK 258
D+K NIL+D KL DFG L +T + GT Y PE+ + +
Sbjct: 174 DIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFD-GTRVYSPPEWIRYHRYHGRS 229
Query: 259 SDVYSFGVVLLEILSGR 275
+ V+S G++L +++ G
Sbjct: 230 AAVWSLGILLYDMVCGD 246
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 8e-24
Identities = 53/202 (26%), Positives = 80/202 (39%), Gaps = 22/202 (10%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
+G G +G V + A K++ + V+ F E+ ++ L HPN++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 140 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKP 195
D LV E G E L + K+ AA + + Y H
Sbjct: 77 DNTDIYLVMELCTGG--E--LFERVVHKRVFR----ESDAARIMKDVLSAVAYCHKLN-- 126
Query: 196 PVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 252
V +RDLK N L KL DFGLA + T+V GT Y +P+ +
Sbjct: 127 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV-GTPYYVSPQVLE- 181
Query: 253 GQLTLKSDVYSFGVVLLEILSG 274
G + D +S GV++ +L G
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCG 203
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 9e-24
Identities = 51/213 (23%), Positives = 84/213 (39%), Gaps = 18/213 (8%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--------EVLML 123
+ + + S LG G FG V+ + N++V +K + + V + E+ +L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 124 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
S + H N++ ++ + LV E G L LD I
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGL---DLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
+ YL K +I+RD+K NI++ + KL DFG A G + GT
Sbjct: 141 SAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIE 194
Query: 244 YCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGR 275
YCAPE + +++S GV L ++
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-23
Identities = 73/213 (34%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 129
+F+ LG G FGRV+ + A+K L + V ++ E LMLS++ HP
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEY 188
++ + G D Q ++ +Y+ G + L + P N K AA LEY
Sbjct: 67 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFP---NPVAKFYAAEVCLALEY 121
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
LH K +IYRDLK NILLD+ H K++DFG AK V D T+ T + GT Y APE
Sbjct: 122 LHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTY--T-LCGTPDYIAPE 173
Query: 249 ------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y K+ D +SFG+++ E+L+G
Sbjct: 174 VVSTKPYNKS------IDWWSFGILIYEMLAGY 200
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-23
Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 32/216 (14%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 130
K F +LG G F V+ + A+K + ++ + E+ +L + H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM-----KIAAGAAR- 184
+V L LV + + G +L D K A+ +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGG-------EL------FDRILERGVYTEKDASLVIQQ 114
Query: 185 ---GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRV 238
++YLH+ +++RDLK N+L + ++DFGL+K + N +ST
Sbjct: 115 VLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTAC 168
Query: 239 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
GT GY APE + D +S GV+ +L G
Sbjct: 169 -GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-23
Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 36/236 (15%)
Query: 56 QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 115
I + + + ++G G FG V++ L ++ VAIK++ +Q R
Sbjct: 24 VIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV----LQDKRF 78
Query: 116 FLVEVLMLSLLHHPNLVNLIGY-----CADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKP 169
E+ ++ ++ HPN+V+L + + L LV EY+P +V + K+
Sbjct: 79 KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQT 137
Query: 170 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAK-LGP 227
+ R L Y+H + +RD+K N+LLD KL DFG AK L
Sbjct: 138 MPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194
Query: 228 VGDNTH-VSTRVMGTYGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
N + +R Y Y APE Y T D++S G V+ E++ G+
Sbjct: 195 GEPNVSYICSR----Y-YRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ 239
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-23
Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 41/228 (17%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-------------------- 118
+G+G +G V Y E+ N A+K L + + F
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 119 ------EVLMLSLLHHPNLVNL--IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 170
E+ +L L HPN+V L + + D +V+E + G V + P KPL
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-----VPTLKPL 134
Query: 171 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230
+ +G+EYLH + +I+RD+K SN+L+ H K++DFG++ G
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKGS 190
Query: 231 NTHVSTRVMGTYGYCAPE---YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ +S V GT + APE + DV++ GV L + G+
Sbjct: 191 DALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-23
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 28/223 (12%)
Query: 64 FRELAAATKNFRSE----SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVE 119
++L + F +G G + + ++ N + A+K +D++ E +E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IE 67
Query: 120 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 179
+ +L HPN++ L DG +V E M G + D + +K + A
Sbjct: 68 I-LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR----QKFFS----EREA 118
Query: 180 AGAAR----GLEYLHDKAKPPVIYRDLKCSNILL-DRGYHP---KLSDFGLAKLGPVGDN 231
+ +EYLH + V++RDLK SNIL D +P ++ DFG AK +N
Sbjct: 119 SAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AEN 174
Query: 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
+ T T + APE + D++S GV+L +L+G
Sbjct: 175 GLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 27/236 (11%)
Query: 56 QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 115
I ++ +++ LG G +G V ++ + + AIK + ++ R
Sbjct: 20 AINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRY 79
Query: 116 FLV-------------EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD 162
E+ +L L HPN++ L D LV E+ G + + + +
Sbjct: 80 SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN 139
Query: 163 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSD 219
+ D I G+ YLH +++RD+K NILL + + K+ D
Sbjct: 140 ----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVD 192
Query: 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
FGL+ + +GT Y APE K + K DV+S GV++ +L G
Sbjct: 193 FGLSS---FFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGY 244
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 2e-23
Identities = 56/244 (22%), Positives = 88/244 (36%), Gaps = 52/244 (21%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-----FLVEVLMLSLLHHPNLVNL 134
+G+G +G V AIK +++N ++ EV ++ LHHPN+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG------------- 181
D LV E G + D L+ +K
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 182 ----------------AAR-------GLEYLHDKAKPPVIYRDLKCSNILL--DRGYHPK 216
+ L YLH++ + +RD+K N L ++ + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIK 210
Query: 217 LSDFGLAKL---GPVGDNTHVSTRVMGTYGYCAPEYAKTGQL--TLKSDVYSFGVVLLEI 271
L DFGL+K G+ ++T+ GT + APE T K D +S GV+L +
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 272 LSGR 275
L G
Sbjct: 270 LMGA 273
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-23
Identities = 63/244 (25%), Positives = 106/244 (43%), Gaps = 43/244 (17%)
Query: 52 GASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ 111
G++D + + +L E +LGEG RV +Q+ A+K +++
Sbjct: 1 GSTDSFSGRFEDVYQL--------QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH 52
Query: 112 GNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 170
EV ++ H N++ LI + + D+ LV+E M GS+ H+H ++
Sbjct: 53 IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK----RRHF 108
Query: 171 DWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILLDRGYHP------KLSDF 220
+ A+ + L++LH+K + +RDLK NIL HP K+ DF
Sbjct: 109 N----ELEASVVVQDVASALDFLHNKG---IAHRDLKPENILC---EHPNQVSPVKICDF 158
Query: 221 GLAK-LGPVGDNTHVSTRVM----GTYGYCAPEYAKTGQLTLKS-----DVYSFGVVLLE 270
L + GD + +ST + G+ Y APE + D++S GV+L
Sbjct: 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYI 218
Query: 271 ILSG 274
+LSG
Sbjct: 219 LLSG 222
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-23
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-------QGNREFLVEVLMLS 124
+R LLG+GGFG V+ G+ + VAIK + RN V L EV +L
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLW 89
Query: 125 LLH----HPNLVNLIGYCADGDQRLLVYEY-MPLGSVEDHLHDLSPGKKPLDWNTRMKIA 179
+ HP ++ L+ + + +LV E +P + D++ + K PL
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFF 145
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAKLGPVGDNTHVSTRV 238
+++ H + V++RD+K NIL+D KL DFG L + +
Sbjct: 146 GQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTDFD 199
Query: 239 MGTYGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGR 275
GT Y PE+ Q L + V+S G++L +++ G
Sbjct: 200 -GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-23
Identities = 69/258 (26%), Positives = 109/258 (42%), Gaps = 22/258 (8%)
Query: 27 LDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFG 86
LD ++++ L +LR K + D + R+L +++ ++G G FG
Sbjct: 26 LDGLDALVYDLD-FPALR-KNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFG 83
Query: 87 RVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCA--DG 141
V +S + A+K L + + + F E +++ + P +V L + A D
Sbjct: 84 EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FYAFQDD 141
Query: 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRD 201
+V EYMP G D ++ +S P W R A L+ +H I+RD
Sbjct: 142 RYLYMVMEYMPGG---DLVNLMSNYDVPEKW-ARF-YTAEVVLALDAIHSMG---FIHRD 193
Query: 202 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE----YAKTGQLTL 257
+K N+LLD+ H KL+DFG T V GT Y +PE G
Sbjct: 194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGR 252
Query: 258 KSDVYSFGVVLLEILSGR 275
+ D +S GV L E+L G
Sbjct: 253 ECDWWSVGVFLYEMLVGD 270
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-23
Identities = 46/205 (22%), Positives = 89/205 (43%), Gaps = 27/205 (13%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA 139
LG G FG V++ ++ + K ++ E+ +++ LHHP L+NL
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 140 DGDQRLLVYEYMPLGSVEDHL----HDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHD 191
D + +L+ E++ G + D + + +S R GL+++H+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSE-----------AEVINYMRQACEGLKHMHE 167
Query: 192 KAKPPVIYRDLKCSNILL--DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
+ +++ D+K NI+ + K+ DFGLA + + V T + APE
Sbjct: 168 HS---IVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTT-ATAEFAAPEI 221
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSG 274
+ +D+++ GV+ +LSG
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-23
Identities = 65/215 (30%), Positives = 93/215 (43%), Gaps = 30/215 (13%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 129
+F LLG+G FG+V ++ + A+K L + + E + E +L HP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 130 NLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLE 187
L L Y RL V EY G + HL + R + A LE
Sbjct: 66 FLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEE---RARFYGAEIVSALE 119
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCA 246
YLH + V+YRD+K N++LD+ H K++DFGL K G T + GT Y A
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLA 173
Query: 247 PE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
PE Y + D + GVV+ E++ GR
Sbjct: 174 PEVLEDNDYGRA------VDWWGLGVVMYEMMCGR 202
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-23
Identities = 59/210 (28%), Positives = 87/210 (41%), Gaps = 34/210 (16%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
+GEG +G V K + + VAIK+ D V + + E+ +L L H NLVNL+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV--KKIAMREIKLLKQLRHENLVNLL 90
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 195
C + LV+E++ L DL LD+ K G+ + H
Sbjct: 91 EVCKKKKRWYLVFEFVDH----TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN-- 144
Query: 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAPEYAKT 252
+I+RD+K NIL+ + KL DFG A+ P V+TR Y APE
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRAPE---- 194
Query: 253 GQLTLKSDVYSFGV-------VLLEILSGR 275
L + Y V ++ E+ G
Sbjct: 195 --LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 3e-23
Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 37/222 (16%)
Query: 71 TKNFRSE----SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--EVLMLS 124
+ F LG+G F V + ++ + A K ++ + + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 125 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM-----KIA 179
L HPN+V L + LV++ + G +L + A
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGG-------EL------FEDIVAREFYSEADA 107
Query: 180 AGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNT 232
+ + + Y H +++R+LK N+LL +G KL+DFGLA V D+
Sbjct: 108 SHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSE 162
Query: 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
GT GY +PE K + D+++ GV+L +L G
Sbjct: 163 AWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-23
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHP 129
+F +G+G FG+V + A+K +++ E E+ ++ L HP
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP 75
Query: 130 NLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLE 187
LVNL Y ++ + +V + + G + HL + +K+ L+
Sbjct: 76 FLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL-----QQNVHFKEETVKLFICELVMALD 129
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
YL ++ +I+RD+K NILLD H ++DF +A + P T + GT Y AP
Sbjct: 130 YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAP 183
Query: 248 E--YAKTGQLTLKS-DVYSFGVVLLEILSGR 275
E ++ G + D +S GV E+L GR
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-23
Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPN 130
N+R +G+G F +V ++VAIK +D+ + + EV ++ +L+HPN
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V L L+ EY G V D+L + ++Y H
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCH 131
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-- 248
K +++RDLK N+LLD + K++DFG + + G Y APE
Sbjct: 132 QKR---IVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFC-GAPPYAAPELF 185
Query: 249 ----YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y G + DV+S GV+L ++SG
Sbjct: 186 QGKKYD--GP---EVDVWSLGVILYTLVSGS 211
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-23
Identities = 65/228 (28%), Positives = 96/228 (42%), Gaps = 38/228 (16%)
Query: 65 RELAAATKNFRSE----SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-- 118
RE F +LG+G FG V K Q+ A+K +++ + +
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR 70
Query: 119 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM-- 176
EV +L L HPN++ L D +V E G +L D +
Sbjct: 71 EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG-------EL------FDEIIKRKR 117
Query: 177 ---KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLG 226
AA + G+ Y+H +++RDLK NILL ++ K+ DFGL+
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC- 173
Query: 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
NT + R+ GT Y APE + G K DV+S GV+L +LSG
Sbjct: 174 -FQQNTKMKDRI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 6e-23
Identities = 56/287 (19%), Positives = 105/287 (36%), Gaps = 43/287 (14%)
Query: 12 RKAKNKKKMKMQQKTLDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAAT 71
R+ + ++ N + + K+N + + S + +
Sbjct: 34 REQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFY 93
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVL---------M 122
+ + + ++G G V + + + A+K ++ + + E L EV +
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 123 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM-----K 177
+ HP+++ LI LV++ M G +L D+ T K
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKG-------EL------FDYLTEKVALSEK 200
Query: 178 IAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233
R + +LH +++RDLK NILLD +LSDFG + +
Sbjct: 201 ETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEK 255
Query: 234 VSTRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSG 274
+ GT GY APE + D+++ GV+L +L+G
Sbjct: 256 LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 6e-23
Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 55/228 (24%)
Query: 80 LGEGGFGRVYKGYLESI--NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG- 136
+G G +G VYK + ++D A+KQ++ G+ + E+ +L L HPN+++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 86
Query: 137 YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA------------ 183
+ + D+++ L+++Y HDL + ++ K
Sbjct: 87 FLSHADRKVWLLFDYAE--------HDL---WHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 184 ---RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKL--GPVGDNTHV 234
G+ YLH V++RDLK +NIL+ K++D G A+L P+ +
Sbjct: 136 QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192
Query: 235 STRVMGTYGYCAPEYAKTGQLTLKS-------DVYSFGVVLLEILSGR 275
V+ T+ Y APE L L + D+++ G + E+L+
Sbjct: 193 DPVVV-TFWYRAPE------LLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 1e-22
Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 36/219 (16%)
Query: 73 NFRSESLLGEGGFGRVY---KGYLESINQDVAIKQLDRNGVQGNREFLVEVLM----LSL 125
F +LG+G FG+V+ K Q A+K L + ++ V M L
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR--VRTKMERDILVE 82
Query: 126 LHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAA 183
++HP +V L Y + +L L+ +++ G + L + +K A A
Sbjct: 83 VNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEE---DVKFYLAELA 136
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTY 242
L++LH +IYRDLK NILLD H KL+DFGL+K + GT
Sbjct: 137 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTV 190
Query: 243 GYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE + ++ +D +SFGV++ E+L+G
Sbjct: 191 EYMAPEVVNRRGHTQS------ADWWSFGVLMFEMLTGT 223
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 1e-22
Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 48/219 (21%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
+GEG +G V+K ++ VA+K++ D GV L E+ +L L H N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV--PSSALREICLLKELKHKNIVRLH 67
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA--------RGLE 187
+ LV+E+ DL KK D + + +GL
Sbjct: 68 DVLHSDKKLTLVFEFCD--------QDL---KKYFD-SCNGDLDPEIVKSFLFQLLKGLG 115
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYC 245
+ H + V++RDLK N+L++R KL++FGLA+ PV + V+ T Y
Sbjct: 116 FCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYR 168
Query: 246 APEYAKTGQLTLKSDVYSFGV-------VLLEILSGRKA 277
P+ + + +YS + + E+ + +
Sbjct: 169 PPD------VLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 56/261 (21%), Positives = 95/261 (36%), Gaps = 23/261 (8%)
Query: 27 LDRINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFG 86
LD + + +L S L ++ + +E+ +F ++G G F
Sbjct: 18 LDLLLGVHQELG-ASELA-QDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFS 75
Query: 87 RVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCA--DG 141
V ++ Q A+K +++ + E F E +L + L + A D
Sbjct: 76 EVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL--HFAFQDE 133
Query: 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRD 201
+ LV EY G + L + P + R A ++ +H ++RD
Sbjct: 134 NYLYLVMEYYVGGDLLTLLSKFGE-RIPAEM-ARF-YLAEIVMAIDSVHRLG---YVHRD 187
Query: 202 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDV 261
+K NILLDR H +L+DFG V GT Y +PE + +
Sbjct: 188 IKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGS 246
Query: 262 Y-------SFGVVLLEILSGR 275
Y + GV E+ G+
Sbjct: 247 YGPECDWWALGVFAYEMFYGQ 267
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-22
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 34/211 (16%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-----EVLMLSLLHHPNLVN 133
LG G FG+V G + VA+K L+R ++ +V E+ L L HP+++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD--VVGKIKREIQNLKLFRHPHIIK 75
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------G 185
L + +V EY+ G + D++ + R++ AR
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYICK----------HGRVEEME--ARRLFQQILSA 123
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
++Y H V++RDLK N+LLD + K++DFGL+ + G+ S G+ Y
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYA 177
Query: 246 APE-YAKTGQLTLKSDVYSFGVVLLEILSGR 275
APE + + D++S GV+L +L G
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-22
Identities = 72/211 (34%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVE--VLMLSLLH 127
+F +LG+G FG+V+ + NQ AIK L ++ V + + +VE VL L+
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-E 76
Query: 128 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARG 185
HP L ++ + L V EY+ G + H+ K L R AA G
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLS---RATFYAAEIILG 130
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGY 244
L++LH K ++YRDLK NILLD+ H K++DFG+ K +GD T GT Y
Sbjct: 131 LQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDY 184
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
APE + D +SFGV+L E+L G+
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-22
Identities = 56/218 (25%), Positives = 88/218 (40%), Gaps = 43/218 (19%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--------EVLMLSLLHHPNL 131
LG G G V + + VAIK + + E+ +L L+HP +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW---NTRM--KIAAGAAR-- 184
+ + + D + +V E M G +L D N R+
Sbjct: 78 IKIKNFF-DAEDYYIVLELMEGG-------EL------FDKVVGNKRLKEATCKLYFYQM 123
Query: 185 --GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 239
++YLH+ +I+RDLK N+LL + K++DFG +K+ +G+ + + T
Sbjct: 124 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC- 177
Query: 240 GTYGYCAPE---YAKTGQLTLKSDVYSFGVVLLEILSG 274
GT Y APE T D +S GV+L LSG
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-22
Identities = 60/220 (27%), Positives = 91/220 (41%), Gaps = 50/220 (22%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
LGEG +G VYK N+ VAIK++ + GV + EV +L L H N++ L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV--PGTAIREVSLLKELQHRNIIELK 99
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA------RGLEYL 189
+ L++EY +DL KK +D N + + + G+ +
Sbjct: 100 SVIHHNHRLHLIFEYAE--------NDL---KKYMDKNPDVSMRVIKSFLYQLINGVNFC 148
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHP-----KLSDFGLAKL--GPVGDNTHVSTRVMGTY 242
H + ++RDLK N+LL K+ DFGLA+ P+ TH ++ T
Sbjct: 149 HSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TL 201
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGV-------VLLEILSGR 275
Y PE + L S YS V + E+L
Sbjct: 202 WYRPPE------ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-22
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 39/220 (17%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL---DRNGVQGNREFLVEVLMLSLLHH 128
+ + LGEG + VYKG + + VA+K++ G + EV +L L H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA--PCTAIREVSLLKDLKH 59
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS----PGKKPLDWNTRMKIAAGAAR 184
N+V L LV+EY+ DL ++ + R
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLD--------KDLKQYLDDCGNIINMHNVKLFLFQLLR 111
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTY 242
GL Y H + V++RDLK N+L++ KL+DFGLA+ P + V+ T
Sbjct: 112 GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TL 164
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGV-------VLLEILSGR 275
Y P+ + L S YS + + E+ +GR
Sbjct: 165 WYRPPD------ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-22
Identities = 56/235 (23%), Positives = 89/235 (37%), Gaps = 50/235 (21%)
Query: 70 ATKNFRSE----SLLGEGGFGRVYKGYLESINQDVAIKQLDR--------NGVQGNREFL 117
+T F +LG G V + + ++ A+K +D VQ RE
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 118 ---VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 174
V++L + HPN++ L LV++ M G +L D+ T
Sbjct: 71 LKEVDILR-KVSGHPNIIQLKDTYETNTFFFLVFDLMKKG-------EL------FDYLT 116
Query: 175 RM-----KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225
K R + LH +++RDLK NILLD + KL+DFG +
Sbjct: 117 EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173
Query: 226 GPVGDNTHVSTRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSG 274
+ + GT Y APE + D++S GV++ +L+G
Sbjct: 174 --LDPGEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 4e-22
Identities = 30/205 (14%), Positives = 60/205 (29%), Gaps = 41/205 (20%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPN 130
+R G + ++ ++++ VA+ +D GV + +E L L LS + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+ ++ L+V E++ GS+++ ++ A + H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAH 146
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
V S + + S G L
Sbjct: 147 RA---GVALSIDHPSRVRV--------SIDGDVVLA--------------YPATMPDA-- 179
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGR 275
+ D+ G L +L R
Sbjct: 180 -----NPQDDIRGIGASLYALLVNR 199
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 4e-22
Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL---DRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
LG G + VYKG ++ VA+K++ G + E+ ++ L H N+V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT--PSTAIREISLMKELKHENIVRLYD 70
Query: 137 YCADGDQRLLVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
++ LV+E+M L D + + L+ N +GL + H+
Sbjct: 71 VIHTENKLTLVFEFMDNDLKKYMDS-RTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK- 128
Query: 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAKT 252
+++RDLK N+L+++ KL DFGLA+ PV + V+ T Y AP+
Sbjct: 129 --ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWYRAPD---- 178
Query: 253 GQLTLKSDVYSFGV-------VLLEILSGR 275
+ + S YS + +L E+++G+
Sbjct: 179 --VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-22
Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 33/217 (15%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVE--VLMLSLLH 127
+F ++G+G FG+V ++ A+K L + + +E + E VL+ ++
Sbjct: 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-K 97
Query: 128 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARG 185
HP LV L + +L V +Y+ G + HL R + AA A
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEP---RARFYAAEIASA 151
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGY 244
L YLH ++YRDLK NILLD H L+DFGL K ++T T GT Y
Sbjct: 152 LGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEY 205
Query: 245 CAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
APE Y +T D + G VL E+L G
Sbjct: 206 LAPEVLHKQPYDRT------VDWWCLGAVLYEMLYGL 236
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 5e-22
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 49/217 (22%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
+GEG +G VYK +S + VA+K++ + G+ + E+ +L LHHPN+V+LI
Sbjct: 29 VGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGI--PSTAIREISLLKELHHPNIVSLI 85
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA--------RGLE 187
LV+E+M DL KK LD + + RG+
Sbjct: 86 DVIHSERCLTLVFEFME--------KDL---KKVLD-ENKTGLQDSQIKIYLYQLLRGVA 133
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYC 245
+ H +++RDLK N+L++ KL+DFGLA+ PV TH V+ T Y
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYR 186
Query: 246 APEYAKTGQLTLKS-------DVYSFGVVLLEILSGR 275
AP+ + + S D++S G + E+++G+
Sbjct: 187 APD------VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-22
Identities = 48/210 (22%), Positives = 86/210 (40%), Gaps = 32/210 (15%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLV-EV-LMLSLLHHPNLVNLIG 136
LG G F V + +S Q+ A K L R Q R ++ E+ ++ P ++NL
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 137 YCADGDQRLLVYEYMPLGS-----VEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLE 187
+ + +L+ EY G + + +S + G+
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSE-----------NDVIRLIKQILEGVY 145
Query: 188 YLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244
YLH +++ DLK NILL K+ DFG+++ +G + + GT Y
Sbjct: 146 YLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELREIM-GTPEY 199
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
APE +T +D+++ G++ +L+
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 6e-22
Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 36/220 (16%)
Query: 73 NFRSESLLGEGGFGRVY---KGYLESINQDVAIKQLDRNGVQGNREFLVEVLM-----LS 124
F +LG+GG+G+V+ K + + A+K L + + N + L
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK-DTAHTKAERNILE 76
Query: 125 LLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGA 182
+ HP +V+LI Y +L L+ EY+ G + L G D A
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLERE--GIFMED---TACFYLAEI 130
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GT 241
+ L +LH K +IYRDLK NI+L+ H KL+DFGL K T GT
Sbjct: 131 SMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFCGT 184
Query: 242 YGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE + + D +S G ++ ++L+G
Sbjct: 185 IEYMAPEILMRSGHNRA------VDWWSLGALMYDMLTGA 218
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 6e-22
Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 28/209 (13%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR------EFLVEVLMLSLLHHPNLVN 133
LG G F V K + ++ A K + + + +R E EV +L + HPN++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYL 189
L + +L+ E + G E L D K+ L T + A + G+ YL
Sbjct: 73 LHDIFENKTDVVLILELVSGG--E--LFDFLAEKESL---TEDE-ATQFLKQILDGVHYL 124
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
H K + + DLK NI+L P KL DFG+A + GT +
Sbjct: 125 HSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKNIF-GTPEFV 178
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSG 274
APE L L++D++S GV+ +LSG
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 6e-22
Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM------LSLL 126
+F +LG+G FG+V + ++ A+K L ++ V + + VE M
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD--VECTMVEKRVLALPG 399
Query: 127 HHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAAR 184
P L L C RL V EY+ G + H+ + G+ AA A
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEP---HAVFYAAEIAI 453
Query: 185 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYG 243
GL +L K +IYRDLK N++LD H K++DFG+ K T T+ GT
Sbjct: 454 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPD 507
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE D ++FGV+L E+L+G+
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-22
Identities = 57/203 (28%), Positives = 85/203 (41%), Gaps = 24/203 (11%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV-LMLSLLHHPNLVNLIGYC 138
LGEG F K + NQ A+K + + ++ E+ + HPN+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAK 194
D LV E + G + + + KK A+ R + ++HD
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKK----KKHFS----ETEASYIMRKLVSAVSHMHDVG- 126
Query: 195 PPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
V++RDLK N+L + K+ DFG A+L P DN + T T Y APE
Sbjct: 127 --VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-PDNQPLKTPC-FTLHYAAPELLN 182
Query: 252 TGQLTLKSDVYSFGVVLLEILSG 274
D++S GV+L +LSG
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSG 205
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 7e-22
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 49/217 (22%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
+GEG +G VYK + + A+K++ + G+ + E+ +L L H N+V L
Sbjct: 10 IGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGI--PSTTIREISILKELKHSNIVKLY 66
Query: 136 GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA--------RGLE 187
+ +LV+E++ DL KK LD + + A G+
Sbjct: 67 DVIHTKKRLVLVFEHLD--------QDL---KKLLD-VCEGGLESVTAKSFLLQLLNGIA 114
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYC 245
Y HD+ V++RDLK N+L++R K++DFGLA+ PV TH ++ T Y
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYR 167
Query: 246 APEYAKTGQLTLKSDVYSFGV-------VLLEILSGR 275
AP+ + + S YS + + E+++G
Sbjct: 168 APD------VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-22
Identities = 54/241 (22%), Positives = 92/241 (38%), Gaps = 33/241 (13%)
Query: 48 ASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR 107
AS G + N+ + LG+G F V + ++ + A K ++
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64
Query: 108 NGVQGNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 165
+ + E + L HPN+V L + LV++ + G +L
Sbjct: 65 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG-------EL-- 115
Query: 166 GKKPLDWNTRM-----KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGY 213
+ A+ + + Y H +++R+LK N+LL +G
Sbjct: 116 ----FEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGA 168
Query: 214 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 273
KL+DFGLA V D+ GT GY +PE K + D+++ GV+L +L
Sbjct: 169 AVKLADFGLAIE--VNDSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225
Query: 274 G 274
G
Sbjct: 226 G 226
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-21
Identities = 69/243 (28%), Positives = 107/243 (44%), Gaps = 33/243 (13%)
Query: 41 SSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDV 100
++ V + +G D++ +F +LG+G FG+V + ++
Sbjct: 1 TTNTVSKFDNNGNRDRMKLT------------DFNFLMVLGKGSFGKVMLSERKGTDELY 48
Query: 101 AIKQLDRNGVQGNREF---LVE--VLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLG 154
A+K L ++ V + + +VE VL L P L L C RL V EY+ G
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQLH-SCFQTMDRLYFVMEYVNGG 106
Query: 155 SVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 213
+ H+ + G+ AA A GL +L K +IYRDLK N++LD
Sbjct: 107 DLMYHIQQV--GRFKEP---HAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEG 158
Query: 214 HPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 272
H K++DFG+ K T T+ GT Y APE D ++FGV+L E+L
Sbjct: 159 HIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 215
Query: 273 SGR 275
+G+
Sbjct: 216 AGQ 218
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-21
Identities = 69/223 (30%), Positives = 99/223 (44%), Gaps = 57/223 (25%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL-------DRNGVQGNREFLVEVLMLSLLHHPNLV 132
LGEG F VYK ++ NQ VAIK++ ++G+ NR L E+ +L L HPN++
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGI--NRTALREIKLLQELSHPNII 75
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA--------- 183
L+ LV+++M DL + + + +
Sbjct: 76 GLLDAFGHKSNISLVFDFME--------TDL---EVIIK---DNSLVLTPSHIKAYMLMT 121
Query: 184 -RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTH-VSTRVM 239
+GLEYLH +++RDLK +N+LLD KL+DFGLAK P TH V TR
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-- 176
Query: 240 GTYGYCAPEYAKTGQLTLKSDVYSFGV-------VLLEILSGR 275
Y APE L + +Y GV +L E+L
Sbjct: 177 ---WYRAPE------LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 26/217 (11%)
Query: 73 NFRSESLLGEGGFGRVY---KGYLESINQDVAIKQLDRNGVQGNREFLVEVLM-----LS 124
NF +LG G +G+V+ K + A+K L + + +
Sbjct: 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 125 LLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGA 182
+ P LV L Y + +L L+ +Y+ G + HL + ++I
Sbjct: 115 IRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQR--ERFTEH---EVQIYVGEI 168
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
LE+LH +IYRD+K NILLD H L+DFGL+K + GT
Sbjct: 169 VLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTI 224
Query: 243 GYCAPE---YAKTGQLTLKS-DVYSFGVVLLEILSGR 275
Y AP+ +G K+ D +S GV++ E+L+G
Sbjct: 225 EYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGA 259
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-21
Identities = 67/217 (30%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVE--VLMLSLLH 127
NF +LG+G FG+V ++ A+K L ++ + + + + E +L L+ +
Sbjct: 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-N 82
Query: 128 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARG 185
HP L L C RL V E++ G + H+ + R + AA
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEA---RARFYAAEIISA 136
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGY 244
L +LHDK +IYRDLK N+LLD H KL+DFG+ K G T T GT Y
Sbjct: 137 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDY 190
Query: 245 CAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
APE Y D ++ GV+L E+L G
Sbjct: 191 IAPEILQEMLYGPA------VDWWAMGVLLYEMLCGH 221
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 48/210 (22%), Positives = 86/210 (40%), Gaps = 28/210 (13%)
Query: 76 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLI 135
S+ +LG G G+V + + Q A+K L + +E V+ P++V ++
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR-QE--VD-HHWQASGGPHIVCIL 88
Query: 136 GYCADGDQR----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLE 187
+ L++ E M G + + + + + R AA R ++
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQE----RGDQAFTERE--AAEIMRDIGTAIQ 142
Query: 188 YLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244
+LH + +RD+K N+L ++ KL+DFG AK + T T Y
Sbjct: 143 FLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPC-YTPYY 195
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
APE + D++S GV++ +L G
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 61/209 (29%), Positives = 90/209 (43%), Gaps = 28/209 (13%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR------EFLVEVLMLSLLHHPNLVN 133
LG G F V K +S + A K + + + +R E EV +L + HPN++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYL 189
L + +L+ E + G E L D K+ L + A + G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGG--E--LFDFLAQKESL----SEEEATSFIKQILDGVNYL 131
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
H K + + DLK NI+L P KL DFGLA + D GT +
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF-GTPEFV 185
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSG 274
APE L L++D++S GV+ +LSG
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-----EVLMLSLLHHPNLVNL 134
+G+G F V + Q A+K +D + E + +L HP++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 135 IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLH 190
+ + +V+E+M + + + ++ + A+ R L Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSEAV--ASHYMRQILEALRYCH 147
Query: 191 DKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
D +I+RD+K +LL + KL FG+A +G++ V+ +GT + AP
Sbjct: 148 DNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMAP 202
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSG 274
E K DV+ GV+L +LSG
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-21
Identities = 60/209 (28%), Positives = 89/209 (42%), Gaps = 28/209 (13%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR------EFLVEVLMLSLLHHPNLVN 133
LG G F V K +S + A K + + + +R E EV +L + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYL 189
L + +L+ E + G E L D K+ L + A + G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGG--E--LFDFLAQKESL----SEEEATSFIKQILDGVNYL 131
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
H K + + DLK NI+L P KL DFGLA + D GT +
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF-GTPEFV 185
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSG 274
APE L L++D++S GV+ +LSG
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-21
Identities = 53/210 (25%), Positives = 79/210 (37%), Gaps = 34/210 (16%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPNLVNLIG 136
+G G FG + + VA+K ++R V E++ L HPN+V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN---VQREIINHRSLRHPNIVRFKE 83
Query: 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------GLEY 188
++ EY G + + + + R AR G+ Y
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICN----------AGRFSED--EARFFFQQLLSGVSY 131
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 246
H + +RDLK N LLD P K+ DFG +K + + V GT Y A
Sbjct: 132 CHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIA 185
Query: 247 PE-YAKTGQLTLKSDVYSFGVVLLEILSGR 275
PE + +DV+S GV L +L G
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 4e-21
Identities = 34/164 (20%), Positives = 63/164 (38%), Gaps = 14/164 (8%)
Query: 119 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 178
++ + N V + + + + +++D + + + + I
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD-WMNRRCSLEDREHGVCLHI 169
Query: 179 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK----------LGPV 228
A +E+LH K +++RDLK SNI K+ DFGL +
Sbjct: 170 FIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 272
T +GT Y +PE + K D++S G++L E+L
Sbjct: 227 MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 8e-08
Identities = 22/109 (20%), Positives = 42/109 (38%), Gaps = 2/109 (1%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPN 130
+F +G GGFG V++ + + + AIK++ + RE + EV L+ L HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 131 LVNLIG-YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 178
+V + ++ E LS + +++
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-21
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVE--VLMLSLLH 127
+F ++G G + +V L+ ++ A+K + + V + + E V + +
Sbjct: 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-N 68
Query: 128 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARG 185
HP LV L C + RL V EY+ G + H+ K P + + +A +
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEE---HARFYSAEISLA 122
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGY 244
L YLH++ +IYRDLK N+LLD H KL+D+G+ K G +T T GT Y
Sbjct: 123 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNY 176
Query: 245 CAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
APE Y + D ++ GV++ E+++GR
Sbjct: 177 IAPEILRGEDYGFS------VDWWALGVLMFEMMAGR 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-21
Identities = 36/204 (17%), Positives = 85/204 (41%), Gaps = 26/204 (12%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYC 138
LG G FG V++ S + K + G ++ + E+ +L++ H N+++L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESF 70
Query: 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM--KIAAGAAR----GLEYLHDK 192
++ ++++E++ + + + + + + L++LH
Sbjct: 71 ESMEELVMIFEFISGL--D--IFE-----RINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 193 AKPPVIYRDLKCSNILL--DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
+ + D++ NI+ R K+ +FG A+ + + Y APE
Sbjct: 122 N---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLF-TAPEYYAPEVH 175
Query: 251 KTGQLTLKSDVYSFGVVLLEILSG 274
+ ++ +D++S G ++ +LSG
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSG 199
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-21
Identities = 62/258 (24%), Positives = 104/258 (40%), Gaps = 33/258 (12%)
Query: 29 RINSIPDKLKMNSSLRVKEASEDGASDQITAQTLTFRELAAATKNFRSESLLGEGGFGRV 88
++ + L S V ++ G + + + A + F ES LG G V
Sbjct: 10 GVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIV 69
Query: 89 YKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148
Y+ + + A+K L + + E+ +L L HPN++ L + LV
Sbjct: 70 YRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127
Query: 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRM-----KIAAGAAR----GLEYLHDKAKPPVIY 199
E + G +L D + AA A + + YLH+ +++
Sbjct: 128 ELVTGG-------EL------FDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVH 171
Query: 200 RDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 256
RDLK N+L K++DFGL+K+ V + T GT GYCAPE +
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTVC-GTPGYCAPEILRGCAYG 228
Query: 257 LKSDVYSFGVVLLEILSG 274
+ D++S G++ +L G
Sbjct: 229 PEVDMWSVGIITYILLCG 246
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-21
Identities = 50/222 (22%), Positives = 84/222 (37%), Gaps = 36/222 (16%)
Query: 71 TKNFRSE----SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--EVLMLS 124
F E LG+G F V + Q+ A ++ + + E +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 125 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM-----KIA 179
LL HPN+V L ++ L+++ + G +L + A
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGG-------EL------FEDIVAREYYSEADA 112
Query: 180 AGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNT 232
+ + + + H V++R+LK N+LL +G KL+DFGLA V
Sbjct: 113 SHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQ 167
Query: 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
GT GY +PE + D+++ GV+L +L G
Sbjct: 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 6e-21
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 30/215 (13%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV---EVLMLSLLHHP 129
++ LG G FG+V G E VA+K L+R ++ E+ L L HP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----- 184
+++ L + +V EY+ G + D++ N R+ +R
Sbjct: 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICK----------NGRLDEKE--SRRLFQQ 124
Query: 185 ---GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
G++Y H V++RDLK N+LLD + K++DFGL+ + G+ S G+
Sbjct: 125 ILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GS 178
Query: 242 YGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE + + D++S GV+L +L G
Sbjct: 179 PNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-20
Identities = 55/217 (25%), Positives = 85/217 (39%), Gaps = 44/217 (20%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR------EFLVEVLMLSLLHHPNLVN 133
LG G F V K +S A K + + + +R + EV +L + HPN++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM--------KIAAGAAR- 184
L + +L+ E + G E L D + + A +
Sbjct: 79 LHEVYENKTDVILILELVAGG--E--LFD------------FLAEKESLTEEEATEFLKQ 122
Query: 185 ---GLEYLHDKAKPPVIYRDLKCSNILLDRGYHP----KLSDFGLAKLGPVGDNTHVSTR 237
G+ YLH + + DLK NI+L P K+ DFGLA +
Sbjct: 123 ILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNI 177
Query: 238 VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 274
GT + APE L L++D++S GV+ +LSG
Sbjct: 178 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF---LVE--VLMLSLLH 127
+F ++G G + +V L+ ++ A++ + + V + + E V + +
Sbjct: 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-N 111
Query: 128 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARG 185
HP LV L C + RL V EY+ G + H+ K P + + +A +
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEE---HARFYSAEISLA 165
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGY 244
L YLH++ +IYRDLK N+LLD H KL+D+G+ K G +T T GT Y
Sbjct: 166 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNY 219
Query: 245 CAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
APE Y + D ++ GV++ E+++GR
Sbjct: 220 IAPEILRGEDYGFS------VDWWALGVLMFEMMAGR 250
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 31/215 (14%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV---EVLMLSLLHHP 129
+ LGEG FG+V Q VA+K + R ++ + + E+ L LL HP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----- 184
+++ L ++V EY G + D++ + RM R
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYAG-GELFDYIVE----------KKRMTEDE--GRRFFQQ 116
Query: 185 ---GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
+EY H +++RDLK N+LLD + K++DFGL+ + G+ S G+
Sbjct: 117 IICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GS 170
Query: 242 YGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE + DV+S G+VL +L GR
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-20
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 52/223 (23%)
Query: 80 LGEGGFGRVYKGY-LESINQDVAIKQL----DRNGV--QGNREFLVEVL-MLSLLHHPNL 131
+GEG +G+V+K L++ + VA+K++ G+ RE V VL L HPN+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE--VAVLRHLETFEHPNV 76
Query: 132 VNLI----GYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA--- 183
V L D + +L LV+E++ DL LD +
Sbjct: 77 VRLFDVCTVSRTDRETKLTLVFEHVD--------QDL---TTYLDKVPEPGVPTETIKDM 125
Query: 184 -----RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 238
RGL++LH V++RDLK NIL+ KL+DFGLA+ +++ V
Sbjct: 126 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVV 180
Query: 239 MGTYGYCAPEYAKTGQLTLKS------DVYSFGVVLLEILSGR 275
+ T Y APE + L+S D++S G + E+ +
Sbjct: 181 V-TLWYRAPE------VLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 3e-20
Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 54/225 (24%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGVQGN-----REFLVEVL-MLSLLHHP 129
+G G +G VYK VA+K + G G RE V +L L HP
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE--VALLRRLEAFEHP 74
Query: 130 NLVNLI----GYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA- 183
N+V L+ D + ++ LV+E++ DL + LD + A
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVD--------QDL---RTYLDKAPPPGLPAETIK 123
Query: 184 -------RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 236
RGL++LH +++RDLK NIL+ G KL+DFGLA+ ++
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--IYSYQMALTP 178
Query: 237 RVMGTYGYCAPEYAKTGQLTLKS------DVYSFGVVLLEILSGR 275
V+ T Y APE + L+S D++S G + E+ +
Sbjct: 179 VVV-TLWYRAPE------VLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 4e-20
Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 127
K +++ +G G G V Y ++++VAIK+L R N R E++++ ++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA-YRELVLMKCVN 119
Query: 128 HPNLVNLIG-YCADGDQRL-----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 181
H N+++L+ + LV E M + +L + + LD +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVI--QMELDHERMSYLLYQ 172
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--HVSTRVM 239
G+++LH +I+RDLK SNI++ K+ DFGLA+ +V TR
Sbjct: 173 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY- 228
Query: 240 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE D++S G ++ E++ +
Sbjct: 229 ----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 4e-20
Identities = 52/253 (20%), Positives = 97/253 (38%), Gaps = 67/253 (26%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN 130
+K + LG G FG V + + + A+K++ ++ NRE + ++ +L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61
Query: 131 LVNLIGY-------------------------------------CADGDQRL-LVYEYMP 152
++ L+ Y ++ L ++ EY+P
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 212
++ L + + N R + ++H + +RD+K N+L++
Sbjct: 122 D-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSK 177
Query: 213 YHP-KLSDFGLAK-LGPVGDNTH-VSTRVMGTYGYCAPE-------YAKTGQLTLKSDVY 262
+ KL DFG AK L P + + +R + Y APE Y T D++
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEY------TPSIDLW 226
Query: 263 SFGVVLLEILSGR 275
S G V E++ G+
Sbjct: 227 SIGCVFGELILGK 239
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-19
Identities = 58/227 (25%), Positives = 91/227 (40%), Gaps = 56/227 (24%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL----DRNGV--QGNREFLVEVLMLSLLHHPNLVN 133
+G+G FG V+K Q VA+K++ ++ G RE + +L LL H N+VN
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALRE----IKILQLLKHENVVN 80
Query: 134 LIGYCADGDQRL--------LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA-- 183
LI C LV+++ HDL L N +K
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDFCE--------HDL---AGLLS-NVLVKFTLSEIKR 128
Query: 184 ------RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVS 235
GL Y+H +++RD+K +N+L+ R KL+DFGLA+ +
Sbjct: 129 VMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 236 TRVMGTYGYCAPEYAKTGQLTLKS-------DVYSFGVVLLEILSGR 275
T + T Y PE L L D++ G ++ E+ +
Sbjct: 186 TNRVVTLWYRPPE------LLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-19
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 127
K +++ +G G G V Y + ++VAIK+L R N R + E++++ ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 82
Query: 128 HPNLVNLIG-YCADGDQRL-----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK-IAA 180
H N++ L+ + +V E M + +L + + LD + RM +
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVI--QMELD-HERMSYLLY 134
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG 240
G+++LH +I+RDLK SNI++ K+ DFGLA + + T +
Sbjct: 135 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVV 188
Query: 241 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
T Y APE D++S G ++ E++ G
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-19
Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 29/207 (14%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC 138
LG G G+V + + + + A+K L D + RE VE L P++V ++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR--RE--VE-LHWRASQCPHIVRIVDVY 124
Query: 139 ADGDQR----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLH 190
+ L+V E + G + + D + + R A+ + ++YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQD----RGDQAFTERE--ASEIMKSIGEAIQYLH 178
Query: 191 DKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
+ +RD+K N+L KL+DFG AK + ++T T Y AP
Sbjct: 179 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPC-YTPYYVAP 232
Query: 248 EYAKTGQLTLKSDVYSFGVVLLEILSG 274
E + D++S GV++ +L G
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 1e-18
Identities = 58/261 (22%), Positives = 96/261 (36%), Gaps = 67/261 (25%)
Query: 80 LGEGGFGRVYKGYLESINQD-----VAIKQL-DRNGVQGNREFLVEV-LMLSLLHHPNLV 132
LG G FG+V + I++ VA+K L + +R + E+ +++ + HH N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 133 NLIGYCADGDQRLLV-YEYMPLGSVEDHLHDLSPG------------------------- 166
NL+G C L+V E+ G++ +L
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149
Query: 167 KKPLDWNTRMKIAAGAARGLE----YLHDKAKPPVIYRDLKCSNILLDRGY--------- 213
K+ LD T + +A + E + ++ P +Y+D L+ +
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 214 ------HPKL---------------SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 252
H L DFGLA+ + + APE
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 269
Query: 253 GQLTLKSDVYSFGVVLLEILS 273
T++SDV+SFGV+L EI S
Sbjct: 270 RVYTIQSDVWSFGVLLWEIFS 290
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-17
Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 38/221 (17%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 127
K + S + +G G +G V + + VAIK+L R + + R E+L+L +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA-YRELLLLKHMQ 81
Query: 128 HPNLVNLI-----GYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 181
H N++ L+ LV +M + L + +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIM--GLKFSEEKIQYLVYQ 134
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
+GL+Y+H V++RDLK N+ ++ K+ DFGLA+ +V TR
Sbjct: 135 MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW--- 188
Query: 242 YGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE Y +T D++S G ++ E+L+G+
Sbjct: 189 --YRAPEVILSWMHYNQT------VDIWSVGCIMAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-17
Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 37/221 (16%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 127
+R +G G +G V VAIK+L R + + R E+ +L +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA-YRELRLLKHMR 82
Query: 128 HPNLVNLIG-YCADGDQRL-----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 181
H N++ L+ + D LV +M L L + L + +
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLM-KHEKLGEDRIQFLVYQ 136
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
+GL Y+H +I+RDLK N+ ++ K+ DFGLA+ +V TR
Sbjct: 137 MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW--- 190
Query: 242 YGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE Y +T D++S G ++ E+++G+
Sbjct: 191 --YRAPEVILNWMRYTQT------VDIWSVGCIMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 33/221 (14%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD--RNGVQGNREFLVEVLMLSLLHH 128
+ + S +GEG +G V Y VAIK++ + R L E+ +L H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRH 84
Query: 129 PNLVNLIG----YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK-IAAGA 182
N++ + + + + +V + M E L+ L + L N +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLL-KTQHLS-NDHICYFLYQI 137
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGT 241
RGL+Y+H A V++RDLK SN+LL+ K+ DFGLA+ P D+T T + T
Sbjct: 138 LRGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 242 YGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE Y K+ D++S G +L E+LS R
Sbjct: 195 RWYRAPEIMLNSKGYTKS------IDIWSVGCILAEMLSNR 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 52/232 (22%), Positives = 88/232 (37%), Gaps = 48/232 (20%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR--NGVQGNREF---------LVE 119
+ + + G +G V G +S VAIK++ + + L E
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 120 VLMLSLLHHPNLVNL----IGYCADGDQRL-LVYEYMPLGSVEDHLHD-LSPGKKPLDWN 173
+ +L+ HHPN++ L + + +L LV E M L + + +
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVIS-P 133
Query: 174 TRMK-IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232
++ GL LH+ V++RDL NILL + DF LA+ N
Sbjct: 134 QHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 233 --HVSTRVMGTYGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+V+ R Y APE + K D++S G V+ E+ + +
Sbjct: 191 THYVTHRW-----YRAPELVMQFKGFTKL------VDMWSAGCVMAEMFNRK 231
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-16
Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 37/221 (16%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 127
+ +++ S +G G +G V + VA+K+L R + + R E+ +L +
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-YRELRLLKHMK 86
Query: 128 HPNLVNLI-----GYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 181
H N++ L+ + + LV M L+++ + L + +
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQ-KLTDDHVQFLIYQ 140
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
RGL+Y+H +I+RDLK SN+ ++ K+ DFGLA+ +V+TR
Sbjct: 141 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW--- 194
Query: 242 YGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE Y +T D++S G ++ E+L+GR
Sbjct: 195 --YRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 40/228 (17%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD--RNGVQGNREFLVEVLMLSLLHH 128
+ +F+ +SLLGEG +G V + + VAIK+++ + R L E+ +L H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFKH 68
Query: 129 PNLVNLIG-YCADGDQRL----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK-IAAGA 182
N++ + D + ++ E M + LH + + L + ++
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQ-MLS-DDHIQYFIYQT 121
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA----KLGPVGDNTHVSTRV 238
R ++ LH + VI+RDLK SN+L++ K+ DFGLA +
Sbjct: 122 LRAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 239 MGTY----GYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
M + Y APE Y++ DV+S G +L E+ R
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRA------MDVWSCGCILAELFLRR 220
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-15
Identities = 46/158 (29%), Positives = 62/158 (39%), Gaps = 15/158 (9%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
NFR +G G FG + G N+ VAIK L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ-LGSGDGIP 68
Query: 133 NLIGYCADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
+ + G +V E LG S+ED L DL L T + IA +EY+H
Sbjct: 69 QVYYFGPCGKYNAMVLEL--LGPSLED-LFDLCDRTFSL--KTVLMIAIQLISRMEYVHS 123
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPK-----LSDFGLAK 224
K +IYRD+K N L+ R + + DF LAK
Sbjct: 124 KN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-15
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 20/213 (9%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH-PNL 131
+R +G G FG +Y G + ++VAIK + + +E + ++ +
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGI 67
Query: 132 VNLIGYCADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+ A+GD ++V E LG S+ED L + K L T + +A +EY+H
Sbjct: 68 PTIRWCGAEGDYNVMVMEL--LGPSLED-LFNFCSRKFSL--KTVLLLADQMISRIEYIH 122
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPK---LSDFGLAKL-GPVGDNTHVSTR----VMGTY 242
K I+RD+K N L+ G + DFGLAK + H+ R + GT
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y + + + + D+ S G VL+ G
Sbjct: 180 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-15
Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 40/229 (17%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLVEVLMLSLLHHP 129
+ LG GG G V+ ++ VAIK++ + L E+ ++ L H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA-LREIKIIRRLDHD 68
Query: 130 NLVNLIG-YCADGDQRL-------------LVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 175
N+V + G Q +V EYM E L ++ + PL
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVL-EQGPLLEEHA 122
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAK-LGPVGDNTH 233
RGL+Y+H V++RDLK +N+ ++ K+ DFGLA+ + P +
Sbjct: 123 RLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 234 VSTRVMGTYGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ + T Y +P Y K D+++ G + E+L+G+
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKA------IDMWAAGCIFAEMLTGK 222
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 22/214 (10%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNL 131
FR +G G FG +Y G N++VAIK + + + L E + +L +
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGI 65
Query: 132 VNLIGYCADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
N+ + +GD +LV + LG S+ED L + K L T + +A +E++H
Sbjct: 66 PNVRWFGVEGDYNVLVMDL--LGPSLED-LFNFCSRKLSL--KTVLMLADQMINRVEFVH 120
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPK---LSDFGLAKL-GPVGDNTHVSTR----VMGTY 242
K+ ++RD+K N L+ G + DFGLAK + H+ R + GT
Sbjct: 121 SKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 243 GYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGR 275
Y A G + + + D+ S G VL+ L G
Sbjct: 178 RY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 53/241 (21%), Positives = 97/241 (40%), Gaps = 48/241 (19%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 127
N+ + L+G G +G VY Y ++ ++VAIK+++R + + R L E+ +L+ L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR-ILREITILNRLK 83
Query: 128 HPNLVNL----IGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK----- 177
++ L I L +V E + L L L +K
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLT-EEHIKTILYN 137
Query: 178 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 237
+ G ++H+ + +I+RDLK +N LL++ K+ DFGLA+ +T++
Sbjct: 138 LL----LGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 238 VMGTYGYCAPEYAKTGQLT--------------LKS-------DVYSFGVVLLEILSGRK 276
+ QLT L D++S G + E+L+ +
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 277 A 277
+
Sbjct: 251 S 251
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-13
Identities = 40/162 (24%), Positives = 71/162 (43%), Gaps = 19/162 (11%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREF----LVEVLMLSLL 126
+ L+G G +G V + Y + + VAIK++ R V + L E+ +L+ L
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR--VFEDLIDCKRILREIAILNRL 109
Query: 127 HHPNLVNL----IGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 181
+H ++V + I + L +V E + L L +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLTELHIKTLLYN 164
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223
G++Y+H A +++RDLK +N L+++ K+ DFGLA
Sbjct: 165 LLVGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 46/210 (21%), Positives = 89/210 (42%), Gaps = 37/210 (17%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLML-SLLHHPNLVNLIGYC 138
LG G + V++ + N+ V +K L + + E+ +L +L PN++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIV 100
Query: 139 ADGDQR--LLVYEYMPLGSVEDHLHDLSPG------KKPLDWNTRMKIAAGAARGLEYLH 190
D R LV+E++ + L+ + L + L+Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------------KALDYCH 147
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAKLGPVGD--NTHVSTRVMGTYGYCAP 247
+++RD+K N+++D + +L D+GLA+ G N V++R + P
Sbjct: 148 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGP 199
Query: 248 EYAKTGQLTLKS-DVYSFGVVLLEILSGRK 276
E Q+ S D++S G +L ++ ++
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 20/214 (9%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
+++ +GEG FG +++G NQ VAIK R L L +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL-LAGCTGIP 69
Query: 133 NLIGYCADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
N+ + +G +LV + LG S+ED L DL K + T A ++ +H+
Sbjct: 70 NVYYFGQEGLHNVLVIDL--LGPSLED-LLDLCGRKFSV--KTVAMAAKQMLARVQSIHE 124
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPK-----LSDFGLAKL-GPVGDNTHVSTR----VMGT 241
K+ ++YRD+K N L+ R + DFG+ K H+ R + GT
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y + + + + D+ + G V + L G
Sbjct: 182 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.0 bits (165), Expect = 4e-13
Identities = 44/264 (16%), Positives = 77/264 (29%), Gaps = 69/264 (26%)
Query: 60 QTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--------DRNGVQ 111
+ F T+ + +GEG FG V++ + + VAIK + + + +
Sbjct: 9 GPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQK 65
Query: 112 GNREFLVEVLMLSLLH---------HPNLVNLIG-YCADG-------------------- 141
E L E+++ L + L +C G
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 142 ---------DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
DQ +V E+ G + + K T I L
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEAS 180
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD-------NTHVSTRVM--GTYG 243
+ +RDL N+LL + KL K + + +R+ G
Sbjct: 181 LR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVV 238
Query: 244 YCAPEYAK---TGQLTLKSDVYSF 264
+C + TG + D+Y
Sbjct: 239 FCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 7e-13
Identities = 29/175 (16%), Positives = 61/175 (34%), Gaps = 29/175 (16%)
Query: 72 KNFRSESLLGEGGFGRVYKGY--------LESINQDVAIKQLDRNG----------VQGN 113
+ ++ +S G +Y+ Q ++K ++G
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 114 REFLVEVLMLSLLHHPNLVNLIGY-CADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLD 171
+ + L + +G+ R LV LG S++ D+S K L
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQS-ALDVS-PKHVLS 157
Query: 172 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK--LSDFGLAK 224
+ +++A LE+LH+ ++ ++ NI +D + L+ +G A
Sbjct: 158 ERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 62/239 (25%), Positives = 102/239 (42%), Gaps = 52/239 (21%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDR---NGVQGNREFLVEVLMLSLLH 127
+ + LG+G +G V+K + VA+K++ N R E+++L+ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT-FREIMILTELS 66
Query: 128 -HPNLVNLIG-YCADGDQRL-LVYEYMPLGSVEDHLH------DLSPG-KKPLDWNTRMK 177
H N+VNL+ AD D+ + LV++YM E LH L P K+ + +
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQL--- 118
Query: 178 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 237
+ ++YLH +++RD+K SNILL+ H K++DFGL++ V +
Sbjct: 119 -----IKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSR-SFVNIRRVTNNI 169
Query: 238 VMGTYGYCAPEYAKTGQLT--------------LKS-------DVYSFGVVLLEILSGR 275
+ LT L S D++S G +L EIL G+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 35/157 (22%), Positives = 61/157 (38%), Gaps = 26/157 (16%)
Query: 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV-LMLSLLHHPNLVNLIGYC 138
LG G G+V + + + + A+K L EV L P++V ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDVY 80
Query: 139 ADGDQR----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLH 190
+ L+V E + G + + D + + R A+ + ++YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQD----RGDQAFTERE--ASEIMKSIGEAIQYLH 134
Query: 191 DKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAK 224
+ +RD+K N+L KL+DFG AK
Sbjct: 135 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 9e-11
Identities = 29/176 (16%), Positives = 66/176 (37%), Gaps = 31/176 (17%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-----------GNRE 115
++ +G+GGFG +Y + S + +K + E
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 116 FLVEVLMLSLLHHPNLVNLIGY----CADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPL 170
+ + + L + + G R ++ + G ++ +++ + +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDR--FGSDLQK-IYEANAKRFSR 151
Query: 171 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK--LSDFGLAK 224
T ++++ LEY+H+ ++ D+K SN+LL+ + L D+GLA
Sbjct: 152 --KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 44/226 (19%), Positives = 88/226 (38%), Gaps = 46/226 (20%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---------- 127
LG G F V+ N VA+K + R E+ +L ++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 128 -HPNLVNLIGY----CADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAG 181
+++ L+ + +G ++V+E LG ++ + PL + +I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALIKKYEHRGIPLI-YVK-QISKQ 139
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP------KLSDFGLAKLGPVGDNTHVS 235
GL+Y+H + +I+ D+K N+L++ P K++D G A +
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 236 TRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
TR Y +PE + +D++S ++ E+++G
Sbjct: 198 TRE-----YRSPEVLLGAPW------GCGADIWSTACLIFELITGD 232
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-10
Identities = 30/175 (17%), Positives = 60/175 (34%), Gaps = 32/175 (18%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
+ +G GGFG +Y + + + A + + Q N E+ + +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDC 95
Query: 132 VN---------------LIGY----CADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLD 171
+ G R +V E LG ++
Sbjct: 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER--LGIDLQKISGQ----NGTFK 149
Query: 172 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK--LSDFGLAK 224
+T +++ LEY+H+ ++ D+K +N+LL + L+D+GL+
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 50/221 (22%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL------HHPNL 131
++G+G FG+V K Y ++Q VA+K + RN + +R+ E+ +L L + N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 132 VNLIGY-------CADGDQRLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTRMKIAAGA 182
++++ C + +E + +L++L + K A
Sbjct: 162 IHMLENFTFRNHIC-------MTFELL-----SMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP--KLSDFGLAKLGPVGDNTHVSTRVMG 240
+ L+ LH K +I+ DLK NILL + K+ DFG + T++ +R
Sbjct: 210 LQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-- 264
Query: 241 TYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE Y + D++S G +L E+L+G
Sbjct: 265 ---YRAPEVILGARY------GMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 6e-09
Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 52/227 (22%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL------- 126
+ +SL+G+G FG+V K Y + VAIK + +N + +EV +L L+
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 127 -HHPNLVNLIGY-------CADGDQRLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTRM 176
++ +V+L + C LV+E + +L+DL + + + N
Sbjct: 115 KYY--IVHLKRHFMFRNHLC-------LVFEML-----SYNLYDLLRNTNFRGVSLNLTR 160
Query: 177 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP--KLSDFGLAKLGPVGDNTHV 234
K A L +L + +I+ DLK NILL K+ DFG + ++
Sbjct: 161 KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 219
Query: 235 STRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+R Y +PE Y L D++S G +L+E+ +G
Sbjct: 220 QSRF-----YRSPEVLLGMPY------DLAIDMWSLGCILVEMHTGE 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 47/264 (17%), Positives = 83/264 (31%), Gaps = 74/264 (28%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-----HH 128
+ LG G F V+ + + VA+K + ++ L E+ +L + +
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTETALDEIRLLKSVRNSDPND 97
Query: 129 PNLVNLIGYC-------ADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAA 180
PN ++ +G +V+E LG + + + PL KI
Sbjct: 98 PNREMVVQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQGLPLP--CVKKIIQ 153
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILL------------------------------- 209
+GL+YLH K + +I+ D+K NILL
Sbjct: 154 QVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 210 ------------------DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
K++D G A + TR Y + E
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLI 266
Query: 252 TGQLTLKSDVYSFGVVLLEILSGR 275
+D++S + E+ +G
Sbjct: 267 GSGYNTPADIWSTACMAFELATGD 290
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 2e-06
Identities = 39/239 (16%), Positives = 74/239 (30%), Gaps = 52/239 (21%)
Query: 4 FPCSGDSFRKAKNKKKMKMQQKTLDRINSIPDKLK-MNSSLRVKEASEDGASDQITAQTL 62
+ D+++ K + + +L+ + P + + M L V S I L
Sbjct: 340 GLATWDNWKHVNCDKLTTIIESSLNVLE--PAEYRKMFDRLSVFPPSAH-----IPTILL 392
Query: 63 -------TFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE 115
++ SL+ + + SI ++ +K + +R
Sbjct: 393 SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI--SIPSIYLELKVKLENE--YALHRS 448
Query: 116 FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP------ 169
+V+ + + +LI D Y Y +G HL ++ ++
Sbjct: 449 -IVDHYNIPKTFDSD--DLIPPYLDQ------YFYSHIG---HHLKNIEHPERMTLFRMV 496
Query: 170 -LDWN-TRMKI----AAGAARG--LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220
LD+ KI A A G L L Y+ C N D Y ++
Sbjct: 497 FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKF----YKPYICDN---DPKYERLVNAI 548
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 7e-05
Identities = 55/244 (22%), Positives = 88/244 (36%), Gaps = 80/244 (32%)
Query: 78 SLLGEGGFGRVYKGY-LESINQDVAIKQLDRNGVQGNREF----LVEVLMLSLLHHP--- 129
LGEG FG+V + ++ + VA+K + +N + E+ +L L+
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIV-KN----VDRYCEAARSEIQVLEHLNTTDPN 74
Query: 130 ---NLVNLIGY-------CADGDQRLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTRMK 177
V ++ + C +V+E LG +D G P + K
Sbjct: 75 STFRCVQMLEWFEHHGHIC-------IVFE--LLGL---STYDFIKENGFLPFRLDHIRK 122
Query: 178 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILL-DRGYHP------------------KLS 218
+A + + +LH + + DLK NIL Y K+
Sbjct: 123 MAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 219 DFGLAKLGPVGDN--THVSTRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLE 270
DFG A ++ T VSTR Y APE + + DV+S G +L+E
Sbjct: 180 DFGSATY--DDEHHSTLVSTRH-----YRAPEVILALGW------SQPCDVWSIGCILIE 226
Query: 271 ILSG 274
G
Sbjct: 227 YYLG 230
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 48/247 (19%), Positives = 77/247 (31%), Gaps = 86/247 (34%)
Query: 78 SLLGEGGFGRVYKGY-LESINQDVAIKQLDRNGVQGNREF----LVEVLMLSLL------ 126
LGEG FG+V + VA+K + RN ++ +E+ +L +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKII-RN----VGKYREAARLEINVLKKIKEKDKE 79
Query: 127 --HHPNLVNLIGY-------CADGDQRLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTR 175
V + + C + +E LG + + +P
Sbjct: 80 NKFL--CVLMSDWFNFHGHMC-------IAFE--LLGK---NTFEFLKENNFQPYPLPHV 125
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-------------------K 216
+A L +LH+ + + DLK NIL +
Sbjct: 126 RHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 217 LSDFGLAKLGPVGDNTH---VSTRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVV 267
++DFG A H V+TR Y PE + DV+S G +
Sbjct: 183 VADFGSATF---DHEHHTTIVATRH-----YRPPEVILELGW------AQPCDVWSIGCI 228
Query: 268 LLEILSG 274
L E G
Sbjct: 229 LFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 57/244 (23%), Positives = 87/244 (35%), Gaps = 76/244 (31%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-----HHPNLV 132
+G+G FGRV + A+K + RN + R +E +L + ++ N+V
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 133 NLIGY-------CADGDQRLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTRMKIAAGAA 183
G C L++E PLG L+++
Sbjct: 100 KYHGKFMYYDHMC-------LIFE--PLGP---SLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-------------------------KLS 218
+ L YL + + + DLK NILLD Y KL
Sbjct: 148 KALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 219 DFGLAKLGPVGDN--THVSTRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLE 270
DFG A D + ++TR Y APE + + SD++SFG VL E
Sbjct: 205 DFGCA--TFKSDYHGSIINTRQ-----YRAPEVILNLGW------DVSSDMWSFGCVLAE 251
Query: 271 ILSG 274
+ +G
Sbjct: 252 LYTG 255
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 297 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.55 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.3 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.29 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.0 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.91 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.81 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.75 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.72 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.64 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.58 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.44 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.29 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.27 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.18 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.98 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.95 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.92 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.9 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.85 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.79 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.61 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.51 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.44 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.29 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.11 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.94 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.39 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.96 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.87 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.92 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=389.46 Aligned_cols=209 Identities=25% Similarity=0.360 Sum_probs=190.3
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999999999999999997542 233467899999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
|||+||+|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999987 577999999999999999999999999 99999999999999999999999999987544
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
........+.+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~ 243 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF 243 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 44444556789999999999999999999999999999999999999999987765543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-57 Score=389.52 Aligned_cols=210 Identities=23% Similarity=0.345 Sum_probs=190.5
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
..|++.+.||+|+||.||+|.++.+|+.||||++........+.+.+|+.+++.++|||||+++++|.+++.+|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999998766666677889999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
+||+|.+++.. ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++.... .
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 223 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--E 223 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS--S
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCC--C
Confidence 99999999975 56999999999999999999999999 99999999999999999999999999986432 2
Q ss_pred cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHHh
Q 022447 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA 291 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~~ 291 (297)
.....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~ 283 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR 283 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 233456789999999999999999999999999999999999999999887766555443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-56 Score=387.77 Aligned_cols=210 Identities=21% Similarity=0.343 Sum_probs=181.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
.++|++++.||+|+||.||+|+++.+|+.||||++...... ..+.+.+|+.+++.++|||||++++++.+++.+|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 36899999999999999999999999999999999765433 3457889999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
|||+||+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++...
T Consensus 103 Ey~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~- 176 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLN- 176 (350)
T ss_dssp ECCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCC-
T ss_pred eCCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeec-
Confidence 9999999999997632 456899999999999999999999999 9999999999999999999999999998532
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
.........+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+..
T Consensus 177 -~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 234 (350)
T 4b9d_A 177 -STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV 234 (350)
T ss_dssp -HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred -CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 1122334568999999999999999999999999999999999999999988765543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=391.58 Aligned_cols=210 Identities=23% Similarity=0.345 Sum_probs=191.4
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
+.|++.+.||+|+||.||+|.++.+|+.||||++........+.+.+|+.+++.++|||||+++++|.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999998776666677899999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
+||+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+.... .
T Consensus 231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~ 300 (423)
T 4fie_A 231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--E 300 (423)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCS--S
T ss_pred CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCC--C
Confidence 99999999975 56999999999999999999999999 99999999999999999999999999986432 2
Q ss_pred cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHHh
Q 022447 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA 291 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~~ 291 (297)
.....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~ 360 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR 360 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 233456789999999999999999999999999999999999999999887766555543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-55 Score=367.49 Aligned_cols=207 Identities=27% Similarity=0.404 Sum_probs=171.8
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++.+.||+|+||.||+|.++.+|+.||||++.+... ....++.+|+.+++.++||||+++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 689999999999999999999999999999999976533 23457889999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+ +|+|.+++.. ..++++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 5899999987 578999999999999999999999999 99999999999999999999999999975322
Q ss_pred CCCcceeecccccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
.....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....
T Consensus 165 ---~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~ 223 (275)
T 3hyh_A 165 ---GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKN 223 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ---CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 223345789999999999988876 5799999999999999999999998776554443
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=376.74 Aligned_cols=208 Identities=28% Similarity=0.372 Sum_probs=178.7
Q ss_pred cCCCCcceecccCcEEEEEEEEC---CCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~---~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
++|++++.||+|+||+||+|++. .+++.||||++++.... ...++.+|+.+++.++||||+++++++.+++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999984 46889999999764322 23467889999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
|||||+||+|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999987 567999999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
.. ......+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+...
T Consensus 177 ~~--~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~ 236 (304)
T 3ubd_A 177 ID--HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT 236 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred cC--CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHH
Confidence 22 2223446789999999999999999999999999999999999999999887665543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-55 Score=375.76 Aligned_cols=204 Identities=23% Similarity=0.272 Sum_probs=178.6
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.+.|++.+.||+|+||.||+|+++.+|+.||||+++..... .+|+.+++.++|||||++++++.+.+.+|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 35678889999999999999999999999999999765332 3599999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC-ceEEecccCccccCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGPVG 229 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~ 229 (297)
|+||+|.+++.. ..++++..++.++.||+.||+|||+++ |+||||||+|||++.+| .+||+|||+++.....
T Consensus 132 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999987 567999999999999999999999999 99999999999999887 6999999999864332
Q ss_pred CCc---ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 230 DNT---HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 230 ~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 264 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL 264 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence 211 122346799999999999999999999999999999999999999988765443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=362.21 Aligned_cols=200 Identities=30% Similarity=0.476 Sum_probs=174.2
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeec----CCeeEEE
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLV 147 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 147 (297)
|++.+.||+|+||.||+|.++.++..||+|++...... ..+++.+|+.+++.++|||||+++++|.+ ...+|+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 35677899999999999999999999999999754332 34568999999999999999999999865 3568999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEc-CCCceEEecccCcccc
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKLG 226 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~-~~~~~kl~Dfg~~~~~ 226 (297)
||||+||+|.+++.. ...+++..++.++.||+.||+|||+++ ++|+||||||+|||++ .++.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999987 577999999999999999999999875 3499999999999997 4789999999999853
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
.. ....+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||...+.
T Consensus 183 ~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~ 234 (290)
T 3fpq_A 183 RA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN 234 (290)
T ss_dssp CT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred CC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence 22 23446789999999998865 699999999999999999999999976544
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=367.70 Aligned_cols=216 Identities=28% Similarity=0.427 Sum_probs=185.5
Q ss_pred cCCCCcceecccCcEEEEEEEEC-----CCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
++|.+.+.||+|+||.||+|.+. .++..||||+++.......+++.+|+.++++++|||||++++++.+++..|+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888899999999999999875 4588999999987665556789999999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEE
Q 022447 147 VYEYMPLGSVEDHLHDLS---------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 217 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl 217 (297)
|||||++|+|.+++.... .....+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 12357999999999999999999999999 999999999999999999999
Q ss_pred ecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHH
Q 022447 218 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 218 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~ 290 (297)
+|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+....+
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999986433333333344569999999999999999999999999999999999 89999998776554443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=365.46 Aligned_cols=216 Identities=30% Similarity=0.485 Sum_probs=179.5
Q ss_pred cCCCCcceecccCcEEEEEEEEC-----CCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
++|.+.+.||+|+||.||+|.++ .++..||||+++.......+++.+|+.++++++|||||++++++.+.+..|+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46778889999999999999875 3688999999987665566789999999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCce
Q 022447 147 VYEYMPLGSVEDHLHDLSP-----------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~ 215 (297)
|||||++|+|.+++..... ...++++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999976432 1356999999999999999999999999 9999999999999999999
Q ss_pred EEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHH
Q 022447 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~ 290 (297)
||+|||+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||...+..+....+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999986544443444456779999999999999999999999999999999999 89999988766554443
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=358.50 Aligned_cols=205 Identities=31% Similarity=0.504 Sum_probs=171.3
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
.+++.+.+.||+|+||+||+|.+.. .||||+++.... ...+.+.+|+.++++++|||||++++++.+ +.+++||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 4678889999999999999998653 599999875433 234678999999999999999999998765 5689999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
|||+||+|.+++... ..++++..+..|+.|++.||+|||+++ ||||||||+|||++.++.+||+|||+++....
T Consensus 111 Ey~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp ECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999999752 467999999999999999999999999 99999999999999999999999999986544
Q ss_pred CCCcceeecccccccccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
..........+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.+...
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~ 244 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD 244 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH
Confidence 333344556789999999999864 358999999999999999999999998765543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=358.11 Aligned_cols=216 Identities=30% Similarity=0.441 Sum_probs=183.9
Q ss_pred cCCCCcceecccCcEEEEEEEEC-----CCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
.++++.+.||+|+||.||+|... .+++.||||+++.... ...++|.+|+.++++++|||||++++++.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34567889999999999999863 4678999999975432 33467999999999999999999999999999999
Q ss_pred EEEecCCCCChHhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC
Q 022447 146 LVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 213 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~ 213 (297)
+|||||++|+|.+++..... ....+++..+..++.||+.|++|||+++ ||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999965321 1246899999999999999999999999 99999999999999999
Q ss_pred ceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHH
Q 022447 214 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 214 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~ 290 (297)
.+||+|||+++..............+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+....+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i 260 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999986443333334455679999999999999999999999999999999998 89999998776654443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=352.88 Aligned_cols=205 Identities=25% Similarity=0.377 Sum_probs=166.1
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCC-------
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGD------- 142 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 142 (297)
.++|++++.||+|+||.||+|.++.+|+.||||++...... ..+.+.+|+.+++.++||||++++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 35699999999999999999999999999999999765433 3356889999999999999999999987544
Q ss_pred -----eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEE
Q 022447 143 -----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 217 (297)
Q Consensus 143 -----~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl 217 (297)
..|+|||||+||+|.+++..... ....++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEE
Confidence 36899999999999999986321 223456778999999999999999999 999999999999999999999
Q ss_pred ecccCccccCCCCCc----------ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 218 SDFGLAKLGPVGDNT----------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 218 ~Dfg~~~~~~~~~~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
+|||+++........ ......+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 999999864332211 12234679999999999999999999999999999999996 887654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=360.36 Aligned_cols=212 Identities=25% Similarity=0.341 Sum_probs=182.3
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeec------CC
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD------GD 142 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 142 (297)
.++|++++.||+|+||+||+|.++.+|+.||||+++..... ..+++.+|+.+++.++||||+++++++.. ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 35799999999999999999999999999999999765332 33568899999999999999999998754 36
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
..|+|||||+ |+|.+++.. ..++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecce
Confidence 7899999997 679999986 678999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCC--CcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHH
Q 022447 223 AKLGPVGD--NTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 223 ~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~ 290 (297)
++...... ......+.+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I 275 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI 275 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 97643221 12234567899999999998775 5799999999999999999999999988776655443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=372.47 Aligned_cols=203 Identities=30% Similarity=0.403 Sum_probs=177.9
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHH---HHHHHhccCCCCccceeeEeecCCee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLV---EVLMLSLLHHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~ 144 (297)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+... ........ ++.+++.++||||++++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 4679999999999999999999999999999999975322 11222333 45667778999999999999999999
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
|+|||||+||+|.+++.. ...+++..++.++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999987 577999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcceeecccccccccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 225 LGPVGDNTHVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
..... ...+.+||+.|||||++. +..|+.++|+|||||++|||++|+.||.+.+..
T Consensus 341 ~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~ 397 (689)
T 3v5w_A 341 DFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397 (689)
T ss_dssp ECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC
T ss_pred ecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 64322 234578999999999996 468999999999999999999999999876544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=350.14 Aligned_cols=205 Identities=25% Similarity=0.339 Sum_probs=174.3
Q ss_pred HHHhcCCCCcceecccCcEEEEEEEEC---CCCeEEEEEEeccCCccchHHHHHHHHHHhcc-CCCCccceeeEeecCCe
Q 022447 68 AAATKNFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~v~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 143 (297)
....++|++.+.||+|+||.||+|+++ .+++.||+|.+.... ...++.+|+.+++.+ +||||+++++++.+.++
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 345678999999999999999999875 467899999986543 345678899999988 69999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC-CceEEecccC
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGL 222 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~-~~~kl~Dfg~ 222 (297)
.|+||||++|++|.+++. .+++.+++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+
T Consensus 95 ~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 999999999999999985 3889999999999999999999999 9999999999999876 8999999999
Q ss_pred ccccCCCCC--------------------------cceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCC
Q 022447 223 AKLGPVGDN--------------------------THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGR 275 (297)
Q Consensus 223 ~~~~~~~~~--------------------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~ 275 (297)
|+....... .......+||+.|+|||++.+. .|+.++||||+||++|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 975322111 1122345799999999998765 5899999999999999999999
Q ss_pred CCCCcchhH
Q 022447 276 KAVDTSKAA 284 (297)
Q Consensus 276 ~Pf~~~~~~ 284 (297)
.||...++.
T Consensus 245 ~Pf~~~~~~ 253 (361)
T 4f9c_A 245 YPFYKASDD 253 (361)
T ss_dssp SSSSCCSSH
T ss_pred CCCCCCCCH
Confidence 999765543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=352.18 Aligned_cols=214 Identities=29% Similarity=0.398 Sum_probs=183.1
Q ss_pred HHHHhcCCCCcceecccCcEEEEEEEECCC-----CeEEEEEEeccCCcc-chHHHHHHHHHHhccCC-CCccceeeEee
Q 022447 67 LAAATKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHH-PNLVNLIGYCA 139 (297)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h-~~i~~~~~~~~ 139 (297)
.....++|++.+.||+|+||.||+|.+..+ ++.||||.+...... ..+.+.+|+.++..++| ||||++++++.
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 334567899999999999999999997653 468999999765433 34568999999999965 99999999987
Q ss_pred cC-CeeEEEEecCCCCChHhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 022447 140 DG-DQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 206 (297)
Q Consensus 140 ~~-~~~~lv~e~~~g~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~N 206 (297)
++ ..+++|||||++|+|.++++.... ....+++..+..++.||+.||+|||+++ ||||||||+|
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~N 215 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARN 215 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccc
Confidence 64 568999999999999999975321 1355899999999999999999999999 9999999999
Q ss_pred EEEcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchh
Q 022447 207 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKA 283 (297)
Q Consensus 207 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~ 283 (297)
||++.++.+||+|||+++..............+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+.
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999986544444444556779999999999999999999999999999999998 9999988653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=367.80 Aligned_cols=210 Identities=24% Similarity=0.338 Sum_probs=189.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|++.+.||+|+||.||+|.++.+|+.||+|++........+.+.+|+.+|+.++||||++++++|.+...+|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46899999999999999999999999999999999876666667788999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC--CceEEecccCccccCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG--YHPKLSDFGLAKLGPV 228 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~--~~~kl~Dfg~~~~~~~ 228 (297)
|+||+|.+++... ...+++.+++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++....
T Consensus 236 ~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 9999999999752 457999999999999999999999999 9999999999999854 8999999999986432
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
. ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....
T Consensus 310 ~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~ 367 (573)
T 3uto_A 310 K---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN 367 (573)
T ss_dssp T---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH
T ss_pred C---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH
Confidence 2 234566899999999999999999999999999999999999999998877665443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=337.97 Aligned_cols=201 Identities=27% Similarity=0.398 Sum_probs=161.6
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCC----eeEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----QRLLV 147 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv 147 (297)
++|.+.+.||+|+||.||+|.++ |+.||||++...... ......|+..+..++||||+++++++.+++ .+|+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 45778899999999999999984 899999999654211 112334566667889999999999997653 57999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA-----KPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
||||++|+|.++++. .++++..+..++.|++.||+|||++. .++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999999999999986 56899999999999999999999871 11299999999999999999999999999
Q ss_pred ccccCCCCCc--ceeecccccccccCccccccC------CCCcccchhhHHHHHHHHHhCCCCCCc
Q 022447 223 AKLGPVGDNT--HVSTRVMGTYGYCAPEYAKTG------QLTLKSDVYSFGVVLLEILSGRKAVDT 280 (297)
Q Consensus 223 ~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g~~Pf~~ 280 (297)
++........ ......+||+.|+|||++.+. .++.++|||||||++|||+||..||..
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 9764333222 122346799999999998764 367899999999999999999877654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=323.96 Aligned_cols=209 Identities=28% Similarity=0.374 Sum_probs=185.8
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
.++|++.+.||+|+||.||+|.++.+|+.||+|++.+.. ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999997542 23345688899999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||++|++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++|+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999986 567999999999999999999999999 9999999999999999999999999997522
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
. ........+||+.|+|||++.+..++.++|+|||||++|||++|+.||...+......
T Consensus 157 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 215 (337)
T 1o6l_A 157 S--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215 (337)
T ss_dssp C--TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred c--CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHH
Confidence 2 1223445689999999999999999999999999999999999999998876655433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=316.34 Aligned_cols=207 Identities=27% Similarity=0.409 Sum_probs=187.1
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999999999999999999776666667788999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
++|++|.+++.. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 169 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE- 169 (297)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST-
T ss_pred CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc-
Confidence 999999999986 46899999999999999999999999 999999999999999999999999998764322
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.....
T Consensus 170 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 225 (297)
T 3fxz_A 170 -QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225 (297)
T ss_dssp -TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred -ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 22334567999999999999999999999999999999999999999887665443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=326.69 Aligned_cols=210 Identities=30% Similarity=0.433 Sum_probs=180.7
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 145 (297)
..++|++.+.||+|+||.||+|.++.+++.||||++.+.. ......+..|..+++.+ +||||+++++++.+.+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4578999999999999999999999999999999997542 22335677899999987 6999999999999999999
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+||||++|++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++|+|||+++.
T Consensus 101 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999987 567999999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+...
T Consensus 174 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~ 234 (353)
T 3txo_A 174 GIC--NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 234 (353)
T ss_dssp SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ccc--CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHH
Confidence 222 2233455789999999999999999999999999999999999999999887655433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=322.29 Aligned_cols=213 Identities=31% Similarity=0.465 Sum_probs=185.7
Q ss_pred HHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcc-CCCCccceeeEeecCCe
Q 022447 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 143 (297)
....++|.+.+.||+|+||.||+|.++.+++.||||++.+.. ......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999999999999999997542 22345677889888876 89999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
.|+||||++|++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhh
Confidence 9999999999999999986 467999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
+..... .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||...+..+....
T Consensus 166 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~ 229 (345)
T 1xjd_A 166 KENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS 229 (345)
T ss_dssp BCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred hhcccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 753222 2234567899999999999999999999999999999999999999998776554433
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=320.86 Aligned_cols=209 Identities=27% Similarity=0.414 Sum_probs=185.9
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
...+|++.+.||+|+||.||+|.+..+|+.||||++..... ....++.+|+.+++.++||||+++++++...+..|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 45689999999999999999999999999999999976432 2345688999999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||++|++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999999987 567999999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCCcceeecccccccccCccccccCCCC-cccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
.. ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+......
T Consensus 166 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 224 (328)
T 3fe3_A 166 VG---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE 224 (328)
T ss_dssp SS---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CC---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 22 233456799999999999887765 79999999999999999999999887665444
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=320.56 Aligned_cols=207 Identities=28% Similarity=0.355 Sum_probs=184.9
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhccCCCCccceeeEeecCCe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 143 (297)
..++|++.+.||+|+||.||+|.++.+|..||+|++...... ....+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 446899999999999999999999999999999999765332 24678899999999999999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC----ceEEec
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSD 219 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~----~~kl~D 219 (297)
.++||||++|++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .++|+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999976 567999999999999999999999999 99999999999998776 799999
Q ss_pred ccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 220 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
||++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 163 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~ 226 (361)
T 2yab_A 163 FGLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 226 (361)
T ss_dssp CSSCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred cCCceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999764332 223456799999999999999999999999999999999999999988766544
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=326.04 Aligned_cols=203 Identities=27% Similarity=0.436 Sum_probs=180.7
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcc-CCCCccceeeEeecCCeeE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 145 (297)
..++|++.+.||+|+||.||+|.++.+++.||+|++.+.... ....+..|..++..+ +||||+++++++.+.+..|
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 346899999999999999999999999999999999765322 234577899998876 8999999999999999999
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+||||++|++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 130 lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999999987 567999999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
... ........+||+.|+|||++.+..++.++|+|||||++|||++|+.||...
T Consensus 203 ~~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 203 GLR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CCC--TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred ccc--CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 221 223345678999999999999999999999999999999999999999643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=316.06 Aligned_cols=204 Identities=33% Similarity=0.466 Sum_probs=183.5
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
.++|++.+.||+|+||.||+|.++.+|+.||+|++.+.. ......+.+|..+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999999999999999997542 22345678899999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||++|++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++....
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999987 567999999999999999999999999 9999999999999999999999999997632
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
. .....+||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+....
T Consensus 158 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 211 (318)
T 1fot_A 158 D-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211 (318)
T ss_dssp S-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred C-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 2 23356799999999999999999999999999999999999999987765443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=320.42 Aligned_cols=208 Identities=28% Similarity=0.389 Sum_probs=184.3
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 145 (297)
..++|++.+.||+|+||.||+|.++.+++.||+|++.+.. ......+..|..++..+ +||+|+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4578999999999999999999999999999999997542 22345678899999887 7999999999999999999
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+||||++|++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 98 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999986 467999999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
... ........+||+.|+|||++.+..++.++|+|||||++|||++|+.||...+..+.
T Consensus 171 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~ 229 (353)
T 2i0e_A 171 NIW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229 (353)
T ss_dssp CCC--TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ccc--CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH
Confidence 222 12234457899999999999999999999999999999999999999998766544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=328.72 Aligned_cols=212 Identities=25% Similarity=0.328 Sum_probs=184.6
Q ss_pred HHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCC
Q 022447 66 ELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD 142 (297)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 142 (297)
++....++|++.+.||+|+||.||+|.++.+++.||+|++.+... .....+.+|+.+++.++||||+++++++.+..
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 334456789999999999999999999999999999999865321 22245778999999999999999999999999
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
..|+||||++||+|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999975 46899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccCccccccCC----CCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ----LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 223 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
+....... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+....
T Consensus 215 a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 281 (410)
T 3v8s_A 215 CMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 281 (410)
T ss_dssp CEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred eEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH
Confidence 97643221 22334678999999999997765 78999999999999999999999998776544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=330.28 Aligned_cols=216 Identities=23% Similarity=0.281 Sum_probs=186.1
Q ss_pred HHHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecC
Q 022447 65 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADG 141 (297)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 141 (297)
.++....++|++.+.||+|+||.||+|.++.+++.||+|++.+... .....+..|..++..++||||+++++++.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 3344456789999999999999999999999999999999975321 1223478899999999999999999999999
Q ss_pred CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg 221 (297)
+..|+||||++||+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999752 367999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceeecccccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
+++..... ........+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+..
T Consensus 221 la~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~ 290 (437)
T 4aw2_A 221 SCLKLMED-GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 290 (437)
T ss_dssp TCEECCTT-SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred hhhhcccC-CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH
Confidence 99754322 222334468999999999986 467899999999999999999999999987765443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=319.68 Aligned_cols=215 Identities=22% Similarity=0.274 Sum_probs=184.8
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC-----ccchHHHHHHHHHHhccCCCCccceeeEeecCCee
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-----VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 144 (297)
..++|++.+.||+|+||.||+|.++.+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3457999999999999999999999999999999986421 12356788999999999999999999999999999
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCc---eEEeccc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLSDFG 221 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~---~kl~Dfg 221 (297)
|+||||++|++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.++. ++|+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999999888754333456899999999999999999999999 999999999999986554 9999999
Q ss_pred CccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
++...... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..........+
T Consensus 179 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i 244 (351)
T 3c0i_A 179 VAIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGI 244 (351)
T ss_dssp TCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHH
T ss_pred ceeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHH
Confidence 99764322 2223456799999999999999999999999999999999999999998765444333
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=317.54 Aligned_cols=201 Identities=27% Similarity=0.442 Sum_probs=179.7
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 146 (297)
.++|++.+.||+|+||.||+|.++.+++.||+|++.+..... ...+.+|..++..+ +||||+++++++.+....|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 367899999999999999999999999999999997653322 34577899999887 89999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||||++|++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++|+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999999986 467999999999999999999999999 999999999999999999999999999752
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDT 280 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 280 (297)
.. ........+||+.|+|||++.+..++.++|+|||||++|||++|+.||..
T Consensus 161 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 161 LR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CC--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cC--CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 21 12234456899999999999999999999999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=309.46 Aligned_cols=207 Identities=30% Similarity=0.422 Sum_probs=178.8
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
.++|++.+.||+|+||.||+|.+..++..||+|++....... .+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999999999999999986543322 35688999999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||++|++|.+++.. ..++++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999987 567999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
... ........||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+...
T Consensus 163 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~ 219 (294)
T 4eqm_A 163 ETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS 219 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH
T ss_pred ccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 221 122334569999999999999999999999999999999999999998876544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=321.04 Aligned_cols=203 Identities=27% Similarity=0.405 Sum_probs=181.1
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999999999999999986532 22346788999999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||+.|++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999986 567999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCcceeecccccccccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus 167 ~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~ 222 (384)
T 4fr4_A 167 RE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222 (384)
T ss_dssp TT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT
T ss_pred CC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC
Confidence 22 23445679999999999864 4589999999999999999999999986544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=316.94 Aligned_cols=205 Identities=27% Similarity=0.320 Sum_probs=184.1
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
.++|++.+.||+|+||.||+|.++.+|+.||+|++.+.. ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367999999999999999999999999999999986542 23346788899999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||++|++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++....
T Consensus 120 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999987 467999999999999999999999999 9999999999999999999999999997632
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
. .....+||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+.....
T Consensus 193 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 247 (350)
T 1rdq_E 193 G-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247 (350)
T ss_dssp S-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred C-----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH
Confidence 2 223467999999999999999999999999999999999999999987665443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=315.55 Aligned_cols=220 Identities=46% Similarity=0.771 Sum_probs=191.1
Q ss_pred HHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 66 ELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
++....++|++.+.||+|+||.||+|.+. ++..||||++..........+.+|+.+++.++||||+++++++.+.+..+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 34456789999999999999999999965 58999999987766566678899999999999999999999999999999
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 999999999999999765444457999999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
..............||+.|+|||++.+..++.++||||||+++|+|++|+.||......+...+
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~ 252 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHH
Confidence 4333333333445689999999999989999999999999999999999999987665444333
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=317.61 Aligned_cols=208 Identities=22% Similarity=0.312 Sum_probs=183.9
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
...++|++.+.||+|+||.||+|.++.++..||+|++...... ....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3456899999999999999999999999999999999765432 33568899999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC---CceEEecccCc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG---YHPKLSDFGLA 223 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~---~~~kl~Dfg~~ 223 (297)
||||++|++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++
T Consensus 106 v~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 9999999999999976 567999999999999999999999999 9999999999999865 45999999999
Q ss_pred cccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+....
T Consensus 179 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~ 238 (362)
T 2bdw_A 179 IEVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 238 (362)
T ss_dssp BCCTTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred eEecCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 754322 223346799999999999998999999999999999999999999988765444
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=308.81 Aligned_cols=203 Identities=24% Similarity=0.361 Sum_probs=182.7
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCC
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
|+..+.||+|+||.||+|.+..+|+.||||++........+.+.+|+.+++.++||||+++++++...+..++||||++|
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 66778999999999999999999999999999876666667889999999999999999999999999999999999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
++|.+++.. ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...... ..
T Consensus 127 ~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 196 (321)
T 2c30_A 127 GALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VP 196 (321)
T ss_dssp CBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SC
T ss_pred CCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccC--cc
Confidence 999999874 56999999999999999999999999 999999999999999999999999998764322 22
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+....
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~ 249 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 23456799999999999999999999999999999999999999987765443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=323.92 Aligned_cols=211 Identities=22% Similarity=0.288 Sum_probs=184.7
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
...++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3457899999999999999999999999999999999765433 33568899999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEc---CCCceEEecccCc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD---RGYHPKLSDFGLA 223 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~---~~~~~kl~Dfg~~ 223 (297)
||||+.|++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 88 v~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 9999999999999987 567999999999999999999999999 99999999999998 4678999999999
Q ss_pred cccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+......
T Consensus 161 ~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~ 223 (444)
T 3soa_A 161 IEVEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQ 223 (444)
T ss_dssp BCCCTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EEecCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 753322 223345679999999999999999999999999999999999999998877655433
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=325.38 Aligned_cols=216 Identities=24% Similarity=0.268 Sum_probs=186.1
Q ss_pred HHHHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeec
Q 022447 64 FRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCAD 140 (297)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 140 (297)
+.+.....++|++.+.||+|+||.||+|.++.+++.||+|++.+... .....+..|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 34444556889999999999999999999999999999999975321 122347789999999999999999999999
Q ss_pred CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecc
Q 022447 141 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (297)
Q Consensus 141 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Df 220 (297)
.+..|+||||++|++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999762 247999999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCCcceeecccccccccCccccc-------cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-------TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
|++....... .......+||+.|+|||++. +..++.++|+|||||++|||++|+.||...+..+.
T Consensus 207 Gla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 278 (412)
T 2vd5_A 207 GSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET 278 (412)
T ss_dssp TTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred hhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH
Confidence 9997643221 22233468999999999987 35689999999999999999999999988776554
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=314.77 Aligned_cols=207 Identities=27% Similarity=0.407 Sum_probs=180.9
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
..++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 457899999999999999999999999999999998754332 2356788999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||++|++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 85 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 99999999999986 567999999999999999999999999 99999999999999999999999999975433
Q ss_pred CCCcceeecccccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
...........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 333333345679999999999987765 7789999999999999999999987654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=320.74 Aligned_cols=208 Identities=29% Similarity=0.380 Sum_probs=176.8
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHH-HhccCCCCccceeeEeecCCeeEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLM-LSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
.++|++.+.||+|+||.||+|.++.++..||+|++.+.... ....+..|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 46899999999999999999999999999999999765432 22345667666 567899999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||||++|++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.++|+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999986 567899999999999999999999999 999999999999999999999999999752
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
... .......+||+.|+|||++.+..++.++|+|||||++|||++|..||...+..+..
T Consensus 190 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~ 248 (373)
T 2r5t_A 190 IEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248 (373)
T ss_dssp BCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH
T ss_pred ccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 221 22344578999999999999999999999999999999999999999887765543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=310.09 Aligned_cols=206 Identities=26% Similarity=0.363 Sum_probs=183.6
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhccCCCCccceeeEeecCCee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 144 (297)
.++|++.+.||+|+||.||+|.+..++..||+|++...... ....+.+|+.+++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 35799999999999999999999999999999998764322 346788999999999999999999999999999
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC----ceEEecc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSDF 220 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~----~~kl~Df 220 (297)
++||||++|++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .++|+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999976 567999999999999999999999999 99999999999999877 7999999
Q ss_pred cCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.
T Consensus 163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 225 (326)
T 2y0a_A 163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225 (326)
T ss_dssp TTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred CCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence 9997643222 23345799999999999989999999999999999999999999987765444
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=309.50 Aligned_cols=206 Identities=18% Similarity=0.270 Sum_probs=183.5
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|++.+.||+|+||.||+|.+..++..||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 478999999999999999999999999999999987543 3345678999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC--CCceEEecccCccccCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR--GYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~--~~~~kl~Dfg~~~~~~~ 228 (297)
++|++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.++|+|||++.....
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999975 2357999999999999999999999999 999999999999987 78999999999986433
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
. .......||+.|+|||++.+..++.++||||||+++|+|++|..||...+....
T Consensus 157 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 211 (321)
T 1tki_A 157 G---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI 211 (321)
T ss_dssp T---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred C---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH
Confidence 2 233456799999999999988899999999999999999999999988766543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=311.07 Aligned_cols=207 Identities=28% Similarity=0.400 Sum_probs=174.2
Q ss_pred hcCCCCcceecccCcEEEEEEEEC---CCCeEEEEEEeccCCc----cchHHHHHHHHHHhccCCCCccceeeEeecCCe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV----QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 143 (297)
.++|++.+.||+|+||.||+|.+. .+++.||+|++..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 468999999999999999999985 6799999999976532 233457789999999999999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
.|+||||++|++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999986 467899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
..... ........+||+.|+|||++.+..++.++||||||+++|+|++|+.||...+....
T Consensus 169 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 229 (327)
T 3a62_A 169 KESIH--DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT 229 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccc--CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 74221 12223456799999999999999999999999999999999999999988765443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=314.71 Aligned_cols=207 Identities=21% Similarity=0.317 Sum_probs=184.3
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46899999999999999999999999999999999876555556788999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC--CCceEEecccCccccCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR--GYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~--~~~~kl~Dfg~~~~~~~ 228 (297)
++|++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.++|+|||++.....
T Consensus 130 ~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999975 2357999999999999999999999999 999999999999974 47799999999986432
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~ 258 (387)
T 1kob_A 204 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET 258 (387)
T ss_dssp TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred Cc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH
Confidence 22 23345799999999999999999999999999999999999999998765443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=325.86 Aligned_cols=211 Identities=29% Similarity=0.391 Sum_probs=177.0
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
.++|++.+.||+|+||.||+|.+..++..||||++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999999999999999999753 222335677899999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
|||++|++|.+++.. ...+++..++.++.||+.||+|||+ .+ |+||||||+|||++.++.++|+|||++...
T Consensus 227 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999986 5679999999999999999999998 88 999999999999999999999999999752
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHH
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~ 290 (297)
.. ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+
T Consensus 300 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 361 (446)
T 4ejn_A 300 IK--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cC--CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 22 222344578999999999999999999999999999999999999999888766554443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=306.12 Aligned_cols=207 Identities=29% Similarity=0.447 Sum_probs=182.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|.+.+.||+|+||.||+|.+..++..||+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 46788999999999999999999999999999998766555667889999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999999863 466999999999999999999999999 9999999999999999999999999997643222
Q ss_pred Ccc------------eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 231 NTH------------VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 231 ~~~------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~ 227 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP 227 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSC
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhh
Confidence 111 11145799999999999999999999999999999999999999876433
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=311.59 Aligned_cols=203 Identities=29% Similarity=0.411 Sum_probs=179.4
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
..+|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++......++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999986532 12235788999999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||+ +|+|.+++.. ...+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 5899999876 567999999999999999999999999 9999999999999999999999999997533
Q ss_pred CCCCcceeecccccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
.. ......+||+.|+|||++.+..+ ++++||||||+++|+|++|+.||......
T Consensus 160 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~ 214 (336)
T 3h4j_B 160 DG---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP 214 (336)
T ss_dssp TS---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST
T ss_pred CC---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH
Confidence 22 22345679999999999988776 68999999999999999999999876443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=326.56 Aligned_cols=207 Identities=28% Similarity=0.415 Sum_probs=183.9
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
.++|.+.+.||+|+||.||+|.++.+|+.||+|++.+... .....+..|+.+++.++||||+++++++.+....|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 3678999999999999999999999999999999975422 2335688899999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||++|++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999865444567999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
... ......+||+.|+|||++.+..++.++|+|||||++|||++|+.||...+
T Consensus 341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 222 22344689999999999999999999999999999999999999998763
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=302.17 Aligned_cols=207 Identities=27% Similarity=0.385 Sum_probs=175.3
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--------------------------chHHHHHHHHHH
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--------------------------GNREFLVEVLML 123 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l 123 (297)
..++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 347899999999999999999999999999999998654321 124578999999
Q ss_pred hccCCCCccceeeEeec--CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecC
Q 022447 124 SLLHHPNLVNLIGYCAD--GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRD 201 (297)
Q Consensus 124 ~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~d 201 (297)
+.++||||+++++++.+ ....++||||+++++|.+++. ..++++..++.++.||+.||.|||+.+ |+|||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D 162 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRD 162 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 99999999999999986 568899999999999988654 357999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCC---CCcccchhhHHHHHHHHHhCCCCC
Q 022447 202 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ---LTLKSDVYSFGVVLLEILSGRKAV 278 (297)
Q Consensus 202 ikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~Pf 278 (297)
|||+|||++.++.++|+|||++...... ........||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCHHHEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 9999999999999999999999764322 22334567999999999987655 377899999999999999999999
Q ss_pred CcchhHhh
Q 022447 279 DTSKAAAE 286 (297)
Q Consensus 279 ~~~~~~~~ 286 (297)
...+....
T Consensus 241 ~~~~~~~~ 248 (298)
T 2zv2_A 241 MDERIMCL 248 (298)
T ss_dssp CCSSHHHH
T ss_pred CCccHHHH
Confidence 88765443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=305.29 Aligned_cols=212 Identities=23% Similarity=0.381 Sum_probs=169.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.++|++.+.||+|+||.||+|.++.+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4689999999999999999999999999999999975533 234678899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 150 YMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|++ ++|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69999887532 12246899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+...
T Consensus 160 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 219 (317)
T 2pmi_A 160 IP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLK 219 (317)
T ss_dssp SC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 22 122334578999999999876 468999999999999999999999999887765543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=308.82 Aligned_cols=210 Identities=27% Similarity=0.407 Sum_probs=175.6
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhccCCCCccceeeEeecCCe---
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQ--- 143 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 143 (297)
..++|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 3478999999999999999999999999999999997654333 2467889999999999999999999876543
Q ss_pred -eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 144 -RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 144 -~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
.|+||||++|++|.+++.. ..++++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||+
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 4999999999999999986 567999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCC-cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 223 AKLGPVGDN-THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 223 ~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
+........ ........||+.|+|||++.+..++.++||||||+++|+|++|+.||...+....
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~ 227 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 975332211 1223345699999999999999999999999999999999999999988776543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=314.99 Aligned_cols=208 Identities=18% Similarity=0.200 Sum_probs=177.7
Q ss_pred HhcCCCCcceecccCcEEEEEE-----EECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC---CCCccceeeEeecC
Q 022447 70 ATKNFRSESLLGEGGFGRVYKG-----YLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---HPNLVNLIGYCADG 141 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~ 141 (297)
..++|.+.+.||+|+||.||+| .+..+++.||||++... ....+..|+.+++.++ |+||+.+++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 4577999999999999999999 46778999999999754 3345667777777776 89999999999999
Q ss_pred CeeEEEEecCCCCChHhhhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC---------
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSP-GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR--------- 211 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~--------- 211 (297)
+..++||||++|++|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 999999999999999999975322 2467999999999999999999999999 999999999999988
Q ss_pred --CCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 212 --GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 212 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 899999999999754333334455667899999999999999999999999999999999999999976544
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=301.64 Aligned_cols=201 Identities=23% Similarity=0.348 Sum_probs=173.9
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999999999999999997654332 3668899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+++ +|.+.+... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~- 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI- 153 (292)
T ss_dssp CCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS-
T ss_pred cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC-
Confidence 9985 666665542 467999999999999999999999999 99999999999999999999999999976422
Q ss_pred CCcceeecccccccccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQ-LTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...
T Consensus 154 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~ 205 (292)
T 3o0g_A 154 -PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_dssp -CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred -ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC
Confidence 222334557899999999987765 899999999999999999988775433
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=304.89 Aligned_cols=216 Identities=33% Similarity=0.524 Sum_probs=176.0
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
....+|++.+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+++.++||||+++++++.+....++
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 34568999999999999999999874 889999998765433 23568899999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ .+|+||||||+||+++.++.++|+|||++...
T Consensus 112 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999998621 0123899999999999999999999875 35999999999999999999999999998752
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHH
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~ 290 (297)
.. .........||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+
T Consensus 190 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~ 251 (309)
T 3p86_A 190 AS--TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH
T ss_pred cc--cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 22 122234567999999999999999999999999999999999999999988776655444
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=310.25 Aligned_cols=216 Identities=27% Similarity=0.405 Sum_probs=183.8
Q ss_pred hcCCCCcceecccCcEEEEEEEEC-------CCCeEEEEEEeccCCcc-chHHHHHHHHHHhcc-CCCCccceeeEeecC
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLE-------SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADG 141 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~-------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 141 (297)
.++|++.+.||+|+||.||+|.+. .++..||||++...... ....+.+|+.+++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467899999999999999999974 34678999999765332 335688999999999 899999999999999
Q ss_pred CeeEEEEecCCCCChHhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili 209 (297)
+..|+||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999986431 1245899999999999999999999999 9999999999999
Q ss_pred cCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 210 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 210 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
+.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |+.||...+..+...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999986443332233334557889999999999999999999999999999999 999999876655443
Q ss_pred H
Q 022447 289 L 289 (297)
Q Consensus 289 l 289 (297)
.
T Consensus 317 ~ 317 (370)
T 2psq_A 317 L 317 (370)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=305.74 Aligned_cols=217 Identities=47% Similarity=0.806 Sum_probs=190.2
Q ss_pred ccccCHHHHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeE
Q 022447 59 AQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGY 137 (297)
Q Consensus 59 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~ 137 (297)
...++..++....++|++.+.||+|+||.||+|.+. ++..||||++...... ....+.+|+.+++.++||||++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 456788899999999999999999999999999854 5899999998765332 23468899999999999999999999
Q ss_pred eecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCeeecCCCCCcEEEcCCCc
Q 022447 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK---AKPPVIYRDLKCSNILLDRGYH 214 (297)
Q Consensus 138 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~~~~ivH~dikp~Nili~~~~~ 214 (297)
+...+..++||||+++++|.+++........++++..++.++.|++.||.|||+. + ++||||||+|||++.++.
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFE 172 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCC
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCC
Confidence 9999999999999999999999987655566799999999999999999999999 8 999999999999999999
Q ss_pred eEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 022447 215 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDT 280 (297)
Q Consensus 215 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 280 (297)
++|+|||++....... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||+.
T Consensus 173 ~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 237 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 237 (326)
T ss_dssp EEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCH
T ss_pred EEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccc
Confidence 9999999998643322 2234455699999999999988999999999999999999999999964
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=296.46 Aligned_cols=207 Identities=24% Similarity=0.318 Sum_probs=184.9
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..++|++.+.||+|+||.||+|.+..++..||+|++........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 45679999999999999999999999999999999987666667789999999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE---cCCCceEEecccCcccc
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili---~~~~~~kl~Dfg~~~~~ 226 (297)
|+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++...
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999999987 567999999999999999999999999 9999999999999 78899999999999754
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
.... ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||...+..+..
T Consensus 160 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 216 (277)
T 3f3z_A 160 KPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM 216 (277)
T ss_dssp CTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 3222 23445699999999988654 899999999999999999999999987665443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=305.56 Aligned_cols=194 Identities=28% Similarity=0.387 Sum_probs=154.2
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC-CCCccceeeEeecCCeeEEEEecCCCCCh
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~g~~L 156 (297)
+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+. ||||+++++++.+....|+||||++|++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 7899999999999999999999999999653 3456778999999997 99999999999999999999999999999
Q ss_pred HhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC---ceEEecccCccccCCCCCcc
Q 022447 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~---~~kl~Dfg~~~~~~~~~~~~ 233 (297)
.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .++|+|||++...... ..
T Consensus 94 ~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~ 164 (325)
T 3kn6_A 94 FERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQ 164 (325)
T ss_dssp HHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC--CC
Confidence 999987 577999999999999999999999999 99999999999998765 8999999999763322 22
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
.....+||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 214 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 33456789999999999999999999999999999999999999987543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=331.97 Aligned_cols=210 Identities=28% Similarity=0.379 Sum_probs=185.4
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 145 (297)
..++|++++.||+|+||.||+|.++.+++.||||++.+.. ......+..|..++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999999999999999997532 22345677899999887 6999999999999999999
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+||||++|++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999987 467999999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+...
T Consensus 492 ~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~ 552 (674)
T 3pfq_A 492 NIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552 (674)
T ss_dssp CCCT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred cccC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 3222 223456789999999999999999999999999999999999999999877655433
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=311.82 Aligned_cols=211 Identities=27% Similarity=0.386 Sum_probs=171.1
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhccC-CCCccceeeEeecCC--e
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGD--Q 143 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~ 143 (297)
...++|++.+.||+|+||.||+|.+..+++.||||++.... .....++.+|+.+++.+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 35679999999999999999999999999999999986542 233456788999999997 999999999997544 6
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
.|+||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999998 689999875 46899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCC-------------------CCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 224 KLGPVG-------------------DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 224 ~~~~~~-------------------~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
+..... .........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 753221 11122344679999999999876 6789999999999999999999999998876
Q ss_pred Hhhhh
Q 022447 284 AAEQS 288 (297)
Q Consensus 284 ~~~~~ 288 (297)
.....
T Consensus 237 ~~~~~ 241 (388)
T 3oz6_A 237 MNQLE 241 (388)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 55543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=302.02 Aligned_cols=207 Identities=26% Similarity=0.367 Sum_probs=175.8
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
..++|++.+.||+|+||.||+|.+.. ++.||+|++...... ....+.+|+.+++.++||||+++++++.+....++|
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 45789999999999999999999964 899999998754332 235688999999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||++ ++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 98 ~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 98 FEFME-KDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EECCS-EEHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EcCCC-CCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 99998 5888887652 456999999999999999999999999 9999999999999999999999999997632
Q ss_pred CCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.
T Consensus 171 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 228 (311)
T 3niz_A 171 IP--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ 228 (311)
T ss_dssp SC--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH
T ss_pred CC--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 22 222344578999999999876 5689999999999999999999999987765544
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=308.63 Aligned_cols=220 Identities=23% Similarity=0.273 Sum_probs=188.5
Q ss_pred cccccCHHHHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC-----CCCcc
Q 022447 58 TAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-----HPNLV 132 (297)
Q Consensus 58 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~ 132 (297)
....+++.+.....++|++.+.||+|+||.||+|.+..+++.||||++... ......+..|+.+++.+. ||||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 344455555556678999999999999999999999999999999999643 223355677999998886 99999
Q ss_pred ceeeEeecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC-
Q 022447 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR- 211 (297)
Q Consensus 133 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~- 211 (297)
++++++...+..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDP 173 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCT
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccc
Confidence 9999999999999999999 899999998632 346999999999999999999999999 999999999999975
Q ss_pred ------------------------CCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHH
Q 022447 212 ------------------------GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVV 267 (297)
Q Consensus 212 ------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~i 267 (297)
++.++|+|||++..... ......||+.|+|||++.+..++.++|||||||+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 248 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence 78899999999975322 2234579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCcchhHhhhhH
Q 022447 268 LLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 268 l~ell~g~~Pf~~~~~~~~~~l 289 (297)
+|+|++|+.||...+..+....
T Consensus 249 l~ell~g~~pf~~~~~~~~~~~ 270 (360)
T 3llt_A 249 LAELYTGSLLFRTHEHMEHLAM 270 (360)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHH
T ss_pred HHHHHHCCCCCCCCcHHHHHHH
Confidence 9999999999998776655443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=302.48 Aligned_cols=206 Identities=28% Similarity=0.344 Sum_probs=183.4
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhccCCCCccceeeEeecCCee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 144 (297)
.++|++.+.||+|+||.||+|.+..++..||+|++...... ....+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 45799999999999999999999999999999998764332 246788999999999999999999999999999
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC----ceEEecc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSDF 220 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~----~~kl~Df 220 (297)
++||||++|++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++ .++|+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999986 567999999999999999999999999 99999999999999887 7999999
Q ss_pred cCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
|++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+.
T Consensus 164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 226 (321)
T 2a2a_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 226 (321)
T ss_dssp TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 9997643321 22345699999999999999999999999999999999999999988765544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=308.31 Aligned_cols=199 Identities=25% Similarity=0.353 Sum_probs=174.5
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
..++|++.+.||+|+||.||+|.++.+++.||+|++...... ..+|+.++..+ +||||+++++++.+....|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 456899999999999999999999999999999999765432 23577788777 7999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC----CceEEecccCcc
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG----YHPKLSDFGLAK 224 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~----~~~kl~Dfg~~~ 224 (297)
||++|++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||+.+. +.++|+|||++.
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999999986 567999999999999999999999999 9999999999998543 359999999997
Q ss_pred ccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 169 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 169 QLRAE--NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp ECBCT--TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cCcCC--CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 63322 22334567999999999998888999999999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=323.40 Aligned_cols=204 Identities=31% Similarity=0.455 Sum_probs=181.8
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
.++|++.+.||+|+||.||+|.++.+|+.||+|++.+.. ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999999999999999996532 22335678899999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||++|++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 263 mEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999997632 345999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
... .....+||+.|+|||++.+..++.++|+|||||++|||++|+.||...+
T Consensus 338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 322 2344589999999999999899999999999999999999999998864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=307.73 Aligned_cols=203 Identities=26% Similarity=0.382 Sum_probs=167.1
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567999999999999999999999999999999997543 33567789999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC---CCceEEecccCcccc
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLG 226 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~---~~~~kl~Dfg~~~~~ 226 (297)
|++|++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.++|+|||++...
T Consensus 129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999986 567999999999999999999999999 999999999999975 889999999998753
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 202 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 256 (349)
T 2w4o_A 202 EH---QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH
T ss_pred Cc---ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc
Confidence 22 12233467999999999999999999999999999999999999999876544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=318.46 Aligned_cols=206 Identities=28% Similarity=0.431 Sum_probs=183.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
..+|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3679999999999999999999999999999999975422 2345788999999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||++|++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999976 567999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCcceeecccccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
.. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+....
T Consensus 168 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~ 224 (476)
T 2y94_A 168 DG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL 224 (476)
T ss_dssp TT---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH
T ss_pred cc---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH
Confidence 32 22345679999999999988765 6899999999999999999999998765544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=309.91 Aligned_cols=203 Identities=24% Similarity=0.325 Sum_probs=169.5
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 34689999999999999999999999999999999976433 33567899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCc--eEEecccCccccC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH--PKLSDFGLAKLGP 227 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~--~kl~Dfg~~~~~~ 227 (297)
|++|++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++...
T Consensus 97 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999999999976 467999999999999999999999999 999999999999987665 9999999987422
Q ss_pred CCCCcceeecccccccccCccccccCCCCcc-cchhhHHHHHHHHHhCCCCCCcchh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK-SDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
. ........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.
T Consensus 170 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 170 L---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred c---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 1 222344579999999999988877655 9999999999999999999987554
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=305.57 Aligned_cols=204 Identities=25% Similarity=0.290 Sum_probs=179.0
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 4689999999999999999999999999999999875432 24577899999999 89999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCc-----eEEecccCcc
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH-----PKLSDFGLAK 224 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~-----~kl~Dfg~~~ 224 (297)
|+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. ++|+|||++.
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 89999999863 367999999999999999999999999 999999999999998887 9999999997
Q ss_pred ccCCCCCcc-----eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 225 LGPVGDNTH-----VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 225 ~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~ 222 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence 643222111 12456799999999999999999999999999999999999999987543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=300.13 Aligned_cols=210 Identities=27% Similarity=0.335 Sum_probs=178.0
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 368999999999999999999999999999999986653332 355788999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 82 EYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp ECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999999998876 567999999999999999999999999 99999999999999999999999999976332
Q ss_pred CCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
. ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....
T Consensus 155 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 214 (311)
T 4agu_A 155 P--SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL 214 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred c--ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 2 222344578999999999876 6789999999999999999999999998877665443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=298.48 Aligned_cols=205 Identities=25% Similarity=0.368 Sum_probs=174.3
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
++|++.+.||+|+||.||+|.+ .+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 5789999999999999999999 56899999998754332 23678899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|++ ++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 81 HLD-QDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CCS-EEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ecC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 998 4899888752 367899999999999999999999999 999999999999999999999999998753221
Q ss_pred CCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.
T Consensus 154 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 209 (288)
T 1ob3_A 154 --VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ 209 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred --ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 122334568999999999875 4589999999999999999999999988765543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=302.80 Aligned_cols=213 Identities=30% Similarity=0.438 Sum_probs=180.5
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCe---EEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
.++|++.+.||+|+||.||+|.+..++. .||||++..... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 4678999999999999999999986554 599999976533 234568899999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||||++|++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 128 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999752 357999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCC-cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhH
Q 022447 227 PVGDN-THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (297)
Q Consensus 227 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l 289 (297)
..... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.......
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~ 266 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS 266 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 33221 112223446788999999999999999999999999999999 9999988776655443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=302.40 Aligned_cols=205 Identities=22% Similarity=0.323 Sum_probs=177.3
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCC--eeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 147 (297)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4679999999999999999999999999999999975432 33466789999999999999999999988655 78999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE----cCCCceEEecccCc
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL----DRGYHPKLSDFGLA 223 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili----~~~~~~kl~Dfg~~ 223 (297)
|||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.++|+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999986322 234999999999999999999999999 9999999999999 77788999999999
Q ss_pred cccCCCCCcceeecccccccccCccccc--------cCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAK--------TGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
....... ......||+.|+|||++. +..++.++|||||||++|+|++|+.||...+
T Consensus 164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp EECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred eecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 7643322 233456999999999886 5778999999999999999999999997543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=297.75 Aligned_cols=217 Identities=27% Similarity=0.348 Sum_probs=182.9
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.++|.+.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 3579999999999999999999999999999999876533 345678899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE---cCCCceEEecccCcccc
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili---~~~~~~kl~Dfg~~~~~ 226 (297)
|+++++|.+++.........+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999999653323477999999999999999999999999 9999999999999 45678999999999753
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHHhhcC
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSE 294 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~~~~~ 294 (297)
... .......||+.|+|||++. ..++.++||||||+++|+|++|+.||...+..+......+..
T Consensus 178 ~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 241 (285)
T 3is5_A 178 KSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE 241 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred CCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC
Confidence 222 2234567999999999885 568899999999999999999999999887766655544433
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=317.17 Aligned_cols=205 Identities=24% Similarity=0.333 Sum_probs=173.2
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhccCCCCccceeeEeecC------
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------ 141 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 141 (297)
..++|++.+.||+|+||.||+|.+..+++.||||++... ......++.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999999999999999999754 223346788999999999999999999999654
Q ss_pred CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg 221 (297)
...|+||||+++ +|.+.+.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEE
Confidence 357999999985 56666643 4889999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
+++.... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+..
T Consensus 210 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~ 272 (464)
T 3ttj_A 210 LARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 272 (464)
T ss_dssp CC--------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred eeeecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9975322 22334567999999999999999999999999999999999999999987765443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=294.22 Aligned_cols=209 Identities=22% Similarity=0.312 Sum_probs=183.9
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
..++|++.+.||+|+||.||+|.+..++..||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 457899999999999999999999999999999998754332 335678899999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCc---eEEecccCcc
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLSDFGLAK 224 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~---~kl~Dfg~~~ 224 (297)
|||+++++|.+.+.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++. ++|+|||.+.
T Consensus 84 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 999999999999887 567999999999999999999999999 999999999999986655 9999999997
Q ss_pred ccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
..... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+......
T Consensus 157 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 217 (284)
T 3kk8_A 157 EVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA 217 (284)
T ss_dssp ECCSS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EcccC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHH
Confidence 53322 22334679999999999999999999999999999999999999998876655443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=308.54 Aligned_cols=201 Identities=26% Similarity=0.350 Sum_probs=174.2
Q ss_pred cceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCCh
Q 022447 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 156 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L 156 (297)
.+.||+|+||.||+|.+..+|..||+|++..........+.+|+.+++.++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56899999999999999999999999999876655667889999999999999999999999999999999999999999
Q ss_pred HhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE--cCCCceEEecccCccccCCCCCcce
Q 022447 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL--DRGYHPKLSDFGLAKLGPVGDNTHV 234 (297)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili--~~~~~~kl~Dfg~~~~~~~~~~~~~ 234 (297)
.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.++|+|||++....... .
T Consensus 174 ~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~ 244 (373)
T 2x4f_A 174 FDRIIDE---SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K 244 (373)
T ss_dssp HHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence 9988752 356899999999999999999999999 9999999999999 567899999999998643222 2
Q ss_pred eecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 235 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 235 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 296 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET 296 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 3345699999999999988999999999999999999999999988766543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=308.87 Aligned_cols=211 Identities=18% Similarity=0.240 Sum_probs=181.3
Q ss_pred HhcCCCCcceeccc--CcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 70 ATKNFRSESLLGEG--GFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 70 ~~~~y~~~~~lg~G--~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
..++|++.+.||+| +||.||+|.+..+++.||||++...... ....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 44689999999999 9999999999999999999999765332 2356788999999999999999999999999999
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||.+..
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999998632 356999999999999999999999999 99999999999999999999999998754
Q ss_pred cCCCC-----CcceeecccccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 226 GPVGD-----NTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 226 ~~~~~-----~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
..... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+...
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 244 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 244 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 21111 0111223468999999999987 678999999999999999999999998765443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=304.59 Aligned_cols=210 Identities=23% Similarity=0.337 Sum_probs=173.1
Q ss_pred HHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
....++|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.+++.++||||+++++++.+....+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 345678999999999999999999999999999999997553332 345778999999999999999999999999999
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEc-----CCCceEEecc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-----RGYHPKLSDF 220 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~-----~~~~~kl~Df 220 (297)
+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ ..+.++|+||
T Consensus 110 lv~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcC
Confidence 9999998 599999987 567999999999999999999999999 99999999999994 4556999999
Q ss_pred cCccccCCCCCcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
|++...... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+..
T Consensus 182 g~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 247 (329)
T 3gbz_A 182 GLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL 247 (329)
T ss_dssp THHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH
Confidence 998753222 2223445689999999998764 5899999999999999999999999887765543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=306.86 Aligned_cols=217 Identities=27% Similarity=0.295 Sum_probs=179.1
Q ss_pred HHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccC-----CccchHHHHHHHHHHhccCCCCccceeeEeecC
Q 022447 67 LAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN-----GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG 141 (297)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 141 (297)
+....++|++.+.||+|+||.||+|.+..++..||+|++... .......+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345668899999999999999999999999999999998653 223446788999999999999999999999999
Q ss_pred CeeEEEEecCCCCChHhhhcccCCC------------------------------------CCCCCHHHHHHHHHHHHHH
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSPG------------------------------------KKPLDWNTRMKIAAGAARG 185 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qi~~a 185 (297)
+..++||||++|++|.+++...... ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999999631110 1224678899999999999
Q ss_pred HHHHHhCCCCCeeecCCCCCcEEEcCCC--ceEEecccCccccCCC--CCcceeecccccccccCcccccc--CCCCccc
Q 022447 186 LEYLHDKAKPPVIYRDLKCSNILLDRGY--HPKLSDFGLAKLGPVG--DNTHVSTRVMGTYGYCAPEYAKT--GQLTLKS 259 (297)
Q Consensus 186 l~~LH~~~~~~ivH~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~ 259 (297)
|.|||+.+ |+||||||+|||++.++ .++|+|||++...... ..........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999999 99999999999998776 8999999999753221 11122345679999999999865 6788999
Q ss_pred chhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 260 DVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 260 DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
||||||+++|+|++|+.||...+..+.
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~ 284 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADT 284 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHH
Confidence 999999999999999999988766544
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=294.28 Aligned_cols=207 Identities=27% Similarity=0.411 Sum_probs=182.1
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 45789999999999999999999999999999999875433 33467889999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 85 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 85 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 99999999999976 567999999999999999999999999 99999999999999999999999999875332
Q ss_pred CCCcceeecccccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
...........|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 222222345679999999999987665 7789999999999999999999987654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=297.70 Aligned_cols=210 Identities=29% Similarity=0.385 Sum_probs=177.0
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-----cchHHHHHHHHHHhccC---CCCccceeeEeecC
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-----QGNREFLVEVLMLSLLH---HPNLVNLIGYCADG 141 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~ 141 (297)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 45799999999999999999999999999999999864321 12245667777777664 99999999999775
Q ss_pred C-----eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceE
Q 022447 142 D-----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (297)
Q Consensus 142 ~-----~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~k 216 (297)
. ..+++||++. ++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.++
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 4 5789999998 69999998632 344999999999999999999999999 99999999999999999999
Q ss_pred EecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 217 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 217 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
|+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+...
T Consensus 161 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 229 (308)
T 3g33_A 161 LADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG 229 (308)
T ss_dssp ECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHH
T ss_pred EeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999753322 22345679999999999999999999999999999999999999998887665543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=310.32 Aligned_cols=217 Identities=30% Similarity=0.414 Sum_probs=181.4
Q ss_pred hcCCCCcceecccCcEEEEEEE-----ECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGY-----LESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~-----~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 144 (297)
.++|++.+.||+|+||.||+|. +..++..||||++..... .....+.+|+.+++.++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4679999999999999999999 455788999999975432 3335688999999999999999999999999999
Q ss_pred EEEEecCCCCChHhhhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC---ceEEe
Q 022447 145 LLVYEYMPLGSVEDHLHDLSP---GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLS 218 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~---~~kl~ 218 (297)
++||||++|++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .++|+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999986432 2246899999999999999999999999 99999999999999554 59999
Q ss_pred cccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHH
Q 022447 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~ 290 (297)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999874322222223334568999999999999999999999999999999998 99999988776555443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=307.88 Aligned_cols=218 Identities=28% Similarity=0.402 Sum_probs=183.3
Q ss_pred CHHHHHHHhcCCCCcceecccCcEEEEEEE-----ECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcc-CCCCcccee
Q 022447 63 TFRELAAATKNFRSESLLGEGGFGRVYKGY-----LESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLI 135 (297)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~-----~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~ 135 (297)
.........++|++.+.||+|+||.||+|. +..+++.||||++...... ....+.+|+.++..+ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 334444566889999999999999999999 5567799999999765333 335688999999999 789999999
Q ss_pred eEeecCCe-eEEEEecCCCCChHhhhcccCCC------------------------------------------------
Q 022447 136 GYCADGDQ-RLLVYEYMPLGSVEDHLHDLSPG------------------------------------------------ 166 (297)
Q Consensus 136 ~~~~~~~~-~~lv~e~~~g~~L~~~l~~~~~~------------------------------------------------ 166 (297)
+++.+.+. .++||||++|++|.+++......
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99887554 89999999999999999864321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCc
Q 022447 167 --------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232 (297)
Q Consensus 167 --------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 232 (297)
...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 122899999999999999999999999 999999999999999999999999999764443333
Q ss_pred ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchh
Q 022447 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKA 283 (297)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~ 283 (297)
.......||+.|+|||++.+..++.++||||||+++|+|++ |+.||.....
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 301 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch
Confidence 34455678999999999999999999999999999999998 9999987654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=300.18 Aligned_cols=208 Identities=25% Similarity=0.366 Sum_probs=184.5
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
..++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34689999999999999999999999999999999875432 234568889999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 119 v~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 119 VLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp EECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 9999999999999886 467999999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
... ........|++.|+|||++.+..++.++||||||+++|+|++|+.||......+.
T Consensus 192 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 249 (335)
T 2owb_A 192 EYD--GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 249 (335)
T ss_dssp CST--TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred ccC--cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence 322 1223446799999999999999999999999999999999999999998765443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=293.89 Aligned_cols=208 Identities=25% Similarity=0.366 Sum_probs=184.1
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
..++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 34679999999999999999999999999999999875432 233568889999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 93 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 93 VLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999999876 467999999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
... ........|++.|+|||.+.+..++.++||||||+++|+|++|+.||......+.
T Consensus 166 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 223 (294)
T 2rku_A 166 EYD--GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223 (294)
T ss_dssp CST--TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred ccC--ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 322 1223345699999999999988999999999999999999999999998765543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=298.72 Aligned_cols=218 Identities=30% Similarity=0.425 Sum_probs=185.2
Q ss_pred HhcCCCCcceecccCcEEEEEEEE-----CCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 143 (297)
..++|.+.+.||+|+||.||+|.+ ..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 346899999999999999999998 34568999999975432 334678899999999999999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSP--------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 203 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dik 203 (297)
.++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ ++|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999986432 1234899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcch
Q 022447 204 CSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSK 282 (297)
Q Consensus 204 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~ 282 (297)
|+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999976443333333334557889999999999999999999999999999999 999999877
Q ss_pred hHhhhhHH
Q 022447 283 AAAEQSLV 290 (297)
Q Consensus 283 ~~~~~~l~ 290 (297)
.......+
T Consensus 258 ~~~~~~~~ 265 (314)
T 2ivs_A 258 PERLFNLL 265 (314)
T ss_dssp GGGHHHHH
T ss_pred HHHHHHHh
Confidence 65544433
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=299.75 Aligned_cols=206 Identities=27% Similarity=0.383 Sum_probs=174.9
Q ss_pred HhcCCCCc-ceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEE
Q 022447 70 ATKNFRSE-SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 70 ~~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 147 (297)
..+.|++. +.||+|+||.||+|.+..+++.||||++..........+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 34678885 7899999999999999999999999999876656667889999999885 799999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCc---eEEecccCcc
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLSDFGLAK 224 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~---~kl~Dfg~~~ 224 (297)
|||++|++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. ++|+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 90 FEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 999999999999987 467999999999999999999999999 999999999999988765 9999999986
Q ss_pred ccCCCCC-----cceeecccccccccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 225 LGPVGDN-----THVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 225 ~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
....... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 5322111 111224569999999999875 568899999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=303.67 Aligned_cols=217 Identities=29% Similarity=0.450 Sum_probs=184.0
Q ss_pred HHhcCCCCcceecccCcEEEEEEEEC-----CCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCC
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGD 142 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 142 (297)
...++|++.+.||+|+||.||+|.+. .++..||+|++...... ....+.+|+.+++.++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578999999999999999999997 35589999999765332 3456889999999999999999999999999
Q ss_pred eeEEEEecCCCCChHhhhcccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPG--------------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDL 202 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~di 202 (297)
..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 999999999999999999864221 267999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcc
Q 022447 203 KCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTS 281 (297)
Q Consensus 203 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~ 281 (297)
||+|||++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999875432222223334568899999999999999999999999999999999 99999887
Q ss_pred hhHhhhh
Q 022447 282 KAAAEQS 288 (297)
Q Consensus 282 ~~~~~~~ 288 (297)
+..+...
T Consensus 281 ~~~~~~~ 287 (343)
T 1luf_A 281 AHEEVIY 287 (343)
T ss_dssp CHHHHHH
T ss_pred ChHHHHH
Confidence 7655443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=294.25 Aligned_cols=208 Identities=31% Similarity=0.453 Sum_probs=181.1
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
..++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 34679999999999999999999999999999999865322 223568889999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999999987 467999999999999999999999999 999999999999999999999999988542
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
.. .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+......
T Consensus 160 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 217 (279)
T 3fdn_A 160 PS----SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK 217 (279)
T ss_dssp ------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred Cc----ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHH
Confidence 22 12234578999999999999999999999999999999999999999877655443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=296.33 Aligned_cols=212 Identities=22% Similarity=0.282 Sum_probs=175.3
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
..++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 4578999999999999999999999999999999997653332 3568899999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
+|||++|++|.+++.. ..++++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 112 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999999987 467999999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
.... ........|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.......
T Consensus 185 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 246 (309)
T 2h34_A 185 TDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH 246 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHH
T ss_pred cccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHH
Confidence 3221 1222345689999999999999999999999999999999999999998876544433
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=303.23 Aligned_cols=208 Identities=26% Similarity=0.391 Sum_probs=173.0
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccch-HHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
++|.+.+.||+|+||.||+|.+..+++.||+|++........ ..+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 579999999999999999999999999999999875432221 2345699999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
++ ++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~-- 152 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI-- 152 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC--
Confidence 98 5899988762 456899999999999999999999999 99999999999999999999999999875322
Q ss_pred CcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+...
T Consensus 153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 211 (324)
T 3mtl_A 153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLH 211 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1222334568999999998876 568999999999999999999999999887766544
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=310.89 Aligned_cols=214 Identities=29% Similarity=0.422 Sum_probs=182.1
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
..++|.+.+.||+|+||.||+|.+..++..||||++...... ....+.+|+.+++.++||||+++++++...+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 346788999999999999999999999999999998754322 2345788999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+++++|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 192 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp ECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999999752 346899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhH
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l 289 (297)
...........+++.|+|||.+.+..++.++||||||+++|||++ |..||...+.......
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~ 327 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF 327 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 211111112235778999999998899999999999999999998 9999998776554443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=297.24 Aligned_cols=206 Identities=23% Similarity=0.356 Sum_probs=180.6
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 45689999999999999999999999999999999986654455678899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE---cCCCceEEecccCcccc
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili---~~~~~~kl~Dfg~~~~~ 226 (297)
|+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||++ +.++.++|+|||++...
T Consensus 87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999999976 467999999999999999999999999 9999999999999 77889999999998753
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+....
T Consensus 160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 215 (304)
T 2jam_A 160 QNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL 215 (304)
T ss_dssp CCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred CCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 221 22345689999999999999999999999999999999999999988765443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=301.40 Aligned_cols=214 Identities=29% Similarity=0.485 Sum_probs=175.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEE----EEEEeccCC-ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDV----AIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v----avK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
.++|++.+.||+|+||.||+|.+..++..+ ++|.+.... ......+.+|+.+++.++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 357899999999999999999998877654 777765432 234567899999999999999999999998754 77
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+++|++.+++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 899999999999999863 456999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHHh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVA 291 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~~ 291 (297)
..............+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||...+.......+.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 233 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH
Confidence 544443333444567889999999999999999999999999999999 999999887766555544
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=299.94 Aligned_cols=207 Identities=24% Similarity=0.354 Sum_probs=174.3
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCC------
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 142 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 142 (297)
..++|++.+.||+|+||.||+|.++.+++.||||++...... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 456899999999999999999999999999999999754433 3467899999999999999999999986543
Q ss_pred ---------------------------------------------------eeEEEEecCCCCChHhhhcccCCCCCCCC
Q 022447 143 ---------------------------------------------------QRLLVYEYMPLGSVEDHLHDLSPGKKPLD 171 (297)
Q Consensus 143 ---------------------------------------------------~~~lv~e~~~g~~L~~~l~~~~~~~~~l~ 171 (297)
..++||||++|++|.+++..... ....+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~ 162 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDRE 162 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSC
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchh
Confidence 37899999999999999986332 34456
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCc----------ceeeccccc
Q 022447 172 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT----------HVSTRVMGT 241 (297)
Q Consensus 172 ~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~g~ 241 (297)
+..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++......... .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 7789999999999999999999 999999999999999999999999999764332211 122345799
Q ss_pred ccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 022447 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDT 280 (297)
Q Consensus 242 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 280 (297)
+.|+|||++.+..++.++||||||+++|+|++|..|+..
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~ 278 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH
Confidence 999999999999999999999999999999999888754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=315.53 Aligned_cols=208 Identities=28% Similarity=0.400 Sum_probs=181.1
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4568999999999999999999999999999999986532 23456788999999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEc---CCCceEEecccCcc
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD---RGYHPKLSDFGLAK 224 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~---~~~~~kl~Dfg~~~ 224 (297)
|||+.|++|.+.+.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.++|+|||++.
T Consensus 100 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 999999999999976 467999999999999999999999999 99999999999995 45679999999997
Q ss_pred ccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+...
T Consensus 173 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 232 (486)
T 3mwu_A 173 CFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK 232 (486)
T ss_dssp TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ECCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 54322 22345679999999999875 58999999999999999999999998877655443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=310.54 Aligned_cols=202 Identities=26% Similarity=0.350 Sum_probs=170.7
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecC-----C
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----D 142 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 142 (297)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+++.+|+.+++.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 35789999999999999999999999999999999975422 2346788999999999999999999999766 5
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
..|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCC
Confidence 7899999997 699999986 567999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCc--------------------ceeecccccccccCcccc-ccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 022447 223 AKLGPVGDNT--------------------HVSTRVMGTYGYCAPEYA-KTGQLTLKSDVYSFGVVLLEILSGRKAVD 279 (297)
Q Consensus 223 ~~~~~~~~~~--------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~ 279 (297)
++........ ......+||+.|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 9864332211 123567899999999985 56679999999999999999998544443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=303.35 Aligned_cols=203 Identities=25% Similarity=0.350 Sum_probs=179.4
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--------chHHHHHHHHHHhccCCCCccceeeEeecC
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--------GNREFLVEVLMLSLLHHPNLVNLIGYCADG 141 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 141 (297)
..++|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999999999999999999765321 223567799999999999999999999999
Q ss_pred CeeEEEEecCCCC-ChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecc
Q 022447 142 DQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (297)
Q Consensus 142 ~~~~lv~e~~~g~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Df 220 (297)
+..++||||+.++ +|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999998666 99999986 567999999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCCcceeecccccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
|++....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....
T Consensus 175 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 234 (335)
T 3dls_A 175 GSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234 (335)
T ss_dssp TTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG
T ss_pred ccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH
Confidence 9997643322 2334679999999999988776 789999999999999999999998754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=307.85 Aligned_cols=200 Identities=23% Similarity=0.319 Sum_probs=166.1
Q ss_pred hcCCCCc-ceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHh-ccCCCCccceeeEeec----CCee
Q 022447 71 TKNFRSE-SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLS-LLHHPNLVNLIGYCAD----GDQR 144 (297)
Q Consensus 71 ~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~----~~~~ 144 (297)
.++|.+. +.||+|+||.||+|.+..+++.||||++.. ...+.+|+.++. ..+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4567776 689999999999999999999999999863 245667888774 4589999999999865 5678
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC---CCceEEeccc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFG 221 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~---~~~~kl~Dfg 221 (297)
|+||||++|++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence 99999999999999998622 346999999999999999999999999 999999999999987 7889999999
Q ss_pred CccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
+++.... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 210 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 210 FAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred cccccCC---CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 9975322 1223456799999999999999999999999999999999999999987653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=300.38 Aligned_cols=216 Identities=25% Similarity=0.382 Sum_probs=166.1
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCe---EEEEEEeccCC--ccchHHHHHHHHHHhccCCCCccceeeEeecCCee
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~---~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 144 (297)
..++|++.+.||+|+||.||+|.+..++. .||||++.... ....+.+.+|+.+++.++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 45689999999999999999999887765 89999987652 23346788999999999999999999999877655
Q ss_pred ------EEEEecCCCCChHhhhcccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceE
Q 022447 145 ------LLVYEYMPLGSVEDHLHDLSP--GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (297)
Q Consensus 145 ------~lv~e~~~g~~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~k 216 (297)
++||||+++++|.+++..... ....+++..++.++.|++.||.|||+++ ++||||||+|||++.++.++
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 899999999999999965321 1236899999999999999999999999 99999999999999999999
Q ss_pred EecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 217 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 217 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+..+...
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~ 250 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN 250 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH
Confidence 999999976433333333334557889999999999999999999999999999999 999999876655443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=302.41 Aligned_cols=215 Identities=28% Similarity=0.463 Sum_probs=180.1
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeE----EEEEEeccCC-ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQD----VAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
.++|++.+.||+|+||.||+|.+..++.. |++|.+.... ......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence 35789999999999999999999888776 7777765432 2233456789999999999999999998864 5688
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+||||+.+++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 999999999999999762 356889999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHHhh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAW 292 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~~~ 292 (297)
..............+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 232 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc
Confidence 554444444455668889999999999999999999999999999999 9999998876665555443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=290.98 Aligned_cols=206 Identities=27% Similarity=0.386 Sum_probs=180.0
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhccCCCCccceeeEeecCCee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 144 (297)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 35789999999999999999999999999999998754322 246788999999999999999999999999999
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC----ceEEecc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSDF 220 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~----~~kl~Df 220 (297)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++ .++|+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999976 567999999999999999999999999 99999999999998876 8999999
Q ss_pred cCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
|.+....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...+..+.
T Consensus 157 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 219 (283)
T 3bhy_A 157 GIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET 219 (283)
T ss_dssp TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred ccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH
Confidence 9997532221 22345689999999999989999999999999999999999999988765543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=316.62 Aligned_cols=208 Identities=27% Similarity=0.402 Sum_probs=183.8
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4468999999999999999999999999999999997543 2345678999999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE---cCCCceEEecccCc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLA 223 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili---~~~~~~kl~Dfg~~ 223 (297)
||||+.|++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.++|+|||++
T Consensus 104 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 9999999999999986 567999999999999999999999999 9999999999999 46789999999998
Q ss_pred cccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+...
T Consensus 177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 237 (484)
T 3nyv_A 177 THFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILK 237 (484)
T ss_dssp HHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 7643322 2344579999999999875 68999999999999999999999999887655443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=292.79 Aligned_cols=205 Identities=31% Similarity=0.486 Sum_probs=160.7
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 4679999999999999999999999999999999865321 2236788999999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||+++++|.+++... ..++++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999999862 367999999999999999999999999 9999999999999999999999999987643
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.
T Consensus 164 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 164 MPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred CCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 221 122345689999999999988999999999999999999999999987654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=291.32 Aligned_cols=206 Identities=26% Similarity=0.395 Sum_probs=182.9
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
.++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999999999999999986532 22345788999999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999987 457999999999999999999999999 9999999999999999999999999986532
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
.. ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+..
T Consensus 166 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 221 (284)
T 2vgo_A 166 SL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH 221 (284)
T ss_dssp SS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred cc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH
Confidence 21 223457999999999999999999999999999999999999999887665443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=302.88 Aligned_cols=218 Identities=29% Similarity=0.407 Sum_probs=185.8
Q ss_pred HhcCCCCcceecccCcEEEEEEEECC-------CCeEEEEEEeccCCcc-chHHHHHHHHHHhcc-CCCCccceeeEeec
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLES-------INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCAD 140 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~-------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 140 (297)
..++|.+.+.||+|+||.||+|.+.. .+..||+|++...... ....+.+|+.+++.+ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 34689999999999999999999753 3468999999765332 336688999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCChHhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEE
Q 022447 141 GDQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 208 (297)
Q Consensus 141 ~~~~~lv~e~~~g~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nil 208 (297)
.+..++||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999987432 1245999999999999999999999999 999999999999
Q ss_pred EcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhh
Q 022447 209 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQ 287 (297)
Q Consensus 209 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~ 287 (297)
++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+..+..
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999986443333333444567899999999999999999999999999999999 99999987766554
Q ss_pred hHH
Q 022447 288 SLV 290 (297)
Q Consensus 288 ~l~ 290 (297)
..+
T Consensus 304 ~~~ 306 (382)
T 3tt0_A 304 KLL 306 (382)
T ss_dssp HHH
T ss_pred HHH
Confidence 443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=315.09 Aligned_cols=209 Identities=27% Similarity=0.396 Sum_probs=178.7
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
..++|++.+.||+|+||.||+|.++.++..||+|++.... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457999999999999999999999999999999997653 23346788999999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC---CceEEecccCcc
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG---YHPKLSDFGLAK 224 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~---~~~kl~Dfg~~~ 224 (297)
|||++|++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.. +.+||+|||++.
T Consensus 115 ~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 115 MECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 999999999999976 567999999999999999999999999 9999999999999764 559999999997
Q ss_pred ccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
..... ......+||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+....
T Consensus 188 ~~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 248 (494)
T 3lij_A 188 VFENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRK 248 (494)
T ss_dssp ECBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ECCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 64322 2234567999999999886 5689999999999999999999999998877655443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=303.52 Aligned_cols=202 Identities=24% Similarity=0.347 Sum_probs=172.1
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCC------
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 142 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 142 (297)
.++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+++.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999999999999999998654322 2356889999999999999999999997653
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 7899999975 46899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 223 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
++.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 175 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 234 (367)
T 1cm8_A 175 ARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234 (367)
T ss_dssp CEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 986322 2334678999999999877 6799999999999999999999999998776544
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=313.68 Aligned_cols=204 Identities=25% Similarity=0.326 Sum_probs=161.1
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeec-----CCe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD-----GDQ 143 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 143 (297)
.++|++.+.||+|+||.||+|.++.+++.||||++..... ...+++.+|+.+++.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4689999999999999999999999999999999865422 234678899999999999999999999843 357
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
.|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 899999985 799999976 567999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCc-------------------------ceeecccccccccCcccc-ccCCCCcccchhhHHHHHHHHHh----
Q 022447 224 KLGPVGDNT-------------------------HVSTRVMGTYGYCAPEYA-KTGQLTLKSDVYSFGVVLLEILS---- 273 (297)
Q Consensus 224 ~~~~~~~~~-------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~---- 273 (297)
+........ ......+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 764322110 123456789999999976 56679999999999999999999
Q ss_pred -------CCCCCCcch
Q 022447 274 -------GRKAVDTSK 282 (297)
Q Consensus 274 -------g~~Pf~~~~ 282 (297)
|++||.+.+
T Consensus 284 ~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSS 299 (458)
T ss_dssp TCSSGGGCCCSCC---
T ss_pred cccccccccccCCCCc
Confidence 777776654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=313.68 Aligned_cols=209 Identities=26% Similarity=0.370 Sum_probs=180.7
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-------------cchHHHHHHHHHHhccCCCCccceee
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-------------QGNREFLVEVLMLSLLHHPNLVNLIG 136 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 136 (297)
..++|.+.+.||+|+||.||+|.++.++..||+|++..... .....+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45789999999999999999999999999999999875432 22356889999999999999999999
Q ss_pred EeecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC---
Q 022447 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY--- 213 (297)
Q Consensus 137 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~--- 213 (297)
++.+....++||||++|++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999999986 567999999999999999999999999 99999999999998775
Q ss_pred ceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 214 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 214 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
.++|+|||++...... .......||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+....
T Consensus 187 ~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 258 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK 258 (504)
T ss_dssp SEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cEEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 6999999999764322 2234567999999999986 4689999999999999999999999998876655433
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=299.39 Aligned_cols=208 Identities=26% Similarity=0.373 Sum_probs=177.6
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 468999999999999999999999999999999986543332 345778999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 104 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999888888765 567999999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
. ........|++.|+|||++.+. .++.++||||||+++|+|++|+.||...+..+..
T Consensus 177 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 234 (331)
T 4aaa_A 177 P--GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL 234 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred C--ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 1 2223445689999999998775 7899999999999999999999999988765543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=303.04 Aligned_cols=202 Identities=31% Similarity=0.450 Sum_probs=173.1
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCC----eeE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----QRL 145 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~ 145 (297)
..++|++.+.||+|+||.||+|.+. ++.||||++..... .......|+.+++.++||||+++++++.... .++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 3468999999999999999999886 79999999965432 2334566888999999999999999998744 469
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeeecCCCCCcEEEcCCCce
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK----------AKPPVIYRDLKCSNILLDRGYHP 215 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----------~~~~ivH~dikp~Nili~~~~~~ 215 (297)
+||||+++++|.+++.. ..+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+
T Consensus 99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCE
T ss_pred EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeE
Confidence 99999999999999976 4599999999999999999999998 8 9999999999999999999
Q ss_pred EEecccCccccCCCCCcceeecccccccccCcccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
||+|||++................||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999976544333333444679999999999876 355678999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=290.23 Aligned_cols=209 Identities=28% Similarity=0.458 Sum_probs=181.4
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|++.+.||+|+||.||+|.+.. +..||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecC-CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 4678999999999999999999974 78899999976543 346788999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 87 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 87 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 9999999999752 456899999999999999999999999 9999999999999999999999999987532211
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+......
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~ 218 (269)
T 4hcu_A 161 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 218 (269)
T ss_dssp -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred -cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 112233456788999999999999999999999999999999 999999877655443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=288.53 Aligned_cols=210 Identities=27% Similarity=0.407 Sum_probs=182.3
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|++.+.||+|+||.||+|.+.. +..||+|++..... ....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4678999999999999999998874 77899999976543 346788999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999762 345899999999999999999999999 9999999999999999999999999997643322
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhH
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l 289 (297)
........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+.......
T Consensus 159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~ 217 (268)
T 3sxs_A 159 -YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK 217 (268)
T ss_dssp -EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred -hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH
Confidence 222234456778999999999899999999999999999999 9999988776655443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=296.40 Aligned_cols=209 Identities=31% Similarity=0.478 Sum_probs=176.7
Q ss_pred HhcCCCCcceecccCcEEEEEEE----ECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeec--CCe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGY----LESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQ 143 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 143 (297)
..++|++.+.||+|+||.||+|. +..++..||||++........+.+.+|+.+++.++||||+++++++.. ...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 34689999999999999999998 567899999999987655555778999999999999999999999865 356
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred eEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 89999999999999999862 345899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCc-ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 224 KLGPVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 224 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
......... .......++..|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~ 223 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 223 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH
Confidence 764332211 1223345778899999999999999999999999999999999999876543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=291.64 Aligned_cols=207 Identities=28% Similarity=0.394 Sum_probs=183.8
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+.|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 568999999999999999999999999999999976543 3446788999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++.. .++++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 102 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 172 (303)
T 3a7i_A 102 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT- 172 (303)
T ss_dssp CTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT-
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc-
Confidence 999999999874 57999999999999999999999999 999999999999999999999999998753222
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
........|++.|+|||++.+..++.++||||||+++|+|++|+.||...+......
T Consensus 173 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 229 (303)
T 3a7i_A 173 -QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF 229 (303)
T ss_dssp -BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred -ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH
Confidence 222345679999999999999999999999999999999999999998876654433
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=292.34 Aligned_cols=204 Identities=24% Similarity=0.303 Sum_probs=178.3
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+ +|++++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 3568999999999999999999999999999999986543 224577899999998 7999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCc-----eEEecccCc
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH-----PKLSDFGLA 223 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~-----~kl~Dfg~~ 223 (297)
||+ +++|.+++... ..++++..++.++.|++.||.|||+++ |+||||||+||+++.++. ++|+|||++
T Consensus 86 e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999 89999999862 346999999999999999999999999 999999999999987765 999999999
Q ss_pred cccCCCCCc-----ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 224 KLGPVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 224 ~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
......... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 764332211 12345679999999999999999999999999999999999999998854
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=299.91 Aligned_cols=210 Identities=24% Similarity=0.366 Sum_probs=182.4
Q ss_pred HHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--------chHHHHHHHHHHhcc-CCCCccceeeE
Q 022447 67 LAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--------GNREFLVEVLMLSLL-HHPNLVNLIGY 137 (297)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~~i~~~~~~ 137 (297)
.....++|.+.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.+++.+ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 344567899999999999999999999999999999998754321 124577899999998 79999999999
Q ss_pred eecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEE
Q 022447 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 217 (297)
Q Consensus 138 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl 217 (297)
+......++||||++|++|.+++.. ...+++..++.++.||+.||.|||+.| ++|+||||+|||++.++.++|
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999986 567999999999999999999999999 999999999999999999999
Q ss_pred ecccCccccCCCCCcceeecccccccccCcccccc------CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 218 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 218 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+....
T Consensus 242 ~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 313 (365)
T 2y7j_A 242 SDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM 313 (365)
T ss_dssp CCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 9999987643322 2345679999999998864 3588899999999999999999999987665443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=300.67 Aligned_cols=211 Identities=30% Similarity=0.459 Sum_probs=178.7
Q ss_pred HhcCCCCcceecccCcEEEEEEEE-----CCCCeEEEEEEeccCC-ccchHHHHHHHHHHhcc-CCCCccceeeEeecCC
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD 142 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 142 (297)
..++|++.+.||+|+||.||+|.+ ..++..||+|++.... ......+.+|+.+++.+ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 346899999999999999999997 3457789999997543 23346788999999999 8999999999999999
Q ss_pred eeEEEEecCCCCChHhhhcccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPG-------------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 203 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dik 203 (297)
..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999863211 134799999999999999999999999 9999999
Q ss_pred CCcEEEcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcch
Q 022447 204 CSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSK 282 (297)
Q Consensus 204 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~ 282 (297)
|+|||++.++.++|+|||++................+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999975433333333445567889999999999999999999999999999998 999998865
Q ss_pred h
Q 022447 283 A 283 (297)
Q Consensus 283 ~ 283 (297)
.
T Consensus 280 ~ 280 (344)
T 1rjb_A 280 V 280 (344)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=290.15 Aligned_cols=218 Identities=46% Similarity=0.764 Sum_probs=187.0
Q ss_pred ccccCHHHHHHHhcCCCCc------ceecccCcEEEEEEEECCCCeEEEEEEeccCC----ccchHHHHHHHHHHhccCC
Q 022447 59 AQTLTFRELAAATKNFRSE------SLLGEGGFGRVYKGYLESINQDVAIKQLDRNG----VQGNREFLVEVLMLSLLHH 128 (297)
Q Consensus 59 ~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h 128 (297)
...+++.++....++|... +.||+|+||.||+|.+ ++..||+|++.... ....+.+.+|+.+++.++|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 4567888888888887766 8999999999999986 48899999986532 1224678899999999999
Q ss_pred CCccceeeEeecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEE
Q 022447 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 208 (297)
Q Consensus 129 ~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nil 208 (297)
|||+++++++.+.+..++||||+++++|.+++.... ...++++..++.++.|++.||.|||+.+ ++||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 999999999999999999999999999999997532 1456999999999999999999999999 999999999999
Q ss_pred EcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 209 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 209 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
++.++.++|+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|..||.....
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 99999999999999876443333333445679999999998865 578999999999999999999999987654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=296.83 Aligned_cols=214 Identities=29% Similarity=0.487 Sum_probs=175.3
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEE----EEEEeccC-CccchHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDV----AIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v----avK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
.++|++.+.||+|+||.||+|.+..++..+ ++|.+... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 468999999999999999999998887765 66666443 3344577899999999999999999999998754 78
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+++|++.+++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 899999999999999863 456999999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHHh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVA 291 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~~ 291 (297)
..............+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 233 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 443333333344557889999999999999999999999999999999 999999887766555443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=307.97 Aligned_cols=203 Identities=26% Similarity=0.370 Sum_probs=168.3
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--------chHHHHHHHHHHhccCCCCccceeeEeec
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--------GNREFLVEVLMLSLLHHPNLVNLIGYCAD 140 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 140 (297)
...++|.+.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4568999999999999999999999999999999998753211 11247889999999999999999999865
Q ss_pred CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC---ceEE
Q 022447 141 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKL 217 (297)
Q Consensus 141 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~---~~kl 217 (297)
...++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence 567999999999999999876 567999999999999999999999999 99999999999997544 5999
Q ss_pred ecccCccccCCCCCcceeecccccccccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 218 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 218 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
+|||++..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 284 ~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 284 TDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred eecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 99999976322 223345679999999999853 567889999999999999999999998654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=303.69 Aligned_cols=208 Identities=22% Similarity=0.327 Sum_probs=174.3
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeec--------
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-------- 140 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 140 (297)
...++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999999999999999998654222 2369999999999999999999843
Q ss_pred ------------------------------CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022447 141 ------------------------------GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190 (297)
Q Consensus 141 ------------------------------~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 190 (297)
....++||||++ ++|.+.+.........+++..++.++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 334789999998 5888777654334678999999999999999999999
Q ss_pred hCCCCCeeecCCCCCcEEEc-CCCceEEecccCccccCCCCCcceeecccccccccCccccccC-CCCcccchhhHHHHH
Q 022447 191 DKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVL 268 (297)
Q Consensus 191 ~~~~~~ivH~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il 268 (297)
+.+ |+||||||+|||++ .++.++|+|||++....... ......||+.|+|||++.+. .++.++|||||||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999 99999999999998 68899999999998643222 23345789999999988764 589999999999999
Q ss_pred HHHHhCCCCCCcchhHhhh
Q 022447 269 LEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 269 ~ell~g~~Pf~~~~~~~~~ 287 (297)
|+|++|+.||.+.+..+..
T Consensus 233 ~ell~g~~pf~~~~~~~~~ 251 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQL 251 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHH
T ss_pred HHHHhCCCCCCCCChHHHH
Confidence 9999999999987765543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=299.91 Aligned_cols=209 Identities=31% Similarity=0.389 Sum_probs=173.8
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc-----hHHHHHHHHHHhccCCCCccceeeEeecCCe
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-----NREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 143 (297)
...++|++.+.||+|+||.||+|.+..+|+.||||++....... ...+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999999999999999987543221 2467889999999999999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
.++||||+++ +|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999985 88888875 2356889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+.
T Consensus 160 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~ 221 (346)
T 1ua2_A 160 KSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ 221 (346)
T ss_dssp STTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred eeccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 753222 223345678999999999865 4589999999999999999999999998776544
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=303.62 Aligned_cols=208 Identities=25% Similarity=0.349 Sum_probs=182.6
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 3579999999999999999999999999999999976532 234568899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
|++|++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.++|+|||++....
T Consensus 112 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~- 183 (360)
T 3eqc_A 112 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI- 183 (360)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH-
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc-
Confidence 9999999999987 45799999999999999999999996 8 9999999999999999999999999986421
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+...+
T Consensus 184 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 241 (360)
T 3eqc_A 184 ---DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 241 (360)
T ss_dssp ---HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHH
T ss_pred ---cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1122345799999999999999999999999999999999999999998776655443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=302.91 Aligned_cols=212 Identities=28% Similarity=0.440 Sum_probs=170.2
Q ss_pred hcCCCCcceecccCcEEEEEEEEC---CCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
..+|.+.+.||+|+||.||+|.+. .++..||||++..... .....+.+|+.+++.++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 358999999999999999999987 4577899999976532 234568899999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 124 v~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999752 356999999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCc-ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 227 PVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 227 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
...... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+......
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~ 261 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK 261 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHH
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 322111 11122335778999999999999999999999999999998 999998776655433
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=295.96 Aligned_cols=217 Identities=24% Similarity=0.317 Sum_probs=183.7
Q ss_pred cCHHHHHHHhcCCCCc-ceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccC-CCCccceeeE
Q 022447 62 LTFRELAAATKNFRSE-SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLH-HPNLVNLIGY 137 (297)
Q Consensus 62 ~~~~~~~~~~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~ 137 (297)
+.+.....+.++|.+. +.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.+. ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3344445667788888 899999999999999999999999999875432 33467889999999985 6999999999
Q ss_pred eecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC---CCc
Q 022447 138 CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYH 214 (297)
Q Consensus 138 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~---~~~ 214 (297)
+.+....++||||++|++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 99999999999999999999998652 2467999999999999999999999999 999999999999987 789
Q ss_pred eEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 215 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 215 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
++|+|||++...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+.
T Consensus 173 ~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 241 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET 241 (327)
T ss_dssp EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEEeeCccccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH
Confidence 999999999764322 123345799999999999999999999999999999999999999988766544
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=300.08 Aligned_cols=203 Identities=24% Similarity=0.342 Sum_probs=169.3
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCC------
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 142 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 142 (297)
.++|++.+.||+|+||.||+|.+..++..||||++..... .....+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4789999999999999999999999999999999975432 23356889999999999999999999997655
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
..++||||++ ++|.+.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 7899999998 578888753 4889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 223 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
+..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....
T Consensus 174 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 234 (371)
T 2xrw_A 174 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ 234 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cccccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 975322 1223346799999999999999999999999999999999999999998776443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=293.01 Aligned_cols=211 Identities=27% Similarity=0.415 Sum_probs=179.3
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 4568999999999999999999887 478899999976543 34678899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+++++|.+++... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 100 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 100 YMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred ccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999999752 356999999999999999999999999 999999999999999999999999998753221
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhH
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l 289 (297)
. ........+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...+.......
T Consensus 174 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~ 233 (283)
T 3gen_A 174 E-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233 (283)
T ss_dssp H-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred c-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH
Confidence 1 112223446788999999999999999999999999999998 9999998776555443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=292.23 Aligned_cols=206 Identities=27% Similarity=0.425 Sum_probs=178.1
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCC-------eEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESIN-------QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 143 (297)
.++|.+.+.||+|+||.||+|.+..++ ..||+|++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 467899999999999999999998776 5799999977666666789999999999999999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCc--------e
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH--------P 215 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~--------~ 215 (297)
.++||||++|++|.+++... ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999862 334899999999999999999999999 999999999999998876 9
Q ss_pred EEecccCccccCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhC-CCCCCcchhHhhhh
Q 022447 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAAEQS 288 (297)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g-~~Pf~~~~~~~~~~ 288 (297)
+|+|||++.... ......|++.|+|||++.+ ..++.++||||||+++|+|++| ..||...+......
T Consensus 161 kl~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~ 229 (289)
T 4fvq_A 161 KLSDPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229 (289)
T ss_dssp EECCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred eeccCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH
Confidence 999999986421 1233458899999999987 7789999999999999999995 56666655544433
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=298.16 Aligned_cols=212 Identities=24% Similarity=0.378 Sum_probs=179.5
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeec--------
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD-------- 140 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 140 (297)
.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36899999999999999999999999999999998654332 23567899999999999999999999876
Q ss_pred CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecc
Q 022447 141 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (297)
Q Consensus 141 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Df 220 (297)
.+..++||||++ ++|.+.+... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccC-CCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 346899999998 4777777652 356999999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCC--CcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 221 GLAKLGPVGD--NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 221 g~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
|++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 240 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 240 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 9997643222 1222344578999999998876 5689999999999999999999999999877655443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=290.83 Aligned_cols=207 Identities=30% Similarity=0.412 Sum_probs=178.0
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..++|++.+.||+|+||.||+|.+..+|..||+|.+.... ....+.+|+.+++.++||||+++++++......++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4568999999999999999999999999999999997643 34678899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 105 ~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (314)
T 3com_A 105 YCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD- 177 (314)
T ss_dssp CCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT-
T ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh-
Confidence 99999999999742 467999999999999999999999999 99999999999999999999999999875322
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
.........|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+....
T Consensus 178 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 233 (314)
T 3com_A 178 -TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA 233 (314)
T ss_dssp -TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred -hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 22223445789999999999998999999999999999999999999988665443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=295.68 Aligned_cols=215 Identities=27% Similarity=0.404 Sum_probs=181.5
Q ss_pred hcCCCCcceecccCcEEEEEEEEC-------CCCeEEEEEEeccCCc-cchHHHHHHHHHHhcc-CCCCccceeeEeecC
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLE-------SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 141 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 141 (297)
.++|++.+.||+|+||.||+|.+. .++..||+|++..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468999999999999999999986 4577899999976533 2345688999999999 899999999999999
Q ss_pred CeeEEEEecCCCCChHhhhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSPG------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili 209 (297)
+..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+.+ |+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 9999999999999999999864321 234899999999999999999999999 9999999999999
Q ss_pred cCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 210 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 210 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
+.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+...
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 9999999999999976443332223334457889999999998899999999999999999999 999998877655443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=301.95 Aligned_cols=204 Identities=25% Similarity=0.361 Sum_probs=162.0
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecC------
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG------ 141 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 141 (297)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... ....++.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 34789999999999999999999999999999999875432 2346788999999999999999999998654
Q ss_pred CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg 221 (297)
...|+++|++ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--
T ss_pred CeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecc
Confidence 5679999999 5899888864 56999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+..
T Consensus 178 ~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l 239 (367)
T 2fst_X 178 LARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 239 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9975321 2344679999999999876 67899999999999999999999999988765543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=287.60 Aligned_cols=208 Identities=25% Similarity=0.394 Sum_probs=174.7
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3468999999999999999999999999999999986532 2234578899999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 89 VMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999999986 467899999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCcceeecccccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
... .......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...+.....
T Consensus 162 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 220 (276)
T 2h6d_A 162 SDG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF 220 (276)
T ss_dssp CC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCC---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 322 12234568999999999987765 68999999999999999999999887655443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=297.10 Aligned_cols=216 Identities=30% Similarity=0.407 Sum_probs=177.5
Q ss_pred HHHHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcc-CCCCccceeeEeec--
Q 022447 64 FRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD-- 140 (297)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-- 140 (297)
+.++....++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3334445678999999999999999999999999999999987543 3346788999999998 79999999999976
Q ss_pred ----CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceE
Q 022447 141 ----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (297)
Q Consensus 141 ----~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~k 216 (297)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 467899999999999999998632 357899999999999999999999999 99999999999999999999
Q ss_pred EecccCccccCCCCCcceeecccccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 217 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 217 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
|+|||++...... ........|++.|+|||++. +..++.++||||||+++|+|++|+.||...+.....
T Consensus 170 l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 243 (326)
T 2x7f_A 170 LVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred EeeCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 9999998753221 12233457999999999986 567889999999999999999999999887655443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=294.45 Aligned_cols=211 Identities=30% Similarity=0.443 Sum_probs=181.9
Q ss_pred HhcCCCCcceecccCcEEEEEEEE-----CCCCeEEEEEEeccCCc-cchHHHHHHHHHHhcc-CCCCccceeeEeecCC
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD 142 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 142 (297)
..++|++.+.||+|+||.||+|.+ ..++..||+|++..... .....+.+|+.+++.+ +||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346899999999999999999985 45688999999976543 2346788999999999 8999999999999999
Q ss_pred eeEEEEecCCCCChHhhhcccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEE
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSP--------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 208 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nil 208 (297)
..++||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ ++||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999986431 1235899999999999999999999999 999999999999
Q ss_pred EcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchh
Q 022447 209 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKA 283 (297)
Q Consensus 209 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~ 283 (297)
++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.....
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 99999999999999976544333333344567889999999999999999999999999999999 9999987654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=297.71 Aligned_cols=203 Identities=24% Similarity=0.313 Sum_probs=169.3
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCC--CCccceeeEeecCCeeE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHH--PNLVNLIGYCADGDQRL 145 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~ 145 (297)
..++|++.+.||+|+||.||+|.+. ++..||||++...... ....+.+|+.+++.++| |||+++++++.+....+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 3467999999999999999999985 5899999998765333 23568899999999976 99999999999999999
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+||| +.+++|.+++.. ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++ ++.++|+|||++..
T Consensus 86 lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEEC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEe-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccc
Confidence 9999 557899999987 567999999999999999999999999 99999999999997 57899999999976
Q ss_pred cCCCCCcceeecccccccccCcccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKT-----------GQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
..............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 443333333445679999999999865 678899999999999999999999998643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=295.79 Aligned_cols=202 Identities=34% Similarity=0.456 Sum_probs=177.0
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
+.|.+.+.||+|+||.||+|.+..++..||||++....... ...+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45889999999999999999999999999999997543322 246889999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+. |+|.+++... ..++++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9998 6888887642 467999999999999999999999999 99999999999999999999999999875321
Q ss_pred CCCcceeecccccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||...+....
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 261 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 261 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 23457999999999884 56789999999999999999999999987765443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=285.85 Aligned_cols=206 Identities=32% Similarity=0.522 Sum_probs=169.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc----chHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ----GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
.++|++.+.||+|+||.||+|.+. +..||||++...... ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 468899999999999999999986 889999998754322 23568899999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC--------CCceEEe
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR--------GYHPKLS 218 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~--------~~~~kl~ 218 (297)
||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+..+++||||||+||+++. ++.++|+
T Consensus 84 v~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 9999999999999864 57999999999999999999999987555889999999999986 6789999
Q ss_pred cccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
|||++...... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.....
T Consensus 159 Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 223 (271)
T 3dtc_A 159 DFGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA 223 (271)
T ss_dssp CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH
T ss_pred cCCcccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99998753221 122456999999999999999999999999999999999999999987655443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=291.85 Aligned_cols=202 Identities=24% Similarity=0.236 Sum_probs=169.2
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 146 (297)
..++|++.+.||+|+||.||+|.+..+++.||||++...... .......|+..+..+ +||||+++++++.+.+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 346899999999999999999999999999999998654332 223455566555554 89999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||||+ +++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 135 v~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999 57999988763 356999999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
... .......||+.|+|||++.+ .++.++|||||||++|||++|..||...+
T Consensus 208 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~ 259 (311)
T 3p1a_A 208 GTA---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE 259 (311)
T ss_dssp C---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH
T ss_pred ccC---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 222 22334569999999998876 78999999999999999999976665543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=288.56 Aligned_cols=211 Identities=24% Similarity=0.345 Sum_probs=177.6
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC----ccchHHHHHHHHHHhccCCCCccceeeEee--cCCe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG----VQGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQ 143 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~ 143 (297)
..++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4578999999999999999999999999999999997542 233467889999999999999999999984 4567
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
.++||||++++ |.+++.... ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence 89999999865 777776533 467999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcceeecccccccccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ--LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
................|++.|+|||++.+.. ++.++||||||+++|+|++|+.||...+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 221 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL 221 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Confidence 7654333333444567999999999987644 37799999999999999999999998765544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=297.31 Aligned_cols=208 Identities=27% Similarity=0.356 Sum_probs=178.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecC-----Cee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 144 (297)
.++|++.+.||+|+||.||+|.+..++..||||++...... ....+.+|+.+++.++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 46899999999999999999999999999999999754332 236788999999999999999999998764 368
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
|+|||++. ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999998 599999875 46999999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCc-ceeecccccccccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 225 LGPVGDNT-HVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 225 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
........ .......||+.|+|||++. +..++.++|||||||++|+|++|+.||...+..+..
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 241 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 241 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH
Confidence 64322111 1123457999999999865 456899999999999999999999999887765543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=293.18 Aligned_cols=207 Identities=25% Similarity=0.374 Sum_probs=169.4
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
..+|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 4579999999999999999999999999999999975432 2335688999999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999999754334567999999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
.. ........|++.|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 188 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 188 SK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred CC--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 21 222334568999999999999999999999999999999999999997654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=288.07 Aligned_cols=209 Identities=28% Similarity=0.352 Sum_probs=181.8
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc---------cchHHHHHHHHHHhccC-CCCccceeeEe
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---------QGNREFLVEVLMLSLLH-HPNLVNLIGYC 138 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 138 (297)
...++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 456789999999999999999999999999999999975431 11245778999999996 99999999999
Q ss_pred ecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEe
Q 022447 139 ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 218 (297)
Q Consensus 139 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~ 218 (297)
......++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence 999999999999999999999987 567999999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCCcceeecccccccccCccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK------TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
|||++....... ......|++.|+|||++. ...++.++||||||+++|+|++|+.||...+.....
T Consensus 167 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 238 (298)
T 1phk_A 167 DFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238 (298)
T ss_dssp CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH
Confidence 999987643222 233456899999999885 456789999999999999999999999877655443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=290.00 Aligned_cols=213 Identities=28% Similarity=0.456 Sum_probs=186.2
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..++|++.+.||+|+||.||+|.+..++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4568899999999999999999999999999999997543 345678899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|++|++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 90 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred cCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999998632 456899999999999999999999999 999999999999999999999999999764322
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhH
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l 289 (297)
. ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+.......
T Consensus 165 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~ 224 (288)
T 3kfa_A 165 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 224 (288)
T ss_dssp S-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred c-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 2 223334557889999999999999999999999999999999 9999988766554443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=302.34 Aligned_cols=202 Identities=23% Similarity=0.313 Sum_probs=170.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccC--CCCccceeeEeecCCeeEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLH--HPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~l 146 (297)
..+|++.+.||+|+||.||+|.+.. +..||||++...... ....+.+|+.+++.+. ||||+++++++...+..|+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 3569999999999999999999876 899999999765332 3366889999999996 5999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||| +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||++...
T Consensus 134 v~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 999 567899999987 567899999999999999999999999 99999999999995 578999999999764
Q ss_pred CCCCCcceeecccccccccCcccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKT-----------GQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 33332223445679999999999865 368899999999999999999999998753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=291.78 Aligned_cols=215 Identities=25% Similarity=0.335 Sum_probs=180.1
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEee--cCCeeE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQRL 145 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 145 (297)
..++|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++. .....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 346899999999999999999999999999999999765432 3356889999999999999999999874 467889
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA--KPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
+||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ..+++||||||+||+++.++.++|+|||.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999999864333456999999999999999999999865 234999999999999999999999999998
Q ss_pred cccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
...... ........|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+....
T Consensus 164 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 224 (279)
T 2w5a_A 164 RILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 224 (279)
T ss_dssp HHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred eeeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH
Confidence 753221 1222345689999999999988999999999999999999999999998765543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=293.44 Aligned_cols=209 Identities=24% Similarity=0.408 Sum_probs=176.9
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..++|++.+.||+|+||.||+|.+..++..||+|++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 34689999999999999999999999999999999987666667789999999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 97 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~-- 168 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL-- 168 (302)
T ss_dssp CCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHH--
T ss_pred eCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccc--
Confidence 99999999988752 356999999999999999999999999 9999999999999999999999999864310
Q ss_pred CCcceeecccccccccCcccc-----ccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYA-----KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
..........|++.|+|||++ .+..++.++||||||+++|+|++|..||...+....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 230 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 230 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence 011122345689999999988 356788999999999999999999999988765443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=293.22 Aligned_cols=217 Identities=27% Similarity=0.404 Sum_probs=171.5
Q ss_pred HHHhcCCCCcceecccCcEEEEEEEECC---CCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCC
Q 022447 68 AAATKNFRSESLLGEGGFGRVYKGYLES---INQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD 142 (297)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 142 (297)
....++|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.+++.++||||+++++++.+..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 3455789999999999999999998765 5668999998755332 3356889999999999999999999998754
Q ss_pred -----eeEEEEecCCCCChHhhhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCce
Q 022447 143 -----QRLLVYEYMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (297)
Q Consensus 143 -----~~~lv~e~~~g~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~ 215 (297)
..++||||+++++|.+++.... .....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 3589999999999999985322 22467999999999999999999999999 9999999999999999999
Q ss_pred EEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhh
Q 022447 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQ 287 (297)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~ 287 (297)
+|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+.....
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 259 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence 9999999876433332233334557889999999999999999999999999999999 89999887665443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=306.10 Aligned_cols=205 Identities=22% Similarity=0.319 Sum_probs=176.4
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCC--eeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 147 (297)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4679999999999999999999999999999999975432 33466789999999999999999999998755 77999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE----cCCCceEEecccCc
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL----DRGYHPKLSDFGLA 223 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili----~~~~~~kl~Dfg~~ 223 (297)
|||++|++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999986322 234999999999999999999999999 9999999999999 77778999999999
Q ss_pred cccCCCCCcceeecccccccccCcccccc--------CCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKT--------GQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 164 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 164 RELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp EECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred eEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 763322 22334679999999999865 567889999999999999999999997543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=286.39 Aligned_cols=204 Identities=34% Similarity=0.616 Sum_probs=174.8
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccch-------HHHHHHHHHHhccCCCCccceeeEeecCCe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN-------REFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 143 (297)
.++|++.+.||+|+||.||+|.+..+++.||+|++........ +.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 4689999999999999999999999999999999865433221 56889999999999999999999997665
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCc-----eEEe
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH-----PKLS 218 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~-----~kl~ 218 (297)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ .+++||||||+||+++.++. ++|+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 6999999999999988752 457999999999999999999999875 45999999999999988776 9999
Q ss_pred cccCccccCCCCCcceeecccccccccCcccc--ccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA--KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
|||++.... .......||+.|+|||.+ ....++.++||||||+++|+|++|+.||...+...
T Consensus 172 Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 235 (287)
T 4f0f_A 172 DFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235 (287)
T ss_dssp CCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred CCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence 999987421 123456799999999998 34567899999999999999999999998765443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=310.90 Aligned_cols=212 Identities=27% Similarity=0.449 Sum_probs=184.3
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
...+|++.+.||+|+||.||+|.++.++..||||.+.... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 3456888899999999999999999999999999997643 345778999999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+++++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 297 ~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 297 FMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred ccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 999999999998632 456899999999999999999999999 999999999999999999999999999864322
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
.........+++.|+|||.+.+..++.++|||||||++|||++ |..||...+......
T Consensus 372 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~ 430 (495)
T 1opk_A 372 -TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 430 (495)
T ss_dssp -CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred -ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 1122233446789999999999999999999999999999999 999998876654433
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=301.00 Aligned_cols=204 Identities=27% Similarity=0.380 Sum_probs=174.7
Q ss_pred hcCCCCcceecccCcEEEEEEEEC---CCCeEEEEEEeccCCc----cchHHHHHHHHHHhcc-CCCCccceeeEeecCC
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLE---SINQDVAIKQLDRNGV----QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD 142 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~---~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 142 (297)
.++|++.+.||+|+||.||+|.+. .+++.||||++..... .....+.+|+.+++.+ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 468999999999999999999984 5799999999875422 2234566799999999 6999999999999999
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999986 467999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 223 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
++..... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 206 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 206 SKEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp EEECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred CeecccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 8753221 1222334679999999999875 357889999999999999999999997543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=288.13 Aligned_cols=211 Identities=28% Similarity=0.385 Sum_probs=169.0
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCC---CeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+..... .....+.+|+.+++.++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 346889999999999999999998654 56799999875432 23456889999999999999999999985 46789
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence 999999999999999862 356999999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
..... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+...
T Consensus 166 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~ 228 (281)
T 1mp8_A 166 MEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 228 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred cCccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHH
Confidence 43221 112233457789999999999999999999999999999997 999998876655433
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=296.82 Aligned_cols=218 Identities=27% Similarity=0.429 Sum_probs=183.7
Q ss_pred HHHhcCCCCcceecccCcEEEEEEEEC-----CCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecC
Q 022447 68 AAATKNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG 141 (297)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 141 (297)
....++|++.+.||+|+||.||+|.+. .++..||+|.+..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 345678999999999999999999876 4578999999875433 2335688999999999999999999999999
Q ss_pred CeeEEEEecCCCCChHhhhcccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCce
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLS------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~ 215 (297)
+..++||||+++++|.+++.... ....++++..++.++.|++.||.|||+++ |+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence 99999999999999999997521 11256789999999999999999999999 9999999999999999999
Q ss_pred EEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
+|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+......
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 251 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence 9999999875322222222233457889999999999999999999999999999999 899998876655443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=285.89 Aligned_cols=205 Identities=26% Similarity=0.370 Sum_probs=175.0
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCC
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 152 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 152 (297)
+|.....||+|+||.||+|.+..++..||+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 45556699999999999999999999999999987665556778999999999999999999999999999999999999
Q ss_pred CCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC-CCceEEecccCccccCCCCC
Q 022447 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 153 g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~-~~~~kl~Dfg~~~~~~~~~~ 231 (297)
+++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. ++.++|+|||++......
T Consensus 103 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~-- 176 (295)
T 2clq_A 103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI-- 176 (295)
T ss_dssp EEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC--
Confidence 999999998632 1345779999999999999999999999 999999999999987 899999999999763322
Q ss_pred cceeecccccccccCccccccCC--CCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 232 THVSTRVMGTYGYCAPEYAKTGQ--LTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
........|++.|+|||++.+.. ++.++||||||+++|+|++|+.||.....
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence 12233457999999999987653 78999999999999999999999976543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=294.73 Aligned_cols=215 Identities=28% Similarity=0.414 Sum_probs=181.4
Q ss_pred HHHHHhcCCCCcceecccCcEEEEEEEE-----CCCCeEEEEEEeccCCcc-chHHHHHHHHHHhcc-CCCCccceeeEe
Q 022447 66 ELAAATKNFRSESLLGEGGFGRVYKGYL-----ESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLIGYC 138 (297)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 138 (297)
......++|++.+.||+|+||.||+|.+ ..+++.||||++...... ....+.+|+.++..+ +||||+++++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 3344567899999999999999999985 456799999999765332 335688999999999 699999999998
Q ss_pred ecCC-eeEEEEecCCCCChHhhhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 022447 139 ADGD-QRLLVYEYMPLGSVEDHLHDLSPG------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 205 (297)
Q Consensus 139 ~~~~-~~~lv~e~~~g~~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~ 205 (297)
...+ ..++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++||||||+
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~ 177 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 177 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccc
Confidence 7754 589999999999999999863321 123889999999999999999999999 999999999
Q ss_pred cEEEcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchh
Q 022447 206 NILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKA 283 (297)
Q Consensus 206 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~ 283 (297)
||+++.++.++|+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 99999999999999999976443333333445568899999999999999999999999999999998 9999987653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=290.60 Aligned_cols=197 Identities=20% Similarity=0.304 Sum_probs=173.8
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC-CCCccceeeEeec--CCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCAD--GDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv 147 (297)
.++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+.+++.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999999999999999998743 3467889999999997 9999999999987 6678999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC-ceEEecccCcccc
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLG 226 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~-~~kl~Dfg~~~~~ 226 (297)
|||+.+++|.+++.. +++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .++|+|||++...
T Consensus 112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 999999999998864 789999999999999999999999 99999999999999766 8999999999764
Q ss_pred CCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
.... ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 182 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 236 (330)
T 3nsz_A 182 HPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236 (330)
T ss_dssp CTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred CCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 3322 2334578999999999877 6789999999999999999999999965443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=289.49 Aligned_cols=206 Identities=23% Similarity=0.285 Sum_probs=163.6
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc-hHH-HHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NRE-FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~-~~~-~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
..++|++.+.||+|+||.||+|.+..+++.||+|++....... ..+ +..+...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3468999999999999999999999999999999997643322 223 34445557888999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
|||++ ++|.+++.........+++..++.++.|++.||.|||++ + ++||||||+||+++.++.++|+|||++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99998 588887765433467899999999999999999999998 8 999999999999999999999999998753
Q ss_pred CCCCCcceeecccccccccCcccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYA----KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
... .......||+.|+|||++ .+..++.++||||||+++|+|++|+.||....
T Consensus 161 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (290)
T 3fme_A 161 VDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG 217 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS
T ss_pred ccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC
Confidence 222 222334699999999996 56678999999999999999999999998643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=300.05 Aligned_cols=205 Identities=18% Similarity=0.228 Sum_probs=170.4
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCC-----CeEEEEEEeccCCccch-----------HHHHHHHHHHhccCCCCccc
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQGN-----------REFLVEVLMLSLLHHPNLVN 133 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~i~~ 133 (297)
..++|++.+.||+|+||.||+|.+..+ ++.||||++........ .....|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 346899999999999999999999765 58899999876432111 12445666777889999999
Q ss_pred eeeEeecC----CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE
Q 022447 134 LIGYCADG----DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (297)
Q Consensus 134 ~~~~~~~~----~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili 209 (297)
+++++... ...++||||+ |++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence 99998764 4589999999 89999999862 367999999999999999999999999 9999999999999
Q ss_pred c--CCCceEEecccCccccCCCCC-----cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 210 D--RGYHPKLSDFGLAKLGPVGDN-----THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 210 ~--~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
+ .++.++|+|||+++....... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9 889999999999975322211 11123455999999999999999999999999999999999999999964
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=307.49 Aligned_cols=204 Identities=16% Similarity=0.204 Sum_probs=163.9
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHH---HHhccCCCCcccee-------eE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN---GVQGNREFLVEVL---MLSLLHHPNLVNLI-------GY 137 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~---~l~~l~h~~i~~~~-------~~ 137 (297)
.++|.+.+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788999999999999999999999999999999743 2233467889994 55556799999998 66
Q ss_pred eecCC-----------------eeEEEEecCCCCChHhhhcccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 022447 138 CADGD-----------------QRLLVYEYMPLGSVEDHLHDLS---PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV 197 (297)
Q Consensus 138 ~~~~~-----------------~~~lv~e~~~g~~L~~~l~~~~---~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i 197 (297)
+.+.+ ..|++|||+ +|+|.+++.... .....+++..++.++.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 55543 278999999 589999998621 01122335888899999999999999999 9
Q ss_pred eecCCCCCcEEEcCCCceEEecccCccccCCCCCcceeecccccccccCccccccC-----------CCCcccchhhHHH
Q 022447 198 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-----------QLTLKSDVYSFGV 266 (297)
Q Consensus 198 vH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~DiwslG~ 266 (297)
+||||||+|||++.++.+||+|||+++.. ........| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~-----~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRD-----GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEET-----TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheec-----CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999752 123345667 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCcchhH
Q 022447 267 VLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 267 il~ell~g~~Pf~~~~~~ 284 (297)
++|+|++|+.||...+..
T Consensus 302 il~elltg~~Pf~~~~~~ 319 (377)
T 3byv_A 302 VIYWIWCADLPITKDAAL 319 (377)
T ss_dssp HHHHHHHSSCCC------
T ss_pred HHHHHHHCCCCCcccccc
Confidence 999999999999876543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=289.74 Aligned_cols=214 Identities=30% Similarity=0.478 Sum_probs=178.4
Q ss_pred HhcCCCCcc-eecccCcEEEEEEEE--CCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCee
Q 022447 70 ATKNFRSES-LLGEGGFGRVYKGYL--ESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 70 ~~~~y~~~~-~lg~G~~g~v~~~~~--~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 144 (297)
..++|.+.+ .||+|+||.||+|.+ ..++..||||++...... ..+.+.+|+.+++.++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 446788888 999999999999954 566899999999765332 246788999999999999999999999 55778
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 999999999999999987 567999999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCcc-eeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHHh
Q 022447 225 LGPVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVA 291 (297)
Q Consensus 225 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~~ 291 (297)
......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+.......+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 234 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 643332221 1222346789999999998889999999999999999999 999999887766554443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=303.92 Aligned_cols=205 Identities=28% Similarity=0.325 Sum_probs=170.5
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeec------CCee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD------GDQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~ 144 (297)
..+|++.+.||+|+||.||+|.+..+++.||||++..... ...+|+.+++.++||||+++++++.. ....
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 3468999999999999999999999999999999865322 22369999999999999999998853 1236
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC-CceEEecccCc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLA 223 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~-~~~kl~Dfg~~ 223 (297)
++||||++ ++|.+.+.........+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 79999998 4677666543333577999999999999999999999999 9999999999999954 67899999999
Q ss_pred cccCCCCCcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.
T Consensus 205 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~ 265 (420)
T 1j1b_A 205 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 265 (420)
T ss_dssp EECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred hhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 8643222 23346789999999998764 789999999999999999999999998765443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=293.73 Aligned_cols=210 Identities=33% Similarity=0.494 Sum_probs=177.3
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEE--EEEEeccCC-ccchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDV--AIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~v--avK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 147 (297)
++|++.+.||+|+||.||+|.+..++..+ ++|.+.... ......+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 68999999999999999999999888865 999886532 23345688999999999 899999999999999999999
Q ss_pred EecCCCCChHhhhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCce
Q 022447 148 YEYMPLGSVEDHLHDLS------------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~ 215 (297)
|||+++++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999998632 12347999999999999999999999999 9999999999999999999
Q ss_pred EEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhh
Q 022447 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQ 287 (297)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~ 287 (297)
+|+|||++..... ........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+.....
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence 9999999864211 112233457889999999998889999999999999999998 99999887765543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=292.96 Aligned_cols=203 Identities=27% Similarity=0.375 Sum_probs=172.8
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--------cchHHHHHHHHHHhccCCCCccceeeEeecC
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--------QGNREFLVEVLMLSLLHHPNLVNLIGYCADG 141 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 141 (297)
..++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 45689999999999999999999999999999999875422 1123478899999999999999999998765
Q ss_pred CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCc---eEEe
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLS 218 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~---~kl~ 218 (297)
. .++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++. ++|+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 8999999999999999976 567999999999999999999999999 999999999999987654 9999
Q ss_pred cccCccccCCCCCcceeecccccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
|||++..... ........||+.|+|||++. ...++.++||||||+++|+|++|..||.....
T Consensus 160 Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 160 DFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp CCTTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred cCccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 9999976322 12223456999999999874 46788999999999999999999999986543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=300.66 Aligned_cols=206 Identities=22% Similarity=0.312 Sum_probs=178.5
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcc------CCCCccceeeEeecCCe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL------HHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~ 143 (297)
...+|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3467999999999999999999999999999999997532 2234567788887776 57799999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCc--eEEeccc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH--PKLSDFG 221 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~--~kl~Dfg 221 (297)
.++||||+. ++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999997 69999998632 345899999999999999999999999 999999999999999887 9999999
Q ss_pred CccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
++..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..
T Consensus 248 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l 308 (429)
T 3kvw_A 248 SSCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL 308 (429)
T ss_dssp TCEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9975322 233457999999999999999999999999999999999999999988765543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=286.68 Aligned_cols=204 Identities=22% Similarity=0.265 Sum_probs=175.0
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 146 (297)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 44689999999999999999999999999999999876432 2345688899999988 89999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC--------------
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-------------- 212 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~-------------- 212 (297)
||||++|++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999863322367899999999999999999999999 9999999999999844
Q ss_pred -----CceEEecccCccccCCCCCcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 213 -----YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 213 -----~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
..++|+|||.+...... ....||+.|+|||.+.+. .++.++||||||+++|+|++|..|+...+
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence 47999999998763321 223589999999998765 56789999999999999999998876554
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=294.53 Aligned_cols=213 Identities=25% Similarity=0.336 Sum_probs=174.2
Q ss_pred CHHHHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc-----------hHHHHHHHHHHhccCCCCc
Q 022447 63 TFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-----------NREFLVEVLMLSLLHHPNL 131 (297)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i 131 (297)
...++....++|.+.+.||+|+||.||+|.+.. +..||||++....... .+.+.+|+.+++.++||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 455677788999999999999999999999876 9999999986532211 2578899999999999999
Q ss_pred cceeeEeec-----CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 022447 132 VNLIGYCAD-----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 206 (297)
Q Consensus 132 ~~~~~~~~~-----~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~N 206 (297)
+++++++.. ....|+||||+. ++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHH
Confidence 999999843 346899999998 688888875 2457999999999999999999999999 9999999999
Q ss_pred EEEcCCCceEEecccCccccCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 207 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 207 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
|+++.++.++|+|||++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 241 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241 (362)
T ss_dssp EEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEEcCCCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999974222 222344578999999998876 678999999999999999999999999876554
Q ss_pred h
Q 022447 286 E 286 (297)
Q Consensus 286 ~ 286 (297)
.
T Consensus 242 ~ 242 (362)
T 3pg1_A 242 Q 242 (362)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=288.66 Aligned_cols=204 Identities=27% Similarity=0.435 Sum_probs=175.1
Q ss_pred cCCCCcceecccCcEEEEEEE----ECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecC--Cee
Q 022447 72 KNFRSESLLGEGGFGRVYKGY----LESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 144 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~----~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 144 (297)
++|++.+.||+|+||.||+|. +..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 568899999999999999999 567899999999975432 3346788999999999999999999999876 668
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 9999999999999999652 456999999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCc-ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 225 LGPVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 225 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
........ .......||..|+|||.+.+..++.++||||||+++|+|++|..|+...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 232 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP 232 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcch
Confidence 64333221 2233456888999999999999999999999999999999999987654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=293.09 Aligned_cols=209 Identities=27% Similarity=0.347 Sum_probs=176.7
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEee----cCCeeE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA----DGDQRL 145 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~ 145 (297)
..++|++.+.||+|+||.||+|.+..+++.||||++..........+.+|+.+++.++||||+++++++. .....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 3468999999999999999999999999999999987665555677889999999999999999999986 345788
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+||||+++++|.+++.........+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999999865444677999999999999999999999999 99999999999999999999999998864
Q ss_pred cCCCCCc-------ceeecccccccccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 226 GPVGDNT-------HVSTRVMGTYGYCAPEYAKTGQ---LTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 226 ~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
....... .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 249 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV 249 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhh
Confidence 2211000 0012245799999999987554 688999999999999999999999753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=294.54 Aligned_cols=208 Identities=32% Similarity=0.465 Sum_probs=181.3
Q ss_pred hcCCCCcceecccCcEEEEEEE----ECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEee--cCCee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGY----LESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 144 (297)
.++|++.+.||+|+||.||+|. +..++..||||++........+.+.+|+.+++.++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 3689999999999999999999 56789999999998766666677899999999999999999999886 45678
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 8999999999999999762 245899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCc-ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 225 LGPVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 225 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
........ .......+++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~ 236 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch
Confidence 64333222 1223345888899999999999999999999999999999999999876653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=282.84 Aligned_cols=208 Identities=28% Similarity=0.442 Sum_probs=180.6
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 467899999999999999999997 578999999976543 346788999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~- 157 (267)
T 3t9t_A 85 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD- 157 (267)
T ss_dssp CTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-
T ss_pred CCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc-
Confidence 9999999999862 356899999999999999999999999 999999999999999999999999998753221
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQ 287 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~ 287 (297)
.........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+.....
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~ 215 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 215 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH
Confidence 1112223457789999999998999999999999999999999 89999987665443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=297.70 Aligned_cols=202 Identities=18% Similarity=0.243 Sum_probs=167.8
Q ss_pred hcCCCCcceecccCcEEEEEEEECC---CCeEEEEEEeccCCccc-----------hHHHHHHHHHHhccCCCCccceee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLES---INQDVAIKQLDRNGVQG-----------NREFLVEVLMLSLLHHPNLVNLIG 136 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~ 136 (297)
.++|.+.+.||+|+||.||+|.+.. ++..+|+|++....... ...+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3679999999999999999999987 78899999987653221 123667888899999999999999
Q ss_pred Eeec----CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC
Q 022447 137 YCAD----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 212 (297)
Q Consensus 137 ~~~~----~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~ 212 (297)
++.. ....|+||||+ |++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 9887 77899999999 8999999986 447999999999999999999999999 9999999999999887
Q ss_pred C--ceEEecccCccccCCCC-----CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCc
Q 022447 213 Y--HPKLSDFGLAKLGPVGD-----NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDT 280 (297)
Q Consensus 213 ~--~~kl~Dfg~~~~~~~~~-----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 280 (297)
+ .++|+|||+++...... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 7 99999999997542211 11112345799999999999999999999999999999999999999965
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=287.54 Aligned_cols=205 Identities=32% Similarity=0.517 Sum_probs=163.4
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
..++|++.+.||+|+||.||+|.+.. .||+|++...... ..+.+.+|+.+++.++||||++++++. .....++|
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 34689999999999999999998753 5999998765433 335688999999999999999999965 55678999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999999652 466999999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCcceeecccccccccCccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
............||+.|+|||++. +..++.++||||||+++|+|++|+.||......
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 231 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH
Confidence 323333344567999999999986 567888999999999999999999999875543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=301.79 Aligned_cols=204 Identities=30% Similarity=0.458 Sum_probs=176.1
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCC-eeEEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVY 148 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 148 (297)
..++|++.+.||+|+||.||+|.+. +..||||+++... ..+.+.+|+.+++.++||||+++++++.... ..++||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 3467889999999999999999986 7899999997653 4567899999999999999999999987655 789999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++....
T Consensus 267 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp ECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999998632 334789999999999999999999999 99999999999999999999999999975321
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQ 287 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~ 287 (297)
. .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+..+..
T Consensus 342 ~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~ 396 (450)
T 1k9a_A 342 T-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 396 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH
T ss_pred c-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 1 122357889999999999999999999999999999998 99999887655443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=296.05 Aligned_cols=211 Identities=29% Similarity=0.443 Sum_probs=180.4
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCe-----EEEEEEeccCCc-cchHHHHHHHHHHhcc-CCCCccceeeEeecCC
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQ-----DVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD 142 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~-----~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 142 (297)
..++|++.+.||+|+||.||+|.+..++. .||+|.+..... .....+.+|+.+++.+ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 45789999999999999999999977654 799999976533 2345688999999999 8999999999999999
Q ss_pred eeEEEEecCCCCChHhhhcccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSP----------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 212 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~ 212 (297)
..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 99999999999999999975311 1346899999999999999999999999 9999999999999999
Q ss_pred CceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchh
Q 022447 213 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKA 283 (297)
Q Consensus 213 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~ 283 (297)
+.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 9999999999975433332233334557889999999999999999999999999999998 9999987654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=288.49 Aligned_cols=207 Identities=24% Similarity=0.355 Sum_probs=171.7
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEee-----------
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA----------- 139 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----------- 139 (297)
.++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999999999999999998765555677889999999999999999999874
Q ss_pred ---cCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEc-CCCce
Q 022447 140 ---DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHP 215 (297)
Q Consensus 140 ---~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~-~~~~~ 215 (297)
+....++||||+. ++|.+++.. .++++..++.++.|++.||+|||+++ ++||||||+||+++ .++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 3467899999998 699999864 56899999999999999999999999 99999999999997 56799
Q ss_pred EEecccCccccCCCC-CcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 216 KLSDFGLAKLGPVGD-NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 216 kl~Dfg~~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
+|+|||++....... .........+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+.
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 233 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999997532211 1112234457999999998765 6789999999999999999999999998876544
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=292.51 Aligned_cols=217 Identities=30% Similarity=0.426 Sum_probs=176.6
Q ss_pred HhcCCCCcceecccCcEEEEEEE-----ECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGY-----LESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~-----~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 143 (297)
..++|++.+.||+|+||.||+|. +..++..||||.+..... ....++.+|+.+++.++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 34689999999999999999999 556788999999975432 334568899999999999999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC---CCceEE
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPG---KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKL 217 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~---~~~~kl 217 (297)
.++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++. +..++|
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999874321 245899999999999999999999999 999999999999984 456999
Q ss_pred ecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhH
Q 022447 218 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (297)
Q Consensus 218 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l 289 (297)
+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+.......
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 257 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 257 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH
Confidence 99999865322222223344568899999999999999999999999999999998 9999998766554443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=291.66 Aligned_cols=215 Identities=27% Similarity=0.429 Sum_probs=162.5
Q ss_pred HHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
....++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 3456789999999999999999999998999999999875432 234567889999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 147 VYEYMPLGSVEDHLHDLS----PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
||||++|++|.+++.... .....+++..++.++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 999999999999987421 12456899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCC---cceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 223 AKLGPVGDN---THVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 223 ~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
+........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 234 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK 234 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh
Confidence 865332211 112234569999999999875 568999999999999999999999998865543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=292.94 Aligned_cols=214 Identities=25% Similarity=0.297 Sum_probs=167.2
Q ss_pred HHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCC---
Q 022447 66 ELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--- 142 (297)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 142 (297)
......++|++.+.||+|+||.||+|.+..++..||||++.... .......+++..+..++||||+++++++....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34566789999999999999999999999999999999986542 22345667888888899999999999986533
Q ss_pred ----eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeeecCCCCCcEEEcC-CCce
Q 022447 143 ----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH--DKAKPPVIYRDLKCSNILLDR-GYHP 215 (297)
Q Consensus 143 ----~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~~~~ivH~dikp~Nili~~-~~~~ 215 (297)
..++||||+++ +|...+.........+++..++.++.|++.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 27899999985 555555433333677899999999999999999999 998 999999999999996 8999
Q ss_pred EEecccCccccCCCCCcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
+|+|||++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.....
T Consensus 172 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 241 (360)
T 3e3p_A 172 KLCDFGSAKKLSPS---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL 241 (360)
T ss_dssp EECCCTTCBCCCTT---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EEeeCCCceecCCC---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH
Confidence 99999999754322 223345789999999988654 4899999999999999999999999987765543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=293.18 Aligned_cols=202 Identities=24% Similarity=0.378 Sum_probs=174.0
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhccCCCCccceeeEeecCCee---
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQR--- 144 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--- 144 (297)
..++|.+.+.||+|+||.||+|.+..+|+.||||++....... ...+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3578999999999999999999999999999999997643332 35688999999999999999999999877655
Q ss_pred ---EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 022447 145 ---LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (297)
Q Consensus 145 ---~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg 221 (297)
++||||+. ++|.+++. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999998 68888774 34899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.
T Consensus 190 ~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 250 (371)
T 4exu_A 190 LARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 250 (371)
T ss_dssp CC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 9975321 2344678999999999877 7889999999999999999999999998765544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=282.85 Aligned_cols=202 Identities=29% Similarity=0.471 Sum_probs=174.5
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeec----CCeeE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRL 145 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 145 (297)
..|.+.+.||+|+||.||+|.+..++..|++|.+..... .....+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 457888899999999999999999999999999875433 234568899999999999999999998865 45689
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEc-CCCceEEecccCcc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAK 224 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~-~~~~~kl~Dfg~~~ 224 (297)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ .+++||||||+||+++ .++.++|+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999986 467899999999999999999999875 3499999999999997 78999999999987
Q ss_pred ccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
..... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||.....
T Consensus 181 ~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 234 (290)
T 1t4h_A 181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN 234 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred ccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc
Confidence 53222 233456999999999886 4589999999999999999999999987544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=285.13 Aligned_cols=205 Identities=25% Similarity=0.349 Sum_probs=171.5
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEe-ecCCeeEEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC-ADGDQRLLVY 148 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~ 148 (297)
..++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999999999999999987654322 3577899999999988777666655 6677889999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE---cCCCceEEecccCccc
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKL 225 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili---~~~~~~kl~Dfg~~~~ 225 (297)
||+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.++|+|||++..
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 89999999852 356999999999999999999999999 9999999999999 7889999999999976
Q ss_pred cCCCCCc-----ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 226 GPVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 226 ~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
....... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 4332221 122356799999999999999999999999999999999999999987543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=283.15 Aligned_cols=211 Identities=29% Similarity=0.441 Sum_probs=177.5
Q ss_pred cCCCCcc-eecccCcEEEEEEEEC--CCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 72 KNFRSES-LLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 72 ~~y~~~~-~lg~G~~g~v~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
++|.+.+ .||+|+||.||+|.+. .++..||+|++..... .....+.+|+.+++.++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4666666 9999999999999864 4688999999976532 2346788999999999999999999999 45678999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 999999999999975 2456999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCc-ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhH
Q 022447 228 VGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (297)
Q Consensus 228 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l 289 (297)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 225 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 225 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 32221 11223446889999999998899999999999999999998 9999988776554443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=279.96 Aligned_cols=204 Identities=24% Similarity=0.366 Sum_probs=175.0
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecC--CeeEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLL 146 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 146 (297)
.++|.+.+.||+|+||.||+|.+. +..||+|++...... ..+.+.+|+.+++.++||||+++++++.+. ...++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 468999999999999999999986 889999999765432 335688999999999999999999999887 78899
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ .+++||||||+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999999998622 336899999999999999999999874 45999999999999999999999988876531
Q ss_pred CCCCCcceeecccccccccCccccccCCCCc---ccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL---KSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
......||+.|+|||.+.+..++. ++||||||+++|+|++|+.||...+....
T Consensus 164 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 219 (271)
T 3kmu_A 164 -------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI 219 (271)
T ss_dssp -------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH
T ss_pred -------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH
Confidence 122346899999999998765554 79999999999999999999988766554
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=290.37 Aligned_cols=208 Identities=25% Similarity=0.337 Sum_probs=176.3
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecC-----Cee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 144 (297)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 4689999999999999999999999999999999965432 2335678999999999999999999987654 678
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
++||||+. ++|.+++.. ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999998 689999875 46899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCcc--------eeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 225 LGPVGDNTH--------VSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 225 ~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 232 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 643221110 1223578999999998754 67899999999999999999999999988765443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=289.89 Aligned_cols=212 Identities=27% Similarity=0.421 Sum_probs=173.3
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCC----eEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESIN----QDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
..+|.+.+.||+|+||.||+|.+..++ ..||+|.+...... ....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 457888899999999999999987543 46999999754322 3356889999999999999999999999999999
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 123 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999762 367999999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCCC-cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 226 GPVGDN-THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 226 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
...... ........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+...
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~ 261 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK 261 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 432211 111223346789999999998999999999999999999999 999998776654433
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=283.13 Aligned_cols=204 Identities=25% Similarity=0.347 Sum_probs=174.7
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEe-ecCCeeEEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC-ADGDQRLLVY 148 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~ 148 (297)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|++++..+..+ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 35789999999999999999999999999999999875433 24678899999999988876666555 5677889999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE---cCCCceEEecccCccc
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKL 225 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili---~~~~~~kl~Dfg~~~~ 225 (297)
||+ +++|.+++... ...+++..++.++.|++.||.|||+++ ++||||||+|||+ +.++.++|+|||++..
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 89999999752 457999999999999999999999999 9999999999999 4788999999999976
Q ss_pred cCCCCCc-----ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 226 GPVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 226 ~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
....... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 4332221 11245679999999999999999999999999999999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=303.51 Aligned_cols=210 Identities=27% Similarity=0.436 Sum_probs=179.0
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..++|.+.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+++.++||||+++++++. ....++|||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred chHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 45678889999999999999999875 7889999997643 34678999999999999999999999986 567899999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 263 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred ecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999999997521 236889999999999999999999999 999999999999999999999999999764221
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
. ........+++.|+|||++....++.++||||||+++|||++ |+.||...+..+...
T Consensus 338 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~ 396 (454)
T 1qcf_A 338 E-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 396 (454)
T ss_dssp H-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred c-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 1 111223346788999999998999999999999999999999 999999876655433
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=286.14 Aligned_cols=199 Identities=27% Similarity=0.423 Sum_probs=166.4
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhc--cCCCCccceeeEeec----CCe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSL--LHHPNLVNLIGYCAD----GDQ 143 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~----~~~ 143 (297)
..++|++.+.||+|+||.||+|.+ +++.||||++... ....+..|.+++.. ++||||+++++++.. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 356899999999999999999988 4899999998653 33455566666665 789999999998654 356
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeecCCCCCcEEEcCCCce
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH--------DKAKPPVIYRDLKCSNILLDRGYHP 215 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~~ivH~dikp~Nili~~~~~~ 215 (297)
.++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+
T Consensus 81 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCE
T ss_pred eEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCE
Confidence 8899999999999999964 57999999999999999999999 888 9999999999999999999
Q ss_pred EEecccCccccCCCCCcc--eeecccccccccCccccccC------CCCcccchhhHHHHHHHHHhC----------CCC
Q 022447 216 KLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAKTG------QLTLKSDVYSFGVVLLEILSG----------RKA 277 (297)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----------~~P 277 (297)
||+|||++.......... ......||+.|+|||++.+. .++.++||||||+++|||++| ..|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999999987533222211 12234799999999999876 455799999999999999999 888
Q ss_pred CCcc
Q 022447 278 VDTS 281 (297)
Q Consensus 278 f~~~ 281 (297)
|...
T Consensus 233 f~~~ 236 (301)
T 3q4u_A 233 FYDV 236 (301)
T ss_dssp TTTT
T ss_pred cccc
Confidence 8653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=297.11 Aligned_cols=205 Identities=26% Similarity=0.357 Sum_probs=167.6
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCC------ee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------QR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~ 144 (297)
..+|++.+.||+|+||.||+|.+..++. ||+|++...... ..+|+.+++.++||||+++++++.... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3579999999999999999999988666 888877543221 225999999999999999999985433 37
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEc-CCCceEEecccCc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLA 223 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~-~~~~~kl~Dfg~~ 223 (297)
++||||+++ ++...+.........+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++
T Consensus 114 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 899999985 444444322222567999999999999999999999999 99999999999999 7899999999999
Q ss_pred cccCCCCCcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
+...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+..
T Consensus 190 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l 251 (394)
T 4e7w_A 190 KILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL 251 (394)
T ss_dssp EECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 7643222 23346789999999988664 5899999999999999999999999988765443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=285.21 Aligned_cols=201 Identities=28% Similarity=0.415 Sum_probs=175.8
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeec--------
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-------- 140 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 140 (297)
....+|++.+.||+|+||.||+|.+..+++.||+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 34568999999999999999999999999999999997543 346679999999999999999998854
Q ss_pred --------CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC
Q 022447 141 --------GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 212 (297)
Q Consensus 141 --------~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~ 212 (297)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDT 158 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCC
Confidence 445789999999999999997632 357899999999999999999999999 9999999999999999
Q ss_pred CceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 213 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 213 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
+.++|+|||++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 159 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 224 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET 224 (284)
T ss_dssp TEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH
T ss_pred CCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH
Confidence 999999999987643321 223456999999999999999999999999999999999999998654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=287.54 Aligned_cols=207 Identities=23% Similarity=0.305 Sum_probs=178.4
Q ss_pred HhcCCCCcceecccCcEEEEEEEE-CCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCC------CccceeeEeecCC
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYL-ESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHP------NLVNLIGYCADGD 142 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~ 142 (297)
..++|++.+.||+|+||.||+|.+ ..++..||+|++.... .....+.+|+.+++.++|+ +++++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 346899999999999999999999 5679999999996432 2345678899999888765 4999999999999
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC-----------
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR----------- 211 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~----------- 211 (297)
..++||||+ +++|.+++.... ..++++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 799999998632 346899999999999999999999999 999999999999987
Q ss_pred --------CCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 212 --------GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 212 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
++.++|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 66899999999975322 22345799999999999999999999999999999999999999998876
Q ss_pred Hhhhh
Q 022447 284 AAEQS 288 (297)
Q Consensus 284 ~~~~~ 288 (297)
.+...
T Consensus 240 ~~~~~ 244 (339)
T 1z57_A 240 KEHLA 244 (339)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 65443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=282.71 Aligned_cols=208 Identities=28% Similarity=0.398 Sum_probs=180.5
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 355789999999999999999999999999999999865432 345678899999999999999999999999999999
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC---CceEEecccCc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG---YHPKLSDFGLA 223 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~---~~~kl~Dfg~~ 223 (297)
|||++++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.+ +.++|+|||++
T Consensus 99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999999876 457999999999999999999999999 9999999999999754 46999999998
Q ss_pred cccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
....... ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||...+..+..
T Consensus 172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 231 (287)
T 2wei_A 172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231 (287)
T ss_dssp GTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred eeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 7543221 2233458999999998875 4899999999999999999999999887665443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=281.82 Aligned_cols=211 Identities=29% Similarity=0.404 Sum_probs=174.0
Q ss_pred CCCCcceecccCcEEEEEEEECCCC---eEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCee-EEE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESIN---QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR-LLV 147 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~lv 147 (297)
.|.+.+.||+|+||.||+|.+..++ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4566789999999999999975544 3799999875433 2346788999999999999999999999876655 899
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||+.+++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999976 2466899999999999999999999999 9999999999999999999999999997532
Q ss_pred CCC--CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhC-CCCCCcchhHhhhhH
Q 022447 228 VGD--NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAAEQSL 289 (297)
Q Consensus 228 ~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~Pf~~~~~~~~~~l 289 (297)
... .........+++.|+|||.+.+..++.++||||||+++|+|++| .+||...+..+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~ 240 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF 240 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH
Confidence 211 11222345688999999999999999999999999999999995 555666555444333
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=290.28 Aligned_cols=203 Identities=22% Similarity=0.314 Sum_probs=177.7
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccch-----------------HHHHHHHHHHhccCCCCcc
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN-----------------REFLVEVLMLSLLHHPNLV 132 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~-----------------~~~~~e~~~l~~l~h~~i~ 132 (297)
..++|++.+.||+|+||.||+|.+ +++.||||++........ ..+.+|+.+++.++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 347899999999999999999999 799999999865322211 6788999999999999999
Q ss_pred ceeeEeecCCeeEEEEecCCCCChHhh------hcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCC
Q 022447 133 NLIGYCADGDQRLLVYEYMPLGSVEDH------LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCS 205 (297)
Q Consensus 133 ~~~~~~~~~~~~~lv~e~~~g~~L~~~------l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~dikp~ 205 (297)
++++++.+.+..++||||+++++|.++ +... ....+++..++.++.|++.||.|||+ .+ ++||||+|+
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~ 181 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPS 181 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGG
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChH
Confidence 999999999999999999999999998 4431 14679999999999999999999999 98 999999999
Q ss_pred cEEEcCCCceEEecccCccccCCCCCcceeecccccccccCccccccC-CCCc-ccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 206 NILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTL-KSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 206 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
||+++.++.++|+|||.+...... ......|++.|+|||.+.+. .++. ++||||||+++|+|++|+.||...+.
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred hEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999999763222 34456799999999999877 6666 99999999999999999999988765
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=282.83 Aligned_cols=211 Identities=27% Similarity=0.409 Sum_probs=175.3
Q ss_pred HhcCCCCcceecccCcEEEEEEEECC---CCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLES---INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34689999999999999999999654 345699999876532 334678899999999999999999999875 4568
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 999999999999999762 356899999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
..... ........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+......
T Consensus 163 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~ 225 (281)
T 3cc6_A 163 IEDED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG 225 (281)
T ss_dssp C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH
T ss_pred ccccc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH
Confidence 33221 112233457889999999998999999999999999999998 999998665554433
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=295.66 Aligned_cols=201 Identities=22% Similarity=0.249 Sum_probs=172.9
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC--------CCCccceeeEee--
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH--------HPNLVNLIGYCA-- 139 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~-- 139 (297)
..++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 347899999999999999999999999999999999743 223456788999998885 788999999987
Q ss_pred --cCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCcEEEcCCC---
Q 022447 140 --DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGY--- 213 (297)
Q Consensus 140 --~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~dikp~Nili~~~~--- 213 (297)
.....++||||+. ++|.+++.... ...+++..++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 114 GVNGTHICMVFEVLG-HHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp ETTEEEEEEEECCCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHH
T ss_pred CCCCceEEEEEeccC-ccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhh
Confidence 5568899999995 67777776521 35699999999999999999999998 8 99999999999998775
Q ss_pred ----------------------------------------------ceEEecccCccccCCCCCcceeecccccccccCc
Q 022447 214 ----------------------------------------------HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247 (297)
Q Consensus 214 ----------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aP 247 (297)
.++|+|||++..... ......||+.|+||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aP 262 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCC
Confidence 799999999976322 23345799999999
Q ss_pred cccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 248 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 248 E~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
|++.+..++.++|||||||++|+|++|+.||...+
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 99999999999999999999999999999998654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=279.64 Aligned_cols=208 Identities=31% Similarity=0.492 Sum_probs=177.3
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+ +..++|||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 3467889999999999999999986 47789999997543 345678899999999999999999999864 56899999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 88 ~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 88 YMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp CCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred cCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 999999999997521 236899999999999999999999999 999999999999999999999999999764322
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
. ........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+.
T Consensus 163 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 219 (279)
T 1qpc_A 163 E-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219 (279)
T ss_dssp C-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred c-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH
Confidence 1 112233456789999999998899999999999999999999 9999988766544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=282.45 Aligned_cols=210 Identities=29% Similarity=0.448 Sum_probs=172.4
Q ss_pred hcCCCCcceecccCcEEEEEEEECCC---CeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEe-ecCCeeE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYC-ADGDQRL 145 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~ 145 (297)
..+|++.+.||+|+||.||+|.+..+ ...|++|.+..... .....+.+|+.+++.++||||+++++++ ......+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 45788999999999999999997543 34689999875433 2346688999999999999999999985 4566789
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++..
T Consensus 104 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 99999999999999975 2456899999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCC--cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 226 GPVGDN--THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 226 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
...... ........+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~ 241 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 241 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH
Confidence 322211 112234557889999999999999999999999999999999 6677776655433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=287.59 Aligned_cols=206 Identities=31% Similarity=0.480 Sum_probs=177.7
Q ss_pred hcCCCCcceecccCcEEEEEEE----ECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCC--ee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGY----LESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 144 (297)
.++|++.+.||+|+||.||+|. +..++..||+|++..........+.+|+.+++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 4578999999999999999998 46689999999998765555677899999999999999999999987644 78
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
++||||+++++|.+++... ...+++..++.++.|++.||.+||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999999862 356899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcc-eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 225 LGPVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 225 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
......... ......++..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 252 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP 252 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH
Confidence 643332211 1223457788999999998889999999999999999999999998653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=284.73 Aligned_cols=208 Identities=27% Similarity=0.395 Sum_probs=176.1
Q ss_pred HhcCCCCcceecccCcEEEEEEEEC-CCCeEEEEEEeccCCcc--chHHHHHHHHHHhcc---CCCCccceeeEee----
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLE-SINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLL---HHPNLVNLIGYCA---- 139 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~---- 139 (297)
..++|++.+.||+|+||.||+|.+. .+++.||+|++...... ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999995 67899999998653222 223466777777666 8999999999987
Q ss_pred -cCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEe
Q 022447 140 -DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 218 (297)
Q Consensus 140 -~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~ 218 (297)
.....++||||+. ++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999998 69999998633 345899999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
|||++..... ........|++.|+|||++.+..++.++||||||+++|+|++|+.||...+..+.
T Consensus 163 Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 227 (326)
T 1blx_A 163 DFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 227 (326)
T ss_dssp SCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 9999875321 2223446789999999999999999999999999999999999999998776543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=294.06 Aligned_cols=201 Identities=19% Similarity=0.249 Sum_probs=171.0
Q ss_pred hcCCCCcceecccCcEEEEEEEECCC--------CeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccc---------
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESI--------NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN--------- 133 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~--------- 133 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 36899999999999999999999874 889999998754 45778999999999999987
Q ss_pred ------eeeEeec-CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 022447 134 ------LIGYCAD-GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 206 (297)
Q Consensus 134 ------~~~~~~~-~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~N 206 (297)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 5566655 67889999999 899999998621 367999999999999999999999999 9999999999
Q ss_pred EEEcCCC--ceEEecccCccccCCCCC-----cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 022447 207 ILLDRGY--HPKLSDFGLAKLGPVGDN-----THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 279 (297)
Q Consensus 207 ili~~~~--~~kl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 279 (297)
||++.++ .++|+|||++........ ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999988 899999999975322111 111234579999999999999999999999999999999999999999
Q ss_pred cch
Q 022447 280 TSK 282 (297)
Q Consensus 280 ~~~ 282 (297)
...
T Consensus 270 ~~~ 272 (352)
T 2jii_A 270 NCL 272 (352)
T ss_dssp GGT
T ss_pred cCC
Confidence 864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=286.46 Aligned_cols=204 Identities=33% Similarity=0.487 Sum_probs=173.8
Q ss_pred cCC-CCcceecccCcEEEEEEEE----CCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeec--CCe
Q 022447 72 KNF-RSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQ 143 (297)
Q Consensus 72 ~~y-~~~~~lg~G~~g~v~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 143 (297)
++| ++.+.||+|+||.||++.. ..+++.||||++..... .....+.+|+.+++.++||||+++++++.+ ...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 344 8999999999999987754 45789999999976533 234568899999999999999999999987 467
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
.++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccc
Confidence 8999999999999999986 45999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCc-ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 224 KLGPVGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 224 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
......... .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 242 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT 242 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccch
Confidence 865433222 223345688899999999999999999999999999999999999987644
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=287.56 Aligned_cols=201 Identities=24% Similarity=0.372 Sum_probs=172.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCe-----
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ----- 143 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 143 (297)
.++|.+.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46899999999999999999999999999999999764332 23568899999999999999999999987654
Q ss_pred -eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 144 -RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 144 -~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
.++||||+. ++|.+++. ..+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999998 68887764 34899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 223 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
+..... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+.
T Consensus 173 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 232 (353)
T 3coi_A 173 ARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 232 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH
T ss_pred ccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 875321 2234578999999999876 6789999999999999999999999998765443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=300.34 Aligned_cols=210 Identities=32% Similarity=0.460 Sum_probs=174.9
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+++.++||||+++++++.+ ...++|||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 34678889999999999999999976 5679999997654 335678999999999999999999999876 67899999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+++++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 259 ~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 259 YMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999997521 356899999999999999999999999 999999999999999999999999999764322
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
. ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+..+...
T Consensus 334 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~ 392 (452)
T 1fmk_A 334 E-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 392 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred c-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 1 112233457789999999999999999999999999999999 999999877655443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=297.98 Aligned_cols=204 Identities=26% Similarity=0.370 Sum_probs=175.0
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCC-CCccceeeEeecCCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 149 (297)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+..|+.+++.+.| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999999999999999998654332 357789999999986 556666666777888999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE---cCCCceEEecccCcccc
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili---~~~~~~kl~Dfg~~~~~ 226 (297)
|+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.++|+|||+++..
T Consensus 84 ~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 89999999752 457999999999999999999999999 9999999999999 57899999999999764
Q ss_pred CCCCCc-----ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 227 PVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 227 ~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 332221 122356799999999999999999999999999999999999999987544
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=288.24 Aligned_cols=211 Identities=27% Similarity=0.395 Sum_probs=161.0
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC-CCCccceeeEee--------c
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCA--------D 140 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--------~ 140 (297)
...+|++.+.||+|+||.||+|.+..+++.||||++..........+.+|+.+++.+. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3458999999999999999999999999999999987665555677889999999996 999999999983 3
Q ss_pred CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecc
Q 022447 141 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (297)
Q Consensus 141 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Df 220 (297)
...++++|||+. ++|.+++..... ..++++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.++|+||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 445789999997 789988865322 456999999999999999999999874 34999999999999999999999999
Q ss_pred cCccccCCCCCc----------ceeecccccccccCcccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 221 GLAKLGPVGDNT----------HVSTRVMGTYGYCAPEYA---KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 221 g~~~~~~~~~~~----------~~~~~~~g~~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
|++......... .......||+.|+|||++ .+..++.++||||||+++|+|++|+.||.....
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 999764322111 111244689999999998 566789999999999999999999999986543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=295.34 Aligned_cols=201 Identities=12% Similarity=0.050 Sum_probs=155.4
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhcc--CCCCcccee-------eEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLL--HHPNLVNLI-------GYC 138 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l--~h~~i~~~~-------~~~ 138 (297)
..+|.+.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34588999999999999999999999999999999875432 234566775444444 699988755 444
Q ss_pred ecC-----------------CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCC
Q 022447 139 ADG-----------------DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR------MKIAAGAARGLEYLHDKAKP 195 (297)
Q Consensus 139 ~~~-----------------~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~------~~i~~qi~~al~~LH~~~~~ 195 (297)
..+ ...|+||||++ ++|.+++... ...+.+..+ +.++.||+.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 332 34799999999 8999999863 123344445 677799999999999999
Q ss_pred CeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcceeecccccccccCcccccc--CCCCcccchhhHHHHHHHHHh
Q 022447 196 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILS 273 (297)
Q Consensus 196 ~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~ 273 (297)
|+||||||+|||++.++.+||+|||++.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETT-----CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecC-----CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 9999999999999999999999999998532 12224567799999999987 779999999999999999999
Q ss_pred CCCCCCcchh
Q 022447 274 GRKAVDTSKA 283 (297)
Q Consensus 274 g~~Pf~~~~~ 283 (297)
|+.||.....
T Consensus 289 g~~Pf~~~~~ 298 (371)
T 3q60_A 289 LFLPFGLVTP 298 (371)
T ss_dssp SSCSTTBCCT
T ss_pred CCCCCCCcCc
Confidence 9999998744
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=291.12 Aligned_cols=206 Identities=25% Similarity=0.308 Sum_probs=176.2
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC-CC-----CccceeeEeecCC
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HP-----NLVNLIGYCADGD 142 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~ 142 (297)
...++|++.+.||+|+||.||+|.+..+++.||||++.... .....+..|+.+++.++ |+ +|+++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 45679999999999999999999999999999999997432 22355677888888775 44 4999999999999
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeeecCCCCCcEEEc--CCCceEEe
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD--KAKPPVIYRDLKCSNILLD--RGYHPKLS 218 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~~~~ivH~dikp~Nili~--~~~~~kl~ 218 (297)
..++||||+. ++|.+++.... ...+++..++.++.|++.||.|||+ .+ |+||||||+|||++ .++.+||+
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEEC
T ss_pred ceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999997 59999998632 3568999999999999999999994 67 99999999999995 47789999
Q ss_pred cccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.
T Consensus 204 DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~ 266 (382)
T 2vx3_A 204 DFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266 (382)
T ss_dssp CCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred eccCceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999976422 22346799999999999999999999999999999999999999998776554
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=279.86 Aligned_cols=204 Identities=30% Similarity=0.457 Sum_probs=169.5
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecC-CeeEEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-DQRLLVY 148 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~ 148 (297)
..++|++.+.||+|+||.||+|.+. +..||+|++.... ..+.+.+|+.+++.++||||+++++++.+. +..++||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 3468999999999999999999885 8899999987543 446788999999999999999999997654 5789999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999999997621 223789999999999999999999999 99999999999999999999999999874322
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQ 287 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~ 287 (297)
. .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+..
T Consensus 170 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 224 (278)
T 1byg_A 170 T-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 224 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH
T ss_pred c-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 1 223457889999999999999999999999999999998 99999887654443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=282.20 Aligned_cols=198 Identities=35% Similarity=0.514 Sum_probs=165.5
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|++.+.||+|+||.||+|.+. ++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 357889999999999999999986 789999998643 344678899999999999999999998874 47899999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCeeecCCCCCcEEEcCCCc-eEEecccCcccc
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD---KAKPPVIYRDLKCSNILLDRGYH-PKLSDFGLAKLG 226 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~~~~ivH~dikp~Nili~~~~~-~kl~Dfg~~~~~ 226 (297)
++|++|.+++.... ....+++..++.++.|++.||.|||+ ++ |+||||||+||+++.++. +||+|||++...
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 81 AEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp CTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred CCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 99999999998632 12347899999999999999999999 67 999999999999998876 799999998643
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 157 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 208 (307)
T 2eva_A 157 QT-----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG 208 (307)
T ss_dssp -------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS
T ss_pred cc-----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc
Confidence 21 12334699999999999999999999999999999999999999986543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=295.83 Aligned_cols=206 Identities=24% Similarity=0.345 Sum_probs=158.0
Q ss_pred cCCCC-cceecccCcEEEEEEEEC--CCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEee--cCCeeEE
Q 022447 72 KNFRS-ESLLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLL 146 (297)
Q Consensus 72 ~~y~~-~~~lg~G~~g~v~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~l 146 (297)
+.|++ .+.||+|+||.||+|.++ .++..||||++..... ...+.+|+.+++.++||||+++++++. .....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 44666 458999999999999976 5689999999975432 356788999999999999999999994 4678999
Q ss_pred EEecCCCCChHhhhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE----cCCCceEE
Q 022447 147 VYEYMPLGSVEDHLHDLS-----PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL----DRGYHPKL 217 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili----~~~~~~kl 217 (297)
||||+. ++|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.++|
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999997 58888776321 11235999999999999999999999999 9999999999999 67789999
Q ss_pred ecccCccccCCCC-CcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 218 SDFGLAKLGPVGD-NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 218 ~Dfg~~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
+|||++....... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 9999997643221 1122345679999999999877 4589999999999999999999999976554
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=308.04 Aligned_cols=205 Identities=30% Similarity=0.491 Sum_probs=171.5
Q ss_pred ceecccCcEEEEEEEE--CCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYL--ESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.||+|+||.||+|.+ +.+++.||||+++.... ...+.+.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999965 45678999999976433 234678999999999999999999999865 567899999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCc-
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT- 232 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 232 (297)
++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999986 567999999999999999999999999 999999999999999999999999999764333221
Q ss_pred ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHH
Q 022447 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 233 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~ 290 (297)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i 585 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 585 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 12233456789999999999999999999999999999998 99999988776654443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=291.19 Aligned_cols=207 Identities=29% Similarity=0.460 Sum_probs=164.3
Q ss_pred CCCCcceecccCcEEEEEEEECCC---CeEEEEEEeccCC-ccchHHHHHHHHHHhccCCCCccceeeEeec-CCeeEEE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLV 147 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 147 (297)
.|++.+.||+|+||.||+|.+..+ +..||+|.+.... .....++.+|+.+++.++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 467788999999999999997533 3468999986533 2334678899999999999999999998654 5678999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999975 2456889999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCc--ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 228 VGDNT--HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 228 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
..... .......+++.|+|||.+.+..++.++||||||+++|||++ |.+||...+..+
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~ 304 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH
Confidence 22111 12233457889999999999999999999999999999999 778887765443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=284.54 Aligned_cols=206 Identities=21% Similarity=0.280 Sum_probs=176.3
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCC-eEEEEEEeccCCccchHHHHHHHHHHhccCCCC------ccceeeEeecCC
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESIN-QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN------LVNLIGYCADGD 142 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~ 142 (297)
..++|++.+.||+|+||.||+|.+..++ ..||+|++... ......+.+|+.+++.++|++ ++.+++++....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 3578999999999999999999998776 79999999743 233456778999998887655 899999999999
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE-------------
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL------------- 209 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili------------- 209 (297)
..++||||+ +++|.+++.... ..++++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence 999999999 577777776522 356999999999999999999999999 9999999999999
Q ss_pred ------cCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 210 ------DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 210 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
+.++.++|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 5678999999999975322 22345799999999999999999999999999999999999999998776
Q ss_pred Hhhh
Q 022447 284 AAEQ 287 (297)
Q Consensus 284 ~~~~ 287 (297)
.+..
T Consensus 245 ~~~~ 248 (355)
T 2eu9_A 245 REHL 248 (355)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=281.80 Aligned_cols=201 Identities=27% Similarity=0.391 Sum_probs=166.6
Q ss_pred HHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhc--cCCCCccceeeEeecC----
Q 022447 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSL--LHHPNLVNLIGYCADG---- 141 (297)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~---- 141 (297)
....++|++.+.||+|+||.||+|.+. +..||||++... .......|.+++.. ++||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 345678999999999999999999986 899999998643 23344556666555 4899999999999877
Q ss_pred CeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeeecCCCCCcEEEcCCC
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK--------AKPPVIYRDLKCSNILLDRGY 213 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------~~~~ivH~dikp~Nili~~~~ 213 (297)
...++||||+++++|.+++.. ..+++..++.++.|++.||.|||+. + |+||||||+|||++.++
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNG 179 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTS
T ss_pred CceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCC
Confidence 788999999999999999975 4699999999999999999999998 8 99999999999999999
Q ss_pred ceEEecccCccccCCCCCc--ceeecccccccccCccccccCCCCcc------cchhhHHHHHHHHHhC----------C
Q 022447 214 HPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAKTGQLTLK------SDVYSFGVVLLEILSG----------R 275 (297)
Q Consensus 214 ~~kl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~------~DiwslG~il~ell~g----------~ 275 (297)
.+||+|||++......... .......||+.|+|||++.+..++.. +|||||||++|||++| .
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 9999999999754322211 11224579999999999987776665 9999999999999999 7
Q ss_pred CCCCcc
Q 022447 276 KAVDTS 281 (297)
Q Consensus 276 ~Pf~~~ 281 (297)
.||...
T Consensus 260 ~p~~~~ 265 (337)
T 3mdy_A 260 LPYHDL 265 (337)
T ss_dssp CTTTTT
T ss_pred ccHhhh
Confidence 777653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=287.41 Aligned_cols=207 Identities=26% Similarity=0.398 Sum_probs=177.4
Q ss_pred HHHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc------hHHHHHHHHHHhccC--CCCccceee
Q 022447 65 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG------NREFLVEVLMLSLLH--HPNLVNLIG 136 (297)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~e~~~l~~l~--h~~i~~~~~ 136 (297)
.+.....++|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.+++.++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 344456688999999999999999999999999999999997643221 234667999999986 599999999
Q ss_pred EeecCCeeEEEEecCCC-CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEc-CCCc
Q 022447 137 YCADGDQRLLVYEYMPL-GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYH 214 (297)
Q Consensus 137 ~~~~~~~~~lv~e~~~g-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~-~~~~ 214 (297)
++...+..++|||++.+ ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ +++.
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCC
Confidence 99999999999999976 899999987 567999999999999999999999999 99999999999999 7899
Q ss_pred eEEecccCccccCCCCCcceeecccccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 215 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 215 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
++|+|||++...... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...+
T Consensus 189 ~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 253 (320)
T 3a99_A 189 LKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 253 (320)
T ss_dssp EEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred EEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh
Confidence 999999999764322 2234569999999999887765 688999999999999999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=305.71 Aligned_cols=210 Identities=28% Similarity=0.432 Sum_probs=172.5
Q ss_pred CCCcc-eecccCcEEEEEEEEC--CCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 74 FRSES-LLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 74 y~~~~-~lg~G~~g~v~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
+.+.+ .||+|+||.||+|.++ .++..||||+++.... ...+.+.+|+.+++.++||||+++++++.. +..++|||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E 415 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 415 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence 33444 7999999999999875 3567899999976532 345779999999999999999999999976 56899999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+.+++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 416 ~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 416 MAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp CCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred eCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999752 456999999999999999999999999 999999999999999999999999999764322
Q ss_pred CCc-ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHH
Q 022447 230 DNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 230 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~ 290 (297)
... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i 552 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 211 11122345689999999999999999999999999999998 99999987766554433
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=282.01 Aligned_cols=205 Identities=25% Similarity=0.341 Sum_probs=155.0
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHH-HHhccCCCCccceeeEeecCCeeEEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
.++|++.+.||+|+||.||+|.++.+++.||||++...... ....+..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 46899999999999999999999999999999999765322 2344556665 677789999999999999999999999
Q ss_pred ecCCCCChHhhhcccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 149 EYMPLGSVEDHLHDLS-PGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||++ ++|.+++.... .....+++..++.++.|++.||.|||+. + ++||||||+||+++.++.++|+|||++...
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9998 48877775311 1246789999999999999999999998 9 999999999999999999999999998753
Q ss_pred CCCCCcceeecccccccccCcccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYA----KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
... .......||+.|+|||++ .+..++.++||||||+++|+|++|+.||....
T Consensus 177 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 177 VDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred ccc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 221 122334699999999998 45678999999999999999999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=303.54 Aligned_cols=210 Identities=32% Similarity=0.460 Sum_probs=178.5
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+++.++||||+++++++.+ ...++|||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 34568888999999999999999976 5679999997654 335678999999999999999999999876 67899999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+.+++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 342 ~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 342 YMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred hhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999999997521 345899999999999999999999999 999999999999999999999999999753221
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
. ........++..|+|||.+.+..++.++|||||||++|||++ |+.||...+..+...
T Consensus 417 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~ 475 (535)
T 2h8h_A 417 E-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 475 (535)
T ss_dssp H-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHH
T ss_pred c-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 1 111223446789999999998999999999999999999999 999999876655443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=285.02 Aligned_cols=204 Identities=30% Similarity=0.457 Sum_probs=168.3
Q ss_pred HHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc------hHHHHHHHHHHhcc----CCCCccceeeE
Q 022447 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG------NREFLVEVLMLSLL----HHPNLVNLIGY 137 (297)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~e~~~l~~l----~h~~i~~~~~~ 137 (297)
....++|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.++..+ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 345678999999999999999999999999999999997653321 22355688888888 89999999999
Q ss_pred eecCCeeEEEEec-CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEc-CCCce
Q 022447 138 CADGDQRLLVYEY-MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHP 215 (297)
Q Consensus 138 ~~~~~~~~lv~e~-~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~-~~~~~ 215 (297)
+...+..++|||+ +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++ .++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 9999999999999 789999999987 467999999999999999999999999 99999999999999 88999
Q ss_pred EEecccCccccCCCCCcceeecccccccccCccccccCCCC-cccchhhHHHHHHHHHhCCCCCCcch
Q 022447 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT-LKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
+|+|||++...... ......|++.|+|||++.+..+. .++||||||+++|+|++|+.||....
T Consensus 180 kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 243 (312)
T 2iwi_A 180 KLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ 243 (312)
T ss_dssp EECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred EEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH
Confidence 99999998764322 23345689999999998776664 58999999999999999999998653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=287.36 Aligned_cols=199 Identities=30% Similarity=0.461 Sum_probs=160.7
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHH--HhccCCCCccceeeEee-----cCC
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLM--LSLLHHPNLVNLIGYCA-----DGD 142 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~-----~~~ 142 (297)
..++|++.+.||+|+||.||+|.+ +++.||||++.... ...+..|..+ +..++||||+++++.+. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 347899999999999999999977 48999999986432 2334444444 45589999999997543 234
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeeecCCCCCcEEEcCCC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK---------AKPPVIYRDLKCSNILLDRGY 213 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---------~~~~ivH~dikp~Nili~~~~ 213 (297)
.+++||||+++++|.+++.. ...++..++.++.||+.||.|||+. + |+||||||+|||++.++
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTS
T ss_pred eEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCC
Confidence 67899999999999999976 4458899999999999999999999 8 99999999999999999
Q ss_pred ceEEecccCccccCCCC------CcceeecccccccccCcccccc-------CCCCcccchhhHHHHHHHHHhCCCCCCc
Q 022447 214 HPKLSDFGLAKLGPVGD------NTHVSTRVMGTYGYCAPEYAKT-------GQLTLKSDVYSFGVVLLEILSGRKAVDT 280 (297)
Q Consensus 214 ~~kl~Dfg~~~~~~~~~------~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~Pf~~ 280 (297)
.+||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 99999999997643221 1122234579999999999876 4567789999999999999999877654
Q ss_pred c
Q 022447 281 S 281 (297)
Q Consensus 281 ~ 281 (297)
.
T Consensus 238 ~ 238 (336)
T 3g2f_A 238 G 238 (336)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=283.74 Aligned_cols=204 Identities=24% Similarity=0.312 Sum_probs=169.0
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccC--CCCccceeeEeecCCee
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLH--HPNLVNLIGYCADGDQR 144 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~ 144 (297)
...++|++.+.||+|+||.||+|.+.. +..||+|++...... ....+.+|+.+++.++ |+||+++++++......
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 345789999999999999999999864 889999999754332 3366889999999997 59999999999999999
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
+++|| +.+++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||++++ +.++|+|||++.
T Consensus 104 ~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccc
Confidence 99999 567899999987 567899999999999999999999999 999999999999965 899999999997
Q ss_pred ccCCCCCcceeecccccccccCcccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKT-----------GQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
...............|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||....
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 6433322223345579999999999865 468889999999999999999999998754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=281.87 Aligned_cols=207 Identities=27% Similarity=0.404 Sum_probs=174.5
Q ss_pred cCHHHHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhc--cCCCCccceeeEee
Q 022447 62 LTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSL--LHHPNLVNLIGYCA 139 (297)
Q Consensus 62 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~ 139 (297)
.++.......++|++.+.||+|+||.||+|.+. ++.||||++... ....+.+|..++.. ++||||+++++++.
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 344444556789999999999999999999984 899999998643 34567778888877 78999999999998
Q ss_pred cCC----eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeecCCCCCcE
Q 022447 140 DGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH--------DKAKPPVIYRDLKCSNI 207 (297)
Q Consensus 140 ~~~----~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~~ivH~dikp~Ni 207 (297)
... ..++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+ ++||||||+||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NI 178 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNI 178 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHE
Confidence 876 78999999999999999975 46899999999999999999999 888 99999999999
Q ss_pred EEcCCCceEEecccCccccCCCCCcc--eeecccccccccCccccccC------CCCcccchhhHHHHHHHHHhC-----
Q 022447 208 LLDRGYHPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAKTG------QLTLKSDVYSFGVVLLEILSG----- 274 (297)
Q Consensus 208 li~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----- 274 (297)
|++.++.++|+|||++.......... ......||+.|+|||++.+. .++.++||||||+++|+|++|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 99999999999999987543322211 22345799999999998765 234689999999999999999
Q ss_pred -----CCCCCcc
Q 022447 275 -----RKAVDTS 281 (297)
Q Consensus 275 -----~~Pf~~~ 281 (297)
..||...
T Consensus 259 ~~~~~~~p~~~~ 270 (342)
T 1b6c_B 259 IHEDYQLPYYDL 270 (342)
T ss_dssp BCCCCCCTTTTT
T ss_pred cccccccCcccc
Confidence 7898765
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=288.15 Aligned_cols=200 Identities=19% Similarity=0.255 Sum_probs=170.0
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC-----------CCCccceeeEee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-----------HPNLVNLIGYCA 139 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~ 139 (297)
..+|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+. ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 368999999999999999999999999999999997532 23356778998888876 789999999987
Q ss_pred cCC----eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCcEEEc----
Q 022447 140 DGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLD---- 210 (297)
Q Consensus 140 ~~~----~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~dikp~Nili~---- 210 (297)
... ..+++||++ +++|.+++.... ...+++..++.++.||+.||.|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 644 788999999 799999998633 35689999999999999999999998 9 99999999999994
Q ss_pred --CCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 211 --RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 211 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
..+.++|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 344799999999975322 2234578999999999999999999999999999999999999998765
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=278.56 Aligned_cols=202 Identities=27% Similarity=0.396 Sum_probs=166.1
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeec---------
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--------- 140 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------- 140 (297)
..++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 456899999999999999999999999999999998643 2334568899999999999999999998754
Q ss_pred ----CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceE
Q 022447 141 ----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (297)
Q Consensus 141 ----~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~k 216 (297)
....++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 35678999999999999999862 356788999999999999999999999 99999999999999999999
Q ss_pred EecccCccccCCCC------------CcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 217 LSDFGLAKLGPVGD------------NTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 217 l~Dfg~~~~~~~~~------------~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
|+|||++....... .........|++.|+|||++.+. .++.++||||||+++|+|++ ||...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 99999987532211 01122345689999999998764 68999999999999999998 66543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=279.88 Aligned_cols=211 Identities=31% Similarity=0.453 Sum_probs=168.5
Q ss_pred hcCCCCcceecccCcEEEEEEEECC-CC--eEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLES-IN--QDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~-~~--~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 144 (297)
.++|++.+.||+|+||.||+|.+.. ++ ..||+|++..... ...+.+.+|+.+++.++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4689999999999999999998643 33 3689999875422 23467889999999999999999999998765 8
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 8999999999999999762 356899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCcc-eeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 225 LGPVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 225 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~ 235 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 235 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH
Confidence 643332221 2233457889999999998889999999999999999999 999998876655433
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=283.19 Aligned_cols=201 Identities=22% Similarity=0.309 Sum_probs=149.0
Q ss_pred HhcCCCCcc-eecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHH-HHHhccCCCCccceeeEeec----CCe
Q 022447 70 ATKNFRSES-LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV-LMLSLLHHPNLVNLIGYCAD----GDQ 143 (297)
Q Consensus 70 ~~~~y~~~~-~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~----~~~ 143 (297)
..++|.+.+ .||+|+||.||+|.++.+++.||||++... ....+|+ ..++.+.||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 446888865 699999999999999999999999998643 1222333 34566789999999999876 456
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC---CCceEEecc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDF 220 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~---~~~~kl~Df 220 (297)
.++||||++|++|.+++.... ...+++..++.++.||+.||.|||+.+ ++||||||+||+++. ++.++|+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecc
Confidence 889999999999999998632 357999999999999999999999999 999999999999976 455999999
Q ss_pred cCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
|++..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 176 g~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (336)
T 3fhr_A 176 GFAKETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235 (336)
T ss_dssp TTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ccceeccc----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence 99975322 1233456899999999998888999999999999999999999999776543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=282.38 Aligned_cols=210 Identities=26% Similarity=0.374 Sum_probs=172.7
Q ss_pred HHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 68 AAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
....++|++.+.||+|+||.||+|.+.. .+++|++..... ...+.+.+|+.+++.++||||+++++++.+....+
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 3456789999999999999999999864 499999875432 22345678999999999999999999999999999
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
++|||++|++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++ ++.++|+|||++..
T Consensus 106 iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred EEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 999999999999999762 346899999999999999999999999 99999999999998 67999999999765
Q ss_pred cCCCC---CcceeecccccccccCcccccc---------CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 226 GPVGD---NTHVSTRVMGTYGYCAPEYAKT---------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 226 ~~~~~---~~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
..... .........|++.|+|||++.+ ..++.++||||||+++|+|++|+.||...+.....
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 252 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII 252 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 32111 1122233458999999999864 45788999999999999999999999987765443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=275.17 Aligned_cols=202 Identities=26% Similarity=0.402 Sum_probs=155.0
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc-hHH-HHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NRE-FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~-~~~-~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
..++|++.+.||+|+||.||+|.+..+++.||||++....... ..+ +..+..+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3468899999999999999999999999999999997654332 223 33445567888999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
|||+ ++.+..+.... ...+++..++.++.|++.||.|||+. + ++|+||||+||+++.++.++|+|||++...
T Consensus 103 ~e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp ECCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred Eecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 9999 45555555431 46789999999999999999999995 8 999999999999999999999999998653
Q ss_pred CCCCCcceeecccccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
... .......|++.|+|||++. +..++.++||||||+++|+|++|+.||...
T Consensus 176 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 176 VDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cCC---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 222 1223456999999999984 456889999999999999999999999874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=301.08 Aligned_cols=206 Identities=29% Similarity=0.428 Sum_probs=175.6
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhccCCCCccceeeEeec------CC
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCAD------GD 142 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 142 (297)
..++|++.+.||+|+||.||+|.+..+|..||||++.... ......+.+|+.+++.++||||+++++++.. .+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 3478999999999999999999999999999999987542 2334568899999999999999999998765 67
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCc---eEEec
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLSD 219 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~---~kl~D 219 (297)
..++||||++|++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. ++|+|
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred eEEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcc
Confidence 78999999999999999986332 346899999999999999999999999 999999999999997665 89999
Q ss_pred ccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 220 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
||++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 168 FG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~ 227 (676)
T 3qa8_A 168 LGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW 227 (676)
T ss_dssp CCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred ccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc
Confidence 99997643322 2344679999999999999999999999999999999999999997653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=286.71 Aligned_cols=193 Identities=19% Similarity=0.190 Sum_probs=161.0
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--------cchHHHHHHHHHHhccC---------CCCc--
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--------QGNREFLVEVLMLSLLH---------HPNL-- 131 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---------h~~i-- 131 (297)
.++|++.+.||+|+||.||+|.+ +|+.||||++..... .....+.+|+.+++.++ ||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46789999999999999999998 589999999976532 22367888999988886 5555
Q ss_pred ---------------cceeeEeec-------------CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHH
Q 022447 132 ---------------VNLIGYCAD-------------GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183 (297)
Q Consensus 132 ---------------~~~~~~~~~-------------~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~ 183 (297)
+++++++.+ ....|+||||+++|++.+.+.. ..+++..++.++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 444554443 6789999999999987777753 5689999999999999
Q ss_pred HHHHHHH-hCCCCCeeecCCCCCcEEEcCCC--------------------ceEEecccCccccCCCCCcceeecccccc
Q 022447 184 RGLEYLH-DKAKPPVIYRDLKCSNILLDRGY--------------------HPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242 (297)
Q Consensus 184 ~al~~LH-~~~~~~ivH~dikp~Nili~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~ 242 (297)
.||.||| +.+ |+||||||+|||++.++ .+||+|||+++.... ...+||+
T Consensus 172 ~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~ 241 (336)
T 2vuw_A 172 ASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCD 241 (336)
T ss_dssp HHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCC
T ss_pred HHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEee
Confidence 9999999 899 99999999999999887 899999999975321 2347999
Q ss_pred cccCccccccCCCCcccchhhHHHH-HHHHHhCCCCCCcc
Q 022447 243 GYCAPEYAKTGQLTLKSDVYSFGVV-LLEILSGRKAVDTS 281 (297)
Q Consensus 243 ~y~aPE~~~~~~~~~~~DiwslG~i-l~ell~g~~Pf~~~ 281 (297)
.|+|||++.+.. +.++||||||++ .+++++|..||...
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~ 280 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV 280 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch
Confidence 999999998776 899999998777 78889999999653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=298.99 Aligned_cols=211 Identities=28% Similarity=0.389 Sum_probs=175.5
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCC---CeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCee
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 144 (297)
...++|++.+.||+|+||.||+|.+..+ +..||+|.+...... ....+.+|+.+++.++||||+++++++.+ +..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence 3456789999999999999999998653 567999998754322 33678899999999999999999999854 568
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred EEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 9999999999999999862 356899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhh
Q 022447 225 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQ 287 (297)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~ 287 (297)
...... ........+++.|+|||++.+..++.++||||||+++|||++ |..||.+.+..+..
T Consensus 540 ~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~ 602 (656)
T 2j0j_A 540 YMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 602 (656)
T ss_dssp SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred ecCCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 643222 112233457789999999999999999999999999999997 99999987665543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=284.50 Aligned_cols=206 Identities=26% Similarity=0.308 Sum_probs=158.3
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEEEec
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
+.|.+.+.||+|+||+||.+ ...+|+.||||++... ..+.+.+|+.+++.+ +||||+++++++.+....|+||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 34556688999999999875 4456999999998653 234577899999876 899999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC-------------Cc
Q 022447 151 MPLGSVEDHLHDLSPGKKP---LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-------------YH 214 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~---l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~-------------~~ 214 (297)
+. ++|.+++......... .++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 97 6999999863221111 133356789999999999999999 9999999999999754 48
Q ss_pred eEEecccCccccCCCCCc--ceeecccccccccCcccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCcchhH
Q 022447 215 PKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAKT-------GQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAA 284 (297)
Q Consensus 215 ~kl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~ 284 (297)
++|+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999999864332211 12234579999999999865 568999999999999999999 99999876544
Q ss_pred h
Q 022447 285 A 285 (297)
Q Consensus 285 ~ 285 (297)
.
T Consensus 247 ~ 247 (434)
T 2rio_A 247 E 247 (434)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=300.30 Aligned_cols=195 Identities=24% Similarity=0.381 Sum_probs=167.3
Q ss_pred HhcCCCCcceecccCcEEEEEEEECC-CCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCe----
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLES-INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ---- 143 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 143 (297)
..++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 34789999999999999999999976 789999999865432 233567899999999999999999999987655
Q ss_pred -eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 144 -RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 144 -~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
.|+||||++|++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEeccc
Confidence 6999999999999887642 6899999999999999999999999 9999999999999885 899999999
Q ss_pred ccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 223 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
+...... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||...
T Consensus 228 a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 228 VSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp CEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred chhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccc
Confidence 9763221 3456999999999987654 88999999999999999999998764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=283.55 Aligned_cols=205 Identities=25% Similarity=0.317 Sum_probs=161.0
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..+|.+.+.||+|+||.|+. ....+++.||||++...... .+.+|+.+++.+ +||||+++++++.+....|+|||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 34688899999999998763 34456899999999754333 245699999998 79999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC---C--CceEEecccCcc
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---G--YHPKLSDFGLAK 224 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~---~--~~~kl~Dfg~~~ 224 (297)
|+. ++|.+++... ...+.+..++.++.||+.||.|||+.+ |+||||||+|||++. + ..++|+|||++.
T Consensus 99 ~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 99 LCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp CCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred CCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 997 6999999763 234555567899999999999999999 999999999999953 2 357899999997
Q ss_pred ccCCCCCc-ceeecccccccccCccccc---cCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhh
Q 022447 225 LGPVGDNT-HVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE 286 (297)
Q Consensus 225 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~ 286 (297)
........ .......||+.|+|||++. ...++.++|||||||++|+|++ |..||........
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~ 238 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA 238 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH
Confidence 64332211 2334567999999999987 4567889999999999999999 9999976654443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=265.70 Aligned_cols=175 Identities=16% Similarity=0.161 Sum_probs=155.5
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
.++|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.++..++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999999999999999997654432 25688999999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||++|++|.+++.. . ....++..++.|++.||.|||+++ |+||||||+|||++.++.++|++++.
T Consensus 110 ~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~----- 175 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPAT----- 175 (286)
T ss_dssp EECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccc-----
Confidence 999999999999964 2 356678999999999999999999 99999999999999999999985542
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
++ .++.++|||||||++|+|++|+.||...+.
T Consensus 176 -----------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 176 -----------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp -----------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred -----------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 22 368899999999999999999999998654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=260.97 Aligned_cols=180 Identities=22% Similarity=0.345 Sum_probs=154.5
Q ss_pred HhcCCCCc-ceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHH-hccCCCCccceeeEeec----CCe
Q 022447 70 ATKNFRSE-SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLML-SLLHHPNLVNLIGYCAD----GDQ 143 (297)
Q Consensus 70 ~~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~ 143 (297)
..++|.+. +.||+|+||.||+|.+..+++.||+|++.. ...+.+|+.++ +..+||||+++++++.. ...
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 34567777 789999999999999999999999999863 24566788887 55689999999999876 677
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC---CCceEEecc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDF 220 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~---~~~~kl~Df 220 (297)
.++||||++|++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++. ++.++|+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecc
Confidence 899999999999999998732 346999999999999999999999999 999999999999998 788999999
Q ss_pred cCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
|++... .+..++.++|||||||++|+|++|+.||...+.
T Consensus 165 g~a~~~------------------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 203 (299)
T 3m2w_A 165 GFAKET------------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 203 (299)
T ss_dssp TTCEEC------------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred cccccc------------------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 988631 124567899999999999999999999976644
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=276.42 Aligned_cols=203 Identities=18% Similarity=0.204 Sum_probs=159.1
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhccCC-CCccc---------eeeE-
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHH-PNLVN---------LIGY- 137 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h-~~i~~---------~~~~- 137 (297)
..|...+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+++.+.| ++... ..+.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4577788999999999999999999999999998743222 24678899999999976 32211 1111
Q ss_pred -----------eec-----CCeeEEEEecCCCCChHhhhccc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 022447 138 -----------CAD-----GDQRLLVYEYMPLGSVEDHLHDL---SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 198 (297)
Q Consensus 138 -----------~~~-----~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iv 198 (297)
+.. ...++++|+++ +++|.+++... ......+++..++.++.||+.||+|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 111 12356777776 48999888521 122456788899999999999999999999 99
Q ss_pred ecCCCCCcEEEcCCCceEEecccCccccCCCCCcceeecccccccccCcccc----------ccCCCCcccchhhHHHHH
Q 022447 199 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA----------KTGQLTLKSDVYSFGVVL 268 (297)
Q Consensus 199 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~DiwslG~il 268 (297)
||||||+|||++.++.+||+|||+++... ......+| +.|+|||++ .+..++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETT-----EEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecC-----CccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999987522 12445668 999999998 555688899999999999
Q ss_pred HHHHhCCCCCCcchhH
Q 022447 269 LEILSGRKAVDTSKAA 284 (297)
Q Consensus 269 ~ell~g~~Pf~~~~~~ 284 (297)
|+|++|+.||...+..
T Consensus 308 ~elltg~~Pf~~~~~~ 323 (413)
T 3dzo_A 308 YWIWCADLPNTDDAAL 323 (413)
T ss_dssp HHHHHSSCCCCTTGGG
T ss_pred HHHHHCCCCCCCcchh
Confidence 9999999999886553
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=275.21 Aligned_cols=185 Identities=17% Similarity=0.118 Sum_probs=131.1
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEeccCCcc----------chHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEEE
Q 022447 80 LGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ----------GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 80 lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
.+.|+.|.+..++....|+.|++|++.+.... ..+++.+|+.+|+++ .|+||++++++++++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 34455555555555566889999999754221 124588999999999 6999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||++|++|.+++.. ..++++. .|+.||+.||+|+|++| ||||||||+|||++.+|.+||+|||+++....
T Consensus 322 Eyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999987 5667764 57899999999999999 99999999999999999999999999986322
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 277 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 277 (297)
......+.+||+.|+|||++.+ .+..++|+||+|+++++++++..|
T Consensus 392 --~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 --DCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred --CCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 2233456789999999999875 456789999999988776555433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=237.00 Aligned_cols=186 Identities=21% Similarity=0.261 Sum_probs=145.2
Q ss_pred CCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc--------hHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 75 RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 75 ~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
...+.||+|+||.||+|.. .+..+++|......... .+++.+|+.+++.++||||+++..++...+..|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 3456899999999999943 47889999865432211 2347899999999999999966666667778899
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||||++|++|.+++.. +..++.|++.+|.|||+++ |+||||||+|||++. .+||+|||+++..
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 9999999999999974 4689999999999999999 999999999999999 9999999999864
Q ss_pred CCCCCcc-----eeecccccccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCC
Q 022447 227 PVGDNTH-----VSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVD 279 (297)
Q Consensus 227 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~ 279 (297)
....... ......||+.|+|||++.. ..|+..+|+||..+-..+-..++-+|.
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 3221111 1235679999999999987 678888999999999988888887764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-27 Score=199.87 Aligned_cols=162 Identities=15% Similarity=0.083 Sum_probs=127.3
Q ss_pred HHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc------------------chHHHHHHHHHHhccCC
Q 022447 67 LAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------------------GNREFLVEVLMLSLLHH 128 (297)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~e~~~l~~l~h 128 (297)
+......|.+.+.||+|+||.||+|.+ .+|..||+|++...... ....+.+|+.+++.++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 334455677889999999999999999 78999999999643221 2345789999999998
Q ss_pred CCccceeeEeecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEE
Q 022447 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 208 (297)
Q Consensus 129 ~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nil 208 (297)
| +++++++.. +..|+||||++|++|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 5 667665543 56799999999999998 421 134579999999999999999 999999999999
Q ss_pred EcCCCceEEecccCccccCCCCCcceeecccccccccCcccccc----------CCCCcccchhh
Q 022447 209 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT----------GQLTLKSDVYS 263 (297)
Q Consensus 209 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----------~~~~~~~Diws 263 (297)
++ ++.++|+|||++.. +..+.|||++.. ..+...+|+|.
T Consensus 226 l~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99 99999999999862 445788998754 33455566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-22 Score=170.53 Aligned_cols=137 Identities=14% Similarity=0.042 Sum_probs=107.4
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeE--EEEEEeccCCccc------------------------hHHHHHHHHHHhcc
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQD--VAIKQLDRNGVQG------------------------NREFLVEVLMLSLL 126 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~--vavK~~~~~~~~~------------------------~~~~~~e~~~l~~l 126 (297)
-|.+.+.||+|+||.||+|.+..+|.. ||||+++...... ...+.+|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999999777999 9999975432110 12578899999999
Q ss_pred CCCCc--cceeeEeecCCeeEEEEecCCC-C----ChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCee
Q 022447 127 HHPNL--VNLIGYCADGDQRLLVYEYMPL-G----SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH-DKAKPPVI 198 (297)
Q Consensus 127 ~h~~i--~~~~~~~~~~~~~~lv~e~~~g-~----~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~~iv 198 (297)
.|+++ ..+++. ...++||||+.+ | +|.+.... .++..+..++.|++.+|.+|| +.+ |+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 88764 333332 356899999942 3 66665443 234567899999999999999 999 99
Q ss_pred ecCCCCCcEEEcCCCceEEecccCccc
Q 022447 199 YRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 199 H~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
||||||+|||++. .++|+|||++..
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred eCCCCHHHEEEcC--cEEEEECccccc
Confidence 9999999999998 899999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=6.4e-20 Score=160.09 Aligned_cols=136 Identities=13% Similarity=0.076 Sum_probs=96.9
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--------------chHHH--------HHHHHHHhccCCCC
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--------------GNREF--------LVEVLMLSLLHHPN 130 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~--------~~e~~~l~~l~h~~ 130 (297)
-|.+...||+|++|.||+|.+. +|+.||||+++..... ..... ..|...+.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4899999999999999999986 5999999997542110 00111 23455555554333
Q ss_pred ccceeeEeecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEc
Q 022447 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 210 (297)
Q Consensus 131 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~ 210 (297)
+.-..-+.. ...++||||++|.+|..+... .....++.||+.+|.+||+.| ||||||||.|||++
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 321111111 223799999999888765432 134578899999999999999 99999999999998
Q ss_pred CCC----------ceEEecccCcc
Q 022447 211 RGY----------HPKLSDFGLAK 224 (297)
Q Consensus 211 ~~~----------~~kl~Dfg~~~ 224 (297)
+++ .+.|+||+-+.
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCE
T ss_pred CCCCcccccccccceEEEEeCCcc
Confidence 776 38999999765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=2.2e-14 Score=119.88 Aligned_cols=146 Identities=17% Similarity=0.096 Sum_probs=113.8
Q ss_pred HHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC-CCCccceeeEeecCCeeEEE
Q 022447 69 AATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 147 (297)
.....|++...++.|+.+.||++... +..+++|............+.+|+.+++.+. +..+.+++++..+.+..|+|
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 34567888888999999999999754 6789999987532233345788999998885 66788899999888899999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA---------------------------------- 193 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------------------------------- 193 (297)
||+++|.+|.+.+.. ......++.+++.++..||+..
T Consensus 89 ~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 89 MSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 999999999876421 1123467889999999999811
Q ss_pred ----------------------CCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 194 ----------------------KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 194 ----------------------~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
...++|+|++|.||++++++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998765667999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.39 E-value=8.1e-13 Score=109.94 Aligned_cols=137 Identities=15% Similarity=0.082 Sum_probs=98.2
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCC--ccceeeEeecCCeeEEEEec
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~ 150 (297)
.|.+....+.|..+.||++.. .+|..+++|+.... ....+..|+.+++.+.+.+ +.+++.+....+..++|||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 444433334566699999964 45778999997653 2245677898888886444 45688888877889999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA------------------------------------- 193 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------- 193 (297)
++|.+|. ... .+ ...++.+++.++..||+..
T Consensus 97 i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 97 VPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred cCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9998883 221 11 1256677778888888643
Q ss_pred ------------------CCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 194 ------------------KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 194 ------------------~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
...++|+|++|.||++++++.+.|+||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12299999999999998776667999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.30 E-value=1.2e-11 Score=108.07 Aligned_cols=142 Identities=13% Similarity=0.181 Sum_probs=105.6
Q ss_pred CcceecccCcEEEEEEEECCCCeEEEEEEec--cCCc-cchHHHHHHHHHHhccCC--CCccceeeEeecC---CeeEEE
Q 022447 76 SESLLGEGGFGRVYKGYLESINQDVAIKQLD--RNGV-QGNREFLVEVLMLSLLHH--PNLVNLIGYCADG---DQRLLV 147 (297)
Q Consensus 76 ~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~~lv 147 (297)
..+.|+.|.++.||++... +..+++|+.. .... .....+.+|+.+++.+.. ..+.+++.++.+. +..|+|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 4567899999999998765 4678898875 3221 223457789999998874 4577888887766 458999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA---------------------------------- 193 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------------------------------- 193 (297)
||+++|..+.+.. ...++......++.+++.+|..||+..
T Consensus 120 me~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 120 MEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999988775422 234678888999999999999999731
Q ss_pred ---------------------CCCeeecCCCCCcEEEcCCCc--eEEecccCccc
Q 022447 194 ---------------------KPPVIYRDLKCSNILLDRGYH--PKLSDFGLAKL 225 (297)
Q Consensus 194 ---------------------~~~ivH~dikp~Nili~~~~~--~kl~Dfg~~~~ 225 (297)
...++|+|++|.||+++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997653 68999998874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.29 E-value=3e-12 Score=109.29 Aligned_cols=190 Identities=18% Similarity=0.191 Sum_probs=124.9
Q ss_pred cceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC-CCC--ccceeeEeecCC---eeEEEEec
Q 022447 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPN--LVNLIGYCADGD---QRLLVYEY 150 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv~e~ 150 (297)
.+.++.|....||++. ..+++|+.... .....+.+|..+++.+. +.. +.+++....... ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4568999999999873 46889986532 23456888999998874 333 334444433332 35789999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA------------------------------------- 193 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------- 193 (297)
++|.+|.+... ..++..+...++.+++..+..||+..
T Consensus 98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99988865432 23667778888888888888888621
Q ss_pred ------------------CCCeeecCCCCCcEEEcC--CCceEEecccCccccCCCCCcceeecccccccc---cCcccc
Q 022447 194 ------------------KPPVIYRDLKCSNILLDR--GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY---CAPEYA 250 (297)
Q Consensus 194 ------------------~~~ivH~dikp~Nili~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y---~aPE~~ 250 (297)
...++|+|++|.||++++ ++.+.|+||+.+......... .....+ ..|+..
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl------~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF------ISLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH------HTTCCTTTSCCHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH------HHHHhhccccCHHHH
Confidence 234899999999999998 556789999988753221100 000000 122211
Q ss_pred cc-----C---------CCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 251 KT-----G---------QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 251 ~~-----~---------~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
.. . ......+.|+++.++|.+.+|..+|-......
T Consensus 246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~~g~~~ 294 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYEEGLNE 294 (304)
T ss_dssp HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHHHHHH
T ss_pred HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHHHHHHH
Confidence 10 0 01123689999999999999999886654443
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=1.6e-08 Score=84.48 Aligned_cols=135 Identities=19% Similarity=0.192 Sum_probs=99.8
Q ss_pred ecccCcE-EEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC-CCCccceeeEeecCCeeEEEEecCCCCChH
Q 022447 80 LGEGGFG-RVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVE 157 (297)
Q Consensus 80 lg~G~~g-~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~ 157 (297)
+..|..+ .||+......+..+++|+.... ....+..|...++.+. +--+.+++.++.+.+..|+|||+++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445444 6899888777888999986532 3456778988888775 333667888888889999999999998887
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 022447 158 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA-------------------------------------------- 193 (297)
Q Consensus 158 ~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------------------------------------------- 193 (297)
+..... ......+..++...+..||+..
T Consensus 109 ~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 109 QVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 765431 1233456667777777777531
Q ss_pred -----------CCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 194 -----------KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 194 -----------~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
...++|+|+.|.||+++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 23489999999999999877777999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=5.4e-08 Score=82.90 Aligned_cols=136 Identities=21% Similarity=0.158 Sum_probs=93.8
Q ss_pred cceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCC---CccceeeEee-cCCeeEEEEecCC
Q 022447 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHP---NLVNLIGYCA-DGDQRLLVYEYMP 152 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~ 152 (297)
.+.++.|....||+. +..+++|+... ......+..|..+++.+.+. .+.+++.+.. ..+..+++||+++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 356788888899988 56788998532 22345688899999988642 2455666653 4556789999999
Q ss_pred CCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 022447 153 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK---------------------------------------- 192 (297)
Q Consensus 153 g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---------------------------------------- 192 (297)
|.++.+..- ..++..+...+..++...+..||+.
T Consensus 97 G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 988876321 1234445555555555555555542
Q ss_pred -----------------CCCCeeecCCCCCcEEEcC---CCc-eEEecccCccc
Q 022447 193 -----------------AKPPVIYRDLKCSNILLDR---GYH-PKLSDFGLAKL 225 (297)
Q Consensus 193 -----------------~~~~ivH~dikp~Nili~~---~~~-~kl~Dfg~~~~ 225 (297)
....++|+|+.|.||+++. ++. +.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1234799999999999987 455 47999998875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=1e-07 Score=82.90 Aligned_cols=81 Identities=11% Similarity=0.030 Sum_probs=54.3
Q ss_pred cee-cccCcEEEEEEEEC--C----CCeEEEEEEeccCC---ccchHHHHHHHHHHhccCC---CCccceeeEeecC---
Q 022447 78 SLL-GEGGFGRVYKGYLE--S----INQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHH---PNLVNLIGYCADG--- 141 (297)
Q Consensus 78 ~~l-g~G~~g~v~~~~~~--~----~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~--- 141 (297)
+.| +.|....+|++... . ++..+++|...... ......+..|..+++.+.. -.+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999988653 1 15678999865432 1112346678888877742 3466777776654
Q ss_pred CeeEEEEecCCCCChHh
Q 022447 142 DQRLLVYEYMPLGSVED 158 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~ 158 (297)
...|+|||+++|.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35789999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=2.8e-07 Score=81.33 Aligned_cols=76 Identities=17% Similarity=0.140 Sum_probs=49.3
Q ss_pred cceecccCcEEEEEEEECCCCeEEEEEEeccCCc-------cchHHHHHHHHHHhccCC--CC-ccceeeEeecCCeeEE
Q 022447 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-------QGNREFLVEVLMLSLLHH--PN-LVNLIGYCADGDQRLL 146 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~~-i~~~~~~~~~~~~~~l 146 (297)
.+.||.|..+.||++....++..++||....... ....++..|..+++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4578999999999997766678899998653211 123456778888887642 33 3345543 3455689
Q ss_pred EEecCCCC
Q 022447 147 VYEYMPLG 154 (297)
Q Consensus 147 v~e~~~g~ 154 (297)
|||+++|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999863
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.44 E-value=4.6e-06 Score=71.70 Aligned_cols=142 Identities=19% Similarity=0.302 Sum_probs=78.3
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCC--CCccceee------EeecCCeeEEEEe
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH--PNLVNLIG------YCADGDQRLLVYE 149 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~------~~~~~~~~~lv~e 149 (297)
+.|+.|....||++... +..+++|+.... ...+..|..+++.+.. -.+.+++. +....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34666778899998764 345899998752 2334445555554431 12333332 1234567899999
Q ss_pred cCCCCChH--------------hhhcccCCCC-CC---------CCHHH-------------------------------
Q 022447 150 YMPLGSVE--------------DHLHDLSPGK-KP---------LDWNT------------------------------- 174 (297)
Q Consensus 150 ~~~g~~L~--------------~~l~~~~~~~-~~---------l~~~~------------------------------- 174 (297)
|++|.++. ..++...... .+ ..+..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 1111111000 00 01110
Q ss_pred HHHHHHHHHHHHHHHHh----------CCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 175 RMKIAAGAARGLEYLHD----------KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 175 ~~~i~~qi~~al~~LH~----------~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+..+..++..++.+|+. .....++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11112223345666652 0123499999999999998888899999998864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.29 E-value=6.7e-06 Score=69.15 Aligned_cols=78 Identities=19% Similarity=0.218 Sum_probs=54.9
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCC---CccceeeEeecCCeeEEEEe
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHP---NLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~~~~lv~e 149 (297)
...-++.+|.|..+.||++... +|+.|++|+...........+..|...|+.+... -+.+++.+ +..++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 3444577999999999999865 5889999987655444445677899988887532 23444443 23478999
Q ss_pred cCCCCC
Q 022447 150 YMPLGS 155 (297)
Q Consensus 150 ~~~g~~ 155 (297)
+++++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 998654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.27 E-value=7.3e-06 Score=69.75 Aligned_cols=139 Identities=18% Similarity=0.189 Sum_probs=89.8
Q ss_pred cceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC---CCCccceeeEeecCCeeEEEEecCCC
Q 022447 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
.+.|+.|....+|+... ++..+++|+.... ....+..|...++.+. ...+.+++.+....+..++|||+++|
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 45789999999999875 3678889987643 2456778888888774 35677888888777889999999998
Q ss_pred CChH--------h---hhcccCC-CCC-----------------CCCHHHHH---HHH----------------HHHHHH
Q 022447 154 GSVE--------D---HLHDLSP-GKK-----------------PLDWNTRM---KIA----------------AGAARG 185 (297)
Q Consensus 154 ~~L~--------~---~l~~~~~-~~~-----------------~l~~~~~~---~i~----------------~qi~~a 185 (297)
..+. . .++.... ... .-++.... .+. .+++..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7642 1 2222211 000 01222211 011 112222
Q ss_pred H-HHHHh-CCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 022447 186 L-EYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (297)
Q Consensus 186 l-~~LH~-~~~~~ivH~dikp~Nili~~~~~~kl~Dfg 221 (297)
+ ..|.. ...+.++|+|+.+.|++++.++ +.|+|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2 23421 2245699999999999999887 8999985
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.18 E-value=1e-05 Score=71.89 Aligned_cols=30 Identities=13% Similarity=0.243 Sum_probs=26.6
Q ss_pred CCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 195 ~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
..++|+|+.|.|||++.++ +.++||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 3399999999999998876 99999998875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.98 E-value=3.9e-05 Score=64.82 Aligned_cols=71 Identities=10% Similarity=0.073 Sum_probs=44.5
Q ss_pred cceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCc-cceeeEeecCCeeEEEEecC-CCC
Q 022447 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYM-PLG 154 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~-~g~ 154 (297)
.+.|+.|....+|++ ..+++|+........ .....|..+++.+...++ .+++.. +.+.-++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 677888999999999 458899876432111 122457777776653333 345543 333457899999 665
Q ss_pred Ch
Q 022447 155 SV 156 (297)
Q Consensus 155 ~L 156 (297)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.95 E-value=0.00023 Score=60.53 Aligned_cols=160 Identities=14% Similarity=0.076 Sum_probs=85.4
Q ss_pred cCHHHHHHHhcCCCCc-----ceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCC--ccce
Q 022447 62 LTFRELAAATKNFRSE-----SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNL 134 (297)
Q Consensus 62 ~~~~~~~~~~~~y~~~-----~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~ 134 (297)
++.+++......|.+. +.|+.|....+|++.... | .+++|...... ....+..|..+++.+...+ +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 4555566666667652 346668888999987643 3 68899887531 1234556777776654222 2333
Q ss_pred eeE------eecCCeeEEEEecCCCCChHh--------------hhcccCCC--CC---CCCHHHHHH------------
Q 022447 135 IGY------CADGDQRLLVYEYMPLGSVED--------------HLHDLSPG--KK---PLDWNTRMK------------ 177 (297)
Q Consensus 135 ~~~------~~~~~~~~lv~e~~~g~~L~~--------------~l~~~~~~--~~---~l~~~~~~~------------ 177 (297)
+.. ....+..++++++++|..+.. .++..... .. ......-..
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 122456789999999865321 11111100 00 011110000
Q ss_pred ---HHHHHHHHHHHHHhC----CCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 178 ---IAAGAARGLEYLHDK----AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 178 ---i~~qi~~al~~LH~~----~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+...+...+..+... ....++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 001133344444421 123499999999999999876668999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.92 E-value=0.00014 Score=65.26 Aligned_cols=74 Identities=12% Similarity=0.007 Sum_probs=47.5
Q ss_pred ceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCc-cceeeEeecCCeeEEEEecCCCCCh
Q 022447 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLGSV 156 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~g~~L 156 (297)
+.|+.|-...+|++.....+..+++|+......... ....|..+++.+...++ .++++.+. + .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 467778889999998765458899998754321111 12468888888875555 45666553 2 259999987544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=4.8e-05 Score=66.47 Aligned_cols=143 Identities=17% Similarity=0.216 Sum_probs=82.3
Q ss_pred ceecccCcEEEEEEEECC-------CCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCc-cceeeEeecCCeeEEEEe
Q 022447 78 SLLGEGGFGRVYKGYLES-------INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e 149 (297)
+.|..|-...+|++.... ++..+++|+.-. .........+|..+++.+...++ .++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 456667778889987642 357899998633 22334556689998888753333 556655543 28999
Q ss_pred cCCCCChHhh--------------h---cccCC-CCCCC--CHHHHHHHHHHHHH-------------------HHHHH-
Q 022447 150 YMPLGSVEDH--------------L---HDLSP-GKKPL--DWNTRMKIAAGAAR-------------------GLEYL- 189 (297)
Q Consensus 150 ~~~g~~L~~~--------------l---~~~~~-~~~~l--~~~~~~~i~~qi~~-------------------al~~L- 189 (297)
|++|.+|... + +.... ...+. -...+..++.++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9997654311 1 11100 01112 23455555544422 12222
Q ss_pred ---Hh-CCCCCeeecCCCCCcEEEcCC----CceEEecccCccc
Q 022447 190 ---HD-KAKPPVIYRDLKCSNILLDRG----YHPKLSDFGLAKL 225 (297)
Q Consensus 190 ---H~-~~~~~ivH~dikp~Nili~~~----~~~kl~Dfg~~~~ 225 (297)
.. .....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 123459999999999999876 7899999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.85 E-value=7.3e-05 Score=66.53 Aligned_cols=74 Identities=18% Similarity=0.234 Sum_probs=49.4
Q ss_pred cceecccCcEEEEEEEECC-------CCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCc-cceeeEeecCCeeEEEE
Q 022447 77 ESLLGEGGFGRVYKGYLES-------INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVY 148 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~ 148 (297)
.+.|+.|....+|++.... ++..+++|+.... .....+..|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3567788889999998653 2578999988432 112455678888888754444 456665432 3899
Q ss_pred ecCCCCCh
Q 022447 149 EYMPLGSV 156 (297)
Q Consensus 149 e~~~g~~L 156 (297)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00033 Score=59.95 Aligned_cols=32 Identities=31% Similarity=0.336 Sum_probs=27.5
Q ss_pred CCeeecCCCCCcEEEcCC----CceEEecccCcccc
Q 022447 195 PPVIYRDLKCSNILLDRG----YHPKLSDFGLAKLG 226 (297)
Q Consensus 195 ~~ivH~dikp~Nili~~~----~~~kl~Dfg~~~~~ 226 (297)
..++|+|+.+.||+++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 449999999999999874 67899999988753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00073 Score=57.55 Aligned_cols=160 Identities=15% Similarity=0.082 Sum_probs=86.0
Q ss_pred ccCHHHHHHHhcCCCC-----cceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCC--ccc
Q 022447 61 TLTFRELAAATKNFRS-----ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVN 133 (297)
Q Consensus 61 ~~~~~~~~~~~~~y~~-----~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~ 133 (297)
.++.+.+......|.+ ...++ |....||++... +|..+++|...... .....+..|..+++.+...+ +.+
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~ 86 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAA 86 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecc
Confidence 3444444444444432 23566 777889987543 36689999986432 13345666777777664222 334
Q ss_pred eeeE-----eecCCeeEEEEecCCCCChHh-----------h---hcccCC-----CCCCCCHHHH--------------
Q 022447 134 LIGY-----CADGDQRLLVYEYMPLGSVED-----------H---LHDLSP-----GKKPLDWNTR-------------- 175 (297)
Q Consensus 134 ~~~~-----~~~~~~~~lv~e~~~g~~L~~-----------~---l~~~~~-----~~~~l~~~~~-------------- 175 (297)
++.. ....+..+++|++++|..+.. . ++.... .....+....
T Consensus 87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 166 (328)
T 1zyl_A 87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI 166 (328)
T ss_dssp CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence 4432 122456688999998754320 0 111000 0011221110
Q ss_pred --------HHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 176 --------MKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 176 --------~~i~~qi~~al~~LH~-~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
...+..++..+..+-. .....++|+|+.|.||+++ + .+.|+||+.+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1112222222222211 1233489999999999999 4 899999988765
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.51 E-value=0.0013 Score=56.48 Aligned_cols=31 Identities=16% Similarity=0.180 Sum_probs=27.4
Q ss_pred CCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 195 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 195 ~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
..++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3499999999999999888899999988764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00054 Score=59.50 Aligned_cols=74 Identities=9% Similarity=0.059 Sum_probs=43.2
Q ss_pred ceecccCcEEEEEEEECC--------CCeEEEEEEeccCCccchHHHHHHHHHHhccCCCC-ccceeeEeecCCeeEEEE
Q 022447 78 SLLGEGGFGRVYKGYLES--------INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN-LVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~ 148 (297)
+.++.|....+|++.... .+..+++|+..... ........|..+++.+...+ ..+++... . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 456778788999987653 13688899875432 11112356777777775333 34566544 2 36899
Q ss_pred ecCCCCCh
Q 022447 149 EYMPLGSV 156 (297)
Q Consensus 149 e~~~g~~L 156 (297)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99997543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0017 Score=51.49 Aligned_cols=103 Identities=15% Similarity=0.086 Sum_probs=67.9
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
-+|.+.+..+ +.+++++++|.++.|.+.+|.-+-.... -..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc---------
Confidence 3788888764 6899999999999999999887632111 12334567999999999887764 1110
Q ss_pred eeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 022447 234 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 277 (297)
Q Consensus 234 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 277 (297)
.....+.|||... ...+.+.=|||||+++|..+--..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1223467888753 3456778899999999998875544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0035 Score=55.50 Aligned_cols=74 Identities=11% Similarity=0.066 Sum_probs=46.7
Q ss_pred ceecccCcEEEEEEEECCC-------CeEEEEEEeccCCccchHHHHHHHHHHhccCCCC-ccceeeEeecCCeeEEEEe
Q 022447 78 SLLGEGGFGRVYKGYLESI-------NQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN-LVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e 149 (297)
+.+..|-...+|++..... +..|++|+..... ...-...+|..+++.+...+ ..++++.+. -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 4566777789999887531 5789999865432 21122346888887775333 345554332 278999
Q ss_pred cCCCCCh
Q 022447 150 YMPLGSV 156 (297)
Q Consensus 150 ~~~g~~L 156 (297)
|++|.+|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.39 E-value=0.019 Score=50.35 Aligned_cols=30 Identities=27% Similarity=0.252 Sum_probs=25.2
Q ss_pred CeeecCCCCCcEEE------cCCCceEEecccCccc
Q 022447 196 PVIYRDLKCSNILL------DRGYHPKLSDFGLAKL 225 (297)
Q Consensus 196 ~ivH~dikp~Nili------~~~~~~kl~Dfg~~~~ 225 (297)
.++|+|+.+.||++ ++++.+.++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 3467799999998764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.96 E-value=0.18 Score=39.82 Aligned_cols=107 Identities=12% Similarity=0.159 Sum_probs=69.7
Q ss_pred EEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHH
Q 022447 101 AIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA 180 (297)
Q Consensus 101 avK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~ 180 (297)
-++.++++.....+ ..|+.+|. ..||+++.. .+-.+.+.+.+.++.-+.+.-+..+. .++....+.++.
T Consensus 20 ~~~~~~ks~ik~~~--~~el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-------~~~~~eKlr~l~ 88 (215)
T 4ann_A 20 DMREIPKSSIKPEH--FHLMYLLE-QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-------SFTKNEKLRYLL 88 (215)
T ss_dssp CEEEEEGGGSCGGG--GGGGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-------GSCHHHHHHHHH
T ss_pred HHHHhcHhhccccC--HHHHHHHh-ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-------hcCHHHHHHHHH
Confidence 35555554333221 12344433 357888876 56666677666666543222222233 367889999999
Q ss_pred HHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 181 qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
+|+....++++ -+|=-+.|+|++++.++.+++.=.|+.
T Consensus 89 ni~~l~~~~~~-----r~tf~L~P~NL~f~~~~~p~i~~RGik 126 (215)
T 4ann_A 89 NIKNLEEVNRT-----RYTFVLAPDELFFTRDGLPIAKTRGLQ 126 (215)
T ss_dssp HGGGGGGGGGS-----SEECCCSGGGEEECTTSCEEESCCEET
T ss_pred HHHHHHHHhcC-----ceEEEEecceEEEcCCCCEEEEEccCc
Confidence 99988865554 378889999999999999999877754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.87 E-value=0.6 Score=36.97 Aligned_cols=83 Identities=11% Similarity=0.070 Sum_probs=60.4
Q ss_pred CCCCccceeeEeecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeeecCCCCC
Q 022447 127 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE-YLHDKAKPPVIYRDLKCS 205 (297)
Q Consensus 127 ~h~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~-~LH~~~~~~ivH~dikp~ 205 (297)
.||++ -..+-.+.+.+.+.++.-++..-+..+.. ++..+.+.++.+|+.... ++++ -+|--+.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57888 44445667777777766543333334433 678899999998888777 5544 478889999
Q ss_pred cEEEcCCCceEEecccCc
Q 022447 206 NILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 206 Nili~~~~~~kl~Dfg~~ 223 (297)
|++++.++.+++.-.|+-
T Consensus 114 NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp GEEECTTCCEEESCCEET
T ss_pred eEEEeCCCcEEEEEcCCc
Confidence 999999999999887764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.92 E-value=0.12 Score=46.27 Aligned_cols=62 Identities=8% Similarity=0.073 Sum_probs=18.1
Q ss_pred CCcceecccCcEEEEEEEECCCCeEEEE------EEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEee
Q 022447 75 RSESLLGEGGFGRVYKGYLESINQDVAI------KQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCA 139 (297)
Q Consensus 75 ~~~~~lg~G~~g~v~~~~~~~~~~~vav------K~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 139 (297)
.+.+.|| ||.||++.......+||+ |........ ....+.+|..+.+.++|||+++.+.+..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456676 999999998765567888 655432221 2245778888888899999999988753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 297 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-69 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-62 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-62 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-52 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-51 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-51 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-51 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-50 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-48 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-47 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-39 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 1e-69
Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPN 130
+G G FG VYKG + DVA+K L+ Q + F EV +L H N
Sbjct: 9 QITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
++ +GY Q +V ++ S+ HLH + + + + IA A+G++YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLH 121
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
K +I+RDLK +NI L K+ DFGLA + +H ++ G+ + APE
Sbjct: 122 AK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 251 KT---GQLTLKSDVYSFGVVLLEILSGRK 276
+ + +SDVY+FG+VL E+++G+
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQL 207
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 5e-66
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNL 131
+F S LG G G V+K + +A K + R + E+ +L + P +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V G + + E+M GS++ L + K++ +GL YL +
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
K K +++RD+K SNIL++ KL DFG++ ++ +GT Y +PE +
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQ 176
Query: 252 TGQLTLKSDVYSFGVVLLEILSGR 275
+++SD++S G+ L+E+ GR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-63
Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 9/205 (4%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
+ + LG G FG V+ GY + VA+K L + G FL E ++ L H L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L + ++ EYM GS+ D L P L N + +AA A G+ ++ +
Sbjct: 71 VRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
+ I+RDL+ +NIL+ K++DFGLA+L + + APE
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAIN 183
Query: 252 TGQLTLKSDVYSFGVVLLEILSGRK 276
G T+KSDV+SFG++L EI++ +
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGR 208
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-62
Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 8/209 (3%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPN 130
++ +G G +GR K +S + + K+LD + + + EV +L L HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 131 LVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
+V D L V EY G + + + ++ LD +++ L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 189 LHDK--AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 246
H + V++RDLK +N+ LD + KL DFGLA++ + +T + +GT Y +
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMS 182
Query: 247 PEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
PE KSD++S G +L E+ +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM 211
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 3e-62
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 9/210 (4%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLD-RNGVQGNREFLVEVLMLSLLHHPN 130
+++ LGEG +G V + VA+K +D + V E+ + +L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V G+ +G+ + L EY G + D + + + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
+ +RD+K N+LLD + K+SDFGLA + + + ++ GT Y APE
Sbjct: 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 251 KTGQL-TLKSDVYSFGVVLLEILSGRKAVD 279
K + DV+S G+VL +L+G D
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 207
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 5e-62
Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 9/205 (4%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
K+ LG G FG V G DVAIK + + G EF+ E ++ L H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L G C ++ EYM G + ++L + +++ +EYL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
K ++RDL N L++ K+SDFGL++ D S + PE
Sbjct: 119 K---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLM 174
Query: 252 TGQLTLKSDVYSFGVVLLEILSGRK 276
+ + KSD+++FGV++ EI S K
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGK 199
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 3e-61
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
+ LG+G FG+VYK + + A K +D + +++VE+ +L+ HPN+V
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
L+ + ++ E+ G+V+ + +L ++PL + + L YLHD
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA-- 250
+I+RDLK NIL KL+DFG++ +GT + APE
Sbjct: 130 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMC 184
Query: 251 ---KTGQLTLKSDVYSFGVVLLEILSGR 275
K K+DV+S G+ L+E+
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIE 212
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (487), Expect = 3e-60
Identities = 62/232 (26%), Positives = 104/232 (44%), Gaps = 22/232 (9%)
Query: 61 TLTFRELAAATKNFRSE---------SLLGEGGFGRVYKGYLESINQD---VAIKQLDRN 108
TF + A + F E ++G G FG V G+L+ + VAIK L
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 109 GVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 167
+ R+FL E ++ HPN+++L G +++ E+M GS++ L
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---ND 122
Query: 168 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227
+ + G A G++YL D ++RDL NIL++ K+SDFGL++
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 228 VGDNTHVSTRV---MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 276
+ T + APE + + T SDV+S+G+V+ E++S +
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 5e-60
Identities = 63/207 (30%), Positives = 92/207 (44%), Gaps = 14/207 (6%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHH 128
++F LG+G FG VY + +A+K L + ++ + EV + S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
PN++ L GY D + L+ EY PLG+V L D A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSY 121
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
H K VI+RD+K N+LL K++DFG + P + T + GT Y PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPE 174
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ K D++S GV+ E L G+
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGK 201
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (485), Expect = 6e-60
Identities = 63/230 (27%), Positives = 97/230 (42%), Gaps = 29/230 (12%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQGNR-EFLVEVLMLSLL 126
N +GEG FGRV++ + VA+K L + +F E +++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 127 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD--------------------LSPG 166
+PN+V L+G CA G L++EYM G + + L SPG
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 167 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226
PL ++ IA A G+ YL + ++RDL N L+ K++DFGL++
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 276
D + PE + T +SDV+++GVVL EI S
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 8e-60
Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
K + +G+G FG V G VA+K + + + FL E +++ L H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNL 62
Query: 132 VNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
V L+G + L +V EYM GS+ D+L S G+ L + +K + +EYL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
++RDL N+L+ K+SDFGL K +T + APE
Sbjct: 121 ---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEAL 172
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGRK 276
+ + + KSDV+SFG++L EI S +
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGR 198
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (481), Expect = 1e-59
Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 7/205 (3%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
+ + LG G +G VY+G + + VA+K L + ++ EFL E ++ + HPNL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L+G C ++ E+M G++ D+L + ++ + + +A + +EYL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE- 132
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
K I+RDL N L+ + K++DFGL++L GD + APE
Sbjct: 133 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 189
Query: 252 TGQLTLKSDVYSFGVVLLEILSGRK 276
+ ++KSDV++FGV+L EI +
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGM 214
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-59
Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 17/212 (8%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHP 129
+ + + +G G F VYKG +VA +L + + + F E ML L HP
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 130 NLVNLIGYCADGDQR----LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
N+V + +LV E M G+++ +L K + +G
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKG 124
Query: 186 LEYLHDKAKPPVIYRDLKCSNILL-DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244
L++LH + PP+I+RDLKC NI + K+ D GLA L + V+GT +
Sbjct: 125 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEF 179
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 276
APE + + DVY+FG+ +LE+ +
Sbjct: 180 MAPEMYE-EKYDESVDVYAFGMCMLEMATSEY 210
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-59
Identities = 65/230 (28%), Positives = 98/230 (42%), Gaps = 29/230 (12%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNRE-FLVEV-LMLSL 125
N +LG G FG+V I++ VA+K L RE + E+ +M L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 126 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH-------------------DLSPG 166
H N+VNL+G C L++EY G + ++L +
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 167 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226
L + + A A+G+E+L K ++RDL N+L+ G K+ DFGLA+
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 276
N V + APE G T+KSDV+S+G++L EI S
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (481), Expect = 3e-59
Identities = 65/211 (30%), Positives = 91/211 (43%), Gaps = 19/211 (9%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLH 127
K F +G G FG VY ++ VAIK++ +G Q N ++ + EV L L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
HPN + G LV EY + + KKPL + GA +GL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLA 129
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 247
YLH +I+RD+K NILL KL DFG A + + +GT + AP
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFVGTPYWMAP 180
Query: 248 EYA---KTGQLTLKSDVYSFGVVLLEILSGR 275
E GQ K DV+S G+ +E+ +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERK 211
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 8e-59
Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 9/205 (4%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
+G G FG V+ GY + VAIK + R G +F+ E ++ L HP L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L G C + LV+E+M G + D+L + T + + G+ YL +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
VI+RDL N L+ K+SDFG+ + D ST + +PE
Sbjct: 120 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFS 175
Query: 252 TGQLTLKSDVYSFGVVLLEILSGRK 276
+ + KSDV+SFGV++ E+ S K
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGK 200
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-58
Identities = 58/223 (26%), Positives = 102/223 (45%), Gaps = 11/223 (4%)
Query: 54 SD-QITAQTLTFRELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG 112
SD +I + + + K + +G+G G VY + Q+VAI+Q++
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK 60
Query: 113 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 172
+ E+L++ +PN+VN + GD+ +V EY+ GS+ D + + +D
Sbjct: 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDE 115
Query: 173 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232
+ + LE+LH VI+RD+K NILL KL+DFG +
Sbjct: 116 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQ 170
Query: 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ ++GT + APE K D++S G++ +E++ G
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 2e-58
Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 12/217 (5%)
Query: 65 RELAAATKNFRSESL-LGEGGFGRVYKGYLESIN--QDVAIKQLDRNGVQGNRE-FLVEV 120
++L N + LG G FG V +G DVAIK L + + + E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 121 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA 180
++ L +P +V LIG C + +LV E G + L ++ + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 181 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVM 239
+ G++YL +K ++RDL N+LL ++ K+SDFGL+K LG +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 240 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 276
+ APE + + +SDV+S+GV + E LS +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 210
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-57
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 77 ESLLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLV 132
+ LG G FG V KGY + + + VA+K L E L E ++ L +P +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
+IG C + + +LV E LG + +L + + +++ + G++YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 193 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAK 251
++RDL N+LL ++ K+SDFGL+K L + T + APE
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 252 TGQLTLKSDVYSFGVVLLEILSGRK 276
+ + KSDV+SFGV++ E S +
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQ 208
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 9e-57
Identities = 67/216 (31%), Positives = 99/216 (45%), Gaps = 9/216 (4%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL 131
++ R E LG+G FG V+ G VAIK L + G FL E ++ L H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 74
Query: 132 VNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD 191
V L + +V EYM GS+ D L K L + +AA A G+ Y+
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 192 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
++RDL+ +NIL+ K++DFGLA+L + + APE A
Sbjct: 132 M---NYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAAL 187
Query: 252 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287
G+ T+KSDV+SFG++L E+ + + E
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 223
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 1e-56
Identities = 64/236 (27%), Positives = 97/236 (41%), Gaps = 24/236 (10%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESI-----NQDVAIKQLDRNGVQGNRE-FLVEVLMLS-L 125
LG G FG+V + + VA+K L + RE + E+ +LS L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 126 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD--------------LSPGKKPLD 171
+H N+VNL+G C G L++ EY G + + L + + LD
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 172 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231
+ + A+G+ +L K I+RDL NILL G K+ DFGLA+ N
Sbjct: 144 LEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287
V + APE T +SDV+S+G+ L E+ S + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-56
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLES--INQDVAIKQLDRNGV-QGNREFLVEV-LMLSLLH 127
+ + + ++GEG FG+V K ++ + D AIK++ +R+F E+ ++ L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD------------LSPGKKPLDWNTR 175
HPN++NL+G C L EY P G++ D L + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 176 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 235
+ AA ARG++YL + I+RDL NIL+ Y K++DFGL++ V
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--- 183
Query: 236 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 276
T + A E T SDV+S+GV+L EI+S
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-56
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 25/217 (11%)
Query: 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG 136
+ +G+G FG V++G ++VA+K + + E+ +L H N++ I
Sbjct: 8 QESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIA 64
Query: 137 YCADGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
+ Q LV +Y GS+ D+L+ + + +K+A A GL +LH +
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHME 119
Query: 193 A-----KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYC 245
KP + +RDLK NIL+ + ++D GLA +T +GT Y
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 246 APEY------AKTGQLTLKSDVYSFGVVLLEILSGRK 276
APE K + ++D+Y+ G+V EI
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 3e-56
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 79 LLGEGGFGRVYKGYLESINQ---DVAIKQLDRNGVQGN-REFLVEVLMLSLLHHPNLVNL 134
++G G FG VY G L + A+K L+R G +FL E +++ HPN+++L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 135 IGYCADGDQR-LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
+G C + L+V YM G + + + + A+G+++L K
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK- 149
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAK 251
++RDL N +LD + K++DFGLA+ D+ H T + A E +
Sbjct: 150 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 252 TGQLTLKSDVYSFGVVLLEILSGRK 276
T + T KSDV+SFGV+L E+++
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGA 232
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 5e-56
Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 10/206 (4%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHP 129
+F+ +LGEG F V + +++ AIK L++ + E ++S L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
V L D ++ Y G + ++ D A LEYL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYL 124
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
H +I+RDLK NILL+ H +++DFG AK+ + +GT Y +PE
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSGR 275
SD+++ G ++ ++++G
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 5e-55
Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQD----VAIKQLDRNGVQGNR-EFLVEVLMLSLLH 127
+ ++G G FG VYKG L++ + VAIK L + R +FL E ++
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
H N++ L G + +++ EYM G+++ L + + + G A G++
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMK 124
Query: 188 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCA 246
YL ++RDL NIL++ K+SDFGL++ L + T+ ++ + A
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 247 PEYAKTGQLTLKSDVYSFGVVLLEILSGRK 276
PE + T SDV+SFG+V+ E+++ +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE 211
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-54
Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 14/212 (6%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGV---QGNREFLVEVLMLSL 125
K+ R LG+G FG V +G ++ + VA+K L + + + +F+ EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 126 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
L H NL+ L G ++ V E PLGS+ D L + T + A A G
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEG 123
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV-STRVMGTYGY 244
+ YL K I+RDL N+LL K+ DFGL + P D+ +V + +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 276
CAPE KT + SD + FGV L E+ + +
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 5e-54
Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 12/208 (5%)
Query: 74 FRSESLLGEGGFGRVYKGYL----ESINQDVAIKQLDR-NGVQGNREFLVEVLMLSLLHH 128
F+ +LG G FG VYKG E + VAIK+L + N+E L E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
P++ L+G C +L + + MP G + D++ + K + + A+G+ Y
Sbjct: 71 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNY 126
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
L D+ +++RDL N+L+ H K++DFGLAKL + + + + A E
Sbjct: 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGRK 276
T +SDV+S+GV + E+++
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGS 211
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 175 bits (445), Expect = 2e-53
Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 11/205 (5%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
++ LG G FG V++ + + A K + E+ +S+L HP LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
NL D ++ +++YE+M G + + + D + + ++ +GL ++H+
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 193 AKPPVIYRDLKCSNILL--DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
++ DLK NI+ R KL DFGL D GT + APE A
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVA 197
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGR 275
+ + +D++S GV+ +LSG
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-52
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 15/217 (6%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQGNR-EFLVEVLMLSL 125
+ LG+G FG VY+G + + +D VAIK ++ R EFL E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 126 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL------SPGKKPLDWNTRMKIA 179
+ ++V L+G + G L++ E M G ++ +L L +P P + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 180 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 239
A G+ YL+ ++RDL N ++ + K+ DFG+ + D + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 240 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 276
+ +PE K G T SDV+SFGVVL EI + +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (439), Expect = 2e-52
Identities = 44/205 (21%), Positives = 88/205 (42%), Gaps = 11/205 (5%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
+ LG G FG V++ ++ + K ++ E+ +++ LHHP L+
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
NL D + +L+ E++ G + D + + + A GL+++H+
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 193 AKPPVIYRDLKCSNILLD--RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
+++ D+K NI+ + + K+ DFGLA + + T + APE
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIV 200
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGR 275
+ +D+++ GV+ +LSG
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 3e-52
Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 12/208 (5%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQD---VAIKQLDRNGVQGNRE-FLVEVLMLSLLHH 128
+GEG FG V++G S VAIK RE FL E L + H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
P++V LIG + + ++ E LG + L K LD + + A + L Y
Sbjct: 68 PHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAY 123
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
L K ++RD+ N+L+ KL DFGL++ + +++ + APE
Sbjct: 124 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 179
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGRK 276
+ T SDV+ FGV + EIL
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV 207
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-51
Identities = 68/207 (32%), Positives = 101/207 (48%), Gaps = 13/207 (6%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSL-LHH 128
+F +LG+G FG+V+ + NQ AIK L ++ V + + +VE +LSL H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
P L ++ + V EY+ G + H+ D + AA GL++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQF 118
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
LH K ++YRDLK NILLD+ H K++DFG+ K +GD GT Y APE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPE 173
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ D +SFGV+L E+L G+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 167 bits (423), Expect = 7e-51
Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 15/213 (7%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN---REFLVEVLMLSLLH 127
+ + +LG GG V+ +++DVA+K L + + F E + L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 128 HPNLVNLIGYCAD----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
HP +V + G +V EY+ ++ D +H + P+ +++ A A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADAC 121
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTY 242
+ L + H +I+RD+K +NI++ K+ DFG+A+ + G++ + V+GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 243 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y +PE A+ + +SDVYS G VL E+L+G
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (429), Expect = 7e-51
Identities = 64/210 (30%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---QGNREFLVEVLMLSLLH-- 127
+F ++G GGFG VY + A+K LD+ + QG L E +MLSL+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 128 -HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
P +V + D+ + + M G + HL AA GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGL 120
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 246
E++H++ V+YRDLK +NILLD H ++SD GLA +GT+GY A
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 247 PEYAKTGQ-LTLKSDVYSFGVVLLEILSGR 275
PE + G +D +S G +L ++L G
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 166 bits (420), Expect = 5e-50
Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHH 128
++F+ LG G FGRV+ + A+K L + V ++ E LMLS++ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
P ++ + G D Q ++ +Y+ L L + AA LEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIE----GGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
LH K +IYRDLK NILLD+ H K++DFG AK P V+ + GT Y APE
Sbjct: 120 LHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPE 171
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGRK 276
T D +SFG+++ E+L+G
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-50
Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQD-------VAIKQLDRNGVQGN-REFLVEV-LML 123
LGEG FG+V +++D VA+K L + + + + + E+ +M
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 124 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG------------KKPLD 171
+ H N++NL+G C ++ EY G++ ++L P ++ L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 172 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231
+ A ARG+EYL K I+RDL N+L+ K++DFGLA+ D
Sbjct: 134 SKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 276
+T + APE T +SDV+SFGV+L EI +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (418), Expect = 7e-50
Identities = 49/206 (23%), Positives = 80/206 (38%), Gaps = 8/206 (3%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHP 129
+ +LG G F V + + VAIK + + ++G E+ +L + HP
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N+V L G L+ + + G + D + + K ++ ++YL
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYL 123
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
HD + LD +SDFGL+K+ D V + GT GY APE
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEV 180
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSGR 275
+ D +S GV+ +L G
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-49
Identities = 40/205 (19%), Positives = 87/205 (42%), Gaps = 12/205 (5%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
+ LG G FG V++ S + K + G E+ +L++ H N++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNIL 64
Query: 133 NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
+L ++ ++++E++ + + ++ L+ + L++LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 193 AKPPVIYRDLKCSNILLD--RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
+ + D++ NI+ R K+ +FG A+ GDN + + Y APE
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVH 175
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGR 275
+ ++ +D++S G ++ +LSG
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGI 200
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-49
Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQD-----VAIKQLDRNGVQG-NREFLVEV-LMLSL 125
+ LG G FG+V + I++ VA+K L +R + E+ +++ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 126 LHHPNLVNLIGYCA-DGDQRLLVYEYMPLGSVEDHLHD------------LSPGKKPLDW 172
HH N+VNL+G C G +++ E+ G++ +L K L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 173 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 232
+ + A+G+E+L + I+RDL NILL K+ DFGLA+ +
Sbjct: 134 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 233 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 276
+ APE T++SDV+SFGV+L EI S
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (404), Expect = 4e-48
Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 26/219 (11%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV---------QGNREFLVEV-LM 122
N+ + +LG G V + + ++ A+K +D G + L EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 123 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGA 182
+ HPN++ L LV++ M G + D+L + K L KI
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRAL 119
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 242
+ LH +++RDLK NILLD + KL+DFG + D V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTP 173
Query: 243 GYCAPEYAKTGQL------TLKSDVYSFGVVLLEILSGR 275
Y APE + + D++S GV++ +L+G
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-47
Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-----NREFLVEVLMLSLLHHPNLVN 133
LGEG F VYK ++ NQ VAIK++ NR L E+ +L L HPN++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 134 LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 193
L+ LV+++M D + L + +GLEYLH
Sbjct: 65 LLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 194 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 253
+++RDLK +N+LLD KL+DFGLAK G T + T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 254 QL-TLKSDVYSFGVVLLEILSGR 275
++ + D+++ G +L E+L
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 6e-47
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 7/208 (3%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHP 129
+ + S +GEG +G V Y VAIK++ Q + L E+ +L H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N++ + + Y+ + L+ L + L + RGL+Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKYI 125
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPE 248
H V++RDLK SN+LL+ K+ DFGLA+ P D+T T + T Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 249 YAKTGQLTLKS-DVYSFGVVLLEILSGR 275
+ KS D++S G +L E+LS R
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-46
Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 17/210 (8%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV 132
++ ++G G FG VY+ L + VAIK++ ++ NR E+ ++ L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 133 NLIGYCADGDQR------LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 186
L + ++ LV +Y+P H S K+ L R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 187 EYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 245
Y+H + +RD+K N+LLD KL DFG AK + + + Y
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRYYRA 190
Query: 246 APEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
T DV+S G VL E+L G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 8e-46
Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 20/212 (9%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNR------EFLVEVLMLSLLH 127
+ + LG G F V K +S A K + + + +R + EV +L +
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 128 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 187
HPN++ L + +L+ E + L D K+ L + G+
Sbjct: 72 HPNVITLHEVYENKTDVILILELVA----GGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 188 YLHDKAKPPVIYRDLKCSNILLDR----GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
YLH + + DLK NI+L K+ DFGLA D + + GT
Sbjct: 128 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 181
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ APE L L++D++S GV+ +LSG
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 152 bits (384), Expect = 6e-45
Identities = 44/215 (20%), Positives = 78/215 (36%), Gaps = 20/215 (9%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPN 130
+++ +GEG FG +++G NQ VAIK R + E LL
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 62
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+ N+ + +G +LV + + L + T A ++ +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLG----PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHP-----KLSDFGLAKLGPVGDNT-----HVSTRVMG 240
+K ++YRD+K N L+ R + DFG+ K + G
Sbjct: 119 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 241 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
T Y + + + + D+ + G V + L G
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 210
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-44
Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 20/212 (9%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE------FLVEVLMLSLLH 127
++ LLG GGFG VY G S N VAIK ++++ + E +EV++L +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 128 --HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 185
++ L+ + D +L+ E L D + L
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQ---DLFDFITERGALQEELARSFFWQVLEA 122
Query: 186 LEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 244
+ + H+ V++RD+K NIL+D KL DFG L V T GT Y
Sbjct: 123 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVY 175
Query: 245 CAPEYAKTGQL-TLKSDVYSFGVVLLEILSGR 275
PE+ + + + V+S G++L +++ G
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-44
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 14/214 (6%)
Query: 70 ATKNFRSESLLGEGGFGRVYKGY-LESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLL 126
A + + + +GEG +G+V+K L++ + VA+K++ + + EV +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 127 ---HHPNLVNLIGYCADGDQRLLVYEYMPLGSV--EDHLHDLSPGKKPLDWNTRMKIAAG 181
HPN+V L C + V + + + + T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 241
RGL++LH V++RDLK NIL+ KL+DFGLA++ T V+ T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 242 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE D++S G + E+ +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 6e-44
Identities = 48/205 (23%), Positives = 88/205 (42%), Gaps = 9/205 (4%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPN 130
NF+ +GEG +G VYK + + VA+K++ D + E+ +L L+HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V L+ ++ LV+E++ + + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
V++RDLK N+L++ KL+DFGLA+ V + V+ +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILL 175
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGR 275
+ D++S G + E+++ R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-43
Identities = 61/207 (29%), Positives = 89/207 (42%), Gaps = 12/207 (5%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHH 128
+F LLG+G FG+V ++ + A+K L + + E + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
P L L D+ V EY G + HL ++ A LEY
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEY 120
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
LH + V+YRD+K N++LD+ H K++DFGL K G T GT Y APE
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPE 175
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ D + GVV+ E++ GR
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (373), Expect = 3e-43
Identities = 47/211 (22%), Positives = 83/211 (39%), Gaps = 18/211 (8%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN 133
+R +G G FG +Y G + ++VAIK + + +E + ++ +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIP 66
Query: 134 LIGYC-ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 192
I +C A+GD ++V E + + + T + +A +EY+H K
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 193 AKPPVIYRDLKCSNIL---LDRGYHPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGY 244
I+RD+K N L +G + DFGLAK + + GT Y
Sbjct: 123 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 245 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
+ + + + D+ S G VL+ G
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 210
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 8e-43
Identities = 47/204 (23%), Positives = 82/204 (40%), Gaps = 19/204 (9%)
Query: 79 LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC 138
+LG G G+V + + + + A+K L ++ + RE L P++V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARREV---ELHWRASQCPHIVRIVDVY 74
Query: 139 ----ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 194
A L+V E + G + + D G + +I ++YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN- 131
Query: 195 PPVIYRDLKCSNILLDRGY---HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 251
+ +RD+K N+L KL+DFG AK ++ T Y APE
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLG 186
Query: 252 TGQLTLKSDVYSFGVVLLEILSGR 275
+ D++S GV++ +L G
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGY 210
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 141 bits (357), Expect = 5e-41
Identities = 46/205 (22%), Positives = 91/205 (44%), Gaps = 11/205 (5%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPN 130
+ +GEG +G VYK + A+K++ ++ + E+ +L L H N
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 131 LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 190
+V L + +LV+E++ +D L + L+ T G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 191 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 250
D+ V++RDLK N+L++R K++DFGLA+ + + ++ +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLM 173
Query: 251 KTGQLTLKSDVYSFGVVLLEILSGR 275
+ + + D++S G + E+++G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 9e-41
Identities = 48/218 (22%), Positives = 89/218 (40%), Gaps = 10/218 (4%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHP 129
+ + +GEG +G V+K ++ VA+K++ D + L E+ +L L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N+V L + LV+E+ +D LD +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
H + V++RDLK N+L++R KL++FGLA+ + S V+ +
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVVTLWYRPPDVL 173
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287
+ D++S G + E+ + + + +Q
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-40
Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 20/216 (9%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPN 130
+ + +G+G FG V+K Q VA+K++ + L E+ +L LL H N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 131 LVNLIGYCADGDQR--------LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGA 182
+VNLI C LV+++ + L + ++
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQML 126
Query: 183 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS--TRVMG 240
GL Y+H + +++RD+K +N+L+ R KL+DFGLA+ + N+ + T +
Sbjct: 127 LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 241 TYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGR 275
T Y PE + D++ G ++ E+ +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 6e-40
Identities = 40/206 (19%), Positives = 82/206 (39%), Gaps = 9/206 (4%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHP 129
+R +G G +G V VAIK+L R + E+ +L + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
N++ L+ + ++ + + L + + +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
H +I+RDLK N+ ++ K+ DFGLA+ ++ ++ V+ +
Sbjct: 138 HAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEVI 190
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSGR 275
+ T D++S G ++ E+++G+
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (350), Expect = 2e-39
Identities = 58/206 (28%), Positives = 85/206 (41%), Gaps = 15/206 (7%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHP 129
F LG G FGRV + A+K LD+ V ++ L E +L ++ P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 130 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
LV L D +V EY+ G + HL AA EYL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYL 157
Query: 190 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 249
H +IYRDLK N+L+D+ + +++DFG AK T + GT APE
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209
Query: 250 AKTGQLTLKSDVYSFGVVLLEILSGR 275
+ D ++ GV++ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (326), Expect = 4e-36
Identities = 39/207 (18%), Positives = 80/207 (38%), Gaps = 19/207 (9%)
Query: 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEV-LMLSLLHHPNL 131
+++ LG G + V++ + N+ V +K L + + E+ ++ +L PN+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNI 92
Query: 132 VNLIGYCADGDQRL--LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 189
+ L D R LV+E++ + + L + L+Y
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYC 145
Query: 190 HDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
H +++RD+K N+++D +L D+GLA+ + RV Y
Sbjct: 146 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHPGQEYNVRVASRYFKGPEL 200
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGR 275
D++S G +L ++ +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 4e-35
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 18/214 (8%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGV----QGNREFLVEVLMLS 124
+NF +LG G +G+V+ S + A+K L + + + E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 125 LL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
+ P LV L + L+ +Y+ G + HL ++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIV 139
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
LE+LH +IYRD+K NILLD H L+DFGL+K V D T + GT
Sbjct: 140 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIE 195
Query: 244 YCAPEYAKTGQ--LTLKSDVYSFGVVLLEILSGR 275
Y AP+ + G D +S GV++ E+L+G
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 9e-35
Identities = 42/207 (20%), Positives = 85/207 (41%), Gaps = 9/207 (4%)
Query: 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHH 128
+ +++ S +G G +G V + VA+K+L R + + E+ +L + H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 129 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 188
N++ L+ + + + + + L + + RGL+Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 189 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 248
+H +I+RDLK SN+ ++ K+ DFGLA+ + ++ V +
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEI 189
Query: 249 YAKTGQLTLKSDVYSFGVVLLEILSGR 275
D++S G ++ E+L+GR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 7e-33
Identities = 49/212 (23%), Positives = 92/212 (43%), Gaps = 21/212 (9%)
Query: 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHP 129
K +++ +G G G V Y ++++VAIK+L R + E++++ ++H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 130 NLVNLIGYCA------DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
N+++L+ + LV E M + + LD +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQML 129
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 243
G+++LH +I+RDLK SNI++ K+ DFGLA+ + + T + T
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRY 183
Query: 244 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
Y APE D++S G ++ E++ +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (297), Expect = 1e-31
Identities = 38/215 (17%), Positives = 76/215 (35%), Gaps = 16/215 (7%)
Query: 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN 133
+ LG G F V+ N VA+K + + V E+ +L ++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTK 73
Query: 134 LIGYCADGDQRLLVYEY------------MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 181
A+ +LL + + + + +I+
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 182 AARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMG 240
GL+Y+H + +I+ D+K N+L++ L +A LG T +
Sbjct: 134 LLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 241 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 275
T Y +PE +D++S ++ E+++G
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.1 bits (194), Expect = 2e-18
Identities = 21/161 (13%), Positives = 45/161 (27%), Gaps = 30/161 (18%)
Query: 78 SLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV----------QGNREFLVEVLMLSLLH 127
L+GEG V+ Y E + +K G+ F V + +
Sbjct: 6 KLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 128 HPNLVNLIGYCA----DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA 183
L L G + ++ E + + ++
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-----------RVENPDEVLDMIL 113
Query: 184 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224
+ + + +++ DL N+L+ + DF +
Sbjct: 114 EEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 297 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.01 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.53 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.5 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.6 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.41 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.3 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=368.74 Aligned_cols=208 Identities=27% Similarity=0.407 Sum_probs=183.1
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
+.++|++.+.||+|+||.||+|.++.+|+.||||++...... ..+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 456899999999999999999999999999999999765433 3356889999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
|||+||+|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 83 Ey~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 83 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred eccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 99999999999976 568999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCcceeecccccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
..........+||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~ 212 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH
Confidence 333334456789999999999988776 57899999999999999999999876543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=366.11 Aligned_cols=206 Identities=27% Similarity=0.411 Sum_probs=187.4
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
++|++.+.||+|+||.||+|.++.+|+.||||++........+.+.+|+.+++.++||||+++++++.+++.+|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999999999999999998766666678999999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
+||+|.+++.. ..+++.+++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-- 169 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc--
Confidence 99999998875 56999999999999999999999999 999999999999999999999999999864322
Q ss_pred cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 232 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.....
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 225 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH
Confidence 22345567999999999999999999999999999999999999999887665443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-54 Score=358.06 Aligned_cols=208 Identities=30% Similarity=0.451 Sum_probs=186.7
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++.+.||+|+||.||+|.++.+++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999986532 233467889999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
|||+||+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999987 567999999999999999999999999 99999999999999999999999999975332
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHH
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~ 290 (297)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 159 ~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i 216 (263)
T d2j4za1 159 S----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 216 (263)
T ss_dssp C----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred C----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 2 234567999999999999999999999999999999999999999988766654443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-54 Score=364.26 Aligned_cols=208 Identities=25% Similarity=0.361 Sum_probs=183.4
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++.+.||+|+||+||+|.++.+|+.||||++.+.. ......+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999997532 223467889999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
|||+||+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999887 578999999999999999999999999 99999999999999999999999999987544
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
..........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 218 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 218 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH
Confidence 4444444567899999999999999999999999999999999999999998766554
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-53 Score=364.59 Aligned_cols=211 Identities=28% Similarity=0.378 Sum_probs=189.6
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 467999999999999999999999999999999997542 23446788999999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||++||+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++...
T Consensus 84 ~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999987 678999999999999999999999999 9999999999999999999999999998633
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHH
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~ 290 (297)
.. .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+
T Consensus 157 ~~--~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i 217 (337)
T d1o6la_ 157 SD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217 (337)
T ss_dssp CT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cC--CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 22 22345678999999999999999999999999999999999999999998876654443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=360.70 Aligned_cols=207 Identities=27% Similarity=0.414 Sum_probs=184.1
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecC
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 151 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 151 (297)
+.|++++.||+|+||.||+|.++.++..||||++........+.+.+|+.+++.++||||+++++++.+++..|+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999999999999999998776666678899999999999999999999999999999999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
+||+|.+++... ..++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.... ..
T Consensus 92 ~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~--~~ 163 (288)
T d2jfla1 92 AGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RT 163 (288)
T ss_dssp TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECH--HH
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccC--CC
Confidence 999999997652 467999999999999999999999999 9999999999999999999999999986421 11
Q ss_pred cceeecccccccccCccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 232 THVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 232 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
.......+||+.|+|||++. +..|+.++|||||||++|+|++|+.||.+.+..+.
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~ 223 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV 223 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH
Confidence 12234567999999999884 45688999999999999999999999988766544
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=356.26 Aligned_cols=215 Identities=25% Similarity=0.345 Sum_probs=174.4
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhccCCCCccceeeEeec--CCeeEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLV 147 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 147 (297)
++|++.+.||+|+||.||+|+++.+|+.||||++....... .+.+.+|+.++++++||||+++++++.+ ...+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999999999999999997764332 3568899999999999999999999865 4568999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA--KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
||||+||+|.+++.........+++..++.++.||+.||.|||+++ ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999754333577999999999999999999999853 12399999999999999999999999999986
Q ss_pred cCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+...
T Consensus 164 ~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~ 224 (269)
T d2java1 164 LNH--DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG 224 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccc--CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHH
Confidence 432 2223445789999999999999999999999999999999999999999877665443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=365.72 Aligned_cols=205 Identities=25% Similarity=0.341 Sum_probs=182.6
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.++|++.+.||+|+||+||+|.++.+|+.||+|+++.... .....+.+|+.+++.++||||++++++|.+++..|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4689999999999999999999999999999999976533 234678899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
|++||+|.+++.. ...+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||+|.....
T Consensus 85 y~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999986 5679999999999999999999997 48 99999999999999999999999999975321
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
....+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+....
T Consensus 158 ----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~ 211 (322)
T d1s9ja_ 158 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211 (322)
T ss_dssp ----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHH
T ss_pred ----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 223456899999999999999999999999999999999999999988765443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-52 Score=358.86 Aligned_cols=207 Identities=26% Similarity=0.383 Sum_probs=169.8
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc-hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.+.|++.+.||+|+||+||+|.++.+++.||||++....... ...+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999999999999999997654332 3457789999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEc---CCCceEEecccCcccc
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD---RGYHPKLSDFGLAKLG 226 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~---~~~~~kl~Dfg~~~~~ 226 (297)
||+|++|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+||++. +++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999986 678999999999999999999999999 99999999999995 5789999999999753
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+..
T Consensus 161 ~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~ 218 (307)
T d1a06a_ 161 DPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF 218 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH
Confidence 222 2334567999999999999999999999999999999999999999887665543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.5e-52 Score=360.38 Aligned_cols=209 Identities=24% Similarity=0.354 Sum_probs=187.4
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|++.+.||+|+||.||+|.++.+|+.||||++........+.+.+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46899999999999999999999999999999999876666667789999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEc--CCCceEEecccCccccCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD--RGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~--~~~~~kl~Dfg~~~~~~~ 228 (297)
|+||+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 105 ~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 9999999998642 457999999999999999999999999 99999999999996 467899999999986432
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 179 ~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~ 235 (350)
T d1koaa2 179 K---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR 235 (350)
T ss_dssp T---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred c---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 2 23445679999999999999999999999999999999999999999877655443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.3e-52 Score=360.27 Aligned_cols=209 Identities=21% Similarity=0.313 Sum_probs=187.6
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|++.+.||+|+||.||+|.++.+|+.||||++..........+.+|+.+++.++||||++++++|.+++.+|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999999999999999999876655566788999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEc--CCCceEEecccCccccCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD--RGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~--~~~~~kl~Dfg~~~~~~~ 228 (297)
|+||+|.+++.. ...++++.+++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 108 ~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999998765 2457999999999999999999999999 99999999999998 578999999999986433
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 182 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~ 238 (352)
T d1koba_ 182 D---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ 238 (352)
T ss_dssp T---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred C---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 2 23445679999999999999999999999999999999999999999877665543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.8e-52 Score=355.76 Aligned_cols=206 Identities=33% Similarity=0.459 Sum_probs=186.3
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
.++|++.+.||+|+||+||+|.++.+|+.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 367999999999999999999999999999999997532 23346788999999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
||||+|++|..++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++...
T Consensus 83 mE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 83 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEec
Confidence 999999999999987 677899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 156 ~-----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 211 (316)
T d1fota_ 156 D-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211 (316)
T ss_dssp S-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred c-----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH
Confidence 2 2345689999999999999999999999999999999999999999887665543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-51 Score=347.10 Aligned_cols=206 Identities=26% Similarity=0.362 Sum_probs=184.1
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhccCCCCccceeeEeecCCee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 144 (297)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+.... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35799999999999999999999999999999999754322 246788999999999999999999999999999
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC----ceEEecc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSDF 220 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~----~~kl~Df 220 (297)
|+|||||+||+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence 999999999999999987 567999999999999999999999999 99999999999998776 4999999
Q ss_pred cCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
|++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.
T Consensus 162 G~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 224 (293)
T d1jksa_ 162 GLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 224 (293)
T ss_dssp TTCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred hhhhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH
Confidence 999764322 233456799999999999999999999999999999999999999998766554
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-51 Score=350.42 Aligned_cols=201 Identities=32% Similarity=0.416 Sum_probs=179.1
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
.|+.++.||+|+||.||+|++..+++.||||++....... .+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4889999999999999999999999999999997654332 2468899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
||.||+|..++.. ..++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 96 ~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~-- 166 (309)
T d1u5ra_ 96 YCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-- 166 (309)
T ss_dssp CCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS--
T ss_pred ecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccC--
Confidence 9999999877765 578999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCcceeecccccccccCcccccc---CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
......||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.
T Consensus 167 ----~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~ 222 (309)
T d1u5ra_ 167 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (309)
T ss_dssp ----SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ----CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 2334679999999999864 4588999999999999999999999987765543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-51 Score=356.53 Aligned_cols=207 Identities=27% Similarity=0.321 Sum_probs=186.3
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
++|++++.||+|+||.||+|.++.+|+.||||++.+.. ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999999999999999986532 233467889999999999999999999999999999999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||+.||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999987 567999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHH
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~ 290 (297)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 194 -----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i 250 (350)
T d1rdqe_ 194 -----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250 (350)
T ss_dssp -----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred -----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH
Confidence 233567999999999999999999999999999999999999999988765554433
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=350.75 Aligned_cols=215 Identities=31% Similarity=0.473 Sum_probs=187.7
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHh-ccCCCCccceeeEeecCCeeEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNG---VQGNREFLVEVLMLS-LLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
++|++.+.||+|+||+||+|.++.+++.||||++.+.. ......+..|..++. .++||||+++++++.+.+..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999999999999999997532 223345667777665 68999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||++||+|.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999987 567999999999999999999999999 9999999999999999999999999997533
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhHHhhcCC
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWSEP 295 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l~~~~~p 295 (297)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....|
T Consensus 155 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~ 220 (320)
T d1xjda_ 155 LG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 220 (320)
T ss_dssp CT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred cc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 22 2334456799999999999999999999999999999999999999998887766555544433
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-51 Score=341.94 Aligned_cols=201 Identities=30% Similarity=0.478 Sum_probs=173.7
Q ss_pred CCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeec----CCeeEEE
Q 022447 74 FRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLV 147 (297)
Q Consensus 74 y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 147 (297)
|++.+.||+|+||+||+|.++.++..||+|++...... ..+.+.+|+.++++++||||+++++++.+ ...+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 36677899999999999999999999999998764332 33568899999999999999999999864 4567899
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEc-CCCceEEecccCcccc
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKLG 226 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~-~~~~~kl~Dfg~~~~~ 226 (297)
|||++||+|.+++.. ...+++..++.++.||+.||+|||+++ .+|+||||||+|||++ +++.+||+|||+++..
T Consensus 91 mE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999999987 567999999999999999999999874 4499999999999996 5789999999999753
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
.. ......+||+.|+|||++.+ .++.++|||||||++|||++|+.||......
T Consensus 166 ~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~ 218 (270)
T d1t4ha_ 166 RA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA 218 (270)
T ss_dssp CT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH
T ss_pred cC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH
Confidence 22 22345689999999998865 5999999999999999999999999865543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=341.13 Aligned_cols=206 Identities=32% Similarity=0.514 Sum_probs=171.5
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 148 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 148 (297)
.++|++.+.||+|+||.||+|..+ ..||||+++.... ...+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 468999999999999999999764 3599999875432 334678899999999999999999998754 5689999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPV 228 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 228 (297)
||++||+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 83 Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 83 QWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp ECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred ecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 999999999999752 456999999999999999999999999 99999999999999999999999999976544
Q ss_pred CCCcceeecccccccccCccccccC---CCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 229 GDNTHVSTRVMGTYGYCAPEYAKTG---QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 229 ~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
...........||+.|+|||++.+. .++.++|||||||++|||+||+.||.+.+....
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~ 217 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH
Confidence 3334444567899999999998643 478999999999999999999999998665443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.4e-50 Score=339.43 Aligned_cols=209 Identities=26% Similarity=0.414 Sum_probs=176.3
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhccCCCCccceeeEeecCC----e
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGD----Q 143 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~ 143 (297)
.++|++.+.||+|+||.||+|.+..+|+.||||+++.....+ ..++.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999999999999999998654433 346889999999999999999999987643 4
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
+|+||||++|++|.+++.. ..++++.+++.++.||+.||+|||+++ |+||||||+|||++.++.++|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 7899999999999999987 567999999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCC-CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 224 KLGPVGD-NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 224 ~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
....... ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 222 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 222 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH
Confidence 6543322 22234456799999999999999999999999999999999999999998776554
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.2e-50 Score=336.93 Aligned_cols=208 Identities=28% Similarity=0.359 Sum_probs=184.1
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc---------hHHHHHHHHHHhccC-CCCccceeeEeec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG---------NREFLVEVLMLSLLH-HPNLVNLIGYCAD 140 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 140 (297)
.++|++.+.||+|+||+||+|++..+|+.||||++.+..... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999999999999999997653321 135788999999997 9999999999999
Q ss_pred CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecc
Q 022447 141 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (297)
Q Consensus 141 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Df 220 (297)
++..|+||||++|++|.+++.. ..++++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999987 567999999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCCcceeecccccccccCcccccc------CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
|+++...... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+..+...
T Consensus 155 G~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~ 225 (277)
T d1phka_ 155 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 225 (277)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred hheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH
Confidence 9998643322 2345679999999998853 346889999999999999999999999988766544
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2e-50 Score=352.45 Aligned_cols=208 Identities=28% Similarity=0.399 Sum_probs=179.4
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc---chHHHHH---HHHHHhccCCCCccceeeEeecCCee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ---GNREFLV---EVLMLSLLHHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~ 144 (297)
.++|++.+.||+|+||.||+|.++.+|+.||||++.+.... ....+.+ ++.+++.++||||+++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 46899999999999999999999999999999998653221 1222333 46777778899999999999999999
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
|+|||||+||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++
T Consensus 83 ~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999999987 577899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcceeecccccccccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 225 LGPVGDNTHVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 225 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
..... .....+||+.|+|||++. +..++.++|||||||++|||++|+.||...+..+...+
T Consensus 156 ~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~ 217 (364)
T d1omwa3 156 DFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 217 (364)
T ss_dssp ECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH
T ss_pred ecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 64322 234567999999999986 45789999999999999999999999988765544433
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=344.13 Aligned_cols=208 Identities=17% Similarity=0.244 Sum_probs=184.4
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..++|++.+.||+|+||+||+|.++.+++.||||+++.... +...+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 35789999999999999999999999999999999976543 33567899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC--CceEEecccCccccC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG--YHPKLSDFGLAKLGP 227 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~--~~~kl~Dfg~~~~~~ 227 (297)
||+|++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.+ ..++|+|||++....
T Consensus 82 ~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccc
Confidence 99999999999762 347999999999999999999999999 9999999999999854 589999999998643
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
. ........+|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+..
T Consensus 156 ~---~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~ 212 (321)
T d1tkia_ 156 P---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212 (321)
T ss_dssp T---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred c---CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 2 22344567999999999999999999999999999999999999999988765543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-50 Score=343.04 Aligned_cols=214 Identities=28% Similarity=0.440 Sum_probs=184.3
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
..++|++.+.||+|+||.||+|.++.++..||||+++... ...+++.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3467888999999999999999999999999999987543 345679999999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 94 FMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp CCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred cccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999999997632 467899999999999999999999999 999999999999999999999999999864332
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCC-CCcchhHhhhhHH
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA-VDTSKAAAEQSLV 290 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P-f~~~~~~~~~~l~ 290 (297)
. ........|++.|+|||++.+..++.++|||||||++|||++|..| |...+.......+
T Consensus 169 ~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i 229 (287)
T d1opja_ 169 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229 (287)
T ss_dssp S-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred C-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH
Confidence 2 2233345689999999999999999999999999999999997655 5555444443333
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.6e-50 Score=339.97 Aligned_cols=213 Identities=27% Similarity=0.433 Sum_probs=171.3
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCe---EEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQ---DVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~---~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
++|++.+.||+|+||.||+|.++.+++ .||||.+...... ..+++.+|+.++++++||||+++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 567888999999999999999987664 5889988654333 346789999999999999999999999999999999
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
||||++|+|.+++.. ....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998875 2456999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCcc---eeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHH
Q 022447 228 VGDNTH---VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 228 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~ 290 (297)
...... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..+....+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i 246 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 246 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 322211 1223457899999999999999999999999999999998 89999988776554433
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=332.22 Aligned_cols=210 Identities=28% Similarity=0.446 Sum_probs=172.9
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|++.+.||+|+||.||+|.+.. +..||||+++... ...+++.+|+.+++.++||||+++++++..++..++||||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 4678999999999999999999874 7889999997643 3456799999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred cCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999999998752 466899999999999999999999999 9999999999999999999999999997643322
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhH
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSL 289 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l 289 (297)
. .......||+.|+|||++.+..++.++|||||||++|||+| |++||...+..+....
T Consensus 156 ~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~ 214 (263)
T d1sm2a_ 156 Y-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 214 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH
T ss_pred c-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence 2 22334568999999999999999999999999999999999 5677776665544443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-49 Score=326.71 Aligned_cols=212 Identities=27% Similarity=0.422 Sum_probs=186.9
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|++.+.||+|+||.||+|+++ ++..||||+++.... ..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 478999999999999999999986 688999999976543 456799999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++|+|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred cCCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9999999997652 467899999999999999999999999 9999999999999999999999999997643332
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHHh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVA 291 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~~ 291 (297)
........||+.|+|||.+.+..++.++|||||||++|||+| |+.||...+..+....+.
T Consensus 155 -~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~ 215 (258)
T d1k2pa_ 155 -YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 215 (258)
T ss_dssp -CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH
T ss_pred -ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH
Confidence 223334679999999999999999999999999999999998 899999988776665443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=342.67 Aligned_cols=211 Identities=30% Similarity=0.458 Sum_probs=178.9
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCC-----eEEEEEEeccCC-ccchHHHHHHHHHHhcc-CCCCccceeeEeecCCe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESIN-----QDVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 143 (297)
.++|++.+.||+|+||.||+|++..++ ..||+|.+.... ......+.+|+.++.++ +||||+++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 367899999999999999999986544 369999986543 33446788999999988 89999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSP-------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKC 204 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp 204 (297)
.|+|||||+||+|.+++..... ....+++..++.++.|++.||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999976321 1245899999999999999999999999 99999999
Q ss_pred CcEEEcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchh
Q 022447 205 SNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKA 283 (297)
Q Consensus 205 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~ 283 (297)
+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+.
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986544444434445678999999999999999999999999999999998 8999987655
Q ss_pred H
Q 022447 284 A 284 (297)
Q Consensus 284 ~ 284 (297)
.
T Consensus 273 ~ 273 (325)
T d1rjba_ 273 D 273 (325)
T ss_dssp S
T ss_pred H
Confidence 3
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=337.61 Aligned_cols=202 Identities=30% Similarity=0.352 Sum_probs=172.8
Q ss_pred CcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc-----hHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 76 SESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG-----NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 76 ~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.+++||+|+||+||+|.++.+|+.||||+++...... ...+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999999999999999987543322 24688999999999999999999999999999999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+.|+++..+... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~- 153 (299)
T d1ua2a_ 82 METDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP- 153 (299)
T ss_dssp CSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-
T ss_pred hcchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC-
Confidence 998877766654 567999999999999999999999999 999999999999999999999999999753322
Q ss_pred CcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|..||...+..+.
T Consensus 154 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~ 209 (299)
T d1ua2a_ 154 -NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ 209 (299)
T ss_dssp -CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred -cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH
Confidence 223345679999999998864 5689999999999999999999999998776554
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=332.94 Aligned_cols=212 Identities=29% Similarity=0.447 Sum_probs=178.9
Q ss_pred cCCCCcce-ecccCcEEEEEEEECC--CCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEE
Q 022447 72 KNFRSESL-LGEGGFGRVYKGYLES--INQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 72 ~~y~~~~~-lg~G~~g~v~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 147 (297)
++|.+.+. ||+|+||.||+|.++. ++..||||+++.... ...+++.+|+.++++++||||+++++++.. +.+|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666674 9999999999998764 456899999976533 334678999999999999999999999875 468899
Q ss_pred EecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccC
Q 022447 148 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP 227 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 227 (297)
|||+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999999865 2467999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCc-ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHH
Q 022447 228 VGDNT-HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 228 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~ 290 (297)
..... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+....+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i 225 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 225 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 33222 22234568999999999999999999999999999999998 99999988766554444
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=330.84 Aligned_cols=205 Identities=30% Similarity=0.489 Sum_probs=173.0
Q ss_pred ceecccCcEEEEEEEEC--CCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEecCCC
Q 022447 78 SLLGEGGFGRVYKGYLE--SINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 153 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~--~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~g 153 (297)
+.||+|+||.||+|.++ .+++.||||+++..... ..+++.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999864 45678999999754322 34678999999999999999999999865 457899999999
Q ss_pred CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCCcc
Q 022447 154 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 233 (297)
Q Consensus 154 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 233 (297)
|+|.+++.. ..++++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999987 677999999999999999999999999 9999999999999999999999999998654333222
Q ss_pred -eeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHH
Q 022447 234 -VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 234 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~ 290 (297)
......||+.|+|||.+.+..++.++|||||||++|||++ |+.||.+.+..+....+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i 223 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 223 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH
Confidence 2234568999999999999999999999999999999998 89999988776655544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=341.18 Aligned_cols=200 Identities=23% Similarity=0.320 Sum_probs=173.6
Q ss_pred hcCCCCcc-eecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhc-cCCCCccceeeEeec----CCee
Q 022447 71 TKNFRSES-LLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSL-LHHPNLVNLIGYCAD----GDQR 144 (297)
Q Consensus 71 ~~~y~~~~-~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~~~ 144 (297)
.++|.+.+ .||+|+||.||+|.+..+++.||||+++. ...+.+|+.++.+ .+||||++++++|.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46888875 59999999999999999999999999864 3456789988655 589999999999865 4678
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC---CCceEEeccc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFG 221 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~---~~~~kl~Dfg 221 (297)
|+|||||+||+|.+++.... ...+++.+++.++.||+.||+|||+++ |+||||||+|||++. .+.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 99999999999999997622 357999999999999999999999999 999999999999985 4679999999
Q ss_pred CccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
+++...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.
T Consensus 160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~ 218 (335)
T d2ozaa1 160 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218 (335)
T ss_dssp TCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC
T ss_pred eeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH
Confidence 998643322 23456799999999999999999999999999999999999999987654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=328.32 Aligned_cols=206 Identities=31% Similarity=0.477 Sum_probs=175.5
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|++.+.||+|+||.||+|.++ ++..||||+++... ...+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 357888999999999999999986 47889999997543 345679999999999999999999998755 567999999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++|+|.+++.... ..++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999999876522 346899999999999999999999999 9999999999999999999999999998643322
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCC-CCCCcchhHh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR-KAVDTSKAAA 285 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~Pf~~~~~~~ 285 (297)
........||+.|+|||++.+..++.++|||||||++|||+||. +||...+..+
T Consensus 164 -~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~ 218 (272)
T d1qpca_ 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218 (272)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred -cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH
Confidence 22334456899999999999999999999999999999999955 5566555443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=331.92 Aligned_cols=206 Identities=25% Similarity=0.370 Sum_probs=175.6
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
++|++++.||+|+||.||+|.+..+|+.||||+++..... ....+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999999999999999999754332 34678899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+.+ .+.+++... ....+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 9985 455555432 2467999999999999999999999999 999999999999999999999999999764322
Q ss_pred CCcceeecccccccccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQ-LTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
........||+.|+|||++.... ++.++|||||||++|+|++|+.||...+..+
T Consensus 156 --~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~ 210 (298)
T d1gz8a_ 156 --VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 210 (298)
T ss_dssp --SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred --cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH
Confidence 22334557999999999876655 5789999999999999999999998876544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-49 Score=330.95 Aligned_cols=201 Identities=26% Similarity=0.400 Sum_probs=174.7
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccc------hHHHHHHHHHHhccC--CCCccceeeEeecCC
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQG------NREFLVEVLMLSLLH--HPNLVNLIGYCADGD 142 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 142 (297)
.++|++.+.||+|+||.||+|.+..+|+.||||++.+..... ..++.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999999999999999987543221 234667999999986 899999999999999
Q ss_pred eeEEEEecCCC-CChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC-CCceEEecc
Q 022447 143 QRLLVYEYMPL-GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDF 220 (297)
Q Consensus 143 ~~~lv~e~~~g-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~-~~~~kl~Df 220 (297)
..++|||++.+ +++.+++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence 99999999975 678888876 567999999999999999999999999 999999999999985 579999999
Q ss_pred cCccccCCCCCcceeecccccccccCccccccCCC-CcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 221 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 221 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
|++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+
T Consensus 156 G~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (273)
T d1xwsa_ 156 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214 (273)
T ss_dssp TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred ccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch
Confidence 999763222 2345679999999999987765 677999999999999999999998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-48 Score=331.48 Aligned_cols=212 Identities=30% Similarity=0.491 Sum_probs=175.8
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCe----EEEEEEeccC-CccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQ----DVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
.+|++++.||+|+||.||+|.+..+|+ .||+|.+... .....+++.+|+.++++++||||+++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999999988776 5888887653 333457799999999999999999999999875 5677
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
++|++.+++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 8899999999998876 2567999999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhhHH
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLV 290 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~l~ 290 (297)
.............||+.|+|||++.+..++.++|||||||++|||+| |..||...+..+....+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i 226 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 54444444445678999999999999999999999999999999998 89999987766554443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=324.10 Aligned_cols=211 Identities=27% Similarity=0.404 Sum_probs=170.6
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCC----eEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESIN----QDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 145 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 145 (297)
+++|++.++||+|+||.||+|.++.++ ..||||++...... ...++.+|+.++++++||||+++++++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 356888899999999999999987654 47999999754333 2356889999999999999999999999999999
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+||||+.++++.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999988762 467999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCC-cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCC-CCCCcchhHhhh
Q 022447 226 GPVGDN-THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR-KAVDTSKAAAEQ 287 (297)
Q Consensus 226 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~Pf~~~~~~~~~ 287 (297)
...... ........||+.|+|||++.+..++.++|||||||++|||++|. +||...+..+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~ 223 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM 223 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHH
Confidence 433222 22233456899999999999999999999999999999999965 555554444433
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=326.04 Aligned_cols=209 Identities=26% Similarity=0.344 Sum_probs=174.3
Q ss_pred hcCCCCcceecccCcEEEEEEEECCC-CeEEEEEEeccCCcc--chHHHHHHHHHHhcc---CCCCccceeeEeec----
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESI-NQDVAIKQLDRNGVQ--GNREFLVEVLMLSLL---HHPNLVNLIGYCAD---- 140 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~-~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~---- 140 (297)
.++|++++.||+|+||+||+|.+..+ ++.||||++...... ....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999765 678999998654222 223466777777665 79999999999853
Q ss_pred -CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEec
Q 022447 141 -GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 219 (297)
Q Consensus 141 -~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~D 219 (297)
....+++||++.++.+...... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 3467899999997766544433 2567899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 220 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 220 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
||++... ..........||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+...
T Consensus 160 fg~~~~~---~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 225 (305)
T d1blxa_ 160 FGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG 225 (305)
T ss_dssp CCSCCCC---CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred hhhhhhh---cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 9998742 22334456789999999999999999999999999999999999999999887655433
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=321.45 Aligned_cols=210 Identities=29% Similarity=0.394 Sum_probs=169.7
Q ss_pred hcCCCCcceecccCcEEEEEEEECCC---CeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCeeEE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 146 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 146 (297)
.++|++.+.||+|+||.||+|.+..+ +..||||.++..... ....+.+|+.++++++||||+++++++.+ +..|+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 46799999999999999999998654 457899988654333 33568899999999999999999999864 67899
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 226 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~ 226 (297)
||||+++|+|.+++... ..++++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||+++..
T Consensus 85 v~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 99999999999987652 467999999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 227 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 227 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
.... ........||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+...
T Consensus 159 ~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~ 220 (273)
T d1mp8a_ 159 EDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 220 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred cCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 3322 223344568999999999999999999999999999999998 899999877665443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.8e-47 Score=322.20 Aligned_cols=205 Identities=24% Similarity=0.335 Sum_probs=175.1
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
++|++++.||+|+||+||+|.++ +|+.||||+++..... ..+++.+|+.+++.++||||+++++++...+..+++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 68999999999999999999996 6899999999765432 24678999999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
++.++.+..+... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+......
T Consensus 81 ~~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 81 HLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CCSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred eehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9987777666654 577999999999999999999999999 999999999999999999999999998763322
Q ss_pred CCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
........+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+..+.
T Consensus 154 --~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~ 209 (286)
T d1ob3a_ 154 --VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ 209 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred --ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH
Confidence 223344568999999998865 4578999999999999999999999988765544
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=320.52 Aligned_cols=212 Identities=32% Similarity=0.444 Sum_probs=174.0
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEec
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 150 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 150 (297)
.++|++.+.||+|+||.||+|+++.+ ..||||+++... ...+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 36799999999999999999999764 679999997543 345679999999999999999999999865 567899999
Q ss_pred CCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCC
Q 022447 151 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 230 (297)
Q Consensus 151 ~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 230 (297)
+++|+|.+++.... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 93 ~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 93 MSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred cCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 99999999987532 356999999999999999999999999 9999999999999999999999999997643222
Q ss_pred CcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhC-CCCCCcchhHhhhhHHh
Q 022447 231 NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAAEQSLVA 291 (297)
Q Consensus 231 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~Pf~~~~~~~~~~l~~ 291 (297)
........||+.|+|||.+.+..++.++|||||||++|||++| ++||......+....+.
T Consensus 168 -~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~ 228 (285)
T d1fmka3 168 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 228 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred -ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 2223345689999999999999999999999999999999995 45566665555555443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-47 Score=323.81 Aligned_cols=218 Identities=29% Similarity=0.454 Sum_probs=184.3
Q ss_pred HhcCCCCcceecccCcEEEEEEEEC-----CCCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCe
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 143 (297)
..++|++.+.||+|+||.||+|.++ .++..||||+++..... ..+++.+|+.+++.++||||+++++++.+...
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3468999999999999999999975 35688999999765433 34578999999999999999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSP--------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 203 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dik 203 (297)
.+++|||+.+++|.+++..... ....+++..++.++.|++.||+|||+++ ++|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 9999999999999999975321 1245889999999999999999999999 9999999
Q ss_pred CCcEEEcCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCC-CCCCcch
Q 022447 204 CSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR-KAVDTSK 282 (297)
Q Consensus 204 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~Pf~~~~ 282 (297)
|+|||++.++.+||+|||+++...............|++.|+|||.+.+..++.++|||||||++|||++|. .||...+
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999997644433334445567899999999999999999999999999999999985 6888887
Q ss_pred hHhhhhHH
Q 022447 283 AAAEQSLV 290 (297)
Q Consensus 283 ~~~~~~l~ 290 (297)
..+....+
T Consensus 248 ~~e~~~~v 255 (301)
T d1lufa_ 248 HEEVIYYV 255 (301)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 76654443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=320.16 Aligned_cols=217 Identities=29% Similarity=0.423 Sum_probs=180.3
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCC-------eEEEEEEeccCCcc-chHHHHHHHHHHhcc-CCCCccceeeEeecC
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESIN-------QDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADG 141 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~-------~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 141 (297)
.++|++.+.||+|+||.||+|++..++ ..||||++...... ....+.+|...+.++ +||||+++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 468889999999999999999976544 47999999765433 336688898888887 799999999999999
Q ss_pred CeeEEEEecCCCCChHhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili 209 (297)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999976431 1356899999999999999999999999 9999999999999
Q ss_pred cCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 210 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 210 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
+.++.+||+|||+++...............|++.|+|||.+.+..|+.++|||||||++|||++ |..||...+......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 9999999999999986544444444555679999999999999999999999999999999998 789998887765544
Q ss_pred HH
Q 022447 289 LV 290 (297)
Q Consensus 289 l~ 290 (297)
.+
T Consensus 249 ~i 250 (299)
T d1fgka_ 249 LL 250 (299)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=323.83 Aligned_cols=210 Identities=25% Similarity=0.334 Sum_probs=173.8
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhccCCCCccceeeEeecCC----eeE
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----QRL 145 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~ 145 (297)
..+|++++.||+|+||+||+|.++.+|+.||||++.+... ...+++.+|+.+++.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 3579999999999999999999999999999999976433 23457889999999999999999999987643 234
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
++++++.|++|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 55556678999999975 46999999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCCc-ceeecccccccccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhh
Q 022447 226 GPVGDNT-HVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS 288 (297)
Q Consensus 226 ~~~~~~~-~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 288 (297)
....... ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||...+..+...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~ 223 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 223 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHH
Confidence 4332211 1234567999999999884 4567899999999999999999999998876654433
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=321.19 Aligned_cols=211 Identities=28% Similarity=0.395 Sum_probs=167.7
Q ss_pred HhcCCCCcceecccCcEEEEEEEECC-----CCeEEEEEEeccCCcc-chHHHHHHHHHHhcc-CCCCccceeeEeecC-
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADG- 141 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~- 141 (297)
..++|++.+.||+|+||.||+|.+.. +++.||||+++..... ..+.+..|..++.++ +|+||+.+++++...
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 34689999999999999999999754 4578999998754333 345677788777776 689999999987654
Q ss_pred CeeEEEEecCCCCChHhhhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE
Q 022447 142 DQRLLVYEYMPLGSVEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (297)
Q Consensus 142 ~~~~lv~e~~~g~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili 209 (297)
...++|||||++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence 568999999999999999975321 1345899999999999999999999999 9999999999999
Q ss_pred cCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhC-CCCCCcchh
Q 022447 210 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG-RKAVDTSKA 283 (297)
Q Consensus 210 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~Pf~~~~~ 283 (297)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++| ..||...+.
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999865444333344456799999999999999999999999999999999996 568877654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=319.71 Aligned_cols=212 Identities=24% Similarity=0.348 Sum_probs=175.8
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhccCCCCccceeeEeec--------
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD-------- 140 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 140 (297)
.++|++++.||+|+||+||+|+++.+|+.||||++..... ....++.+|+.+++.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 3689999999999999999999999999999999865433 234678899999999999999999998855
Q ss_pred CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecc
Q 022447 141 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 220 (297)
Q Consensus 141 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Df 220 (297)
....|++||++.++.+...... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence 3467899999987766655444 567999999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCCc--ceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhHhhhhH
Q 022447 221 GLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL 289 (297)
Q Consensus 221 g~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~l 289 (297)
|++......... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~ 233 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 233 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHH
Confidence 999764332211 223345799999999998755 689999999999999999999999998776665443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=323.42 Aligned_cols=203 Identities=24% Similarity=0.345 Sum_probs=171.5
Q ss_pred HhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCC-----
Q 022447 70 ATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD----- 142 (297)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 142 (297)
..++|++++.||+|+||+||+|.++.+|+.||||++...... ..+.+.+|+.+++.++||||++++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 357899999999999999999999999999999999764332 2356889999999999999999999997654
Q ss_pred -eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEeccc
Q 022447 143 -QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 221 (297)
Q Consensus 143 -~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg 221 (297)
.+|+||||+ |.+|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccc
Confidence 569999999 5778877764 57999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 222 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+....
T Consensus 167 ~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~ 227 (346)
T d1cm8a_ 167 LARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 227 (346)
T ss_dssp TCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ceeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH
Confidence 9986322 2345679999999998876 4578999999999999999999999998866544
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=314.54 Aligned_cols=204 Identities=30% Similarity=0.458 Sum_probs=169.7
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeec-CCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 149 (297)
.++|++.+.||+|+||.||+|.++ |..||||+++.. ...+.+.+|+.++++++||||+++++++.+ .+.+++|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 457888999999999999999985 789999999754 334678999999999999999999999865 466899999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
|+++|+|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+++....
T Consensus 82 y~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~- 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 155 (262)
T ss_dssp CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC-
Confidence 999999999997521 245899999999999999999999999 99999999999999999999999999975321
Q ss_pred CCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
......+++.|+|||++.+..++.++|||||||++|||+| |++||...+..+...
T Consensus 156 ----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~ 211 (262)
T d1byga_ 156 ----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 211 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH
T ss_pred ----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 2234468899999999999999999999999999999998 789998876655433
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=316.77 Aligned_cols=211 Identities=31% Similarity=0.454 Sum_probs=169.7
Q ss_pred hcCCCCcceecccCcEEEEEEEECCC---CeEEEEEEeccCCc---cchHHHHHHHHHHhccCCCCccceeeEeecCCee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESI---NQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 144 (297)
.++|++.+.||+|+||.||+|....+ ...||||++.+... ...+++.+|+.++++++||||+++++++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 36799999999999999999986533 34789999876432 223578999999999999999999999976 467
Q ss_pred EEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCcc
Q 022447 145 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 224 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~ 224 (297)
++||||++++++.+++... ..++++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhh
Confidence 8999999999999988752 356999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcc-eeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHhhhh
Q 022447 225 LGPVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQS 288 (297)
Q Consensus 225 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~ 288 (297)
......... ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||.+.+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~ 225 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 225 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH
Confidence 754433322 2234457889999999999999999999999999999998 899998887766543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-45 Score=313.30 Aligned_cols=204 Identities=24% Similarity=0.301 Sum_probs=176.1
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCC-CCccceeeEeecCCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 149 (297)
.++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+|+..++.+.| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 4689999999999999999999999999999999865432 2346778889988875 899999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC-----CCceEEecccCcc
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-----GYHPKLSDFGLAK 224 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~-----~~~~kl~Dfg~~~ 224 (297)
|+ +++|.+++... ...+++..+..++.|++.||+|||++| |+||||||+|||++. ++.++|+|||+++
T Consensus 82 ~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 58999988762 457999999999999999999999999 999999999999964 5789999999998
Q ss_pred ccCCCCC-----cceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 225 LGPVGDN-----THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 225 ~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
....... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 6432211 1223456799999999999999999999999999999999999999986543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=321.81 Aligned_cols=204 Identities=28% Similarity=0.316 Sum_probs=169.8
Q ss_pred CCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCccceeeEeec------CCeeEE
Q 022447 73 NFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD------GDQRLL 146 (297)
Q Consensus 73 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~l 146 (297)
+|+.+++||+|+||+||+|++..+|+.||||++...... ..+|+.+++.++||||+++++++.. ..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 678889999999999999999999999999999764322 2369999999999999999999853 335789
Q ss_pred EEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCC-ceEEecccCccc
Q 022447 147 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKL 225 (297)
Q Consensus 147 v~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~-~~kl~Dfg~~~~ 225 (297)
|||||+++ +.+.+.........+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||++..
T Consensus 97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999855 44444322223578999999999999999999999999 99999999999999765 899999999976
Q ss_pred cCCCCCcceeecccccccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 226 GPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 226 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
.... ......+|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+..
T Consensus 173 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l 232 (350)
T d1q5ka_ 173 LVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232 (350)
T ss_dssp CCTT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH
T ss_pred ccCC---cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHH
Confidence 4332 22345679999999998765 57899999999999999999999999887765543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-46 Score=317.38 Aligned_cols=211 Identities=32% Similarity=0.473 Sum_probs=176.5
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeE--EEEEEeccC-CccchHHHHHHHHHHhcc-CCCCccceeeEeecCCeeEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQD--VAIKQLDRN-GVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 147 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 147 (297)
++|++.+.||+|+||.||+|.++.++.. ||||.+... .....+.+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6888999999999999999999888764 677777543 233446789999999998 799999999999999999999
Q ss_pred EecCCCCChHhhhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCce
Q 022447 148 YEYMPLGSVEDHLHDLS------------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 215 (297)
Q Consensus 148 ~e~~~g~~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~ 215 (297)
|||++||+|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999997531 22467999999999999999999999999 9999999999999999999
Q ss_pred EEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCC-CCCCcchhHhhhh
Q 022447 216 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR-KAVDTSKAAAEQS 288 (297)
Q Consensus 216 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~Pf~~~~~~~~~~ 288 (297)
||+|||+++.... ........||..|+|||.+.+..++.++|||||||++|||++|. +||...+..+...
T Consensus 167 kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237 (309)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred EEccccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999975322 11223456899999999999999999999999999999999965 6788777665433
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=311.79 Aligned_cols=203 Identities=23% Similarity=0.314 Sum_probs=178.2
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecCCeeEEEEe
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 149 (297)
++|++++.||+|+||+||+|++..+++.||||+++..... ...++.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999999999999999999755332 34678899999999999999999999999999999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCC
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 229 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 229 (297)
++.|++|..++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+......
T Consensus 82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999998888776 678899999999999999999999999 999999999999999999999999999864332
Q ss_pred CCcceeecccccccccCccccccCC-CCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 230 DNTHVSTRVMGTYGYCAPEYAKTGQ-LTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 230 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
........+++.|+|||.+.+.. ++.++|||||||++|||++|+.||.....
T Consensus 155 --~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 207 (292)
T d1unla_ 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_dssp --CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS
T ss_pred --CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC
Confidence 22333456788999999887654 68999999999999999999998755443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=315.79 Aligned_cols=212 Identities=30% Similarity=0.437 Sum_probs=181.8
Q ss_pred hcCCCCcceecccCcEEEEEEEEC-----CCCeEEEEEEeccCCc-cchHHHHHHHHHHhcc-CCCCccceeeEeecCCe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLE-----SINQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 143 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 143 (297)
.++|++.+.||+|+||.||+|.+. .++..||||+++.... .....+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 368889999999999999999863 4678999999976533 3345688999999998 69999999999999999
Q ss_pred eEEEEecCCCCChHhhhcccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEE
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSP--------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 209 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili 209 (297)
.++|||||++|+|.+++..... ....+++..+..++.||+.|++|||+++ ++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 9999999999999999976431 2346899999999999999999999999 9999999999999
Q ss_pred cCCCceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCcchhHh
Q 022447 210 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAA 285 (297)
Q Consensus 210 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~ 285 (297)
+.++.++++|||.++...............||+.|+|||.+.+..++.++|||||||++|||+| |.+||...+..+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999987554444444556789999999999999999999999999999999999 566676655533
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.8e-45 Score=315.08 Aligned_cols=198 Identities=20% Similarity=0.294 Sum_probs=172.0
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC-CCCccceeeEeec--CCeeEEEE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCAD--GDQRLLVY 148 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~ 148 (297)
++|++++.||+|+||+||+|+++.+|+.||||+++.. ..+++.+|+.+++.++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999999999999999999753 3467889999999995 9999999999874 45689999
Q ss_pred ecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCC-CceEEecccCccccC
Q 022447 149 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKLGP 227 (297)
Q Consensus 149 e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~-~~~kl~Dfg~~~~~~ 227 (297)
||+.+++|..+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.++|+|||++....
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 999999987654 34899999999999999999999999 9999999999999865 469999999998643
Q ss_pred CCCCcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 228 VGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 228 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
... .....++|+.|+|||.+.+. .++.++|||||||++|+|++|+.||.......
T Consensus 182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~ 237 (328)
T d3bqca1 182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237 (328)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred CCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH
Confidence 322 23456799999999998765 57999999999999999999999998766543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-46 Score=318.66 Aligned_cols=207 Identities=27% Similarity=0.392 Sum_probs=177.8
Q ss_pred hcCCCCcceecccCcEEEEEEEE---CCCCeEEEEEEeccCCc----cchHHHHHHHHHHhccCC-CCccceeeEeecCC
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYL---ESINQDVAIKQLDRNGV----QGNREFLVEVLMLSLLHH-PNLVNLIGYCADGD 142 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~---~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 142 (297)
.++|++++.||+|+||.||+|.+ +.+|+.||||++++... ...+.+.+|+.++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 36799999999999999999997 44689999999875432 233567789999999976 89999999999999
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
..+++|||+.|++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.++|+|||+
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred ceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccc
Confidence 99999999999999999987 567889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccCccccccC--CCCcccchhhHHHHHHHHHhCCCCCCcchhHh
Q 022447 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG--QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 285 (297)
Q Consensus 223 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 285 (297)
++...... ........|++.|+|||.+.+. .++.++|||||||+||+|++|+.||...+..+
T Consensus 176 a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~ 239 (322)
T d1vzoa_ 176 SKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239 (322)
T ss_dssp EEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred hhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 97543222 2233456799999999998654 46789999999999999999999998875443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=312.77 Aligned_cols=216 Identities=27% Similarity=0.421 Sum_probs=183.5
Q ss_pred hcCCCCcceecccCcEEEEEEEECC-----CCeEEEEEEeccCCcc-chHHHHHHHHHHhccCCCCccceeeEeecCCee
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLES-----INQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 144 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 144 (297)
.++|++.+.||+|+||.||+|.++. ++..||||+++..... ....+.+|+.++++++||||+++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 4688899999999999999998853 3578999999754332 334688999999999999999999999999999
Q ss_pred EEEEecCCCCChHhhhcccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEe
Q 022447 145 LLVYEYMPLGSVEDHLHDLS------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 218 (297)
Q Consensus 145 ~lv~e~~~g~~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~ 218 (297)
++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999986421 12345789999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhC-CCCCCcchhHhhhhH
Q 022447 219 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAAEQSL 289 (297)
Q Consensus 219 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~Pf~~~~~~~~~~l 289 (297)
|||+++...............||+.|+|||.+.+..++.++||||||+++|||+|| +.||...+..+....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~ 247 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999764333333334455689999999999999999999999999999999998 588988777665443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-45 Score=316.27 Aligned_cols=203 Identities=24% Similarity=0.328 Sum_probs=166.2
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeec------CC
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD------GD 142 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 142 (297)
.++|++++.||+|+||+||+|.++.+|..||||++...... ...++.+|+.+++.++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 36899999999999999999999999999999999765332 33568899999999999999999999964 46
Q ss_pred eeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccC
Q 022447 143 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 222 (297)
Q Consensus 143 ~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~ 222 (297)
..|+||||+.++ +.+.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.++++|||+
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhh
Confidence 789999999855 444443 35899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhHhh
Q 022447 223 AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 286 (297)
Q Consensus 223 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 286 (297)
++.... .......++|+.|+|||++.+..+++++||||+||++|+|++|+.||.+.+....
T Consensus 166 ~~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~ 226 (355)
T d2b1pa1 166 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred hhcccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH
Confidence 875322 2233456799999999999999999999999999999999999999988765544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-44 Score=307.79 Aligned_cols=205 Identities=25% Similarity=0.304 Sum_probs=170.4
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCc-cceeeEeecCCeeEEEEe
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e 149 (297)
.++|++.+.||+|+||.||+|++..+|+.||||++..... ..++..|+.+++.++|+++ +.+..++.+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 3579999999999999999999999999999999875432 2457789999999987665 555566677888999999
Q ss_pred cCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcC---CCceEEecccCcccc
Q 022447 150 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLG 226 (297)
Q Consensus 150 ~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~---~~~~kl~Dfg~~~~~ 226 (297)
|+. ++|.+.+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. +..++|+|||+++..
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LLG-PSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CCC-CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EcC-Cchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 995 666666654 2467999999999999999999999999 999999999999864 457999999999864
Q ss_pred CCCCCc-----ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchhH
Q 022447 227 PVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 284 (297)
Q Consensus 227 ~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 284 (297)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~ 219 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchH
Confidence 332221 2234567999999999999999999999999999999999999999876543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-45 Score=315.78 Aligned_cols=204 Identities=23% Similarity=0.344 Sum_probs=172.7
Q ss_pred hcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhccCCCCccceeeEeecC-----Ce
Q 022447 71 TKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQ 143 (297)
Q Consensus 71 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 143 (297)
.++|++++.||+|+||+||+|++..+|+.||||++...... ..+++.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999999999999999999765332 335688999999999999999999998643 34
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCc
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 223 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~ 223 (297)
.+++|+++.|++|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.++++|||.+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 4666777889999999964 56999999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCcceeecccccccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCcchhHhhh
Q 022447 224 KLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 287 (297)
Q Consensus 224 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 287 (297)
... ........|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+.....
T Consensus 169 ~~~-----~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~ 228 (348)
T d2gfsa1 169 RHT-----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 228 (348)
T ss_dssp -CC-----TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccc-----CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHH
Confidence 642 2233456799999999987665 5689999999999999999999999887665443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=306.64 Aligned_cols=200 Identities=29% Similarity=0.469 Sum_probs=168.5
Q ss_pred cceecccCcEEEEEEEECCCC---eEEEEEEeccC-CccchHHHHHHHHHHhccCCCCccceeeEeec-CCeeEEEEecC
Q 022447 77 ESLLGEGGFGRVYKGYLESIN---QDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYEYM 151 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 151 (297)
.++||+|+||+||+|.+..++ ..||||.++.. .....+++.+|+.++++++||||+++++++.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 468999999999999986543 46899999753 33344679999999999999999999999865 56889999999
Q ss_pred CCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceEEecccCccccCCCCC
Q 022447 152 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 231 (297)
Q Consensus 152 ~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 231 (297)
++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999998752 456788899999999999999999999 99999999999999999999999999986433322
Q ss_pred c--ceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcch
Q 022447 232 T--HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSK 282 (297)
Q Consensus 232 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 282 (297)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~ 238 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC
Confidence 1 22233568999999999999999999999999999999999887776544
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=307.54 Aligned_cols=197 Identities=28% Similarity=0.417 Sum_probs=161.8
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHH--HHHHHhccCCCCccceeeEeecCC----eeE
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPNLVNLIGYCADGD----QRL 145 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~--e~~~l~~l~h~~i~~~~~~~~~~~----~~~ 145 (297)
.+|.+.+.||+|+||.||+|+.. |..||||+++... ...... |+..+..++||||+++++++.+.+ ..|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 45677889999999999999874 8999999986542 233333 455556789999999999987643 578
Q ss_pred EEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCCCCeeecCCCCCcEEEcCCCceEE
Q 022447 146 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD--------KAKPPVIYRDLKCSNILLDRGYHPKL 217 (297)
Q Consensus 146 lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--------~~~~~ivH~dikp~Nili~~~~~~kl 217 (297)
+||||+++|+|.+++++ .++++..++.++.|++.||.|||+ ++ |+||||||+|||++.++.+||
T Consensus 78 lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~---IvHrDlKp~NILl~~~~~~Kl 149 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCI 149 (303)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---eeccccCccceEEcCCCCeEE
Confidence 99999999999999986 468999999999999999999997 46 999999999999999999999
Q ss_pred ecccCccccCCCCCcc--eeecccccccccCccccccCC------CCcccchhhHHHHHHHHHhCCCCCCcc
Q 022447 218 SDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAKTGQ------LTLKSDVYSFGVVLLEILSGRKAVDTS 281 (297)
Q Consensus 218 ~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~------~~~~~DiwslG~il~ell~g~~Pf~~~ 281 (297)
+|||+++......... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||...
T Consensus 150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~ 221 (303)
T d1vjya_ 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp CCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred EecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcc
Confidence 9999997643332221 234567999999999987643 567899999999999999999887553
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.5e-38 Score=275.47 Aligned_cols=202 Identities=20% Similarity=0.220 Sum_probs=159.7
Q ss_pred cCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC-----------CCCccceeeEeec
Q 022447 72 KNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-----------HPNLVNLIGYCAD 140 (297)
Q Consensus 72 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~ 140 (297)
.+|++++.||+|+||+||+|+++.+|+.||||+++.... ..+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 359999999999999999999999999999999976432 2356677888887765 5789999988754
Q ss_pred --CCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCcEEEcCCC----
Q 022447 141 --GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGY---- 213 (297)
Q Consensus 141 --~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~dikp~Nili~~~~---- 213 (297)
....+++++++..+......... .....+++..++.++.||+.|++|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence 45566666666444332222211 125678999999999999999999997 88 99999999999998654
Q ss_pred --ceEEecccCccccCCCCCcceeecccccccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCcchh
Q 022447 214 --HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 283 (297)
Q Consensus 214 --~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 283 (297)
.++++|||.+..... .....+||+.|+|||++.+..++.++|||||||++++|++|+.||...+.
T Consensus 168 ~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred cceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence 389999999875322 23456799999999999999999999999999999999999999986543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=3.6e-26 Score=181.06 Aligned_cols=162 Identities=14% Similarity=0.074 Sum_probs=117.5
Q ss_pred CCcceecccCcEEEEEEEECCCCeEEEEEEeccCCcc-----c-------------hHHHHHHHHHHhccCCCCccceee
Q 022447 75 RSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQ-----G-------------NREFLVEVLMLSLLHHPNLVNLIG 136 (297)
Q Consensus 75 ~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-----~-------------~~~~~~e~~~l~~l~h~~i~~~~~ 136 (297)
.+.+.||+|+||.||+|.+. +|+.||||+++..... . ......|...+..+.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 45689999999999999986 5899999987532111 0 012455788888999999998876
Q ss_pred EeecCCeeEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcEEEcCCCceE
Q 022447 137 YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 216 (297)
Q Consensus 137 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~dikp~Nili~~~~~~k 216 (297)
+.. .+++|||+++..+.+ ++...+..++.|++.++.|||+++ |+||||||+|||++++ .++
T Consensus 82 ~~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEE
T ss_pred ecC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEE
Confidence 632 379999999765543 223346789999999999999999 9999999999999965 589
Q ss_pred EecccCccccCCCCCcceeecccccccccC------ccccccCCCCcccchhhHHHH
Q 022447 217 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCA------PEYAKTGQLTLKSDVYSFGVV 267 (297)
Q Consensus 217 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~a------PE~~~~~~~~~~~DiwslG~i 267 (297)
|+|||.+........ ..|.. .+.+ .+.|+..+|+||+.--
T Consensus 143 liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 143 IIDFPQSVEVGEEGW----------REILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp ECCCTTCEETTSTTH----------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred EEECCCcccCCCCCc----------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 999999865321111 11111 1112 3567889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.01 E-value=1e-09 Score=89.31 Aligned_cols=150 Identities=17% Similarity=0.100 Sum_probs=103.7
Q ss_pred HHHHHHhcCCCCcceecccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccC-CCCccceeeEeecCCe
Q 022447 65 RELAAATKNFRSESLLGEGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 143 (297)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 143 (297)
.++......|++.+..+.++.+.||++.. ++..+++|............+.+|...+..+. +--+.+++.+..+++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 34556667787777665566678998853 46678889876554444445677888877664 3335677888888889
Q ss_pred eEEEEecCCCCChHhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 022447 144 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA------------------------------ 193 (297)
Q Consensus 144 ~~lv~e~~~g~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------ 193 (297)
.++||++++|.++.+.... . . ....++.++...+..||+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~~----~--~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED----E--Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT----C--S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred eEEEEEecccccccccccc----c--c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 9999999998888665432 1 1 12234555666666666421
Q ss_pred --------------------------CCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 194 --------------------------KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 194 --------------------------~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
...++|+|+.|.||++++++.+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 23379999999999999876677999998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.53 E-value=3.2e-07 Score=78.80 Aligned_cols=77 Identities=18% Similarity=0.125 Sum_probs=49.2
Q ss_pred cceecccCcEEEEEEEECCCCeEEEEEEeccC-------CccchHHHHHHHHHHhccC-C-C-CccceeeEeecCCeeEE
Q 022447 77 ESLLGEGGFGRVYKGYLESINQDVAIKQLDRN-------GVQGNREFLVEVLMLSLLH-H-P-NLVNLIGYCADGDQRLL 146 (297)
Q Consensus 77 ~~~lg~G~~g~v~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~-h-~-~i~~~~~~~~~~~~~~l 146 (297)
.+.||.|....||++.+..+++.++||..... ......+...|...++.+. + | .+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 34689999999999998877889999975421 1122345667888877663 2 3 34445443 4556789
Q ss_pred EEecCCCCC
Q 022447 147 VYEYMPLGS 155 (297)
Q Consensus 147 v~e~~~g~~ 155 (297)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.50 E-value=5.1e-07 Score=72.45 Aligned_cols=130 Identities=16% Similarity=0.112 Sum_probs=85.1
Q ss_pred ecccCc-EEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCC--CccceeeEeecCCeeEEEEecCCCCCh
Q 022447 80 LGEGGF-GRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHP--NLVNLIGYCADGDQRLLVYEYMPLGSV 156 (297)
Q Consensus 80 lg~G~~-g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~g~~L 156 (297)
+..|.. +.||+.... ++..+++|....... ..+..|...++.+... -+.+++.+..+++..++||++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECT-TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeC-CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344443 678988754 466788898764432 2355677777766432 356678887888889999999998665
Q ss_pred HhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 022447 157 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA------------------------------------------- 193 (297)
Q Consensus 157 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------------- 193 (297)
.+.. .... ..+.++...+..||+..
T Consensus 94 ~~~~---------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSSH---------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTSC---------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cccc---------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 4311 1111 12234444455555311
Q ss_pred ------------CCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 194 ------------KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 194 ------------~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
...++|+|+.|.||++++++.+-|+||+.+..
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 23389999999999999876678999988753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.60 E-value=0.00021 Score=60.69 Aligned_cols=73 Identities=18% Similarity=0.245 Sum_probs=49.4
Q ss_pred ceecccCcEEEEEEEECC-------CCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCc-cceeeEeecCCeeEEEEe
Q 022447 78 SLLGEGGFGRVYKGYLES-------INQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYE 149 (297)
Q Consensus 78 ~~lg~G~~g~v~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e 149 (297)
+.|+.|-.-.+|++.... ..+.|++++.-. ........+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 467778888999998753 246688888753 2233445678888888764444 466666543 68999
Q ss_pred cCCCCCh
Q 022447 150 YMPLGSV 156 (297)
Q Consensus 150 ~~~g~~L 156 (297)
|++|.+|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.41 E-value=0.0012 Score=53.88 Aligned_cols=160 Identities=14% Similarity=0.035 Sum_probs=82.0
Q ss_pred cCHHHHHHHhcCCCCcceec-----ccCcEEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCc--cce
Q 022447 62 LTFRELAAATKNFRSESLLG-----EGGFGRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL--VNL 134 (297)
Q Consensus 62 ~~~~~~~~~~~~y~~~~~lg-----~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~ 134 (297)
++.+++.....+|.+.+... .|---+.|++.... ..+++|++.... ....+..|..++..+...++ ...
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~--g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK--DPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS--CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC--CcEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence 56677888888898765443 45556789887653 458999986532 22344456666665542221 111
Q ss_pred ee------EeecCCeeEEEEecCCCCChHh--------------hhcccCC-----CCCCCCH-----------------
Q 022447 135 IG------YCADGDQRLLVYEYMPLGSVED--------------HLHDLSP-----GKKPLDW----------------- 172 (297)
Q Consensus 135 ~~------~~~~~~~~~lv~e~~~g~~L~~--------------~l~~~~~-----~~~~l~~----------------- 172 (297)
+. +.........++.++.|..... .++.... .......
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 11 1222345566677766533221 0000000 0000000
Q ss_pred -HHHHHHHHHHHHHHHHHHhC-CCCCeeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 173 -NTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 173 -~~~~~i~~qi~~al~~LH~~-~~~~ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
......+..+...+...... -..++||+|+.++|++++.+...-++||+.+..
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 01112222222233332211 122399999999999999887778999998763
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.30 E-value=0.00082 Score=55.32 Aligned_cols=136 Identities=15% Similarity=0.098 Sum_probs=75.3
Q ss_pred EEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhccCCCCc--ccee-----eEeecCCeeEEEEecCCCCChHh
Q 022447 86 GRVYKGYLESINQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL--VNLI-----GYCADGDQRLLVYEYMPLGSVED 158 (297)
Q Consensus 86 g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~-----~~~~~~~~~~lv~e~~~g~~L~~ 158 (297)
-.||++... +|..|++|+..... .....+..|...+..|...++ +..+ ..+......+.+++++.|..+..
T Consensus 36 N~vy~v~~~-dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 36 NRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred ceeEEEEcC-CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 579998764 48889999986542 234567778877776642222 1111 12334567788999988643220
Q ss_pred --------------hhcc----cCC-CCCCCC----------------------HHHHHHHHHHHHHHHHHHH-hCCCCC
Q 022447 159 --------------HLHD----LSP-GKKPLD----------------------WNTRMKIAAGAARGLEYLH-DKAKPP 196 (297)
Q Consensus 159 --------------~l~~----~~~-~~~~l~----------------------~~~~~~i~~qi~~al~~LH-~~~~~~ 196 (297)
.++. ... .....+ .......+.++...+..+- ......
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0000 000 001111 1122233333333333321 122334
Q ss_pred eeecCCCCCcEEEcCCCceEEecccCccc
Q 022447 197 VIYRDLKCSNILLDRGYHPKLSDFGLAKL 225 (297)
Q Consensus 197 ivH~dikp~Nili~~~~~~kl~Dfg~~~~ 225 (297)
+||+|+.|.|||++++ ..++||+.+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999743 45899998875
|